{"title_page": "Friedrich Paulus", "text_new": "{{Infobox military person\n|honorific_prefix = ''[[Generalfeldmarschall]]''\n|name             = Friedrich Paulus\n|honorific_suffix = \n|image            = Bundesarchiv Bild 183-B24575, Friedrich Paulus.jpg\n|image_upright    = \n|alt              = \n|caption          = General Friedrich Paulus (1942)\n|native_name      = \n|native_name_lang = \n|birth_name       = Friedrich Wilhelm Ernst Paulus\n|other_name       = \n|nickname         = \n|birth_date       = {{birth date|1890|9|23|df=y}}\n|birth_place      = [[Guxhagen]], [[German Empire]]\n|death_date       = {{death date and age|1957|2|1|1890|9|23|df=y}}\n|death_place      = [[Dresden]], [[East Germany]]\n|placeofburial    = \n|placeofburial_label = \n|placeofburial_coordinates = <!--{{coord|LAT|LONG|display=inline,title}}-->\n|allegiance       = {{flag|German Empire}} (1910-1918)<br />{{flag|Weimar Republic}} (1918-1933)<br />{{flag|Nazi Germany|1935}} (1933-1943)<br>{{flagdeco|German Empire}} [[National Committee for a Free Germany]] (1944-1945)<br>{{flag|East Germany}} (1953-1956)\n|branch           = {{army|Nazi Germany}}\n|branch_label     = Branch\n|serviceyears     = 1910\u201343\n|serviceyears_label = \n|rank             = [[File:Wehrmacht GenFeldmarschall 1942h1.svg|40px]] [[Generalfeldmarschall]]\n|rank_label       = \n|servicenumber    = \n|unit             = \n|commands         = [[6th Army (Wehrmacht)|Sixth Army]]\n|battles          = [[World War I]]\n*[[Western Front (World War I)|France]]\n*The [[Balkans campaign (World War I)|Balkans]]\n{{hr}}\n[[World War II]]\n* [[Invasion of Poland]]\n* [[Battle of France]]\n* [[Operation Barbarossa]]\n* [[Operation Blue]]\n* [[Battle of Voronezh (1942)|Battle of Voronezh]]\n* [[Battle of Stalingrad]]\n|battles_label    = \n|awards           = [[Knight's Cross of the Iron Cross with Oak Leaves]]\n|memorials        = \n|alma_mater       = [[Marburg University]]\n|spouse           = {{marriage|Constance Elena Rosetti-Solescu{{sfn|Fraschka|2008|p=8}}|1912|1949|end=d.}}\n|children         = \n|relations        = \n|laterwork        = \n|signature        = Friedrich Paulus signature.svg\n|signature_size   = \n|signature_alt    = \n|website          = <!--{{URL|example.com}}-->\n|module           = \n}}\n\n'''Friedrich Wilhelm Ernst Paulus''' (23 September 1890 \u2013 1 February 1957) was a German [[Generalfeldmarschall|field marshal]] during [[World War II]] who commanded the [[6th Army (Wehrmacht)|6th Army]] during the [[Battle of Stalingrad]] (August 1942 to February 1943). The battle ended in disaster for the ''[[Wehrmacht]]'' when Soviet forces encircled the Germans within the city, leading to the ultimate defeat and capture of about 265,000 German personnel, their [[Axis powers of World War II|Axis allies]] and [[Hiwis|collaborators]].<!-- Edited out due to vagueness/dubiousness: \"home\" as in individual homes or home countries? Including those who later lived in East Germany/Soviet Union or third countries? Of the 91,000 Axis troops captured, only 5,000 survived captivity and returned home by 1955. -->\n\nPaulus fought in [[World War I]] and saw action in [[Western Front (World War I)|France]] and the [[Balkans campaign (World War I)|Balkans]]. He was considered a promising officer; by the time World War II broke out he had been promoted to [[major general]]. Paulus took part in the [[Invasion of Poland|Poland]] and [[Battle of France|Low Countries]] campaigns, after which he was named deputy chief of the [[Oberkommando des Heeres|German General Staff]]. In that capacity, Paulus helped plan the [[Operation Barbarossa|invasion of the Soviet Union]].\n\nIn 1942, Paulus was given command of the 6th Army despite his lack of field experience. He led the drive to [[Stalingrad]] but was cut off and surrounded in the subsequent Soviet counter-offensive. [[Adolf Hitler]] prohibited attempts to break out or capitulate, and German defence was gradually worn down. Paulus surrendered in Stalingrad on 31 January 1943,{{refn|Paulus claimed that \"I didn't surrender. I was taken by surprise\". (Paulus in conversation with Marshal Voronov).{{sfn|Beevor|1998|p=390}}|group=\"Note\"}} the same day on which he was informed of his promotion to [[field marshal]] by Hitler. Hitler expected Paulus to commit suicide,<ref>\"Rise and Fall of the Third Reich, Shirer, digital page 1569</ref> repeating to his staff that there was no precedent of a German field marshal ever being captured alive.\n\nWhile in Soviet captivity during the war, Paulus became a vocal critic of the Nazi regime and joined the Soviet-sponsored [[National Committee for a Free Germany]]. In 1953, Paulus moved to [[East Germany]], where he worked in military history research. He lived out the rest of his life in [[Dresden]].\n\n==Early life==\nPaulus was born in [[Guxhagen]] and grew up in [[Kassel]], [[Hesse-Nassau]], the son of a treasurer.<ref>''K\u00f6niglich Preu\u00dfischer Staatsdienst-Kalender f\u00fcr den Regierungsbezirk Cassel auf das Jahr 1890/91.'' Reformirtes Waisenhaus, Cassel 1891, p. 249 ([http://orka.bibliothek.uni-kassel.de/viewer/image/1395757445221_1890/273/ ''Corrections- und Landarmen-Anstalt zu Breitenau.''] [[Kassel University Library|ORKA]]).</ref> He tried, unsuccessfully, to secure a cadetship in the [[Imperial German Navy]] and briefly studied law at [[Marburg University]].{{Citation needed|date=December 2019}}\n\nMany English language sources and publications from the 1940s to the present day give Paulus' family name the prefix \"von\". For example: Mark Arnold-Forster's ''The World At War'', companion volume to the [[The World at War|documentary of the same name]], Stein and Day, 1973, pp.&nbsp;139\u201342; other examples are [[W. E. D. Allen|Allen]] and [[Paul Muratoff|Muratoff's]] \"The Russian Campaigns of 1941-1943,\" published in 1944 <ref>{{cite book |title= The Russian Campaigns of 1941-1943 |last= Allen |first= W.E.D.  |last2= Muratoff  |first2= Paul |year= 1944  |publisher= Penguin |location= Harmondsworth, England  |isbn=   |ref=harv}} (pp 99,101,108,112)</ref> and Peter Margaritis (2019)<ref> {{cite book | last = Margaritis | first = Peter | authorlink =  | title = Countdown to D-Day: The German Perspective: The German High Command in Occupied France, 1944 | publisher = Casemate | date = 2019 | location = PA, USA & Oxford, UK | page = | pages = 199,201,228,333 | url = | doi = | id = | isbn = 978-1-61200-769-4 }} </ref>. This is incorrect, as Paulus' family was never part of the nobility,{{Citation needed|date=December 2019}} and [[Antony Beevor]] refers to his \"comparatively humble birth\" (like [[Erwin Rommel|Rommel's]] family; their \"sole similarity\").<ref> {{cite book | last = Beevor | first = Antony | authorlink = Antony Beevor | title = The Second World War | publisher = Weidenfield & Nicolson | date = 2012 | location = London | page = 214 | pages = | url = | doi = | id = | isbn = 978-0-297-84497-6 }} </ref>\n\n==World War I==\nAfter leaving the university without a degree, he joined the 111th Infantry Regiment as an officer cadet in February 1910. On 4 July 1912 he married the Romanian {{ill|Elena Rosetti-Solescu|ro}}, the sister of a colleague who served in the same regiment. When [[World War I]] began, Paulus' regiment was part of the thrust into [[French Third Republic|France]], and he saw action in the [[Vosges]] and around [[Arras]] in the autumn of 1914. After a leave of absence due to illness, he joined the ''[[Alpenkorps (German Empire)|Alpenkorps]]'' as a staff officer, serving in [[Macedonia (region)|Macedonia]], France, [[Romania during World War I|Romania]] and [[Kingdom of Serbia|Serbia]]. By the end of the war, he was a [[Captain (land)|captain]].\n\n==Interwar period==\nAfter the Armistice, Paulus was a brigade adjutant with the [[Freikorps]]. He was chosen as one of only 4,000 officers to serve in the [[Reichswehr]], the defensive army that the [[Treaty of Versailles]] had limited to 100,000 men. He was assigned to the 13th Infantry Regiment at [[Stuttgart]] as a company commander. He served in various staff positions for over a decade (1921\u201333). In 1920s, as part of the military cooperation between Weimar Republic and Soviet Union to escape Treaty of Versailles, Paulus presented guest lectures in Moscow, Soviet Union.<ref name=sk>{{cite book |author1=Stephen Kotkin |title=Stalin:Volume 2 |publisher=Penguin Press |location=New York |page=22 }}</ref>\n\nLater, Paulus briefly commanded a motorized battalion (1934\u201335) before being named chief of staff for [[Panzer]] headquarters in October 1935. This was a new formation under the direction of [[Oswald Lutz]] that directed the training and development of the ''Panzerwaffen'', or tank forces of the German army.\n\n==World War II==\n[[File:Bundesarchiv Bild 183-B24543, Hauptquartier Heeresgruppe S\u00fcd, Lagebesprechung.jpg|thumb|Paulus attending a meeting at the headquarters of Army Group South with Adolf Hitler on 1 June 1942]]\nIn February 1938 Paulus was appointed ''Chef des Generalstabes'' to Gen. [[Heinz Guderian]]'s new [[XVI Army Corps (Wehrmacht)|XVI Armeekorps (Motorisiert)]], which replaced Lutz's command. Guderian described him as \"brilliantly clever, conscientious, hard working, original and talented\" but had severe doubts about his decisiveness, toughness and lack of command experience. He remained in that post until May 1939, when he was promoted to [[major general]] and became chief of staff for the [[10th Army (Wehrmacht)|German Tenth Army]], with which he saw service in [[Second Polish Republic|Poland]]. The unit was renamed the [[6th Army (Wehrmacht)|Sixth Army]] and engaged in the spring offensives of 1940 through the [[Netherlands]] and [[Belgium]]. Paulus was promoted to [[lieutenant general]] in August 1940. The following month he was named deputy chief of the [[German General Staff]] (Oberquartiermeister I). In that role he helped draft the plans for the invasion of the [[Soviet Union]], [[Operation Barbarossa]].\n\n===Stalingrad===\n[[File:Bundesarchiv Bild 101I-021-2081-31A, General Friedrich Paulus.jpg|thumb|Paulus arriving in southern Russia, January 1942]]\n\nIn November 1941, after German Sixth Army's commander Field Marshal [[Walther von Reichenau]]\u2014Paulus' patron\u2014became commander of the entire Army Group South, Paulus, who had never commanded a larger unit than a battalion prior to this time, was promoted to ''[[General der Panzertruppe]]'' and became commander of the Sixth Army.{{sfn|Glantz|House|2009|p=22}} However, he only took over his new command on 20 January, six days after the sudden death of Reichenau,<ref name=Adam>{{Cite book |last=Adam |first=Wilhelm |first2=Otto |last2=Ruhle |translator=Tony Le Tissier |title=With Paulus at Stalingrad |publisher=Pen and Sword Books Ltd. |year=2015 |isbn=9781473833869 |pages=2\u20133}}</ref> leaving him on his own and without the support of his more experienced sponsor.\n\nPaulus led the drive on [[Stalingrad]] during that summer. His troops fought Soviet forces defending  Stalingrad over three months in increasingly brutal urban warfare. In November 1942, when the Soviet [[Red Army]] launched a massive counter-offensive, code-named [[Operation Uranus]], Paulus found himself surrounded by an entire Soviet Army Group.\n\n[[File:Bundesarchiv Bild 146-1971-070-73, Russland, Paulus und v. Seydlitz-Kurzbach.jpg|thumb|Paulus (right) with General [[Walther von Seydlitz-Kurzbach]] in Stalingrad, November 1942]]\n\nPaulus followed [[Adolf Hitler]]'s orders to hold his forces' position in Stalingrad under all circumstances, despite the fact that he was completely surrounded by strong Soviet forces. [[Operation Winter Storm]], a relief effort by [[Army Group Don]] under Field Marshal [[Erich von Manstein]], was launched in December. Following his orders, Paulus prepared to cooperate with the offensive by trying to break out of Stalingrad. In the meantime, he kept his entire army in fixed defensive positions. Manstein told Paulus that the relief would need assistance from the Sixth Army, but the order to initiate the breakout never came. Paulus remained absolutely firm in obeying the orders he had been given. Manstein's forces were unable to reach Stalingrad on their own and their efforts were eventually halted due to Soviet offensives elsewhere on the front.<ref name=Adam/>{{rp|137,142,150,153,156}}\n\n[[Kurt Zeitzler]], the newly appointed chief of the [[German General Staff|Army General Staff]], eventually got Hitler to allow Paulus to break out\u2014provided he continue to hold Stalingrad, an impossible task.\n\nFor the next two months Paulus and his men fought on. However, the lack of food and ammunition, equipment attrition and the deteriorating physical condition of the German troops gradually wore down the German defense. With the new year Hitler promoted Paulus to [[Colonel General]].<ref name=Adam/>{{rp|164}}\n\nRegarding the resistance to capitulate, according to Adam, Paulus stated {{quote|What would become of the war if our army in the Caucasus were also surrounded? That danger is real. But as long as we keep on fighting, the Red Army has to remain here. They need these forces for a big offensive against Army Group 'A' in the Caucasus and along the still-unstable front from Voronesh to the Black Sea. We must hold them here to the last so that the eastern front can be stabilized. Only if that happens is there a chance of the war going well for Germany.\"<ref name=Adam/>{{rp|174}}}}\n\n====Crisis====\nOn 7 January 1943 General [[Konstantin Rokossovsky]], commander of the Red Army on the Don front, called a cease-fire and offered Paulus' men generous surrender terms: normal rations, medical treatment for the ill and wounded, permission to retain their badges, decorations, uniforms and personal effects. As part of his communication, Rokossovsky advised Paulus that he was in an impossible situation. Paulus requested permission from Hitler to surrender. Even though it was obvious the Sixth Army was in an untenable position, the German Army High Command rejected Paulus' request, stating, \"Capitulation out of the question. Every day that the army holds out longer helps the whole front and draws away the Russian divisions from it.\"<ref name=Adam/>{{rp|166\u2013169}}\n\nAfter a heavy Soviet offensive overran the last emergency airstrip in Stalingrad on 25 January, the Soviets again offered Paulus a chance to surrender. Paulus radioed Hitler once again for permission. Telling Hitler that collapse was \"inevitable,\" Paulus stressed that his men were without ammunition or food, and he was no longer able to command them. He also said that 18,000 men were wounded and were in immediate need of medical attention. Once again, Hitler rejected Paulus' request out of hand, and ordered Paulus to hold Stalingrad to the death. On 30 January Paulus informed Hitler that his men were only hours from collapse. Hitler responded by showering a raft of [[field promotion]]s by radio on Paulus' officers to build up their spirits and steel their will to hold their ground. Most significantly, he promoted Paulus to field marshal. In deciding to promote him, Hitler noted that there was no known record of a [[Kingdom of Prussia|Prussian]] or German field marshal ever having surrendered. The implication was clear: Paulus was to commit suicide. Hitler implied that if Paulus allowed himself to be taken alive, he would shame Germany's military history.\n\n====Capitulation====\nPaulus and his staff were captured on the morning of 31 January 1943. The events of that day were recorded by Col. [[Wilhelm Adam]], one of Paulus' aides and an adjutant in the XXIII Army Corps, in his personal diary:\n\n[[File:Bundesarchiv Bild 183-F0316-0204-005, Russland, Paulus in Kriegsgefangenschaft.jpg|thumb|upright|Paulus (left) and his aides Col. [[Wilhelm Adam (politician)|Wilhelm Adam]] (right) and Lt.-Gen. [[Arthur Schmidt (soldier)|Arthur Schmidt]] (middle), after their surrender in Stalingrad.]]\n{{quote|January 31, 1943 \u2013 7.00 a.m. It was still dark but day was dawning almost imperceptibly. Paulus was asleep. It was some time before I could break out of the maze of thoughts and strange dreams that depressed me so greatly. But I don't think I remained in this state for very long. I was going to get up quietly when someone knocked at the door. Paulus awoke and sat up. It was the HQ commander. He handed the colonel general a piece of paper and said: 'Congratulations. The rank of field marshal has been conferred upon you. The dispatch came early this morning \u2013 it was the last one.'\n\n'One can't help feeling it's an invitation to suicide. However I'm not going to do them such a favour.' said Paulus after reading the dispatch. Schmidt continued: 'At the same time I have to inform you that the Russians are at the door.' with these words he opened the door and a Soviet general and his interpreter entered the room. The general announced that we were his prisoners. I placed my revolver on the table.\n\n'Prepare yourself for departure. We shall be back for you at 9.00. You will go in your personal car.' said the Soviet general through his interpreter. Then they left the room. I had the official seal with me. I prepared for my last official duty. I recorded Paulus's new rank in his military document, stamped it with the seal then threw the seal into the glowing fire.\n\nThe main entrance to the cellar was closed and guarded by the Soviet soldiers. An officer, the head of the guards, allowed me and the driver to go out and get the car ready. Climbing out of the cellar, I stood dumbfounded. Soviet and German soldiers, who just a few hours earlier had been shooting at one another, now stood quietly together in the yard. They were all armed, some with weapons in their hands, some with them over their shoulders.\n\nMy God, what a contrast between the two sides! The German soldiers, ragged and in light coats, looked like ghosts with hollow, unshaven cheeks. The Red Army fighters looked fresh and wore warm winter uniforms. Involuntarily I remembered the chain of unfortunate events which had prevented me from sleeping for so many nights. The appearance of the Red Army soldiers seemed symbolic. At 9.00 sharp the HQ commander of the 6th Army arrived to take the commander of the vanquished German 6th Army and its staff towards the rear. The march towards the Volga had ended.\"<ref>'Meeting The Victors', Sputnik Magazine, 1968, USSR; (English language article).</ref>}}\n\nOn 2 February 1943 the remainder of Sixth Army capitulated. Upon finding out about Paulus' \"surrender\", Hitler flew into a rage and vowed never to appoint another field marshal again. He would, in fact, go on to appoint another seven field marshals during the last two years of the war. Speaking about the surrender of Paulus, Hitler told his staff:\n\n{{quote|In peacetime Germany, about 18,000 or 20,000 people a year chose to commit suicide, even without being in such a position. Here is a man who sees 50,000 or 60,000 of his soldiers die defending themselves bravely to the end. How can he surrender himself to the [[Bolshevist]]s?!{{sfn|Overy|1997|p=185}}}}[[File:Dyatlenko.jpg|thumb|Paulus' interrogation at Don Front HQ: Gen. [[Konstantin Rokossovsky|Rokossovsky]], Marshal [[Nikolay Voronov|Voronov]], translator [[Nikolay Dyatlenko]] and Paulus (left to right)]]\n\nPaulus, a [[Roman Catholic]], was opposed to suicide. During his captivity, according to Gen. [[Max Pfeffer]], Paulus said of Hitler's expectation: \"I have no intention of shooting myself for this [[Bohemian corporal]].\" Another general told the [[NKVD]] (the public and secret police organisation of the Soviet Union) that Paulus had told him about his promotion to field marshal and said, \"It looks like an invitation to commit suicide, but I will not do this favor for him.\" Paulus also forbade his soldiers from standing on top of their trenches in order to be shot by the enemy.{{sfn|Beevor|1998|p=381}}\n\nShortly before surrendering, Paulus sent his wedding ring back to his wife on the last plane departing his position. He had not seen her since 1942 and would not see her again, as she died in 1949 while he was still in captivity.<ref>{{cite web|url=http://www.historyinanhour.com/2012/02/02/battle-of-stalingrad-summary/|title=Battle of Stalingrad - a summary - History in an Hour|author=|date=2 February 2012|website=historyinanhour.com|accessdate=3 April 2018}}</ref>\n\n==After Stalingrad and postwar==\n[[File:Bundesarchiv Bild 183-25343-0001, Berlin, Pressekonferenz, Friedrich Paulus.jpg|thumb|upright|Paulus speaking at a press conference in East Berlin in 1954.]]\nAt first Paulus refused to collaborate with the Soviets. However, after the [[20 July Plot|attempted assassination]] of Hitler on 20 July 1944, he became a vocal critic of the Nazi regime while in Soviet captivity, joining the Soviet-sponsored [[National Committee for a Free Germany]] appealing to Germans to surrender. He later acted as a witness for the prosecution at the [[Nuremberg Trials]]. He was allowed to move to the [[German Democratic Republic]] in 1953, two years before the repatriation of the remaining German POWs.\n\nDuring the Nuremberg Trials, Paulus was asked about the Stalingrad prisoners by a journalist. He told the journalist to tell the wives and mothers that their husbands and sons were well.{{sfn|Craig|1973|p=280}} Of the 91,000 German prisoners taken at Stalingrad, half had died on the march to [[Siberia]]n prison camps, and nearly as many died in captivity; only about 6,000 survived and returned home.{{refn|They put the number of POW captured at Stalingrad at 100,000 of whom 6,000 survived.{{sfn|Werth et al. Paczkowski 1999|p=322}}|group=\"Note\"}}\n\n[[File:Villa und Wohnort von Generalfeldmarschall Friedrich Wilhelm Ernst Paulus in Dresden Oberloschwitz.jpg|thumb|left|Villa Generalfeldmarschall Paulus \u2013 Dresden Oberloschwitz (2017)]]\n\nFrom 1953-56 he lived in [[Dresden]], East Germany, where he worked as the civilian chief of the East German Military History Research Institute. In late 1956 he developed [[amyotrophic lateral sclerosis]] and became progressively weaker. He died within a few months, in Dresden, on 1 February 1957, 14 years and one day after his surrender at Stalingrad. As part of his last will and testament, his body was transported to Baden-Baden, West Germany, to be buried at the ''Hauptfriedhof'' (main cemetery)<ref>{{cite web|url=https://ww2gravestone.com/people/paulus-friedrich-von-der-lord/|title=Paulus, Friedrich von \"der Lord\". - WW2 Gravestone|author=|date=|website=ww2gravestone.com|accessdate=3 April 2018}}</ref> next to his wife, who had died eight years earlier in 1949, not having seen her husband since his departure for the Eastern Front in the summer of 1942.<ref group=\"Note\">On one of the final Luftwaffe flights out of Stalingrad, Paulus had sent his wedding ring to his wife (''[[Commanders at War]]'', on the [[Military Channel]], 28 May 2010).</ref>\n\n==Awards and decorations==\n{{Spoken Wikipedia|En-FreidrichPaulus-article.ogg|2017-12-13}}\n* [[Iron Cross]] of 1914, 1st and 2nd class<ref name=r22>{{cite book\n | last =\n | first =\n | title = Rangliste des Deutschen Reichsheeres\n | publisher = Mittler & Sohn Verlag\n | year = 1930\n | language= German\n | location =\n | page = 132\n | url =\n | doi =\n | id =  }}</ref>\n* [[Military Merit Order (Bavaria)|Military Merit Order]], 4th class with Swords (Bavaria)<ref name=r22 />\n* Knight's Cross Second Class of the [[Order of the Z\u00e4hringer Lion]] with swords<ref name=r22 />\n* [[Military Merit Cross (Mecklenburg-Schwerin)|Military Merit Cross]], 1st and 2nd class (Mecklenburg-Schwerin)<ref name=r22 />\n* [[Cross for Merit in War]] (Saxe-Meiningen)<ref name=r22 />\n* [[Military Merit Cross (Austria-Hungary)|Military Merit Cross]], 3rd class with War Decoration (Austria-Hungary)<ref name=r22 />\n* [[Clasp to the Iron Cross]] (1939)\n** 1st Class (21 September 1939){{sfn|Thomas|1998|p=143}}\n** 2nd Class (27 September 1939){{sfn|Thomas|1998|p=143}}\n* [[Knight's Cross of the Iron Cross with Oak Leaves]]\n** Knight's Cross on 26 August 1942 as ''[[General der Panzertruppe]]'' and Commander-in-chief of the 6. Armee{{sfn|Scherzer|2007|p=585}}\n** 178th Oak Leaves on 15 January 1943 as ''[[Generaloberst]]'' and Commander-in-chief of the 6. Armee{{sfn|Scherzer|2007|p=585}}\n* [[Order of the Cross of Liberty]], 1st class with Oak Leaves and Swords (Finland)\n* [[Order of Michael the Brave]], 1st class (Romania)\n* [[Military Order of the Iron Trefoil]], First Class with Oak Leaves, ([[Independent State of Croatia]])<ref>[http://www.emedals.com/collectors-gallery/europe/croatia/documents-photos/general-der-panzertruppen-von-paulus-award-doc-eu4642 \"Award Document to General der Panzertruppe Paulus, Item Number: EU4642\". eMedals,  Web. 12 Dec 2013.] {{webarchive |url=https://web.archive.org/web/20131206161143/http://www.emedals.com/collectors-gallery/europe/croatia/documents-photos/general-der-panzertruppen-von-paulus-award-doc-eu4642 |date=December 6, 2013 }}</ref>\n\n==Notes==\n{{Reflist|group=\"Note\"}}\n\n==References==\n\n===Citations===\n{{Reflist|25em}}\n\n===Bibliography===\n{{Refbegin|30ema}}\n* Adam, Wilhelm & Otto Ruhle. ''With Paulus at Stalingrad'', Pen & Sword Books Ltd., England, 2015.  {{ISBN|978-1-47383-386-9}}.\n* {{Cite book\n |first=Antony\n |last=Beevor\n |authorlink=Antony Beevor\n |title=Stalingrad, The Fateful Siege: 1942\u20131943\n |location=New York\n |publisher=[[Penguin Books]]\n |year=1998\n |isbn=978-0-670-87095-0\n |ref=harv\n|title-link=Stalingrad (book)\n }}\n* {{Cite book\n |first=William\n |last=Craig\n |authorlink=William Craig (author)\n |title=Enemy at the Gates. The Battle for Stalingrad\n |location=Victoria\n |publisher=Penguin Books\n |year=1973\n |isbn=0-14-139017-4\n |ref=harv\n}}\n* {{Cite book\n |last1=Glantz\n |first1=David M.\n |last2=House\n |first2=Jonathan\n |date=2009\n |title=To the Gates of Stalingrad: Soviet-German Combat Operations, April\u2013August 1942\n |publisher=University Press of Kansas\n |location=Lawrence, Kansas\n |isbn=978-0-7006-1630-5\n |ref=harv\n}}\n* {{cite book |last1=Fraschka |first1=Mark Alexander |title=Friedrich Paulus nach Stalingrad |date=2008 |publisher=Julius-Maximilians-Universit\u00e4t |location=W\u00fcrzburg |url=https://opus.bibliothek.uni-wuerzburg.de/opus4-wuerzburg/frontdoor/deliver/index/docId/2879/file/Magisterarbeit_Fraschka_geaendert.pdf |accessdate=18 December 2019 |language=German |ref=harv}}\n* {{Cite book\n |last=Overy\n |first=Richard\n |authorlink=Richard Overy\n |title=Russia's War\n |year=1997\n |publisher=Penguin\n |location=United Kingdom\n |isbn=0-14-027169-4\n |ref=harv\n |url=https://archive.org/details/russiaswar00over_0\n }}\n* {{Cite book\n |last=Scherzer\n |first=Veit\n |year=2007\n |title=Die Ritterkreuztr\u00e4ger 1939\u20131945 Die Inhaber des Ritterkreuzes des Eisernen Kreuzes 1939 von Heer, Luftwaffe, Kriegsmarine, Waffen-SS, Volkssturm sowie mit Deutschland verb\u00fcndeter Streitkr\u00e4fte nach den Unterlagen des Bundesarchives\n |trans-title=The Knight's Cross Bearers 1939\u20131945 the Holders of the Knight's Cross of the Iron Cross 1939 by Army, Air Force, Navy, Waffen-SS, Volkssturm and Allied Forces with Germany According to the Documents of the Federal Archives\n |language=German\n |location=Jena, Germany\n |publisher=Scherzers Militaer-Verlag\n |isbn=978-3-938845-17-2\n |ref=harv\n}}\n* {{Cite book\n |last=Thomas\n |first=Franz\n |year=1998\n |title=Die Eichenlaubtr\u00e4ger 1939\u20131945 Band 2: L\u2013Z\n |trans-title=The Oak Leaves Bearers 1939\u20131945 Volume 2: L\u2013Z\n |language=German\n |location=Osnabr\u00fcck, Germany\n |publisher=Biblio-Verlag\n |isbn=978-3-7648-2300-9\n |ref=harv\n}}\n* {{Cite book\n |first1=Nicolas\n |last1=Werth\n |author1link=Nicolas Werth\n |first2=Karel\n |last2=Barto\u0161ek\n |first3=Jean-Louis\n |last3=Pann\u00e9\n |first4=Jean-Louis\n |last4=Margolin\n |first5=Andrzej\n |last5=Paczkowski\n |author5link=Andrzej Paczkowski\n |first6=St\u00e9phane\n |last6=Courtois\n |author6link=St\u00e9phane Courtois\n |title=The Black Book of Communism: Crimes, Terror, Repression\n |publisher=Harvard University Press\n |year=1999\n |page=858\n |isbn=0-674-07608-7\n |ref={{sfnRef|Werth et al. Paczkowski 1999}}\n|title-link=The Black Book of Communism: Crimes, Terror, Repression\n }}\n{{Refend}}\n\n==External links==\n{{Wikiquote}}\n* {{PM20|FID=pe/013314}}\n\n{{s-start}}\n{{s-mil}}\n{{succession box|\nbefore=Generalfeldmarschall [[Walther von Reichenau]]|\nafter=General [[Karl-Adolf Hollidt]]|title= Commander of [[6th Army (Wehrmacht)|6. Armee]]|\nyears=30 December 1941 \u2013 3 February 1943\n}}\n{{s-end}}\n\n{{Battle of Stalingrad |People}}\n{{GFMofWWII}}\n{{Subject bar\n| portal1=Biography\n| portal2=Military of Germany\n| portal3=World War I\n| portal4=World War II\n| commons=y\n}}\n{{Authority control}}\n\n{{DEFAULTSORT:Paulus, Friedrich}}\n[[Category:1890 births]]\n[[Category:1957 deaths]]\n[[Category:20th-century Freikorps personnel]]\n[[Category:East German people]]\n[[Category:Field marshals of Nazi Germany]]\n[[Category:German commanders at the Battle of Stalingrad]]\n[[Category:German male non-fiction writers]]\n[[Category:German military historians]]\n[[Category:German prisoners of war in World War II held by the Soviet Union]]\n[[Category:German Roman Catholics]]\n[[Category:National Committee for a Free Germany members]]\n[[Category:People from Hesse-Nassau]]\n[[Category:People from Schwalm-Eder-Kreis]]\n[[Category:Recipients of the clasp to the Iron Cross, 1st class]]\n[[Category:Recipients of the Knight's Cross of the Iron Cross with Oak Leaves]]\n[[Category:Recipients of the Military Merit Cross (Mecklenburg-Schwerin), 1st class]]\n[[Category:Recipients of the Order of Michael the Brave, 1st class]]\n[[Category:Recipients of the Order of the Cross of Liberty, 1st Class]]\n", "text_old": "{{Infobox military person\n|honorific_prefix = ''[[Generalfeldmarschall]]''\n|name             = Friedrich Paulus\n|honorific_suffix = \n|image            = Bundesarchiv Bild 183-B24575, Friedrich Paulus.jpg\n|image_upright    = \n|alt              = \n|caption          = General Friedrich Paulus (1942)\n|native_name      = \n|native_name_lang = \n|birth_name       = Friedrich Wilhelm Ernst Paulus\n|other_name       = \n|nickname         = \n|birth_date       = {{birth date|1890|9|23|df=y}}\n|birth_place      = [[Guxhagen]], [[German Empire]]\n|death_date       = {{death date and age|1957|2|1|1890|9|23|df=y}}\n|death_place      = [[Dresden]], [[East Germany]]\n|placeofburial    = \n|placeofburial_label = \n|placeofburial_coordinates = <!--{{coord|LAT|LONG|display=inline,title}}-->\n|allegiance       = {{flag|German Empire}} (1910-1918)<br />{{flag|Weimar Republic}} (1918-1933)<br />{{flag|Nazi Germany|1935}} (1933-1943)<br>{{flagdeco|German Empire}} [[National Committee for a Free Germany]] (1944-1945)<br>{{flag|East Germany}} (1953-1956)\n|branch           = {{army|Nazi Germany}}\n|branch_label     = Branch\n|serviceyears     = 1910\u201343\n|serviceyears_label = \n|rank             = [[File:Wehrmacht GenFeldmarschall 1942h1.svg|40px]] [[Generalfeldmarschall]]\n|rank_label       = \n|servicenumber    = \n|unit             = \n|commands         = [[6th Army (Wehrmacht)|Sixth Army]]\n|battles          = [[World War I]]\n*[[Western Front (World War I)|France]]\n*The [[Balkans campaign (World War I)|Balkans]]\n{{hr}}\n[[World War II]]\n* [[Invasion of Poland]]\n* [[Battle of France]]\n* [[Operation Barbarossa]]\n* [[Operation Blue]]\n* [[Battle of Voronezh (1942)|Battle of Voronezh]]\n* [[Battle of Stalingrad]]\n|battles_label    = \n|awards           = [[Knight's Cross of the Iron Cross with Oak Leaves]]\n|memorials        = \n|alma_mater       = [[Marburg University]]\n|spouse           = {{marriage|Constance Elena Rosetti-Solescu{{sfn|Fraschka|2008|p=8}}|1912|1949|end=d.}}\n|children         = \n|relations        = \n|laterwork        = \n|signature        = Friedrich Paulus signature.svg\n|signature_size   = \n|signature_alt    = \n|website          = <!--{{URL|example.com}}-->\n|module           = \n}}\n\n'''Friedrich Wilhelm Ernst Paulus''' (23 September 1890 \u2013 1 February 1957) was a German [[Generalfeldmarschall|field marshal]] during [[World War II]] who commanded the [[6th Army (Wehrmacht)|6th Army]] during the [[Battle of Stalingrad]] (August 1942 to February 1943). The battle ended in disaster for the ''[[Wehrmacht]]'' when Soviet forces encircled the Germans within the city, leading to the ultimate defeat and capture of about 265,000 German personnel, their [[Axis powers of World War II|Axis allies]] and [[Hiwis|collaborators]].<!-- Edited out due to vagueness/dubiousness: \"home\" as in individual homes or home countries? Including those who later lived in East Germany/Soviet Union or third countries? Of the 91,000 Axis troops captured, only 5,000 survived captivity and returned home by 1955. -->\n\nPaulus fought in [[World War I]] and saw action in [[Western Front (World War I)|France]] and the [[Balkans campaign (World War I)|Balkans]]. He was considered a promising officer; by the time World War II broke out he had been promoted to [[major general]]. Paulus took part in the [[Invasion of Poland|Poland]] and [[Battle of France|Low Countries]] campaigns, after which he was named deputy chief of the [[Oberkommando des Heeres|German General Staff]]. In that capacity, Paulus helped plan the [[Operation Barbarossa|invasion of the Soviet Union]].\n\nIn 1942, Paulus was given command of the 6th Army despite his lack of field experience. He led the drive to [[Stalingrad]] but was cut off and surrounded in the subsequent Soviet counter-offensive. [[Adolf Hitler]] prohibited attempts to break out or capitulate, and German defence was gradually worn down. Paulus surrendered in Stalingrad on 31 January 1943,{{refn|Paulus claimed that \"I didn't surrender. I was taken by surprise\". (Paulus in conversation with Marshal Voronov).{{sfn|Beevor|1998|p=390}}|group=\"Note\"}} the same day on which he was informed of his promotion to [[field marshal]] by Hitler. Hitler expected Paulus to commit suicide,<ref>\"Rise and Fall of the Third Reich, Shirer, digital page 1569</ref> repeating to his staff that there was no precedent of a German field marshal ever being captured alive.\n\nWhile in Soviet captivity during the war, Paulus became a vocal critic of the Nazi regime and joined the Soviet-sponsored [[National Committee for a Free Germany]]. In 1953, Paulus moved to [[East Germany]], where he worked in military history research. He lived out the rest of his life in [[Dresden]].\n\n==Early life==\nPaulus was born in [[Guxhagen]] and grew up in [[Kassel]], [[Hesse-Nassau]], the son of a treasurer.<ref>''K\u00f6niglich Preu\u00dfischer Staatsdienst-Kalender f\u00fcr den Regierungsbezirk Cassel auf das Jahr 1890/91.'' Reformirtes Waisenhaus, Cassel 1891, p. 249 ([http://orka.bibliothek.uni-kassel.de/viewer/image/1395757445221_1890/273/ ''Corrections- und Landarmen-Anstalt zu Breitenau.''] [[Kassel University Library|ORKA]]).</ref> He tried, unsuccessfully, to secure a cadetship in the [[Imperial German Navy]] and briefly studied law at [[Marburg University]].{{Citation needed|date=December 2019}}\n\nMany English language sources and publications from the 1940s to the present day give Paulus' family name the prefix \"von\". For example: Mark Arnold-Forster's ''The World At War'', companion volume to the [[The World at War|documentary of the same name]], Stein and Day, 1973, pp.&nbsp;139\u201342; other examples are [[W. E. D. Allen|Allen]] and [[Paul Muratoff|Muratoff's]] \"The Russian Campaigns of 1941-1943,\" published in 1944 <ref>{{cite book |title= The Russian Campaigns of 1941-1943 |last= Allen |first= W.E.D.  |last2= Muratoff  |first2= Paul |year= 1944  |publisher= Penguin |location= Harmondsworth, England  |isbn=   |ref=harv}} (pp 99,101,108,112)</ref> and Peter Margaritis (2019)<ref> {{cite book | last = Margaritis | first = Peter | authorlink =  | title = Countdown to D-Day: The German Perspective: The German High Command in Occupied France, 1944 | publisher = Casemate | date = 2019 | location = PA, USA & Oxford, UK | page = | pages = 199,201,228,333 | url = | doi = | id = | isbn = 978-1-61200-769-4 }} </ref>. This is incorrect, as Paulus' family was never part of the nobility,{{Citation needed|date=December 2019}} and [[Antony Beevor]] refers to his \"comparatively humble birth\" (like [[Irwin Rommel|Rommel's]] family; their \"sole similarity\").<ref> {{cite book | last = Beevor | first = Antony | authorlink = Antony Beevor | title = The Second World War | publisher = Weidenfield & Nicolson | date = 2012 | location = London | page = 214 | pages = | url = | doi = | id = | isbn = 978-0-297-84497-6 }} </ref>\n\n==World War I==\nAfter leaving the university without a degree, he joined the 111th Infantry Regiment as an officer cadet in February 1910. On 4 July 1912 he married the Romanian {{ill|Elena Rosetti-Solescu|ro}}, the sister of a colleague who served in the same regiment. When [[World War I]] began, Paulus' regiment was part of the thrust into [[French Third Republic|France]], and he saw action in the [[Vosges]] and around [[Arras]] in the autumn of 1914. After a leave of absence due to illness, he joined the ''[[Alpenkorps (German Empire)|Alpenkorps]]'' as a staff officer, serving in [[Macedonia (region)|Macedonia]], France, [[Romania during World War I|Romania]] and [[Kingdom of Serbia|Serbia]]. By the end of the war, he was a [[Captain (land)|captain]].\n\n==Interwar period==\nAfter the Armistice, Paulus was a brigade adjutant with the [[Freikorps]]. He was chosen as one of only 4,000 officers to serve in the [[Reichswehr]], the defensive army that the [[Treaty of Versailles]] had limited to 100,000 men. He was assigned to the 13th Infantry Regiment at [[Stuttgart]] as a company commander. He served in various staff positions for over a decade (1921\u201333). In 1920s, as part of the military cooperation between Weimar Republic and Soviet Union to escape Treaty of Versailles, Paulus presented guest lectures in Moscow, Soviet Union.<ref name=sk>{{cite book |author1=Stephen Kotkin |title=Stalin:Volume 2 |publisher=Penguin Press |location=New York |page=22 }}</ref>\n\nLater, Paulus briefly commanded a motorized battalion (1934\u201335) before being named chief of staff for [[Panzer]] headquarters in October 1935. This was a new formation under the direction of [[Oswald Lutz]] that directed the training and development of the ''Panzerwaffen'', or tank forces of the German army.\n\n==World War II==\n[[File:Bundesarchiv Bild 183-B24543, Hauptquartier Heeresgruppe S\u00fcd, Lagebesprechung.jpg|thumb|Paulus attending a meeting at the headquarters of Army Group South with Adolf Hitler on 1 June 1942]]\nIn February 1938 Paulus was appointed ''Chef des Generalstabes'' to Gen. [[Heinz Guderian]]'s new [[XVI Army Corps (Wehrmacht)|XVI Armeekorps (Motorisiert)]], which replaced Lutz's command. Guderian described him as \"brilliantly clever, conscientious, hard working, original and talented\" but had severe doubts about his decisiveness, toughness and lack of command experience. He remained in that post until May 1939, when he was promoted to [[major general]] and became chief of staff for the [[10th Army (Wehrmacht)|German Tenth Army]], with which he saw service in [[Second Polish Republic|Poland]]. The unit was renamed the [[6th Army (Wehrmacht)|Sixth Army]] and engaged in the spring offensives of 1940 through the [[Netherlands]] and [[Belgium]]. Paulus was promoted to [[lieutenant general]] in August 1940. The following month he was named deputy chief of the [[German General Staff]] (Oberquartiermeister I). In that role he helped draft the plans for the invasion of the [[Soviet Union]], [[Operation Barbarossa]].\n\n===Stalingrad===\n[[File:Bundesarchiv Bild 101I-021-2081-31A, General Friedrich Paulus.jpg|thumb|Paulus arriving in southern Russia, January 1942]]\n\nIn November 1941, after German Sixth Army's commander Field Marshal [[Walther von Reichenau]]\u2014Paulus' patron\u2014became commander of the entire Army Group South, Paulus, who had never commanded a larger unit than a battalion prior to this time, was promoted to ''[[General der Panzertruppe]]'' and became commander of the Sixth Army.{{sfn|Glantz|House|2009|p=22}} However, he only took over his new command on 20 January, six days after the sudden death of Reichenau,<ref name=Adam>{{Cite book |last=Adam |first=Wilhelm |first2=Otto |last2=Ruhle |translator=Tony Le Tissier |title=With Paulus at Stalingrad |publisher=Pen and Sword Books Ltd. |year=2015 |isbn=9781473833869 |pages=2\u20133}}</ref> leaving him on his own and without the support of his more experienced sponsor.\n\nPaulus led the drive on [[Stalingrad]] during that summer. His troops fought Soviet forces defending  Stalingrad over three months in increasingly brutal urban warfare. In November 1942, when the Soviet [[Red Army]] launched a massive counter-offensive, code-named [[Operation Uranus]], Paulus found himself surrounded by an entire Soviet Army Group.\n\n[[File:Bundesarchiv Bild 146-1971-070-73, Russland, Paulus und v. Seydlitz-Kurzbach.jpg|thumb|Paulus (right) with General [[Walther von Seydlitz-Kurzbach]] in Stalingrad, November 1942]]\n\nPaulus followed [[Adolf Hitler]]'s orders to hold his forces' position in Stalingrad under all circumstances, despite the fact that he was completely surrounded by strong Soviet forces. [[Operation Winter Storm]], a relief effort by [[Army Group Don]] under Field Marshal [[Erich von Manstein]], was launched in December. Following his orders, Paulus prepared to cooperate with the offensive by trying to break out of Stalingrad. In the meantime, he kept his entire army in fixed defensive positions. Manstein told Paulus that the relief would need assistance from the Sixth Army, but the order to initiate the breakout never came. Paulus remained absolutely firm in obeying the orders he had been given. Manstein's forces were unable to reach Stalingrad on their own and their efforts were eventually halted due to Soviet offensives elsewhere on the front.<ref name=Adam/>{{rp|137,142,150,153,156}}\n\n[[Kurt Zeitzler]], the newly appointed chief of the [[German General Staff|Army General Staff]], eventually got Hitler to allow Paulus to break out\u2014provided he continue to hold Stalingrad, an impossible task.\n\nFor the next two months Paulus and his men fought on. However, the lack of food and ammunition, equipment attrition and the deteriorating physical condition of the German troops gradually wore down the German defense. With the new year Hitler promoted Paulus to [[Colonel General]].<ref name=Adam/>{{rp|164}}\n\nRegarding the resistance to capitulate, according to Adam, Paulus stated {{quote|What would become of the war if our army in the Caucasus were also surrounded? That danger is real. But as long as we keep on fighting, the Red Army has to remain here. They need these forces for a big offensive against Army Group 'A' in the Caucasus and along the still-unstable front from Voronesh to the Black Sea. We must hold them here to the last so that the eastern front can be stabilized. Only if that happens is there a chance of the war going well for Germany.\"<ref name=Adam/>{{rp|174}}}}\n\n====Crisis====\nOn 7 January 1943 General [[Konstantin Rokossovsky]], commander of the Red Army on the Don front, called a cease-fire and offered Paulus' men generous surrender terms: normal rations, medical treatment for the ill and wounded, permission to retain their badges, decorations, uniforms and personal effects. As part of his communication, Rokossovsky advised Paulus that he was in an impossible situation. Paulus requested permission from Hitler to surrender. Even though it was obvious the Sixth Army was in an untenable position, the German Army High Command rejected Paulus' request, stating, \"Capitulation out of the question. Every day that the army holds out longer helps the whole front and draws away the Russian divisions from it.\"<ref name=Adam/>{{rp|166\u2013169}}\n\nAfter a heavy Soviet offensive overran the last emergency airstrip in Stalingrad on 25 January, the Soviets again offered Paulus a chance to surrender. Paulus radioed Hitler once again for permission. Telling Hitler that collapse was \"inevitable,\" Paulus stressed that his men were without ammunition or food, and he was no longer able to command them. He also said that 18,000 men were wounded and were in immediate need of medical attention. Once again, Hitler rejected Paulus' request out of hand, and ordered Paulus to hold Stalingrad to the death. On 30 January Paulus informed Hitler that his men were only hours from collapse. Hitler responded by showering a raft of [[field promotion]]s by radio on Paulus' officers to build up their spirits and steel their will to hold their ground. Most significantly, he promoted Paulus to field marshal. In deciding to promote him, Hitler noted that there was no known record of a [[Kingdom of Prussia|Prussian]] or German field marshal ever having surrendered. The implication was clear: Paulus was to commit suicide. Hitler implied that if Paulus allowed himself to be taken alive, he would shame Germany's military history.\n\n====Capitulation====\nPaulus and his staff were captured on the morning of 31 January 1943. The events of that day were recorded by Col. [[Wilhelm Adam]], one of Paulus' aides and an adjutant in the XXIII Army Corps, in his personal diary:\n\n[[File:Bundesarchiv Bild 183-F0316-0204-005, Russland, Paulus in Kriegsgefangenschaft.jpg|thumb|upright|Paulus (left) and his aides Col. [[Wilhelm Adam (politician)|Wilhelm Adam]] (right) and Lt.-Gen. [[Arthur Schmidt (soldier)|Arthur Schmidt]] (middle), after their surrender in Stalingrad.]]\n{{quote|January 31, 1943 \u2013 7.00 a.m. It was still dark but day was dawning almost imperceptibly. Paulus was asleep. It was some time before I could break out of the maze of thoughts and strange dreams that depressed me so greatly. But I don't think I remained in this state for very long. I was going to get up quietly when someone knocked at the door. Paulus awoke and sat up. It was the HQ commander. He handed the colonel general a piece of paper and said: 'Congratulations. The rank of field marshal has been conferred upon you. The dispatch came early this morning \u2013 it was the last one.'\n\n'One can't help feeling it's an invitation to suicide. However I'm not going to do them such a favour.' said Paulus after reading the dispatch. Schmidt continued: 'At the same time I have to inform you that the Russians are at the door.' with these words he opened the door and a Soviet general and his interpreter entered the room. The general announced that we were his prisoners. I placed my revolver on the table.\n\n'Prepare yourself for departure. We shall be back for you at 9.00. You will go in your personal car.' said the Soviet general through his interpreter. Then they left the room. I had the official seal with me. I prepared for my last official duty. I recorded Paulus's new rank in his military document, stamped it with the seal then threw the seal into the glowing fire.\n\nThe main entrance to the cellar was closed and guarded by the Soviet soldiers. An officer, the head of the guards, allowed me and the driver to go out and get the car ready. Climbing out of the cellar, I stood dumbfounded. Soviet and German soldiers, who just a few hours earlier had been shooting at one another, now stood quietly together in the yard. They were all armed, some with weapons in their hands, some with them over their shoulders.\n\nMy God, what a contrast between the two sides! The German soldiers, ragged and in light coats, looked like ghosts with hollow, unshaven cheeks. The Red Army fighters looked fresh and wore warm winter uniforms. Involuntarily I remembered the chain of unfortunate events which had prevented me from sleeping for so many nights. The appearance of the Red Army soldiers seemed symbolic. At 9.00 sharp the HQ commander of the 6th Army arrived to take the commander of the vanquished German 6th Army and its staff towards the rear. The march towards the Volga had ended.\"<ref>'Meeting The Victors', Sputnik Magazine, 1968, USSR; (English language article).</ref>}}\n\nOn 2 February 1943 the remainder of Sixth Army capitulated. Upon finding out about Paulus' \"surrender\", Hitler flew into a rage and vowed never to appoint another field marshal again. He would, in fact, go on to appoint another seven field marshals during the last two years of the war. Speaking about the surrender of Paulus, Hitler told his staff:\n\n{{quote|In peacetime Germany, about 18,000 or 20,000 people a year chose to commit suicide, even without being in such a position. Here is a man who sees 50,000 or 60,000 of his soldiers die defending themselves bravely to the end. How can he surrender himself to the [[Bolshevist]]s?!{{sfn|Overy|1997|p=185}}}}[[File:Dyatlenko.jpg|thumb|Paulus' interrogation at Don Front HQ: Gen. [[Konstantin Rokossovsky|Rokossovsky]], Marshal [[Nikolay Voronov|Voronov]], translator [[Nikolay Dyatlenko]] and Paulus (left to right)]]\n\nPaulus, a [[Roman Catholic]], was opposed to suicide. During his captivity, according to Gen. [[Max Pfeffer]], Paulus said of Hitler's expectation: \"I have no intention of shooting myself for this [[Bohemian corporal]].\" Another general told the [[NKVD]] (the public and secret police organisation of the Soviet Union) that Paulus had told him about his promotion to field marshal and said, \"It looks like an invitation to commit suicide, but I will not do this favor for him.\" Paulus also forbade his soldiers from standing on top of their trenches in order to be shot by the enemy.{{sfn|Beevor|1998|p=381}}\n\nShortly before surrendering, Paulus sent his wedding ring back to his wife on the last plane departing his position. He had not seen her since 1942 and would not see her again, as she died in 1949 while he was still in captivity.<ref>{{cite web|url=http://www.historyinanhour.com/2012/02/02/battle-of-stalingrad-summary/|title=Battle of Stalingrad - a summary - History in an Hour|author=|date=2 February 2012|website=historyinanhour.com|accessdate=3 April 2018}}</ref>\n\n==After Stalingrad and postwar==\n[[File:Bundesarchiv Bild 183-25343-0001, Berlin, Pressekonferenz, Friedrich Paulus.jpg|thumb|upright|Paulus speaking at a press conference in East Berlin in 1954.]]\nAt first Paulus refused to collaborate with the Soviets. However, after the [[20 July Plot|attempted assassination]] of Hitler on 20 July 1944, he became a vocal critic of the Nazi regime while in Soviet captivity, joining the Soviet-sponsored [[National Committee for a Free Germany]] appealing to Germans to surrender. He later acted as a witness for the prosecution at the [[Nuremberg Trials]]. He was allowed to move to the [[German Democratic Republic]] in 1953, two years before the repatriation of the remaining German POWs.\n\nDuring the Nuremberg Trials, Paulus was asked about the Stalingrad prisoners by a journalist. He told the journalist to tell the wives and mothers that their husbands and sons were well.{{sfn|Craig|1973|p=280}} Of the 91,000 German prisoners taken at Stalingrad, half had died on the march to [[Siberia]]n prison camps, and nearly as many died in captivity; only about 6,000 survived and returned home.{{refn|They put the number of POW captured at Stalingrad at 100,000 of whom 6,000 survived.{{sfn|Werth et al. Paczkowski 1999|p=322}}|group=\"Note\"}}\n\n[[File:Villa und Wohnort von Generalfeldmarschall Friedrich Wilhelm Ernst Paulus in Dresden Oberloschwitz.jpg|thumb|left|Villa Generalfeldmarschall Paulus \u2013 Dresden Oberloschwitz (2017)]]\n\nFrom 1953-56 he lived in [[Dresden]], East Germany, where he worked as the civilian chief of the East German Military History Research Institute. In late 1956 he developed [[amyotrophic lateral sclerosis]] and became progressively weaker. He died within a few months, in Dresden, on 1 February 1957, 14 years and one day after his surrender at Stalingrad. As part of his last will and testament, his body was transported to Baden-Baden, West Germany, to be buried at the ''Hauptfriedhof'' (main cemetery)<ref>{{cite web|url=https://ww2gravestone.com/people/paulus-friedrich-von-der-lord/|title=Paulus, Friedrich von \"der Lord\". - WW2 Gravestone|author=|date=|website=ww2gravestone.com|accessdate=3 April 2018}}</ref> next to his wife, who had died eight years earlier in 1949, not having seen her husband since his departure for the Eastern Front in the summer of 1942.<ref group=\"Note\">On one of the final Luftwaffe flights out of Stalingrad, Paulus had sent his wedding ring to his wife (''[[Commanders at War]]'', on the [[Military Channel]], 28 May 2010).</ref>\n\n==Awards and decorations==\n{{Spoken Wikipedia|En-FreidrichPaulus-article.ogg|2017-12-13}}\n* [[Iron Cross]] of 1914, 1st and 2nd class<ref name=r22>{{cite book\n | last =\n | first =\n | title = Rangliste des Deutschen Reichsheeres\n | publisher = Mittler & Sohn Verlag\n | year = 1930\n | language= German\n | location =\n | page = 132\n | url =\n | doi =\n | id =  }}</ref>\n* [[Military Merit Order (Bavaria)|Military Merit Order]], 4th class with Swords (Bavaria)<ref name=r22 />\n* Knight's Cross Second Class of the [[Order of the Z\u00e4hringer Lion]] with swords<ref name=r22 />\n* [[Military Merit Cross (Mecklenburg-Schwerin)|Military Merit Cross]], 1st and 2nd class (Mecklenburg-Schwerin)<ref name=r22 />\n* [[Cross for Merit in War]] (Saxe-Meiningen)<ref name=r22 />\n* [[Military Merit Cross (Austria-Hungary)|Military Merit Cross]], 3rd class with War Decoration (Austria-Hungary)<ref name=r22 />\n* [[Clasp to the Iron Cross]] (1939)\n** 1st Class (21 September 1939){{sfn|Thomas|1998|p=143}}\n** 2nd Class (27 September 1939){{sfn|Thomas|1998|p=143}}\n* [[Knight's Cross of the Iron Cross with Oak Leaves]]\n** Knight's Cross on 26 August 1942 as ''[[General der Panzertruppe]]'' and Commander-in-chief of the 6. Armee{{sfn|Scherzer|2007|p=585}}\n** 178th Oak Leaves on 15 January 1943 as ''[[Generaloberst]]'' and Commander-in-chief of the 6. Armee{{sfn|Scherzer|2007|p=585}}\n* [[Order of the Cross of Liberty]], 1st class with Oak Leaves and Swords (Finland)\n* [[Order of Michael the Brave]], 1st class (Romania)\n* [[Military Order of the Iron Trefoil]], First Class with Oak Leaves, ([[Independent State of Croatia]])<ref>[http://www.emedals.com/collectors-gallery/europe/croatia/documents-photos/general-der-panzertruppen-von-paulus-award-doc-eu4642 \"Award Document to General der Panzertruppe Paulus, Item Number: EU4642\". eMedals,  Web. 12 Dec 2013.] {{webarchive |url=https://web.archive.org/web/20131206161143/http://www.emedals.com/collectors-gallery/europe/croatia/documents-photos/general-der-panzertruppen-von-paulus-award-doc-eu4642 |date=December 6, 2013 }}</ref>\n\n==Notes==\n{{Reflist|group=\"Note\"}}\n\n==References==\n\n===Citations===\n{{Reflist|25em}}\n\n===Bibliography===\n{{Refbegin|30ema}}\n* Adam, Wilhelm & Otto Ruhle. ''With Paulus at Stalingrad'', Pen & Sword Books Ltd., England, 2015.  {{ISBN|978-1-47383-386-9}}.\n* {{Cite book\n |first=Antony\n |last=Beevor\n |authorlink=Antony Beevor\n |title=Stalingrad, The Fateful Siege: 1942\u20131943\n |location=New York\n |publisher=[[Penguin Books]]\n |year=1998\n |isbn=978-0-670-87095-0\n |ref=harv\n|title-link=Stalingrad (book)\n }}\n* {{Cite book\n |first=William\n |last=Craig\n |authorlink=William Craig (author)\n |title=Enemy at the Gates. The Battle for Stalingrad\n |location=Victoria\n |publisher=Penguin Books\n |year=1973\n |isbn=0-14-139017-4\n |ref=harv\n}}\n* {{Cite book\n |last1=Glantz\n |first1=David M.\n |last2=House\n |first2=Jonathan\n |date=2009\n |title=To the Gates of Stalingrad: Soviet-German Combat Operations, April\u2013August 1942\n |publisher=University Press of Kansas\n |location=Lawrence, Kansas\n |isbn=978-0-7006-1630-5\n |ref=harv\n}}\n* {{cite book |last1=Fraschka |first1=Mark Alexander |title=Friedrich Paulus nach Stalingrad |date=2008 |publisher=Julius-Maximilians-Universit\u00e4t |location=W\u00fcrzburg |url=https://opus.bibliothek.uni-wuerzburg.de/opus4-wuerzburg/frontdoor/deliver/index/docId/2879/file/Magisterarbeit_Fraschka_geaendert.pdf |accessdate=18 December 2019 |language=German |ref=harv}}\n* {{Cite book\n |last=Overy\n |first=Richard\n |authorlink=Richard Overy\n |title=Russia's War\n |year=1997\n |publisher=Penguin\n |location=United Kingdom\n |isbn=0-14-027169-4\n |ref=harv\n |url=https://archive.org/details/russiaswar00over_0\n }}\n* {{Cite book\n |last=Scherzer\n |first=Veit\n |year=2007\n |title=Die Ritterkreuztr\u00e4ger 1939\u20131945 Die Inhaber des Ritterkreuzes des Eisernen Kreuzes 1939 von Heer, Luftwaffe, Kriegsmarine, Waffen-SS, Volkssturm sowie mit Deutschland verb\u00fcndeter Streitkr\u00e4fte nach den Unterlagen des Bundesarchives\n |trans-title=The Knight's Cross Bearers 1939\u20131945 the Holders of the Knight's Cross of the Iron Cross 1939 by Army, Air Force, Navy, Waffen-SS, Volkssturm and Allied Forces with Germany According to the Documents of the Federal Archives\n |language=German\n |location=Jena, Germany\n |publisher=Scherzers Militaer-Verlag\n |isbn=978-3-938845-17-2\n |ref=harv\n}}\n* {{Cite book\n |last=Thomas\n |first=Franz\n |year=1998\n |title=Die Eichenlaubtr\u00e4ger 1939\u20131945 Band 2: L\u2013Z\n |trans-title=The Oak Leaves Bearers 1939\u20131945 Volume 2: L\u2013Z\n |language=German\n |location=Osnabr\u00fcck, Germany\n |publisher=Biblio-Verlag\n |isbn=978-3-7648-2300-9\n |ref=harv\n}}\n* {{Cite book\n |first1=Nicolas\n |last1=Werth\n |author1link=Nicolas Werth\n |first2=Karel\n |last2=Barto\u0161ek\n |first3=Jean-Louis\n |last3=Pann\u00e9\n |first4=Jean-Louis\n |last4=Margolin\n |first5=Andrzej\n |last5=Paczkowski\n |author5link=Andrzej Paczkowski\n |first6=St\u00e9phane\n |last6=Courtois\n |author6link=St\u00e9phane Courtois\n |title=The Black Book of Communism: Crimes, Terror, Repression\n |publisher=Harvard University Press\n |year=1999\n |page=858\n |isbn=0-674-07608-7\n |ref={{sfnRef|Werth et al. Paczkowski 1999}}\n|title-link=The Black Book of Communism: Crimes, Terror, Repression\n }}\n{{Refend}}\n\n==External links==\n{{Wikiquote}}\n* {{PM20|FID=pe/013314}}\n\n{{s-start}}\n{{s-mil}}\n{{succession box|\nbefore=Generalfeldmarschall [[Walther von Reichenau]]|\nafter=General [[Karl-Adolf Hollidt]]|title= Commander of [[6th Army (Wehrmacht)|6. Armee]]|\nyears=30 December 1941 \u2013 3 February 1943\n}}\n{{s-end}}\n\n{{Battle of Stalingrad |People}}\n{{GFMofWWII}}\n{{Subject bar\n| portal1=Biography\n| portal2=Military of Germany\n| portal3=World War I\n| portal4=World War II\n| commons=y\n}}\n{{Authority control}}\n\n{{DEFAULTSORT:Paulus, Friedrich}}\n[[Category:1890 births]]\n[[Category:1957 deaths]]\n[[Category:20th-century Freikorps personnel]]\n[[Category:East German people]]\n[[Category:Field marshals of Nazi Germany]]\n[[Category:German commanders at the Battle of Stalingrad]]\n[[Category:German male non-fiction writers]]\n[[Category:German military historians]]\n[[Category:German prisoners of war in World War II held by the Soviet Union]]\n[[Category:German Roman Catholics]]\n[[Category:National Committee for a Free Germany members]]\n[[Category:People from Hesse-Nassau]]\n[[Category:People from Schwalm-Eder-Kreis]]\n[[Category:Recipients of the clasp to the Iron Cross, 1st class]]\n[[Category:Recipients of the Knight's Cross of the Iron Cross with Oak Leaves]]\n[[Category:Recipients of the Military Merit Cross (Mecklenburg-Schwerin), 1st class]]\n[[Category:Recipients of the Order of Michael the Brave, 1st class]]\n[[Category:Recipients of the Order of the Cross of Liberty, 1st Class]]\n", "name_user": "EdmundT", "label": "safe", "comment": "\u2192\u200eEarly life:Spelling", "url_page": "//en.wikipedia.org/wiki/Friedrich_Paulus"}
{"title_page": "Miranda Lambert discography", "text_new": "{{Infobox artist discography\n|Artist       = [[Miranda Lambert]]\n|Image        = Miranda Lambert.jpg\n|Caption      = Miranda Lambert in 2007\n|Studio       = 8\n|Compilation  =\n|Singles      = 29\n|EP           = 1\n|Music videos = 24\n|Option       = 16\n|Option name  = Other appearances\n|Soundtrack   = 1\n}}\n\nThe [[discography]] of [[Miranda Lambert]], an American [[Country music|country]] artist, consists of eight [[studio album]]s, one [[extended play]], seven other appearances, 27 [[Single (music)|singles]] (including four as a featured artist), and 12 [[music video]]s. Lambert has sold an estimated 7 million albums in the United States, with her first six studio albums being certified platinum.<ref>{{Cite news|url=https://www.rollingstone.com/country/news/what-miranda-lamberts-sales-say-about-sexism-at-radio-w492857|title=What Miranda Lambert's Album Sales Say About Sexism at Country Radio|work=Rolling Stone|access-date=2017-07-24}}</ref> In 2001, Lambert released a self-titled and self-financed independent album.<ref name=\"countryuniverse\">{{cite web|url=http://www.countryuniverse.net/2008/03/27/100-greatest-women-90-miranda-lambert/|title=100 Greatest Women \u2013 #90: Miranda Lambert|last=Coyne|first=Kevin John|publisher=Country Universe|accessdate=6 December 2009}}</ref> After gaining exposure as the third-place winner of the television competition ''[[Nashville Star]],'' Lambert signed with [[Epic Nashville]] in 2004.<ref name=\"allmusicbio\">{{cite web|url={{Allmusic|class=artist|id=p684675|pure_url=yes}}|title=Miranda Lambert > Biography|last=Leggett|first=Steve|website=[[AllMusic]]|accessdate=6 December 2009}}</ref>\n\nLambert's debut major-label album, ''[[Kerosene (album)|Kerosene]]'', was released in March 2005. Although its debut single, \"[[Me and Charlie Talking]]\", only reached 27 on the ''[[Billboard (magazine)|Billboard]]'' [[Hot Country Songs]] chart, the album debuted at number 1 on the ''Billboard'' [[Top Country Albums]] chart and 18 on the [[Billboard 200|''Billboard'' 200]] list. The second single, entitled \"Bring Me Down\", was a second Top 40 hit. The release did not spawn a major hit until the [[Kerosene (song)|title track]] was issued, peaking at number 15 on the Hot Country Songs chart, pressing the album to certify platinum in the United States.<ref name=\"countryuniverse\"/> Her third album, ''[[Crazy Ex-Girlfriend (album)|Crazy Ex-Girlfriend]],'' was released in May 2007, and also debuted at number 1 on the Top Country Albums chart, but peaked at number 6 on the ''Billboard'' 200 list. The title track was released as the lead single, but only peaked at number 50. The album's second single, \"[[Famous in a Small Town]]\", became her highest-peaking hit at that point, reaching number 14 in mid-2007. It was the third spawned single, entitled \"[[Gunpowder & Lead]]\", that yielded Lambert her first Top 10 hit on the ''Billboard'' Country Songs chart, peaking at number 7. The song's background and story yielded ''Crazy Ex-Girlfriend'' to certify gold in the United States in 2008, after selling 500,000 copies.<ref>{{cite web|url=http://data.tennessean.com/v2/bin/pluckTools/display/groupblog.php?blog=9aef6269-d696-46dd-8913-5e9eac4b08b2&plckController=Blog&plckScript=blogScript&plckElementId=blogDest&plckBlogPage=BlogViewPost&plckPostId=Blog%3a9aef6269-d696-46dd-8913-5e9eac4b08b2Post%3a01564ef5-ec5e-4d2a-860a-fee7e2094768&plckCommentSortOrder=TimeStampAscending&sid=sitelife.tennessean.com|title=Miranda Lambert Surprised with Gold Album|last=Keel|first=Beverly|publisher=''[[The Tennesseean]]|accessdate=2009-12-06}}</ref> The final single, \"[[More Like Her]]\", became her fourth Top 20 hit, after peaking at 17 in early 2009.\n\n''[[Revolution (Miranda Lambert album)|Revolution]]'', was released in September 2009.<ref name=\"allmusicbio\"/> It became Lambert's third release to debut at number 1 on the ''Billboard'' Top Country Albums chart, while also debuting at number 8 on the ''Billboard'' 200.<ref>{{cite web|url=http://www.cmt.com/news/country-music/1623560/miranda-lamberts-revolution-seizes-the-album-summit.jhtml|title=Miranda Lambert's Revolution Seizes the Album Summit|last=Morris|first=Edward|date=10 October 2009|publisher=[[Country Music Television]]|accessdate=6 December 2009}}</ref> The lead single, \"[[Dead Flowers (Miranda Lambert song)|Dead Flowers]]\", was released in May 2009, and peaked within the Top 40. The album's second and third singles, \"[[White Liar]]\" and \"[[The House That Built Me]]\", have become her highest charting singles to date. The final two singles from ''Revolution'' were \"[[Only Prettier]]\" and \"[[Heart Like Mine]]\", the latter has become Miranda's second number one hit. Miranda Lambert has sold about 3 million records according to the [[Recording Industry Association of America]].<ref>{{cite web|url=http://riaa.com/goldandplatinumdata.php?resultpage=1&table=SEARCH_RESULTS&action=&title=&artist=Miranda%20Lambert&format=&debutLP=&category=&sex=&releaseDate=&requestNo=&type=&level=&label=&company=&certificationDate=&awardDescription=&catalogNo=&aSex=&rec_id=&charField=&gold=&platinum=&multiPlat=&level2=&certDate=&album=&id=&after=&before=&startMonth=1&endMonth=1&startYear=1958&endYear=2009&sort=Artist&perPage=25|title=RIAA Gold & Platinum \u2013 Miranda Lambert |publisher=[[Recording Industry Association of America]]|accessdate=2009-12-06}}</ref> Her fifth studio album, ''[[Four the Record]]'', was released in November 2011. The album produced five singles: \"[[Baggage Claim]]\", \"[[Over You (Miranda Lambert song)|Over You]]\", \"[[Fastest Girl in Town]]\", \"[[Mama's Broken Heart]]\", and \"[[All Kinds of Kinds]]\". The first four singles reached the top 10 of the ''Billboard'' Hot Country Songs chart, with \"Over You\" becoming her third number one country single.\n\nLambert released her sixth studio album ''[[Platinum (Miranda Lambert album)|Platinum]]'' on June 3, 2014. The album debuted at number one on Billboard Top Country Albums as well as became her first number one on the ''Billboard'' 200 selling 180,000 copies in its first week. On the Top Country Albums chart, Lambert became the first artist to debut at number one on that chart with five consecutive albums. The album was met with widespread critical acclaim and earned her the [[Grammy Award for Best Country Album]] as well as a [[Country Music Association Awards|CMA Award]] and [[Academy of Country Music Awards|ACM Award]] in the same category. The album was certified platinum by the [[Recording Industry Association of America|RIAA]].\n\nOn November 18, 2016, Lambert released her seventh studio album titled ''[[The Weight of These Wings]]''. It debuted at number three on the ''Billboard'' 200 and number one on Top Country albums chart selling 133,000 [[Billboard 200#Incorporation of streaming data and track sales|equivalent album units]] in its first week of release,<ref>{{cite web|url=http://www.billboard.com/articles/columns/chart-beat/7588880/billboard-200-metallica-no-1-album|title=Metallica Rocks With Sixth No. 1 Album on Billboard 200 Chart|work=[[Billboard (magazine)|Billboard]]|last=Caulfield|first=Keith|date=November 28, 2016|accessdate=November 29, 2016}}</ref><ref name=\"TOC11-28-2016\">{{cite web|last=Houghton|first=Cillea|title=Miranda Lambert Soars to Top of Charts With 'The Weight of These Wings'|url=http://tasteofcountry.com/miranda-lambert-weight-of-these-wings-chart-debut/|website=Taste of Country|publisher=Taste of Country Network|accessdate=November 28, 2016|date=November 28, 2016}}</ref> becoming her sixth consecutive number one debut on the latter chart.\n\n==Studio albums==\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\" \n|-\n! scope=\"col\" rowspan=\"2\" style=\"width:12em;\"| Title\n! scope=\"col\" rowspan=\"2\" style=\"width:19em;\"| Album details\n! scope=\"col\" colspan=\"6\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\" style=\"width:10em;\"| [[List of music recording certifications|Certifications]]<br>([[List of best selling music artists|sales threshold]])\n! scope=\"col\" rowspan=\"2\" style=\"width:10em;\"| Sales\n|-\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[Billboard 200|US]]<br><ref name=\"Billboard 200\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/billboard-200|title=Miranda Lambert Chart History: ''Billboard'' 200|work=[[Billboard (magazine)|Billboard]]|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[Top Country Albums|US<br/><small> Country</small>]]<br><ref name=\"Country Albums\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/country-albums|title=Miranda Lambert Chart History: Country Albums|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[ARIA Charts|AUS]]<br /><ref>{{cite web|url=http://www.ariacharts.com.au/charts/albums-chart|title=ARIA Australian Top 50 Albums|publisher=[[Australian Recording Industry Association]]|date=November 28, 2016|accessdate=November 26, 2016}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[Canadian Albums Chart|CAN]]<br><ref>{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/canadian-albums|title=Miranda Lambert Chart History: Canadian Albums|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[UK Albums Chart|UK]]<br /><ref>Peak positions on UK Albums Chart:\n* ''Platinum'': {{cite web|title=Official Albums Chart Top 100|url=http://www.officialcharts.com/charts/albums-chart/20140608/7502/|publisher=[[Official Charts Company]]|format=08 June 2014 \u2013 14 June 2014|accessdate=May 10, 2018}}\n* ''The Weight of These Wings'': {{cite web|title=Official Albums Chart Top 100|url=http://www.officialcharts.com/charts/albums-chart/20161125/7502/|publisher=[[Official Charts Company]]|format=25 November 2016 \u2013 01 December 2016|accessdate=May 10, 2018}}\n* ''Wildcard'': {{cite web|title=Official Albums Chart Top 100|url=http://www.officialcharts.com/charts/albums-chart/20191108/7502/|publisher=Official Charts Company|accessdate=November 9, 2019}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[Official Charts Company|UK <br/><small>Country</small>]]<br /><ref>Peak positions on UK Country Artists Albums Chart:\n* ''Four the Record'': {{cite web|title=Official Country Artists Albums Chart Top 20|url=http://www.officialcharts.com/charts/country-artists-albums-chart/20111106/21/|publisher=Official Charts Company|format=06 November 2011 \u2013 12 November 2011|accessdate=May 10, 2018}}\n* ''Platinum'': {{cite web|title=Official Country Artists Albums Chart Top 20|url=http://www.officialcharts.com/charts/country-artists-albums-chart/20140608/21/|publisher=Official Charts Company|format=08 June 2014 \u2013 14 June 2014|accessdate=May 10, 2018}}\n* ''The Weight of These Wings'': {{cite web|title=Official Country Artists Albums Chart Top 20|url=http://www.officialcharts.com/charts/country-artists-albums-chart/20161125/21/|publisher=Official Charts Company|format=25 November 2016 \u2013 01 December 2016|accessdate=May 10, 2018}}\n* ''Wildcard'': {{cite web|title=Official Country Artists Albums Chart Top 20|url=http://www.officialcharts.com/charts/country-artists-albums-chart/20191108/21/|publisher=Official Charts Company|accessdate=November 9, 2019}}</ref>\n|-\n! scope=\"row\"| ''Miranda Lambert''<ref>{{cite web|url={{Allmusic|class=artist|id=miranda-lambert-p684675/biography|pure_url=yes}}|title=Miranda Lambert: AllMusic|website=[[AllMusic]]|accessdate=October 30, 2010}}</ref>\n|\n* Release date: September 21, 2001\n* Label: [[Self-publishing|Self-released]]\n* Format: [[Compact disc|CD]]\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \n|\n|-\n! scope=\"row\"| ''[[Kerosene (album)|Kerosene]]''\n| align=\"left\"| \n* Release date: March 15, 2005\n* Label: [[Epic Records|Epic Nashville]]\n* Format: CD, [[music download|digital download]]\n| 18\n| 1\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n|\n* [[Recording Industry Association of America|RIAA]]: Platinum{{Certification Cite Ref|region=United States|type=album|title=Kerosene|artist=Miranda Lambert}}\n|\n* [[Nielsen SoundScan|US]]: 1,121,000<ref>{{cite web|url=http://riaa.com/goldandplatinumdata.php?resultpage=1&table=SEARCH_RESULTS&action=&title=Kerosene&artist=Miranda%20Lambert&format=ALBUM&debutLP=&category=&sex=&releaseDate=&requestNo=&type=&level=&label=&company=&certificationDate=&awardDescription=&catalogNo=&aSex=&rec_id=&charField=&gold=&platinum=&multiPlat=&level2=&certDate=&album=&id=&after=&before=&startMonth=1&endMonth=1&startYear=1958&endYear=2009&sort=Artist&perPage=25|title=RIAA Gold & Platinum \u2013 ''Kerosene''|publisher=[[Recording Industry Association of America]]|accessdate=8 December 2009|url-status=dead|archiveurl=https://web.archive.org/web/20150924151606/http://www.riaa.com/goldandplatinumdata.php?resultpage=1|archivedate=24 September 2015}}</ref>\n|-\n! scope=\"row\"| ''[[Crazy Ex-Girlfriend (album)|Crazy Ex-Girlfriend]]''\n|\n* Release date: May 1, 2007\n* Label: [[Sony Music Nashville|Columbia Nashville]]\n* Format: CD, digital download\n| 6\n| 1\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n|\n* RIAA: 2\u00d7 Platinum{{Certification Cite Ref|region=United States|type=album|title=Crazy Ex-Girlfriend|artist=Miranda Lambert}}\n|\n* US: 1,573,300<ref>{{cite news|url=http://roughstock.com/news/2017/04/41722-top-country-catalog-album-sales-chart-april-18-2017|title=Top Country Catalog Album Sales Chart: April 18, 2017|first=Matt|last=Bjorke|date=April 18, 2017|accessdate=April 25, 2017|work=Roughstock}}</ref>\n|-\n! scope=\"row\"| ''[[Revolution (Miranda Lambert album)|Revolution]]''\n| align=\"left\"| \n* Release date: September 29, 2009\n* Label: Columbia Nashville\n* Format: CD, digital download\n| 8\n| 1\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n|\n* RIAA: 2\u00d7 Platinum{{Certification Cite Ref|region=United States|type=album|title=Revolution|artist=Miranda Lambert}}\n* [[Music Canada|MC]]: Gold{{Certification Cite Ref|region=Canada|type=album|title=Revolution|artist=Miranda Lambert}}\n\n|\n* US: 1,790,000<ref name=\"album sales 2015\">{{cite news |url=http://roughstock.com/news/2015/01/31909-country-album-chart-report-january-8-2015/ |title=Country Album Chart Report For January 8, 2015 | author= Matt Bjorke |date= January 8, 2015 |work=Roughstock }}</ref>\n|-\n! scope=\"row\"| ''[[Four the Record]]''\n|\n* Release date: November 1, 2011\n* Label: [[RCA Records Nashville|RCA Nashville]]\n* Format: CD, digital download\n| 3\n| 1\n| \u2014\n| 12\n| \u2014\n| 5\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=album|title=Four the Record|artist=Miranda Lambert}}\n|\n* US: 1,014,000<ref>{{cite web|url=http://www.roughstock.com/blog/country-music-s-top-10-albums-the-week-of-may-28-2014|title=http://www.roughstock.com/blog/country-music-s-top-10-albums-the-week-of-may-28-2014|url-status=dead|archiveurl=https://web.archive.org/web/20140529084352/http://www.roughstock.com/blog/country-music-s-top-10-albums-the-week-of-may-28-2014|archivedate=2014-05-29}}</ref>\n|-\n! scope=\"row\"| ''[[Platinum (Miranda Lambert album)|Platinum]]''\n|\n* Release date: June 3, 2014\n* Label: RCA Nashville\n* Format: CD, digital download\n| 1\n| 1\n| 8\n| 1\n| 52\n| 2\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=album|title=Platinum|artist=Miranda Lambert}}\n|\n* US: 850,000<ref>{{cite news|url=http://hitsdailydouble.com/new_album_releases |title=Miranda Lambert Sales |date=October 5, 2016 |work=Hits Daily Double |url-status=bot: unknown |archiveurl=https://web.archive.org/web/20161005091256/http://hitsdailydouble.com/new_album_releases |archivedate=October 5, 2016 }}</ref>\n* CAN: 9,300<ref>{{cite web|url=http://ajournalofmusicalthings.com/weekly-music-sales-report-analysis-june-11-2014/|title=Weekly Music Sales Report and Analysis for June 11, 2014|website=ajournalofmusicalthings.com|accessdate=June 19, 2014}}</ref>\n|-\n! scope=\"row\"| {{nowrap|''[[The Weight of These Wings]]''}}\n|\n* Release date: November 18, 2016\n* Label: RCA Nashville\n* Format: CD, LP, digital download\n| 3\n| 1\n| 26\n| 5\n| 70\n| 3\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=album|title=The Weight of These Wings|artist=Miranda Lambert}}\n|\n* US: 438,500<ref>{{cite news |url=http://roughstock.com/news/2018/09/43329-the-top-10-country-albums-september-4-2018 |title=The Top 10 Country Albums: September 4, 2018 |first= Matt |last= Bjorke |date=September 4, 2018 |work=Roughstock |accessdate=September 29, 2018 }}</ref>\n|-\n! scope=\"row\"| ''[[Wildcard (Miranda Lambert album)|Wildcard]]''\n|\n* Release date: November 1, 2019\n* Label: RCA Nashville\n* Format: CD, LP, digital download\n| 4\n| 1\n| 19<br /><ref>{{cite web|url=http://www.ariacharts.com.au/charts/albums-chart|title=ARIA Australian Top 50 Albums|publisher=[[Australian Recording Industry Association]]|date=November 11, 2019|accessdate=November 9, 2019}}</ref>\n| 12\n| 57\n| 1\n|\n|\n* US: 110,300<ref>{{cite web |url=http://roughstock.com/news/2020/03/44165-top-10-country-albums-pure-sales-chart-march-9-2020|title=Top 10 Country Albums Pure Sales Chart: March 9, 2020 |work=RoughStock|first=Matt |last=Bjorke |date= March 10, 2020 |accessdate=March 22, 2020 }}</ref>\n|-\n|colspan=\"10\" style=\"font-size:90%\"| \"\u2014\" denotes a recording that did not chart or was not released in that territory.\n|}\n\n==Extended plays==\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\" \n|-\n! scope=\"col\" style=\"width:12em;\"| Title\n! scope=\"col\" style=\"width:18em;\"| Extended play details\n|-\n! scope=\"row\"| ''[[Dead Flowers (Miranda Lambert song)#Dead Flowers - EP|Dead Flowers]]''\n| align=\"left\"| \n* Release date: September 8, 2009\n* Label: Columbia Nashville\n* Format: CD\n|}\n\n==Singles==\n===2000s===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:20em;\"| Single\n! scope=\"col\" colspan=\"4\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\" style=\"width:12em;\"| [[List of music recording certifications|Certifications]]<br><small>([[List of best selling music artists|sales threshold]])</small>\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Country Airplay|US Country Airplay]]<br><ref name=\"Country Airplay\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/country-airplay|title=Miranda Lambert Chart History: Country Airplay|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Billboard Hot 100|US]]<br><ref name=\"Hot 100\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/hot-100|title=Miranda Lambert Chart History: Hot 100|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canada Country|CAN Country]]<br><ref name=\"Canada Country\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/canada-country|title=Miranda Lambert Chart History: Canada Country|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canadian Hot 100|CAN]]<br><ref name=\"Canadian Hot 100\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/canadian-hot-100|title=Miranda Lambert Chart History: Canadian Hot 100|work=Billboard|accessdate=May 10, 2018}}</ref>\n|-\n| 2004\n! scope=\"row\"| \"[[Me and Charlie Talking]]\"\n| 27\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\" rowspan=\"4\"| ''Kerosene''\n|-\n| rowspan=\"2\"| 2005\n! scope=\"row\"| \"[[Bring Me Down (Miranda Lambert song)|Bring Me Down]]\"\n| 32\n| \u2014\n| \u2014\n| \u2014\n| \n|-\n! scope=\"row\"| \"[[Kerosene (song)|Kerosene]]\"\n| 15\n| 61\n| \u2014\n| \u2014\n| align=\"left\"| \n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Kerosene|artist=Miranda Lambert}}\n|-\n| rowspan=\"2\"| 2006\n! scope=\"row\"| \"[[New Strings]]\"\n| 25\n| \u2014{{efn-ua|\"New Strings\" did not enter the ''Billboard'' Hot 100, but peaked at number 25 on the [[Bubbling Under Hot 100 Singles]] chart.<ref name=\"Bubbling\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/HBU|title=Miranda Lambert Chart History: Bubbling Under Hot 100|work=Billboard|accessdate=April 9, 2020}}</ref>}}\n| \u2014\n| \u2014\n| \n|-\n! scope=\"row\"| \"Crazy Ex-Girlfriend\"\n| 50\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\" rowspan=\"4\"| ''Crazy Ex-Girlfriend''\n|-\n| 2007\n! scope=\"row\"| \"[[Famous in a Small Town]]\"\n| 14\n| 87\n| 32\n| \u2014\n| \n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Famous in a Small Town|artist=Miranda Lambert}}\n|-\n| rowspan=\"2\"| 2008\n! scope=\"row\"| \"[[Gunpowder & Lead]]\"\n| 7\n| 52\n| 19\n| \u2014\n| align=\"left\"| \n* RIAA: 2\u00d7 Platinum{{Certification Cite Ref|region=United States|type=single|title=Gunpowder & Lead|artist=Miranda Lambert}}\n|-\n! scope=\"row\"| \"[[More Like Her]]\"\n| 17\n| 90\n| 34\n| \u2014\n| \n|-\n| rowspan=\"2\"| 2009\n! scope=\"row\"| \"[[Dead Flowers (Miranda Lambert song)|Dead Flowers]]\"\n| 37\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\" rowspan=\"2\"| ''Revolution''\n|-\n! scope=\"row\"| \"[[White Liar]]\"\n| 2\n| 38\n| 2\n| 67\n| align=\"left\"| \n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=White Liar|artist=Miranda Lambert}}\n|-\n| colspan=\"10\" style=\"font-size:8pt\"| \"\u2014\" denotes releases that did not chart\n|-\n|}\n\n===2010s===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:22em;\"| Single\n! scope=\"col\" colspan=\"5\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\" style=\"width:12em;\"| [[List of music recording certifications|Certifications]]<br><small>([[List of best selling music artists|sales threshold]])</small>\n! rowspan=\"2\"| Sales\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Songs]]<br><ref name=\"Country Songs\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/country-songs|title=Miranda Lambert Chart History: Hot Country Songs|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Country Airplay|US Country Airplay]]<br><ref name=\"Country Airplay\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Billboard Hot 100|US]]<br><ref name=\"Hot 100\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canada Country|CAN Country]]<br><ref name=\"Canada Country\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canadian Hot 100|CAN]]<br><ref name=\"Canadian Hot 100\" />\n|-\n| rowspan=\"2\"| 2010\n! scope=\"row\"| \"[[The House That Built Me]]\"\n| colspan=\"2\"| 1\n| 28\n| 2\n| 52\n| align=\"left\"|\n* RIAA: 3\u00d7 Platinum{{Certification Cite Ref|region=United States|type=single|title=The House That Built Me|artist=Miranda Lambert}}\n|\n* US: 2,267,000<ref>{{Cite news|url=http://roughstock.com/news/2016/04/40097-top-30-digital-singles-april-4-2016|title=The Top 30 Digital Country Singles: April 4, 2016 {{!}} RoughStock|last=http://www.roughstock.com|first=Roughstock -|work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n| align=\"left\" rowspan=\"3\"| ''Revolution''\n|-\n! scope=\"row\"| \"[[Only Prettier]]\"\n| colspan=\"2\"| 12\n| 61\n| 31\n| \u2014\n| \n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Only Prettier|artist=Miranda Lambert}}\n|\n|-\n| rowspan=\"2\"| 2011\n! scope=\"row\"| \"[[Heart Like Mine]]\"\n| colspan=\"2\"| 1\n| 44\n| 2\n| 69\n|\n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Heart Like Mine|artist=Miranda Lambert}}\n|\n|-\n! scope=\"row\"| \"[[Baggage Claim]]\"\n| colspan=\"2\"| 3\n| 44\n| 2\n| 74\n| \n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Baggage Claim|artist=Miranda Lambert}}\n|\n| align=\"left\" rowspan=\"5\"| ''Four the Record''\n|-\n| rowspan=\"2\"| 2012\n! scope=\"row\"| \"[[Over You (Miranda Lambert song)|Over You]]\"\n| colspan=\"2\"| 1\n| 35\n| 1\n| 52\n|\n* RIAA: 2\u00d7 Platinum{{Certification Cite Ref|region=United States|type=single|title=Over You|artist=Miranda Lambert}}\n|\n* US: 1,338,000<ref>{{Cite web|url=http://www.roughstock.com/blog/june-5-2013-florida-georgia-line-danielle-bradbery-blake-shelton-cole-swindell-lead|archive-url=https://web.archive.org/web/20131103230029/http://www.roughstock.com/blog/june-5-2013-florida-georgia-line-danielle-bradbery-blake-shelton-cole-swindell-lead|url-status=dead|archive-date=2013-11-03|title=June 5, 2013: Florida Georgia Line, Danielle Bradbery, Blake Shelton, Cole Swindell Lead {{!}} New Country Music, Listen to Songs & Video {{!}} Roughstock.com|date=2013-11-03|access-date=2017-08-08}}</ref>\n|-\n! scope=\"row\"| \"[[Fastest Girl in Town]]\"\n| 7\n| 3\n| 47\n| 10\n| 72\n|\n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Fastest Girl in Town|artist=Miranda Lambert}}\n|\n|-\n| rowspan=\"2\"|2013\n! scope=\"row\"| \"[[Mama's Broken Heart]]\"\n| 2\n| 2\n| 20\n| 1\n| 30\n|\n* RIAA: 3\u00d7 Platinum{{Certification Cite Ref|region=United States|type=single|title=Mama%27s Broken Heart|artist=Miranda Lambert}}\n|\n* US: 1,960,000<ref>{{Cite news|url=http://roughstock.com/news/2015/09/37550-top-30-digital-country-singles-september-8-2015|title=Top 30 Digital Country Singles: September 8, 2015 {{!}}|first= Matt |last=Bjorke |work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n|-\n! scope=\"row\"| \"[[All Kinds of Kinds]]\"\n| 24\n| 15\n| 89\n| 12\n| 94\n|\n|\n* US: 160,000<ref>{{Cite web|url=http://www.roughstock.com/blog/country-chart-news-the-top-30-digital-singles-november-13-2013-cma-awards-drive-sales-eric-church-the-outsiders-1-taylor-swift-red-3|archive-url=https://web.archive.org/web/20140421103627/http://www.roughstock.com/blog/country-chart-news-the-top-30-digital-singles-november-13-2013-cma-awards-drive-sales-eric-church-the-outsiders-1-taylor-swift-red-3|url-status=dead|archive-date=2014-04-21|title=Country Chart News \u2013 The Top 30 Digital Singles \u2013 November 13, 2013: CMA Awards Drive Sales; Eric Church \"The Outsiders\" #1; Taylor Swift \"Red\" #3 {{!}} New Country Music, Listen to Songs & Video {{!}} Roughstock.com|date=2014-04-21|access-date=2017-08-08}}</ref>\n|-\n| rowspan=\"2\"| 2014\n! scope=\"row\"| \"[[Automatic (Miranda Lambert song)|Automatic]]\"\n| 4\n| 3\n| 35\n| 1\n| 34\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Automatic|artist=Miranda Lambert}}\n|\n* US: 473,000<ref>{{Cite web|url=http://www.roughstock.com/blog/country-chart-news-the-top-30-digital-singles-for-june-25-2014|archive-url=https://web.archive.org/web/20140702163737/http://www.roughstock.com/blog/country-chart-news-the-top-30-digital-singles-for-june-25-2014|url-status=dead|archive-date=2014-07-02|title=Country Chart News: The Top 30 Digital Singles For June 25, 2014 {{!}} New Country Music, Listen to Songs & Video {{!}} Roughstock.com|date=2014-07-02|access-date=2017-08-08}}</ref>\n| align=\"left\" rowspan=\"4\"| ''Platinum''\n|-\n! scope=\"row\"| \"[[Somethin' Bad]]\" <small>(with [[Carrie Underwood]])</small>\n| 1\n| 7\n| 19\n| 6\n| 33\n| \n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Somethin%27 Bad|artist=Miranda Lambert}}\n|\n* US: 1,080,000<ref>{{Cite news|url=http://roughstock.com/news/2015/04/34263-country-musics-top-30-digital-singles-week-april-15-2015/|title=Country Music's Top 30 Digital Singles: Week of April 15, 2015 {{!}} |first= Matt |last=Bjorke |work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n|-\n| rowspan=\"2\"| 2015\n! scope=\"row\"| \"[[Little Red Wagon (song)|Little Red Wagon]]\"\n| 5\n| 16\n| 55\n| 22\n| 56\n|\n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Little Red Wagon|artist=Miranda Lambert}}\n|\n* US: 432,000<ref>{{Cite news|url=http://roughstock.com/news/2015/07/36601-top-30-digital-country-singles-july-28-2015|title=The Top 30 Digital Country Singles: July 28, 2015 {{!}}|first= Matt |last=Bjorke |work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n|-\n! scope=\"row\"| \"[[Smokin' and Drinkin']]\" {{small|(featuring [[Little Big Town]])}}\n| 32\n| 33\n| \u2014\n| 46\n| \u2014\n| \n|\n* US: 132,000<ref>{{Cite news|url=http://roughstock.com/news/2015/09/38115-top-30-digital-country-singles-september-14-2015|title=Top 30 Digital Country Singles: September 14, 2015 {{!}} |first= Matt |last=Bjorke |work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n|-\n| rowspan=\"2\"| 2016\n! scope=\"row\"| \"[[Vice (Miranda Lambert song)|Vice]]\"\n| 2\n| 11\n| 47\n| 4\n| 78\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Vice|artist=Miranda Lambert}}\n|\n* US: 508,000<ref>{{cite news |url=http://roughstock.com/news/2017/03/41521-top-30-digital-singles-sales-report-march-6-2017 |title=Top 30 Digital Singles Sales Report: March 6, 2017 |first= Matt |last=Bjorke |date= March 6, 2017  |work=Roughstock }}</ref>\n| rowspan=\"4\" align=\"left\"| ''The Weight of These Wings''\n|-\n! scope=\"row\"| \"[[We Should Be Friends]]\"\n| 25\n| 26\n| \u2014{{efn-ua|\"We Should Be Friends\" did not enter the ''Billboard'' Hot 100, but peaked at number six on the Bubbling Under Hot 100 Singles chart.<ref name=\"Bubbling\"/>}}\n| 20\n| \u2014\n|\n|\n|-\n| 2017\n! scope=\"row\"| \"[[Tin Man (Miranda Lambert song)|Tin Man]]\"\n| 15\n| 22\n| 75\n| 50\n| \u2014\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Tin Man|artist=Miranda Lambert}}\n|\n* US: 386,000<ref>{{cite news|url=http://roughstock.com/news/2018/04/42999-top-30-digital-country-singles-april-30-2018|title=Top 30 Digital Country Singles: April 30, 2018 |work=Roughstock|last=Bjorke|first=Matt|date=April 30, 2018 |accessdate=April 30, 2018 }}</ref>\n|-\n| 2018\n! scope=\"row\"| \"Keeper of the Flame\"\n| \u2014\n| 55\n| \u2014\n| \u2014\n| \u2014\n|\n|\n|-\n| rowspan=\"2\"| 2019\n! scope=\"row\"| \"[[It All Comes Out in the Wash]]\"\n| 12\n| 14\n| 70\n| 10\n| \u2014\n|\n|\n*US: 43,000<ref>{{cite web |last=Bjorke |first=Matt |title=Top 30 Digital Country Songs: November 24, 2019 |url=http://roughstock.com/news/2019/12/44051-top-30-digital-country-songs-november-24-2019 |work=Rough Stock |date=November 30, 2019 |accessdate=December 12, 2019}}</ref>\n| align=\"left\" rowspan=\"2\"| ''Wildcard''\n|-\n! scope=\"row\"| \"[[Bluebird (Miranda Lambert song)|Bluebird]]\"\n| 21\n| 25\n| \u2014{{efn-ua|\"Bluebird\" did not enter the ''Billboard'' Hot 100, but peaked at number four on the Bubbling Under Hot 100 chart.<ref name=\"Bubbling\"/>}}\n| \u2014\n| \u2014\n|\n|\n*US: 26,000<ref>{{cite web |last=Bjorke |first=Matt |title=Top 30 Digital Country Singles Sales Chart: March 2, 2020|url=http://roughstock.com/news/2020/03/44155-top-30-digital-country-singles-sales-chart-march-2-2020|work=Rough Stock |date=March 4, 2020 |accessdate=March 14, 2020}}</ref>\n|-\n| colspan=\"11\" style=\"font-size:8pt\" | \"\u2014\" denotes releases that did not chart\n|}\n\n===Featured singles===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:16em;\"| Single\n! scope=\"col\" rowspan=\"2\" style=\"width:14em;\"| Artist(s)\n! scope=\"col\" colspan=\"7\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\" style=\"width:10em;\"| [[List of music recording certifications|Certifications]]<br><small>([[List of best selling music artists|sales threshold]])</small>\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Songs]]<br /><ref name=\"Country Songs\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Country Airplay|US Country Airplay]]<br /><ref name=\"Country Airplay\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Billboard Hot 100|US]]<br /><ref name=\"Hot 100\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canada Country|CAN Country]]<br /><ref name=\"Canada Country\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canadian Hot 100|CAN]]<br /><ref name=\"Canadian Hot 100\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[ARIA Charts|AUS]]<br /><ref>Peak positions on Australian Singles Chart:\n* \"Forever Country\": {{cite web|title=ARIA Report (Issue #1388)|url=http://pandora.nla.gov.au/pan/23790/20161004-0000/Issue1388.pdf|publisher=[[Australian Recording Industry Association]]|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Scottish Singles and Albums Charts|SCO]]<br /><ref>Peak positions on Scottish Singles Chart:\n* \"Forever Country\": {{cite web|title=Official Scottish Singles Sales Chart Top 100|url=http://www.officialcharts.com/charts/scottish-singles-chart/20160930/41/|publisher=[[Official Charts Company]]|format=30 September 2016 \u2013 06 October 2016|accessdate=May 10, 2018}}</ref>\n|-\n| 2010\n! scope=\"row\"| \"[[Coal Miner's Daughter (song)|Coal Miner's Daughter]]\"\n| [[Loretta Lynn]]<br><small>(featuring [[Sheryl Crow]])</small>\n| colspan=\"2\"| 55\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\"| ''[[Coal Miner's Daughter: A Tribute To Loretta Lynn|Coal Miner's Daughter:<br />A Tribute to Loretta Lynn]]''\n|-\n| rowspan=\"2\"| 2013\n! scope=\"row\"| \"[[We Were Us]]\"\n| [[Keith Urban]]\n| 1\n| 1\n| 26\n| 2\n| 25\n| \u2014\n| \u2014\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=We Were Us|artist=Keith Urban}}\n* MC: Gold{{Certification Cite Ref|region=Canada|type=digital download|title=We Were Us|artist=Keith Urban}}\n| align=\"left\"| ''[[Fuse (Keith Urban album)|Fuse]]''\n|-\n! scope=\"row\"| \"Wrote a Song for Everyone\"\n| [[John Fogerty]]<br><small>(featuring [[Tom Morello]])</small>\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\"| ''[[Wrote a Song for Everyone]]''\n|-\n| 2014\n! scope=\"row\"| \"Annie's New Gun\"\n| [[Gwen Sebastian]]\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\"| ''Gwen Sebastian''\n|-\n| 2016\n! scope=\"row\"| \"[[Forever Country]]\"\n| Artists of Then, Now & Forever\n| 1\n| 33\n| 21\n| 39\n| 25\n| 26\n| 29\n|\n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Forever Country|artist=Artist Of Then, Now & Forever}}\n| {{n/a|Non-album single}}\n|-\n| 2018\n! scope=\"row\"| \"[[Drowns the Whiskey]]\"\n| [[Jason Aldean]]\n| 3\n| 1\n| 32\n| 1\n| 53\n| \u2014\n| \u2014\n| \n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Drowns the Whiskey|artist=Jason Aldean}}\n| align=\"left\"| ''[[Rearview Town]]''\n|-\n| colspan=\"14\" style=\"font-size:8pt\"| \"\u2014\" denotes releases that did not chart\n|}\n\n===Promotional singles===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\" style=\"width:1em;\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:22em;\"| Single\n! scope=\"col\" colspan=\"2\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Songs]]<br /><ref name=\"Country Songs\"/>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Digital]]<br /><ref name=countrydig>{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/country-digital-song-sales|title=Miranda Lambert Chart History: Country Digital Song Sales|work=Billboard|accessdate=May 10, 2018}}</ref>\n|-\n| rowspan=\"6\"| 2019\n! scope=\"row\"| \"Locomotive\"\n| \u2014\n| 25\n| rowspan=\"4\" align=\"left\"| ''Wildcard''\n|-\n! scope=\"row\"| \"Mess with My Head\"\n| 45\n| 6\n|-\n! scope=\"row\"| \"Way Too Pretty for Prison\" <small>(with [[Maren Morris]])</small><ref>{{cite magazine|url=https://www.billboard.com/articles/columns/country/8528295/miranda-lambert-maren-morris-way-too-pretty-for-prison|title=Miranda Lambert Teases Midnight Drop of Maren Morris Collaboration 'Way Too Pretty for Prison'|author=Hilary Hughes|date=August 25, 2019|magazine=Billboard.com|accessdate=August 25, 2019}}</ref>\n| \u2014\n| 11\n|-\n! scope=\"row\"| \"Pretty Bitchin'\"\n| \u2014\n| 18\n|-\n! scope=\"row\"| \"[[Fooled Around and Fell in Love]]\" {{small|(featuring Maren Morris, [[Ashley McBryde]], [[Tenille Townes]], [[Caylee Hammack]], and [[Elle King]])}}\n| 47\n| 7\n| {{n/a|Non-album single}}\n|-\n! scope=\"row\"| \"Tequila Does\"\n| \u2014\n| 8\n| align=\"left\"| ''Wildcard''\n|-\n| colspan=\"5\" style=\"font-size:8pt\"| \"\u2014\" denotes releases that did not chart\n|}\n\n==Other charted songs==\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:20em;\"| Single\n! scope=\"col\" colspan=\"4\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Songs]]<br /><ref name=\"Country Songs\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Country Airplay|US Country Airplay]]<br /><ref name=\"Country Airplay\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Digital]]<br /><ref name=countrydig/>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canada Country|CAN Country]]<br><ref name=\"Canada Country\" />\n|-\n| rowspan=\"2\"| 2012\n! scope=\"row\"| \"Run Daddy Run\" <small>(featuring [[Pistol Annies]])</small>\n| \u2014\n| \u2014\n| 31\n| \u2014\n| align=\"left\"| {{nowrap|''[[The Hunger Games: Songs from District 12 and Beyond]]''}}\n|-\n|-\n! scope=\"row\"| \"[[Jingle Bell Rock]]\" <small>(with [[Blake Shelton]])</small>\n| 37\n| 34\n| \u2014\n| 45\n| align=\"left\"| ''[[Cheers, It's Christmas]]''\n|-\n| 2014\n! scope=\"row\"| \"Platinum\"\n| 50\n| \u2014\n| \u2014\n| \u2014\n| align=\"left\"| ''Platinum''\n|-\n| rowspan=\"2\"| 2015\n! scope=\"row\"| \"Roots and Wings\"\n| 32\n| \u2014\n| 7\n| \u2014\n| {{n/a|Non-album song}}\n|-\n! scope=\"row\"| \"Bathroom Sink\"\n| \u2014\n| \u2014\n| 49\n| \u2014\n| align=\"left\"| ''Platinum''\n|-\n| 2016\n! scope=\"row\"| \"Sweet By & By\"\n| 40\n| \u2014\n| 20\n| \u2014\n| align=\"left\"| ''Southern Family''\n|-\n| colspan=\"8\" style=\"font-size:8pt\"| \"\u2014\" denotes releases that did not chart\n|}\n\n==Videography==\n===Video albums===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! style=\"width:16em;\"| Title\n! style=\"width:18em;\"| Details\n|-\n! scope=\"row\"| ''Revolution: Live by Candlelight''\n| \n* Release date: October 12, 2010\n* Label: Sony Music Nashville\n* Format: [[DVD]]\n|}\n\n===Music videos===\n{| class=\"wikitable plainrowheaders\"\n|- \n! Year\n! style=\"width:15em;\"| Title\n! Director\n|- \n| 2004\n! scope=\"row\"| \"Me and Charlie Talking\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/37161/me-and-charlie-talking.jhtml|title=CMT : Videos : Miranda Lambert : Me and Charlie Talking|publisher=[[Country Music Television]]|accessdate=September 26, 2010}}</ref>\n| [[Trey Fanjoy]]\n|-\n| rowspan=\"2\"| 2005\n! scope=\"row\"| \"Bring Me Down\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/53036/bring-me-down.jhtml|title=CMT : Videos : Miranda Lambert : Bring Me Down|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| Kristin Barlowe\n|-\n! scope=\"row\"| \"Kerosene\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/62278/kerosene.jhtml|title=CMT : Videos : Miranda Lambert : Kerosene|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| rowspan=\"3\"| Trey Fanjoy\n|-\n| 2006\n! scope=\"row\"| \"New Strings\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/84709/new-strings.jhtml|title=CMT : Videos : Miranda Lambert : New Strings|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n|-\n| 2007\n! scope=\"row\"| \"Famous in a Small Town\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/142121/famous-in-a-small-town.jhtml|title=CMT : Videos : Miranda Lambert : Famous in a Small Town|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n|-\n| rowspan=\"2\"| 2008\n! scope=\"row\"| \"Gunpowder & Lead\" <small>(Live)</small><ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/177205/gunpowder-lead-from-cmt-cross-country.jhtml|title=CMT : Videos : Miranda Lambert : Gunpowder & Lead|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| Ivan Dudynsky\n|-\n! scope=\"row\"| \"More Like Her\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/294949/more-like-her.jhtml|title=CMT : Videos : Miranda Lambert : More Like Her|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| rowspan=\"2\"| Randee St. Nicholas\n|-\n| rowspan=\"2\"| 2009\n! scope=\"row\"| \"Dead Flowers\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/410454/dead-flowers.jhtml|title=CMT : Videos : Miranda Lambert : Dead Flowers|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n|-\n! scope=\"row\"| \"White Liar\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/437633/white-liar.jhtml|title=CMT : Videos : Miranda Lambert : White Liar|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| [[Chris Hicky]]\n|-\n| rowspan=\"2\"| 2010\n! scope=\"row\"| \"The House That Built Me\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/500805/the-house-that-built-me.jhtml|title=CMT : Videos : Miranda Lambert : The House That Built Me|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| rowspan=\"2\"| Trey Fanjoy\n|-\n! scope=\"row\"| \"Only Prettier\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/548058/only-prettier.jhtml|title=CMT : Videos : Miranda Lambert : Only Prettier|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n|-\n| rowspan=\"2\"| 2011\n! scope=\"row\"| \"Heart Like Mine\" <small>(Live)</small><ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/615708/heart-like-mine.jhtml|title=CMT : Videos : Miranda Lambert : Heart Like Mine|publisher=Country Music Television|accessdate=January 21, 2011}}</ref>\n| Justin Luffman\n|-\n! scope=\"row\"| \"Baggage Claim\" <small>(Live)</small><ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/713178/baggage-claim-2011-cma-awards.jhtml|title=CMT : Videos : Miranda Lambert : Baggage Claim (2011 CMA Awards)|publisher=Country Music Television|accessdate=November 28, 2011}}</ref>\n| Paul Miller\n|-\n| rowspan=\"2\"| 2012\n! scope=\"row\"| \"Over You\"\n| rowspan=\"3\"| Trey Fanjoy\n|-\n! scope=\"row\"| \"Fastest Girl in Town\"<ref>{{cite news|last=Wyland|first=Sarah|title=Miranda Lambert's New Video Co-Stars NASCAR Driver Danica Patrick|url=http://blog.gactv.com/blog/2012/07/13/miranda-lamberts-new-video-co-stars-nascar-driver-danica-patrick/|accessdate=July 15, 2012|newspaper=[[Great American Country]]|date=July 13, 2012}}</ref>\n|-\n| rowspan=\"2\"| 2013\n! scope=\"row\"| \"Mama's Broken Heart\"<ref>{{cite news|last=Carter|first=Liv|title=New Video: 'Mama's Broken Heart' \u2013 Miranda Lambert|url=http://www.urbancountrynews.com/new-video-mamas-broken-heart-miranda-lambert/|accessdate=March 4, 2013|newspaper=Urban Country News|date=March 4, 2013}}</ref>\n|-\n! scope=\"row\"| \"All Kinds of Kinds\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/945518/all-kinds-of-kinds.jhtml|title=CMT : Videos : Miranda Lambert : All Kinds of Kinds|publisher=[[Country Music Television]]|accessdate=August 12, 2013}}</ref>\n| Bluford Sanders\n|-\n| rowspan=\"2\"|2014\n! scope=\"row\"| \"Automatic\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/1014033/automatic.jhtml|title=CMT : Videos : Miranda Lambert : Automatic|publisher=[[Country Music Television]]|accessdate=March 24, 2014}}</ref>\n| rowspan=\"3\"|Trey Fanjoy\n|-\n! scope=\"row\"| \"Somethin' Bad\"<br /><small>(with [[Carrie Underwood]])</small>\n|-\n| rowspan=\"2\"|2015\n! scope=\"row\"| \"Little Red Wagon\"<ref>{{cite news|last1=Vinson|first1=Christina|title=Miranda Lambert Debuts 'Little Red Wagon' Music Video|url=http://theboot.com/miranda-lambert-little-red-wagon-video/|accessdate=March 12, 2015|work=The Boot|date=March 11, 2015}}</ref>\n|-\n! scope=\"row\"| \"Smokin' and Drinkin'\" <small>(Live)</small><ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/1230807/smokin-and-drinkin-feat-little-big-town-live-cma-performance.jhtml|title=CMT : Videos : Miranda Lambert : Smokin' and Drinkin' (feat. Little Big Town) [Live CMA Performance]|publisher=[[Country Music Television]]|accessdate=September 15, 2015}}</ref><br /><small>(with [[Little Big Town]])</small>\n| Paul Miller\n|-\n| 2016\n! scope=\"row\"| \"Vice\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/1541628/vice.jhtml|title=CMT : Videos : Miranda Lambert : Vice|publisher=[[Country Music Television]]|accessdate=September 9, 2016}}</ref>\n| rowspan=\"2\"|Trey Fanjoy\n|-\n| rowspan=\"2\"| 2017\n! scope=\"row\"| \"We Should Be Friends\"<ref>{{cite magazine|url=https://www.rollingstone.com/country/news/see-miranda-lamberts-we-should-be-friends-video-w465999|title=See Miranda Lambert's Fabulous Makeover in 'We Should Be Friends' Video|author=Brittney McKenna|date=February 9, 2017|magazine=RollingStone|accessdate=March 7, 2017}}</ref>\n|-\n! scope=\"row\"| \"Tin Man\" <small>(Live)</small>\n| Joe DeMaio\n|-\n| 2018\n! scope=\"row\"| \"Keeper of the Flame\"<ref>{{cite web|url=http://www.cmt.com/video-clips/sso9c2/music-videos-miranda-lambert-keeper-of-the-flame|title=CMT : Miranda Lambert - \"Keeper of the Flame : Music Video S, E|publisher=Vevo|accessdate=August 5, 2018}}</ref>\n| rowspan=\"2\"|Trey Fanjoy\n|-\n| rowspan=\"2\"| 2019\n! scope=\"row\"| \"It All Comes Out in the Wash\"<ref>{{cite web|url=http://www.cmt.com/news/1811234/watch-miranda-lambert-make-a-clean-getaway-from-a-big-mess/|title=Watch Miranda Lambert Make a Clean Getaway from a Big Mess\n|author=Alison Bonaguro|date=August 29, 2019|publisher=CMT|accessdate=August 29, 2019}}</ref>\n|-\n! scope=\"row\"| \"Fooled Around and Fell in Love\"\n|\n|-\n| 2020\n! scope=\"row\"| \"Bluebird\"<ref>{{cite web|url=https://tasteofcountry.com/miranda-lambert-bluebird-music-video/|title=Watch: Miranda Lambert Can't Be Caged in 'Bluebird' Music Video|author=Billy Dukes|date=March 20, 2020|work=|publisher=Taste of Country|accessdate=March 20, 2020}}</ref>\n| Trey Fanjoy\n|-\n|}\n\n===Guest appearances===\n{| class=\"wikitable plainrowheaders\"\n|-\n! Year\n! Title\n! Director\n|-\n| rowspan=\"2\"| 2010\n! scope=\"row\"| \"Bad Angel\" <small>(with [[Dierks Bentley]] and [[Jamey Johnson]])</small><ref>{{cite web|url=http://www.cmt.com/videos/dierks-bentley/558158/bad-angel.jhtml|title=CMT : Videos : Dierks Bentley : Bad Angel|publisher=[[Country Music Television]]|accessdate=September 26, 2010}}</ref>\n| George Flanigen\n|-\n! scope=\"row\"| \"Coal Miner's Daughter\" <small>(with [[Loretta Lynn]] and [[Sheryl Crow]])</small><ref>{{cite web|url=http://www.cmt.com/videos/sheryl-crow/594366/loretta-lynn-sheryl-crow-and-miranda-lambert-coal-miners-daughter.jhtml|title=CMT : Videos : Sheryl Crow : Loretta Lynn, Sheryl Crow and Miranda Lambert \"Coal Miner's Daughter\"|publisher=[[Country Music Television]]|accessdate=November 6, 2010}}</ref>\n| [[Deaton-Flanigen Productions|Deaton-Flanigen]]\n|-\n| 2013\n! scope=\"row\"| \"We Were Us\" <small>(with [[Keith Urban]])</small><ref>{{cite web|url=http://www.cmt.com/videos/keith-urban/979529/we-were-us.jhtml|title=CMT : Videos : Keith Urban : We Were Us|publisher=[[Country Music Television]]|accessdate=November 17, 2013}}</ref>\n| Reid Long\n|-\n| 2016\n! scope=\"row\"| \"Forever Country\" <small>(Artists of Then, Now & Forever)</small>\n| [[Joseph Kahn]]\n|-\n| 2018\n! scope=\"row\"| \"Drowns the Whiskey\" <small>(with [[Jason Aldean]])</small><ref>{{cite web|url=http://www.soundslikenashville.com/news/jason-aldean-drowns-whiskey-video/|title=Jason Aldean 'Drowns The Whiskey' With Miranda Lambert in New Video|publisher=Sounds Like Nashville|date=June 18, 2018|accessdate=November 29, 2018}}</ref>\n| [[Shaun Silva]]\n|-\n|}\n\n==Other appearances==\nThe following songs have not appeared on any of Lambert's albums.\n\n{| class=\"wikitable\"\n|-\n! Year\n! Song\n! Album\n|-\n| 2003\n| \"Today I Started Loving You Again\" <small>(with [[Buddy Jewell]])</small>\n| ''[[Buddy Jewell (album)|Buddy Jewell]]''<ref>{{cite web|url={{Allmusic|class=album|id=r647015|pure_url=yes}}|title=''Buddy Jewell'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|-\n| rowspan=2| 2007\n| \"[[Jailhouse Rock (song)|Jailhouse Rock]]\"\n| ''Elvis: Viva Las Vegas'' <small>(soundtrack)</small><ref>{{cite web|url={{Allmusic|class=album|id=r1311687|pure_url=yes}}|title=''Elvis: Viva Las Vegas'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|-\n| \"Grown Woman\" <small>(with [[Jason Aldean]])</small>\n| ''[[Relentless (Jason Aldean album)|Relentless]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1067893|pure_url=yes}}|title=''Relentless'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|-\n| rowspan=2| 2008\n| \"[[Home (Michael Bubl\u00e9 song)#Blake Shelton version|Home]]\" <small>(with [[Blake Shelton]])</small>\n| ''[[Pure BS]] Deluxe Edition''<ref>{{cite web|url=http://voices.yahoo.com/miranda-lambertcountry-music-star-6454960.html|title=Yahoo|publisher=|access-date=2012-04-07|archive-url=https://web.archive.org/web/20140729042517/http://voices.yahoo.com/miranda-lambertcountry-music-star-6454960.html|archive-date=2014-07-29|url-status=dead}}</ref>\n|-\n| \"Bare Skin Rug\" <small>(with Blake Shelton)</small>\n| ''[[Startin' Fires]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1446559|pure_url=yes}}|title=''Startin' Fires'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|-\n| rowspan=2| 2009\n| \"The Fabric of My Life\"\n| ''Cotton: The Fabric of My Life'' (free ad campaign)<ref>{{cite web|url=http://www.thefabricofourlives.com/TheFabricOfMyLife/music.html |title=Cotton: The Fabric of My Life |publisher=The Fabric of Our Lives.com |accessdate=6 December 2009 |url-status=dead |archiveurl=https://web.archive.org/web/20090614201909/http://www.thefabricofourlives.com/TheFabricOfMyLife/music.html |archivedate=14 June 2009 }}</ref>\n|-\n| \"Strangers on a Train\" <small>(with [[David Nail]])</small>\n| ''[[I'm About to Come Alive]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1579435|pure_url=yes}}|title=''I'm About to Come Alive'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|- \n| rowspan=2| 2010\n| \"Bad Angel\" <small>(with [[Dierks Bentley]] and [[Jamey Johnson]])</small>\n| ''[[Up on the Ridge]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1785236|pure_url=yes}}|title=''Up On the Ridge'' > Overview|website=[[Allmusic]]|accessdate=September 26, 2010}}</ref>\n|-\n| \"Draggin' the River\" <small>(with Blake Shelton)</small>\n| ''[[All About Tonight (EP)|All About Tonight]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1841653|pure_url=yes}}|title=''All About Tonight'' > Overview|website=[[Allmusic]]|accessdate=September 26, 2010}}</ref>\n|-\n| 2011\n| \"Red River Blue\" <small>(with Blake Shelton)</small>\n| ''[[Red River Blue]]''\n|-\n| 2012\n| \"[[Jingle Bell Rock]]\" <small>(with Blake Shelton)</small>\n| ''[[Cheers It's Christmas]]''\n|-\n| rowspan=4|2013\n| \"Wrote a Song for Everyone\" <small>(with [[John Fogerty]] & [[Tom Morello]])</small>\n| ''[[Wrote a Song for Everyone]]''\n|-\n| \"We Were Us\" <small>(with [[Keith Urban]])</small>\n| ''[[Fuse (Keith Urban album)|Fuse]]''\n|-\n| \"Old Habits\" <small>(with [[Justin Moore]])</small>\n| ''[[Off the Beaten Path (Justin Moore album)|Off the Beaten Path]]''\n|-\n| \"She Was No Good for Me\" <small>(with [[Willie Nelson]])</small>\n| ''[[To All the Girls...]]''\n|-\n| 2015\n| \"Two of a Crime\"\n|''[[Hot Pursuit (2015 film)|Hot Pursuit]]''\n|-\n|-\n| rowspan=\"3\"| 2016\n| \"Sweet By and By\"\n| ''Southern Family''\n|-\n| \"[[Forever Country]]\" <small>(Artists of Then, Now & Forever)</small>\n| non-album single\n|-\n| \"I Wish You Were Here\" <small>(with [[Charles Kelley]])</small>\n| ''[[The Driver (Charles Kelley album)|The Driver]]''\n|-\n| 2017\n| \"Ordinary World\" <small>(with [[Billie Joe Armstrong]])</small>\n| ''[[Greatest Hits: God's Favorite Band]]''\n|-\n| rowspan=2| 2018\n| \"Drowns the Whiskey\" <small>(with Jason Aldean)</small>\n| ''Rearview Town''\n|-\n| \"[[My Father's Gun]]\"\n| ''[[Revamp & Restoration#Restoration|Restoration: Reimagining the Songs of Elton John and Bernie Taupin]]''\n|}\n\n==Notes==\n{{notelist-ua}}\n\n==See also==\n*[[Pistol Annies]]\n\n==References==\n{{reflist}}\n\n==External links==\n* [http://www.mirandalambert.com/music/ Official Discography of Miranda Lambert]\n* [{{Allmusic|class=artist|id=p684675|pure_url=yes}} Discography of Miranda Lambert] at [[Allmusic]]\n\n{{Miranda Lambert}}\n\n{{DEFAULTSORT:Lambert, Miranda}}\n[[Category:Miranda Lambert|Discography]]\n[[Category:Country music discographies]]\n[[Category:Discographies of American artists]]\n", "text_old": "{{Infobox artist discography\n|Artist       = [[Miranda Lambert]]\n|Image        = Miranda Lambert.jpg\n|Caption      = Miranda Lambert in 2007\n|Studio       = 8\n|Compilation  =\n|Singles      = 29\n|EP           = 1\n|Music videos = 24\n|Option       = 16\n|Option name  = Other appearances\n|Soundtrack   = 1\n}}\n\nThe [[discography]] of [[Miranda Lambert]], an American [[Country music|country]] artist, consists of eight [[studio album]]s, one [[extended play]], seven other appearances, 27 [[Single (music)|singles]] (including four as a featured artist), and 12 [[music video]]s. Lambert has sold an estimated 7 million albums in the United States, with her first six studio albums being certified platinum.<ref>{{Cite news|url=https://www.rollingstone.com/country/news/what-miranda-lamberts-sales-say-about-sexism-at-radio-w492857|title=What Miranda Lambert's Album Sales Say About Sexism at Country Radio|work=Rolling Stone|access-date=2017-07-24}}</ref> In 2001, Lambert released a self-titled and self-financed independent album.<ref name=\"countryuniverse\">{{cite web|url=http://www.countryuniverse.net/2008/03/27/100-greatest-women-90-miranda-lambert/|title=100 Greatest Women \u2013 #90: Miranda Lambert|last=Coyne|first=Kevin John|publisher=Country Universe|accessdate=6 December 2009}}</ref> After gaining exposure as the third-place winner of the television competition ''[[Nashville Star]],'' Lambert signed with [[Epic Nashville]] in 2004.<ref name=\"allmusicbio\">{{cite web|url={{Allmusic|class=artist|id=p684675|pure_url=yes}}|title=Miranda Lambert > Biography|last=Leggett|first=Steve|website=[[AllMusic]]|accessdate=6 December 2009}}</ref>\n\nLambert's debut major-label album, ''[[Kerosene (album)|Kerosene]]'', was released in March 2005. Although its debut single, \"[[Me and Charlie Talking]]\", only reached 27 on the ''[[Billboard (magazine)|Billboard]]'' [[Hot Country Songs]] chart, the album debuted at number 1 on the ''Billboard'' [[Top Country Albums]] chart and 18 on the [[Billboard 200|''Billboard'' 200]] list. The second single, entitled \"Bring Me Down\", was a second Top 40 hit. The release did not spawn a major hit until the [[Kerosene (song)|title track]] was issued, peaking at number 15 on the Hot Country Songs chart, pressing the album to certify platinum in the United States.<ref name=\"countryuniverse\"/> Her third album, ''[[Crazy Ex-Girlfriend (album)|Crazy Ex-Girlfriend]],'' was released in May 2007, and also debuted at number 1 on the Top Country Albums chart, but peaked at number 6 on the ''Billboard'' 200 list. The title track was released as the lead single, but only peaked at number 50. The album's second single, \"[[Famous in a Small Town]]\", became her highest-peaking hit at that point, reaching number 14 in mid-2007. It was the third spawned single, entitled \"[[Gunpowder & Lead]]\", that yielded Lambert her first Top 10 hit on the ''Billboard'' Country Songs chart, peaking at number 7. The song's background and story yielded ''Crazy Ex-Girlfriend'' to certify gold in the United States in 2008, after selling 500,000 copies.<ref>{{cite web|url=http://data.tennessean.com/v2/bin/pluckTools/display/groupblog.php?blog=9aef6269-d696-46dd-8913-5e9eac4b08b2&plckController=Blog&plckScript=blogScript&plckElementId=blogDest&plckBlogPage=BlogViewPost&plckPostId=Blog%3a9aef6269-d696-46dd-8913-5e9eac4b08b2Post%3a01564ef5-ec5e-4d2a-860a-fee7e2094768&plckCommentSortOrder=TimeStampAscending&sid=sitelife.tennessean.com|title=Miranda Lambert Surprised with Gold Album|last=Keel|first=Beverly|publisher=''[[The Tennesseean]]|accessdate=2009-12-06}}</ref> The final single, \"[[More Like Her]]\", became her fourth Top 20 hit, after peaking at 17 in early 2009.\n\n''[[Revolution (Miranda Lambert album)|Revolution]]'', was released in September 2009.<ref name=\"allmusicbio\"/> It became Lambert's third release to debut at number 1 on the ''Billboard'' Top Country Albums chart, while also debuting at number 8 on the ''Billboard'' 200.<ref>{{cite web|url=http://www.cmt.com/news/country-music/1623560/miranda-lamberts-revolution-seizes-the-album-summit.jhtml|title=Miranda Lambert's Revolution Seizes the Album Summit|last=Morris|first=Edward|date=10 October 2009|publisher=[[Country Music Television]]|accessdate=6 December 2009}}</ref> The lead single, \"[[Dead Flowers (Miranda Lambert song)|Dead Flowers]]\", was released in May 2009, and peaked within the Top 40. The album's second and third singles, \"[[White Liar]]\" and \"[[The House That Built Me]]\", have become her highest charting singles to date. The final two singles from ''Revolution'' were \"[[Only Prettier]]\" and \"[[Heart Like Mine]]\", the latter has become Miranda's second number one hit. Miranda Lambert has sold about 3 million records according to the [[Recording Industry Association of America]].<ref>{{cite web|url=http://riaa.com/goldandplatinumdata.php?resultpage=1&table=SEARCH_RESULTS&action=&title=&artist=Miranda%20Lambert&format=&debutLP=&category=&sex=&releaseDate=&requestNo=&type=&level=&label=&company=&certificationDate=&awardDescription=&catalogNo=&aSex=&rec_id=&charField=&gold=&platinum=&multiPlat=&level2=&certDate=&album=&id=&after=&before=&startMonth=1&endMonth=1&startYear=1958&endYear=2009&sort=Artist&perPage=25|title=RIAA Gold & Platinum \u2013 Miranda Lambert |publisher=[[Recording Industry Association of America]]|accessdate=2009-12-06}}</ref> Her fifth studio album, ''[[Four the Record]]'', was released in November 2011. The album produced five singles: \"[[Baggage Claim]]\", \"[[Over You (Miranda Lambert song)|Over You]]\", \"[[Fastest Girl in Town]]\", \"[[Mama's Broken Heart]]\", and \"[[All Kinds of Kinds]]\". The first four singles reached the top 10 of the ''Billboard'' Hot Country Songs chart, with \"Over You\" becoming her third number one country single.\n\nLambert released her sixth studio album ''[[Platinum (Miranda Lambert album)|Platinum]]'' on June 3, 2014. The album debuted at number one on Billboard Top Country Albums as well as became her first number one on the ''Billboard'' 200 selling 180,000 copies in its first week. On the Top Country Albums chart, Lambert became the first artist to debut at number one on that chart with five consecutive albums. The album was met with widespread critical acclaim and earned her the [[Grammy Award for Best Country Album]] as well as a [[Country Music Association Awards|CMA Award]] and [[Academy of Country Music Awards|ACM Award]] in the same category. The album was certified platinum by the [[Recording Industry Association of America|RIAA]].\n\nOn November 18, 2016, Lambert released her seventh studio album titled ''[[The Weight of These Wings]]''. It debuted at number three on the ''Billboard'' 200 and number one on Top Country albums chart selling 133,000 [[Billboard 200#Incorporation of streaming data and track sales|equivalent album units]] in its first week of release,<ref>{{cite web|url=http://www.billboard.com/articles/columns/chart-beat/7588880/billboard-200-metallica-no-1-album|title=Metallica Rocks With Sixth No. 1 Album on Billboard 200 Chart|work=[[Billboard (magazine)|Billboard]]|last=Caulfield|first=Keith|date=November 28, 2016|accessdate=November 29, 2016}}</ref><ref name=\"TOC11-28-2016\">{{cite web|last=Houghton|first=Cillea|title=Miranda Lambert Soars to Top of Charts With 'The Weight of These Wings'|url=http://tasteofcountry.com/miranda-lambert-weight-of-these-wings-chart-debut/|website=Taste of Country|publisher=Taste of Country Network|accessdate=November 28, 2016|date=November 28, 2016}}</ref> becoming her sixth consecutive number one debut on the latter chart.\n\n==Studio albums==\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\" \n|-\n! scope=\"col\" rowspan=\"2\" style=\"width:12em;\"| Title\n! scope=\"col\" rowspan=\"2\" style=\"width:19em;\"| Album details\n! scope=\"col\" colspan=\"6\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\" style=\"width:10em;\"| [[List of music recording certifications|Certifications]]<br>([[List of best selling music artists|sales threshold]])\n! scope=\"col\" rowspan=\"2\" style=\"width:10em;\"| Sales\n|-\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[Billboard 200|US]]<br><ref name=\"Billboard 200\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/billboard-200|title=Miranda Lambert Chart History: ''Billboard'' 200|work=[[Billboard (magazine)|Billboard]]|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[Top Country Albums|US<br/><small> Country</small>]]<br><ref name=\"Country Albums\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/country-albums|title=Miranda Lambert Chart History: Country Albums|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[ARIA Charts|AUS]]<br /><ref>{{cite web|url=http://www.ariacharts.com.au/charts/albums-chart|title=ARIA Australian Top 50 Albums|publisher=[[Australian Recording Industry Association]]|date=November 28, 2016|accessdate=November 26, 2016}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[Canadian Albums Chart|CAN]]<br><ref>{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/canadian-albums|title=Miranda Lambert Chart History: Canadian Albums|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[UK Albums Chart|UK]]<br /><ref>Peak positions on UK Albums Chart:\n* ''Platinum'': {{cite web|title=Official Albums Chart Top 100|url=http://www.officialcharts.com/charts/albums-chart/20140608/7502/|publisher=[[Official Charts Company]]|format=08 June 2014 \u2013 14 June 2014|accessdate=May 10, 2018}}\n* ''The Weight of These Wings'': {{cite web|title=Official Albums Chart Top 100|url=http://www.officialcharts.com/charts/albums-chart/20161125/7502/|publisher=[[Official Charts Company]]|format=25 November 2016 \u2013 01 December 2016|accessdate=May 10, 2018}}\n* ''Wildcard'': {{cite web|title=Official Albums Chart Top 100|url=http://www.officialcharts.com/charts/albums-chart/20191108/7502/|publisher=Official Charts Company|accessdate=November 9, 2019}}</ref>\n! scope=\"col\" style=\"width:3.5em;font-size:90%;\"| [[Official Charts Company|UK <br/><small>Country</small>]]<br /><ref>Peak positions on UK Country Artists Albums Chart:\n* ''Four the Record'': {{cite web|title=Official Country Artists Albums Chart Top 20|url=http://www.officialcharts.com/charts/country-artists-albums-chart/20111106/21/|publisher=Official Charts Company|format=06 November 2011 \u2013 12 November 2011|accessdate=May 10, 2018}}\n* ''Platinum'': {{cite web|title=Official Country Artists Albums Chart Top 20|url=http://www.officialcharts.com/charts/country-artists-albums-chart/20140608/21/|publisher=Official Charts Company|format=08 June 2014 \u2013 14 June 2014|accessdate=May 10, 2018}}\n* ''The Weight of These Wings'': {{cite web|title=Official Country Artists Albums Chart Top 20|url=http://www.officialcharts.com/charts/country-artists-albums-chart/20161125/21/|publisher=Official Charts Company|format=25 November 2016 \u2013 01 December 2016|accessdate=May 10, 2018}}\n* ''Wildcard'': {{cite web|title=Official Country Artists Albums Chart Top 20|url=http://www.officialcharts.com/charts/country-artists-albums-chart/20191108/21/|publisher=Official Charts Company|accessdate=November 9, 2019}}</ref>\n|-\n! scope=\"row\"| ''Miranda Lambert''<ref>{{cite web|url={{Allmusic|class=artist|id=miranda-lambert-p684675/biography|pure_url=yes}}|title=Miranda Lambert: AllMusic|website=[[AllMusic]]|accessdate=October 30, 2010}}</ref>\n|\n* Release date: September 21, 2001\n* Label: [[Self-publishing|Self-released]]\n* Format: [[Compact disc|CD]]\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \n|\n|-\n! scope=\"row\"| ''[[Kerosene (album)|Kerosene]]''\n| align=\"left\"| \n* Release date: March 15, 2005\n* Label: [[Epic Records|Epic Nashville]]\n* Format: CD, [[music download|digital download]]\n| 18\n| 1\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n|\n* [[Recording Industry Association of America|RIAA]]: Platinum{{Certification Cite Ref|region=United States|type=album|title=Kerosene|artist=Miranda Lambert}}\n|\n* [[Nielsen SoundScan|US]]: 1,121,000<ref>{{cite web|url=http://riaa.com/goldandplatinumdata.php?resultpage=1&table=SEARCH_RESULTS&action=&title=Kerosene&artist=Miranda%20Lambert&format=ALBUM&debutLP=&category=&sex=&releaseDate=&requestNo=&type=&level=&label=&company=&certificationDate=&awardDescription=&catalogNo=&aSex=&rec_id=&charField=&gold=&platinum=&multiPlat=&level2=&certDate=&album=&id=&after=&before=&startMonth=1&endMonth=1&startYear=1958&endYear=2009&sort=Artist&perPage=25|title=RIAA Gold & Platinum \u2013 ''Kerosene''|publisher=[[Recording Industry Association of America]]|accessdate=8 December 2009|url-status=dead|archiveurl=https://web.archive.org/web/20150924151606/http://www.riaa.com/goldandplatinumdata.php?resultpage=1|archivedate=24 September 2015}}</ref>\n|-\n! scope=\"row\"| ''[[Crazy Ex-Girlfriend (album)|Crazy Ex-Girlfriend]]''\n|\n* Release date: May 1, 2007\n* Label: [[Sony Music Nashville|Columbia Nashville]]\n* Format: CD, digital download\n| 6\n| 1\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n|\n* RIAA: 2\u00d7 Platinum{{Certification Cite Ref|region=United States|type=album|title=Crazy Ex-Girlfriend|artist=Miranda Lambert}}\n|\n* US: 1,573,300<ref>{{cite news|url=http://roughstock.com/news/2017/04/41722-top-country-catalog-album-sales-chart-april-18-2017|title=Top Country Catalog Album Sales Chart: April 18, 2017|first=Matt|last=Bjorke|date=April 18, 2017|accessdate=April 25, 2017|work=Roughstock}}</ref>\n|-\n! scope=\"row\"| ''[[Revolution (Miranda Lambert album)|Revolution]]''\n| align=\"left\"| \n* Release date: September 29, 2009\n* Label: Columbia Nashville\n* Format: CD, digital download\n| 8\n| 1\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n|\n* RIAA: 2\u00d7 Platinum{{Certification Cite Ref|region=United States|type=album|title=Revolution|artist=Miranda Lambert}}\n* [[Music Canada|MC]]: Gold{{Certification Cite Ref|region=Canada|type=album|title=Revolution|artist=Miranda Lambert}}\n\n|\n* US: 1,790,000<ref name=\"album sales 2015\">{{cite news |url=http://roughstock.com/news/2015/01/31909-country-album-chart-report-january-8-2015/ |title=Country Album Chart Report For January 8, 2015 | author= Matt Bjorke |date= January 8, 2015 |work=Roughstock }}</ref>\n|-\n! scope=\"row\"| ''[[Four the Record]]''\n|\n* Release date: November 1, 2011\n* Label: [[RCA Records Nashville|RCA Nashville]]\n* Format: CD, digital download\n| 3\n| 1\n| \u2014\n| 12\n| \u2014\n| 5\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=album|title=Four the Record|artist=Miranda Lambert}}\n|\n* US: 1,014,000<ref>{{cite web|url=http://www.roughstock.com/blog/country-music-s-top-10-albums-the-week-of-may-28-2014|title=http://www.roughstock.com/blog/country-music-s-top-10-albums-the-week-of-may-28-2014|url-status=dead|archiveurl=https://web.archive.org/web/20140529084352/http://www.roughstock.com/blog/country-music-s-top-10-albums-the-week-of-may-28-2014|archivedate=2014-05-29}}</ref>\n|-\n! scope=\"row\"| ''[[Platinum (Miranda Lambert album)|Platinum]]''\n|\n* Release date: June 3, 2014\n* Label: RCA Nashville\n* Format: CD, digital download\n| 1\n| 1\n| 8\n| 1\n| 52\n| 2\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=album|title=Platinum|artist=Miranda Lambert}}\n|\n* US: 850,000<ref>{{cite news|url=http://hitsdailydouble.com/new_album_releases |title=Miranda Lambert Sales |date=October 5, 2016 |work=Hits Daily Double |url-status=bot: unknown |archiveurl=https://web.archive.org/web/20161005091256/http://hitsdailydouble.com/new_album_releases |archivedate=October 5, 2016 }}</ref>\n* CAN: 9,300<ref>{{cite web|url=http://ajournalofmusicalthings.com/weekly-music-sales-report-analysis-june-11-2014/|title=Weekly Music Sales Report and Analysis for June 11, 2014|website=ajournalofmusicalthings.com|accessdate=June 19, 2014}}</ref>\n|-\n! scope=\"row\"| {{nowrap|''[[The Weight of These Wings]]''}}\n|\n* Release date: November 18, 2016\n* Label: RCA Nashville\n* Format: CD, LP, digital download\n| 3\n| 1\n| 26\n| 5\n| 70\n| 3\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=album|title=The Weight of These Wings|artist=Miranda Lambert}}\n|\n* US: 438,500<ref>{{cite news |url=http://roughstock.com/news/2018/09/43329-the-top-10-country-albums-september-4-2018 |title=The Top 10 Country Albums: September 4, 2018 |first= Matt |last= Bjorke |date=September 4, 2018 |work=Roughstock |accessdate=September 29, 2018 }}</ref>\n|-\n! scope=\"row\"| ''[[Wildcard (Miranda Lambert album)|Wildcard]]''\n|\n* Release date: November 1, 2019\n* Label: RCA Nashville\n* Format: CD, LP, digital download\n| 4\n| 1\n| 19<br /><ref>{{cite web|url=http://www.ariacharts.com.au/charts/albums-chart|title=ARIA Australian Top 50 Albums|publisher=[[Australian Recording Industry Association]]|date=November 11, 2019|accessdate=November 9, 2019}}</ref>\n| 12\n| 57\n| 1\n|\n|\n* US: 110,300<ref>{{cite web |url=http://roughstock.com/news/2020/03/44165-top-10-country-albums-pure-sales-chart-march-9-2020|title=Top 10 Country Albums Pure Sales Chart: March 9, 2020 |work=RoughStock|first=Matt |last=Bjorke |date= March 10, 2020 |accessdate=March 22, 2020 }}</ref>\n|-\n|colspan=\"10\" style=\"font-size:90%\"| \"\u2014\" denotes a recording that did not chart or was not released in that territory.\n|}\n\n==Extended plays==\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\" \n|-\n! scope=\"col\" style=\"width:12em;\"| Title\n! scope=\"col\" style=\"width:18em;\"| Extended play details\n|-\n! scope=\"row\"| ''[[Dead Flowers (Miranda Lambert song)#Dead Flowers - EP|Dead Flowers]]''\n| align=\"left\"| \n* Release date: September 8, 2009\n* Label: Columbia Nashville\n* Format: CD\n|}\n\n==Singles==\n===2000s===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:20em;\"| Single\n! scope=\"col\" colspan=\"4\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\" style=\"width:12em;\"| [[List of music recording certifications|Certifications]]<br><small>([[List of best selling music artists|sales threshold]])</small>\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Country Airplay|US Country Airplay]]<br><ref name=\"Country Airplay\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/country-airplay|title=Miranda Lambert Chart History: Country Airplay|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Billboard Hot 100|US]]<br><ref name=\"Hot 100\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/hot-100|title=Miranda Lambert Chart History: Hot 100|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canada Country|CAN Country]]<br><ref name=\"Canada Country\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/canada-country|title=Miranda Lambert Chart History: Canada Country|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canadian Hot 100|CAN]]<br><ref name=\"Canadian Hot 100\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/canadian-hot-100|title=Miranda Lambert Chart History: Canadian Hot 100|work=Billboard|accessdate=May 10, 2018}}</ref>\n|-\n| 2004\n! scope=\"row\"| \"[[Me and Charlie Talking]]\"\n| 27\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\" rowspan=\"4\"| ''Kerosene''\n|-\n| rowspan=\"2\"| 2005\n! scope=\"row\"| \"[[Bring Me Down (Miranda Lambert song)|Bring Me Down]]\"\n| 32\n| \u2014\n| \u2014\n| \u2014\n| \n|-\n! scope=\"row\"| \"[[Kerosene (song)|Kerosene]]\"\n| 15\n| 61\n| \u2014\n| \u2014\n| align=\"left\"| \n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Kerosene|artist=Miranda Lambert}}\n|-\n| rowspan=\"2\"| 2006\n! scope=\"row\"| \"[[New Strings]]\"\n| 25\n| \u2014{{efn-ua|\"New Strings\" did not enter the ''Billboard'' Hot 100, but peaked at number 25 on the [[Bubbling Under Hot 100 Singles]] chart.<ref name=\"Bubbling\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/HBU|title=Miranda Lambert Chart History: Bubbling Under Hot 100|work=Billboard|accessdate=March 24, 2020}}</ref>}}\n| \u2014\n| \u2014\n| \n|-\n! scope=\"row\"| \"Crazy Ex-Girlfriend\"\n| 50\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\" rowspan=\"4\"| ''Crazy Ex-Girlfriend''\n|-\n| 2007\n! scope=\"row\"| \"[[Famous in a Small Town]]\"\n| 14\n| 87\n| 32\n| \u2014\n| \n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Famous in a Small Town|artist=Miranda Lambert}}\n|-\n| rowspan=\"2\"| 2008\n! scope=\"row\"| \"[[Gunpowder & Lead]]\"\n| 7\n| 52\n| 19\n| \u2014\n| align=\"left\"| \n* RIAA: 2\u00d7 Platinum{{Certification Cite Ref|region=United States|type=single|title=Gunpowder & Lead|artist=Miranda Lambert}}\n|-\n! scope=\"row\"| \"[[More Like Her]]\"\n| 17\n| 90\n| 34\n| \u2014\n| \n|-\n| rowspan=\"2\"| 2009\n! scope=\"row\"| \"[[Dead Flowers (Miranda Lambert song)|Dead Flowers]]\"\n| 37\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\" rowspan=\"2\"| ''Revolution''\n|-\n! scope=\"row\"| \"[[White Liar]]\"\n| 2\n| 38\n| 2\n| 67\n| align=\"left\"| \n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=White Liar|artist=Miranda Lambert}}\n|-\n| colspan=\"10\" style=\"font-size:8pt\"| \"\u2014\" denotes releases that did not chart\n|-\n|}\n\n===2010s===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:22em;\"| Single\n! scope=\"col\" colspan=\"5\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\" style=\"width:12em;\"| [[List of music recording certifications|Certifications]]<br><small>([[List of best selling music artists|sales threshold]])</small>\n! rowspan=\"2\"| Sales\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Songs]]<br><ref name=\"Country Songs\">{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/country-songs|title=Miranda Lambert Chart History: Hot Country Songs|work=Billboard|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Country Airplay|US Country Airplay]]<br><ref name=\"Country Airplay\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Billboard Hot 100|US]]<br><ref name=\"Hot 100\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canada Country|CAN Country]]<br><ref name=\"Canada Country\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canadian Hot 100|CAN]]<br><ref name=\"Canadian Hot 100\" />\n|-\n| rowspan=\"2\"| 2010\n! scope=\"row\"| \"[[The House That Built Me]]\"\n| colspan=\"2\"| 1\n| 28\n| 2\n| 52\n| align=\"left\"|\n* RIAA: 3\u00d7 Platinum{{Certification Cite Ref|region=United States|type=single|title=The House That Built Me|artist=Miranda Lambert}}\n|\n* US: 2,267,000<ref>{{Cite news|url=http://roughstock.com/news/2016/04/40097-top-30-digital-singles-april-4-2016|title=The Top 30 Digital Country Singles: April 4, 2016 {{!}} RoughStock|last=http://www.roughstock.com|first=Roughstock -|work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n| align=\"left\" rowspan=\"3\"| ''Revolution''\n|-\n! scope=\"row\"| \"[[Only Prettier]]\"\n| colspan=\"2\"| 12\n| 61\n| 31\n| \u2014\n| \n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Only Prettier|artist=Miranda Lambert}}\n|\n|-\n| rowspan=\"2\"| 2011\n! scope=\"row\"| \"[[Heart Like Mine]]\"\n| colspan=\"2\"| 1\n| 44\n| 2\n| 69\n|\n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Heart Like Mine|artist=Miranda Lambert}}\n|\n|-\n! scope=\"row\"| \"[[Baggage Claim]]\"\n| colspan=\"2\"| 3\n| 44\n| 2\n| 74\n| \n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Baggage Claim|artist=Miranda Lambert}}\n|\n| align=\"left\" rowspan=\"5\"| ''Four the Record''\n|-\n| rowspan=\"2\"| 2012\n! scope=\"row\"| \"[[Over You (Miranda Lambert song)|Over You]]\"\n| colspan=\"2\"| 1\n| 35\n| 1\n| 52\n|\n* RIAA: 2\u00d7 Platinum{{Certification Cite Ref|region=United States|type=single|title=Over You|artist=Miranda Lambert}}\n|\n* US: 1,338,000<ref>{{Cite web|url=http://www.roughstock.com/blog/june-5-2013-florida-georgia-line-danielle-bradbery-blake-shelton-cole-swindell-lead|archive-url=https://web.archive.org/web/20131103230029/http://www.roughstock.com/blog/june-5-2013-florida-georgia-line-danielle-bradbery-blake-shelton-cole-swindell-lead|url-status=dead|archive-date=2013-11-03|title=June 5, 2013: Florida Georgia Line, Danielle Bradbery, Blake Shelton, Cole Swindell Lead {{!}} New Country Music, Listen to Songs & Video {{!}} Roughstock.com|date=2013-11-03|access-date=2017-08-08}}</ref>\n|-\n! scope=\"row\"| \"[[Fastest Girl in Town]]\"\n| 7\n| 3\n| 47\n| 10\n| 72\n|\n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Fastest Girl in Town|artist=Miranda Lambert}}\n|\n|-\n| rowspan=\"2\"|2013\n! scope=\"row\"| \"[[Mama's Broken Heart]]\"\n| 2\n| 2\n| 20\n| 1\n| 30\n|\n* RIAA: 3\u00d7 Platinum{{Certification Cite Ref|region=United States|type=single|title=Mama%27s Broken Heart|artist=Miranda Lambert}}\n|\n* US: 1,960,000<ref>{{Cite news|url=http://roughstock.com/news/2015/09/37550-top-30-digital-country-singles-september-8-2015|title=Top 30 Digital Country Singles: September 8, 2015 {{!}}|first= Matt |last=Bjorke |work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n|-\n! scope=\"row\"| \"[[All Kinds of Kinds]]\"\n| 24\n| 15\n| 89\n| 12\n| 94\n|\n|\n* US: 160,000<ref>{{Cite web|url=http://www.roughstock.com/blog/country-chart-news-the-top-30-digital-singles-november-13-2013-cma-awards-drive-sales-eric-church-the-outsiders-1-taylor-swift-red-3|archive-url=https://web.archive.org/web/20140421103627/http://www.roughstock.com/blog/country-chart-news-the-top-30-digital-singles-november-13-2013-cma-awards-drive-sales-eric-church-the-outsiders-1-taylor-swift-red-3|url-status=dead|archive-date=2014-04-21|title=Country Chart News \u2013 The Top 30 Digital Singles \u2013 November 13, 2013: CMA Awards Drive Sales; Eric Church \"The Outsiders\" #1; Taylor Swift \"Red\" #3 {{!}} New Country Music, Listen to Songs & Video {{!}} Roughstock.com|date=2014-04-21|access-date=2017-08-08}}</ref>\n|-\n| rowspan=\"2\"| 2014\n! scope=\"row\"| \"[[Automatic (Miranda Lambert song)|Automatic]]\"\n| 4\n| 3\n| 35\n| 1\n| 34\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Automatic|artist=Miranda Lambert}}\n|\n* US: 473,000<ref>{{Cite web|url=http://www.roughstock.com/blog/country-chart-news-the-top-30-digital-singles-for-june-25-2014|archive-url=https://web.archive.org/web/20140702163737/http://www.roughstock.com/blog/country-chart-news-the-top-30-digital-singles-for-june-25-2014|url-status=dead|archive-date=2014-07-02|title=Country Chart News: The Top 30 Digital Singles For June 25, 2014 {{!}} New Country Music, Listen to Songs & Video {{!}} Roughstock.com|date=2014-07-02|access-date=2017-08-08}}</ref>\n| align=\"left\" rowspan=\"4\"| ''Platinum''\n|-\n! scope=\"row\"| \"[[Somethin' Bad]]\" <small>(with [[Carrie Underwood]])</small>\n| 1\n| 7\n| 19\n| 6\n| 33\n| \n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Somethin%27 Bad|artist=Miranda Lambert}}\n|\n* US: 1,080,000<ref>{{Cite news|url=http://roughstock.com/news/2015/04/34263-country-musics-top-30-digital-singles-week-april-15-2015/|title=Country Music's Top 30 Digital Singles: Week of April 15, 2015 {{!}} |first= Matt |last=Bjorke |work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n|-\n| rowspan=\"2\"| 2015\n! scope=\"row\"| \"[[Little Red Wagon (song)|Little Red Wagon]]\"\n| 5\n| 16\n| 55\n| 22\n| 56\n|\n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Little Red Wagon|artist=Miranda Lambert}}\n|\n* US: 432,000<ref>{{Cite news|url=http://roughstock.com/news/2015/07/36601-top-30-digital-country-singles-july-28-2015|title=The Top 30 Digital Country Singles: July 28, 2015 {{!}}|first= Matt |last=Bjorke |work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n|-\n! scope=\"row\"| \"[[Smokin' and Drinkin']]\" {{small|(featuring [[Little Big Town]])}}\n| 32\n| 33\n| \u2014\n| 46\n| \u2014\n| \n|\n* US: 132,000<ref>{{Cite news|url=http://roughstock.com/news/2015/09/38115-top-30-digital-country-singles-september-14-2015|title=Top 30 Digital Country Singles: September 14, 2015 {{!}} |first= Matt |last=Bjorke |work=RoughStock|access-date=2017-08-08|language=en-US}}</ref>\n|-\n| rowspan=\"2\"| 2016\n! scope=\"row\"| \"[[Vice (Miranda Lambert song)|Vice]]\"\n| 2\n| 11\n| 47\n| 4\n| 78\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Vice|artist=Miranda Lambert}}\n|\n* US: 508,000<ref>{{cite news |url=http://roughstock.com/news/2017/03/41521-top-30-digital-singles-sales-report-march-6-2017 |title=Top 30 Digital Singles Sales Report: March 6, 2017 |first= Matt |last=Bjorke |date= March 6, 2017  |work=Roughstock }}</ref>\n| rowspan=\"4\" align=\"left\"| ''The Weight of These Wings''\n|-\n! scope=\"row\"| \"[[We Should Be Friends]]\"\n| 25\n| 26\n| \u2014{{efn-ua|\"We Should Be Friends\" did not enter the ''Billboard'' Hot 100, but peaked at number six on the Bubbling Under Hot 100 Singles chart.<ref name=\"Bubbling\"/>}}\n| 20\n| \u2014\n|\n|\n|-\n| 2017\n! scope=\"row\"| \"[[Tin Man (Miranda Lambert song)|Tin Man]]\"\n| 15\n| 22\n| 75\n| 50\n| \u2014\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Tin Man|artist=Miranda Lambert}}\n|\n* US: 386,000<ref>{{cite news|url=http://roughstock.com/news/2018/04/42999-top-30-digital-country-singles-april-30-2018|title=Top 30 Digital Country Singles: April 30, 2018 |work=Roughstock|last=Bjorke|first=Matt|date=April 30, 2018 |accessdate=April 30, 2018 }}</ref>\n|-\n| 2018\n! scope=\"row\"| \"Keeper of the Flame\"\n| \u2014\n| 55\n| \u2014\n| \u2014\n| \u2014\n|\n|\n|-\n| rowspan=\"2\"| 2019\n! scope=\"row\"| \"[[It All Comes Out in the Wash]]\"\n| 12\n| 14\n| 70\n| 10\n| \u2014\n|\n|\n*US: 43,000<ref>{{cite web |last=Bjorke |first=Matt |title=Top 30 Digital Country Songs: November 24, 2019 |url=http://roughstock.com/news/2019/12/44051-top-30-digital-country-songs-november-24-2019 |work=Rough Stock |date=November 30, 2019 |accessdate=December 12, 2019}}</ref>\n| align=\"left\" rowspan=\"2\"| ''Wildcard''\n|-\n! scope=\"row\"| \"[[Bluebird (Miranda Lambert song)|Bluebird]]\"\n| 21\n| 25\n| \u2014{{efn-ua|\"Bluebird\" did not enter the ''Billboard'' Hot 100, but peaked at number 11 on the Bubbling Under Hot 100 chart.<ref name=\"Bubbling\"/>}}\n| \u2014\n| \u2014\n|\n|\n*US: 26,000<ref>{{cite web |last=Bjorke |first=Matt |title=Top 30 Digital Country Singles Sales Chart: March 2, 2020|url=http://roughstock.com/news/2020/03/44155-top-30-digital-country-singles-sales-chart-march-2-2020|work=Rough Stock |date=March 4, 2020 |accessdate=March 14, 2020}}</ref>\n|-\n| colspan=\"11\" style=\"font-size:8pt\" | \"\u2014\" denotes releases that did not chart\n|}\n\n===Featured singles===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:16em;\"| Single\n! scope=\"col\" rowspan=\"2\" style=\"width:14em;\"| Artist(s)\n! scope=\"col\" colspan=\"7\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\" style=\"width:10em;\"| [[List of music recording certifications|Certifications]]<br><small>([[List of best selling music artists|sales threshold]])</small>\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Songs]]<br /><ref name=\"Country Songs\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Country Airplay|US Country Airplay]]<br /><ref name=\"Country Airplay\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Billboard Hot 100|US]]<br /><ref name=\"Hot 100\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canada Country|CAN Country]]<br /><ref name=\"Canada Country\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canadian Hot 100|CAN]]<br /><ref name=\"Canadian Hot 100\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[ARIA Charts|AUS]]<br /><ref>Peak positions on Australian Singles Chart:\n* \"Forever Country\": {{cite web|title=ARIA Report (Issue #1388)|url=http://pandora.nla.gov.au/pan/23790/20161004-0000/Issue1388.pdf|publisher=[[Australian Recording Industry Association]]|accessdate=May 10, 2018}}</ref>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Scottish Singles and Albums Charts|SCO]]<br /><ref>Peak positions on Scottish Singles Chart:\n* \"Forever Country\": {{cite web|title=Official Scottish Singles Sales Chart Top 100|url=http://www.officialcharts.com/charts/scottish-singles-chart/20160930/41/|publisher=[[Official Charts Company]]|format=30 September 2016 \u2013 06 October 2016|accessdate=May 10, 2018}}</ref>\n|-\n| 2010\n! scope=\"row\"| \"[[Coal Miner's Daughter (song)|Coal Miner's Daughter]]\"\n| [[Loretta Lynn]]<br><small>(featuring [[Sheryl Crow]])</small>\n| colspan=\"2\"| 55\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\"| ''[[Coal Miner's Daughter: A Tribute To Loretta Lynn|Coal Miner's Daughter:<br />A Tribute to Loretta Lynn]]''\n|-\n| rowspan=\"2\"| 2013\n! scope=\"row\"| \"[[We Were Us]]\"\n| [[Keith Urban]]\n| 1\n| 1\n| 26\n| 2\n| 25\n| \u2014\n| \u2014\n|\n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=We Were Us|artist=Keith Urban}}\n* MC: Gold{{Certification Cite Ref|region=Canada|type=digital download|title=We Were Us|artist=Keith Urban}}\n| align=\"left\"| ''[[Fuse (Keith Urban album)|Fuse]]''\n|-\n! scope=\"row\"| \"Wrote a Song for Everyone\"\n| [[John Fogerty]]<br><small>(featuring [[Tom Morello]])</small>\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\"| ''[[Wrote a Song for Everyone]]''\n|-\n| 2014\n! scope=\"row\"| \"Annie's New Gun\"\n| [[Gwen Sebastian]]\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \u2014\n| \n| align=\"left\"| ''Gwen Sebastian''\n|-\n| 2016\n! scope=\"row\"| \"[[Forever Country]]\"\n| Artists of Then, Now & Forever\n| 1\n| 33\n| 21\n| 39\n| 25\n| 26\n| 29\n|\n* RIAA: Gold{{Certification Cite Ref|region=United States|type=single|title=Forever Country|artist=Artist Of Then, Now & Forever}}\n| {{n/a|Non-album single}}\n|-\n| 2018\n! scope=\"row\"| \"[[Drowns the Whiskey]]\"\n| [[Jason Aldean]]\n| 3\n| 1\n| 32\n| 1\n| 53\n| \u2014\n| \u2014\n| \n* RIAA: Platinum{{Certification Cite Ref|region=United States|type=single|title=Drowns the Whiskey|artist=Jason Aldean}}\n| align=\"left\"| ''[[Rearview Town]]''\n|-\n| colspan=\"14\" style=\"font-size:8pt\"| \"\u2014\" denotes releases that did not chart\n|}\n\n===Promotional singles===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\" style=\"width:1em;\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:22em;\"| Single\n! scope=\"col\" colspan=\"2\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Songs]]<br /><ref name=\"Country Songs\"/>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Digital]]<br /><ref name=countrydig>{{cite web|url=https://www.billboard.com/music/miranda-lambert/chart-history/country-digital-song-sales|title=Miranda Lambert Chart History: Country Digital Song Sales|work=Billboard|accessdate=May 10, 2018}}</ref>\n|-\n| rowspan=\"6\"| 2019\n! scope=\"row\"| \"Locomotive\"\n| \u2014\n| 25\n| rowspan=\"4\" align=\"left\"| ''Wildcard''\n|-\n! scope=\"row\"| \"Mess with My Head\"\n| 45\n| 6\n|-\n! scope=\"row\"| \"Way Too Pretty for Prison\" <small>(with [[Maren Morris]])</small><ref>{{cite magazine|url=https://www.billboard.com/articles/columns/country/8528295/miranda-lambert-maren-morris-way-too-pretty-for-prison|title=Miranda Lambert Teases Midnight Drop of Maren Morris Collaboration 'Way Too Pretty for Prison'|author=Hilary Hughes|date=August 25, 2019|magazine=Billboard.com|accessdate=August 25, 2019}}</ref>\n| \u2014\n| 11\n|-\n! scope=\"row\"| \"Pretty Bitchin'\"\n| \u2014\n| 18\n|-\n! scope=\"row\"| \"[[Fooled Around and Fell in Love]]\" {{small|(featuring Maren Morris, [[Ashley McBryde]], [[Tenille Townes]], [[Caylee Hammack]], and [[Elle King]])}}\n| 47\n| 7\n| {{n/a|Non-album single}}\n|-\n! scope=\"row\"| \"Tequila Does\"\n| \u2014\n| 8\n| align=\"left\"| ''Wildcard''\n|-\n| colspan=\"5\" style=\"font-size:8pt\"| \"\u2014\" denotes releases that did not chart\n|}\n\n==Other charted songs==\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! scope=\"col\" rowspan=\"2\"| Year\n! scope=\"col\" rowspan=\"2\" style=\"width:20em;\"| Single\n! scope=\"col\" colspan=\"4\"| Peak chart positions\n! scope=\"col\" rowspan=\"2\"| Album\n|-\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Songs]]<br /><ref name=\"Country Songs\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Country Airplay|US Country Airplay]]<br /><ref name=\"Country Airplay\" />\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Hot Country Songs|US Country Digital]]<br /><ref name=countrydig/>\n! scope=\"col\" style=\"width:4.5em;font-size:75%;\"| [[Canada Country|CAN Country]]<br><ref name=\"Canada Country\" />\n|-\n| rowspan=\"2\"| 2012\n! scope=\"row\"| \"Run Daddy Run\" <small>(featuring [[Pistol Annies]])</small>\n| \u2014\n| \u2014\n| 31\n| \u2014\n| align=\"left\"| {{nowrap|''[[The Hunger Games: Songs from District 12 and Beyond]]''}}\n|-\n|-\n! scope=\"row\"| \"[[Jingle Bell Rock]]\" <small>(with [[Blake Shelton]])</small>\n| 37\n| 34\n| \u2014\n| 45\n| align=\"left\"| ''[[Cheers, It's Christmas]]''\n|-\n| 2014\n! scope=\"row\"| \"Platinum\"\n| 50\n| \u2014\n| \u2014\n| \u2014\n| align=\"left\"| ''Platinum''\n|-\n| rowspan=\"2\"| 2015\n! scope=\"row\"| \"Roots and Wings\"\n| 32\n| \u2014\n| 7\n| \u2014\n| {{n/a|Non-album song}}\n|-\n! scope=\"row\"| \"Bathroom Sink\"\n| \u2014\n| \u2014\n| 49\n| \u2014\n| align=\"left\"| ''Platinum''\n|-\n| 2016\n! scope=\"row\"| \"Sweet By & By\"\n| 40\n| \u2014\n| 20\n| \u2014\n| align=\"left\"| ''Southern Family''\n|-\n| colspan=\"8\" style=\"font-size:8pt\"| \"\u2014\" denotes releases that did not chart\n|}\n\n==Videography==\n===Video albums===\n{| class=\"wikitable plainrowheaders\" style=\"text-align:center;\"\n|-\n! style=\"width:16em;\"| Title\n! style=\"width:18em;\"| Details\n|-\n! scope=\"row\"| ''Revolution: Live by Candlelight''\n| \n* Release date: October 12, 2010\n* Label: Sony Music Nashville\n* Format: [[DVD]]\n|}\n\n===Music videos===\n{| class=\"wikitable plainrowheaders\"\n|- \n! Year\n! style=\"width:15em;\"| Title\n! Director\n|- \n| 2004\n! scope=\"row\"| \"Me and Charlie Talking\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/37161/me-and-charlie-talking.jhtml|title=CMT : Videos : Miranda Lambert : Me and Charlie Talking|publisher=[[Country Music Television]]|accessdate=September 26, 2010}}</ref>\n| [[Trey Fanjoy]]\n|-\n| rowspan=\"2\"| 2005\n! scope=\"row\"| \"Bring Me Down\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/53036/bring-me-down.jhtml|title=CMT : Videos : Miranda Lambert : Bring Me Down|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| Kristin Barlowe\n|-\n! scope=\"row\"| \"Kerosene\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/62278/kerosene.jhtml|title=CMT : Videos : Miranda Lambert : Kerosene|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| rowspan=\"3\"| Trey Fanjoy\n|-\n| 2006\n! scope=\"row\"| \"New Strings\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/84709/new-strings.jhtml|title=CMT : Videos : Miranda Lambert : New Strings|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n|-\n| 2007\n! scope=\"row\"| \"Famous in a Small Town\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/142121/famous-in-a-small-town.jhtml|title=CMT : Videos : Miranda Lambert : Famous in a Small Town|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n|-\n| rowspan=\"2\"| 2008\n! scope=\"row\"| \"Gunpowder & Lead\" <small>(Live)</small><ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/177205/gunpowder-lead-from-cmt-cross-country.jhtml|title=CMT : Videos : Miranda Lambert : Gunpowder & Lead|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| Ivan Dudynsky\n|-\n! scope=\"row\"| \"More Like Her\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/294949/more-like-her.jhtml|title=CMT : Videos : Miranda Lambert : More Like Her|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| rowspan=\"2\"| Randee St. Nicholas\n|-\n| rowspan=\"2\"| 2009\n! scope=\"row\"| \"Dead Flowers\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/410454/dead-flowers.jhtml|title=CMT : Videos : Miranda Lambert : Dead Flowers|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n|-\n! scope=\"row\"| \"White Liar\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/437633/white-liar.jhtml|title=CMT : Videos : Miranda Lambert : White Liar|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| [[Chris Hicky]]\n|-\n| rowspan=\"2\"| 2010\n! scope=\"row\"| \"The House That Built Me\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/500805/the-house-that-built-me.jhtml|title=CMT : Videos : Miranda Lambert : The House That Built Me|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n| rowspan=\"2\"| Trey Fanjoy\n|-\n! scope=\"row\"| \"Only Prettier\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/548058/only-prettier.jhtml|title=CMT : Videos : Miranda Lambert : Only Prettier|publisher=Country Music Television|accessdate=September 26, 2010}}</ref>\n|-\n| rowspan=\"2\"| 2011\n! scope=\"row\"| \"Heart Like Mine\" <small>(Live)</small><ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/615708/heart-like-mine.jhtml|title=CMT : Videos : Miranda Lambert : Heart Like Mine|publisher=Country Music Television|accessdate=January 21, 2011}}</ref>\n| Justin Luffman\n|-\n! scope=\"row\"| \"Baggage Claim\" <small>(Live)</small><ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/713178/baggage-claim-2011-cma-awards.jhtml|title=CMT : Videos : Miranda Lambert : Baggage Claim (2011 CMA Awards)|publisher=Country Music Television|accessdate=November 28, 2011}}</ref>\n| Paul Miller\n|-\n| rowspan=\"2\"| 2012\n! scope=\"row\"| \"Over You\"\n| rowspan=\"3\"| Trey Fanjoy\n|-\n! scope=\"row\"| \"Fastest Girl in Town\"<ref>{{cite news|last=Wyland|first=Sarah|title=Miranda Lambert's New Video Co-Stars NASCAR Driver Danica Patrick|url=http://blog.gactv.com/blog/2012/07/13/miranda-lamberts-new-video-co-stars-nascar-driver-danica-patrick/|accessdate=July 15, 2012|newspaper=[[Great American Country]]|date=July 13, 2012}}</ref>\n|-\n| rowspan=\"2\"| 2013\n! scope=\"row\"| \"Mama's Broken Heart\"<ref>{{cite news|last=Carter|first=Liv|title=New Video: 'Mama's Broken Heart' \u2013 Miranda Lambert|url=http://www.urbancountrynews.com/new-video-mamas-broken-heart-miranda-lambert/|accessdate=March 4, 2013|newspaper=Urban Country News|date=March 4, 2013}}</ref>\n|-\n! scope=\"row\"| \"All Kinds of Kinds\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/945518/all-kinds-of-kinds.jhtml|title=CMT : Videos : Miranda Lambert : All Kinds of Kinds|publisher=[[Country Music Television]]|accessdate=August 12, 2013}}</ref>\n| Bluford Sanders\n|-\n| rowspan=\"2\"|2014\n! scope=\"row\"| \"Automatic\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/1014033/automatic.jhtml|title=CMT : Videos : Miranda Lambert : Automatic|publisher=[[Country Music Television]]|accessdate=March 24, 2014}}</ref>\n| rowspan=\"3\"|Trey Fanjoy\n|-\n! scope=\"row\"| \"Somethin' Bad\"<br /><small>(with [[Carrie Underwood]])</small>\n|-\n| rowspan=\"2\"|2015\n! scope=\"row\"| \"Little Red Wagon\"<ref>{{cite news|last1=Vinson|first1=Christina|title=Miranda Lambert Debuts 'Little Red Wagon' Music Video|url=http://theboot.com/miranda-lambert-little-red-wagon-video/|accessdate=March 12, 2015|work=The Boot|date=March 11, 2015}}</ref>\n|-\n! scope=\"row\"| \"Smokin' and Drinkin'\" <small>(Live)</small><ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/1230807/smokin-and-drinkin-feat-little-big-town-live-cma-performance.jhtml|title=CMT : Videos : Miranda Lambert : Smokin' and Drinkin' (feat. Little Big Town) [Live CMA Performance]|publisher=[[Country Music Television]]|accessdate=September 15, 2015}}</ref><br /><small>(with [[Little Big Town]])</small>\n| Paul Miller\n|-\n| 2016\n! scope=\"row\"| \"Vice\"<ref>{{cite web|url=http://www.cmt.com/videos/miranda-lambert/1541628/vice.jhtml|title=CMT : Videos : Miranda Lambert : Vice|publisher=[[Country Music Television]]|accessdate=September 9, 2016}}</ref>\n| rowspan=\"2\"|Trey Fanjoy\n|-\n| rowspan=\"2\"| 2017\n! scope=\"row\"| \"We Should Be Friends\"<ref>{{cite magazine|url=https://www.rollingstone.com/country/news/see-miranda-lamberts-we-should-be-friends-video-w465999|title=See Miranda Lambert's Fabulous Makeover in 'We Should Be Friends' Video|author=Brittney McKenna|date=February 9, 2017|magazine=RollingStone|accessdate=March 7, 2017}}</ref>\n|-\n! scope=\"row\"| \"Tin Man\" <small>(Live)</small>\n| Joe DeMaio\n|-\n| 2018\n! scope=\"row\"| \"Keeper of the Flame\"<ref>{{cite web|url=http://www.cmt.com/video-clips/sso9c2/music-videos-miranda-lambert-keeper-of-the-flame|title=CMT : Miranda Lambert - \"Keeper of the Flame : Music Video S, E|publisher=Vevo|accessdate=August 5, 2018}}</ref>\n| rowspan=\"2\"|Trey Fanjoy\n|-\n| rowspan=\"2\"| 2019\n! scope=\"row\"| \"It All Comes Out in the Wash\"<ref>{{cite web|url=http://www.cmt.com/news/1811234/watch-miranda-lambert-make-a-clean-getaway-from-a-big-mess/|title=Watch Miranda Lambert Make a Clean Getaway from a Big Mess\n|author=Alison Bonaguro|date=August 29, 2019|publisher=CMT|accessdate=August 29, 2019}}</ref>\n|-\n! scope=\"row\"| \"Fooled Around and Fell in Love\"\n|\n|-\n| 2020\n! scope=\"row\"| \"Bluebird\"<ref>{{cite web|url=https://tasteofcountry.com/miranda-lambert-bluebird-music-video/|title=Watch: Miranda Lambert Can't Be Caged in 'Bluebird' Music Video|author=Billy Dukes|date=March 20, 2020|work=|publisher=Taste of Country|accessdate=March 20, 2020}}</ref>\n| Trey Fanjoy\n|-\n|}\n\n===Guest appearances===\n{| class=\"wikitable plainrowheaders\"\n|-\n! Year\n! Title\n! Director\n|-\n| rowspan=\"2\"| 2010\n! scope=\"row\"| \"Bad Angel\" <small>(with [[Dierks Bentley]] and [[Jamey Johnson]])</small><ref>{{cite web|url=http://www.cmt.com/videos/dierks-bentley/558158/bad-angel.jhtml|title=CMT : Videos : Dierks Bentley : Bad Angel|publisher=[[Country Music Television]]|accessdate=September 26, 2010}}</ref>\n| George Flanigen\n|-\n! scope=\"row\"| \"Coal Miner's Daughter\" <small>(with [[Loretta Lynn]] and [[Sheryl Crow]])</small><ref>{{cite web|url=http://www.cmt.com/videos/sheryl-crow/594366/loretta-lynn-sheryl-crow-and-miranda-lambert-coal-miners-daughter.jhtml|title=CMT : Videos : Sheryl Crow : Loretta Lynn, Sheryl Crow and Miranda Lambert \"Coal Miner's Daughter\"|publisher=[[Country Music Television]]|accessdate=November 6, 2010}}</ref>\n| [[Deaton-Flanigen Productions|Deaton-Flanigen]]\n|-\n| 2013\n! scope=\"row\"| \"We Were Us\" <small>(with [[Keith Urban]])</small><ref>{{cite web|url=http://www.cmt.com/videos/keith-urban/979529/we-were-us.jhtml|title=CMT : Videos : Keith Urban : We Were Us|publisher=[[Country Music Television]]|accessdate=November 17, 2013}}</ref>\n| Reid Long\n|-\n| 2016\n! scope=\"row\"| \"Forever Country\" <small>(Artists of Then, Now & Forever)</small>\n| [[Joseph Kahn]]\n|-\n| 2018\n! scope=\"row\"| \"Drowns the Whiskey\" <small>(with [[Jason Aldean]])</small><ref>{{cite web|url=http://www.soundslikenashville.com/news/jason-aldean-drowns-whiskey-video/|title=Jason Aldean 'Drowns The Whiskey' With Miranda Lambert in New Video|publisher=Sounds Like Nashville|date=June 18, 2018|accessdate=November 29, 2018}}</ref>\n| [[Shaun Silva]]\n|-\n|}\n\n==Other appearances==\nThe following songs have not appeared on any of Lambert's albums.\n\n{| class=\"wikitable\"\n|-\n! Year\n! Song\n! Album\n|-\n| 2003\n| \"Today I Started Loving You Again\" <small>(with [[Buddy Jewell]])</small>\n| ''[[Buddy Jewell (album)|Buddy Jewell]]''<ref>{{cite web|url={{Allmusic|class=album|id=r647015|pure_url=yes}}|title=''Buddy Jewell'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|-\n| rowspan=2| 2007\n| \"[[Jailhouse Rock (song)|Jailhouse Rock]]\"\n| ''Elvis: Viva Las Vegas'' <small>(soundtrack)</small><ref>{{cite web|url={{Allmusic|class=album|id=r1311687|pure_url=yes}}|title=''Elvis: Viva Las Vegas'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|-\n| \"Grown Woman\" <small>(with [[Jason Aldean]])</small>\n| ''[[Relentless (Jason Aldean album)|Relentless]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1067893|pure_url=yes}}|title=''Relentless'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|-\n| rowspan=2| 2008\n| \"[[Home (Michael Bubl\u00e9 song)#Blake Shelton version|Home]]\" <small>(with [[Blake Shelton]])</small>\n| ''[[Pure BS]] Deluxe Edition''<ref>{{cite web|url=http://voices.yahoo.com/miranda-lambertcountry-music-star-6454960.html|title=Yahoo|publisher=|access-date=2012-04-07|archive-url=https://web.archive.org/web/20140729042517/http://voices.yahoo.com/miranda-lambertcountry-music-star-6454960.html|archive-date=2014-07-29|url-status=dead}}</ref>\n|-\n| \"Bare Skin Rug\" <small>(with Blake Shelton)</small>\n| ''[[Startin' Fires]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1446559|pure_url=yes}}|title=''Startin' Fires'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|-\n| rowspan=2| 2009\n| \"The Fabric of My Life\"\n| ''Cotton: The Fabric of My Life'' (free ad campaign)<ref>{{cite web|url=http://www.thefabricofourlives.com/TheFabricOfMyLife/music.html |title=Cotton: The Fabric of My Life |publisher=The Fabric of Our Lives.com |accessdate=6 December 2009 |url-status=dead |archiveurl=https://web.archive.org/web/20090614201909/http://www.thefabricofourlives.com/TheFabricOfMyLife/music.html |archivedate=14 June 2009 }}</ref>\n|-\n| \"Strangers on a Train\" <small>(with [[David Nail]])</small>\n| ''[[I'm About to Come Alive]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1579435|pure_url=yes}}|title=''I'm About to Come Alive'' > Overview|website=allmusic|accessdate=6 December 2009}}</ref>\n|- \n| rowspan=2| 2010\n| \"Bad Angel\" <small>(with [[Dierks Bentley]] and [[Jamey Johnson]])</small>\n| ''[[Up on the Ridge]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1785236|pure_url=yes}}|title=''Up On the Ridge'' > Overview|website=[[Allmusic]]|accessdate=September 26, 2010}}</ref>\n|-\n| \"Draggin' the River\" <small>(with Blake Shelton)</small>\n| ''[[All About Tonight (EP)|All About Tonight]]''<ref>{{cite web|url={{Allmusic|class=album|id=r1841653|pure_url=yes}}|title=''All About Tonight'' > Overview|website=[[Allmusic]]|accessdate=September 26, 2010}}</ref>\n|-\n| 2011\n| \"Red River Blue\" <small>(with Blake Shelton)</small>\n| ''[[Red River Blue]]''\n|-\n| 2012\n| \"[[Jingle Bell Rock]]\" <small>(with Blake Shelton)</small>\n| ''[[Cheers It's Christmas]]''\n|-\n| rowspan=4|2013\n| \"Wrote a Song for Everyone\" <small>(with [[John Fogerty]] & [[Tom Morello]])</small>\n| ''[[Wrote a Song for Everyone]]''\n|-\n| \"We Were Us\" <small>(with [[Keith Urban]])</small>\n| ''[[Fuse (Keith Urban album)|Fuse]]''\n|-\n| \"Old Habits\" <small>(with [[Justin Moore]])</small>\n| ''[[Off the Beaten Path (Justin Moore album)|Off the Beaten Path]]''\n|-\n| \"She Was No Good for Me\" <small>(with [[Willie Nelson]])</small>\n| ''[[To All the Girls...]]''\n|-\n| 2015\n| \"Two of a Crime\"\n|''[[Hot Pursuit (2015 film)|Hot Pursuit]]''\n|-\n|-\n| rowspan=\"3\"| 2016\n| \"Sweet By and By\"\n| ''Southern Family''\n|-\n| \"[[Forever Country]]\" <small>(Artists of Then, Now & Forever)</small>\n| non-album single\n|-\n| \"I Wish You Were Here\" <small>(with [[Charles Kelley]])</small>\n| ''[[The Driver (Charles Kelley album)|The Driver]]''\n|-\n| 2017\n| \"Ordinary World\" <small>(with [[Billie Joe Armstrong]])</small>\n| ''[[Greatest Hits: God's Favorite Band]]''\n|-\n| rowspan=2| 2018\n| \"Drowns the Whiskey\" <small>(with Jason Aldean)</small>\n| ''Rearview Town''\n|-\n| \"[[My Father's Gun]]\"\n| ''[[Revamp & Restoration#Restoration|Restoration: Reimagining the Songs of Elton John and Bernie Taupin]]''\n|}\n\n==Notes==\n{{notelist-ua}}\n\n==See also==\n*[[Pistol Annies]]\n\n==References==\n{{reflist}}\n\n==External links==\n* [http://www.mirandalambert.com/music/ Official Discography of Miranda Lambert]\n* [{{Allmusic|class=artist|id=p684675|pure_url=yes}} Discography of Miranda Lambert] at [[Allmusic]]\n\n{{Miranda Lambert}}\n\n{{DEFAULTSORT:Lambert, Miranda}}\n[[Category:Miranda Lambert|Discography]]\n[[Category:Country music discographies]]\n[[Category:Discographies of American artists]]\n", "name_user": "Ss112", "label": "safe", "comment": "\u2192\u200eSingles:updated", "url_page": "//en.wikipedia.org/wiki/Miranda_Lambert_discography"}
{"title_page": "Coronavirus disease 2019", "text_new": "{{About|the disease|the virus|Severe acute respiratory syndrome coronavirus 2|the pandemic|2019\u201320 coronavirus pandemic}}\n{{pp-protected|small=yes}}\n{{Short description|Viral respiratory disease first detected in 2019}}\n{{Use Commonwealth English|date=March 2020}}\n{{Use dmy dates|date=March 2020}}\n{{Infobox medical condition\n| name          = Coronavirus disease 2019 (COVID-19)\n| synonyms      = * Coronavirus\n* 2019-nCoV acute respiratory disease\n* Novel coronavirus pneumonia<ref>{{cite web|url=https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)30211-7.pdf|title=Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study|last=|first=|date=14 February 2020|website=The Lancet|url-status=live|archive-url=|archive-date=|access-date=}}</ref><ref>{{Cite journal|last=Han|first=Xiaoyu|last2=Cao|first2=Yukun|last3=Jiang|first3=Nanchuan|last4=Chen|first4=Yan|last5=Alwalid|first5=Osamah|last6=Zhang|first6=Xin|last7=Gu|first7=Jin|last8=Dai|first8=Meng|last9=Liu|first9=Jie|last10=Zhu|first10=Wanyue|last11=Zheng|first11=Chuansheng|title=Novel Coronavirus Pneumonia (COVID-19) Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section CT Features During Recovery|journal=Clinical Infectious Diseases|year=2020|language=en|doi=10.1093/cid/ciaa271|pmid=32227091}}</ref>\n* Wuhan pneumonia<ref name=TIMEinfo>{{cite news | first = Charlie | last = Campbell | name-list-format = vanc | title = The Wuhan Pneumonia Crisis Highlights the Danger in China's Opaque Way of Doing Things | date = 20 January 2020 | accessdate = 13 March 2020 | url = https://time.com/5768230/wuhan-pneumonia-flu-crisis-china-government/ | work = [[Time (magazine)|Time]] | archive-url = https://web.archive.org/web/20200313053341/https://time.com/5768230/wuhan-pneumonia-flu-crisis-china-government/ | archive-date = 13 March 2020 | url-status = live }}</ref><ref name=FPinfo>{{cite web | first1 = Daniel | last1 = Lucey | first2 = Annie | last2 = Sparrow | name-list-format = vanc | title = China Deserves Some Credit for Its Handling of the Wuhan Pneumonia | date = 14 January 2020 | accessdate = 13 March 2020 | url = https://foreignpolicy.com/2020/01/14/china-response-wuhan-pneumonia-better-sars/ | work = [[Foreign Policy]] | archive-url = https://web.archive.org/web/20200115042408/https://foreignpolicy.com/2020/01/14/china-response-wuhan-pneumonia-better-sars/ | archive-date = 15 January 2020 | url-status = live }}</ref>\n| image         = Symptoms of coronavirus disease 2019 3.0.svg\n| width         = \n| alt           = COVID-19 symptoms\n| caption       = Symptoms of COVID-19\n| pronounce     = {{IPAc-en|k|\u0259|\u02c8|r|o\u028a|n|\u0259|\u02cc|v|a\u026a|r|\u0259|s|_|d|\u026a|\u02c8|z|i:|z}}, {{IPAc-en|\u02c8|k|o\u028a|v|\u026a|d}}\n| specialty     = [[Infectious disease (medical specialty)|Infectious diseases]]\n| symptoms      = Fever, cough, shortness of breath, none<ref name=CDC2020Sym/><ref name=WHO2020QA/>\n| complications = [[Viral pneumonia|Pneumonia]], [[viral sepsis]], [[acute respiratory distress syndrome]], [[Acute kidney injury|kidney failure]]\n| onset         = 2\u201314 days (typically 5) from exposure\n| duration      = \n| types         = \n| cause         = [[Severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2)\n| risks         = Travel, viral exposure\n| diagnosis     = [[Reverse transcription polymerase chain reaction|rRT-PCR testing]], [[CT scan]]\n| differential  = \n| prevention    = [[Hand washing]], [[quarantine]], [[social distancing]]\n| treatment     = [[Symptomatic treatment|Symptomatic]] and [[supportive treatment|supportive]]\n| medication    = \n| prognosis     = \n| frequency     = {{Cases in 2019\u201320 coronavirus pandemic|confirmed|editlink=|ref=yes}} confirmed cases\n| deaths        = {{Cases in 2019\u201320 coronavirus pandemic|deaths|editlink=|ref=no}} ({{Cases in 2019\u201320 coronavirus pandemic|ratio|editlink=|ref=no}} of confirmed cases){{Cases in 2019\u201320 coronavirus pandemic|ref=yes}}\n}}\n<!--Definition and symptoms-->\n'''Coronavirus disease 2019''' ('''COVID-19''') is an [[infectious disease]] caused by [[severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2).<ref>{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it |title=Naming the coronavirus disease (COVID-19) and the virus that causes it |publisher=[[World Health Organization]] (WHO) |url-status=live |archive-url=https://web.archive.org/web/20200228035651/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it |archive-date=28 February 2020 |accessdate=28 February 2020| name-list-format = vanc}}</ref> The disease was first identified in December 2019 in [[Wuhan]], the capital of China's [[Hubei]] province, and has since spread globally, resulting in the ongoing [[2019\u201320 coronavirus pandemic]].<ref name=\"Hui14Jan2020\">{{cite journal |author-last1=Hui |author-first1=D. S. |author2=I. Azhar E. |author-last3=Madani |author-first3=T. A. |author-last4=Ntoumi |author-first4=F. |author-last5=Kock |author-first5=R. |author-last6=Dar |author-first6=O. |author-last7=Ippolito |author-first7=G. |author-last8=Mchugh |author-first8=T. D. |author-last9=Memish |author-first9=Z. A. |author-last10=Drosten |author-first10=Christian |author-link10=Christian Drosten |author-last11=Zumla |author-first11=A. |author-last12=Petersen |author-first12=E. | title=The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014The latest 2019 novel coronavirus outbreak in Wuhan, China | journal=Int J Infect Dis | date=February 2020 | volume=91 | issue= | pages=264\u201366 | pmid=31953166 | doi=10.1016/j.ijid.2020.01.009 | doi-access=free }}</ref><ref name=\"WHOPandemic\">{{cite press release | title=WHO Director-General's opening remarks at the media briefing on COVID-19 | website=[[World Health Organization]] (WHO) | date=11 March 2020 | url=https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 |accessdate=12 March 2020 | url-status=live | archive-url=https://web.archive.org/web/20200311212521/https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 | archive-date=11 March 2020 }}</ref> Common [[symptom]]s include [[fever]], [[cough]] and [[shortness of breath]].<ref name=\"CDCSym\" /> Other symptoms may include fatigue, [[Myalgia|muscle pain]], [[diarrhea]], [[sore throat]], [[loss of smell]] and abdominal pain.<ref name=\"CDC2020Sym\" /><ref name=\"whoqa\">{{cite web|url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|title=Q&A on coronaviruses (COVID-19)|url-status=live|accessdate=11 March 2020|publisher=[[World Health Organization]] (WHO)|archive-url=https://web.archive.org/web/20200120174649/https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|archive-date=20 January 2020}}</ref><ref name=\"entuk-anosmia\" /> The [[incubation period|time from exposure to onset of symptoms]] is typically around five days, but may range from two to 14 days.<ref name=CDCSym>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|title=Symptoms of Novel Coronavirus (2019-nCoV) |date=10 February 2020|website=www.cdc.gov|access-date=11 February 2020|archive-url=https://web.archive.org/web/20200130202038/https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|archive-date=30 January 2020|url-status=live }}</ref><ref>{{Cite journal|author-last1=Velavan |author-first1=T. P. |author-last2=Meyer |author-first2=C. G. |title=The COVID-19 epidemic|journal=Tropical Medicine & International Health|volume=n/a|issue=n/a|pages=278\u201380|doi=10.1111/tmi.13383 |doi-access=free |pmid=32052514|date=March 2020 }}</ref> While the majority of cases result in mild symptoms, some progress to viral [[pneumonia]] and [[multi-organ failure]].<ref name=\"Hui14Jan2020\" /><ref name=\"WHO-q-a\">{{cite web |url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses |title=Q&A on coronaviruses |website=[[World Health Organization]] (WHO) |url-status=live |archive-url=https://web.archive.org/web/20200120174649/https://www.who.int/news-room/q-a-detail/q-a-coronaviruses |archive-date=20 January 2020 |accessdate=27 January 2020| name-list-format = vanc}}</ref> As of {{Cases in 2019\u201320 coronavirus pandemic|date|editlink=|ref=no}}, more than {{Cases in 2019\u201320 coronavirus pandemic|conround|editlink=|ref=yes}} [[2019\u201320 coronavirus pandemic cases/WHO situation reports|cases]] have been reported in more than 200 countries and territories,<ref name=\"WOM\">{{cite web |title=Coronavirus Update (Live): 1,001,069 Cases and 51,378 Deaths from COVID-19 Virus Outbreak\u2014Worldometer |url=https://www.worldometers.info/coronavirus/ |website=www.worldometers.info |accessdate=2 April 2020 |language=en}}</ref> resulting in more than {{Cases in 2019\u201320 coronavirus pandemic|dround|editlink=|ref=no}} [[2019\u201320 coronavirus pandemic deaths/WHO situation reports|deaths]].{{Cases in 2019\u201320 coronavirus pandemic|ref=yes}} More than {{Cases in 2019\u201320 coronavirus pandemic|recround|editlink=|ref=no}} people have recovered.{{Cases in 2019\u201320 coronavirus pandemic|ref=yes}}\n\n<!--Spread-->\n<!--DO NOT INTERFERE WITH THE SECTION BEGIN/END TAGS, AS IT WILL BREAK THE PANDEMIC ARTICLE--><section begin=\"Spread\"/>The virus is mainly [[Transmission (medicine)|spread]] during close contact{{efn|Close contact is defined as one metre (three feet) by the WHO<ref name=\"WHO2020QA\" /> and two metres (six feet) by the CDC.<ref name=\"CDCTrans\" />}} and by [[Respiratory droplet|small droplets]] produced when those infected cough,{{efn|An uncovered cough can travel up to {{convert|8.2|m|ft|abbr=off}}.<ref name=\"Bourouiba, JAMA, 26 March\"/>}} sneeze or talk.<ref name=WHO2020QA/><!--Quote: \"The main way the disease spreads is through respiratory droplets expelled by someone who is coughing.\"--><ref name=CDCTrans/><!--The virus is thought to spread mainly from person-to-person [...] Between people who are in close contact with one another [...] Through respiratory droplets produced when an infected person coughs, sneezes or talks.--><ref name=\"ECDCQA\" /><!--The virus seems to be transmitted mainly via small respiratory droplets through sneezing, coughing, or when people interact with each other for some time in close proximity (usually less than one metre).--> These droplets may also be produced during breathing; however, they rapidly fall to the ground or surfaces and are not generally [[Airborne disease|spread through the air over large distances]].<ref name=WHO2020QA/><!--The disease can spread from person to person through small droplets from the nose or mouth which are spread when a person with COVID-19 coughs or exhales. These droplets land on objects and surfaces around the person.--><ref name=Modes>{{cite web |title=Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations |url=https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations |website=World Health Organization |accessdate=3 April 2020 |language=en |date=29 March 2020 |quote=According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes.}}</ref><!--airborne transmission was not reported... Airborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles <5\u03bcm in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than a meter.--><ref>{{cite web |last1=Organization (WHO) |first1=World Health |title=FACT: #COVID19 is NOT airborne. The #coronavirus is mainly transmitted through droplets generated when an infected person coughs, sneezes or speaks.To protect yourself:-keep 1m distance from others-disinfect surfaces frequently-wash/rub your -avoid touching your pic.twitter.com/fpkcpHAJx7 |url=https://twitter.com/WHO/status/1243972193169616898/photo/1 |website=@WHO |accessdate=3 April 2020 |language=en |date=28 March 2020 |quote=These droplets are too heavy to hang in the air. They quickly fall on floors or sufaces.}}</ref> People may also become infected by touching a contaminated surface and then their face.<ref name=WHO2020QA/><!--These droplets land on objects and surfaces around the person. Other people then catch COVID-19 by touching these objects or surfaces, then touching their eyes, nose or mouth.--><ref name=CDCTrans/><!--The virus is thought to spread mainly from person-to-person [...] Between people who are in close contact with one another--> The virus can survive on surfaces for up to 72 hours.<ref name=\"StableNIH\"/><!--Quote: The scientists found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detectable in aerosols for up to three hours, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.--> Coronavirus is most contagious during the first three days after onset of symptoms, although spread may be possible before symptoms appear and in later stages of the disease.<!--Quote: \"People are thought to be most contagious when they are most symptomatic (the sickest) [...] Some spread might be possible before people show symptoms\"--><ref name=\":22\">{{cite web|url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_4|title=Coronavirus disease 2019 (COVID-19) Situation Report\u201473|last=|first=|date=2 April 2020|website=World Health Organization|url-status=live|archive-url=|archive-date=|access-date=3 April 2020}}</ref><!--Quote: shedding of the COVID-19 virus is highest in upper respiratory tract (nose and throat) early in the course of the disease.8-11 That is, within the first three days from onset of symptoms.10-11 Preliminary data suggests that people may be more contagious around the time of symptom onset as compared to later on in the disease.--><!--DO NOT REMOVE THE FOLLOWING TAG--><section end=\"Spread\"/> \n\n<!--Diagnosis-->\nThe standard method of [[diagnosis]] is by [[real-time reverse transcription polymerase chain reaction]] (rRT-PCR) from a [[nasopharyngeal swab]].<ref name=CDC2020Testing>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html |website=Centers for Disease Control and Prevention |accessdate=26 March 2020 |language=en-us |date=11 February 2020 |archive-url=https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |archive-date=4 March 2020 |url-status=live }}</ref> The infection can also be diagnosed from a combination of symptoms, [[risk factor]]s and a chest [[CT scan]] showing features of pneumonia.<ref name=Jin2020 /><ref name=\":4\">{{cite web|url=https://www.sciencedaily.com/releases/2020/02/200226151951.htm|title=CT provides best diagnosis for COVID-19|date=26 February 2020|website=ScienceDaily|url-status=live|access-date=2 March 2020|archive-url=https://web.archive.org/web/20200318210532/https://www.sciencedaily.com/releases/2020/02/200226151951.htm|archive-date=18 March 2020}}</ref>\n\n<!--Prevention and management-->\nRecommended measures to prevent infection include frequent [[hand washing]], [[social distancing]] (maintaining physical distance from others, especially from those with symptoms), covering coughs and sneezes with a tissue or inner elbow and keeping unwashed hands away from the face.<ref name=\"Advice for public\">{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public|title=Advice for public|website=[[World Health Organization]] (WHO)|access-date=25 February 2020|archive-url=https://web.archive.org/web/20200126025750/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public|archive-date=26 January 2020|url-status=live| name-list-format = vanc}}</ref><ref>{{cite web|url=https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults|title=Guidance on social distancing for everyone in the UK|website=GOV.UK|language=en|access-date=25 March 2020|archive-url=https://web.archive.org/web/20200324214400/https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults|archive-date=24 March 2020|url-status=live}}</ref> The use of [[Surgical mask|masks]] is recommended for those who suspect they have the virus and their caregivers.<ref name=\"CDC2020IfSick\">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/steps-when-sick.html|title=2019&nbsp;Novel Coronavirus (2019-nCoV)|author=CDC|date=11 February 2020|website=Centers for Disease Control and Prevention|url-status=live|archive-url=https://web.archive.org/web/20200214153016/https://www.cdc.gov/coronavirus/2019-ncov/about/steps-when-sick.html|archive-date=14 February 2020|access-date=15 February 2020| name-list-format = vanc}}</ref> Recommendations for mask use by the general public vary, with some authorities recommending against their use, some recommending their use and others requiring their use.<ref>{{Cite journal|last=Feng|first=Shuo |last2=Shen|first2=Chen |last3=Xia|first3=Nan |last4=Song|first4=Wei |last5=Fan|first5=Mengzhen |last6=Cowling|first6=Benjamin J.|date=2020-03-20|title=Rational use of face masks in the COVID-19 pandemic|url=https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X/abstract|journal=The Lancet Respiratory Medicine|language=English|volume=0|doi=10.1016/S2213-2600(20)30134-X|issn=2213-2600|pmid=32203710|pmc=7118603 }}</ref><ref>{{cite web |title=When and how to use masks |url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks |website=www.who.int |accessdate=31 March 2020 |language=en |archive-url=https://web.archive.org/web/20200307013848/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks |archive-date=7 March 2020 |url-status=live }}</ref><!--Quote: \"If you are healthy, you only need to wear a mask if you are taking care of a person with suspected 2019-nCoV infection.\"--><ref>{{Cite news|last=Tait|first=Robert|url=https://www.theguardian.com/world/2020/mar/30/czechs-get-to-work-making-masks-after-government-decree-coronavirus|title=Czechs get to work making masks after government decree|date=2020-03-30|work=The Guardian|access-date=2020-03-31|language=en-GB|issn=0261-3077|archive-url=https://web.archive.org/web/20200330235911/https://www.theguardian.com/world/2020/mar/30/czechs-get-to-work-making-masks-after-government-decree-coronavirus|archive-date=30 March 2020|url-status=live}}</ref> Currently, there is no [[vaccine]] or specific [[antiviral treatment]] for COVID-19.<ref name=WHO2020QA/><!--To date, there is no vaccine and no specific antiviral medicine to prevent or treat COVID-2019.--> Management involves [[Palliative care|treatment of symptoms]], [[supportive care]], [[isolation (health care)|isolation]] and [[Medical research|experimental measures]].<ref name=\"cdc21Jan20202\">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/prevention-treatment.html|title=Coronavirus Disease 2019 (COVID-19)|date=15 February 2020|publisher=[[Centers for Disease Control and Prevention]] (CDC)|url-status=live|archive-url=https://web.archive.org/web/20200226145347/https://www.cdc.gov/coronavirus/2019-ncov/about/prevention-treatment.html|archive-date=26 February 2020|access-date=20 February 2020| name-list-format = vanc}}</ref>\n\n<!--Epidemiology and history-->\nThe [[World Health Organization]] (WHO) declared the 2019\u201320 coronavirus [[outbreak]] a [[Public Health Emergency of International Concern]] (PHEIC)<ref>{{cite web|url=https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)|title=Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)|website=[[World Health Organization]] (WHO)|access-date=11 February 2020|archive-url=https://web.archive.org/web/20200131005904/https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)|archive-date=31 January 2020|url-status=live| name-list-format = vanc}}</ref><ref>{{Cite news | author-last1=Mahtani |author-first1=S. |author-last2=Berger |author-first2=M. |author-last3=O'Grady |author-first3=S. |author-last4=Iati |author-first4=M. | url = https://www.washingtonpost.com/world/asia_pacific/coronavirus-china-live-updates/2020/02/05/114ced8a-479c-11ea-bc78-8a18f7afcee7_story.html |title = Hundreds of evacuees to be held on bases in California; Hong Kong and Taiwan restrict travel from mainland China | work = [[The Washington Post]] | date = 6 February 2020 | access-date = 11 February 2020 | archive-url = https://web.archive.org/web/20200207134650/https://www.washingtonpost.com/world/asia_pacific/coronavirus-china-live-updates/2020/02/05/114ced8a-479c-11ea-bc78-8a18f7afcee7_story.html | archive-date = 7 February 2020 | url-status = live }}</ref> on 30 January 2020 and a [[pandemic]] on 11 March 2020.<ref name=\"WHOPandemic\" /> [[Local transmission]] of the disease has been recorded in many countries across all six [[WHO regions]].<ref>{{cite web|url=http://who.int/docs/default-source/coronaviruse/situation-reports/20200325-sitrep-65-covid-19.pdf|title=WHO Situation Report #65|last=|first=|date=25 March 2020|website=WHO|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n[[File:Wikipedia-VideoWiki-Coronavirus disease 2019.webm|thumb|thumbtime=0:02|upright=1.4|Video summary ([[Wikipedia:VideoWiki/Coronavirus disease 2019|script]])]]\n{{TOC limit}}\n\n==Signs and symptoms==\n\n{{clear}}\n{| class=\"wikitable\" style = \"float:right; margin-left:1em; text-align:center\"\n!Symptom<ref name=\"WHOReport24Feb2020\">{{cite report | title = Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) | date = 16\u201324 February 2020 | url = https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf | publisher = [[World Health Organization]] (WHO) | access-date = 21 March 2020 | archive-url = https://web.archive.org/web/20200229221222/https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf | archivedate = 29 February 2020 | url-status = live }}</ref>\n!%\n|-\n|Fever\n|88\n|-\n|Dry cough\n|68\n|-\n|Fatigue\n|38\n|-\n|[[Sputum]] production\n|33\n|-\n| [[Anosmia|Loss of smell]]\n| 15<ref name=Palus/> to 30<ref name=\"entuk-anosmia\"/><ref name=\"Iacobucci2020\"/>\n|-\n|Shortness of breath\n|19\n|-\n|[[Muscle pain|Muscle]] or [[Arthralgia|joint pain]]\n|15\n|-\n|Sore throat\n|14\n|-\n|Headache\n|14\n|-\n|Chills\n|11\n|-\n|Nausea or vomiting\n|5\n|-\n|Nasal congestion\n|5\n|-\n|[[Diarrhoea]]\n|4 to 31<ref name=\":10\" />\n|-\n|[[Haemoptysis]]\n|0.9\n|-\n|[[Pink eye]]s\n|0.8\n|}\n\nThose infected with the virus may be [[asymptomatic carrier|asymptomatic]] or develop [[influenza-like illness|flu-like symptoms,]] including fever, cough, fatigue and shortness of breath.<ref name=\"CDC2020Sym\"><!--KEEP THIS NAMED REFERENCE-->{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|title=Coronavirus Disease 2019 (COVID-19) Symptoms|date=10 February 2020|website=[[Centers for Disease Control and Prevention]]|location=United States|url-status=live|archive-url=https://web.archive.org/web/20200130202038/https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|archive-date=30 January 2020|access-date=| name-list-format = vanc}}</ref><ref name=\":2\">{{cite journal |author-last1= Chen |author-first1=N. |author-last2=Zhou |author-first2=M. |author-last3=Dong |author-first3=X. |author-last4=Qu |author-first4=J. |author-last5=Gong |author-first5=F. |author-last6=Han |author-first6=Y. |author-last7=Qiu |author-first7=Y. |author-last8=Wang |author-first8=J. |author-last9=Liu |author-first9=Y. |author-last10=Wei |author-first10=Y. |author-last11=Xia |author-first11=J. |author-last12=Yu |author-first12=T. |author-last13=Zhang |author-first13=X. |author-last14=Zhang |author-first14=L. | title = Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study | language = English | journal = Lancet | volume = 395 | issue = 10223 | pages = 507\u2013513 | date = February 2020 | pmid = 32007143 | doi = 10.1016/S0140-6736(20)30211-7 | doi-access = free }}</ref><ref name=\"Hessen27Jan2020\">{{cite web |url=https://www.elsevier.com/connect/coronavirus-information-center |title=Novel Coronavirus Information Center: Expert guidance and commentary |last=Hessen |first=Margaret Trexler | name-list-format = vanc |date=27 January 2020 |website=Elsevier Connect |url-status=live |access-date=31 January 2020 |archive-url=https://web.archive.org/web/20200130171622/https://www.elsevier.com/connect/coronavirus-information-center |archive-date=30 January 2020 }}</ref> Emergency symptoms include difficulty breathing, persistent chest pain or pressure, confusion, difficulty waking and bluish face or lips; immediate medical attention is advised if these symptoms are present.<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19)\u2014Symptoms |url=https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html |website=Centers for Disease Control and Prevention |access-date=21 March 2020 |language=en-us |date=20 March 2020 |archive-url=https://web.archive.org/web/20200320231801/https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html |archive-date=20 March 2020 |url-status=live }}</ref> Less commonly, [[upper respiratory]] symptoms, such as [[sneeze|sneezing]], [[rhinorrhoea|runny nose]] or [[sore throat]] may be seen. Symptoms such as [[nausea]], [[vomiting]] and [[diarrhoea]] have been observed in varying percentages.<ref name=\":10\">{{Cite news|title=Clinical Characteristics of SARS-CoV-2 Infected Pneumonia with Diarrhea|first1=Xiao-Shan|last1=Wei|first2=Xuan|last2=Wang|first3=Yi-Ran|last3=Niu|first4=Lin-Lin|last4=Ye|first5=Wen-Bei|last5=Peng|first6=Zi-Hao|last6=Wang|first7=Wei-Bing|last7=Yang|first8=Bo-Han|last8=Yang|first9=Jian-Chu|last9=Zhang|first10=Wan-Li|last10=Ma|first11=Xiao-Rong|last11=Wang|first12=Qiong|last12=Zhou|date=26 February 2020|doi=10.2139/ssrn.3546120|ssrn = }}</ref><ref name=\"Huang24Jan2020\">{{cite journal | vauthors = Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B | display-authors = 6 | title = Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | journal = Lancet | volume = 395 | issue = 10223 | pages = 497\u2013506 | date = February 2020 | pmid = 31986264 | doi = 10.1016/S0140-6736(20)30183-5 | doi-access = free }}</ref><ref>{{Cite journal|last1=Lai|first1=Chih-Cheng|last2=Shih|first2=Tzu-Ping|last3=Ko|first3=Wen-Chien|last4=Tang|first4=Hung-Jen|last5=Hsueh|first5=Po-Ren|date=1 March 2020|title=Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges|journal=International Journal of Antimicrobial Agents|language=en|volume=55|issue=3|page=105924|doi=10.1016/j.ijantimicag.2020.105924|pmid=32081636|issn=0924-8579}}</ref> Some cases in China initially presented only with [[chest pain|chest tightness]] and [[palpitations]].<ref name=\"Zheng Ma Zhang Xie p.\">{{cite journal | vauthors = Zheng YY, Ma YT, Zhang JY, Xie X | title = COVID-19 and the cardiovascular system | journal = Nature Reviews. Cardiology | date = March 2020 | pmid = 32139904 | doi = 10.1038/s41569-020-0360-5 | doi-access = free }}</ref> In March 2020 there were reports indicating that [[Anosmia|loss of the sense of smell]] (anosmia) may be a common symptom among those who have mild disease,<ref name=\"entuk-anosmia\">{{cite web|url=https://www.entuk.org/loss-sense-smell-marker-covid-19-infection|title=Loss of sense of smell as marker of COVID-19 infection|last=Hopkins|first=Claire|date=|website=Ear, Nose and Throat surgery body of United Kingdom|url-status=live|archive-url=|archive-date=|access-date=|accessdate=2020-03-28}}</ref><ref name=\"Iacobucci2020\">{{cite journal|last1=Iacobucci|first1=Gareth|title=Sixty seconds on . . . anosmia|journal=BMJ|year=2020|volume=368|pages=m1202|issn=1756-1833|doi=10.1136/bmj.m1202|pmid=32209546}}</ref> although not as common as initially reported.<ref name=Palus>{{cite web|url=https://slate.com/technology/2020/03/coronavirus-sense-of-smell-nytimes-fact-check.html|title=The Key Stat in the NYTimes' Piece About Losing Your Sense of Smell Was Wrong|last=Palus|first=Shannon|date=2020-03-27|website=Slate Magazine|language=en|access-date=2020-03-28|archive-url=https://web.archive.org/web/20200328163737/https://slate.com/technology/2020/03/coronavirus-sense-of-smell-nytimes-fact-check.html|archive-date=28 March 2020|url-status=live}}</ref> In some, the disease may progress to [[pneumonia]], [[multiple organ dysfunction syndrome|multi-organ failure]] and [[death]].<ref name=\"Hui14Jan2020\" /><ref name=\"WHO-q-a\" /> In those who develop severe symptoms, time from symptom onset to needing [[mechanical ventilation]] is typically eight days.<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html |website=Centers for Disease Control and Prevention |language=en-us |date=11 February 2020 |access-date=26 March 2020 |archive-url=https://web.archive.org/web/20200302201644/https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html |archive-date=2 March 2020 |url-status=live }}</ref>\n\nAs is common with infections, there is a delay between the moment when a person is infected with the virus and the time when they develop symptoms. This is called the [[incubation period]]. The incubation period for COVID-19 is typically five to six days but may range from two to 14 days.<ref>{{Cite document | vauthors=((World Health Organization)) |title=Coronavirus disease 2019 (COVID-19): situation report, 29 |date=19 February 2020|website=[[World Health Organization]] (WHO) | hdl=10665/331118 | hdl-access=free }}</ref><ref>{{cite web|url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|title=Q&A on coronaviruses (COVID-19): How long is the incubation period for COVID-19?|date=|website=[[World Health Organization]] (WHO)|url-status=live|archive-url=https://web.archive.org/web/20200120174649/https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|archive-date=20 January 2020|access-date=26 February 2020| name-list-format = vanc}}</ref> 97.5% of people who develop symptoms will do so within 11.5 days of infection.<ref>{{cite journal|last1=Lauer|first1=Stephen A.|last2=Grantz|first2=Kyra H.|last3=Bi|first3=Qifang|last4=Jones|first4=Forrest K.|last5=Zheng|first5=Qulu|last6=Meredith|first6=Hannah R.|last7=Azman|first7=Andrew S.|last8=Reich|first8=Nicholas G.|last9=Lessler|first9=Justin|date=10 March 2020|title=The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application|url=https://annals.org/aim/fullarticle/2762808/incubation-period-coronavirus-disease-2019-covid-19-from-publicly-reported|journal=Annals of Internal Medicine|language=en|doi=10.7326/M20-0504|pmid=32150748|pmc=7081172|issn=0003-4819|access-date=24 March 2020|archive-url=https://web.archive.org/web/20200324032020/https://annals.org/aim/fullarticle/2762808/incubation-period-coronavirus-disease-2019-covid-19-from-publicly-reported|archive-date=24 March 2020|url-status=live}}</ref>\n\nReports indicate that not all who are infected develop symptoms, but their role in transmission is unknown.<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html|title=Coronavirus Disease 2019 (COVID-19)|last=|date=2020-02-11|website=Centers for Disease Control and Prevention|language=en-us|access-date=2020-03-31|archive-url=https://web.archive.org/web/20200214023335/https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html|archive-date=14 February 2020|url-status=live}}</ref> Preliminary evidence suggests asymptomatic cases may contribute to the spread of the disease.<ref>{{Cite journal|last=Bai|first=Yan|last2=Yao|first2=Lingsheng|last3=Wei|first3=Tao|last4=Tian|first4=Fei|last5=Jin|first5=Dong-Yan|last6=Chen|first6=Lijuan|last7=Wang|first7=Meiyun|date=2020-02-21|title=Presumed Asymptomatic Carrier Transmission of COVID-19|url=https://jamanetwork.com/journals/jama/fullarticle/2762028|journal=JAMA|language=en|doi=10.1001/jama.2020.2565|issn=0098-7484|pmc=7042844|pmid=32083643|access-date=8 March 2020|archive-url=https://web.archive.org/web/20200304210815/https://jamanetwork.com/journals/jama/fullarticle/2762028|archive-date=4 March 2020|url-status=live}}</ref><ref name=\":1\">{{cite web|url=https://www.bloomberg.com/news/articles/2020-03-31/china-reveals-1-541-symptom-free-virus-cases-under-pressure|title=China Reveals 1,541 Symptom-Free Virus Cases Under Pressure|last=|first=|date=31 March 2020|website=www.bloomberg.com|url-status=live|archive-url=|archive-date=|access-date=2020-03-31}}</ref> The proportion of infected people who do not display symptoms is currently unknown and being studied, with the [[Korea Centers for Disease Control and Prevention]] (KCDC) reporting that 20% of all confirmed cases remained asymptomatic during their hospital stay.<ref name=\":1\" /><ref>{{cite web|url=http://www.ktv.go.kr/program/home/PG1110921D/content/595426|title=\ucf54\ub85c\ub09819 \uad6d\ub0b4 \ubc1c\uc0dd\ud604\ud669 \ube0c\ub9ac\ud551 (20. 03. 16. 14\uc2dc)|website=ktv.go.kr|language=ko|access-date=2020-03-31}}</ref> China's [[National Health Commission]] began including asymptomatic cases in its daily cases on 1 April, of the 166 infections on that day, 130 (78%) were asymptomatic.<ref>{{Cite journal|last=Day|first=Michael|date=2020-04-02|title=Covid-19: four fifths of cases are asymptomatic, China figures indicate|journal=BMJ|volume=369|language=en|pages=m1375|doi=10.1136/bmj.m1375|pmid=32241884|issn=1756-1833}}</ref>\n\n==Cause==\n\n{{See also|Severe acute respiratory syndrome coronavirus 2}}\n\n===Transmission===\n\n[[File:Sneeze.JPG|alt=Cough/sneeze droplets visualised in dark background using Tyndall scattering|thumb|Respiratory droplets produced when a man is [[sneeze|sneezing]] visualised using [[Tyndall scattering]]]]\n[[File:COVID19 in numbers- R0, the case fatality rate and why we need to flatten the curve.webm|thumb|thumbtime=4:02|A video discussing the [[basic reproduction number]] and [[case fatality rate]] in the context of the pandemic]]\n\nSome details about how the disease is [[transmission (medicine)|spread]] are still being determined.<ref name=\"CDCTrans\">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/prepare/transmission.html|title=Coronavirus Disease 2019 (COVID-19)\u2014Transmission|last=|first=|date=April 2, 2020|website=Centers for Disease Control and Prevention|language=en-us|url-status=live|archive-url=https://web.archive.org/web/20200403001235/https://www.cdc.gov/coronavirus/2019-ncov/prepare/transmission.html|archive-date=April 3, 2020|accessdate=April 3, 2020}}</ref><!--Quote: \"We are still learning how it spreads\"--><ref name=\"ECDCQA\">{{cite web|url=https://www.ecdc.europa.eu/en/novel-coronavirus-china/questions-answers|title=Q & A on COVID-19|website=European Centre for Disease Prevention and Control|language=en|url-status=live|archive-url=https://web.archive.org/web/20200205054338/https://www.ecdc.europa.eu/en/novel-coronavirus-china/questions-answers|archive-date=5 February 2020|accessdate=23 March 2020}}</ref> The WHO and the US [[Centers for Disease Control and Prevention]] (CDC) say it is primarily spread during close contact and by [[respiratory droplets|small droplets]] produced when people cough, sneeze or talk;<ref name=\"WHO2020QA\">{{cite web|url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|title=Q&A on coronaviruses|date=11 February 2020|work=[[World Health Organization]]|url-status=live|archive-url=https://web.archive.org/web/20200120174649/https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|archive-date=20 January 2020|accessdate=24 February 2020}}</ref><ref name=CDCTrans/><!--The virus is thought to spread mainly from person-to-person ... Between people who are in close contact with one another ... Via respiratory droplets produced when an infected person coughs or sneezes.--><!--Quote: \"The main way the disease spreads is through respiratory droplets expelled by someone who is coughing.\"--> with close contact being within {{cvt|1|\u2013|3|m}}.<ref name=WHO2020QA/><!--This is why it is important to stay more than a meter (3 feet) away from a person who is sick.--> A study in Singapore found that an uncovered cough can lead to droplets travelling up to {{convert|4.5|m|ft|abbr=off|sp=us}}.<ref>{{cite journal |display-authors=etal |last1=Loh |first1=Ne-Hooi Will |last2=Tan |first2=Yanni |last3=Taculod |first3=Juvel H. |title=The Impact of High-Flow Nasal Cannula (HFNC) on Coughing Distance: Implications on Its Use During the Novel Coronavirus Disease Outbreak |journal=Canadian Journal of Anesthesia |date=18 March 2020 |doi=10.1007/s12630-020-01634-3 |pmid=32189218 |pmc=7090637}}</ref>A second study, produced during the 2020 pandemic, found that advice on the distance droplets could travel might be based on old 1930s research which ignored the protective effect and speed of the warm moist outbreath surrounding the droplets.  This study found that an uncovered cough or sneeze can travel up to {{convert|8.2|m|ft|abbr=off}}.<ref name=\"Bourouiba, JAMA, 26 March\">{{Cite journal| doi = 10.1001/jama.2020.4756| last = Bourouiba| first = Lydia| title = Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19| journal = JAMA| accessdate = 2020-04-06| date = 2020-03-26| pmid = 32215590| url = https://jamanetwork.com/journals/jama/fullarticle/2763852}}</ref>\n\nRespiratory droplets may also be produced while breathing out, including when talking. Though the virus is not generally [[Airborne disease|airborne]],<ref name=WHO2020QA/><!--when a person with COVID-19 coughs or exhales ... Studies to date suggest that the virus that causes COVID-19 is mainly transmitted through contact with respiratory droplets rather than through the air.--><ref name=WHOMar27Airborne>{{cite web |title=Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations |url=https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations |website=www.who.int |accessdate=29 March 2020 |language=en}}</ref><!--Based on the available evidence, including the recent publications mentioned above, the WHO continues to recommend droplet and contact precautions for those people caring for COVID-19 patients and contact and airborne precautions for circumstances and settings in which aerosol generating procedures are performed.--> The National Academy of Science has suggested that [[bioaerosol]] transmission may be possible and air collectors positioned in the hallway outside of people's rooms yielded samples positive for viral RNA.<ref>{{cite web|title=Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic|date=1 April 2020|url=https://www.nap.edu/catalog/25769/rapid-expert-consultation-on-the-possibility-of-bioaerosol-spread-of-sars-cov-2-for-the-covid-19-pandemic-april-1-2020|publisher=The National Academies Press|accessdate=1 April 2020}}</ref> The droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs.<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19)\u2014Transmission |url=https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Ftransmission.html |website=Centers for Disease Control and Prevention |accessdate=29 March 2020 |language=en-us |date=17 March 2020}}</ref><!--Quote: \"These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs.\"--> Some medical procedures such as intubation and [[cardiopulmonary resuscitation]] (CPR) may cause respiratory secretions to be aerosolised and thus result in airborne spread.<ref name=WHOMar27Airborne/> It may also spread when one touches a contaminated surface, known as [[fomite]] transmission, and then touches ones eyes, nose or mouth.<ref name=WHO2020QA/><!--These droplets land on objects and surfaces around the person. Other people then catch COVID-19 by touching these objects or surfaces, then touching their eyes, nose or mouth.--> While there are concerns it may spread by [[Fecal\u2013oral route|feces]], this risk is believed to be low.<ref name=WHO2020QA/><!--The risk of catching COVID-19 from the feces of an infected person appears to be low.--><ref name=CDCTrans/><!--within about six feet-->\n\nThe virus is most contagious when people are symptomatic; while spread may be possible before symptoms appear, this risk is low.<ref name=WHO2020QA/><!--Quote: \"The risk of catching COVID-19 from someone with no symptoms at all is very low.\"--><ref name=CDCTrans/><!--Quote: \"People are thought to be most contagious when they are most symptomatic (the sickest) [...] Some spread might be possible before people show symptoms\"--> The [[European Centre for Disease Prevention and Control]] (ECDC) says while it is not entirely clear how easily the disease spreads, one person generally infects two to three others.<ref name=\"ECDCQA\" />\n\nThe virus survives for hours to days on surfaces.<ref name=WHO2020QA/><!--Quote: \"Current evidence suggests that novel coronavirus may remain viable for hours to days on surfaces made from a variety of materials\"--><ref name=\"ECDCQA\" /> Specifically, the virus was found to be detectable for one day on cardboard, for up to three days on plastic and stainless steel and for up to four hours on copper.<ref name=\"StableNIH\">{{cite web|url=https://www.nih.gov/news-events/news-releases/new-coronavirus-stable-hours-surfaces|title=New coronavirus stable for hours on surfaces|date=17 March 2020|publisher=[[National Institutes of Health]]|url-status=live|archive-url=https://web.archive.org/web/20200323032520/https://www.nih.gov/news-events/news-releases/new-coronavirus-stable-hours-surfaces|archive-date=23 March 2020|accessdate=23 March 2020}}</ref><ref>{{Cite journal|last=van Doremalen|first=Neeltje|last2=Bushmaker|first2=Trenton|last3=Morris|first3=Dylan H.|last4=Holbrook|first4=Myndi G.|last5=Gamble|first5=Amandine|last6=Williamson|first6=Brandi N.|last7=Tamin|first7=Azaibi|last8=Harcourt|first8=Jennifer L.|last9=Thornburg|first9=Natalie J.|last10=Gerber|first10=Susan I.|last11=Lloyd-Smith|first11=James O.|date=2020-03-17|title=Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1|journal=New England Journal of Medicine|language=en|pages=NEJMc2004973|doi=10.1056/NEJMc2004973|issn=0028-4793|pmc=7121658|pmid=32182409}}</ref> This, however, varies based on the humidity and temperature.<ref>{{cite journal |last1=Moriyama |first1=M |last2=Hugentobler |first2=WJ |last3=Iwasaki |first3=A |title=Seasonality of Respiratory Viral Infections. |journal=Annual Review of Virology |date=20 March 2020 |volume=7 |doi=10.1146/annurev-virology-012420-022445 |pmid=32196426}}</ref><ref>Holden, Emily, ''[https://www.theguardian.com/world/2020/apr/02/do-you-need-to-wash-your-groceries-and-other-advice-for-shopping-safely Do you need to wash your groceries? And other advice for shopping safely]'', [[The Guardian]], Thursday, April 2, 2020</ref> Surfaces may be decontaminated with a number of solutions (within one minute of exposure to the disinfectant to achieve a 4 or more [[log reduction]]), including 78\u201395% [[ethanol]] (alcohol used in spirits), 70\u2013100% [[2-propanol]] (isopropyl alcohol), the combination of 45% 2-propanol with 30% [[1-propanol]], 0.21% [[sodium hypochlorite]] (bleach), 0.5% [[hydrogen peroxide]], or 0.23\u20137.5% [[povidone-iodine]]. [[Soap]] and [[detergent]] are also effective if correctly used; soap products degrade the virus' fatty protective layer, deactivating it, as well as freeing them from skin and other surfaces.<ref name=\"cnn-soap\">{{cite news|author= |url=https://edition.cnn.com/2020/03/24/health/soap-warm-water-hand-sanitizer-coronavirus-wellness-scn/index.html |title=COVID-19 prevention: Why soap, sanitizer and warm water work against coronavirus - CNN |publisher=Edition.cnn.com |date=2020-03-24 |accessdate=2020-04-07}}</ref> Other solutions, such as [[benzalkonium chloride]] and [[chlorhexidine|chlorhexidine gluconate]] (a surgical disinfectant), are less effective.<ref name=\"SurfacePersistence\">{{cite journal |last1=Kampf |first1=G. |last2=Todt |first2=D. |last3=Pfaender |first3=S. |last4=Steinmann |first4=E. |title=Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents |url=https://www.journalofhospitalinfection.com/article/S0195-6701(20)30046-3/fulltext |journal=The Journal of Hospital Infection |volume=104 |issue=3 |pages=246\u2013251 |date=March 2020 |pmid=32035997 |doi=10.1016/j.jhin.2020.01.022}} {{free access}}</ref>\n\n===Virology===\n\n{{Main|Severe acute respiratory syndrome coronavirus 2}}\n[[File:Coronavirus virion structure.svg|thumb|Illustration of [[SARSr-CoV]] virion]]\nSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a [[novel virus|novel]] severe acute respiratory syndrome coronavirus, first isolated from three people with pneumonia connected to the [[Disease cluster|cluster]] of acute respiratory illness cases in Wuhan.<ref name=\"ECDC risk assessment\">{{cite web |url=https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-risk-assessment-14-feb-2020.pdf |title=Outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): increased transmission beyond China\u2014fourth update |publisher=European Centre for Disease Prevention and Control |date=14 February 2020 |access-date=8 March 2020}}</ref> All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.<ref name=\"NM-20200317\" />\nOutside the human body, the virus is killed by household [[soap]], which bursts its protective bubble.<ref name=\":0\" />\n\nSARS-CoV-2 is closely related to the original SARS-CoV.<ref name=\"Zhu24Jan2020\">{{cite journal |vauthors=Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W |display-authors=6 |title=A Novel Coronavirus from Patients with Pneumonia in China, 2019 |journal=[[The New England Journal of Medicine]] |volume=382 |issue=8 |pages=727\u2013733 |date=February 2020 |pmid=31978945 |doi=10.1056/NEJMoa2001017|pmc=7092803 }}</ref> It is thought to have a [[Zoonosis|zoonotic]] origin. Genetic analysis has revealed that the coronavirus genetically clusters with the genus ''[[Betacoronavirus]]'', in subgenus [[Severe acute respiratory syndrome-related coronavirus|''Sarbecovirus'']] (lineage B) together with two bat-derived strains. It is 96% identical at the whole [[genome]] level to other bat coronavirus samples (BatCov RaTG13).<ref name=\"WHOReport24Feb2020\" /> In February 2020, Chinese researchers found that there is only one [[amino acid]] difference in certain parts of the genome sequences between the viruses from [[pangolins]] and those from humans, however, whole-genome comparison to date found at most 92% of genetic material shared between pangolin coronavirus and SARS-CoV-2, which is insufficient to prove pangolins to be the [[intermediate host]].<ref name=\"Cyranoski26Feb2020\">{{cite journal |title=Mystery deepens over animal source of coronavirus |journal=Nature |volume=579 |pages=18\u201319 |date=26 February 2020 |doi=10.1038/d41586-020-00548-w |pmid=32127703 |vauthors=Cyranoski D |issue=7797 |bibcode=2020Natur.579...18C}}</ref>\n\n==Pathophysiology==\n\nThe lungs are the organs most affected by COVID-19 because the virus accesses host cells via the enzyme [[angiotensin-converting enzyme 2]] (ACE2), which is most abundant in the [[Type II cell|type II alveolar cells]] of the lungs. The virus uses a special surface glycoprotein called a \"spike\" ([[peplomer]]) to connect to ACE2 and enter the host cell.<ref name=\"Nature Microbiology\">{{cite journal | title=Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses | journal=Nature Microbiology | doi=10.1038/s41564-020-0688-y | doi-access=free | pmid=32094589 | date=2020 | vauthors=Letko M, Marzi A, Munster V | volume=5 | issue=4 | pages=562\u2013569 }}</ref> The density of ACE2 in each tissue correlates with the severity of the disease in that tissue and some have suggested that decreasing ACE2 activity might be protective,<ref name=\"Zhang Penninger Li Zhong p.\">{{cite journal | vauthors=Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS | title=Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | journal=Intensive Care Medicine | date=March 2020 | volume=46 | issue=4 | pages=586\u2013590 |doi=10.1007/s00134-020-05985-9 | doi-access=free | pmid=32125455 | pmc=7079879 }}</ref><ref name=\"Xu Zhong Deng Peng p.\">{{cite journal | vauthors=Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q | display-authors=6 | title=High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa | journal=International Journal of Oral Science | volume=12 | issue=1 | page=8 | date=February 2020 | doi=10.1038/s41368-020-0074-x |doi-access=free | pmid=32094336 | pmc=7039956 }}</ref> though another view is that increasing ACE2 using [[angiotensin II receptor blocker]] medications could be protective and that these hypotheses need to be tested.<ref>{{cite journal | vauthors=Gurwitz D | title=Angiotensin receptor blockers as tentative SARS\u2010CoV\u20102 therapeutics | journal=Drug Development Research | doi=10.1002/ddr.21656 | doi-access=free | pmid=32129518 | date=March 2020 }}</ref> As the alveolar disease progresses, respiratory failure might develop and death may follow.<ref name=\"Xu Zhong Deng Peng p.\"/>\n\nThe virus also affects gastrointestinal organs as ACE2 is abundantly expressed in the [[gland]]ular cells of [[Stomach|gastric]], [[Duodenum|duodenal]] and [[Rectum|rectal]] [[epithelium]]<ref name=\":11\">{{Cite journal|last1=Gu|first1=Jinyang|last2=Han|first2=Bing|last3=Wang|first3=Jian|date=27 February 2020|title=COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission|journal=Gastroenterology|volume=|pages=|doi=10.1053/j.gastro.2020.02.054|pmid=32142785|issn=0016-5085}}</ref> as well as [[Endothelium|endothelial]] cells and [[enterocyte]]s of the [[small intestine]].<ref>{{Cite journal|last1=Hamming|first1=I.|last2=Timens|first2=W.|last3=Bulthuis|first3=M. L. C.|last4=Lely|first4=A. T.|last5=Navis|first5=G. J.|last6=Goor|first6=H. van|date=2004|title=Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis|journal=The Journal of Pathology|language=en|volume=203|issue=2|pages=631\u2013637|doi=10.1002/path.1570|pmid=15141377|issn=1096-9896}}</ref>\n\nThe expanding part of the lungs, [[Pulmonary alveolus|pulmonary alveoli]], contain two main types of functioning cells. One cell, [[Pulmonary alveolus#Type I|type I]], absorbs from the air, i.e. [[gas exchange]]. The other, [[Pulmonary alveolus#Type II|type II]], produces [[surfactant]]s, which serve to keep the lungs fluid, clean, infection free, etc. COVID-19 finds a way into a surfactant producing type II cell and smothers it by reproducing COVID-19 virus within it. Each type II cell which perishes to the virus causes an extreme reaction in the lungs. Fluids, pus and dead cell material flood the lung, causing the coronavirus pulmonary disease.<ref name=\"DrVuong\">{{cite web|url=https://www.youtube.com/watch?v=4J0d59dd-qM |author=Doctor Duc C Vuong|title=HOW COVID-19 KILLS--I'm a Surgeon--And Why We Can't Save You |publisher=YouTube |date=23 March 2020 |accessdate=5 April 2020 |archiveurl = |archivedate = |url-status=live}}</ref>\n\n===Immunopathology===\n\nAlthough SARS-COV-2 has a tropism for ACE2-expressing epithelial cells of the respitatory tract, patients with severe COVID-19 have symptoms of systemic hyperinflammation. Clinical labratory findings of elevated IL-2, IL-7, IL-6, [[granulocyte-macrophage colony-stimulating factor]] (GM-CSF), interferon-\u03b3 inducible protein 10 (IP-10), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1-\u03b1 (MIP-1\u03b1), and tumour necrosis factor-\u03b1 (TNF-\u03b1) indicative of [[cytokine release syndrome]] (CRS) suggest an underlying immunopathology.<ref name=\"LancetCRS\">{{cite journal | vauthors = Huang C et al | display-authors = 1 | title = Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | journal = The Lancet | date = 2020 | volume = 395 | issue = 10223 | pages = 497\u2013506 | doi = 10.1016/S0140-6736(20)30183-5 | pmid = 31986264 | url = https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext}}</ref> \n\nAdditionally, people with COVID-19 and [[acute respiratory distress syndrome]] (ARDS) have classical serum biomarkers of CRS including elevated C-reactive protein (CRP), [[lactate dehydrogenase]] (LDH), D-dimer, and ferritin.<ref>{{cite journal | vauthors = Zhang C et al. | title = The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality | journal = International Journal of Antimicrobial Agents | year = 2020 | pages = 105954 | doi = 10.1016/j.ijantimicag.2020.105954 | pmid = 32234467 | pmc = 7118634 | url = https://www.sciencedirect.com/science/article/pii/S0924857920301047}}</ref> \n\nSystemic inflammation results in vasodilation, allowing inflammatory lymphocytic and monocytic infiltration of the lung and the heart. In particular, pathogenic GM-CSF-secreting T-cells were shown to correlate with the recruitment of inflammatory IL-6-secreting monocytes and severe lung pathology in COVID-19 patients.<ref>{{cite journal | vauthors = Zhou Y et al. | title = Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus | journal = bioRxiv Pre-print | year = 2020 | doi = 10.1101/2020.02.12.945576 | url = https://www.biorxiv.org/content/10.1101/2020.02.12.945576v1}}</ref>\n\n==Diagnosis==\n\n{{main|COVID-19 testing}}\n[[File:Infektionsschutzzentrum im Rautenstrauch-Joest-Museum, K\u00f6ln-6313 (cropped).jpg|thumb|Demonstration of a [[nasopharyngeal swab]] for [[COVID-19 testing]]]]\n[[File:CDC 2019-nCoV Laboratory Test Kit.jpg|thumb|[[Centers for Disease Control and Prevention|CDC]] [[rRT-PCR]] test kit for COVID-19<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/testing.html|title=CDC Tests for 2019-nCoV|author=|date=5 February 2020|website=Centers for Disease Control and Prevention|url-status=live|archive-url=https://web.archive.org/web/20200214023335/https://www.cdc.gov/coronavirus/2019-ncov/about/testing.html|archive-date=14 February 2020|access-date=12 February 2020| name-list-format = vanc}}</ref>]]\nThe WHO has published several testing protocols for the disease.<ref>{{cite web|url=https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117|title=Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases|website=[[World Health Organization]] (WHO)|access-date=13 March 2020|archive-url=https://web.archive.org/web/20200317023052/https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117|archive-date=17 March 2020|url-status=live}}</ref> The standard method of testing is [[real-time reverse transcription polymerase chain reaction]] (rRT-PCR).<ref name=\"20200130cdc\">{{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/summary.html |title=2019 Novel Coronavirus (2019-nCoV) Situation Summary |date=30 January 2020 |website=[[Centers for Disease Control and Prevention]] |url-status=live |archive-url=https://web.archive.org/web/20200126210549/https://www.cdc.gov/coronavirus/2019-nCoV/summary.html |archive-date=26 January 2020 |access-date=30 January 2020| name-list-format = vanc}}</ref> The test is typically done on respiratory samples obtained by a [[nasopharyngeal swab]], however a nasal swab or [[sputum]] sample may also be used.<ref name=\"CDC2020Testing\"/><ref name=\"20200129cdc\">{{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html |title=Real-Time RT-PCR Panel for Detection 2019-nCoV |date=29 January 2020 |website=[[Centers for Disease Control and Prevention]] |access-date=1 February 2020 |archive-url=https://web.archive.org/web/20200130202031/https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html |archive-date=30 January 2020 |url-status=live | name-list-format = vanc}}</ref> Results are generally available within a few hours to two days.<ref name=\"globenewswire1977226\">{{cite web |url=https://www.globenewswire.com/news-release/2020/01/30/1977226/0/en/Curetis-Group-Company-Ares-Genetics-and-BGI-Group-Collaborate-to-Offer-Next-Generation-Sequencing-and-PCR-based-Coronavirus-2019-nCoV-Testing-in-Europe.html |title=Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe |date=30 January 2020 |website=GlobeNewswire News Room |access-date=1 February 2020 |archive-url=https://web.archive.org/web/20200131201626/https://www.globenewswire.com/news-release/2020/01/30/1977226/0/en/Curetis-Group-Company-Ares-Genetics-and-BGI-Group-Collaborate-to-Offer-Next-Generation-Sequencing-and-PCR-based-Coronavirus-2019-nCoV-Testing-in-Europe.html |archive-date=31 January 2020 |url-status=live | name-list-format = vanc}}</ref><ref name=\"20200130businessinsider\">{{cite web |url=https://www.businessinsider.com/how-to-know-if-you-have-the-coronavirus-pcr-test-2020-1 |title=There's only one way to know if you have the coronavirus, and it involves machines full of spit and mucus |last=Brueck |first=Hilary | name-list-format = vanc |date=30 January 2020 |website=Business Insider |access-date=1 February 2020 |archive-url= https://web.archive.org/web/20200201034232/https://www.businessinsider.com/how-to-know-if-you-have-the-coronavirus-pcr-test-2020-1 |archive-date=1 February 2020 |url-status=live }}</ref> Blood tests can be used, but these require two blood samples taken two weeks apart and the results have little immediate value.<ref>{{cite web |url=https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 |title=Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases |access-date=26 February 2020 |archive-url=https://web.archive.org/web/20200221192745/https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 |archive-date=21 February 2020 |url-status=live }}</ref> Chinese scientists were able to isolate a strain of the coronavirus and publish the [[Nucleic acid sequence|genetic sequence]] so laboratories across the world could independently develop [[polymerase chain reaction]] (PCR) tests to detect infection by the virus.<ref name=\"Hui14Jan2020\" /><ref name=\"Cohen17Jan20202\">{{cite journal | vauthors = Cohen J, Normile D | title = New SARS-like virus in China triggers alarm | journal = Science | volume = 367 | issue = 6475 | pages = 234\u201335 | date = January 2020 | pmid = 31949058 |doi=10.1126/science.367.6475.234 | bibcode = 2020Sci...367..234C | url = https://mcb.uconn.edu/wp-content/uploads/sites/2341/2020/01/WuhanScience24Jan2020.pdf | access-date = 11 February 2020 | url-status = live | archive-url = https://web.archive.org/web/20200211230310/https://mcb.uconn.edu/wp-content/uploads/sites/2341/2020/01/WuhanScience24Jan2020.pdf | archive-date = 11 February 2020 }}</ref><ref name=\"ncbiWuhanGenomes\">{{cite web |url=https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&VirusLineage_ss=Wuhan%20seafood%20market%20pneumonia%20virus,%20taxid:2697049 |title=Severe acute respiratory syndrome coronavirus 2 data hub |website=NCBI |url-status=live |access-date=4 March 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200321235550/https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&VirusLineage_ss=Wuhan%20seafood%20market%20pneumonia%20virus,%20taxid:2697049 |archive-date=21 March 2020 }}</ref> {{As of|2020|April|4}}, [[antibody titer|antibody test]]s (which may detect active infections and whether a person had been infected in the past) were in development, but not yet widely used.<ref>{{Cite journal|last=Petherick|first=Anna|date=4 April 2020|title=Developing antibody tests for SARS-CoV-2|journal=The Lancet|volume=395|issue=10230|pages=1101\u20131102|doi=10.1016/s0140-6736(20)30788-1|pmid=32247384|issn=0140-6736}}</ref><ref name=\"Vogel2020\">{{cite journal |title=New blood tests for antibodies could show true scale of coronavirus pandemic |last=Vogel| first=Gretchen |journal=Science |issn=0036-8075 |doi=10.1126/science.abb8028|date=2020-03-19}}</ref><ref>{{cite journal | vauthors = Pang J, Wang MX, Ang IY, Tan SH, Lewis RF, Chen JI, Gutierrez RA, Gwee SX, Chua PE, Yang Q, Ng XY, Yap RK, Tan HY, Teo YY, Tan CC, Cook AR, Yap JC, Hsu LY | display-authors = 6 | title = Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review | journal = Journal of Clinical Medicine | volume = 9 | issue = 3 | page = 623 | date = February 2020 | pmid = 32110875 | doi = 10.3390/jcm9030623 }}</ref> The FDA approved the first [[Point-of-care testing|point-of-care test]] on 21 March 2020 for use at the end of that month.<ref>{{cite press release |title= Coronavirus (COVID-19) Update: FDA Issues first Emergency Use Authorization for Point of Care Diagnostic |date= 21 March 2020 |publisher= FDA |url= https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-use-authorization-point-care-diagnostic |access-date= 22 March 2020 |archive-url= https://web.archive.org/web/20200321224700/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-use-authorization-point-care-diagnostic |archive-date= 21 March 2020 |url-status= live }}</ref>\n\nDiagnostic guidelines released by Zhongnan Hospital of [[Wuhan University]] suggested methods for detecting infections based upon clinical features and epidemiological risk. These involved identifying people who had at least two of the following symptoms in addition to a history of travel to [[Wuhan]] or contact with other infected people: fever, imaging features of pneumonia, normal or reduced white blood cell count or reduced [[lymphocyte]] count.<ref name=Jin2020>{{cite journal | vauthors=Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, Fang C, Huang D, Huang LQ, Huang Q, Han Y, Hu B, Hu F, Li BH, Li YR, Liang K, Lin LK, Luo LS, Ma J, Ma LL, Peng ZY, Pan YB, Pan ZY, Ren XQ, Sun HM, Wang Y, Wang YY, Weng H, Wei CJ, Wu DF, Xia J, Xiong Y, Xu HB, Yao XM, Yuan YF, Ye TS, Zhang XC, Zhang YW, Zhang YG, Zhang HM, Zhao Y, Zhao MJ, Zi H, Zeng XT, Wang YY, Wang XH | display-authors=6 | title=A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) | journal=Military Medical Research | date=February 2020 | volume=7 | issue=1 | page=4 | doi=10.1186/s40779-020-0233-6 | doi-access=free | pmid=32029004 | pmc=7003341 }}</ref>\n\nA March 2020 review concluded that [[Chest radiograph|chest X-rays]] are of little value in early stages, whereas CT scans of the chest are useful even before symptoms occur.<ref name=\":0\">{{Cite journal|last=Salehi|first=Sana|last2=Abedi|first2=Aidin|last3=Balakrishnan|first3=Sudheer|last4=Gholamrezanezhad|first4=Ali|date=2020-03-14|title=Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients|journal=American Journal of Roentgenology|language=en|pages=1\u20137|doi=10.2214/AJR.20.23034|issn=0361-803X|pmid=32174129}}</ref> Typical features on CT include bilateral multilobar [[Ground glass opacity|ground-glass opacificities]] with a peripheral, asymmetric and posterior distribution.<ref name=\":0\" /> [[Pleural cavity|Subpleural dominance]], [[crazy paving (medicine)|crazy paving]] (lobular septal thickening with variable alveolar filling) and [[Pulmonary consolidation|consolidation]] develop as the disease evolves.<ref>{{cite journal|last1=Lee|first1=Elaine Y. P.|last2=Ng|first2=Ming-Yen|last3=Khong|first3=Pek-Lan|date=24 February 2020|title=COVID-19 pneumonia: what has CT taught us?|url=https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30134-1/fulltext|journal=The Lancet Infectious Diseases|language=English|volume=0|issue=4|pages=384\u2013385|doi=10.1016/S1473-3099(20)30134-1|issn=1473-3099|pmid=32105641|accessdate=13 March 2020|archive-url=https://web.archive.org/web/20200308143943/https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30134-1/fulltext|archive-date=8 March 2020|url-status=live}}</ref> As of March 2020, the [[American College of Radiology]] recommends that \"CT should not be used to screen for or as a first-line test to diagnose COVID-19\".<ref>{{cite web|url=https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection|title=ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection|last=|first=|date=2020-03-22|website=American College of Radiology|url-status=live|archive-url=https://web.archive.org/web/20200328055813/https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection|archive-date=28 March 2020|access-date=}}</ref>\n<gallery mode=packed heights=100px>\nFile:COVID19CT2.webp|Typical [[CT imaging]] findings\nFile:COVID19CT1.webp|[[CT imaging]] of rapid progression stage\n</gallery>\n\n===Pathology===\n\nFew data are available about microscopic lesions and the pathophysiology of COVID-19.<ref>[https://jcp.bmj.com/content/early/2020/03/20/jclinpath-2020-206522 Autopsy in suspected COVID-19 cases] {{Webarchive|url=https://web.archive.org/web/20200328202232/https://jcp.bmj.com/content/early/2020/03/20/jclinpath-2020-206522 |date=28 March 2020 }}, Hanley B et al, J Clin Pathol, {{PMID|32198191}}</ref><ref>[https://www.ncbi.nlm.nih.gov/pubmed/32172546 A pathological report of three COVID-19 cases by minimally invasive autopsies], Yao XH et al., {{PMID|32172546}}</ref> The main pathological findings at autopsy are: \n* [[macroscopic scale|Macroscopy]]: [[pleurisy]], [[pericarditis]], [[lung consolidation]] and [[pulmonary oedema]]\n* Four types of severity of [[viral pneumonia]] can be observed: \n** minor [[pneumonia]]: minor serous [[Exudate|exudation]], minor [[fibrin]] exudation\n** mild pneumonia: [[pulmonary oedema]], [[pneumocyte]] [[hyperplasia]], large atypical [[pneumocyte]]s, interstitial [[inflammation]] with [[lymphocytic]] [[Infiltration (medical)|infiltration]] and [[giant cell|multinucleated giant cell]] formation \n** severe pneumonia: [[diffuse alveolar damage]] (DAD) with diffuse [[Pulmonary alveolus|alveolar]] [[exudates]]. DAD is the cause of [[acute respiratory distress syndrome]] (ARDS) and severe [[hypoxemia]].\n** healing pneumonia: [[healing|organisation]] of [[exudate]]s in [[Pulmonary alveolus|alveolar cavities]] and [[Pulmonary fibrosis|pulmonary interstitial fibrosis]]\n** [[plasma cell|plasmocytosis]] in [[Bronchoalveolar lavage|BAL]]<ref>{{Cite journal|title=Exuberant plasmocytosis in bronchoalveolar lavage of the first patient requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe|first1=Marco|last1=Giani|first2=Davide|last2=Seminati|first3=Alberto|last3=Lucchini|first4=Giuseppe|last4=Foti|first5=Fabio|last5=Pagni|date=16 March 2020|journal=Journal of Thoracic Oncology|doi=10.1016/j.jtho.2020.03.008|pmid=32194247|pmc=7118681}}</ref>\n* [[Blood]]: [[disseminated intravascular coagulation]] (DIC);<ref>{{Cite journal|title=Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia|first=David|last=Lillicrap|date=1 April 2020|journal=Journal of Thrombosis and Haemostasis: JTH|volume=18|issue=4|pages=786\u2013787|doi=10.1111/jth.14781|pmid=32212240}}</ref> leukoerythroblastic reaction<ref>{{Cite journal|title=Leukoerythroblastic reaction in a patient with COVID-19 infection|first1=Anupam|last1=Mitra|first2=Denis M.|last2=Dwyre|first3=Michael|last3=Schivo|first4=George R.|last4=Thompson|first5=Stuart H.|last5=Cohen|first6=Nam|last6=Ku|first7=John P.|last7=Graff|date=25 March 2020|journal=American Journal of Hematology|doi=10.1002/ajh.25793|pmid=32212392}}</ref>\n* [[Liver]]: microvesicular [[steatosis]]\n\n==Prevention==\n\n{{See also|2019\u201320 coronavirus pandemic#Prevention|flatten the curve|workplace hazard controls for COVID-19}}\n[[File:20200403 Flatten the curve animated GIF.gif|thumb|upright=1.5|Inhibiting new infections to reduce the number of cases at any given time\u2014known as \"[[flattening the curve]]\"\u2014allows healthcare services to better manage the same volume of patients.<ref>{{cite web |last=Wiles |first=Siouxsie |author-link=Siouxsie Wiles |title=The three phases of Covid-19\u2014and how we can make it manageable |url=https://thespinoff.co.nz/society/09-03-2020/the-three-phases-of-covid-19-and-how-we-can-make-it-manageable/ |website=The Spinoff |access-date=9 March 2020 |date=9 March 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200327120015/https://thespinoff.co.nz/society/09-03-2020/the-three-phases-of-covid-19-and-how-we-can-make-it-manageable/ |archive-date=27 March 2020 |url-status=live }}</ref><ref name=\"Lancet2020Flatten\">{{cite journal | vauthors = Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD | title = How will country-based mitigation measures influence the course of the COVID-19 epidemic? | journal = Lancet | date = March 2020 | volume = 395 | issue = 10228 | pages = 931\u2013934 | pmid = 32164834 | doi = 10.1016/S0140-6736(20)30567-5 | quote = A key issue for epidemiologists is helping policy makers decide the main objectives of mitigation\u2014e.g. minimising morbidity and associated mortality, avoiding an epidemic peak that overwhelms health-care services, keeping the effects on the economy within manageable levels, and flattening the epidemic curve to wait for vaccine development and manufacture on scale and antiviral drug therapies. | doi-access = free }}</ref><ref>{{cite web|url=https://www.vox.com/2020/3/10/21171481/coronavirus-us-cases-quarantine-cancellation|title=How canceled events and self-quarantines save lives, in one chart|first=Eliza|last=Barclay|date=10 March 2020|website=Vox|name-list-format=vanc|access-date=12 March 2020|archive-url=https://web.archive.org/web/20200312161852/https://www.vox.com/2020/3/10/21171481/coronavirus-us-cases-quarantine-cancellation|archive-date=12 March 2020|url-status=live}}</ref>]]\n[[File:Covid-19-curves-graphic2-stopthespread-v3.gif|thumb|upright=1.5|Alternatives to flattening the curve<ref>{{cite web |last=Wiles |first=Siouxsie |title=After 'Flatten the Curve', we must now 'Stop the Spread'. Here's what that means |url=https://thespinoff.co.nz/society/14-03-2020/after-flatten-the-curve-we-must-now-stop-the-spread-heres-what-that-means/ |website=The Spinoff |access-date=13 March 2020 |date=14 March 2020 |archive-url=https://web.archive.org/web/20200326232315/https://thespinoff.co.nz/society/14-03-2020/after-flatten-the-curve-we-must-now-stop-the-spread-heres-what-that-means/ |archive-date=26 March 2020 |url-status=live }}</ref><ref>{{cite journal | vauthors = Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD | title = How will country-based mitigation measures influence the course of the COVID-19 epidemic? | journal = Lancet | date = March 2020 | volume = 395 | issue = 10228 | pages = 931\u2013934 | pmid = 32164834 | doi = 10.1016/S0140-6736(20)30567-5 }}</ref>]]\nPreventive measures to reduce the chances of infection include staying at home, avoiding crowded places, washing hands with soap and water often and for at least 20 seconds, practising good respiratory hygiene and avoiding touching the eyes, nose or mouth with unwashed hands.<ref name=\"CDC-Prevention & Treatment\">{{cite web | url = https://www.cdc.gov/coronavirus/about/prevention.html | author = Centers for Disease Control | title = Coronavirus Disease 2019 (COVID-19): Prevention & Treatment | date = 3 February 2020 | language = en-us | access-date = 10 February 2020 | archive-url = https://web.archive.org/web/20191215193934/https://www.cdc.gov/coronavirus/about/prevention.html | archive-date = 15 December 2019 | url-status = live| author-link = Centers for Disease Control }}</ref><ref name=\"WHO Advice for Public\">{{cite web | url = https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public | title = Advice for Public | vauthors = ((World Health Organization)) | access-date = 10 February 2020 | archive-url = https://web.archive.org/web/20200126025750/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public | archive-date = 26 January 2020 | url-status = live| author-link = World Health Organization | name-list-format = vanc}}</ref><ref>{{cite web|url=https://www.npr.org/sections/goatsandsoda/2020/03/17/814221111/my-hand-washing-song-readers-offer-lyrics-for-a-20-second-scrub|title=My Hand-Washing Song: Readers Offer Lyrics For A 20-Second Scrub|website=NPR.org|language=en|access-date=20 March 2020|archive-url=https://web.archive.org/web/20200320145553/https://www.npr.org/sections/goatsandsoda/2020/03/17/814221111/my-hand-washing-song-readers-offer-lyrics-for-a-20-second-scrub|archive-date=20 March 2020|url-status=live}}</ref> The CDC recommends covering the mouth and nose with a tissue when coughing or sneezing and recommends using the inside of the elbow if no tissue is available.<ref name = \"CDC-Prevention & Treatment\"/> They also recommend proper hand hygiene after any cough or sneeze.<ref name = \"CDC-Prevention & Treatment\"/> [[Social distancing]] strategies aim to reduce contact of infected persons with large groups by closing schools and workplaces, restricting travel and cancelling mass gatherings.<ref name=\"JHUSocialDistancing\">{{cite web | first = Lisa Lockerd | last = Maragakis | name-list-format = vanc | title = Coronavirus, Social Distancing and Self Quarantine | url = https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-social-distancing-and-self-quarantine | website = www.hopkinsmedicine.org | publisher = Johns Hopkins University | access-date = 18 March 2020 | archive-url = https://web.archive.org/web/20200318012357/https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-social-distancing-and-self-quarantine | archive-date = 18 March 2020 | url-status = live }}</ref> Social distancing also includes that people stay at least {{Convert|6|ft||abbr=}} apart.<ref>{{Cite news|last=Parker-Pope|first=Tara|url=https://www.nytimes.com/2020/03/19/well/live/coronavirus-quarantine-social-distancing.html|title=Deciding How Much Distance You Should Keep|date=19 March 2020|work=The New York Times|access-date=20 March 2020|language=en-US|issn=0362-4331|archive-url=https://web.archive.org/web/20200320003705/https://www.nytimes.com/2020/03/19/well/live/coronavirus-quarantine-social-distancing.html|archive-date=20 March 2020|url-status=live}}</ref>\n\nAs a [[COVID-19 vaccine|vaccine]] is not expected until 2021 at the earliest,<ref>{{cite web | url = https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away | title = Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus | website = Science Alert | first1 = Rob | last1 = Grenfell | first2 = Trevor | last2 = Drew | name-list-format = vanc | date = 17 February 2020 | access-date = 26 February 2020 | archive-url = https://web.archive.org/web/20200228010631/https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away | archive-date = 28 February 2020 | url-status = live }}</ref> a key part of managing COVID-19 is trying to decrease the epidemic peak, known as \"flattening the [[epidemic curve|curve]]\".<ref name=\"Lancet2020Flatten\" /> This is done by slowing the infection rate to decrease the risk of health services being overwhelmed, allowing for better treatment of current cases and delaying additional cases until effective treatments or a vaccine become available.<ref name=\"Lancet2020Flatten\" /><ref>{{cite web |last=Wiles |first=Siouxsie |title=After 'Flatten the Curve', we must now 'Stop the Spread'. Here's what that means |url=https://thespinoff.co.nz/society/14-03-2020/after-flatten-the-curve-we-must-now-stop-the-spread-heres-what-that-means/ |website=The Spinoff |access-date=13 March 2020 |date=14 March 2020 |archive-url=https://web.archive.org/web/20200326232315/https://thespinoff.co.nz/society/14-03-2020/after-flatten-the-curve-we-must-now-stop-the-spread-heres-what-that-means/ |archive-date=26 March 2020 |url-status=live }}</ref><ref>{{cite journal | vauthors = Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD | title = How will country-based mitigation measures influence the course of the COVID-19 epidemic? | journal = Lancet | date = March 2020 | volume = 395 | issue = 10228 | pages = 931\u2013934 | pmid = 32164834 | doi = 10.1016/S0140-6736(20)30567-5 }}</ref>\n\nAccording to the WHO, the use of masks is recommended only if a person is coughing or sneezing or when one is taking care of someone with a suspected infection.{{update inline|date=April 2020}}<ref>{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks|title=When and how to use masks|website=[[World Health Organization]] (WHO)|access-date=8 March 2020|name-list-format=vanc|archive-url=https://web.archive.org/web/20200307013848/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks|archive-date=7 March 2020|url-status=live}}</ref> Some countries also recommend healthy individuals to wear face masks, including China,<ref name=\"nhc_masks\">{{cite web |url=http://en.nhc.gov.cn/2020-02/07/c_76337.htm |title=For different groups of people: how to choose masks |work=NHC.gov.cn |publisher=National Health Commission of the People's Republic of China |date=7 February 2020 |access-date=22 March 2020 |archive-url= |archive-date= |quote=\"Disposable medical masks: Recommended for: \u00b7 People in crowded places \u00b7 Indoor working environment with a relatively dense population \u00b7 People going to medical institutions \u00b7 Children in kindergarten and students at school gathering to study and do other activities\" }}{{Dead link|date=April 2020 |bot=InternetArchiveBot |fix-attempted=yes }}</ref> [[Hong Kong]],<ref>{{cite web |url=https://www.chp.gov.hk/files/pdf/prevention_of_covid_19_en.pdf |title=Prevention of Coronavirus Disease 2019 (COVID-19) |website=[[Centre for Health Protection]] |access-date=22 March 2020 |quote=\"Wear a surgical mask when taking public transport or staying in crowded places.\" |archive-url=https://web.archive.org/web/20200321175110/https://www.chp.gov.hk/files/pdf/prevention_of_covid_19_en.pdf |archive-date=21 March 2020 |url-status=live }}</ref> [[Thailand]],<ref>{{cite news |title='Better than nothing': Thailand encourages cloth masks amid surgical mask shortage |url=https://www.reuters.com/article/us-health-coronavirus-thailand-masks/better-than-nothing-thailand-encourages-cloth-masks-amid-surgical-mask-shortage-idUSKBN20Z0UT |first=Jiraporn |last=Kuhakan |work=Reuters |date=12 March 2020 |quote=\"Thailand's health authorities are encouraging people to make cloth face masks at home to guard against the spread of the coronavirus amid a shortage of surgical masks.{{nbsp}}... The droplet from coughing and sneezing is around five microns and we have tested already that cloth masks can protect against droplets bigger than one micron.\" |access-date=22 March 2020 |archive-url=https://web.archive.org/web/20200321192522/https://www.reuters.com/article/us-health-coronavirus-thailand-masks/better-than-nothing-thailand-encourages-cloth-masks-amid-surgical-mask-shortage-idUSKBN20Z0UT |archive-date=21 March 2020 |url-status=live }}</ref> Czech Republic,<ref>{{cite web|url=https://www.euronews.com/2020/03/24/coronavirus-czechs-facing-up-to-covid-19-crisis-by-making-masks-mandatory|title=Coronavirus: Czechs facing up to COVID-19 crisis by making masks mandatory|last=|first=|date=2020|website=euronews|url-status=live|archive-url=https://web.archive.org/web/20200330233916/https://www.euronews.com/2020/03/24/coronavirus-czechs-facing-up-to-covid-19-crisis-by-making-masks-mandatory|archive-date=30 March 2020|access-date=}}</ref> and Austria.<ref>{{cite web|url=https://www.cbsnews.com/news/austria-supermarket-face-mask/|title=Austria is making everyone who goes inside a supermarket wear a face mask|website=www.cbsnews.com|language=en-US|access-date=2020-03-31|archive-url=https://web.archive.org/web/20200331192209/https://www.cbsnews.com/news/austria-supermarket-face-mask/|archive-date=31 March 2020|url-status=live}}</ref> In order to meet the need for masks, the WHO estimates that global production will need to increase by 40%. Hoarding and speculation have worsened the problem, with the price of masks increasing sixfold, [[N95 masks|N95 respirators]] tripled, and gowns doubled.<ref>{{cite press release |title= Shortage of personal protective equipment endangering health workers worldwide |date= 3 March 2020 |publisher= WHO |url= https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide |access-date= 24 March 2020 |archive-url= https://web.archive.org/web/20200305052623/https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide |archive-date= 5 March 2020 |url-status= live }}</ref> Some health experts consider wearing non-medical grade masks and other face coverings like scarves or bandanas a good way to prevent people from touching their mouths and noses, even if non-medical coverings would not protect against a direct sneeze or cough from an infected person.<ref>{{cite web|url=https://www.bostonglobe.com/2020/03/19/opinion/guidance-against-wearing-masks-coronavirus-is-wrong-you-should-cover-your-face/|title=Guidance against wearing masks for the coronavirus is wrong\u2014you should cover your face\u2014The Boston Globe|website=BostonGlobe.com|access-date=22 March 2020|archive-url=https://web.archive.org/web/20200322181032/https://www.bostonglobe.com/2020/03/19/opinion/guidance-against-wearing-masks-coronavirus-is-wrong-you-should-cover-your-face/|archive-date=22 March 2020|url-status=live}}</ref>\n \nThose diagnosed with COVID-19 or who believe they may be infected are advised by the CDC to stay home except to get medical care, call ahead before visiting a healthcare provider, wear a face mask before entering the healthcare provider's office and when in any room or vehicle with another person, cover coughs and sneezes with a tissue, regularly wash hands with soap and water and avoid sharing personal household items.<ref>{{cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/about/prevention.html | title = Coronavirus Disease 2019 (COVID-19)\u2014Prevention & Treatment | date = 10 March 2020 | work = Centers for Disease Control and Prevention | publisher = U.S. Department of Health & Human Services | access-date = 11 March 2020 | archive-url = https://web.archive.org/web/20200311163637/https://www.cdc.gov/coronavirus/2019-ncov/about/prevention.html | archive-date = 11 March 2020 | url-status = live }}</ref><ref>{{cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/about/steps-when-sick.html | title = What to do if you are sick with 2019&nbsp;Novel Coronavirus (2019-nCoV) | author = [[Centers for Disease Control and Prevention]] | date = 11 February 2020 | language = en-us | url-status = live | archive-url = https://web.archive.org/web/20200214153016/https://www.cdc.gov/coronavirus/2019-ncov/about/steps-when-sick.html | archive-date = 14 February 2020 | access-date = 13 February 2020| name-list-format = vanc}}</ref> The CDC also recommends that individuals wash hands often with soap and water for at least 20 seconds, especially after going to the toilet or when hands are visibly dirty, before eating and after blowing one's nose, coughing or sneezing. It further recommends using an alcohol-based [[hand sanitiser]] with at least 60% alcohol, but only when soap and water are not readily available.<ref name=\"CDC-Prevention & Treatment\" />\n\nFor areas where commercial hand sanitisers are not readily available, the WHO provides two formulations for local production. In these formulations, the antimicrobial activity arises from [[ethanol]] or [[isopropanol]]. [[Hydrogen peroxide]] is used to help eliminate [[bacterial spores]] in the alcohol; it is \"not an active substance for hand [[antisepsis]]\". [[Glycerol]] is added as a [[humectant]].<ref>{{cite book | chapter-url = https://www.ncbi.nlm.nih.gov/books/NBK144054/ | chapter = WHO-recommended handrub formulations | title = WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care. |date=19 March 2009 |publisher=World Health Organization|access-date=19 March 2020 }}</ref>\n<gallery mode=packed heights=200px>\nFile:Covid-19-Transmission-graphic-01.gif|Prevention efforts are multiplicative, with effects far beyond that of a single spread. Each avoided case leads to more avoided cases down the line, which in turn can stop the outbreak in its tracks.\nFile:COVID19 W ENG.ogv|[[Handwashing]] instructions\n</gallery>\n\n==Management==\n\n[[File:DonningCDC2020.jpg|thumb|Four steps to putting on [[personal protective equipment]] (PPE)<ref>{{cite web |title=Sequence for Putting On Personal Protective Equipment (PPE) |url=https://www.cdc.gov/hai/pdfs/ppe/PPE-Sequence.pdf |website=CDC |access-date=8 March 2020 |archive-url=https://web.archive.org/web/20200305173617/https://www.cdc.gov/hai/pdfs/ppe/ppe-sequence.pdf |archive-date=5 March 2020 |url-status=live }}</ref>]]\nPeople are managed with [[supportive care]], which may include fluid therapy, [[oxygen support]] and supporting other affected vital organs.<ref name=\"NatureDale Fisher & David Heymann\">{{cite journal | vauthors=Fisher D, Heymann D |title = Q&A: The novel coronavirus outbreak causing COVID-19 |journal=BMC Medicine |volume=18 |issue=1 |page=57 |doi=10.1186/s12916-020-01533-w |doi-access=free |pmid=32106852 |pmc=7047369 | date=February 2020 }}</ref><ref name=\"KuiFang2020\">{{cite journal | vauthors = Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG | display-authors = 6 | title = Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province | journal = Chinese Medical Journal | page = 1 | date = February 2020 | pmid = 32044814 |doi=10.1097/CM9.0000000000000744 |doi-access=free }}</ref><ref name=\"Wang Du Zhu Cao 2020 p.\">{{cite journal | vauthors = Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B | title = Comorbidities and multi-organ injuries in the treatment of COVID-19 | journal = Lancet | date = March 2020 | volume = 395 | issue = 10228 | pages = e52 | pmid = 32171074 | doi = 10.1016/s0140-6736(20)30558-4 | publisher = Elsevier BV }}</ref> The CDC recommends that those who suspect they carry the virus wear a simple face mask.<ref name=CDC2020IfSick/> [[Extracorporeal membrane oxygenation]] (ECMO) has been used to address the issue of respiratory failure, but its benefits are still under consideration.<ref name=\"Guan Ni Hu Liang p.\" /><ref name=\"Henry 2020 p.\">{{cite journal | last=Henry | first=Brandon Michael | name-list-format = vanc | title=COVID-19, ECMO, and lymphopenia: a word of caution | journal=The Lancet Respiratory Medicine | publisher=Elsevier BV | date=2020 | volume=8 | issue=4 | pages=e24 | issn=2213-2600 | doi=10.1016/s2213-2600(20)30119-3 | pmid=32178774 | pmc=7118650 }}</ref>\n\nThe WHO and [[National Health Commission|Chinese National Health Commission]] have published recommendations for taking care of people who are hospitalised with COVID-19.<ref name=\"Cheng2020\">{{cite journal | vauthors = Cheng ZJ, Shan J | title = 2019 Novel coronavirus: where we are and what we know | journal = Infection | date = February 2020 | volume = 48 | issue = 2 | pages = 155\u2013163 | pmid = 32072569 |doi=10.1007/s15010-020-01401-y |doi-access=free }}</ref><ref>{{cite web|url=https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected|title=Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected|website=[[World Health Organization]] (WHO)|access-date=13 February 2020|archive-url=https://web.archive.org/web/20200131032122/https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected|archive-date=31 January 2020|url-status=live }}</ref> [[Critical care medicine|Intensivists]] and [[Pulmonology|pulmonologists]] in the US have compiled treatment recommendations from various agencies into a free resource, the [[EMCrit|IBCC]].<ref name=\"IBCC\">{{cite book |last=Farkas |first=Josh | name-list-format = vanc |date=March 2020 |title=COVID-19\u2014The Internet Book of Critical Care |url=https://emcrit.org/ibcc/covid19/ |url-status=live |format=digital |type=Reference manual |language=English |location=USA |publisher=EMCrit |archive-url=https://web.archive.org/web/20200311195758/https://emcrit.org/ibcc/covid19/ |archive-date=11 March 2020 |access-date=13 March 2020}}</ref><ref name=\"UPenn-IBCC\">{{cite web |url=https://guides.library.upenn.edu/covid-19 |title=COVID19\u2014Resources for Health Care Professionals |publisher=[[Penn Libraries]] |date=11 March 2020 |access-date=13 March 2020 |archive-url=https://web.archive.org/web/20200314035631/https://guides.library.upenn.edu/covid-19 |archive-date=14 March 2020 |url-status=live }}</ref>\n\n===Medications===\n\nSome medical professionals recommend [[paracetamol]] (acetaminophen) over [[ibuprofen]] for first-line use.<ref name=\"Day 2020 p.\">{{cite journal | title = Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists | journal = BMJ | volume = 368 | date = 17 March 2020 | pmid = 32184201 | doi = 10.1136/bmj.m1086 | issn=1756-1833 | url = https://www.bmj.com/content/368/bmj.m1086 | access-date = 18 March 2020 | last = Day | first = Michael | pages = m1086 | archive-url = https://web.archive.org/web/20200319181945/https://www.bmj.com/content/368/bmj.m1086 | archive-date = 19 March 2020 | url-status = live }}</ref><ref>{{cite web|url=https://www.nhs.uk/conditions/coronavirus-covid-19/self-isolation-advice/|title=Self-isolation advice\u2014Coronavirus (COVID-19)|date=2020-02-28|website=National Health Service (United Kingdom)|language=en|access-date=2020-03-27|archive-url=https://web.archive.org/web/20200328000128/https://www.nhs.uk/conditions/coronavirus-covid-19/self-isolation-advice/|archive-date=28 March 2020|url-status=live}}</ref><ref>{{cite web\n |last         = Godoy\n |first        = Maria\n |date         = 18 March 2020\n |url          = https://www.npr.org/sections/health-shots/2020/03/18/818026613/advice-from-france-to-avoid-ibuprofen-for-covid-19-leaves-experts-baffled\n |title        = Concerned About Taking Ibuprofen For Coronavirus Symptoms? Here's What Experts Say\n |website      = [[NPR]]\n |access-date  = 8 April 2020\n}}</ref> The WHO does not oppose the use of [[non-steroidal anti-inflammatory drugs]] (NSAIDs) such as ibuprofen for symptoms,<ref name=\"AFP 2020b\">{{cite web|url=https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms|title=Updated: WHO Now Doesn't Recommend Avoiding Ibuprofen For COVID-19 Symptoms|author=AFP|date=19 March 2020|website=ScienceAlert|access-date=19 March 2020|archive-url=https://web.archive.org/web/20200318222020/https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms|archive-date=18 March 2020|url-status=live}}</ref> and the [[Food and Drug Administration|FDA]] says currently there is no evidence that NSAIDs worsen COVID-19 symptoms.<ref>{{Cite journal|last=Research|first=Center for Drug Evaluation and|date=2020-03-19|title=FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19|url=http://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19|journal=Drug Safety and Availability|language=en|access-date=27 March 2020|archive-url=https://web.archive.org/web/20200327194633/https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19|archive-date=27 March 2020|url-status=live}}</ref>\n\nWhile theoretical concerns have been raised about [[ACE inhibitors]] and [[angiotensin receptor blocker]]s, as of 19 March 2020, these are not sufficient to justify stopping these medications.<ref>{{cite web |title=Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician |url=https://www.hfsa.org/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician/ |access-date=21 March 2020 |archive-url=https://web.archive.org/web/20200321172112/https://www.hfsa.org/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician/ |archive-date=21 March 2020 |url-status=live }}</ref><ref>{{cite press release | title=Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician | website=American Heart Association | date=17 March 2020 | url=https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician | access-date=25 March 2020 | archive-url=https://web.archive.org/web/20200324050912/https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician | archive-date=24 March 2020 | url-status=live }}</ref><ref name=\"ESCPositionStatement\">{{cite web |last=de Simone |first=Giovanni |title=Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers |url=https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang |website=Council on Hypertension of the European Society of Cardiology |access-date=24 March 2020 |archive-url=https://web.archive.org/web/20200324073257/https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang |archive-date=24 March 2020 |url-status=live }}</ref> [[Steroids]], such as [[methylprednisolone]], are not recommended unless the disease is complicated by [[acute respiratory distress syndrome]].<ref name=\"Vetter Eckerle Kaiser 2020 p.\">{{cite journal | vauthors=Vetter P, Eckerle I, Kaiser L | title=Covid-19: a puzzle with many missing pieces | journal=BMJ | volume=368 | pages=m627 | date=February 2020 | pmid=32075791 | doi=10.1136/bmj.m627 |doi-access=free }}</ref><ref>{{cite web |title=Novel Coronavirus\u2014COVID-19: What Emergency Clinicians Need to Know |url=https://www.ebmedicine.net/topics/infectious-disease/COVID-19 |website=www.ebmedicine.net |access-date=9 March 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200314163512/https://www.ebmedicine.net/topics/infectious-disease/COVID-19 |archive-date=14 March 2020 |url-status=live }}</ref>\n\n===Personal protective equipment===\n\nPrecautions must be taken to minimise the risk of virus transmission, especially in healthcare settings when performing procedures that can generate [[aerosol]]s, such as [[intubation]] or [[bag valve mask|hand ventilation]].<ref name=\"Cheung Ho Cheng Cham 2020 p.\">{{cite journal | vauthors=Cheung JC, Ho LT, Cheng JV, Cham EY, Lam KN | title=Staff safety during emergency airway management for COVID-19 in Hong Kong | journal=Lancet Respiratory Medicine | date=February 2020 | volume=8 | issue=4 | pages=e19 | doi=10.1016/s2213-2600(20)30084-9 | doi-access=free | pmid=32105633 }}</ref> For healthcare professionals caring for people with COVID-19, the CDC recommends placing the person in an Airborne Infection Isolation Room (AIIR) in addition to using [[standard precautions]], contact precautions and airborne precautions.<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-patients-H.pdf|title=What healthcare personnel should know about caring for patients with confirmed or possible coronavirus disease 2|last=|date=12 March 2020|website=CDC|url-status=live|archive-url=|archive-date=|access-date=31 March 2020}}</ref>\n\nCDC outlines the specific guidelines for the use of [[personal protective equipment]] (PPE) during the pandemic. The recommended gear includes:\n* [[Respirator]] or [[surgical mask|facemask]]<ref>[https://www.cdc.gov/niosh/docs/2018-130/ Filtering out Confusion: Frequently Asked Questions about Respiratory Protection, User Seal Check] {{Webarchive|url=https://web.archive.org/web/20190816114738/https://www.cdc.gov/niosh/docs/2018-130/ |date=16 August 2019 }}. The National Institute for Occupational Safety and Health (April 2018). Retrieved 16 March 2020.</ref><ref>[http://blogs.cdc.gov/niosh-science-blog/2020/03/16/n95-preparedness/?deliveryName=USCDC_170-DM22692 Proper N95 Respirator Use for Respiratory Protection Preparedness] {{Webarchive|url=https://web.archive.org/web/20200327073252/https://blogs.cdc.gov/niosh-science-blog/2020/03/16/n95-preparedness/?deliveryName=USCDC_170-DM22692 |date=27 March 2020 }}. NIOSH Science Blog (16 March 2020). Retrieved 16 March 2020.</ref>\n* [[Hospital gown|Gown]]<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html |website=Centers for Disease Control and Prevention |date=11 February 2020 |accessdate=4 April 2020}}</ref>\n* [[Medical glove]]s<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html |website=Centers for Disease Control and Prevention |access-date=11 March 2020 |date=11 February 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html |archive-date=4 March 2020 |url-status=live }}</ref><ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-patients.html |website=Centers for Disease Control and Prevention |access-date=8 March 2020 |date=11 February 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-patients.html |archive-date=4 March 2020 |url-status=live }}</ref>\n* [[Eye protection]]<ref>{{cite web|title=Strategies for Optimizing the Supply of Eye Protection|date=11 February 2020|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/eye-protection.html|publisher=CDC|access-date=23 March 2020|archive-url=https://web.archive.org/web/20200323173916/https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/eye-protection.html|archive-date=23 March 2020|url-status=live}}</ref>\n\nWhen available, respirators (instead of facemasks) are preferred.<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html|title=Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings|author=CDC|date=11 February 2020|website=Centers for Disease Control and Prevention|language=en-us|url-status=live|archive-url=https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html|archive-date=4 March 2020|access-date=25 March 2020}}</ref> N95 respirators are approved for industrial settings but the FDA has authorised the masks for use under an [[Emergency Use Authorisation]] (EUA). They are designed to protect from airborne particles like dust but effectiveness against a specific biological agent is not guaranteed for off-label uses.<ref>{{cite web|title=Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions|url=https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19-frehttps://oc.wikipedia.org/wiki/Malauti%C3%A1_de_coronavirus_de_2019quently-asked-questions#5e78ba94b86da|website=Food and Drug Administration}}</ref> When masks are not available, the CDC recommends using face shields or, as a last resort, [[Cloth facemask|homemade masks]].<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html|title=Strategies for Optimizing the Supply of Facemasks|date=11 February 2020|publisher=CDC|access-date=23 March 2020|archive-url=https://web.archive.org/web/20200323173927/https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html|archive-date=23 March 2020|url-status=live}}</ref>\n\n===Mechanical ventilation===\n\nMost cases of COVID-19 are not severe enough to require [[mechanical ventilation]] (artificial assistance to support breathing), but a percentage of cases do.<ref name=\"murthy\">{{cite journal | vauthors = Murthy S, Gomersall CD, Fowler RA | title = Care for Critically Ill Patients With COVID-19 | journal = JAMA | date = 11 March 2020 | pmid = 32159735 | doi = 10.1001/jama.2020.3633 | url = https://jamanetwork.com/journals/jama/fullarticle/2762996 | access-date = 18 March 2020 | archive-url = https://web.archive.org/web/20200318203852/https://jamanetwork.com/journals/jama/fullarticle/2762996 |archive-date=18 March 2020 |url-status=live}}</ref><ref>{{cite web|author=World Health Organization|date=28 January 2020|title=Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected|url=https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf|journal=|volume=|pages=|via=|access-date=18 March 2020|archive-url=https://web.archive.org/web/20200226041620/https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf|archive-date=26 February 2020|url-status=live}}</ref> Some Canadian doctors recommend the use of invasive [[mechanical ventilation]] because this technique limits the spread of [[Airborne disease|aerosolised]] transmission [[Vector (epidemiology)|vectors]].<ref name=\"murthy\"/> Severe cases are most common in older adults (those older than 60 years<ref name=\"murthy\"/> and especially those older than 80 years).<ref>{{Cite document |last1=Ferguson |first1=N. |last2=Laydon |first2=D.|last3=Nedjati Gilani |first3=G. |last4=Imai |first4=N. |last5=Ainslie |first5=K. |last6=Baguelin |first6=M. |last7=Bhatia |first7=S. |last8=Boonyasiri|first8=A.|last9=Cucunuba Perez|first9=Zulma|last10=Cuomo-Dannenburg |first10=G. |last11=Dighe |first11=A. |date=16 March 2020 |title=Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand|publisher=[[Imperial College London]] |url=http://spiral.imperial.ac.uk/handle/10044/1/77482|doi=10.25561/77482|hdl=20.1000/100|doi-access=free|at=Table 1|journal=|access-date=25 March 2020|archive-url=https://web.archive.org/web/20200321133445/https://spiral.imperial.ac.uk/handle/10044/1/77482|archive-date=21 March 2020|url-status=live}}</ref> Many developed countries do not have enough [[List of countries by hospital beds|hospital beds per capita]], which limits a [[health system]]'s capacity to handle a sudden spike in the number of COVID-19 cases severe enough to require hospitalisation.<ref name=\"VoxCOVID\">{{cite news |last=Scott |first=Dylan |title=Coronavirus is exposing all of the weaknesses in the US health system High health care costs and low medical capacity made the US uniquely vulnerable to the coronavirus. |url=https://www.vox.com/policy-and-politics/2020/3/16/21173766/coronavirus-covid-19-us-cases-health-care-system |accessdate=18 March 2020 |publisher=Vox |date=16 March 2020 |archive-url=https://web.archive.org/web/20200318022237/https://www.vox.com/policy-and-politics/2020/3/16/21173766/coronavirus-covid-19-us-cases-health-care-system |archive-date=18 March 2020 |url-status=live}}</ref> This limited capacity is a significant driver of the need to [[flatten the curve]] (to keep the speed at which new cases occur and thus the number of people sick at one point in time lower).<ref name=\"VoxCOVID\"/> One study in China found 5% were admitted to [[intensive care unit]]s, 2.3% needed mechanical support of ventilation, and 1.4% died.<ref name=\"Guan Ni Hu Liang p.\">{{cite journal | vauthors = Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS | display-authors = 6 | title = Clinical Characteristics of Coronavirus Disease 2019 in China | journal = The New England Journal of Medicine | date = February 2020 | pmid = 32109013 | doi = 10.1056/nejmoa2002032 | publisher = Massachusetts Medical Society | pmc = 7092819 | doi-access = free }}</ref> Around 20\u201330% of the people in hospital with pneumonia from COVID-19 needed ICU care for respiratory support.<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html|title=Coronavirus Disease 2019 (COVID-19)|last=|date=2020-02-11|website=Centers for Disease Control and Prevention|language=en-us|access-date=2020-03-29|archive-url=https://web.archive.org/web/20200302201644/https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html|archive-date=2 March 2020|url-status=live}}</ref>\n\n===Acute respiratory distress syndrome===\n\n{{main|Acute respiratory distress syndrome}}\n[[Mechanical ventilation]] becomes more complex as [[acute respiratory distress syndrome]] (ARDS) develops in COVID-19 and oxygenation becomes increasingly difficult.<ref name=\"LancetRespMar2020\" /> Ventilators capable of [[Modes of mechanical ventilation|pressure control modes]] and high [[PEEP]]<ref>{{cite journal |last1=Briel |first1=Matthias |last2=Meade |first2=Maureen |last3=Mercat |first3=Alain |last4=Brower |first4=Roy G. |last5=Talmor |first5=Daniel |last6=Walter |first6=Stephen D. |last7=Slutsky |first7=Arthur S. |last8=Pullenayegum |first8=Eleanor |last9=Zhou |first9=Qi |last10=Cook |first10=Deborah |last11=Brochard |first11=Laurent |last12=Richard |first12=Jean-Christophe M. |last13=Lamontagne |first13=Fran\u00e7ois |last14=Bhatnagar |first14=Neera |last15=Stewart |first15=Thomas E. |last16=Guyatt |first16=Gordon |title=Higher vs Lower Positive End-Expiratory Pressure in Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome |journal=JAMA |date=3 March 2010 |volume=303 |issue=9 |pages=865\u201373 |doi=10.1001/jama.2010.218|pmid=20197533 }}</ref> are needed to maximise oxygen delivery while minimising the risk of [[ventilator-associated lung injury]] and [[pneumothorax]].<ref name=\"barotrauma\">{{cite book |last1=Diaz |first1=Raiko |last2=Heller |first2=Daniel |title=Barotrauma And Mechanical Ventilation |url=https://www.ncbi.nlm.nih.gov/books/NBK545226/ |website=StatPearls |publisher=StatPearls Publishing |date=2020|pmid=31424810 }}</ref> High PEEP may not be available on older ventilators.\n\n{| class=\"wikitable\" style=\"text-align:center; margin-right:1em;\"\n|+ style=\"background:#E5AFAA;\" | Options for ARDS<ref name=LancetRespMar2020>{{cite journal |last1=Matthay |first1=Michael A. |last2=Aldrich |first2=J. Matthew |last3=Gotts |first3=Jeffrey E. |title=Treatment for severe acute respiratory distress syndrome from COVID-19 |journal=The Lancet Respiratory Medicine |date=March 2020 |doi=10.1016/S2213-2600(20)30127-2|pmid=32203709 |pmc=7118607 }}</ref>\n|- style=\"background: #E5AFAA;text-align:center;\"\n! Therapy\n! Recommendations\n|-\n| [[Nasal cannula|High-flow nasal oxygen]]\n| For [[oxygen saturation|SpO<sub>2</sub>]] <93%. May prevent the need for intubation and ventilation\n|-\n| [[Tidal volume]]\n| 6mL per kg and can be reduced to 4mL/kg\n|-\n| [[Plateau pressure|Plateau airway pressure]]\n| Keep below 30 [[Centimetre of water|cmH<sub>2</sub>O]] if possible (high [[respiratory rate]] (35 per minute) may be required)\n|-\n| [[Positive end-expiratory pressure]]\n| Moderate to high levels\n|-\n| [[Prone position]]ing\n| For worsening oxygenation\n|-\n| [[Fluid replacement|Fluid management]]\n| Goal is a negative balance of 0.5\u20131[[liter|L]] per day\n|-\n| [[Antibiotics]]\n| For secondary bacterial infections\n|-\n| [[Glucocorticoids]]\n| Not recommended\n|}\n\n===Experimental treatment===\n\n{{see also|Coronavirus disease 2019#Research|label 1=Research}}\nNo medications are approved to treat the disease by the WHO although some are recommended by individual national medical authorities.<ref name=\"LiDeClerq\">{{cite journal | vauthors = Li G, De Clercq E | title = Therapeutic options for the 2019&nbsp;novel coronavirus (2019-nCoV) | journal = Nature Reviews. Drug Discovery | volume = 19 | issue = 3 | pages = 149\u2013150 | date = March 2020 | pmid = 32127666 | doi = 10.1038/d41573-020-00016-0 | doi-access = free }}</ref> Research into potential treatments started in January 2020,<ref>{{Cite news|url=https://www.reuters.com/article/us-china-health-hospital-idUSKBN20B1M6|title=Chinese doctors using plasma therapy on coronavirus, WHO says 'very valid' approach|newspaper=Reuters|date=17 February 2020|via=www.reuters.com|access-date=19 March 2020|archive-url=https://web.archive.org/web/20200304173709/https://www.reuters.com/article/us-china-health-hospital-idUSKBN20B1M6|archive-date=4 March 2020|url-status=live}}</ref> and several antiviral drugs are in clinical trials.<ref name=\"Reut_NIH_Moderna_3months\" /><ref name=\"clinicaltrialsarena\">{{cite web|url=https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/|title=Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19|last=Duddu|first=Praveen|date=19 February 2020|work=clinicaltrialsarena.com|archive-url=https://web.archive.org/web/20200219184512/https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/|archive-date=19 February 2020|name-list-format=vanc}}</ref> Although new medications may take until 2021 to develop,<ref>{{cite journal|vauthors=Lu H|date=28 January 2020|title=Drug treatment options for the 2019-new coronavirus (2019-nCoV).|journal=Biosci Trends|volume=14|issue=1|pages=69\u201371|doi=10.5582/bst.2020.01020|pmid=31996494}}</ref> several of the medications being tested are already approved for other uses or are already in advanced testing.<ref name=\"LiDeClerq\" /> Antiviral medication may be tried in people with severe disease.<ref name=\"NatureDale Fisher & David Heymann\" /> The WHO recommended volunteers take part in trials of the effectiveness and safety of potential treatments.<ref name=\"ThomReut_notreatment_20200205\">{{cite news|last1=Nebehay|first1=Stephanie|url=https://www.reuters.com/article/us-china-health-treatments-who-idUSKBN1ZZ1M6|title=WHO: 'no known effective' treatments for new coronavirus|date=5 February 2020|access-date=5 February 2020|url-status=live |archive-url=https://web.archive.org/web/20200205155653/https://www.reuters.com/article/us-china-health-treatments-who-idUSKBN1ZZ1M6|archive-date=5 February 2020|agency=[[Thomson Reuters]]|last2=Kelland|first2=Kate|last3=Liu|first3=Roxanne|name-list-format=vanc}}</ref>\n\n===Information technology===\n\n{{See also|Government by algorithm}}\nIn February 2020, China launched a [[mobile app]] to deal with the disease outbreak.<ref>{{cite news |title=China launches coronavirus 'close contact' app |url=https://www.bbc.com/news/technology-51439401 |access-date=7 March 2020 |work=BBC News |date=11 February 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200228003957/https://www.bbc.com/news/technology-51439401 |archive-date=28 February 2020 |url-status=live }}</ref> Users are asked to enter their name and ID number. The app is able to detect 'close contact' using surveillance data and therefore a potential risk of infection. Every user can also check the status of three other users. If a potential risk is detected, the app not only recommends self-quarantine, it also alerts local health officials.<ref>{{cite web |last1=Chen |first1=Angela | name-list-format = vanc |title=China's coronavirus app could have unintended consequences |url=https://www.technologyreview.com/s/615199/coronavirus-china-app-close-contact-surveillance-covid-19-technology/ |website=MIT Technology Review |access-date=7 March 2020 }}</ref>\n\n[[Big data]] analytics on cellphone data, [[Facial recognition system|facial recognition]] technology, [[mobile phone tracking]] and [[artificial intelligence]] are used to track infected people and people whom they contacted in South Korea, Taiwan and Singapore.<ref>{{cite news |title=Gov in the Time of Corona |url=https://govinsider.asia/innovation/gov-in-the-time-of-corona/ |access-date=20 March 2020 |work=GovInsider |date=19 March 2020 |archive-url=https://web.archive.org/web/20200320125215/https://govinsider.asia/innovation/gov-in-the-time-of-corona/ |archive-date=20 March 2020 |url-status=live }}</ref><ref>{{cite news |last=Manancourt |first=Vincent |title=Coronavirus tests Europe's resolve on privacy |url=https://www.politico.eu/article/coronavirus-tests-europe-resolve-on-privacy-tracking-apps-germany-italy/ |access-date=20 March 2020 |work=POLITICO |date=10 March 2020 |archive-url=https://web.archive.org/web/20200320105744/https://www.politico.eu/article/coronavirus-tests-europe-resolve-on-privacy-tracking-apps-germany-italy/ |archive-date=20 March 2020 |url-status=live }}</ref> In March 2020, the Israeli government enabled security agencies to track mobile phone data of people supposed to have coronavirus. The measure was taken to enforce quarantine and protect those who may come into contact with infected citizens.<ref>{{Cite news|last=Tidy|first=Joe|url=https://www.bbc.com/news/technology-51930681|title=Coronavirus: Israel enables emergency spy powers|date=17 March 2020|work=BBC News|access-date=18 March 2020|language=en-GB|archive-url=https://web.archive.org/web/20200318113608/https://www.bbc.com/news/technology-51930681|archive-date=18 March 2020|url-status=live}}</ref> Also in March 2020, [[Deutsche Telekom]] shared aggregated phone location data with the German federal government agency, [[Robert Koch Institute]], in order to research and prevent the spread of the virus.<ref name=\"heise-handydaten\">{{cite news |last=B\u00fcnte |first=Oliver |title=Corona-Krise: Deutsche Telekom liefert anonymisierte Handydaten an RKI |url=https://www.heise.de/newsticker/meldung/Corona-Krise-Deutsche-Telekom-liefert-anonymisierte-Handydaten-an-RKI-4685191.html |accessdate=25 March 2020 |work=Heise Online |date=18 March 2020 |language=German |trans-title=Corona crisis: Deutsche Telekom delivers anonymized cell phone data to RKI |archive-url=https://web.archive.org/web/20200324115410/https://www.heise.de/newsticker/meldung/Corona-Krise-Deutsche-Telekom-liefert-anonymisierte-Handydaten-an-RKI-4685191.html |archive-date=24 March 2020 |url-status=live }}</ref> Russia deployed facial recognition technology to detect quarantine breakers.<ref>{{cite news |title=Moscow deploys facial recognition technology for coronavirus quarantine |url=https://www.reuters.com/article/us-china-health-moscow-technology-idUSKBN20F1RZ |access-date=20 March 2020 |work=Reuters |date=21 February 2020 |language=en |archive-url=https://web.archive.org/web/20200222215731/https://www.reuters.com/article/us-china-health-moscow-technology-idUSKBN20F1RZ |archive-date=22 February 2020 |url-status=live }}</ref> Italian regional health commissioner [[Giulio Gallera]] said he has been informed by mobile phone operators that \"40% of people are continuing to move around anyway\".<ref>{{cite news |title=Italians scolded for flouting lockdown as death toll nears 3,000 |url=https://www.post-gazette.com/news/world/2020/03/18/Italy-coronavirus-475-deaths-one-day-death-toll-2978-COVID-19-doctors/stories/202003180182 |access-date=20 March 2020 |work=Pittsburgh Post-Gazette |language=en |archive-url=https://web.archive.org/web/20200320110555/https://www.post-gazette.com/news/world/2020/03/18/Italy-coronavirus-475-deaths-one-day-death-toll-2978-COVID-19-doctors/stories/202003180182 |archive-date=20 March 2020 |url-status=live }}</ref> German government conducted a 48 hours weekend [[hackathon]] with more than 42.000 participants.<ref>{{cite web |title=Kreative L\u00f6sungen gesucht |url=https://www.bundesregierung.de/breg-de/themen/coronavirus/wir-vs-virus-1731968 |website=Startseite |language=de |access-date=23 March 2020 |archive-url=https://web.archive.org/web/20200324085627/https://www.bundesregierung.de/breg-de/themen/coronavirus/wir-vs-virus-1731968 |archive-date=24 March 2020 |url-status=live }}</ref><ref>{{cite news |last1=Dannewitz |first1=Juliane |title=Hackathon Germany: #WirvsVirus |url=https://www.datenschutzbeauftragter-info.de/hackathon-germany-wirvsvirus/ |work=Datenschutzbeauftragter |date=23 March 2020 |language=de-DE}}</ref> Also the president of Estonia, [[Kersti Kaljulaid]], made a global call for creative solutions against the spread of coronavirus.<ref>{{cite news |first=Andrew |last=Whyte |title=President makes global call to combat coronavirus via hackathon |url=https://news.err.ee/1067171/president-makes-global-call-to-combat-coronavirus-via-hackathon |work=ERR |date=21 March 2020 |language=en |access-date=23 March 2020 |archive-url=https://web.archive.org/web/20200324050421/https://news.err.ee/1067171/president-makes-global-call-to-combat-coronavirus-via-hackathon |archive-date=24 March 2020 |url-status=live }}</ref>\n\n===Psychological support===\n\n{{see also|Mental health during the 2019\u201320 coronavirus pandemic}}\nIndividuals may experience distress from quarantine, travel restrictions, side effects of treatment or fear of the infection itself. To address these concerns, the [[National Health Commission|National Health Commission of China]] published a national guideline for psychological crisis intervention on 27 January 2020.<ref name=\"Xiang4Feb2020\">{{cite journal | vauthors = Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH | display-authors = 6 | title = Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed | journal = The Lancet. Psychiatry | volume = 7 | issue = 3 | pages = 228\u201329 | date = March 2020 | pmid = 32032543 |doi=10.1016/S2215-0366(20)30046-8 |doi-access=free }}</ref><ref name=\"Kang5Feb2020\">{{cite journal | vauthors = Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, Wang Y, Hu J, Lai J, Ma X, Chen J, Guan L, Wang G, Ma H, Liu Z | display-authors = 6 | title = The mental health of medical workers in Wuhan, China dealing with the 2019&nbsp;novel coronavirus | journal = The Lancet. Psychiatry | volume = 7 | issue = 3 | pages = e14 | date = March 2020 | pmid = 32035030 |doi=10.1016/S2215-0366(20)30047-X |doi-access=free }}</ref>\n\n==Prognosis==\n\n{{Primary sources|date=March 2020}}\n{{multiple image\n | align         = right\n | direction     = vertical\n | total_width   = 400\n | caption_align = center\n<!--image 1-->\n | image1        = Severity-of-coronavirus-cases-in-China-1.png\n | alt1          = The severity of diagnosed cases in China\n | caption1      = The severity of diagnosed COVID-19 cases in China<ref>{{cite journal |last1=Roser |first1=Max |last2=Ritchie |first2=Hannah |last3=Ortiz-Ospina |first3=Esteban |name-list-format=vanc |title=Coronavirus Disease (COVID-19) |url=https://ourworldindata.org/coronavirus |journal=Our World in Data |access-date=12 March 2020 |date=4 March 2020 |archive-url=https://web.archive.org/web/20200319171947/https://ourworldindata.org/coronavirus |archive-date=19 March 2020 |url-status=live }}</ref>\n<!--image 2-->\n | image2        = Illustration of SARS-COV-2 Case Fatality Rate 200228 01-1.png\n | alt2          = 3D Medical Animation Still Shot graph showing Case Fatality rates by age group from SARS-COV-2 in China.\n | caption2      = Case fatality rates by age group in China. Data through 11 February 2020.<ref name=\"Epidemiology2020Feb17\" />\n<!--image 3-->\n | image3        = Comorbidity and severity in covid-19 data from China CDC Weekly 2020, 2(8), pp. 113-122 (cropped).png\n | alt3          = Case fatality rate depending on other health problems\n | caption3      = Case fatality rate in China depending on other health problems. Data through 11 February 2020.<ref name=\"Epidemiology2020Feb17\" />\n<!--image 4-->\n | image4        = Covid-19-total-confirmed-cases-vs-total-confirmed-deaths.png\n | alt4          = Case fatality rate by country and number of cases\n | caption4      = The number of deaths vs total cases by country and approximate case fatality rate<ref>{{cite journal |last1=Roser |first1=Max |last2=Ritchie |first2=Hannah |last3=Ortiz-Ospina |first3=Esteban |name-list-format=vanc |title=Coronavirus Disease (COVID-19) |url=https://ourworldindata.org/coronavirus |journal=Our World in Data |access-date=6 April 2020 |date=6 April 2020}}</ref>\n}}\n\nThe severity of COVID-19 varies. The disease may take a mild course with few or no symptoms, resembling other common upper respiratory diseases such as the [[common cold]]. Mild cases typically recover within two weeks, while those with severe or critical diseases may take three to six weeks to recover. Among those who have died, the time from symptom onset to death has ranged from two to eight weeks.<ref name=\"WHOReport24Feb2020\" />\n\nChildren are susceptible to the disease, but are likely to have milder symptoms and a lower chance of severe disease than adults; in those younger than 50 years, the risk of death is less than 0.5%, while in those older than 70 it is more than 8%.<ref name=\"Lu Zhang Du Zhang p.\">{{cite journal|display-authors=6|vauthors=Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y, Bao S, Li Y, Wu C, Liu H, Liu D, Shao J, Peng X, Yang Y, Liu Z, Xiang Y, Zhang F, Silva RM, Pinkerton KE, Shen K, Xiao H, Xu S, Wong GW|date=18 March 2020|title=SARS-CoV-2 Infection in Children|journal=New England Journal of Medicine|publisher=Massachusetts Medical Society|page=|doi=10.1056/nejmc2005073|issn=0028-4793|pmid=32187458|pmc=7121177}}</ref><ref name=\"pediatrics_tong\">{{cite journal | vauthors = Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S | journal = Pediatrics | title = Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China | date = 2020 | pages = e20200702 | url = https://pediatrics.aappublications.org/content/pediatrics/early/2020/03/16/peds.2020-0702.full.pdf | doi = 10.1542/peds.2020-0702 | pmid = 32179660 | access-date = 16 March 2020 | archive-url = https://web.archive.org/web/20200317223427/https://pediatrics.aappublications.org/content/pediatrics/early/2020/03/16/peds.2020-0702.full.pdf | archive-date = 17 March 2020 | url-status = live }}</ref> [[COVID-19 in pregnancy|Pregnant women]] may be at higher risk for severe infection with COVID-19 based on data from other similar viruses, like [[Severe acute respiratory syndrome|SARS]] and [[Middle East respiratory syndrome|MERS]], but data for COVID-19 is lacking.<ref>{{cite journal | vauthors = Fang L, Karakiulakis G, Roth M | title = Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? | journal = [[The Lancet Respiratory Medicine]] | volume = 395 | issue = 10224 | pages = e40 | date = March 2020 | pmid = 32171062 | doi = 10.1016/S0140-6736(20)30311-1 | pmc = 7118626 }}</ref><ref name=\"CDC 2020children\">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/children-faq.html|title=Coronavirus Disease 2019 (COVID-19)|author=|date=11 February 2020|website=Centers for Disease Control and Prevention|access-date=2 March 2020|name-list-format=vanc|archive-url=https://web.archive.org/web/20200302064104/https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/children-faq.html|archive-date=2 March 2020|url-status=live}}</ref>\n\nIn some people, COVID-19 may affect the lungs causing [[pneumonia]]. In those most severely affected, COVID-19 may rapidly progress to [[acute respiratory distress syndrome]] (ARDS) causing respiratory failure, septic shock or multi-organ failure.<ref name=\"Heymann Shindo 2020 pp. 542\u2013545\">{{cite journal | vauthors = Heymann DL, Shindo N | collaboration = WHO Scientific and Technical Advisory Group for Infectious Hazards | title = COVID-19: what is next for public health? | journal = Lancet | volume = 395 | issue = 10224 | pages = 542\u2013545 | date = February 2020 | pmid = 32061313 | doi = 10.1016/s0140-6736(20)30374-3 | publisher = Elsevier BV }}</ref><ref>{{cite book | vauthors = Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R | chapter = Features, Evaluation and Treatment Coronavirus (COVID-19) | date = 2020 | pmid = 32150360 | chapter-url = http://www.ncbi.nlm.nih.gov/books/NBK554776/ | access-date = 18 March 2020 | publisher = StatPearls Publishing | location = Treasure Island (FL) | title = StatPearls }}</ref> Complications associated with COVID-19 include [[sepsis]], [[Coagulopathy|abnormal clotting]] and damage to the heart, kidneys and liver. Clotting abnormalities, specifically an increase in [[prothrombin time]], have been described in 6% of those admitted to hospital with COVID-19, while abnormal kidney function is seen in 4% of this group.<ref name=\"Zhou Yu Du Fan 2020 p.\">{{cite journal|display-authors=6|vauthors=Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L|date=2020|title=Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study|journal=The Lancet|volume=395|issue=10229|pages=1054\u20131062|publisher=Elsevier BV|doi=10.1016/s0140-6736(20)30566-3|issn=0140-6736|pmid=32171076}}</ref> Liver injury as shown by blood markers of liver damage is frequently seen in severe cases.<ref>{{cite journal | vauthors = Xu L, Liu J, Lu M, Yang D, Zheng X | title = Liver injury during highly pathogenic human coronavirus infections | journal = Liver International | date = March 2020 | pmid = 32170806 | doi = 10.1111/liv.14435 }}</ref>\n\nSome studies have found that the [[neutrophil to lymphocyte ratio]] (NLR) may be helpful in early screening for severe illness.<ref>{{cite journal|title=Dysregulation of immune response in patients with COVID-19 in Wuhan, China|journal=Clinical Infectious Diseases|doi=10.1093/cid/ciaa248|date=12 March 2020|last1=Tian|first1=Dai-Shi|last2=Wang|first2=Wei|last3=Shang|first3=Ke|last4=Ma|first4=Ke|last5=Xie|first5=Cuihong|last6=Tao|first6=Yu|last7=Yang|first7=Sheng|last8=Zhang|first8=Shuoqi|last9=Hu|first9=Ziwei|last10=Zhou|first10=Luoqi|last11=Qin|first11=Chuan|pmid=32161940|pmc=7108125}}</ref>\n\nMany of those who die of COVID-19 have [[pre-existing condition|pre-existing (underlying) conditions]], including [[hypertension]], [[diabetes mellitus]] and [[cardiovascular disease]].<ref name=\":8\">{{cite web |url=https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-the-advice-of-the-ihr-emergency-committee-on-novel-coronavirus |title=WHO Director-General's statement on the advice of the IHR Emergency Committee on Novel Coronavirus |website=[[World Health Organization]] (WHO) }}</ref> The [[Istituto Superiore di Sanit\u00e0]] reported that out of 8.8% of deaths where [[medical record|medical charts]] were available for review, 97.2% of sampled patients had at least one [[comorbidity]] with the average patient having 2.7 diseases.<ref name=\"ISSCharacteristics\">{{Cite report|vauthors=Palmieri L, Andrianou X, Barbariol P, Bella A, Bellino S, Benelli E, Bertinato L, Boros S, Brambilla G, Calcagnini G, Canevelli M, Castrucci MR, Censi F, Ciervo A, Colaizzo E, D'Ancona F, Del Manso M, Donfrancesco C, Fabiani M, Filia A, Floridia M, Giuliano M, Grisetti T, Langer M, Lega I, Lo Noce C, Maiozzi P, Malchiodi Albedi F, Manno V, Martini M, Mateo Urdiales A, Mattei E, Meduri C, Meli P, Minelli G, Nebuloni M, Nistic\u00f2 L, Nonis M, Onder G, Palmisano L, Petrosillo N, Pezzotti P, Pricci F, Punzo O, Puro V, Raparelli V, Rezza G, Riccardo F, Rota MC, Salerno P, Serra D, Siddu A, Stefanelli P, Tamburo De Bella M, Tiple D, Unim B, Vaianella L, Vanacore N, Vichi M, Villani ER, Brusaferro S|display-authors= 6|title=Characteristics of COVID-19 patients dying in Italy Report based on available data on April 2th, 2020|url=https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_2_april_2020.pdf|date=3 April 2020|publisher=[[Istituto Superiore di Sanit\u00e0]]|access-date=3 April 2020|url-status=live}}</ref> According to the same report, the median time between onset of symptoms and death was ten days, with five being spent hospitalised. However, patients transferred to an ICU had a median time of seven days between hospitalisation and death.<ref name=\"ISSCharacteristics\" /> In a study of early cases, the median time from exhibiting initial symptoms to death was 14 days, with a full range of six to 41 days.<ref>{{cite journal | vauthors = Wang W, Tang J, Wei F | title = Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China | journal = Journal of Medical Virology | volume = 92 | issue = 4 | pages = 441\u201347 | date = April 2020 | pmid = 31994742 |doi=10.1002/jmv.25689 |doi-access=free }}</ref> In a study by the [[National Health Commission]] (NHC) of China, men had a death rate of 2.8% while women had a death rate of 1.7%.<ref name=\"WM2020Feb26\">{{cite web |title=Coronavirus Age, Sex, Demographics (COVID-19) |url=https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/ |website=www.worldometers.info |access-date=26 February 2020 |archive-url=https://web.archive.org/web/20200227112932/https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/ |archive-date=27 February 2020 |url-status=live | name-list-format = vanc}}</ref> [[Histopathology|Histopathological]] examinations of post-mortem lung samples show [[diffuse alveolar damage]] with cellular fibromyxoid [[exudate]]s in both lungs. Viral [[cytopathic effect|cytopathic]] changes were observed in the [[pneumocytes]]. The lung picture resembled [[acute respiratory distress syndrome]] (ARDS).<ref name=\"WHOReport24Feb2020\" /> In 11.8% of the deaths reported by the National Health Commission of China, heart damage was noted by elevated levels of [[Troponin I|troponin]] or cardiac arrest.<ref name=\"Zheng Ma Zhang Xie p.\" />\n\nAvailability of medical resources and the [[socioeconomics]] of a region may also affect mortality.<ref name=\"Ji Ma Peppelenbosch Pan 2020 p.\">{{cite journal | vauthors=Ji Y, Ma Z, Peppelenbosch MP, Pan Q | title=Potential association between COVID-19 mortality and health-care resource availability | journal=Lancet Global Health | volume= 8| date=February 2020 | issue=4 | pages=e480 | pmid=32109372 | doi=10.1016/S2214-109X(20)30068-1 | doi-access=free }}</ref> Estimates of the mortality from the condition vary because of those regional differences,<ref name=\"pmid32159317\">{{cite journal | vauthors = Li XQ, Cai WF, Huang LF, Chen C, Liu YF, Zhang ZB, Yuan J, Li TG, Wang M | display-authors = 6 | title = [Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou] | language = Chinese | journal = Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi | volume = 41 | issue = 5 | pages = 634\u2013637 | date = March 2020 | pmid = 32159317 | doi = 10.3760/cma.j.cn112338-20200228-00209 }}</ref> but also because of [[Methodology|methodological]] difficulties. The under-counting of mild cases can cause the mortality rate to be overestimated.<ref>{{cite journal | vauthors = Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, Kobayashi T, Kinoshita R, Nishiura H | display-authors = 6 | title = Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases | journal = Journal of Clinical Medicine | volume = 9 | issue = 2 | page = 523 | date = February 2020 | pmid = 32075152 | doi = 10.3390/jcm9020523 | pmc = 7074479 }}</ref> However, the fact that deaths are the result of cases contracted in the past can mean the current mortality rate is underestimated.<ref>{{cite journal | vauthors = Chughtai A, Malik A | title = Is Coronavirus disease (COVID-19) case fatality ratio underestimated? | journal = Global Biosecurity | date = March 2020 | volume = 1 | issue = 3 | doi = 10.31646/gbio.56 | doi-broken-date = 19 March 2020 }}</ref><ref>{{cite journal | vauthors = Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G | title = Real estimates of mortality following COVID-19 infection. | journal = The Lancet Infectious Diseases | date = March 2020 | doi = 10.1016/S1473-3099(20)30195-X | pmid = 32171390 | pmc = 7118515 }}</ref>\n\nConcerns have been raised about long-term [[sequela]]e of the disease. The [[Hong Kong Hospital Authority]] found a drop of 20% to 30% in lung capacity in some people who recovered from the disease, and lung scans suggested organ damage.<ref>{{cite web |last1=Cheung |first1=Elizabeth |name-list-format=vanc |title=Some recovered Covid-19 patients may have lung damage, doctors say |url=https://www.scmp.com/news/hong-kong/health-environment/article/3074988/coronavirus-some-recovered-patients-may-have |website=[[South China Morning Post]] |language=en |date=13 March 2020 |access-date=15 March 2020 |archive-url=https://web.archive.org/web/20200315172445/https://www.scmp.com/news/hong-kong/health-environment/article/3074988/coronavirus-some-recovered-patients-may-have |archive-date=15 March 2020 |url-status=live }}</ref>\n\n{| class=\"wikitable\"\n|+Case fatality rates (%) by age and country\n|-\n!Age\n!0\u20139\n!10\u201319\n!20\u201329\n!30\u201339\n!40\u201349\n!50\u201359\n!60\u201369\n!70\u201379\n!80-89\n!90+\n|-\n|China as of 11 February<ref name=\"Epidemiology2020Feb17\" />\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|1.3\n|style=\"text-align:center;\"|3.6\n|style=\"text-align:center;\"|8.0\n|colspan=\"2\" style=\"text-align:center;\"|14.8\n|-\n|Denmark as of 6 April<ref name=\"SSIReport\">{{cite report|url=https://www.ssi.dk/-/media/ssi-files/covid19-overvaagningsrapport-06042020-hu4v.pdf|title=COVID-19 i Danmark: Epidemiologisk overv\u00e5gningsrapport den 6. april 2020|date=6 April 2020|publisher=[[Statens Serum Institut]]|language=Danish|access-date=6 April 2020|url-status=live}}</ref>\n|colspan=\"6\" style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|3.2\n|style=\"text-align:center;\"|11.0\n|style=\"text-align:center;\"|20.3\n|style=\"text-align:center;\"|32.6\n|-\n|Italy as of 6 April<ref name=\"ISSReport\">{{cite report|url=https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_6-aprile-2020.pdf|title=Epidemia COVID-19. Aggiornamento nazionale 6 aprile 2020|last=|first=|date=6 April 2020|publisher=[[Istituto Superiore di Sanit\u00e0]]|issue=|doi=|location=Rome|volume=|language=Italian|pmid=|access-date=7 April 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|0.8\n|style=\"text-align:center;\"|2.3\n|style=\"text-align:center;\"|8.4\n|style=\"text-align:center;\"|22.7\n|style=\"text-align:center;\"|30.6\n|style=\"text-align:center;\"|26.8\n|-\n|Netherlands as of 3 April<ref name=\"RIVMReport\">{{cite report|url=https://www.rivm.nl/sites/default/files/2020-04/COVID-19_WebSite_rapport_20200406_1005_1.pdf|title=Epidemiologische situatie COVID-19 in Nederland 06 april 2020|date=6 April 2020|publisher=[[Netherlands National Institute for Public Health and the Environment|Rijksinstituut voor Volksgezondheid en Milie]]|location=Bilthoven|language=Dutch|access-date=6 April 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|1.2\n|style=\"text-align:center;\"|6.2\n|style=\"text-align:center;\"|16.0\n|style=\"text-align:center;\"|25.1\n|style=\"text-align:center;\"|22.0\n|-\n|South Korea as of 5 April<ref name=\"KCDCReport\">{{cite report|url=https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030|title=The updates on COVID-19 in Korea as of 5 April|date=5 April 2020|publisher=[[Korea Centers for Disease Control and Prevention]]|access-date=6 April 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.7\n|style=\"text-align:center;\"|1.9\n|style=\"text-align:center;\"|7.5\n|colspan=\"2\" style=\"text-align:center;\"|19.7\n|-\n|Spain as of 5 April<ref name=\"MSCBSReport\">{{cite report|url=https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_67_COVID-19.pdf|title=Actualizaci\u00f3n n\u00ba 67. Enfermedad por el coronavirus (COVID-19).|date=6 April 2020|publisher=[[Ministry of Health (Spain)|Ministerio de Sanidad, Consumo y Bienestar Social]]|language=Spanish|access-date=6 April 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|0.9\n|style=\"text-align:center;\"|2.8\n|style=\"text-align:center;\"|9.4\n|style=\"text-align:center;\"|18.9\n|style=\"text-align:center;\"|22.9\n|}\n{| class=\"wikitable\"\n|+Case fatality rates (%) by age in the United States\n|-\n!Age\n!0\u201319\n!20\u201344\n!45\u201354\n!55\u201364\n!65\u201374\n!75\u201384\n!85+\n|-\n|United States as of 16 March<ref name=\"CDCMMWR18Mar2020\">{{cite journal|author=CDC COVID-19 Response Team|title=Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)\u2014United States, February 12 \u2013 March 16, 2020|url=https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm|journal=[[Morbidity and Mortality Weekly Report]]|volume=69|issue=12|pages=343\u2013346|date=18 March 2020|publisher=[[Centers for Disease Control]]|doi=10.15585/mmwr.mm6912e2|pmid=32214079|access-date=22 March 2020|archive-url=https://web.archive.org/web/20200322021219/https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm|archive-date=22 March 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.1\u20130.2\n|style=\"text-align:center;\"|0.5\u20130.8\n|style=\"text-align:center;\"|1.4\u20132.6\n|style=\"text-align:center;\"|2.7\u20134.9\n|style=\"text-align:center;\"|4.3\u201310.5\n|style=\"text-align:center;\"|10.4\u201327.3\n|-\n| colspan=\"8\" |Note: The lower bound includes all cases. The upper bound excludes cases that were missing data.\n|}\n\n{| class=\"wikitable\"\n|+Estimate of infection fatality rates and probability of severe disease course (%) by age based on cases from China<ref>{{Cite journal|last=Verity|first=Robert|last2=Okell|first2=Lucy C|last3=Dorigatti|first3=Ilaria|last4=Winskill|first4=Peter|last5=Whittaker|first5=Charles|last6=Imai|first6=Natsuko|last7=Cuomo-Dannenburg|first7=Gina|last8=Thompson|first8=Hayley|last9=Walker|first9=Patrick G T|last10=Fu|first10=Han|last11=Dighe|first11=Amy|date=30 March 2020|title=Estimates of the severity of coronavirus disease 2019: a model-based analysis|journal=The Lancet Infectious Diseases|doi=10.1016/s1473-3099(20)30243-7|pmid=32240634|doi-access=free|issn=1473-3099}}</ref>\n|-\n!\n!0\u20139\n!10\u201319\n!20\u201329\n!30\u201339\n!40\u201349\n!50\u201359\n!60\u201369\n!70\u201379\n!80+\n|-\n!Severe disease\n|style=\"text-align:center;\"|0.0<br /><small>(0.0\u20130.0)</small>\n|style=\"text-align:center;\"|0.04<br /><small>(0.02\u20130.08)</small>\n|style=\"text-align:center;\"|1.0<br /><small>(0.62\u20132.1)</small>\n|style=\"text-align:center;\"|3.4<br /><small>(2.0\u20137.0)</small>\n|style=\"text-align:center;\"|4.3<br /><small>(2.5\u20138.7)</small>\n|style=\"text-align:center;\"|8.2<br /><small>(4.9\u201317)</small>\n|style=\"text-align:center;\"|11<br /><small>(7.0\u201324)</small>\n|style=\"text-align:center;\"|17<br /><small>(9.9\u201334)</small>\n|style=\"text-align:center;\"|18<br /><small>(11\u201338)</small>\n|-\n!Death\n|style=\"text-align:center;\"|0.0016<br /><small>(0.00016\u20130.025)</small>\n|style=\"text-align:center;\"|0.0070<br /><small>(0.0015\u20130.050)</small>\n|style=\"text-align:center;\"|0.031<br /><small>(0.014\u20130.092)</small>\n|style=\"text-align:center;\"|0.084<br /><small>(0.041\u20130.19)</small>\n|style=\"text-align:center;\"|0.16<br /><small>(0.076\u20130.32)</small>\n|style=\"text-align:center;\"|0.60<br /><small>(0.34\u20131.3)</small>\n|style=\"text-align:center;\"|1.9<br /><small>(1.1\u20133.9)</small>\n|style=\"text-align:center;\"|4.3<br /><small>(2.5\u20138.4)</small>\n|style=\"text-align:center;\"|7.8<br /><small>(3.8\u201313)</small>\n|-\n|colspan=10| Total infection fatality rate is estimated to be 0.66% (0.39\u20131.3). Infection fatality rate is fatality per all infected individuals, regardless of whether they were diagnosed or had any symptoms. Numbers in parentheses are 95% [[credible interval]]s for the estimates. \n|}\n\n===Reinfection===\n\nAs of March 2020, it was unknown if past infection provides effective and long-term [[Immunity (medical)|immunity]] in people who recover from the disease.<ref>{{cite web|url=https://www.immunology.org/news/bsi-open-letter-government-sars-cov-2-outbreak-response|title=BSI open letter to Government on SARS-CoV-2 outbreak response | publisher= British Society for Immunology|website= immunology.org|access-date=15 March 2020|archive-url= https://web.archive.org/web/20200314221816/https://www.immunology.org/news/bsi-open-letter-government-sars-cov-2-outbreak-response|archive-date=14 March 2020 |url-status=live}}</ref> Immunity is seen as likely, based on the behaviour of other coronaviruses,<ref>{{cite news| url= https://www.independent.co.uk/life-style/health-and-families/coronavirus-immunity-reinfection-get-covid-19-twice-sick-spread-relapse-a9400691.html |title= Can you get coronavirus twice or does it cause immunity?|date=13 March 2020|website=The Independent|language=en|access-date=15 March 2020|archive-url= https://web.archive.org/web/20200314211439/https://www.independent.co.uk/life-style/health-and-families/coronavirus-immunity-reinfection-get-covid-19-twice-sick-spread-relapse-a9400691.html|archive-date=14 March 2020|url-status=live}}</ref> but cases in which recovery from COVID-19 have been followed by positive tests for coronavirus at a later date have been reported.<ref>{{cite web|url=https://www.latimes.com/world-nation/story/2020-03-13/china-japan-korea-coronavirus-reinfection-test-positive|title=They survived the coronavirus. Then they tested positive again. Why?|date=13 March 2020|website=Los Angeles Times|language=en-US|access-date=15 March 2020|archive-url=https://web.archive.org/web/20200314220822/https://www.latimes.com/world-nation/story/2020-03-13/china-japan-korea-coronavirus-reinfection-test-positive|archive-date=14 March 2020|url-status=live}}</ref><ref>{{cite web |url= https://www.caixinglobal.com/2020-02-26/14-of-recovered-covid-19-patients-in-guangdong-tested-positive-again-101520415.html|title=14% of Recovered Covid-19 Patients in Guangdong Tested Positive Again| publisher= Caixin Global|website= caixinglobal.com|language=en|access-date=15 March 2020|archive-url= https://web.archive.org/web/20200303181249/https://www.caixinglobal.com/2020-02-26/14-of-recovered-covid-19-patients-in-guangdong-tested-positive-again-101520415.html|archive-date=3 March 2020|url-status=live}}</ref><ref name=\"Omer2020\">{{cite journal |last1=Omer |first1=SB |last2=Malani |first2=P |last3=del Rio |first3=C |title=The COVID-19 Pandemic in the US A Clinical Update |journal=JAMA |date= 6 April 2020 |doi=10.1001/jama.2020.5788|pmid=32250388 }}</ref> These cases are believed to be worsening of a lingering infection rather than re-infection.<ref name=\"Omer2020\"/>\n\n==History==\n\nThe virus is thought to be natural and have an [[zoonosis|animal origin]],<ref name=\"NM-20200317\">{{cite journal |vauthors=Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF |title=The proximal origin of SARS-CoV-2 |url=https://www.nature.com/articles/s41591-020-0820-9 |date=17 March 2020 |journal=[[Nature Medicine]] |pages=1\u20133 |doi=10.1038/s41591-020-0820-9 |issn=1546-170X |access-date=18 March 2020 |archive-url=https://web.archive.org/web/20200318001738/https://www.nature.com/articles/s41591-020-0820-9 |archive-date=18 March 2020 |url-status=live }}</ref> through [[spillover infection]].<ref>{{cite web|url=http://nautil.us/issue/83/intelligence/the-man-who-saw-the-pandemic-coming|title=The Man Who Saw the Pandemic Coming|last=Berger|first=Kevin|name-list-format=vanc|date=12 March 2020|website=Nautilus|access-date=16 March 2020|archive-url=https://web.archive.org/web/20200315180124/http://nautil.us/issue/83/intelligence/the-man-who-saw-the-pandemic-coming|archive-date=15 March 2020|url-status=live}}</ref> The origin is unknown but by December 2019 the spread of infection was almost entirely driven by human-to-human transmission.<ref name=\"Epidemiology2020Feb17\">{{cite journal|vauthors=Yanping Z, et al.|collaboration=The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team|title=The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)\u2014China, 2020|url=http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51|journal=China CDC Weekly|volume=2|issue=8|pages=113\u2013122|date=17 February 2020|publisher=[[Chinese Center for Disease Control and Prevention]]|access-date=18 March 2020|archive-url=https://web.archive.org/web/20200219142101/http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51|archive-date=19 February 2020|url-status=live}}</ref><ref name=\"Heymann Shindo 2020 pp. 542\u201345\">{{cite journal | vauthors=Heymann DL, Shindo N | title=COVID-19: what is next for public health? | journal=Lancet | volume=395 | issue=10224 | date=February 2020 | pmid=32061313 | doi=10.1016/S0140-6736(20)30374-3 | doi-access=free | pages=542\u201345 }}</ref> The earliest reported infection has been unofficially reported to have occurred on 17 November 2019 in [[2019\u201320 coronavirus pandemic in Hubei|Wuhan, China]].<ref name=Davidson13March2020>{{cite news |author= Davidson, Helen |date= 13 March 2020 |title= First Covid-19 case happened in November, China government records show\u2014report |url= https://www.theguardian.com/world/2020/mar/13/first-covid-19-case-happened-in-november-china-government-records-show-report |work= The Guardian |access-date= 21 March 2020 |archive-url= https://web.archive.org/web/20200320235432/https://www.theguardian.com/world/2020/mar/13/first-covid-19-case-happened-in-november-china-government-records-show-report |archive-date= 20 March 2020 |url-status= live }}</ref> A study of the first 41 cases of confirmed COVID-19, published in January 2020 in ''The Lancet'', revealed the earliest date of onset of symptoms as 1{{nbsp}}December 2019.<ref name=WuMarch2020>{{Cite journal|last=Wu|first=Yi-Chi|last2=Chen|first2=Ching-Sung|last3=Chan|first3=Yu-Jiun|date=March 2020|title=The outbreak of COVID-19: An overview|journal=Journal of the Chinese Medical Association|language=en-US|volume=83|issue=3|pages=217\u2013220|doi=10.1097/JCMA.0000000000000270|issn=1726-4901}}</ref><ref name=\"Wang24Jan2020\">{{cite journal |last1=Wang |first1=C. |last2=Horby |first2=P. W. |last3=Hayden |first3=F. G. |last4=Gao |first4=G. F. |title=A novel coronavirus outbreak of global health concern |journal=[[Lancet (journal)|Lancet]] |volume=395 |issue=10223 |pages=470\u2013473 |date=February 2020 |pmid=31986257 |doi=10.1016/S0140-6736(20)30185-9 |url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30185-9/abstract}} {{free access}}</ref><ref name=\"AutoDW-67\">{{Cite journal |last=Cohen |first=Jon |date=January 2020 |title=Wuhan seafood market may not be source of novel virus spreading globally |url=https://www.sciencemag.org/news/2020/01/wuhan-seafood-market-may-not-be-source-novel-virus-spreading-globally |journal=[[Science (journal)|Science]] |doi=10.1126/science.abb0611}}</ref> Official publications from the WHO reported the earliest onset of symptoms as 8{{nbsp}}December 2019.<ref name=Davidson13March2020/>\n\n==Epidemiology==\n\n{{main|2019\u201320 coronavirus pandemic}}\nSeveral measures are commonly used to quantify mortality.<ref>{{cite web|url=https://www.cdc.gov/csels/dsepd/ss1978/lesson3/section3.html|title=Principles of Epidemiology {{!}} Lesson 3\u2014Section 3|date=18 February 2019|website=www.cdc.gov|language=en-us|access-date=28 March 2020|archive-url=https://web.archive.org/web/20200228150607/https://www.cdc.gov/csels/dsepd/ss1978/lesson3/section3.html|archive-date=28 February 2020|url-status=live}}</ref> These numbers vary by region and over time and are influenced by the volume of testing, healthcare system quality, treatment options, time since initial outbreak and population characteristics such as age, sex and overall health.<ref>{{cite web |url=https://ourworldindata.org/covid-mortality-risk |title=What do we know about the risk of dying from COVID-19? |last=Ritchie |first=Hannah |last2=Roser |first2=Max |date=25 March 2020 |editor-last=Chivers |editor-first=Tom |website=[[Our World in Data]] |url-status=live |access-date=28 March 2020 |archive-url=https://web.archive.org/web/20200328192730/https://ourworldindata.org/covid-mortality-risk |archive-date=28 March 2020 }}</ref> In late 2019, WHO assigned the emergency [[ICD-10]] disease codes [[ICD-10 Chapter XXII: Codes for special purposes|U07.1]] for deaths from lab-confirmed SARS-CoV-2 infection and U07.2 for deaths from clinically or epidemiologically diagnosed COVID-19 without lab-confirmed SARS-CoV-2 infection.<ref name=\"ICD10_2019_U07p2\">{{cite web | title = ICD-10 Version:2019 | website = [[World Health Organization]] | quote = U07.2\u2014COVID-19, virus not identified\u2014COVID-19 NOS\u2014Use this code when COVID-19 is diagnosed clinically or epidemiologically but laboratory testing is inconclusive or not available. Use additional code, if desired, to identify pneumonia or other manifestations | year = 2019 | url = https://icd.who.int/browse10/2019/en#/U07.1 | accessdate = 2020-03-31 | archiveurl = https://archive.today/20200331004754/https://icd.who.int/browse10/2019/en%23/U07.1#/U07.1 | archivedate = 31 March 2020 | url-status = live | url-access = <!--(subscription/registration/limited) default=free--> }}</ref>\n\nThe death-to-case ratio reflects the number of deaths divided by the number of diagnosed cases within a given time interval. Based on Johns Hopkins University statistics, the global death-to-case ratio is {{Cases in 2019\u201320 coronavirus pandemic|ratio|editlink=|ref=no}} ({{Cases in 2019\u201320 coronavirus pandemic|deaths|editlink=|ref=no}}/{{Cases in 2019\u201320 coronavirus pandemic|confirmed|editlink=|ref=no}}) as of {{Cases in 2019\u201320 coronavirus pandemic|date|editlink=|ref=no}}.{{Cases in 2019\u201320 coronavirus pandemic|ref=yes}} The number varies by region.<ref>{{Cite journal |last=Lazzerini |first=Marzia |last2=Putoto |first2=Giovanni |date=18 March 2020 |title=COVID-19 in Italy: momentous decisions and many uncertainties |url=https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30110-8/abstract |journal=The Lancet Global Health |language=English |volume=0 |doi=10.1016/S2214-109X(20)30110-8 |issn=2214-109X |pmid=32199072|pmc=7104294 }}</ref>\n\nOther measures include the [[case fatality rate]] (CFR), which reflects the percent of diagnosed individuals who die from a disease, and the infection fatality rate (IFR), which reflects the percent of infected individuals (diagnosed and undiagnosed) who die from a disease. These statistics are not time bound and follow a specific population from infection through case resolution. A number of academics have attempted to calculate these numbers for specific populations.<ref>{{cite web |url=https://ourworldindata.org/covid-mortality-risk |title=What do we know about the risk of dying from COVID-19? |website=Our World in Data |access-date=28 March 2020 |archive-url=https://web.archive.org/web/20200328192730/https://ourworldindata.org/covid-mortality-risk |archive-date=28 March 2020 |url-status=live }}</ref> In the epicentre of the outbreak in Italy, Castiglione d'Adda, a small village of 4500, 80 (1.8%) are already dead. Most people in the village appear to have developed [[antibodies]] and plausible immunity, most did so without being diagnosed, and many did not have symptoms.<ref>{{cite web|url=http://www.ilcittadino.it/cronaca/2020/04/02/contagiati-senza-saperlo-all-avis-sono-ben-40-su-60/KYwVaGiHShP3odU4dY4zx3/index.html|title=Castiglione: contagiati senza saperlo, all'Avis sono ben 40 donatori su 60|website=Il Cittadino di Lodi|language=it|access-date=2020-04-05}}</ref><ref>{{cite web|url=https://www.ilgiornale.it/news/cronache/asintomatici-anticorpi-loro-plasma-cura-virus-1848999.html|title=Asintomatici, ma con anticorpi: dal loro plasma arriva la cura?|last=Bernasconi|first=Francesca|date=2020-04-02|website=ilGiornale.it|language=it|access-date=2020-04-05}}</ref> An investigation is underway to test the entire population to learn more about the disease.<ref>{{cite web|url=https://www.adnkronos.com/fatti/cronaca/2020/04/02/coronavirus-galli-pronti-test-tappeto-castiglione-adda_p1pDUsh8cd1En9PvyqTRWM.html|title=Coronavirus, Galli: \"Pronti a test a tappeto a Castiglione d'Adda\"|website=Adnkronos|access-date=2020-04-05}}</ref>\n<gallery mode=\"packed\" heights=\"210\">\nFile:Total-cases-covid-19-who.png|Total confirmed cases over time\nFile:Total-deaths-covid-19-who (1).png|Total deaths over time\nFile:Total-confirmed-cases-of-covid-19-per-million-people.png|Total confirmed cases of COVID-19 per million people, 20 March 2020<ref>{{cite web |title=Total confirmed cases of COVID-19 per million people |url=https://ourworldindata.org/grapher/total-confirmed-cases-of-covid-19-per-million-people |website=Our World in Data |access-date=20 March 2020 |archive-url=https://web.archive.org/web/20200319163452/https://ourworldindata.org/grapher/total-confirmed-cases-of-covid-19-per-million-people |archive-date=19 March 2020 |url-status=live }}</ref>\nFile:Total-covid-deaths-per-million.png|Total confirmed deaths due to COVID-19 per million people, 24 March 2020<ref>{{cite web |title=Total confirmed deaths due to COVID-19 per million people |url=https://ourworldindata.org/grapher/total-covid-deaths-per-million |website=Our World in Data |access-date=24 March 2020 |archive-url=https://web.archive.org/web/20200319163452/https://ourworldindata.org/grapher/total-covid-deaths-per-million |archive-date=19 March 2020 |url-status=live }}</ref>\n</gallery>\n\n==Society and culture==\n===Nomenclature===\n\nThe [[World Health Organization]] announced in February 2020 that COVID-19 is the official name of the disease. World Health Organisation chief [[Tedros Adhanom|Tedros Adhanom Ghebreyesus]] explained that ''CO'' stands for {{Em|corona}}, ''VI'' for {{Em|virus}} and ''D'' for {{Em|disease}}, while ''19'' is for when the outbreak was first identified: 31 December 2019.<ref>{{cite news |title=Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK\u2014sixth update |url=https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.pdf |access-date=26 March 2020 |publisher=ecdc |archive-url=https://web.archive.org/web/20200314223709/https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.pdf |archive-date=14 March 2020 |url-status=live }}</ref> The name had been chosen to avoid references to a specific geographical location (e.g. China), animal species or group of people, in line with international recommendations for naming aimed at preventing [[Social stigma|stigmatisation]].<ref>{{cite news |title=Novel coronavirus named 'Covid-19': WHO |url=https://www.todayonline.com/world/wuhan-novel-coronavirus-named-covid-19-who |access-date=11 February 2020 |publisher=TODAYonline |name-list-format=vanc |archive-url=https://archive.today/20200321085608/https://www.todayonline.com/world/wuhan-novel-coronavirus-named-covid-19-who |archive-date=21 March 2020 |url-status=live }}</ref><ref name=\"veconomist\">{{cite news|author= |title= The coronavirus spreads racism against\u2014and among\u2014ethnic Chinese|url= https://www.economist.com/china/2020/02/17/the-coronavirus-spreads-racism-against-and-among-ethnic-chinese|work= [[The Economist]]|date= 17 February 2020|access-date= 17 February 2020|archive-url= https://web.archive.org/web/20200217223902/https://www.economist.com/china/2020/02/17/the-coronavirus-spreads-racism-against-and-among-ethnic-chinese|archive-date= 17 February 2020|url-status= live| name-list-format = vanc}}</ref>\n\nThe virus that causes COVID-19 is named [[severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2).<ref name=\"WHO-naming\">{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it|title=Naming the coronavirus disease (COVID-19) and the virus that causes it|website=[[World Health Organization]] (WHO)|access-date=13 March 2020|archive-url=https://web.archive.org/web/20200228035651/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it|archive-date=28 February 2020|url-status=live}}</ref> The WHO additionally uses \"the COVID-19 virus\" and \"the virus responsible for COVID-19\" in public communications.<ref name=\"WHO-naming\" /> Coronaviruses were named in 1968 for their appearance in [[electron microscope|electron micrographs]] which was reminiscent of the [[solar corona]], [[:wikt:corona#Latin|''cor\u014dna'']] meaning crown in [[Latin]].<ref>{{cite journal|title=Virology: Coronaviruses|journal=Nature|volume=220|issue=5168|date=1968|page=650|issn=0028-0836|doi=10.1038/220650b0|bibcode=1968Natur.220..650.}}</ref><ref>{{citation |title= Definition of Coronavirus by Merriam-Webster |publisher= Merriam-Webster |url= https://www.merriam-webster.com/dictionary/coronavirus |access-date= 24 March 2020 |archive-url= https://web.archive.org/web/20200323161218/https://www.merriam-webster.com/dictionary/coronavirus |archive-date= 23 March 2020 |url-status= live }}</ref><ref>{{citation |title= Definition of Corona by Merriam-Webster |publisher= Merriam-Webster |url= https://www.merriam-webster.com/dictionary/corona |access-date= 24 March 2020 |archive-url= https://web.archive.org/web/20200324161709/https://www.merriam-webster.com/dictionary/corona |archive-date= 24 March 2020 |url-status= live }}</ref> Both the disease and virus are commonly referred to as \"coronavirus\".\n\nDuring the initial outbreak in Wuhan, China, the virus and disease were commonly referred to as \"coronavirus\" and \"Wuhan coronavirus\".<ref>{{cite web|url=https://www.npr.org/sections/health-shots/2020/01/24/799208865/a-second-u-s-case-of-wuhan-coronavirus-is-confirmed|title=2nd U.S. Case Of Wuhan Coronavirus Confirmed|website=NPR.org|language=en|access-date=2020-04-04}}</ref><ref>{{Cite news|last=Jr|first=Donald G. McNeil|url=https://www.nytimes.com/2020/02/02/health/coronavirus-pandemic-china.html|title=Wuhan Coronavirus Looks Increasingly Like a Pandemic, Experts Say|date=2020-02-02|work=The New York Times|access-date=2020-04-04|language=en-US|issn=0362-4331}}</ref><ref>{{cite news|url=https://www.cnn.com/2020/02/05/asia/wuhan-coronavirus-update-death-toll-spike-intl-hnk/index.html|title=Wuhan coronavirus deaths spike again as outbreak shows no signs of slowing|last=Griffiths|first=James|website=CNN|access-date=2020-04-04}}</ref> In January 2020, WHO recommended 2019-nCov<ref>{{cite web|url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf|title=Novel Coronavirus (2019-nCoV) SITUATION REPORT\u20141|last=|first=|date=21 January 2020|website=WHO|url-status=live|archive-url=|archive-date=|access-date=}}</ref> and 2019-nCoV acute respiratory disease<ref>{{cite web|url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf|title=Novel Coronavirus(2019-nCoV) Situation Report\u201410|last=|first=|date=30 January 2020|website=WHO|url-status=live|archive-url=|archive-date=|access-date=}}</ref> as interim names for the virus and disease in accordance with 2015 guidance against using locations in disease and virus names.<ref>{{cite web|url=https://apps.who.int/iris/bitstream/handle/10665/163636/WHO_HSE_FOS_15.1_eng.pdf|title=World Health Organization Best Practices for the Naming of New Human Infectious Diseases|last=|first=|date=May 2015|website=WHO|url-status=live|archive-url=|archive-date=|access-date=}}</ref> The official names COVID-19 and SARS-CoV-2 were issued on 11 February 2020.<ref>{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it|title=Naming the coronavirus disease (COVID-19) and the virus that causes it|website=www.who.int|language=en|access-date=2020-04-04}}</ref><ref>{{cite web|url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2|title=Novel Coronavirus(2019-nCoV) Situation Report\u201410|date=30 January 2020|website=[[World Health Organization]] (WHO)|url-status=live|archive-url=https://web.archive.org/web/20200131005409/https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf|archive-date=31 January 2020|access-date=15 March 2020}}</ref>\n\n===Manufacturing===\n\nDue to capacity limitations in the standard [[supply chain]]s, some digital manufacturers are [[3D printing|printing]] healthcare material such as nasal swabs and ventilator parts.<ref>{{cite news |last1=Temple |first1=James |title=How 3D printing could save lives in the coronavirus outbreak |url=https://www.technologyreview.com/s/615420/3d-printing-coronavirus-covid-19-medical-supplies-devices/ |accessdate=5 April 2020 |work=MIT Technology Review}}</ref><ref>{{cite news |last1=Tibken |first1=Shara |title=3D printing may help supply more essential coronavirus medical gear |url=https://www.cnet.com/news/3d-printing-may-help-supply-more-essential-coronavirus-medical-gear/ |accessdate=5 April 2020 |work=CNET |language=en}}</ref> In one example, when an Italian hospital urgently required a ventilator valve, and the supplier was unable to deliver in the timescale required, a local startup reverse-engineered and printed the required 100 valves overnight.<ref>{{cite news |title=[Updating] Italian hospital saves Covid-19 patients lives by 3D printing valves for reanimation devices |url=https://www.3dprintingmedia.network/covid-19-3d-printed-valve-for-reanimation-device/ |accessdate=20 March 2020 |work=3D Printing Media Network |date=14 March 2020}}</ref><ref>{{cite news |last1=Peters |first1=Jay |title=Volunteers produce 3D-printed valves for life-saving coronavirus treatments |url=https://www.theverge.com/2020/3/17/21184308/coronavirus-italy-medical-3d-print-valves-treatments |accessdate=20 March 2020 |work=The Verge |date=17 March 2020 |language=en}}</ref>\n\n===Misinformation===\n\n{{main|Misinformation related to the 2019\u201320 coronavirus pandemic}}\nAfter the initial [[2019\u201320 coronavirus pandemic|outbreak]] of COVID-19, conspiracy theories, [[misinformation]] and [[disinformation]] emerged regarding the origin, scale, prevention, treatment and other aspects of the disease and rapidly spread online.<ref name=\"bbc_misinfo\">{{Cite news |url=https://www.bbc.com/news/blogs-trending-51271037 |title=China coronavirus: Misinformation spreads online about origin and scale |date=30 January 2020 |work=[[BBC News]] |access-date=10 February 2020 |archive-url= https://web.archive.org/web/20200204163412/https://www.bbc.com/news/blogs-trending-51271037 |archive-date=4 February 2020 |url-status=live}}</ref><ref name=GUAR>{{cite newspaper | url=https://www.theguardian.com/world/2020/jan/31/bat-soup-dodgy-cures-and-diseasology-the-spread-of-coronavirus-bunkum | title=Bat soup, dodgy cures and 'diseasology': the spread of coronavirus misinformation | date=January 31, 2020 | accessdate=February 3, 2020 | first=Josh | last=Taylor | newspaper=[[The Guardian]] | archive-url=https://web.archive.org/web/20200202141231/https://www.theguardian.com/world/2020/jan/31/bat-soup-dodgy-cures-and-diseasology-the-spread-of-coronavirus-bunkum | archive-date=February 2, 2020 | url-status=live }}</ref><ref name=Lowy>{{Cite news|first=Natasha|last=Kassam|url=https://www.lowyinstitute.org/the-interpreter/disinformation-and-coronavirus|work=The Interpreter|publisher=Lowy Institute|title=Disinformation and coronavirus|date=March 25, 2020}}</ref><ref name=RunningList>{{cite web |url=https://www.buzzfeednews.com/article/janelytvynenko/coronavirus-disinformation-spread |title=Here's A Running List Of Disinformation Spreading About The Coronavirus |website=Buzzfeed News |access-date=February 8, 2020 |archive-url=https://web.archive.org/web/20200206212717/https://www.buzzfeednews.com/article/janelytvynenko/coronavirus-disinformation-spread |archive-date=February 6, 2020 |url-status=live }}</ref>\n\n==Research==\n\n{{Main|COVID-19 drug development}}\nInternational [[clinical research]] programs on vaccines and therapeutic drug candidates having potential to reduce illnesses caused by COVID-19 are underway by government organisations, academic groups and industry researchers.<ref name=\"dhama\">{{cite journal | vauthors=Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W | display-authors=6 | title=COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics | journal=Human Vaccines and Immunotherapeutics| date=March 2020 | issn=2164-5515 | pmid=32186952 | doi=10.1080/21645515.2020.1735227 | pages=1\u20137 | pmc=7103671 |doi-access=free}}</ref><ref name=\"zhang2020\">{{cite journal | vauthors=Zhang L, Liu Y | title=Potential interventions for novel coronavirus in China: A systematic review | journal=Journal of Medical Virology | volume=92 | issue=5 | date=March 2020 | issn=0146-6615 | doi=10.1002/jmv.25707 | pages=479\u201390 | pmid=32052466 }}</ref> In March, the [[World Health Organization]] initiated the \"[[Solidarity Trial|SOLIDARITY Trial]]\" in 10 countries, enrolling thousands of people infected with COVID-19 to assess treatment effects of four existing antiviral compounds with the most promise of efficacy.<ref name=\"kai\">{{cite journal|last1=Kupferschmidt|first1=Kai|last2=Cohen|first2=Jon| title=WHO launches global megatrial of the four most promising coronavirus treatments |journal=Science Magazine | date=22 March 2020 | url=https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-four-most-promising-coronavirus-treatments | access-date=27 March 2020|doi=10.1126/science.abb8497}}</ref>\n\nPersonal hygiene and a healthy lifestyle and [[Healthy diet|diet]] have been recommended to improve immunity.<ref>{{cite journal |last1=Wang |first1=Li-sheng |last2=Wang |first2=Yi-ru |last3=Ye |first3=Da-wei |last4=Liu |first4=Qing-quan |title=A review of the 2019 novel coronavirus (COVID-19) based on current evidence |journal=International Journal of Antimicrobial Agents |date=19 March 2020 |page=105948 |doi=10.1016/j.ijantimicag.2020.105948 |pmid=32201353 |url=https://www.sciencedirect.com/science/article/pii/S0924857920300984 |accessdate=27 March 2020 |language=en |issn=0924-8579 |archive-url=https://web.archive.org/web/20200327232545/https://www.sciencedirect.com/science/article/pii/S0924857920300984 |archive-date=27 March 2020 |url-status=live }}</ref>\n\n===Vaccine===\n\n{{main|COVID-19 vaccine}}\nThere is no available vaccine, but various agencies are actively developing vaccine candidates. Previous work on [[SARS-CoV]] is being utilised because SARS-CoV-2 and SARS-CoV both use the ACE2 receptor to enter human cells.<ref>{{cite book | vauthors=Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R | chapter=Features, Evaluation and Treatment Coronavirus (COVID-19) | title=StatPearls [Internet] | chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK554776/ |date=March 2020 | publisher=StatPearls |pmid= 32150360 | id=Bookshelf ID: NBK554776 }}</ref> There are three vaccination strategies being investigated. First, researchers aim to build a whole virus vaccine. The use of such a virus, be it [[inactivated vaccine|inactive]] or dead, aims to elicit a prompt [[immune response]] of the human body to a new infection with COVID-19. A second strategy, subunit vaccines, aims to create a vaccine that sensitises the immune system to certain subunits of the virus. In the case of SARS-CoV-2, such research focuses on the S-spike protein that helps the virus intrude the [[ACE2 enzyme]] receptor. A third strategy is that of the nucleic acid vaccines ([[DNA vaccination|DNA]] or [[RNA vaccines]], a novel technique for creating a vaccination). Experimental vaccines from any of these strategies would have to be tested for safety and efficacy.<ref name=\"Chen Strych Hotez Bottazzi p.\">{{cite journal | vauthors = Chen WH, Strych U, Hotez PJ, Bottazzi ME | title=The SARS-CoV-2 Vaccine Pipeline: an Overview | journal=Current Tropical Medicine Reports | date=3 March 2020 | pages=1\u20134 |doi=10.1007/s40475-020-00201-6 |doi-access=free | pmid=32219057 | pmc=7094941 | name-list-format = vanc}}</ref>\n\nOn 16 March 2020, the first clinical trial of a vaccine started with four volunteers in [[Seattle]]. The vaccine contains a harmless genetic code copied from the virus that causes the disease.<ref>{{Cite news |last=Roberts |first=Michelle |name-list-format=vanc |url=https://www.bbc.com/news/health-51906604 |title=Coronavirus: US volunteers test first vaccine |date=17 March 2020 |work=BBC News |access-date=17 March 2020 |language=en-GB |archive-url=https://web.archive.org/web/20200317034657/https://www.bbc.com/news/health-51906604 |archive-date=17 March 2020 |url-status=live }}</ref>\n\nA key challenge for vaccine development for SARS-COV-2, SARS-COV, and MERS-COV is the phenomenon of [[antibody dependent enhancement]].\n\n===Post-infection treatments===\n\n{{Main|COVID-19 drug repurposing research}}\nAccording to two organisations tracking clinical trial progress on potential therapeutic drugs for COVID-19 infections, 29 Phase II-IV efficacy trials were concluded in March 2020 or scheduled to provide results in April from hospitals in China &ndash; which experienced the first outbreak of COVID-19 in late 2019.<ref name=\"milken\">{{cite web |title=COVID-19 treatment and vaccine tracker |url=https://milkeninstitute.org/sites/default/files/2020-04/Covid19%20Tracker%20NEW4-2-20-final.pdf |publisher=Milken Institute |accessdate=2 April 2020 |date=2 April 2020 |lay-url=https://milkeninstitute.org/covid-19-tracker }}</ref><ref name=\"koch\">{{cite web |author1=Selina Koch |author2=Winnie Pong |title=First up for COVID-19: nearly 30 clinical readouts before end of April |url=https://www.biocentury.com/article/304658 |publisher=BioCentury Inc. |accessdate=1 April 2020 |date=13 March 2020}}</ref> Seven trials were evaluating repurposed drugs already approved to treat [[malaria]], including four studies on hydroxychloroquine or chloroquine phosphate.<ref name=koch/> Repurposed [[antiviral drug]]s make up most of the Chinese research, with nine Phase III trials on remdesivir across several countries due to report by the end of April.<ref name=milken/><ref name=koch/> Other potential therapeutic candidates under pivotal clinical trials concluding in March\u2013April are [[vasodilator]]s, [[corticosteroid]]s, [[immunotherapy|immune therapies]], [[lipoic acid]], [[bevacizumab]] and [[recombinant DNA|recombinant]] [[angiotensin-converting enzyme 2]], among others.<ref name=koch/>\n\nThe COVID-19 Clinical Research Coalition has goals to 1) facilitate rapid reviews of clinical trial proposals by [[ethics committee]]s and national regulatory agencies, 2) fast-track approvals for the candidate therapeutic compounds, 3) ensure standardised and rapid analysis of emerging efficacy and safety data and 4) facilitate sharing of clinical trial outcomes before publication.<ref name=\"coalition\">{{cite journal | title=Global coalition to accelerate COVID-19 clinical research in resource-limited settings | journal=The Lancet |author=COVID-19 Clinical Research Coalition| year=2020 | issn=0140-6736 | doi=10.1016/s0140-6736(20)30798-4 | pmid=32247324 |url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30798-4/fulltext#articleInformation}}</ref><ref name=\"maguire\">{{cite journal | last=Maguire | first=Brittany J. | last2=Gu\u00e9rin | first2=Philippe J. | title=A living systematic review protocol for COVID-19 clinical trial registrations | journal=Wellcome Open Research | volume=5 | date=2 April 2020 | issn=2398-502X | doi=10.12688/wellcomeopenres.15821.1 | page=60|url=https://wellcomeopenresearch.org/articles/5-60/v1}}</ref> A dynamic review of clinical development for COVID-19 vaccine and drug candidates was in place, as of April 2020.<ref name=maguire/>\n\nSeveral existing [[Antiviral drug|antiviral medications]] are being evaluated for treatment of COVID-19,<ref name=\"LiDeClerq\" /> including [[remdesivir]], [[chloroquine]] and [[hydroxychloroquine]], [[lopinavir/ritonavir]] and lopinavir/ritonavir combined with [[Interferon-beta|interferon beta]].<ref name=kai/><ref>{{cite web|url=https://news.un.org/en/story/2020/03/1059722|title=UN health chief announces global 'solidarity trial' to jumpstart search for COVID-19 treatment|date=18 March 2020|website=UN News|language=en|access-date=23 March 2020|archive-url=https://web.archive.org/web/20200323101633/https://news.un.org/en/story/2020/03/1059722|archive-date=23 March 2020|url-status=live}}</ref> There is tentative evidence for efficacy by remdesivir, as of March 2020.<ref>{{cite journal|vauthors=Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR|date=March 2020|title=Arguments in favor of remdesivir for treating SARS-CoV-2 infections|journal=International Journal of Antimicrobial Agents|page=105933|doi=10.1016/j.ijantimicag.2020.105933|pmid=32147516|doi-access=free}}</ref> Remdesivir inhibits SARS-CoV-2 ''[[in vitro]]''.<ref name=\"pmid32020029\">{{cite journal|display-authors=6|vauthors=Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G|date=February 2020 |title= Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro|journal=Cell Research |volume= 30| issue= 3|pages=269\u201371|doi=10.1038/s41422-020-0282-0|pmc=7054408|pmid=32020029|doi-access=free|name-list-format=vanc}}</ref> [[Phase 3 clinical trial]]s are being conducted in the U.S., China and Italy.<ref name=\"LiDeClerq\" /><ref name=milken/><ref>{{cite journal |last1=Beeching |first1=Nicholas J. |last2=Fletcher |first2=Tom E. |last3=Fowler |first3=Robert |name-list-format=vanc |date=2020 |title=BMJ Best Practices: COVID-19 |url= https://bestpractice.bmj.com/topics/en-gb/3000168/pdf/3000168/COVID-19.pdf |url-status=live |journal=BMJ |access-date=11 March 2020 |archive-url=https://web.archive.org/web/20200222170544/https://bestpractice.bmj.com/topics/en-gb/3000168/pdf/3000168/COVID-19.pdf |archive-date=22 February 2020 }}</ref>\n\nChloroquine, previously used to treat [[malaria]], was studied in China in February 2020, with preliminary results.<ref name=\"JianjunZhXu_chloroquine\">{{cite journal | vauthors = Gao J, Tian Z, Yang X | title = Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies | journal = Bioscience Trends | volume = 14 | pages = 72\u201373 | date = February 2020 | issue = 1 | pmid = 32074550 |doi=10.5582/bst.2020.01047 |doi-access=free | name-list-format = vanc}}</ref> However, there are calls for peer review of the research.<ref>{{cite journal | vauthors = Touret F, de Lamballerie X | title = Of chloroquine and COVID-19 | journal = Antiviral Research | volume = 177 | page = 104762 | date = March 2020 | pmid = 32147496 | doi = 10.1016/j.antiviral.2020.104762 }}</ref> The Guangdong Provincial Department of Science and Technology and the Guangdong Provincial Health and Health Commission issued a report stating that chloroquine phosphate \"improves the success rate of treatment and shortens the length of person's hospital stay\" and recommended it for people diagnosed with mild, moderate and severe cases of novel coronavirus pneumonia.<ref>{{cite journal | title = [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia] | journal = Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases | volume = 43 | pages = E019 | date = February 2020 | pmid = 32075365 | doi = 10.3760/cma.j.issn.1001-0939.2020.0019 | author1 = multicenter collaboration group of Department of Science Technology of Guangdong Province Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia }}</ref>\n\nOn 17 March, the Italian Pharmaceutical Agency included chloroquine and hydroxychloroquine in the list of drugs with positive preliminary results for treatment of COVID-19.<ref name=\":15\">{{cite web|url=https://aifa.gov.it/-/azioni-intraprese-per-favorire-la-ricerca-e-l-accesso-ai-nuovi-farmaci-per-il-trattamento-del-covid-19|title=Azioni intraprese per favorire la ricerca e l'accesso ai nuovi farmaci per il trattamento del COVID-19 |website= aifa.gov.it|language=it-IT|access-date=18 March 2020}}</ref> Korean and Chinese Health Authorities recommend the use of [[chloroquine]].<ref>{{cite web|url=http://m.koreabiomed.com/news/articleView.html?idxno=7428|title=Physicians work out treatment guidelines for coronavirus|date=13 February 2020|website=m.koreabiomed.com|language=Korean|name-list-format=vanc|access-date=10 March 2020|archive-url= https://web.archive.org/web/20200317061347/http://m.koreabiomed.com/news/articleView.html?idxno=7428|archive-date=17 March 2020|url-status=live}}</ref><ref name=\":9\">{{cite web|url=https://www.chinalawtranslate.com/en/coronavirus-treatment-plan-7/|title=Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Provisional 7th Edition)|date=4 March 2020|website=China Law Translate|name-list-format=vanc|access-date=10 March 2020|archive-url= https://web.archive.org/web/20200310082919/https://www.chinalawtranslate.com/en/coronavirus-treatment-plan-7/|archive-date=10 March 2020|url-status=live}}</ref> However, the Wuhan Institute of Virology, while recommending a daily dose of one gram, notes that twice that dose is highly dangerous and could be lethal. On 28 March 2020, the [[Food and Drug Administration|FDA]] issued an [[emergency use authorisation]] for hydroxychloroquine and chloroquine at the discretion of physicians treating people with COVID-19.<ref name=\"hinton\">{{cite web |author1=Denise M Hinton |title=Request for Emergency Use Authorization For Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease |url=https://www.fda.gov/media/136534/download |publisher=US Food and Drug Administration |accessdate=30 March 2020 |date=28 March 2020 |archive-url=https://web.archive.org/web/20200330074008/https://www.fda.gov/media/136534/download |archive-date=30 March 2020 |url-status=live }}</ref><ref>{{cite web |last1=Commissioner |first1=Office of the |title=Emergency Use Authorization |url=https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization |website=FDA |accessdate=30 March 2020 |language=en |date=29 March 2020 |archive-url=https://web.archive.org/web/20200305013118/https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization |archive-date=5 March 2020 |url-status=live }}</ref>\n\nThe Chinese 7th edition guidelines also include [[interferon]], [[ribavirin]] or [[umifenovir]] for use against COVID-19.<ref name=\":9\" />\n\nIn 2020, a trial found that lopinavir/ritonavir was ineffective in the treatment of severe illness.<ref>{{cite journal | vauthors = Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C | display-authors = 6 | title = A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 | journal = The New England Journal of Medicine | date = March 2020 | pmid = 32187464 | doi = 10.1056/NEJMoa2001282 | pmc = 7121492 }}</ref> [[Nitazoxanide]] has been recommended for further ''[[in vivo]]'' study after demonstrating low concentration inhibition of SARS-CoV-2.<ref name=\"pmid32020029\" />\n\nStudies have demonstrated that initial spike protein priming by transmembrane protease serine{{nbsp}}2 ([[TMPRSS2]]) is essential for entry of SARS-CoV-2 via interaction with the [[ACE2]] receptor.<ref>{{cite journal | vauthors = Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N | title = TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection | journal = Journal of Virology | volume = 93 | issue = 6 | date = March 2019 | pmid = 30626688 | pmc = 6401451 | doi = 10.1128/JVI.01815-18 | doi-access = free }}</ref> These findings suggest that the TMPRSS2 inhibitor [[camostat]] approved for use in Japan for inhibiting fibrosis in liver and kidney disease might constitute an effective off-label treatment.\n\nIn February 2020, [[favipiravir]] was being studied in China for experimental treatment of the emergent COVID-19 disease.<ref>Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). ''Nature Reviews Drug Discovery'' 2020 Feb {{doi|10.1038/d41573-020-00016-0}}</ref><ref>[https://www.reuters.com/article/brief-corrected-zhejiang-hisun-pharma-ge/brief-corrected-zhejiang-hisun-pharma-gets-approval-for-clinical-trial-to-test-flu-drug-favipiravir-for-pneumonia-caused-by-new-coronavirus-idUSL4N2AH0C8 BRIEF-Corrected-Zhejiang Hisun Pharma gets approval for clinical trial to test flu drug Favipiravir for pneumonia caused by new coronavirus] {{Webarchive|url=https://web.archive.org/web/20200318220901/https://www.reuters.com/article/brief-corrected-zhejiang-hisun-pharma-ge/brief-corrected-zhejiang-hisun-pharma-gets-approval-for-clinical-trial-to-test-flu-drug-favipiravir-for-pneumonia-caused-by-new-coronavirus-idUSL4N2AH0C8 |date=18 March 2020 }}. Reuters Healthcare, 16 February 2020.</ref>\n\nIn April 2020 [[ivermectin]] is being studied in Australia for a possible treatment for COVID-19 and has been shown to stop viral growth within 48 hours in vitro.<ref>{{Cite journal|url=http://www.sciencedirect.com/science/article/pii/S0166354220302011|title=The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro|first1=Leon|last1=Caly|first2=Julian D.|last2=Druce|first3=Mike G.|last3=Catton|first4=David A.|last4=Jans|first5=Kylie M.|last5=Wagstaff|date=3 April 2020|journal=Antiviral Research|page=104787|via=ScienceDirect|doi=10.1016/j.antiviral.2020.104787|pmid=32251768}}</ref><ref>{{cite web|website=Monash Biomedicine Discovery Institute|title= Possible coronavirus drug identified by Monash University scientists |url=https://www.monash.edu/discovery-institute/news-and-events/news/2020-articles/possible-coronavirus-drug-identified-by-monash-university-scientists |date=3 April 2020|access-date= 7 April 2020}}</ref>\n\nThere are mixed results as of April 3 as to the effectiveness of [[hydroxychloroquine]] as a treatment for COVID-19. With studies showing little to no improvement over the control groups.<ref>{{cite news |last1=Seley-Radtke |first1=Katherine |title=Professor of Chemistry and Biochemistry and President-Elect of the International Society for Antiviral Research, University of Maryland, Baltimore County |url=https://theconversation.com/a-small-trial-finds-that-hydroxychloroquine-is-not-effective-for-treating-coronavirus-135484 |accessdate=5 April 2020 |publisher=The Conversation |date=3 April 2020}}</ref>\n\n===Anti-cytokine storm===\n\n[[Cytokine release syndrome|Cytokine storm]] can be a complication in the later stages of severe COVID-19. There is evidence that [[hydroxychloroquine]] may have anti-cytokine storm properties.<ref name=\"pmid32150618\">{{cite journal |vauthors=Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D |title=In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |journal=Clin. Infect. Dis. |volume= |issue= |pages= |date=March 2020 |pmid=32150618 |doi=10.1093/cid/ciaa237 |pmc=7108130 }}</ref>\n\n[[Tocilizumab]] has been included in treatment guidelines by China's [[National Health Commission]] after a small study was completed.<ref name=\"tocil-1\">{{cite news|last1=Liu|first1=Roxanne|last2=Miller|first2=Josh|name-list-format=vanc|url=https://www.reuters.com/article/us-health-coronavirus-china-roche-hldg/china-approves-use-of-roche-arthritis-drug-for-coronavirus-patients-idUSKBN20R0LF|title=China approves use of Roche drug in battle against coronavirus complications|date=3 March 2020|work=[[Reuters]]|access-date=14 March 2020|archive-url=https://web.archive.org/web/20200312204625/https://www.reuters.com/article/us-health-coronavirus-china-roche-hldg/china-approves-use-of-roche-arthritis-drug-for-coronavirus-patients-idUSKBN20R0LF|archive-date=12 March 2020|url-status=live}}</ref><ref name=\"tocil-2\">{{cite document |date=5 March 2020 |title=Effective Treatment of Severe COVID-19 Patients with Tocilizumab |url=http://chinaxiv.org/abs/202003.00026 |publisher=ChinaXiv.org |doi=10.12074/202003.00026|doi-broken-date=2020-03-16 |accessdate=14 March 2020|journal=|archive-url=https://web.archive.org/web/20200319022047/http://chinaxiv.org/abs/202003.00026|archive-date=19 March 2020|url-status=live}}</ref> It is undergoing a [[Phase IIb|phase{{nbsp}}2]] non randomised test at the national level in Italy after showing positive results in people with severe disease.<ref name=\":15\" /><ref name=\"tocil-3\">{{cite web|url=http://www.ansa.it/english/news/general_news/2020/03/13/3-patients-get-better-on-arthritis-drug_90d4764d-d93f-463e-ab07-168b34b084d0.html|title=3 patients get better on arthritis drug|date=5 March 2020|accessdate=14 March 2020|archive-url=https://web.archive.org/web/20200319022045/http://www.ansa.it/english/news/general_news/2020/03/13/3-patients-get-better-on-arthritis-drug_90d4764d-d93f-463e-ab07-168b34b084d0.html|archive-date=19 March 2020|url-status=live}}</ref><ref name=\"tocil-4\">{{cite news|url=https://www.ilmessaggero.it/italia/coronavirus_farmaco_artrite_ultime_notizie_news_napoli-5109045.html|title=Coronavirus, via libera dell'Aifa al farmaco anti-artrite efficace su 3 pazienti e a un antivirale: test in 5 centri|trans-title=Coronavirus, Aifa gives go-ahead to effective anti-arthritis drug on 3 patients and an antiviral: test in 5 centers|newspaper=[[Il Messaggero]]|language=it|accessdate=14 March 2020|archive-url=https://web.archive.org/web/20200319022047/https://www.ilmessaggero.it/italia/coronavirus_farmaco_artrite_ultime_notizie_news_napoli-5109045.html|archive-date=19 March 2020|url-status=live}}</ref>{{MEDRS|date=March 2020}} Combined with a [[Ferritin|serum ferritin blood test]] to identify [[Cytokine release syndrome|cytokine storms]], it is meant to counter such developments, which are thought to be the cause of death in some affected people.<ref name=\"tocil-5\">{{cite web|url=https://www.vox.com/2020/3/12/21176783/coronavirus-covid-19-deaths-china-treatment-cytokine-storm-syndrome|title=How doctors can potentially significantly reduce the number of deaths from Covid-19|publisher=[[Vox (website)|Vox]]|accessdate=14 March 2020|date=12 March 2020|archive-url=https://web.archive.org/web/20200319155218/https://www.vox.com/2020/3/12/21176783/coronavirus-covid-19-deaths-china-treatment-cytokine-storm-syndrome|archive-date=19 March 2020|url-status=live}}</ref><ref name=\"tocil-6\">{{cite journal | vauthors = Ruan Q, Yang K, Wang W, Jiang L, Song J | title = Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China | journal = Intensive Care Medicine | date = March 2020 | pmid = 32125452 | doi = 10.1007/s00134-020-05991-x | pmc = 7080116 }}</ref><ref name=\"tocil-8\">{{cite journal |display-authors=3 |vauthors=Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ |title=COVID-19: consider cytokine storm syndromes and immunosuppression |journal=[[The Lancet]] |date=16 March 2020 |volume=395 |issue=10229 |pages=1033\u20131034 |doi=10.1016/S0140-6736(20)30628-0 |pmid=32192578 |url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext |access-date=19 March 2020 |archive-url=https://web.archive.org/web/20200322045751/https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext |archive-date=22 March 2020 |url-status=live }}</ref> The [[Interleukin 6|interleukin-6]] [[receptor antagonist]] was approved by the [[Food and Drug Administration|FDA]] based on retrospective case studies for treatment of steroid refractory cytokine release syndrome induced by a different cause, [[Chimeric antigen receptor T cell|CAR T cell]] [[Gene therapy|therapy]], in 2017.<ref name=\"tocil-7\">{{cite web|url=https://www.fiercepharma.com/pharma-asia/china-turns-roche-arthritis-drug-actemra-against-covid-19-new-treatment-guidelines|title=China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines|publisher=FiercePharma|accessdate=14 March 2020|archive-url=https://web.archive.org/web/20200319022042/https://www.fiercepharma.com/pharma-asia/china-turns-roche-arthritis-drug-actemra-against-covid-19-new-treatment-guidelines|archive-date=19 March 2020|url-status=live}}</ref>{{MEDRS|date=March 2020}} To date, there is no randomised, controlled evidence that [[tocilizumab]] is an efficacious treatment for CRS. Prophylactic [[tocilizumab]] has been shown increase serum IL-6 levels by saturating the IL-6R, driving IL-6 across the blood brain barrier and exacerbating neurotoxicity while having no impact on incidence of CRS.<ref>{{cite journal | vauthors = Locke F et al | display-authors = 1 | title = Preliminary Results of Prophylactic Tocilizumab after Axicabtageneciloleucel (axi-cel; KTE-C19) Treatment for Patients with Refractory,Aggressive Non-Hodgkin Lymphoma (NHL) | journal = Blood | date = 2017 | url = https://ashpublications.org/blood/article/130/Supplement%201/1547/79746}}</ref>\n\n[[Lenzilumab]], an anti-GM-CSF monoclonal antibody, has been shown to be protective in murine models for [[Chimeric antigen receptor T cell|CAR T cell]] induced CRS and neurotoxicity and is a viable therapeutic option due to the observed increase of pathogenic GM-CSF secreting T-cells in hospitalised patients with COVID-19.<ref>{{cite journal | vauthors = Sterner RM et al. | display-authors = 1 | title = GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts. | journal = Blood. | date = 2019 | pmid = 30463995 | doi = 10.1182/blood-2018-10-881722 | volume = 133 | issue = 7 | pmc = 6376281 | pages = 697\u2013709}}</ref>\n\nThe [[Feinstein Institute for Medical Research|Feinstein Institute]] of [[Northwell Health]] announced in March a study on \"a human antibody that may prevent the activity\" of IL-6.<ref>{{cite news|url=https://www.longislandpress.com/2020/03/21/northwell-health-initiates-clinical-trials-of-2-covid-19-drugs/|title=Northwell Health Initiates Clinical Trials of 2 COVID-19 Drugs|date=21 March 2020|accessdate=23 March 2020|archive-url=https://web.archive.org/web/20200323081238/https://www.longislandpress.com/2020/03/21/northwell-health-initiates-clinical-trials-of-2-covid-19-drugs/|archive-date=23 March 2020|url-status=live}}</ref>\n\n===Passive antibody therapy===\n\nTransferring purified and concentrated [[Immunoglobulin therapy|antibodies]] produced by the [[immune system]]s of those who have recovered from COVID-19 to people who need them is being investigated as a non-vaccine method of [[Passive immunity|passive immunisation]].<ref name=\"pmid-32167489\">{{cite journal | vauthors = Casadevall A, Pirofski LA | title = The convalescent sera option for containing COVID-19 | journal = The Journal of Clinical Investigation | date = March 2020 | volume = 130 | issue = 4 | pages = 1545\u20131548 | pmid = 32167489 | doi = 10.1172/JCI138003 | pmc = 7108922 }}</ref> This strategy was tried for SARS with inconclusive results.<ref name=\"pmid-32167489\" /> [[Neutralisation (immunology)|Viral neutralisation]] is the anticipated [[mechanism of action]] by which passive antibody therapy can mediate defence against SARS-CoV-2. Other mechanisms however, such as [[antibody-dependent cellular cytotoxicity]] and/or [[phagocytosis]], may be possible.<ref name=\"pmid-32167489\" /> Other forms of passive antibody therapy, for example, using manufactured [[Monoclonal antibody|monoclonal antibodies]], are in development.<ref name=\"pmid-32167489\" /> Production of [[convalescent serum]], which consists of the liquid portion of the blood from recovered patients and contains antibodies specific to this virus, could be increased for quicker deployment.<ref name=\"Pearce-2020-03-13\">{{cite web |last=Pearce |first=Katie |name-list-format=vanc |date=13 March 2020 |title=Antibodies from COVID-19 survivors could be used to treat patients, protect those at risk: Infusions of antibody-laden blood have been used with reported success in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic |work=The Hub at Johns Hopkins University |url=https://hub.jhu.edu/2020/03/13/covid-19-antibody-sera-arturo-casadevall/ |accessdate=14 March 2020 |archive-url=https://web.archive.org/web/20200314185825/https://hub.jhu.edu/2020/03/13/covid-19-antibody-sera-arturo-casadevall/ |archive-date=14 March 2020 |url-status=live }}</ref>\n\n==See also==\n\n* {{annotated link|Coronavirus Act 2020}}\n* [[Coronavirus Aid, Relief, and Economic Security Act]], a US law\n* [[Coronavirus disease]]s, a group of closely related syndromes\n* [[Coronavirus recession]]\n* [[Disease X]], a WHO term\n* [[Li Wenliang]], a doctor at [[Central Hospital of Wuhan]], who later contracted and died of COVID-19 after raising awareness of the spread of the virus.\n* [[:Template:2019\u201320 coronavirus pandemic]] for conditions in various countries\n\n==Notes==\n\n{{notelist}}\n\n==References==\n\n{{reflist|refs=\n<ref name=\"Reut_NIH_Moderna_3months\">{{cite news | last1= Steenhuysen | first1= Julie | last2= Kelland | first2= Kate | name-list-format = vanc | title= With Wuhan virus genetic code in hand, scientists begin work on a vaccine | date= 24 January 2020 | agency= [[Reuters]] | url= https://www.reuters.com/article/us-china-health-vaccines-idUSKBN1ZN2J8 |accessdate=25 January 2020 |archive-url= https://web.archive.org/web/20200125203723/https://www.reuters.com/article/us-china-health-vaccines-idUSKBN1ZN2J8 |archive-date= 25 January 2020 |url-status=live }}</ref>\n}}\n\n==External links==\n\n{{Portalbar|border=n|Coronavirus disease 2019 | Medicine | Viruses}}\n{{Sister project links|wikt=COVID-19|c=category:COVID-19|n=category:COVID-19|q=COVID-19|s=category:COVID-19|voy=2019\u20132020 coronavirus pandemic|v=COVID-19|b=no}}\n{{Scholia|topic}}\n* [https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Coronavirus disease (COVID-19)] by the [[World Health Organization]]\n* [https://www.cdc.gov/coronavirus/2019-ncov/index.html Coronavirus 2019 (COVID-19)] by the [[Centers for Disease Control and Prevention|U.S. Centers for Disease Control and Prevention]]\n* {{Curlie|Health/Conditions_and_Diseases/Respiratory_Disorders/COVID-19|COVID-19}}\n* [https://openmd.com/directory/covid-19 COVID-19 Resource Directory on OpenMD]\n* [https://jamanetwork.com/journals/jama/pages/coronavirus-alert Coronavirus Disease 2019 (COVID-19)] by ''[[JAMA (journal)|JAMA]]''\n* [https://www.bmj.com/coronavirus Coronavirus: News and Resources] by the [[BMJ (company)|BMJ Publishing Group]]\n* [https://www.elsevier.com/connect/coronavirus-information-center Novel Coronavirus Information Center] by [[Elsevier]]\n* [https://www.thelancet.com/coronavirus COVID-19 Resource Centre] by ''[[The Lancet]]''\n* [https://www.springernature.com/gp/researchers/campaigns/coronavirus SARS-CoV-2 and COVID-19] by ''[[Nature (journal)|Nature]]''\n* [https://www.nejm.org/coronavirus Coronavirus (Covid-19)] by the ''[[New England Journal of Medicine]]''\n* [https://novel-coronavirus.onlinelibrary.wiley.com/ Covid-19: Novel Coronavirus] by [[Wiley (publisher)|Wiley Publishing]]\n* [http://gabgoh.github.io/COVID/index.html Epidemiology simulator]<!--referenced by https://medium.com/@tomaspueyo/coronavirus-the-hammer-and-the-dance-be9337092b56 , in turn endorsed by hundreds of experts https://medium.com/tomas-pueyo/coronavirus-articles-endorsements-fdc68614f8e3-->\n\n{{medical resources| ICD10 = {{ICD10|U07.1}}, {{ICD10|U07.2}}}}\n{{Respiratory pathology}}\n{{Viral diseases}}\n{{2019\u201320 coronavirus pandemic}}\n{{Authority control}}\n\n[[Category:COVID-19| ]]\n[[Category:Occupational safety and health]]\n[[Category:Viral respiratory tract infections]]\n[[Category:Zoonoses]]\n", "text_old": "{{About|the disease|the virus|Severe acute respiratory syndrome coronavirus 2|the pandemic|2019\u201320 coronavirus pandemic}}\n{{pp-protected|small=yes}}\n{{Short description|Viral respiratory disease first detected in 2019}}\n{{Use Commonwealth English|date=March 2020}}\n{{Use dmy dates|date=March 2020}}\n{{Infobox medical condition\n| name          = Coronavirus disease 2019 (COVID-19)\n| synonyms      = * Coronavirus\n* 2019-nCoV acute respiratory disease\n* Novel coronavirus pneumonia<ref>{{cite web|url=https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)30211-7.pdf|title=Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study|last=|first=|date=14 February 2020|website=The Lancet|url-status=live|archive-url=|archive-date=|access-date=}}</ref><ref>{{Cite journal|last=Han|first=Xiaoyu|last2=Cao|first2=Yukun|last3=Jiang|first3=Nanchuan|last4=Chen|first4=Yan|last5=Alwalid|first5=Osamah|last6=Zhang|first6=Xin|last7=Gu|first7=Jin|last8=Dai|first8=Meng|last9=Liu|first9=Jie|last10=Zhu|first10=Wanyue|last11=Zheng|first11=Chuansheng|title=Novel Coronavirus Pneumonia (COVID-19) Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section CT Features During Recovery|journal=Clinical Infectious Diseases|year=2020|language=en|doi=10.1093/cid/ciaa271|pmid=32227091}}</ref>\n* Wuhan pneumonia<ref name=TIMEinfo>{{cite news | first = Charlie | last = Campbell | name-list-format = vanc | title = The Wuhan Pneumonia Crisis Highlights the Danger in China's Opaque Way of Doing Things | date = 20 January 2020 | accessdate = 13 March 2020 | url = https://time.com/5768230/wuhan-pneumonia-flu-crisis-china-government/ | work = [[Time (magazine)|Time]] | archive-url = https://web.archive.org/web/20200313053341/https://time.com/5768230/wuhan-pneumonia-flu-crisis-china-government/ | archive-date = 13 March 2020 | url-status = live }}</ref><ref name=FPinfo>{{cite web | first1 = Daniel | last1 = Lucey | first2 = Annie | last2 = Sparrow | name-list-format = vanc | title = China Deserves Some Credit for Its Handling of the Wuhan Pneumonia | date = 14 January 2020 | accessdate = 13 March 2020 | url = https://foreignpolicy.com/2020/01/14/china-response-wuhan-pneumonia-better-sars/ | work = [[Foreign Policy]] | archive-url = https://web.archive.org/web/20200115042408/https://foreignpolicy.com/2020/01/14/china-response-wuhan-pneumonia-better-sars/ | archive-date = 15 January 2020 | url-status = live }}</ref>\n| image         = Symptoms of coronavirus disease 2019 3.0.svg\n| width         = \n| alt           = COVID-19 symptoms\n| caption       = Symptoms of COVID-19\n| pronounce     = {{IPAc-en|k|\u0259|\u02c8|r|o\u028a|n|\u0259|\u02cc|v|a\u026a|r|\u0259|s|_|d|\u026a|\u02c8|z|i:|z}}, {{IPAc-en|\u02c8|k|o\u028a|v|\u026a|d}}\n| specialty     = [[Infectious disease (medical specialty)|Infectious diseases]]\n| symptoms      = Fever, cough, shortness of breath, none<ref name=CDC2020Sym/><ref name=WHO2020QA/>\n| complications = [[Viral pneumonia|Pneumonia]], [[viral sepsis]], [[acute respiratory distress syndrome]], [[Acute kidney injury|kidney failure]]\n| onset         = 2\u201314 days (typically 5) from exposure\n| duration      = \n| types         = \n| cause         = [[Severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2)\n| risks         = Travel, viral exposure\n| diagnosis     = [[Reverse transcription polymerase chain reaction|rRT-PCR testing]], [[CT scan]]\n| differential  = \n| prevention    = [[Hand washing]], [[quarantine]], [[social distancing]]\n| treatment     = [[Symptomatic treatment|Symptomatic]] and [[supportive treatment|supportive]]\n| medication    = \n| prognosis     = \n| frequency     = {{Cases in 2019\u201320 coronavirus pandemic|confirmed|editlink=|ref=yes}} confirmed cases\n| deaths        = {{Cases in 2019\u201320 coronavirus pandemic|deaths|editlink=|ref=no}} ({{Cases in 2019\u201320 coronavirus pandemic|ratio|editlink=|ref=no}} of confirmed cases){{Cases in 2019\u201320 coronavirus pandemic|ref=yes}}\n}}\n<!--Definition and symptoms-->\n'''Coronavirus disease 2019''' ('''COVID-19''') is an [[infectious disease]] caused by [[severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2).<ref>{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it |title=Naming the coronavirus disease (COVID-19) and the virus that causes it |publisher=[[World Health Organization]] (WHO) |url-status=live |archive-url=https://web.archive.org/web/20200228035651/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it |archive-date=28 February 2020 |accessdate=28 February 2020| name-list-format = vanc}}</ref> The disease was first identified in December 2019 in [[Wuhan]], the capital of China's [[Hubei]] province, and has since spread globally, resulting in the ongoing [[2019\u201320 coronavirus pandemic]].<ref name=\"Hui14Jan2020\">{{cite journal |author-last1=Hui |author-first1=D. S. |author2=I. Azhar E. |author-last3=Madani |author-first3=T. A. |author-last4=Ntoumi |author-first4=F. |author-last5=Kock |author-first5=R. |author-last6=Dar |author-first6=O. |author-last7=Ippolito |author-first7=G. |author-last8=Mchugh |author-first8=T. D. |author-last9=Memish |author-first9=Z. A. |author-last10=Drosten |author-first10=Christian |author-link10=Christian Drosten |author-last11=Zumla |author-first11=A. |author-last12=Petersen |author-first12=E. | title=The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014The latest 2019 novel coronavirus outbreak in Wuhan, China | journal=Int J Infect Dis | date=February 2020 | volume=91 | issue= | pages=264\u201366 | pmid=31953166 | doi=10.1016/j.ijid.2020.01.009 | doi-access=free }}</ref><ref name=\"WHOPandemic\">{{cite press release | title=WHO Director-General's opening remarks at the media briefing on COVID-19 | website=[[World Health Organization]] (WHO) | date=11 March 2020 | url=https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 |accessdate=12 March 2020 | url-status=live | archive-url=https://web.archive.org/web/20200311212521/https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 | archive-date=11 March 2020 }}</ref> Common [[symptom]]s include [[fever]], [[cough]] and [[shortness of breath]].<ref name=\"CDCSym\" /> Other symptoms may include fatigue, [[Myalgia|muscle pain]], [[diarrhea]], [[sore throat]], [[loss of smell]] and abdominal pain.<ref name=\"CDC2020Sym\" /><ref name=\"whoqa\">{{cite web|url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|title=Q&A on coronaviruses (COVID-19)|url-status=live|accessdate=11 March 2020|publisher=[[World Health Organization]] (WHO)|archive-url=https://web.archive.org/web/20200120174649/https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|archive-date=20 January 2020}}</ref><ref name=\"entuk-anosmia\" /> The [[incubation period|time from exposure to onset of symptoms]] is typically around five days, but may range from two to 14 days.<ref name=CDCSym>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|title=Symptoms of Novel Coronavirus (2019-nCoV) |date=10 February 2020|website=www.cdc.gov|access-date=11 February 2020|archive-url=https://web.archive.org/web/20200130202038/https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|archive-date=30 January 2020|url-status=live }}</ref><ref>{{Cite journal|author-last1=Velavan |author-first1=T. P. |author-last2=Meyer |author-first2=C. G. |title=The COVID-19 epidemic|journal=Tropical Medicine & International Health|volume=n/a|issue=n/a|pages=278\u201380|doi=10.1111/tmi.13383 |doi-access=free |pmid=32052514|date=March 2020 }}</ref> While the majority of cases result in mild symptoms, some progress to viral [[pneumonia]] and [[multi-organ failure]].<ref name=\"Hui14Jan2020\" /><ref name=\"WHO-q-a\">{{cite web |url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses |title=Q&A on coronaviruses |website=[[World Health Organization]] (WHO) |url-status=live |archive-url=https://web.archive.org/web/20200120174649/https://www.who.int/news-room/q-a-detail/q-a-coronaviruses |archive-date=20 January 2020 |accessdate=27 January 2020| name-list-format = vanc}}</ref> As of {{Cases in 2019\u201320 coronavirus pandemic|date|editlink=|ref=no}}, more than {{Cases in 2019\u201320 coronavirus pandemic|conround|editlink=|ref=yes}} [[2019\u201320 coronavirus pandemic cases/WHO situation reports|cases]] have been reported in more than 200 countries and territories,<ref name=\"WOM\">{{cite web |title=Coronavirus Update (Live): 1,001,069 Cases and 51,378 Deaths from COVID-19 Virus Outbreak\u2014Worldometer |url=https://www.worldometers.info/coronavirus/ |website=www.worldometers.info |accessdate=2 April 2020 |language=en}}</ref> resulting in more than {{Cases in 2019\u201320 coronavirus pandemic|dround|editlink=|ref=no}} [[2019\u201320 coronavirus pandemic deaths/WHO situation reports|deaths]].{{Cases in 2019\u201320 coronavirus pandemic|ref=yes}} More than {{Cases in 2019\u201320 coronavirus pandemic|recround|editlink=|ref=no}} people have recovered.{{Cases in 2019\u201320 coronavirus pandemic|ref=yes}}\n\n<!--Spread-->\n<!--DO NOT INTERFERE WITH THE SECTION BEGIN/END TAGS, AS IT WILL BREAK THE PANDEMIC ARTICLE--><section begin=\"Spread\"/>The virus is mainly [[Transmission (medicine)|spread]] during close contact{{efn|Close contact is defined as one metre (three feet) by the WHO<ref name=\"WHO2020QA\" /> and two metres (six feet) by the CDC.<ref name=\"CDCTrans\" />}} and by [[Respiratory droplet|small droplets]] produced when those infected cough,{{efn|An uncovered cough can travel up to {{convert|8.2|m|ft|abbr=off}}.<ref name=\"Bourouiba, JAMA, 26 March\"/>}} sneeze or talk.<ref name=WHO2020QA/><!--Quote: \"The main way the disease spreads is through respiratory droplets expelled by someone who is coughing.\"--><ref name=CDCTrans/><!--The virus is thought to spread mainly from person-to-person [...] Between people who are in close contact with one another [...] Through respiratory droplets produced when an infected person coughs, sneezes or talks.--><ref name=\"ECDCQA\" /><!--The virus seems to be transmitted mainly via small respiratory droplets through sneezing, coughing, or when people interact with each other for some time in close proximity (usually less than one metre).--> These droplets may also be produced during breathing; however, they rapidly fall to the ground or surfaces and are not generally [[Airborne disease|spread through the air over large distances]].<ref name=WHO2020QA/><!--The disease can spread from person to person through small droplets from the nose or mouth which are spread when a person with COVID-19 coughs or exhales. These droplets land on objects and surfaces around the person.--><ref name=Modes>{{cite web |title=Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations |url=https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations |website=World Health Organization |accessdate=3 April 2020 |language=en |date=29 March 2020 |quote=According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes.}}</ref><!--airborne transmission was not reported... Airborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles <5\u03bcm in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than a meter.--><ref>{{cite web |last1=Organization (WHO) |first1=World Health |title=FACT: #COVID19 is NOT airborne. The #coronavirus is mainly transmitted through droplets generated when an infected person coughs, sneezes or speaks.To protect yourself:-keep 1m distance from others-disinfect surfaces frequently-wash/rub your -avoid touching your pic.twitter.com/fpkcpHAJx7 |url=https://twitter.com/WHO/status/1243972193169616898/photo/1 |website=@WHO |accessdate=3 April 2020 |language=en |date=28 March 2020 |quote=These droplets are too heavy to hang in the air. They quickly fall on floors or sufaces.}}</ref> People may also become infected by touching a contaminated surface and then their face.<ref name=WHO2020QA/><!--These droplets land on objects and surfaces around the person. Other people then catch COVID-19 by touching these objects or surfaces, then touching their eyes, nose or mouth.--><ref name=CDCTrans/><!--The virus is thought to spread mainly from person-to-person [...] Between people who are in close contact with one another--> The virus can survive on surfaces for up to 72 hours.<ref name=\"StableNIH\"/><!--Quote: The scientists found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detectable in aerosols for up to three hours, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.--> Coronavirus is most contagious during the first three days after onset of symptoms, although spread may be possible before symptoms appear and in later stages of the disease.<!--Quote: \"People are thought to be most contagious when they are most symptomatic (the sickest) [...] Some spread might be possible before people show symptoms\"--><ref name=\":22\">{{cite web|url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_4|title=Coronavirus disease 2019 (COVID-19) Situation Report\u201473|last=|first=|date=2 April 2020|website=World Health Organization|url-status=live|archive-url=|archive-date=|access-date=3 April 2020}}</ref><!--Quote: shedding of the COVID-19 virus is highest in upper respiratory tract (nose and throat) early in the course of the disease.8-11 That is, within the first three days from onset of symptoms.10-11 Preliminary data suggests that people may be more contagious around the time of symptom onset as compared to later on in the disease.--><!--DO NOT REMOVE THE FOLLOWING TAG--><section end=\"Spread\"/> \n\n<!--Diagnosis-->\nThe standard method of [[diagnosis]] is by [[real-time reverse transcription polymerase chain reaction]] (rRT-PCR) from a [[nasopharyngeal swab]].<ref name=CDC2020Testing>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html |website=Centers for Disease Control and Prevention |accessdate=26 March 2020 |language=en-us |date=11 February 2020 |archive-url=https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |archive-date=4 March 2020 |url-status=live }}</ref> The infection can also be diagnosed from a combination of symptoms, [[risk factor]]s and a chest [[CT scan]] showing features of pneumonia.<ref name=Jin2020 /><ref name=\":4\">{{cite web|url=https://www.sciencedaily.com/releases/2020/02/200226151951.htm|title=CT provides best diagnosis for COVID-19|date=26 February 2020|website=ScienceDaily|url-status=live|access-date=2 March 2020|archive-url=https://web.archive.org/web/20200318210532/https://www.sciencedaily.com/releases/2020/02/200226151951.htm|archive-date=18 March 2020}}</ref>\n\n<!--Prevention and management-->\nRecommended measures to prevent infection include frequent [[hand washing]], [[social distancing]] (maintaining physical distance from others, especially from those with symptoms), covering coughs and sneezes with a tissue or inner elbow and keeping unwashed hands away from the face.<ref name=\"Advice for public\">{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public|title=Advice for public|website=[[World Health Organization]] (WHO)|access-date=25 February 2020|archive-url=https://web.archive.org/web/20200126025750/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public|archive-date=26 January 2020|url-status=live| name-list-format = vanc}}</ref><ref>{{cite web|url=https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults|title=Guidance on social distancing for everyone in the UK|website=GOV.UK|language=en|access-date=25 March 2020|archive-url=https://web.archive.org/web/20200324214400/https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults|archive-date=24 March 2020|url-status=live}}</ref> The use of [[Surgical mask|masks]] is recommended for those who suspect they have the virus and their caregivers.<ref name=\"CDC2020IfSick\">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/steps-when-sick.html|title=2019&nbsp;Novel Coronavirus (2019-nCoV)|author=CDC|date=11 February 2020|website=Centers for Disease Control and Prevention|url-status=live|archive-url=https://web.archive.org/web/20200214153016/https://www.cdc.gov/coronavirus/2019-ncov/about/steps-when-sick.html|archive-date=14 February 2020|access-date=15 February 2020| name-list-format = vanc}}</ref> Recommendations for mask use by the general public vary, with some authorities recommending against their use, some recommending their use and others requiring their use.<ref>{{Cite journal|last=Feng|first=Shuo |last2=Shen|first2=Chen |last3=Xia|first3=Nan |last4=Song|first4=Wei |last5=Fan|first5=Mengzhen |last6=Cowling|first6=Benjamin J.|date=2020-03-20|title=Rational use of face masks in the COVID-19 pandemic|url=https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X/abstract|journal=The Lancet Respiratory Medicine|language=English|volume=0|doi=10.1016/S2213-2600(20)30134-X|issn=2213-2600|pmid=32203710|pmc=7118603 }}</ref><ref>{{cite web |title=When and how to use masks |url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks |website=www.who.int |accessdate=31 March 2020 |language=en |archive-url=https://web.archive.org/web/20200307013848/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks |archive-date=7 March 2020 |url-status=live }}</ref><!--Quote: \"If you are healthy, you only need to wear a mask if you are taking care of a person with suspected 2019-nCoV infection.\"--><ref>{{Cite news|last=Tait|first=Robert|url=https://www.theguardian.com/world/2020/mar/30/czechs-get-to-work-making-masks-after-government-decree-coronavirus|title=Czechs get to work making masks after government decree|date=2020-03-30|work=The Guardian|access-date=2020-03-31|language=en-GB|issn=0261-3077|archive-url=https://web.archive.org/web/20200330235911/https://www.theguardian.com/world/2020/mar/30/czechs-get-to-work-making-masks-after-government-decree-coronavirus|archive-date=30 March 2020|url-status=live}}</ref> Currently, there is no [[vaccine]] or specific [[antiviral treatment]] for COVID-19.<ref name=WHO2020QA/><!--To date, there is no vaccine and no specific antiviral medicine to prevent or treat COVID-2019.--> Management involves [[Palliative care|treatment of symptoms]], [[supportive care]], [[isolation (health care)|isolation]] and [[Medical research|experimental measures]].<ref name=\"cdc21Jan20202\">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/prevention-treatment.html|title=Coronavirus Disease 2019 (COVID-19)|date=15 February 2020|publisher=[[Centers for Disease Control and Prevention]] (CDC)|url-status=live|archive-url=https://web.archive.org/web/20200226145347/https://www.cdc.gov/coronavirus/2019-ncov/about/prevention-treatment.html|archive-date=26 February 2020|access-date=20 February 2020| name-list-format = vanc}}</ref>\n\n<!--Epidemiology and history-->\nThe [[World Health Organization]] (WHO) declared the 2019\u201320 coronavirus [[outbreak]] a [[Public Health Emergency of International Concern]] (PHEIC)<ref>{{cite web|url=https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)|title=Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)|website=[[World Health Organization]] (WHO)|access-date=11 February 2020|archive-url=https://web.archive.org/web/20200131005904/https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)|archive-date=31 January 2020|url-status=live| name-list-format = vanc}}</ref><ref>{{Cite news | author-last1=Mahtani |author-first1=S. |author-last2=Berger |author-first2=M. |author-last3=O'Grady |author-first3=S. |author-last4=Iati |author-first4=M. | url = https://www.washingtonpost.com/world/asia_pacific/coronavirus-china-live-updates/2020/02/05/114ced8a-479c-11ea-bc78-8a18f7afcee7_story.html |title = Hundreds of evacuees to be held on bases in California; Hong Kong and Taiwan restrict travel from mainland China | work = [[The Washington Post]] | date = 6 February 2020 | access-date = 11 February 2020 | archive-url = https://web.archive.org/web/20200207134650/https://www.washingtonpost.com/world/asia_pacific/coronavirus-china-live-updates/2020/02/05/114ced8a-479c-11ea-bc78-8a18f7afcee7_story.html | archive-date = 7 February 2020 | url-status = live }}</ref> on 30 January 2020 and a [[pandemic]] on 11 March 2020.<ref name=\"WHOPandemic\" /> [[Local transmission]] of the disease has been recorded in many countries across all six [[WHO regions]].<ref>{{cite web|url=http://who.int/docs/default-source/coronaviruse/situation-reports/20200325-sitrep-65-covid-19.pdf|title=WHO Situation Report #65|last=|first=|date=25 March 2020|website=WHO|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n[[File:Wikipedia-VideoWiki-Coronavirus disease 2019.webm|thumb|thumbtime=0:02|upright=1.4|Video summary ([[Wikipedia:VideoWiki/Coronavirus disease 2019|script]])]]\n{{TOC limit}}\n\n==Signs and symptoms==\n\n{{clear}}\n{| class=\"wikitable\" style = \"float:right; margin-left:1em; text-align:center\"\n!Symptom<ref name=\"WHOReport24Feb2020\">{{cite report | title = Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) | date = 16\u201324 February 2020 | url = https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf | publisher = [[World Health Organization]] (WHO) | access-date = 21 March 2020 | archive-url = https://web.archive.org/web/20200229221222/https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf | archivedate = 29 February 2020 | url-status = live }}</ref>\n!%\n|-\n|Fever\n|88\n|-\n|Dry cough\n|68\n|-\n|Fatigue\n|38\n|-\n|[[Sputum]] production\n|33\n|-\n| [[Anosmia|Loss of smell]]\n| 15<ref name=Palus/> to 30<ref name=\"entuk-anosmia\"/><ref name=\"Iacobucci2020\"/>\n|-\n|Shortness of breath\n|19\n|-\n|[[Muscle pain|Muscle]] or [[Arthralgia|joint pain]]\n|15\n|-\n|Sore throat\n|14\n|-\n|Headache\n|14\n|-\n|Chills\n|11\n|-\n|Nausea or vomiting\n|5\n|-\n|Nasal congestion\n|5\n|-\n|[[Diarrhoea]]\n|4 to 31<ref name=\":10\" />\n|-\n|[[Haemoptysis]]\n|0.9\n|-\n|[[Pink eye]]s\n|0.8\n|}\n\nThose infected with the virus may be [[asymptomatic carrier|asymptomatic]] or develop [[influenza-like illness|flu-like symptoms,]] including fever, cough, fatigue and shortness of breath.<ref name=\"CDC2020Sym\"><!--KEEP THIS NAMED REFERENCE-->{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|title=Coronavirus Disease 2019 (COVID-19) Symptoms|date=10 February 2020|website=[[Centers for Disease Control and Prevention]]|location=United States|url-status=live|archive-url=https://web.archive.org/web/20200130202038/https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html|archive-date=30 January 2020|access-date=| name-list-format = vanc}}</ref><ref name=\":2\">{{cite journal |author-last1= Chen |author-first1=N. |author-last2=Zhou |author-first2=M. |author-last3=Dong |author-first3=X. |author-last4=Qu |author-first4=J. |author-last5=Gong |author-first5=F. |author-last6=Han |author-first6=Y. |author-last7=Qiu |author-first7=Y. |author-last8=Wang |author-first8=J. |author-last9=Liu |author-first9=Y. |author-last10=Wei |author-first10=Y. |author-last11=Xia |author-first11=J. |author-last12=Yu |author-first12=T. |author-last13=Zhang |author-first13=X. |author-last14=Zhang |author-first14=L. | title = Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study | language = English | journal = Lancet | volume = 395 | issue = 10223 | pages = 507\u2013513 | date = February 2020 | pmid = 32007143 | doi = 10.1016/S0140-6736(20)30211-7 | doi-access = free }}</ref><ref name=\"Hessen27Jan2020\">{{cite web |url=https://www.elsevier.com/connect/coronavirus-information-center |title=Novel Coronavirus Information Center: Expert guidance and commentary |last=Hessen |first=Margaret Trexler | name-list-format = vanc |date=27 January 2020 |website=Elsevier Connect |url-status=live |access-date=31 January 2020 |archive-url=https://web.archive.org/web/20200130171622/https://www.elsevier.com/connect/coronavirus-information-center |archive-date=30 January 2020 }}</ref> Emergency symptoms include difficulty breathing, persistent chest pain or pressure, confusion, difficulty waking and bluish face or lips; immediate medical attention is advised if these symptoms are present.<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19)\u2014Symptoms |url=https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html |website=Centers for Disease Control and Prevention |access-date=21 March 2020 |language=en-us |date=20 March 2020 |archive-url=https://web.archive.org/web/20200320231801/https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html |archive-date=20 March 2020 |url-status=live }}</ref> Less commonly, [[upper respiratory]] symptoms, such as [[sneeze|sneezing]], [[rhinorrhoea|runny nose]] or [[sore throat]] may be seen. Symptoms such as [[nausea]], [[vomiting]] and [[diarrhoea]] have been observed in varying percentages.<ref name=\":10\">{{Cite news|title=Clinical Characteristics of SARS-CoV-2 Infected Pneumonia with Diarrhea|first1=Xiao-Shan|last1=Wei|first2=Xuan|last2=Wang|first3=Yi-Ran|last3=Niu|first4=Lin-Lin|last4=Ye|first5=Wen-Bei|last5=Peng|first6=Zi-Hao|last6=Wang|first7=Wei-Bing|last7=Yang|first8=Bo-Han|last8=Yang|first9=Jian-Chu|last9=Zhang|first10=Wan-Li|last10=Ma|first11=Xiao-Rong|last11=Wang|first12=Qiong|last12=Zhou|date=26 February 2020|doi=10.2139/ssrn.3546120|ssrn = }}</ref><ref name=\"Huang24Jan2020\">{{cite journal | vauthors = Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B | display-authors = 6 | title = Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | journal = Lancet | volume = 395 | issue = 10223 | pages = 497\u2013506 | date = February 2020 | pmid = 31986264 | doi = 10.1016/S0140-6736(20)30183-5 | doi-access = free }}</ref><ref>{{Cite journal|last1=Lai|first1=Chih-Cheng|last2=Shih|first2=Tzu-Ping|last3=Ko|first3=Wen-Chien|last4=Tang|first4=Hung-Jen|last5=Hsueh|first5=Po-Ren|date=1 March 2020|title=Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges|journal=International Journal of Antimicrobial Agents|language=en|volume=55|issue=3|page=105924|doi=10.1016/j.ijantimicag.2020.105924|pmid=32081636|issn=0924-8579}}</ref> Some cases in China initially presented only with [[chest pain|chest tightness]] and [[palpitations]].<ref name=\"Zheng Ma Zhang Xie p.\">{{cite journal | vauthors = Zheng YY, Ma YT, Zhang JY, Xie X | title = COVID-19 and the cardiovascular system | journal = Nature Reviews. Cardiology | date = March 2020 | pmid = 32139904 | doi = 10.1038/s41569-020-0360-5 | doi-access = free }}</ref> In March 2020 there were reports indicating that [[Anosmia|loss of the sense of smell]] (anosmia) may be a common symptom among those who have mild disease,<ref name=\"entuk-anosmia\">{{cite web|url=https://www.entuk.org/loss-sense-smell-marker-covid-19-infection|title=Loss of sense of smell as marker of COVID-19 infection|last=Hopkins|first=Claire|date=|website=Ear, Nose and Throat surgery body of United Kingdom|url-status=live|archive-url=|archive-date=|access-date=|accessdate=2020-03-28}}</ref><ref name=\"Iacobucci2020\">{{cite journal|last1=Iacobucci|first1=Gareth|title=Sixty seconds on . . . anosmia|journal=BMJ|year=2020|volume=368|pages=m1202|issn=1756-1833|doi=10.1136/bmj.m1202|pmid=32209546}}</ref> although not as common as initially reported.<ref name=Palus>{{cite web|url=https://slate.com/technology/2020/03/coronavirus-sense-of-smell-nytimes-fact-check.html|title=The Key Stat in the NYTimes' Piece About Losing Your Sense of Smell Was Wrong|last=Palus|first=Shannon|date=2020-03-27|website=Slate Magazine|language=en|access-date=2020-03-28|archive-url=https://web.archive.org/web/20200328163737/https://slate.com/technology/2020/03/coronavirus-sense-of-smell-nytimes-fact-check.html|archive-date=28 March 2020|url-status=live}}</ref> In some, the disease may progress to [[pneumonia]], [[multiple organ dysfunction syndrome|multi-organ failure]] and [[death]].<ref name=\"Hui14Jan2020\" /><ref name=\"WHO-q-a\" /> In those who develop severe symptoms, time from symptom onset to needing [[mechanical ventilation]] is typically eight days.<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html |website=Centers for Disease Control and Prevention |language=en-us |date=11 February 2020 |access-date=26 March 2020 |archive-url=https://web.archive.org/web/20200302201644/https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html |archive-date=2 March 2020 |url-status=live }}</ref>\n\nAs is common with infections, there is a delay between the moment when a person is infected with the virus and the time when they develop symptoms. This is called the [[incubation period]]. The incubation period for COVID-19 is typically five to six days but may range from two to 14 days.<ref>{{Cite document | vauthors=((World Health Organization)) |title=Coronavirus disease 2019 (COVID-19): situation report, 29 |date=19 February 2020|website=[[World Health Organization]] (WHO) | hdl=10665/331118 | hdl-access=free }}</ref><ref>{{cite web|url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|title=Q&A on coronaviruses (COVID-19): How long is the incubation period for COVID-19?|date=|website=[[World Health Organization]] (WHO)|url-status=live|archive-url=https://web.archive.org/web/20200120174649/https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|archive-date=20 January 2020|access-date=26 February 2020| name-list-format = vanc}}</ref> 97.5% of people who develop symptoms will do so within 11.5 days of infection.<ref>{{cite journal|last1=Lauer|first1=Stephen A.|last2=Grantz|first2=Kyra H.|last3=Bi|first3=Qifang|last4=Jones|first4=Forrest K.|last5=Zheng|first5=Qulu|last6=Meredith|first6=Hannah R.|last7=Azman|first7=Andrew S.|last8=Reich|first8=Nicholas G.|last9=Lessler|first9=Justin|date=10 March 2020|title=The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application|url=https://annals.org/aim/fullarticle/2762808/incubation-period-coronavirus-disease-2019-covid-19-from-publicly-reported|journal=Annals of Internal Medicine|language=en|doi=10.7326/M20-0504|pmid=32150748|pmc=7081172|issn=0003-4819|access-date=24 March 2020|archive-url=https://web.archive.org/web/20200324032020/https://annals.org/aim/fullarticle/2762808/incubation-period-coronavirus-disease-2019-covid-19-from-publicly-reported|archive-date=24 March 2020|url-status=live}}</ref>\n\nReports indicate that not all who are infected develop symptoms, but their role in transmission is unknown.<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html|title=Coronavirus Disease 2019 (COVID-19)|last=|date=2020-02-11|website=Centers for Disease Control and Prevention|language=en-us|access-date=2020-03-31|archive-url=https://web.archive.org/web/20200214023335/https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html|archive-date=14 February 2020|url-status=live}}</ref> Preliminary evidence suggests asymptomatic cases may contribute to the spread of the disease.<ref>{{Cite journal|last=Bai|first=Yan|last2=Yao|first2=Lingsheng|last3=Wei|first3=Tao|last4=Tian|first4=Fei|last5=Jin|first5=Dong-Yan|last6=Chen|first6=Lijuan|last7=Wang|first7=Meiyun|date=2020-02-21|title=Presumed Asymptomatic Carrier Transmission of COVID-19|url=https://jamanetwork.com/journals/jama/fullarticle/2762028|journal=JAMA|language=en|doi=10.1001/jama.2020.2565|issn=0098-7484|pmc=7042844|pmid=32083643|access-date=8 March 2020|archive-url=https://web.archive.org/web/20200304210815/https://jamanetwork.com/journals/jama/fullarticle/2762028|archive-date=4 March 2020|url-status=live}}</ref><ref name=\":1\">{{cite web|url=https://www.bloomberg.com/news/articles/2020-03-31/china-reveals-1-541-symptom-free-virus-cases-under-pressure|title=China Reveals 1,541 Symptom-Free Virus Cases Under Pressure|last=|first=|date=31 March 2020|website=www.bloomberg.com|url-status=live|archive-url=|archive-date=|access-date=2020-03-31}}</ref> The proportion of infected people who do not display symptoms is currently unknown and being studied, with the [[Korea Centers for Disease Control and Prevention]] (KCDC) reporting that 20% of all confirmed cases remained asymptomatic during their hospital stay.<ref name=\":1\" /><ref>{{cite web|url=http://www.ktv.go.kr/program/home/PG1110921D/content/595426|title=\ucf54\ub85c\ub09819 \uad6d\ub0b4 \ubc1c\uc0dd\ud604\ud669 \ube0c\ub9ac\ud551 (20. 03. 16. 14\uc2dc)|website=ktv.go.kr|language=ko|access-date=2020-03-31}}</ref> China's [[National Health Commission]] began including asymptomatic cases in its daily cases on 1 April, of the 166 infections on that day, 130 (78%) were asymptomatic.<ref>{{Cite journal|last=Day|first=Michael|date=2020-04-02|title=Covid-19: four fifths of cases are asymptomatic, China figures indicate|journal=BMJ|volume=369|language=en|pages=m1375|doi=10.1136/bmj.m1375|pmid=32241884|issn=1756-1833}}</ref>\n\n==Cause==\n\n{{See also|Severe acute respiratory syndrome coronavirus 2}}\n\n===Transmission===\n\n[[File:Sneeze.JPG|alt=Cough/sneeze droplets visualised in dark background using Tyndall scattering|thumb|Respiratory droplets produced when a man is [[sneeze|sneezing]] visualised using [[Tyndall scattering]]]]\n[[File:COVID19 in numbers- R0, the case fatality rate and why we need to flatten the curve.webm|thumb|thumbtime=4:02|A video discussing the [[basic reproduction number]] and [[case fatality rate]] in the context of the pandemic]]\n\nSome details about how the disease is [[transmission (medicine)|spread]] are still being determined.<ref name=\"CDCTrans\">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/prepare/transmission.html|title=Coronavirus Disease 2019 (COVID-19)\u2014Transmission|last=|first=|date=April 2, 2020|website=Centers for Disease Control and Prevention|language=en-us|url-status=live|archive-url=https://web.archive.org/web/20200403001235/https://www.cdc.gov/coronavirus/2019-ncov/prepare/transmission.html|archive-date=April 3, 2020|accessdate=April 3, 2020}}</ref><!--Quote: \"We are still learning how it spreads\"--><ref name=\"ECDCQA\">{{cite web|url=https://www.ecdc.europa.eu/en/novel-coronavirus-china/questions-answers|title=Q & A on COVID-19|website=European Centre for Disease Prevention and Control|language=en|url-status=live|archive-url=https://web.archive.org/web/20200205054338/https://www.ecdc.europa.eu/en/novel-coronavirus-china/questions-answers|archive-date=5 February 2020|accessdate=23 March 2020}}</ref> The WHO and the US [[Centers for Disease Control and Prevention]] (CDC) say it is primarily spread during close contact and by [[respiratory droplets|small droplets]] produced when people cough, sneeze or talk;<ref name=\"WHO2020QA\">{{cite web|url=https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|title=Q&A on coronaviruses|date=11 February 2020|work=[[World Health Organization]]|url-status=live|archive-url=https://web.archive.org/web/20200120174649/https://www.who.int/news-room/q-a-detail/q-a-coronaviruses|archive-date=20 January 2020|accessdate=24 February 2020}}</ref><ref name=CDCTrans/><!--The virus is thought to spread mainly from person-to-person ... Between people who are in close contact with one another ... Via respiratory droplets produced when an infected person coughs or sneezes.--><!--Quote: \"The main way the disease spreads is through respiratory droplets expelled by someone who is coughing.\"--> with close contact being within {{cvt|1|\u2013|3|m}}.<ref name=WHO2020QA/><!--This is why it is important to stay more than a meter (3 feet) away from a person who is sick.--> A study in Singapore found that an uncovered cough can lead to droplets travelling up to {{convert|4.5|m|ft|abbr=off|sp=us}}.<ref>{{cite journal |display-authors=etal |last1=Loh |first1=Ne-Hooi Will |last2=Tan |first2=Yanni |last3=Taculod |first3=Juvel H. |title=The Impact of High-Flow Nasal Cannula (HFNC) on Coughing Distance: Implications on Its Use During the Novel Coronavirus Disease Outbreak |journal=Canadian Journal of Anesthesia |date=18 March 2020 |doi=10.1007/s12630-020-01634-3 |pmid=32189218 |pmc=7090637}}</ref>A second study, produced during the 2020 pandemic, found that advice on the distance droplets could travel might be based on old 1930s research which ignored the protective effect and speed of the warm moist outbreath surrounding the droplets.  This study found that an uncovered cough or sneeze can travel up to {{convert|8.2|m|ft|abbr=off}}.<ref name=\"Bourouiba, JAMA, 26 March\">{{Cite journal| doi = 10.1001/jama.2020.4756| last = Bourouiba| first = Lydia| title = Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19| journal = JAMA| accessdate = 2020-04-06| date = 2020-03-26| pmid = 32215590| url = https://jamanetwork.com/journals/jama/fullarticle/2763852}}</ref>\n\nRespiratory droplets may also be produced while breathing out, including when talking. Though the virus is not generally [[Airborne disease|airborne]],<ref name=WHO2020QA/><!--when a person with COVID-19 coughs or exhales ... Studies to date suggest that the virus that causes COVID-19 is mainly transmitted through contact with respiratory droplets rather than through the air.--><ref name=WHOMar27Airborne>{{cite web |title=Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations |url=https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations |website=www.who.int |accessdate=29 March 2020 |language=en}}</ref><!--Based on the available evidence, including the recent publications mentioned above, the WHO continues to recommend droplet and contact precautions for those people caring for COVID-19 patients and contact and airborne precautions for circumstances and settings in which aerosol generating procedures are performed.--> The National Academy of Science has suggested that [[bioaerosol]] transmission may be possible and air collectors positioned in the hallway outside of people's rooms yielded samples positive for viral RNA.<ref>{{cite web|title=Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic|date=1 April 2020|url=https://www.nap.edu/catalog/25769/rapid-expert-consultation-on-the-possibility-of-bioaerosol-spread-of-sars-cov-2-for-the-covid-19-pandemic-april-1-2020|publisher=The National Academies Press|accessdate=1 April 2020}}</ref> The droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs.<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19)\u2014Transmission |url=https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Ftransmission.html |website=Centers for Disease Control and Prevention |accessdate=29 March 2020 |language=en-us |date=17 March 2020}}</ref><!--Quote: \"These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs.\"--> Some medical procedures such as intubation and [[cardiopulmonary resuscitation]] (CPR) may cause respiratory secretions to be aerosolised and thus result in airborne spread.<ref name=WHOMar27Airborne/> It may also spread when one touches a contaminated surface, known as [[fomite]] transmission, and then touches ones eyes, nose or mouth.<ref name=WHO2020QA/><!--These droplets land on objects and surfaces around the person. Other people then catch COVID-19 by touching these objects or surfaces, then touching their eyes, nose or mouth.--> While there are concerns it may spread by [[Fecal\u2013oral route|feces]], this risk is believed to be low.<ref name=WHO2020QA/><!--The risk of catching COVID-19 from the feces of an infected person appears to be low.--><ref name=CDCTrans/><!--within about six feet-->\n\nThe virus is most contagious when people are symptomatic; while spread may be possible before symptoms appear, this risk is low.<ref name=WHO2020QA/><!--Quote: \"The risk of catching COVID-19 from someone with no symptoms at all is very low.\"--><ref name=CDCTrans/><!--Quote: \"People are thought to be most contagious when they are most symptomatic (the sickest) [...] Some spread might be possible before people show symptoms\"--> The [[European Centre for Disease Prevention and Control]] (ECDC) says while it is not entirely clear how easily the disease spreads, one person generally infects two to three others.<ref name=\"ECDCQA\" />\n\nThe virus survives for hours to days on surfaces.<ref name=WHO2020QA/><!--Quote: \"Current evidence suggests that novel coronavirus may remain viable for hours to days on surfaces made from a variety of materials\"--><ref name=\"ECDCQA\" /> Specifically, the virus was found to be detectable for one day on cardboard, for up to three days on plastic and stainless steel and for up to four hours on copper.<ref name=\"StableNIH\">{{cite web|url=https://www.nih.gov/news-events/news-releases/new-coronavirus-stable-hours-surfaces|title=New coronavirus stable for hours on surfaces|date=17 March 2020|publisher=[[National Institutes of Health]]|url-status=live|archive-url=https://web.archive.org/web/20200323032520/https://www.nih.gov/news-events/news-releases/new-coronavirus-stable-hours-surfaces|archive-date=23 March 2020|accessdate=23 March 2020}}</ref><ref>{{Cite journal|last=van Doremalen|first=Neeltje|last2=Bushmaker|first2=Trenton|last3=Morris|first3=Dylan H.|last4=Holbrook|first4=Myndi G.|last5=Gamble|first5=Amandine|last6=Williamson|first6=Brandi N.|last7=Tamin|first7=Azaibi|last8=Harcourt|first8=Jennifer L.|last9=Thornburg|first9=Natalie J.|last10=Gerber|first10=Susan I.|last11=Lloyd-Smith|first11=James O.|date=2020-03-17|title=Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1|journal=New England Journal of Medicine|language=en|pages=NEJMc2004973|doi=10.1056/NEJMc2004973|issn=0028-4793|pmc=7121658|pmid=32182409}}</ref> This, however, varies based on the humidity and temperature.<ref>{{cite journal |last1=Moriyama |first1=M |last2=Hugentobler |first2=WJ |last3=Iwasaki |first3=A |title=Seasonality of Respiratory Viral Infections. |journal=Annual Review of Virology |date=20 March 2020 |volume=7 |doi=10.1146/annurev-virology-012420-022445 |pmid=32196426}}</ref><ref>Holden, Emily, ''[https://www.theguardian.com/world/2020/apr/02/do-you-need-to-wash-your-groceries-and-other-advice-for-shopping-safely Do you need to wash your groceries? And other advice for shopping safely]'', [[The Guardian]], Thursday, April 2, 2020</ref> Surfaces may be decontaminated with a number of solutions (within one minute of exposure to the disinfectant to achieve a 4 or more [[log reduction]]), including 78\u201395% [[ethanol]] (alcohol used in spirits), 70\u2013100% [[2-propanol]] (isopropyl alcohol), the combination of 45% 2-propanol with 30% [[1-propanol]], 0.21% [[sodium hypochlorite]] (bleach), 0.5% [[hydrogen peroxide]], or 0.23\u20137.5% [[povidone-iodine]]. [[Soap]] and [[detergent]] are also effective if correctly used; soap products degrade the virus' fatty protective layer, deactivating it, as well as freeing them from skin and other surfaces.<ref name=\"cnn-soap\">{{cite news|author= |url=https://edition.cnn.com/2020/03/24/health/soap-warm-water-hand-sanitizer-coronavirus-wellness-scn/index.html |title=COVID-19 prevention: Why soap, sanitizer and warm water work against coronavirus - CNN |publisher=Edition.cnn.com |date=2020-03-24 |accessdate=2020-04-07}}</ref> Other solutions, such as [[benzalkonium chloride]] and [[chlorhexidine|chlorhexidine gluconate]] (a surgical disinfectant), are less effective.<ref name=\"SurfacePersistence\">{{cite journal |last1=Kampf |first1=G. |last2=Todt |first2=D. |last3=Pfaender |first3=S. |last4=Steinmann |first4=E. |title=Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents |url=https://www.journalofhospitalinfection.com/article/S0195-6701(20)30046-3/fulltext |journal=The Journal of Hospital Infection |volume=104 |issue=3 |pages=246\u2013251 |date=March 2020 |pmid=32035997 |doi=10.1016/j.jhin.2020.01.022}} {{free access}}</ref>\n\n===Virology===\n\n{{Main|Severe acute respiratory syndrome coronavirus 2}}\n[[File:Coronavirus virion structure.svg|thumb|Illustration of [[SARSr-CoV]] virion]]\nSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a [[novel virus|novel]] severe acute respiratory syndrome coronavirus, first isolated from three people with pneumonia connected to the [[Disease cluster|cluster]] of acute respiratory illness cases in Wuhan.<ref name=\"ECDC risk assessment\">{{cite web |url=https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-risk-assessment-14-feb-2020.pdf |title=Outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): increased transmission beyond China\u2014fourth update |publisher=European Centre for Disease Prevention and Control |date=14 February 2020 |access-date=8 March 2020}}</ref> All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.<ref name=\"NM-20200317\" />\nOutside the human body, the virus is killed by household [[soap]], which bursts its protective bubble.<ref name=\":0\" />\n\nSARS-CoV-2 is closely related to the original SARS-CoV.<ref name=\"Zhu24Jan2020\">{{cite journal |vauthors=Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W |display-authors=6 |title=A Novel Coronavirus from Patients with Pneumonia in China, 2019 |journal=[[The New England Journal of Medicine]] |volume=382 |issue=8 |pages=727\u2013733 |date=February 2020 |pmid=31978945 |doi=10.1056/NEJMoa2001017|pmc=7092803 }}</ref> It is thought to have a [[Zoonosis|zoonotic]] origin. Genetic analysis has revealed that the coronavirus genetically clusters with the genus ''[[Betacoronavirus]]'', in subgenus [[Severe acute respiratory syndrome-related coronavirus|''Sarbecovirus'']] (lineage B) together with two bat-derived strains. It is 96% identical at the whole [[genome]] level to other bat coronavirus samples (BatCov RaTG13).<ref name=\"WHOReport24Feb2020\" /> In February 2020, Chinese researchers found that there is only one [[amino acid]] difference in certain parts of the genome sequences between the viruses from [[pangolins]] and those from humans, however, whole-genome comparison to date found at most 92% of genetic material shared between pangolin coronavirus and SARS-CoV-2, which is insufficient to prove pangolins to be the [[intermediate host]].<ref name=\"Cyranoski26Feb2020\">{{cite journal |title=Mystery deepens over animal source of coronavirus |journal=Nature |volume=579 |pages=18\u201319 |date=26 February 2020 |doi=10.1038/d41586-020-00548-w |pmid=32127703 |vauthors=Cyranoski D |issue=7797 |bibcode=2020Natur.579...18C}}</ref>\n\n==Pathophysiology==\n\nThe lungs are the organs most affected by COVID-19 because the virus accesses host cells via the enzyme [[angiotensin-converting enzyme 2]] (ACE2), which is most abundant in the [[Type II cell|type II alveolar cells]] of the lungs. The virus uses a special surface glycoprotein called a \"spike\" ([[peplomer]]) to connect to ACE2 and enter the host cell.<ref name=\"Nature Microbiology\">{{cite journal | title=Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses | journal=Nature Microbiology | doi=10.1038/s41564-020-0688-y | doi-access=free | pmid=32094589 | date=2020 | vauthors=Letko M, Marzi A, Munster V | volume=5 | issue=4 | pages=562\u2013569 }}</ref> The density of ACE2 in each tissue correlates with the severity of the disease in that tissue and some have suggested that decreasing ACE2 activity might be protective,<ref name=\"Zhang Penninger Li Zhong p.\">{{cite journal | vauthors=Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS | title=Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | journal=Intensive Care Medicine | date=March 2020 | volume=46 | issue=4 | pages=586\u2013590 |doi=10.1007/s00134-020-05985-9 | doi-access=free | pmid=32125455 | pmc=7079879 }}</ref><ref name=\"Xu Zhong Deng Peng p.\">{{cite journal | vauthors=Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q | display-authors=6 | title=High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa | journal=International Journal of Oral Science | volume=12 | issue=1 | page=8 | date=February 2020 | doi=10.1038/s41368-020-0074-x |doi-access=free | pmid=32094336 | pmc=7039956 }}</ref> though another view is that increasing ACE2 using [[angiotensin II receptor blocker]] medications could be protective and that these hypotheses need to be tested.<ref>{{cite journal | vauthors=Gurwitz D | title=Angiotensin receptor blockers as tentative SARS\u2010CoV\u20102 therapeutics | journal=Drug Development Research | doi=10.1002/ddr.21656 | doi-access=free | pmid=32129518 | date=March 2020 }}</ref> As the alveolar disease progresses, respiratory failure might develop and death may follow.<ref name=\"Xu Zhong Deng Peng p.\"/>\n\nThe virus also affects gastrointestinal organs as ACE2 is abundantly expressed in the [[gland]]ular cells of [[Stomach|gastric]], [[Duodenum|duodenal]] and [[Rectum|rectal]] [[epithelium]]<ref name=\":11\">{{Cite journal|last1=Gu|first1=Jinyang|last2=Han|first2=Bing|last3=Wang|first3=Jian|date=27 February 2020|title=COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission|journal=Gastroenterology|volume=|pages=|doi=10.1053/j.gastro.2020.02.054|pmid=32142785|issn=0016-5085}}</ref> as well as [[Endothelium|endothelial]] cells and [[enterocyte]]s of the [[small intestine]].<ref>{{Cite journal|last1=Hamming|first1=I.|last2=Timens|first2=W.|last3=Bulthuis|first3=M. L. C.|last4=Lely|first4=A. T.|last5=Navis|first5=G. J.|last6=Goor|first6=H. van|date=2004|title=Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis|journal=The Journal of Pathology|language=en|volume=203|issue=2|pages=631\u2013637|doi=10.1002/path.1570|pmid=15141377|issn=1096-9896}}</ref>\n\nThe expanding part of the lungs, [[Pulmonary alveolus|pulmonary alveoli]], contain two main types of functioning cells. One cell, [[Pulmonary alveolus#Type I|type I]], absorbs from the air, i.e. [[gas exchange]]. The other, [[Pulmonary alveolus#Type II|type II]], produces [[surfactant]]s, which serve to keep the lungs fluid, clean, infection free, etc. COVID-19 finds a way into a surfactant producing type II cell and smothers it by reproducing COVID-19 virus within it. Each type II cell which perishes to the virus causes an extreme reaction in the lungs. Fluids, pus and dead cell material flood the lung, causing the coronavirus pulmonary disease.<ref name=\"DrVuong\">{{cite web|url=https://www.youtube.com/watch?v=4J0d59dd-qM |author=Doctor Duc C Vuong|title=HOW COVID-19 KILLS--I'm a Surgeon--And Why We Can't Save You |publisher=YouTube |date=23 March 2020 |accessdate=5 April 2020 |archiveurl = |archivedate = |url-status=live}}</ref>\n\n===Immunopathology===\n\nAlthough, SARS-COV-2 has a tropism for ACE2-expressing epithelial cells of the respitatory tract, patients with severe COVID-19 have symptoms of systemic hyperinflammation. Clinical labratory findings of elevated IL-2, IL-7, IL-6, [[granulocyte-macrophage colony-stimulating factor]] (GM-CSF), interferon-\u03b3 inducible protein 10 (IP-10), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1-\u03b1 (MIP-1\u03b1), and tumour necrosis factor-\u03b1 (TNF-\u03b1) indicative of [[cytokine release syndrome]] (CRS) suggest an underlying immunopathology.<ref name=\"LancetCRS\">{{cite journal | vauthors = Huang C et al | display-authors = 1 | title = Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | journal = The Lancet | date = 2020 | volume = 395 | issue = 10223 | pages = 497\u2013506 | doi = 10.1016/S0140-6736(20)30183-5 | pmid = 31986264 | url = https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext}}</ref> \n\nAdditionally, people with COVID-19 and [[acute respiratory distress syndrome]] (ARDS) have classical serum biomarkers of CRS including elevated C-reactive protein (CRP), [[lactate dehydrogenase]] (LDH), D-dimer, and ferritin.<ref>{{cite journal | vauthors = Zhang C et al. | title = The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality | journal = International Journal of Antimicrobial Agents | year = 2020 | pages = 105954 | doi = 10.1016/j.ijantimicag.2020.105954 | pmid = 32234467 | pmc = 7118634 | url = https://www.sciencedirect.com/science/article/pii/S0924857920301047}}</ref> \n\nSystemic inflammation results in vasodilation, allowing inflammatory lymphocytic and monocytic infiltration of the lung and the heart. In particular, pathogenic GM-CSF-secreting T-cells were shown to correlate with the recruitment of inflammatory IL-6-secreting monocytes and severe lung pathology in COVID-19 patients.<ref>{{cite journal | vauthors = Zhou Y et al. | title = Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus | journal = bioRxiv Pre-print | year = 2020 | doi = 10.1101/2020.02.12.945576 | url = https://www.biorxiv.org/content/10.1101/2020.02.12.945576v1}}</ref>\n\n==Diagnosis==\n\n{{main|COVID-19 testing}}\n[[File:Infektionsschutzzentrum im Rautenstrauch-Joest-Museum, K\u00f6ln-6313 (cropped).jpg|thumb|Demonstration of a [[nasopharyngeal swab]] for [[COVID-19 testing]]]]\n[[File:CDC 2019-nCoV Laboratory Test Kit.jpg|thumb|[[Centers for Disease Control and Prevention|CDC]] [[rRT-PCR]] test kit for COVID-19<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/about/testing.html|title=CDC Tests for 2019-nCoV|author=|date=5 February 2020|website=Centers for Disease Control and Prevention|url-status=live|archive-url=https://web.archive.org/web/20200214023335/https://www.cdc.gov/coronavirus/2019-ncov/about/testing.html|archive-date=14 February 2020|access-date=12 February 2020| name-list-format = vanc}}</ref>]]\nThe WHO has published several testing protocols for the disease.<ref>{{cite web|url=https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117|title=Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases|website=[[World Health Organization]] (WHO)|access-date=13 March 2020|archive-url=https://web.archive.org/web/20200317023052/https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117|archive-date=17 March 2020|url-status=live}}</ref> The standard method of testing is [[real-time reverse transcription polymerase chain reaction]] (rRT-PCR).<ref name=\"20200130cdc\">{{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/summary.html |title=2019 Novel Coronavirus (2019-nCoV) Situation Summary |date=30 January 2020 |website=[[Centers for Disease Control and Prevention]] |url-status=live |archive-url=https://web.archive.org/web/20200126210549/https://www.cdc.gov/coronavirus/2019-nCoV/summary.html |archive-date=26 January 2020 |access-date=30 January 2020| name-list-format = vanc}}</ref> The test is typically done on respiratory samples obtained by a [[nasopharyngeal swab]], however a nasal swab or [[sputum]] sample may also be used.<ref name=\"CDC2020Testing\"/><ref name=\"20200129cdc\">{{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html |title=Real-Time RT-PCR Panel for Detection 2019-nCoV |date=29 January 2020 |website=[[Centers for Disease Control and Prevention]] |access-date=1 February 2020 |archive-url=https://web.archive.org/web/20200130202031/https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html |archive-date=30 January 2020 |url-status=live | name-list-format = vanc}}</ref> Results are generally available within a few hours to two days.<ref name=\"globenewswire1977226\">{{cite web |url=https://www.globenewswire.com/news-release/2020/01/30/1977226/0/en/Curetis-Group-Company-Ares-Genetics-and-BGI-Group-Collaborate-to-Offer-Next-Generation-Sequencing-and-PCR-based-Coronavirus-2019-nCoV-Testing-in-Europe.html |title=Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe |date=30 January 2020 |website=GlobeNewswire News Room |access-date=1 February 2020 |archive-url=https://web.archive.org/web/20200131201626/https://www.globenewswire.com/news-release/2020/01/30/1977226/0/en/Curetis-Group-Company-Ares-Genetics-and-BGI-Group-Collaborate-to-Offer-Next-Generation-Sequencing-and-PCR-based-Coronavirus-2019-nCoV-Testing-in-Europe.html |archive-date=31 January 2020 |url-status=live | name-list-format = vanc}}</ref><ref name=\"20200130businessinsider\">{{cite web |url=https://www.businessinsider.com/how-to-know-if-you-have-the-coronavirus-pcr-test-2020-1 |title=There's only one way to know if you have the coronavirus, and it involves machines full of spit and mucus |last=Brueck |first=Hilary | name-list-format = vanc |date=30 January 2020 |website=Business Insider |access-date=1 February 2020 |archive-url= https://web.archive.org/web/20200201034232/https://www.businessinsider.com/how-to-know-if-you-have-the-coronavirus-pcr-test-2020-1 |archive-date=1 February 2020 |url-status=live }}</ref> Blood tests can be used, but these require two blood samples taken two weeks apart and the results have little immediate value.<ref>{{cite web |url=https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 |title=Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases |access-date=26 February 2020 |archive-url=https://web.archive.org/web/20200221192745/https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 |archive-date=21 February 2020 |url-status=live }}</ref> Chinese scientists were able to isolate a strain of the coronavirus and publish the [[Nucleic acid sequence|genetic sequence]] so laboratories across the world could independently develop [[polymerase chain reaction]] (PCR) tests to detect infection by the virus.<ref name=\"Hui14Jan2020\" /><ref name=\"Cohen17Jan20202\">{{cite journal | vauthors = Cohen J, Normile D | title = New SARS-like virus in China triggers alarm | journal = Science | volume = 367 | issue = 6475 | pages = 234\u201335 | date = January 2020 | pmid = 31949058 |doi=10.1126/science.367.6475.234 | bibcode = 2020Sci...367..234C | url = https://mcb.uconn.edu/wp-content/uploads/sites/2341/2020/01/WuhanScience24Jan2020.pdf | access-date = 11 February 2020 | url-status = live | archive-url = https://web.archive.org/web/20200211230310/https://mcb.uconn.edu/wp-content/uploads/sites/2341/2020/01/WuhanScience24Jan2020.pdf | archive-date = 11 February 2020 }}</ref><ref name=\"ncbiWuhanGenomes\">{{cite web |url=https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&VirusLineage_ss=Wuhan%20seafood%20market%20pneumonia%20virus,%20taxid:2697049 |title=Severe acute respiratory syndrome coronavirus 2 data hub |website=NCBI |url-status=live |access-date=4 March 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200321235550/https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&VirusLineage_ss=Wuhan%20seafood%20market%20pneumonia%20virus,%20taxid:2697049 |archive-date=21 March 2020 }}</ref> {{As of|2020|April|4}}, [[antibody titer|antibody test]]s (which may detect active infections and whether a person had been infected in the past) were in development, but not yet widely used.<ref>{{Cite journal|last=Petherick|first=Anna|date=4 April 2020|title=Developing antibody tests for SARS-CoV-2|journal=The Lancet|volume=395|issue=10230|pages=1101\u20131102|doi=10.1016/s0140-6736(20)30788-1|pmid=32247384|issn=0140-6736}}</ref><ref name=\"Vogel2020\">{{cite journal |title=New blood tests for antibodies could show true scale of coronavirus pandemic |last=Vogel| first=Gretchen |journal=Science |issn=0036-8075 |doi=10.1126/science.abb8028|date=2020-03-19}}</ref><ref>{{cite journal | vauthors = Pang J, Wang MX, Ang IY, Tan SH, Lewis RF, Chen JI, Gutierrez RA, Gwee SX, Chua PE, Yang Q, Ng XY, Yap RK, Tan HY, Teo YY, Tan CC, Cook AR, Yap JC, Hsu LY | display-authors = 6 | title = Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review | journal = Journal of Clinical Medicine | volume = 9 | issue = 3 | page = 623 | date = February 2020 | pmid = 32110875 | doi = 10.3390/jcm9030623 }}</ref> The FDA approved the first [[Point-of-care testing|point-of-care test]] on 21 March 2020 for use at the end of that month.<ref>{{cite press release |title= Coronavirus (COVID-19) Update: FDA Issues first Emergency Use Authorization for Point of Care Diagnostic |date= 21 March 2020 |publisher= FDA |url= https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-use-authorization-point-care-diagnostic |access-date= 22 March 2020 |archive-url= https://web.archive.org/web/20200321224700/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-use-authorization-point-care-diagnostic |archive-date= 21 March 2020 |url-status= live }}</ref>\n\nDiagnostic guidelines released by Zhongnan Hospital of [[Wuhan University]] suggested methods for detecting infections based upon clinical features and epidemiological risk. These involved identifying people who had at least two of the following symptoms in addition to a history of travel to [[Wuhan]] or contact with other infected people: fever, imaging features of pneumonia, normal or reduced white blood cell count or reduced [[lymphocyte]] count.<ref name=Jin2020>{{cite journal | vauthors=Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, Fang C, Huang D, Huang LQ, Huang Q, Han Y, Hu B, Hu F, Li BH, Li YR, Liang K, Lin LK, Luo LS, Ma J, Ma LL, Peng ZY, Pan YB, Pan ZY, Ren XQ, Sun HM, Wang Y, Wang YY, Weng H, Wei CJ, Wu DF, Xia J, Xiong Y, Xu HB, Yao XM, Yuan YF, Ye TS, Zhang XC, Zhang YW, Zhang YG, Zhang HM, Zhao Y, Zhao MJ, Zi H, Zeng XT, Wang YY, Wang XH | display-authors=6 | title=A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) | journal=Military Medical Research | date=February 2020 | volume=7 | issue=1 | page=4 | doi=10.1186/s40779-020-0233-6 | doi-access=free | pmid=32029004 | pmc=7003341 }}</ref>\n\nA March 2020 review concluded that [[Chest radiograph|chest X-rays]] are of little value in early stages, whereas CT scans of the chest are useful even before symptoms occur.<ref name=\":0\">{{Cite journal|last=Salehi|first=Sana|last2=Abedi|first2=Aidin|last3=Balakrishnan|first3=Sudheer|last4=Gholamrezanezhad|first4=Ali|date=2020-03-14|title=Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients|journal=American Journal of Roentgenology|language=en|pages=1\u20137|doi=10.2214/AJR.20.23034|issn=0361-803X|pmid=32174129}}</ref> Typical features on CT include bilateral multilobar [[Ground glass opacity|ground-glass opacificities]] with a peripheral, asymmetric and posterior distribution.<ref name=\":0\" /> [[Pleural cavity|Subpleural dominance]], [[crazy paving (medicine)|crazy paving]] (lobular septal thickening with variable alveolar filling) and [[Pulmonary consolidation|consolidation]] develop as the disease evolves.<ref>{{cite journal|last1=Lee|first1=Elaine Y. P.|last2=Ng|first2=Ming-Yen|last3=Khong|first3=Pek-Lan|date=24 February 2020|title=COVID-19 pneumonia: what has CT taught us?|url=https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30134-1/fulltext|journal=The Lancet Infectious Diseases|language=English|volume=0|issue=4|pages=384\u2013385|doi=10.1016/S1473-3099(20)30134-1|issn=1473-3099|pmid=32105641|accessdate=13 March 2020|archive-url=https://web.archive.org/web/20200308143943/https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30134-1/fulltext|archive-date=8 March 2020|url-status=live}}</ref> As of March 2020, the [[American College of Radiology]] recommends that \"CT should not be used to screen for or as a first-line test to diagnose COVID-19\".<ref>{{cite web|url=https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection|title=ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection|last=|first=|date=2020-03-22|website=American College of Radiology|url-status=live|archive-url=https://web.archive.org/web/20200328055813/https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection|archive-date=28 March 2020|access-date=}}</ref>\n<gallery mode=packed heights=100px>\nFile:COVID19CT2.webp|Typical [[CT imaging]] findings\nFile:COVID19CT1.webp|[[CT imaging]] of rapid progression stage\n</gallery>\n\n===Pathology===\n\nFew data are available about microscopic lesions and the pathophysiology of COVID-19.<ref>[https://jcp.bmj.com/content/early/2020/03/20/jclinpath-2020-206522 Autopsy in suspected COVID-19 cases] {{Webarchive|url=https://web.archive.org/web/20200328202232/https://jcp.bmj.com/content/early/2020/03/20/jclinpath-2020-206522 |date=28 March 2020 }}, Hanley B et al, J Clin Pathol, {{PMID|32198191}}</ref><ref>[https://www.ncbi.nlm.nih.gov/pubmed/32172546 A pathological report of three COVID-19 cases by minimally invasive autopsies], Yao XH et al., {{PMID|32172546}}</ref> The main pathological findings at autopsy are: \n* [[macroscopic scale|Macroscopy]]: [[pleurisy]], [[pericarditis]], [[lung consolidation]] and [[pulmonary oedema]]\n* Four types of severity of [[viral pneumonia]] can be observed: \n** minor [[pneumonia]]: minor serous [[Exudate|exudation]], minor [[fibrin]] exudation\n** mild pneumonia: [[pulmonary oedema]], [[pneumocyte]] [[hyperplasia]], large atypical [[pneumocyte]]s, interstitial [[inflammation]] with [[lymphocytic]] [[Infiltration (medical)|infiltration]] and [[giant cell|multinucleated giant cell]] formation \n** severe pneumonia: [[diffuse alveolar damage]] (DAD) with diffuse [[Pulmonary alveolus|alveolar]] [[exudates]]. DAD is the cause of [[acute respiratory distress syndrome]] (ARDS) and severe [[hypoxemia]].\n** healing pneumonia: [[healing|organisation]] of [[exudate]]s in [[Pulmonary alveolus|alveolar cavities]] and [[Pulmonary fibrosis|pulmonary interstitial fibrosis]]\n** [[plasma cell|plasmocytosis]] in [[Bronchoalveolar lavage|BAL]]<ref>{{Cite journal|title=Exuberant plasmocytosis in bronchoalveolar lavage of the first patient requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe|first1=Marco|last1=Giani|first2=Davide|last2=Seminati|first3=Alberto|last3=Lucchini|first4=Giuseppe|last4=Foti|first5=Fabio|last5=Pagni|date=16 March 2020|journal=Journal of Thoracic Oncology|doi=10.1016/j.jtho.2020.03.008|pmid=32194247|pmc=7118681}}</ref>\n* [[Blood]]: [[disseminated intravascular coagulation]] (DIC);<ref>{{Cite journal|title=Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia|first=David|last=Lillicrap|date=1 April 2020|journal=Journal of Thrombosis and Haemostasis: JTH|volume=18|issue=4|pages=786\u2013787|doi=10.1111/jth.14781|pmid=32212240}}</ref> leukoerythroblastic reaction<ref>{{Cite journal|title=Leukoerythroblastic reaction in a patient with COVID-19 infection|first1=Anupam|last1=Mitra|first2=Denis M.|last2=Dwyre|first3=Michael|last3=Schivo|first4=George R.|last4=Thompson|first5=Stuart H.|last5=Cohen|first6=Nam|last6=Ku|first7=John P.|last7=Graff|date=25 March 2020|journal=American Journal of Hematology|doi=10.1002/ajh.25793|pmid=32212392}}</ref>\n* [[Liver]]: microvesicular [[steatosis]]\n\n==Prevention==\n\n{{See also|2019\u201320 coronavirus pandemic#Prevention|flatten the curve|workplace hazard controls for COVID-19}}\n[[File:20200403 Flatten the curve animated GIF.gif|thumb|upright=1.5|Inhibiting new infections to reduce the number of cases at any given time\u2014known as \"[[flattening the curve]]\"\u2014allows healthcare services to better manage the same volume of patients.<ref>{{cite web |last=Wiles |first=Siouxsie |author-link=Siouxsie Wiles |title=The three phases of Covid-19\u2014and how we can make it manageable |url=https://thespinoff.co.nz/society/09-03-2020/the-three-phases-of-covid-19-and-how-we-can-make-it-manageable/ |website=The Spinoff |access-date=9 March 2020 |date=9 March 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200327120015/https://thespinoff.co.nz/society/09-03-2020/the-three-phases-of-covid-19-and-how-we-can-make-it-manageable/ |archive-date=27 March 2020 |url-status=live }}</ref><ref name=\"Lancet2020Flatten\">{{cite journal | vauthors = Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD | title = How will country-based mitigation measures influence the course of the COVID-19 epidemic? | journal = Lancet | date = March 2020 | volume = 395 | issue = 10228 | pages = 931\u2013934 | pmid = 32164834 | doi = 10.1016/S0140-6736(20)30567-5 | quote = A key issue for epidemiologists is helping policy makers decide the main objectives of mitigation\u2014e.g. minimising morbidity and associated mortality, avoiding an epidemic peak that overwhelms health-care services, keeping the effects on the economy within manageable levels, and flattening the epidemic curve to wait for vaccine development and manufacture on scale and antiviral drug therapies. | doi-access = free }}</ref><ref>{{cite web|url=https://www.vox.com/2020/3/10/21171481/coronavirus-us-cases-quarantine-cancellation|title=How canceled events and self-quarantines save lives, in one chart|first=Eliza|last=Barclay|date=10 March 2020|website=Vox|name-list-format=vanc|access-date=12 March 2020|archive-url=https://web.archive.org/web/20200312161852/https://www.vox.com/2020/3/10/21171481/coronavirus-us-cases-quarantine-cancellation|archive-date=12 March 2020|url-status=live}}</ref>]]\n[[File:Covid-19-curves-graphic2-stopthespread-v3.gif|thumb|upright=1.5|Alternatives to flattening the curve<ref>{{cite web |last=Wiles |first=Siouxsie |title=After 'Flatten the Curve', we must now 'Stop the Spread'. Here's what that means |url=https://thespinoff.co.nz/society/14-03-2020/after-flatten-the-curve-we-must-now-stop-the-spread-heres-what-that-means/ |website=The Spinoff |access-date=13 March 2020 |date=14 March 2020 |archive-url=https://web.archive.org/web/20200326232315/https://thespinoff.co.nz/society/14-03-2020/after-flatten-the-curve-we-must-now-stop-the-spread-heres-what-that-means/ |archive-date=26 March 2020 |url-status=live }}</ref><ref>{{cite journal | vauthors = Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD | title = How will country-based mitigation measures influence the course of the COVID-19 epidemic? | journal = Lancet | date = March 2020 | volume = 395 | issue = 10228 | pages = 931\u2013934 | pmid = 32164834 | doi = 10.1016/S0140-6736(20)30567-5 }}</ref>]]\nPreventive measures to reduce the chances of infection include staying at home, avoiding crowded places, washing hands with soap and water often and for at least 20 seconds, practising good respiratory hygiene and avoiding touching the eyes, nose or mouth with unwashed hands.<ref name=\"CDC-Prevention & Treatment\">{{cite web | url = https://www.cdc.gov/coronavirus/about/prevention.html | author = Centers for Disease Control | title = Coronavirus Disease 2019 (COVID-19): Prevention & Treatment | date = 3 February 2020 | language = en-us | access-date = 10 February 2020 | archive-url = https://web.archive.org/web/20191215193934/https://www.cdc.gov/coronavirus/about/prevention.html | archive-date = 15 December 2019 | url-status = live| author-link = Centers for Disease Control }}</ref><ref name=\"WHO Advice for Public\">{{cite web | url = https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public | title = Advice for Public | vauthors = ((World Health Organization)) | access-date = 10 February 2020 | archive-url = https://web.archive.org/web/20200126025750/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public | archive-date = 26 January 2020 | url-status = live| author-link = World Health Organization | name-list-format = vanc}}</ref><ref>{{cite web|url=https://www.npr.org/sections/goatsandsoda/2020/03/17/814221111/my-hand-washing-song-readers-offer-lyrics-for-a-20-second-scrub|title=My Hand-Washing Song: Readers Offer Lyrics For A 20-Second Scrub|website=NPR.org|language=en|access-date=20 March 2020|archive-url=https://web.archive.org/web/20200320145553/https://www.npr.org/sections/goatsandsoda/2020/03/17/814221111/my-hand-washing-song-readers-offer-lyrics-for-a-20-second-scrub|archive-date=20 March 2020|url-status=live}}</ref> The CDC recommends covering the mouth and nose with a tissue when coughing or sneezing and recommends using the inside of the elbow if no tissue is available.<ref name = \"CDC-Prevention & Treatment\"/> They also recommend proper hand hygiene after any cough or sneeze.<ref name = \"CDC-Prevention & Treatment\"/> [[Social distancing]] strategies aim to reduce contact of infected persons with large groups by closing schools and workplaces, restricting travel and cancelling mass gatherings.<ref name=\"JHUSocialDistancing\">{{cite web | first = Lisa Lockerd | last = Maragakis | name-list-format = vanc | title = Coronavirus, Social Distancing and Self Quarantine | url = https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-social-distancing-and-self-quarantine | website = www.hopkinsmedicine.org | publisher = Johns Hopkins University | access-date = 18 March 2020 | archive-url = https://web.archive.org/web/20200318012357/https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-social-distancing-and-self-quarantine | archive-date = 18 March 2020 | url-status = live }}</ref> Social distancing also includes that people stay at least {{Convert|6|ft||abbr=}} apart.<ref>{{Cite news|last=Parker-Pope|first=Tara|url=https://www.nytimes.com/2020/03/19/well/live/coronavirus-quarantine-social-distancing.html|title=Deciding How Much Distance You Should Keep|date=19 March 2020|work=The New York Times|access-date=20 March 2020|language=en-US|issn=0362-4331|archive-url=https://web.archive.org/web/20200320003705/https://www.nytimes.com/2020/03/19/well/live/coronavirus-quarantine-social-distancing.html|archive-date=20 March 2020|url-status=live}}</ref>\n\nAs a [[COVID-19 vaccine|vaccine]] is not expected until 2021 at the earliest,<ref>{{cite web | url = https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away | title = Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus | website = Science Alert | first1 = Rob | last1 = Grenfell | first2 = Trevor | last2 = Drew | name-list-format = vanc | date = 17 February 2020 | access-date = 26 February 2020 | archive-url = https://web.archive.org/web/20200228010631/https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away | archive-date = 28 February 2020 | url-status = live }}</ref> a key part of managing COVID-19 is trying to decrease the epidemic peak, known as \"flattening the [[epidemic curve|curve]]\".<ref name=\"Lancet2020Flatten\" /> This is done by slowing the infection rate to decrease the risk of health services being overwhelmed, allowing for better treatment of current cases and delaying additional cases until effective treatments or a vaccine become available.<ref name=\"Lancet2020Flatten\" /><ref>{{cite web |last=Wiles |first=Siouxsie |title=After 'Flatten the Curve', we must now 'Stop the Spread'. Here's what that means |url=https://thespinoff.co.nz/society/14-03-2020/after-flatten-the-curve-we-must-now-stop-the-spread-heres-what-that-means/ |website=The Spinoff |access-date=13 March 2020 |date=14 March 2020 |archive-url=https://web.archive.org/web/20200326232315/https://thespinoff.co.nz/society/14-03-2020/after-flatten-the-curve-we-must-now-stop-the-spread-heres-what-that-means/ |archive-date=26 March 2020 |url-status=live }}</ref><ref>{{cite journal | vauthors = Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD | title = How will country-based mitigation measures influence the course of the COVID-19 epidemic? | journal = Lancet | date = March 2020 | volume = 395 | issue = 10228 | pages = 931\u2013934 | pmid = 32164834 | doi = 10.1016/S0140-6736(20)30567-5 }}</ref>\n\nAccording to the WHO, the use of masks is recommended only if a person is coughing or sneezing or when one is taking care of someone with a suspected infection.{{update inline|date=April 2020}}<ref>{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks|title=When and how to use masks|website=[[World Health Organization]] (WHO)|access-date=8 March 2020|name-list-format=vanc|archive-url=https://web.archive.org/web/20200307013848/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks|archive-date=7 March 2020|url-status=live}}</ref> Some countries also recommend healthy individuals to wear face masks, including China,<ref name=\"nhc_masks\">{{cite web |url=http://en.nhc.gov.cn/2020-02/07/c_76337.htm |title=For different groups of people: how to choose masks |work=NHC.gov.cn |publisher=National Health Commission of the People's Republic of China |date=7 February 2020 |access-date=22 March 2020 |archive-url= |archive-date= |quote=\"Disposable medical masks: Recommended for: \u00b7 People in crowded places \u00b7 Indoor working environment with a relatively dense population \u00b7 People going to medical institutions \u00b7 Children in kindergarten and students at school gathering to study and do other activities\" }}{{Dead link|date=April 2020 |bot=InternetArchiveBot |fix-attempted=yes }}</ref> [[Hong Kong]],<ref>{{cite web |url=https://www.chp.gov.hk/files/pdf/prevention_of_covid_19_en.pdf |title=Prevention of Coronavirus Disease 2019 (COVID-19) |website=[[Centre for Health Protection]] |access-date=22 March 2020 |quote=\"Wear a surgical mask when taking public transport or staying in crowded places.\" |archive-url=https://web.archive.org/web/20200321175110/https://www.chp.gov.hk/files/pdf/prevention_of_covid_19_en.pdf |archive-date=21 March 2020 |url-status=live }}</ref> [[Thailand]],<ref>{{cite news |title='Better than nothing': Thailand encourages cloth masks amid surgical mask shortage |url=https://www.reuters.com/article/us-health-coronavirus-thailand-masks/better-than-nothing-thailand-encourages-cloth-masks-amid-surgical-mask-shortage-idUSKBN20Z0UT |first=Jiraporn |last=Kuhakan |work=Reuters |date=12 March 2020 |quote=\"Thailand's health authorities are encouraging people to make cloth face masks at home to guard against the spread of the coronavirus amid a shortage of surgical masks.{{nbsp}}... The droplet from coughing and sneezing is around five microns and we have tested already that cloth masks can protect against droplets bigger than one micron.\" |access-date=22 March 2020 |archive-url=https://web.archive.org/web/20200321192522/https://www.reuters.com/article/us-health-coronavirus-thailand-masks/better-than-nothing-thailand-encourages-cloth-masks-amid-surgical-mask-shortage-idUSKBN20Z0UT |archive-date=21 March 2020 |url-status=live }}</ref> Czech Republic,<ref>{{cite web|url=https://www.euronews.com/2020/03/24/coronavirus-czechs-facing-up-to-covid-19-crisis-by-making-masks-mandatory|title=Coronavirus: Czechs facing up to COVID-19 crisis by making masks mandatory|last=|first=|date=2020|website=euronews|url-status=live|archive-url=https://web.archive.org/web/20200330233916/https://www.euronews.com/2020/03/24/coronavirus-czechs-facing-up-to-covid-19-crisis-by-making-masks-mandatory|archive-date=30 March 2020|access-date=}}</ref> and Austria.<ref>{{cite web|url=https://www.cbsnews.com/news/austria-supermarket-face-mask/|title=Austria is making everyone who goes inside a supermarket wear a face mask|website=www.cbsnews.com|language=en-US|access-date=2020-03-31|archive-url=https://web.archive.org/web/20200331192209/https://www.cbsnews.com/news/austria-supermarket-face-mask/|archive-date=31 March 2020|url-status=live}}</ref> In order to meet the need for masks, the WHO estimates that global production will need to increase by 40%. Hoarding and speculation have worsened the problem, with the price of masks increasing sixfold, [[N95 masks|N95 respirators]] tripled, and gowns doubled.<ref>{{cite press release |title= Shortage of personal protective equipment endangering health workers worldwide |date= 3 March 2020 |publisher= WHO |url= https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide |access-date= 24 March 2020 |archive-url= https://web.archive.org/web/20200305052623/https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide |archive-date= 5 March 2020 |url-status= live }}</ref> Some health experts consider wearing non-medical grade masks and other face coverings like scarves or bandanas a good way to prevent people from touching their mouths and noses, even if non-medical coverings would not protect against a direct sneeze or cough from an infected person.<ref>{{cite web|url=https://www.bostonglobe.com/2020/03/19/opinion/guidance-against-wearing-masks-coronavirus-is-wrong-you-should-cover-your-face/|title=Guidance against wearing masks for the coronavirus is wrong\u2014you should cover your face\u2014The Boston Globe|website=BostonGlobe.com|access-date=22 March 2020|archive-url=https://web.archive.org/web/20200322181032/https://www.bostonglobe.com/2020/03/19/opinion/guidance-against-wearing-masks-coronavirus-is-wrong-you-should-cover-your-face/|archive-date=22 March 2020|url-status=live}}</ref>\n \nThose diagnosed with COVID-19 or who believe they may be infected are advised by the CDC to stay home except to get medical care, call ahead before visiting a healthcare provider, wear a face mask before entering the healthcare provider's office and when in any room or vehicle with another person, cover coughs and sneezes with a tissue, regularly wash hands with soap and water and avoid sharing personal household items.<ref>{{cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/about/prevention.html | title = Coronavirus Disease 2019 (COVID-19)\u2014Prevention & Treatment | date = 10 March 2020 | work = Centers for Disease Control and Prevention | publisher = U.S. Department of Health & Human Services | access-date = 11 March 2020 | archive-url = https://web.archive.org/web/20200311163637/https://www.cdc.gov/coronavirus/2019-ncov/about/prevention.html | archive-date = 11 March 2020 | url-status = live }}</ref><ref>{{cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/about/steps-when-sick.html | title = What to do if you are sick with 2019&nbsp;Novel Coronavirus (2019-nCoV) | author = [[Centers for Disease Control and Prevention]] | date = 11 February 2020 | language = en-us | url-status = live | archive-url = https://web.archive.org/web/20200214153016/https://www.cdc.gov/coronavirus/2019-ncov/about/steps-when-sick.html | archive-date = 14 February 2020 | access-date = 13 February 2020| name-list-format = vanc}}</ref> The CDC also recommends that individuals wash hands often with soap and water for at least 20 seconds, especially after going to the toilet or when hands are visibly dirty, before eating and after blowing one's nose, coughing or sneezing. It further recommends using an alcohol-based [[hand sanitiser]] with at least 60% alcohol, but only when soap and water are not readily available.<ref name=\"CDC-Prevention & Treatment\" />\n\nFor areas where commercial hand sanitisers are not readily available, the WHO provides two formulations for local production. In these formulations, the antimicrobial activity arises from [[ethanol]] or [[isopropanol]]. [[Hydrogen peroxide]] is used to help eliminate [[bacterial spores]] in the alcohol; it is \"not an active substance for hand [[antisepsis]]\". [[Glycerol]] is added as a [[humectant]].<ref>{{cite book | chapter-url = https://www.ncbi.nlm.nih.gov/books/NBK144054/ | chapter = WHO-recommended handrub formulations | title = WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care. |date=19 March 2009 |publisher=World Health Organization|access-date=19 March 2020 }}</ref>\n<gallery mode=packed heights=200px>\nFile:Covid-19-Transmission-graphic-01.gif|Prevention efforts are multiplicative, with effects far beyond that of a single spread. Each avoided case leads to more avoided cases down the line, which in turn can stop the outbreak in its tracks.\nFile:COVID19 W ENG.ogv|[[Handwashing]] instructions\n</gallery>\n\n==Management==\n\n[[File:DonningCDC2020.jpg|thumb|Four steps to putting on [[personal protective equipment]] (PPE)<ref>{{cite web |title=Sequence for Putting On Personal Protective Equipment (PPE) |url=https://www.cdc.gov/hai/pdfs/ppe/PPE-Sequence.pdf |website=CDC |access-date=8 March 2020 |archive-url=https://web.archive.org/web/20200305173617/https://www.cdc.gov/hai/pdfs/ppe/ppe-sequence.pdf |archive-date=5 March 2020 |url-status=live }}</ref>]]\nPeople are managed with [[supportive care]], which may include fluid therapy, [[oxygen support]] and supporting other affected vital organs.<ref name=\"NatureDale Fisher & David Heymann\">{{cite journal | vauthors=Fisher D, Heymann D |title = Q&A: The novel coronavirus outbreak causing COVID-19 |journal=BMC Medicine |volume=18 |issue=1 |page=57 |doi=10.1186/s12916-020-01533-w |doi-access=free |pmid=32106852 |pmc=7047369 | date=February 2020 }}</ref><ref name=\"KuiFang2020\">{{cite journal | vauthors = Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG | display-authors = 6 | title = Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province | journal = Chinese Medical Journal | page = 1 | date = February 2020 | pmid = 32044814 |doi=10.1097/CM9.0000000000000744 |doi-access=free }}</ref><ref name=\"Wang Du Zhu Cao 2020 p.\">{{cite journal | vauthors = Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B | title = Comorbidities and multi-organ injuries in the treatment of COVID-19 | journal = Lancet | date = March 2020 | volume = 395 | issue = 10228 | pages = e52 | pmid = 32171074 | doi = 10.1016/s0140-6736(20)30558-4 | publisher = Elsevier BV }}</ref> The CDC recommends that those who suspect they carry the virus wear a simple face mask.<ref name=CDC2020IfSick/> [[Extracorporeal membrane oxygenation]] (ECMO) has been used to address the issue of respiratory failure, but its benefits are still under consideration.<ref name=\"Guan Ni Hu Liang p.\" /><ref name=\"Henry 2020 p.\">{{cite journal | last=Henry | first=Brandon Michael | name-list-format = vanc | title=COVID-19, ECMO, and lymphopenia: a word of caution | journal=The Lancet Respiratory Medicine | publisher=Elsevier BV | date=2020 | volume=8 | issue=4 | pages=e24 | issn=2213-2600 | doi=10.1016/s2213-2600(20)30119-3 | pmid=32178774 | pmc=7118650 }}</ref>\n\nThe WHO and [[National Health Commission|Chinese National Health Commission]] have published recommendations for taking care of people who are hospitalised with COVID-19.<ref name=\"Cheng2020\">{{cite journal | vauthors = Cheng ZJ, Shan J | title = 2019 Novel coronavirus: where we are and what we know | journal = Infection | date = February 2020 | volume = 48 | issue = 2 | pages = 155\u2013163 | pmid = 32072569 |doi=10.1007/s15010-020-01401-y |doi-access=free }}</ref><ref>{{cite web|url=https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected|title=Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected|website=[[World Health Organization]] (WHO)|access-date=13 February 2020|archive-url=https://web.archive.org/web/20200131032122/https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected|archive-date=31 January 2020|url-status=live }}</ref> [[Critical care medicine|Intensivists]] and [[Pulmonology|pulmonologists]] in the US have compiled treatment recommendations from various agencies into a free resource, the [[EMCrit|IBCC]].<ref name=\"IBCC\">{{cite book |last=Farkas |first=Josh | name-list-format = vanc |date=March 2020 |title=COVID-19\u2014The Internet Book of Critical Care |url=https://emcrit.org/ibcc/covid19/ |url-status=live |format=digital |type=Reference manual |language=English |location=USA |publisher=EMCrit |archive-url=https://web.archive.org/web/20200311195758/https://emcrit.org/ibcc/covid19/ |archive-date=11 March 2020 |access-date=13 March 2020}}</ref><ref name=\"UPenn-IBCC\">{{cite web |url=https://guides.library.upenn.edu/covid-19 |title=COVID19\u2014Resources for Health Care Professionals |publisher=[[Penn Libraries]] |date=11 March 2020 |access-date=13 March 2020 |archive-url=https://web.archive.org/web/20200314035631/https://guides.library.upenn.edu/covid-19 |archive-date=14 March 2020 |url-status=live }}</ref>\n\n===Medications===\n\nSome medical professionals recommend [[paracetamol]] (acetaminophen) over [[ibuprofen]] for first-line use.<ref name=\"Day 2020 p.\">{{cite journal | title = Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists | journal = BMJ | volume = 368 | date = 17 March 2020 | pmid = 32184201 | doi = 10.1136/bmj.m1086 | issn=1756-1833 | url = https://www.bmj.com/content/368/bmj.m1086 | access-date = 18 March 2020 | last = Day | first = Michael | pages = m1086 | archive-url = https://web.archive.org/web/20200319181945/https://www.bmj.com/content/368/bmj.m1086 | archive-date = 19 March 2020 | url-status = live }}</ref><ref>{{cite web|url=https://www.nhs.uk/conditions/coronavirus-covid-19/self-isolation-advice/|title=Self-isolation advice\u2014Coronavirus (COVID-19)|date=2020-02-28|website=National Health Service (United Kingdom)|language=en|access-date=2020-03-27|archive-url=https://web.archive.org/web/20200328000128/https://www.nhs.uk/conditions/coronavirus-covid-19/self-isolation-advice/|archive-date=28 March 2020|url-status=live}}</ref><ref>{{cite web\n |last         = Godoy\n |first        = Maria\n |date         = 18 March 2020\n |url          = https://www.npr.org/sections/health-shots/2020/03/18/818026613/advice-from-france-to-avoid-ibuprofen-for-covid-19-leaves-experts-baffled\n |title        = Concerned About Taking Ibuprofen For Coronavirus Symptoms? Here's What Experts Say\n |website      = [[NPR]]\n |access-date  = 8 April 2020\n}}</ref> The WHO does not oppose the use of [[non-steroidal anti-inflammatory drugs]] (NSAIDs) such as ibuprofen for symptoms,<ref name=\"AFP 2020b\">{{cite web|url=https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms|title=Updated: WHO Now Doesn't Recommend Avoiding Ibuprofen For COVID-19 Symptoms|author=AFP|date=19 March 2020|website=ScienceAlert|access-date=19 March 2020|archive-url=https://web.archive.org/web/20200318222020/https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms|archive-date=18 March 2020|url-status=live}}</ref> and the [[Food and Drug Administration|FDA]] says currently there is no evidence that NSAIDs worsen COVID-19 symptoms.<ref>{{Cite journal|last=Research|first=Center for Drug Evaluation and|date=2020-03-19|title=FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19|url=http://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19|journal=Drug Safety and Availability|language=en|access-date=27 March 2020|archive-url=https://web.archive.org/web/20200327194633/https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19|archive-date=27 March 2020|url-status=live}}</ref>\n\nWhile theoretical concerns have been raised about [[ACE inhibitors]] and [[angiotensin receptor blocker]]s, as of 19 March 2020, these are not sufficient to justify stopping these medications.<ref>{{cite web |title=Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician |url=https://www.hfsa.org/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician/ |access-date=21 March 2020 |archive-url=https://web.archive.org/web/20200321172112/https://www.hfsa.org/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician/ |archive-date=21 March 2020 |url-status=live }}</ref><ref>{{cite press release | title=Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician | website=American Heart Association | date=17 March 2020 | url=https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician | access-date=25 March 2020 | archive-url=https://web.archive.org/web/20200324050912/https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician | archive-date=24 March 2020 | url-status=live }}</ref><ref name=\"ESCPositionStatement\">{{cite web |last=de Simone |first=Giovanni |title=Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers |url=https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang |website=Council on Hypertension of the European Society of Cardiology |access-date=24 March 2020 |archive-url=https://web.archive.org/web/20200324073257/https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang |archive-date=24 March 2020 |url-status=live }}</ref> [[Steroids]], such as [[methylprednisolone]], are not recommended unless the disease is complicated by [[acute respiratory distress syndrome]].<ref name=\"Vetter Eckerle Kaiser 2020 p.\">{{cite journal | vauthors=Vetter P, Eckerle I, Kaiser L | title=Covid-19: a puzzle with many missing pieces | journal=BMJ | volume=368 | pages=m627 | date=February 2020 | pmid=32075791 | doi=10.1136/bmj.m627 |doi-access=free }}</ref><ref>{{cite web |title=Novel Coronavirus\u2014COVID-19: What Emergency Clinicians Need to Know |url=https://www.ebmedicine.net/topics/infectious-disease/COVID-19 |website=www.ebmedicine.net |access-date=9 March 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200314163512/https://www.ebmedicine.net/topics/infectious-disease/COVID-19 |archive-date=14 March 2020 |url-status=live }}</ref>\n\n===Personal protective equipment===\n\nPrecautions must be taken to minimise the risk of virus transmission, especially in healthcare settings when performing procedures that can generate [[aerosol]]s, such as [[intubation]] or [[bag valve mask|hand ventilation]].<ref name=\"Cheung Ho Cheng Cham 2020 p.\">{{cite journal | vauthors=Cheung JC, Ho LT, Cheng JV, Cham EY, Lam KN | title=Staff safety during emergency airway management for COVID-19 in Hong Kong | journal=Lancet Respiratory Medicine | date=February 2020 | volume=8 | issue=4 | pages=e19 | doi=10.1016/s2213-2600(20)30084-9 | doi-access=free | pmid=32105633 }}</ref> For healthcare professionals caring for people with COVID-19, the CDC recommends placing the person in an Airborne Infection Isolation Room (AIIR) in addition to using [[standard precautions]], contact precautions and airborne precautions.<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-patients-H.pdf|title=What healthcare personnel should know about caring for patients with confirmed or possible coronavirus disease 2|last=|date=12 March 2020|website=CDC|url-status=live|archive-url=|archive-date=|access-date=31 March 2020}}</ref>\n\nCDC outlines the specific guidelines for the use of [[personal protective equipment]] (PPE) during the pandemic. The recommended gear includes:\n* [[Respirator]] or [[surgical mask|facemask]]<ref>[https://www.cdc.gov/niosh/docs/2018-130/ Filtering out Confusion: Frequently Asked Questions about Respiratory Protection, User Seal Check] {{Webarchive|url=https://web.archive.org/web/20190816114738/https://www.cdc.gov/niosh/docs/2018-130/ |date=16 August 2019 }}. The National Institute for Occupational Safety and Health (April 2018). Retrieved 16 March 2020.</ref><ref>[http://blogs.cdc.gov/niosh-science-blog/2020/03/16/n95-preparedness/?deliveryName=USCDC_170-DM22692 Proper N95 Respirator Use for Respiratory Protection Preparedness] {{Webarchive|url=https://web.archive.org/web/20200327073252/https://blogs.cdc.gov/niosh-science-blog/2020/03/16/n95-preparedness/?deliveryName=USCDC_170-DM22692 |date=27 March 2020 }}. NIOSH Science Blog (16 March 2020). Retrieved 16 March 2020.</ref>\n* [[Hospital gown|Gown]]<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html |website=Centers for Disease Control and Prevention |date=11 February 2020 |accessdate=4 April 2020}}</ref>\n* [[Medical glove]]s<ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html |website=Centers for Disease Control and Prevention |access-date=11 March 2020 |date=11 February 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html |archive-date=4 March 2020 |url-status=live }}</ref><ref>{{cite web |title=Coronavirus Disease 2019 (COVID-19) |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-patients.html |website=Centers for Disease Control and Prevention |access-date=8 March 2020 |date=11 February 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-patients.html |archive-date=4 March 2020 |url-status=live }}</ref>\n* [[Eye protection]]<ref>{{cite web|title=Strategies for Optimizing the Supply of Eye Protection|date=11 February 2020|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/eye-protection.html|publisher=CDC|access-date=23 March 2020|archive-url=https://web.archive.org/web/20200323173916/https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/eye-protection.html|archive-date=23 March 2020|url-status=live}}</ref>\n\nWhen available, respirators (instead of facemasks) are preferred.<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html|title=Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings|author=CDC|date=11 February 2020|website=Centers for Disease Control and Prevention|language=en-us|url-status=live|archive-url=https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html|archive-date=4 March 2020|access-date=25 March 2020}}</ref> N95 respirators are approved for industrial settings but the FDA has authorised the masks for use under an [[Emergency Use Authorisation]] (EUA). They are designed to protect from airborne particles like dust but effectiveness against a specific biological agent is not guaranteed for off-label uses.<ref>{{cite web|title=Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions|url=https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19-frehttps://oc.wikipedia.org/wiki/Malauti%C3%A1_de_coronavirus_de_2019quently-asked-questions#5e78ba94b86da|website=Food and Drug Administration}}</ref> When masks are not available, the CDC recommends using face shields or, as a last resort, [[Cloth facemask|homemade masks]].<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html|title=Strategies for Optimizing the Supply of Facemasks|date=11 February 2020|publisher=CDC|access-date=23 March 2020|archive-url=https://web.archive.org/web/20200323173927/https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html|archive-date=23 March 2020|url-status=live}}</ref>\n\n===Mechanical ventilation===\n\nMost cases of COVID-19 are not severe enough to require [[mechanical ventilation]] (artificial assistance to support breathing), but a percentage of cases do.<ref name=\"murthy\">{{cite journal | vauthors = Murthy S, Gomersall CD, Fowler RA | title = Care for Critically Ill Patients With COVID-19 | journal = JAMA | date = 11 March 2020 | pmid = 32159735 | doi = 10.1001/jama.2020.3633 | url = https://jamanetwork.com/journals/jama/fullarticle/2762996 | access-date = 18 March 2020 | archive-url = https://web.archive.org/web/20200318203852/https://jamanetwork.com/journals/jama/fullarticle/2762996 |archive-date=18 March 2020 |url-status=live}}</ref><ref>{{cite web|author=World Health Organization|date=28 January 2020|title=Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected|url=https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf|journal=|volume=|pages=|via=|access-date=18 March 2020|archive-url=https://web.archive.org/web/20200226041620/https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf|archive-date=26 February 2020|url-status=live}}</ref> Some Canadian doctors recommend the use of invasive [[mechanical ventilation]] because this technique limits the spread of [[Airborne disease|aerosolised]] transmission [[Vector (epidemiology)|vectors]].<ref name=\"murthy\"/> Severe cases are most common in older adults (those older than 60 years<ref name=\"murthy\"/> and especially those older than 80 years).<ref>{{Cite document |last1=Ferguson |first1=N. |last2=Laydon |first2=D.|last3=Nedjati Gilani |first3=G. |last4=Imai |first4=N. |last5=Ainslie |first5=K. |last6=Baguelin |first6=M. |last7=Bhatia |first7=S. |last8=Boonyasiri|first8=A.|last9=Cucunuba Perez|first9=Zulma|last10=Cuomo-Dannenburg |first10=G. |last11=Dighe |first11=A. |date=16 March 2020 |title=Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand|publisher=[[Imperial College London]] |url=http://spiral.imperial.ac.uk/handle/10044/1/77482|doi=10.25561/77482|hdl=20.1000/100|doi-access=free|at=Table 1|journal=|access-date=25 March 2020|archive-url=https://web.archive.org/web/20200321133445/https://spiral.imperial.ac.uk/handle/10044/1/77482|archive-date=21 March 2020|url-status=live}}</ref> Many developed countries do not have enough [[List of countries by hospital beds|hospital beds per capita]], which limits a [[health system]]'s capacity to handle a sudden spike in the number of COVID-19 cases severe enough to require hospitalisation.<ref name=\"VoxCOVID\">{{cite news |last=Scott |first=Dylan |title=Coronavirus is exposing all of the weaknesses in the US health system High health care costs and low medical capacity made the US uniquely vulnerable to the coronavirus. |url=https://www.vox.com/policy-and-politics/2020/3/16/21173766/coronavirus-covid-19-us-cases-health-care-system |accessdate=18 March 2020 |publisher=Vox |date=16 March 2020 |archive-url=https://web.archive.org/web/20200318022237/https://www.vox.com/policy-and-politics/2020/3/16/21173766/coronavirus-covid-19-us-cases-health-care-system |archive-date=18 March 2020 |url-status=live}}</ref> This limited capacity is a significant driver of the need to [[flatten the curve]] (to keep the speed at which new cases occur and thus the number of people sick at one point in time lower).<ref name=\"VoxCOVID\"/> One study in China found 5% were admitted to [[intensive care unit]]s, 2.3% needed mechanical support of ventilation, and 1.4% died.<ref name=\"Guan Ni Hu Liang p.\">{{cite journal | vauthors = Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS | display-authors = 6 | title = Clinical Characteristics of Coronavirus Disease 2019 in China | journal = The New England Journal of Medicine | date = February 2020 | pmid = 32109013 | doi = 10.1056/nejmoa2002032 | publisher = Massachusetts Medical Society | pmc = 7092819 | doi-access = free }}</ref> Around 20\u201330% of the people in hospital with pneumonia from COVID-19 needed ICU care for respiratory support.<ref>{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html|title=Coronavirus Disease 2019 (COVID-19)|last=|date=2020-02-11|website=Centers for Disease Control and Prevention|language=en-us|access-date=2020-03-29|archive-url=https://web.archive.org/web/20200302201644/https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html|archive-date=2 March 2020|url-status=live}}</ref>\n\n===Acute respiratory distress syndrome===\n\n{{main|Acute respiratory distress syndrome}}\n[[Mechanical ventilation]] becomes more complex as [[acute respiratory distress syndrome]] (ARDS) develops in COVID-19 and oxygenation becomes increasingly difficult.<ref name=\"LancetRespMar2020\" /> Ventilators capable of [[Modes of mechanical ventilation|pressure control modes]] and high [[PEEP]]<ref>{{cite journal |last1=Briel |first1=Matthias |last2=Meade |first2=Maureen |last3=Mercat |first3=Alain |last4=Brower |first4=Roy G. |last5=Talmor |first5=Daniel |last6=Walter |first6=Stephen D. |last7=Slutsky |first7=Arthur S. |last8=Pullenayegum |first8=Eleanor |last9=Zhou |first9=Qi |last10=Cook |first10=Deborah |last11=Brochard |first11=Laurent |last12=Richard |first12=Jean-Christophe M. |last13=Lamontagne |first13=Fran\u00e7ois |last14=Bhatnagar |first14=Neera |last15=Stewart |first15=Thomas E. |last16=Guyatt |first16=Gordon |title=Higher vs Lower Positive End-Expiratory Pressure in Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome |journal=JAMA |date=3 March 2010 |volume=303 |issue=9 |pages=865\u201373 |doi=10.1001/jama.2010.218|pmid=20197533 }}</ref> are needed to maximise oxygen delivery while minimising the risk of [[ventilator-associated lung injury]] and [[pneumothorax]].<ref name=\"barotrauma\">{{cite book |last1=Diaz |first1=Raiko |last2=Heller |first2=Daniel |title=Barotrauma And Mechanical Ventilation |url=https://www.ncbi.nlm.nih.gov/books/NBK545226/ |website=StatPearls |publisher=StatPearls Publishing |date=2020|pmid=31424810 }}</ref> High PEEP may not be available on older ventilators.\n\n{| class=\"wikitable\" style=\"text-align:center; margin-right:1em;\"\n|+ style=\"background:#E5AFAA;\" | Options for ARDS<ref name=LancetRespMar2020>{{cite journal |last1=Matthay |first1=Michael A. |last2=Aldrich |first2=J. Matthew |last3=Gotts |first3=Jeffrey E. |title=Treatment for severe acute respiratory distress syndrome from COVID-19 |journal=The Lancet Respiratory Medicine |date=March 2020 |doi=10.1016/S2213-2600(20)30127-2|pmid=32203709 |pmc=7118607 }}</ref>\n|- style=\"background: #E5AFAA;text-align:center;\"\n! Therapy\n! Recommendations\n|-\n| [[Nasal cannula|High-flow nasal oxygen]]\n| For [[oxygen saturation|SpO<sub>2</sub>]] <93%. May prevent the need for intubation and ventilation\n|-\n| [[Tidal volume]]\n| 6mL per kg and can be reduced to 4mL/kg\n|-\n| [[Plateau pressure|Plateau airway pressure]]\n| Keep below 30 [[Centimetre of water|cmH<sub>2</sub>O]] if possible (high [[respiratory rate]] (35 per minute) may be required)\n|-\n| [[Positive end-expiratory pressure]]\n| Moderate to high levels\n|-\n| [[Prone position]]ing\n| For worsening oxygenation\n|-\n| [[Fluid replacement|Fluid management]]\n| Goal is a negative balance of 0.5\u20131[[liter|L]] per day\n|-\n| [[Antibiotics]]\n| For secondary bacterial infections\n|-\n| [[Glucocorticoids]]\n| Not recommended\n|}\n\n===Experimental treatment===\n\n{{see also|Coronavirus disease 2019#Research|label 1=Research}}\nNo medications are approved to treat the disease by the WHO although some are recommended by individual national medical authorities.<ref name=\"LiDeClerq\">{{cite journal | vauthors = Li G, De Clercq E | title = Therapeutic options for the 2019&nbsp;novel coronavirus (2019-nCoV) | journal = Nature Reviews. Drug Discovery | volume = 19 | issue = 3 | pages = 149\u2013150 | date = March 2020 | pmid = 32127666 | doi = 10.1038/d41573-020-00016-0 | doi-access = free }}</ref> Research into potential treatments started in January 2020,<ref>{{Cite news|url=https://www.reuters.com/article/us-china-health-hospital-idUSKBN20B1M6|title=Chinese doctors using plasma therapy on coronavirus, WHO says 'very valid' approach|newspaper=Reuters|date=17 February 2020|via=www.reuters.com|access-date=19 March 2020|archive-url=https://web.archive.org/web/20200304173709/https://www.reuters.com/article/us-china-health-hospital-idUSKBN20B1M6|archive-date=4 March 2020|url-status=live}}</ref> and several antiviral drugs are in clinical trials.<ref name=\"Reut_NIH_Moderna_3months\" /><ref name=\"clinicaltrialsarena\">{{cite web|url=https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/|title=Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19|last=Duddu|first=Praveen|date=19 February 2020|work=clinicaltrialsarena.com|archive-url=https://web.archive.org/web/20200219184512/https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/|archive-date=19 February 2020|name-list-format=vanc}}</ref> Although new medications may take until 2021 to develop,<ref>{{cite journal|vauthors=Lu H|date=28 January 2020|title=Drug treatment options for the 2019-new coronavirus (2019-nCoV).|journal=Biosci Trends|volume=14|issue=1|pages=69\u201371|doi=10.5582/bst.2020.01020|pmid=31996494}}</ref> several of the medications being tested are already approved for other uses or are already in advanced testing.<ref name=\"LiDeClerq\" /> Antiviral medication may be tried in people with severe disease.<ref name=\"NatureDale Fisher & David Heymann\" /> The WHO recommended volunteers take part in trials of the effectiveness and safety of potential treatments.<ref name=\"ThomReut_notreatment_20200205\">{{cite news|last1=Nebehay|first1=Stephanie|url=https://www.reuters.com/article/us-china-health-treatments-who-idUSKBN1ZZ1M6|title=WHO: 'no known effective' treatments for new coronavirus|date=5 February 2020|access-date=5 February 2020|url-status=live |archive-url=https://web.archive.org/web/20200205155653/https://www.reuters.com/article/us-china-health-treatments-who-idUSKBN1ZZ1M6|archive-date=5 February 2020|agency=[[Thomson Reuters]]|last2=Kelland|first2=Kate|last3=Liu|first3=Roxanne|name-list-format=vanc}}</ref>\n\n===Information technology===\n\n{{See also|Government by algorithm}}\nIn February 2020, China launched a [[mobile app]] to deal with the disease outbreak.<ref>{{cite news |title=China launches coronavirus 'close contact' app |url=https://www.bbc.com/news/technology-51439401 |access-date=7 March 2020 |work=BBC News |date=11 February 2020 |name-list-format=vanc |archive-url=https://web.archive.org/web/20200228003957/https://www.bbc.com/news/technology-51439401 |archive-date=28 February 2020 |url-status=live }}</ref> Users are asked to enter their name and ID number. The app is able to detect 'close contact' using surveillance data and therefore a potential risk of infection. Every user can also check the status of three other users. If a potential risk is detected, the app not only recommends self-quarantine, it also alerts local health officials.<ref>{{cite web |last1=Chen |first1=Angela | name-list-format = vanc |title=China's coronavirus app could have unintended consequences |url=https://www.technologyreview.com/s/615199/coronavirus-china-app-close-contact-surveillance-covid-19-technology/ |website=MIT Technology Review |access-date=7 March 2020 }}</ref>\n\n[[Big data]] analytics on cellphone data, [[Facial recognition system|facial recognition]] technology, [[mobile phone tracking]] and [[artificial intelligence]] are used to track infected people and people whom they contacted in South Korea, Taiwan and Singapore.<ref>{{cite news |title=Gov in the Time of Corona |url=https://govinsider.asia/innovation/gov-in-the-time-of-corona/ |access-date=20 March 2020 |work=GovInsider |date=19 March 2020 |archive-url=https://web.archive.org/web/20200320125215/https://govinsider.asia/innovation/gov-in-the-time-of-corona/ |archive-date=20 March 2020 |url-status=live }}</ref><ref>{{cite news |last=Manancourt |first=Vincent |title=Coronavirus tests Europe's resolve on privacy |url=https://www.politico.eu/article/coronavirus-tests-europe-resolve-on-privacy-tracking-apps-germany-italy/ |access-date=20 March 2020 |work=POLITICO |date=10 March 2020 |archive-url=https://web.archive.org/web/20200320105744/https://www.politico.eu/article/coronavirus-tests-europe-resolve-on-privacy-tracking-apps-germany-italy/ |archive-date=20 March 2020 |url-status=live }}</ref> In March 2020, the Israeli government enabled security agencies to track mobile phone data of people supposed to have coronavirus. The measure was taken to enforce quarantine and protect those who may come into contact with infected citizens.<ref>{{Cite news|last=Tidy|first=Joe|url=https://www.bbc.com/news/technology-51930681|title=Coronavirus: Israel enables emergency spy powers|date=17 March 2020|work=BBC News|access-date=18 March 2020|language=en-GB|archive-url=https://web.archive.org/web/20200318113608/https://www.bbc.com/news/technology-51930681|archive-date=18 March 2020|url-status=live}}</ref> Also in March 2020, [[Deutsche Telekom]] shared aggregated phone location data with the German federal government agency, [[Robert Koch Institute]], in order to research and prevent the spread of the virus.<ref name=\"heise-handydaten\">{{cite news |last=B\u00fcnte |first=Oliver |title=Corona-Krise: Deutsche Telekom liefert anonymisierte Handydaten an RKI |url=https://www.heise.de/newsticker/meldung/Corona-Krise-Deutsche-Telekom-liefert-anonymisierte-Handydaten-an-RKI-4685191.html |accessdate=25 March 2020 |work=Heise Online |date=18 March 2020 |language=German |trans-title=Corona crisis: Deutsche Telekom delivers anonymized cell phone data to RKI |archive-url=https://web.archive.org/web/20200324115410/https://www.heise.de/newsticker/meldung/Corona-Krise-Deutsche-Telekom-liefert-anonymisierte-Handydaten-an-RKI-4685191.html |archive-date=24 March 2020 |url-status=live }}</ref> Russia deployed facial recognition technology to detect quarantine breakers.<ref>{{cite news |title=Moscow deploys facial recognition technology for coronavirus quarantine |url=https://www.reuters.com/article/us-china-health-moscow-technology-idUSKBN20F1RZ |access-date=20 March 2020 |work=Reuters |date=21 February 2020 |language=en |archive-url=https://web.archive.org/web/20200222215731/https://www.reuters.com/article/us-china-health-moscow-technology-idUSKBN20F1RZ |archive-date=22 February 2020 |url-status=live }}</ref> Italian regional health commissioner [[Giulio Gallera]] said he has been informed by mobile phone operators that \"40% of people are continuing to move around anyway\".<ref>{{cite news |title=Italians scolded for flouting lockdown as death toll nears 3,000 |url=https://www.post-gazette.com/news/world/2020/03/18/Italy-coronavirus-475-deaths-one-day-death-toll-2978-COVID-19-doctors/stories/202003180182 |access-date=20 March 2020 |work=Pittsburgh Post-Gazette |language=en |archive-url=https://web.archive.org/web/20200320110555/https://www.post-gazette.com/news/world/2020/03/18/Italy-coronavirus-475-deaths-one-day-death-toll-2978-COVID-19-doctors/stories/202003180182 |archive-date=20 March 2020 |url-status=live }}</ref> German government conducted a 48 hours weekend [[hackathon]] with more than 42.000 participants.<ref>{{cite web |title=Kreative L\u00f6sungen gesucht |url=https://www.bundesregierung.de/breg-de/themen/coronavirus/wir-vs-virus-1731968 |website=Startseite |language=de |access-date=23 March 2020 |archive-url=https://web.archive.org/web/20200324085627/https://www.bundesregierung.de/breg-de/themen/coronavirus/wir-vs-virus-1731968 |archive-date=24 March 2020 |url-status=live }}</ref><ref>{{cite news |last1=Dannewitz |first1=Juliane |title=Hackathon Germany: #WirvsVirus |url=https://www.datenschutzbeauftragter-info.de/hackathon-germany-wirvsvirus/ |work=Datenschutzbeauftragter |date=23 March 2020 |language=de-DE}}</ref> Also the president of Estonia, [[Kersti Kaljulaid]], made a global call for creative solutions against the spread of coronavirus.<ref>{{cite news |first=Andrew |last=Whyte |title=President makes global call to combat coronavirus via hackathon |url=https://news.err.ee/1067171/president-makes-global-call-to-combat-coronavirus-via-hackathon |work=ERR |date=21 March 2020 |language=en |access-date=23 March 2020 |archive-url=https://web.archive.org/web/20200324050421/https://news.err.ee/1067171/president-makes-global-call-to-combat-coronavirus-via-hackathon |archive-date=24 March 2020 |url-status=live }}</ref>\n\n===Psychological support===\n\n{{see also|Mental health during the 2019\u201320 coronavirus pandemic}}\nIndividuals may experience distress from quarantine, travel restrictions, side effects of treatment or fear of the infection itself. To address these concerns, the [[National Health Commission|National Health Commission of China]] published a national guideline for psychological crisis intervention on 27 January 2020.<ref name=\"Xiang4Feb2020\">{{cite journal | vauthors = Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH | display-authors = 6 | title = Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed | journal = The Lancet. Psychiatry | volume = 7 | issue = 3 | pages = 228\u201329 | date = March 2020 | pmid = 32032543 |doi=10.1016/S2215-0366(20)30046-8 |doi-access=free }}</ref><ref name=\"Kang5Feb2020\">{{cite journal | vauthors = Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, Wang Y, Hu J, Lai J, Ma X, Chen J, Guan L, Wang G, Ma H, Liu Z | display-authors = 6 | title = The mental health of medical workers in Wuhan, China dealing with the 2019&nbsp;novel coronavirus | journal = The Lancet. Psychiatry | volume = 7 | issue = 3 | pages = e14 | date = March 2020 | pmid = 32035030 |doi=10.1016/S2215-0366(20)30047-X |doi-access=free }}</ref>\n\n==Prognosis==\n\n{{Primary sources|date=March 2020}}\n{{multiple image\n | align         = right\n | direction     = vertical\n | total_width   = 400\n | caption_align = center\n<!--image 1-->\n | image1        = Severity-of-coronavirus-cases-in-China-1.png\n | alt1          = The severity of diagnosed cases in China\n | caption1      = The severity of diagnosed COVID-19 cases in China<ref>{{cite journal |last1=Roser |first1=Max |last2=Ritchie |first2=Hannah |last3=Ortiz-Ospina |first3=Esteban |name-list-format=vanc |title=Coronavirus Disease (COVID-19) |url=https://ourworldindata.org/coronavirus |journal=Our World in Data |access-date=12 March 2020 |date=4 March 2020 |archive-url=https://web.archive.org/web/20200319171947/https://ourworldindata.org/coronavirus |archive-date=19 March 2020 |url-status=live }}</ref>\n<!--image 2-->\n | image2        = Illustration of SARS-COV-2 Case Fatality Rate 200228 01-1.png\n | alt2          = 3D Medical Animation Still Shot graph showing Case Fatality rates by age group from SARS-COV-2 in China.\n | caption2      = Case fatality rates by age group in China. Data through 11 February 2020.<ref name=\"Epidemiology2020Feb17\" />\n<!--image 3-->\n | image3        = Comorbidity and severity in covid-19 data from China CDC Weekly 2020, 2(8), pp. 113-122 (cropped).png\n | alt3          = Case fatality rate depending on other health problems\n | caption3      = Case fatality rate in China depending on other health problems. Data through 11 February 2020.<ref name=\"Epidemiology2020Feb17\" />\n<!--image 4-->\n | image4        = Covid-19-total-confirmed-cases-vs-total-confirmed-deaths.png\n | alt4          = Case fatality rate by country and number of cases\n | caption4      = The number of deaths vs total cases by country and approximate case fatality rate<ref>{{cite journal |last1=Roser |first1=Max |last2=Ritchie |first2=Hannah |last3=Ortiz-Ospina |first3=Esteban |name-list-format=vanc |title=Coronavirus Disease (COVID-19) |url=https://ourworldindata.org/coronavirus |journal=Our World in Data |access-date=6 April 2020 |date=6 April 2020}}</ref>\n}}\n\nThe severity of COVID-19 varies. The disease may take a mild course with few or no symptoms, resembling other common upper respiratory diseases such as the [[common cold]]. Mild cases typically recover within two weeks, while those with severe or critical diseases may take three to six weeks to recover. Among those who have died, the time from symptom onset to death has ranged from two to eight weeks.<ref name=\"WHOReport24Feb2020\" />\n\nChildren are susceptible to the disease, but are likely to have milder symptoms and a lower chance of severe disease than adults; in those younger than 50 years, the risk of death is less than 0.5%, while in those older than 70 it is more than 8%.<ref name=\"Lu Zhang Du Zhang p.\">{{cite journal|display-authors=6|vauthors=Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y, Bao S, Li Y, Wu C, Liu H, Liu D, Shao J, Peng X, Yang Y, Liu Z, Xiang Y, Zhang F, Silva RM, Pinkerton KE, Shen K, Xiao H, Xu S, Wong GW|date=18 March 2020|title=SARS-CoV-2 Infection in Children|journal=New England Journal of Medicine|publisher=Massachusetts Medical Society|page=|doi=10.1056/nejmc2005073|issn=0028-4793|pmid=32187458|pmc=7121177}}</ref><ref name=\"pediatrics_tong\">{{cite journal | vauthors = Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S | journal = Pediatrics | title = Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China | date = 2020 | pages = e20200702 | url = https://pediatrics.aappublications.org/content/pediatrics/early/2020/03/16/peds.2020-0702.full.pdf | doi = 10.1542/peds.2020-0702 | pmid = 32179660 | access-date = 16 March 2020 | archive-url = https://web.archive.org/web/20200317223427/https://pediatrics.aappublications.org/content/pediatrics/early/2020/03/16/peds.2020-0702.full.pdf | archive-date = 17 March 2020 | url-status = live }}</ref> [[COVID-19 in pregnancy|Pregnant women]] may be at higher risk for severe infection with COVID-19 based on data from other similar viruses, like [[Severe acute respiratory syndrome|SARS]] and [[Middle East respiratory syndrome|MERS]], but data for COVID-19 is lacking.<ref>{{cite journal | vauthors = Fang L, Karakiulakis G, Roth M | title = Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? | journal = [[The Lancet Respiratory Medicine]] | volume = 395 | issue = 10224 | pages = e40 | date = March 2020 | pmid = 32171062 | doi = 10.1016/S0140-6736(20)30311-1 | pmc = 7118626 }}</ref><ref name=\"CDC 2020children\">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/children-faq.html|title=Coronavirus Disease 2019 (COVID-19)|author=|date=11 February 2020|website=Centers for Disease Control and Prevention|access-date=2 March 2020|name-list-format=vanc|archive-url=https://web.archive.org/web/20200302064104/https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/children-faq.html|archive-date=2 March 2020|url-status=live}}</ref>\n\nIn some people, COVID-19 may affect the lungs causing [[pneumonia]]. In those most severely affected, COVID-19 may rapidly progress to [[acute respiratory distress syndrome]] (ARDS) causing respiratory failure, septic shock or multi-organ failure.<ref name=\"Heymann Shindo 2020 pp. 542\u2013545\">{{cite journal | vauthors = Heymann DL, Shindo N | collaboration = WHO Scientific and Technical Advisory Group for Infectious Hazards | title = COVID-19: what is next for public health? | journal = Lancet | volume = 395 | issue = 10224 | pages = 542\u2013545 | date = February 2020 | pmid = 32061313 | doi = 10.1016/s0140-6736(20)30374-3 | publisher = Elsevier BV }}</ref><ref>{{cite book | vauthors = Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R | chapter = Features, Evaluation and Treatment Coronavirus (COVID-19) | date = 2020 | pmid = 32150360 | chapter-url = http://www.ncbi.nlm.nih.gov/books/NBK554776/ | access-date = 18 March 2020 | publisher = StatPearls Publishing | location = Treasure Island (FL) | title = StatPearls }}</ref> Complications associated with COVID-19 include [[sepsis]], [[Coagulopathy|abnormal clotting]] and damage to the heart, kidneys and liver. Clotting abnormalities, specifically an increase in [[prothrombin time]], have been described in 6% of those admitted to hospital with COVID-19, while abnormal kidney function is seen in 4% of this group.<ref name=\"Zhou Yu Du Fan 2020 p.\">{{cite journal|display-authors=6|vauthors=Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L|date=2020|title=Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study|journal=The Lancet|volume=395|issue=10229|pages=1054\u20131062|publisher=Elsevier BV|doi=10.1016/s0140-6736(20)30566-3|issn=0140-6736|pmid=32171076}}</ref> Liver injury as shown by blood markers of liver damage is frequently seen in severe cases.<ref>{{cite journal | vauthors = Xu L, Liu J, Lu M, Yang D, Zheng X | title = Liver injury during highly pathogenic human coronavirus infections | journal = Liver International | date = March 2020 | pmid = 32170806 | doi = 10.1111/liv.14435 }}</ref>\n\nSome studies have found that the [[neutrophil to lymphocyte ratio]] (NLR) may be helpful in early screening for severe illness.<ref>{{cite journal|title=Dysregulation of immune response in patients with COVID-19 in Wuhan, China|journal=Clinical Infectious Diseases|doi=10.1093/cid/ciaa248|date=12 March 2020|last1=Tian|first1=Dai-Shi|last2=Wang|first2=Wei|last3=Shang|first3=Ke|last4=Ma|first4=Ke|last5=Xie|first5=Cuihong|last6=Tao|first6=Yu|last7=Yang|first7=Sheng|last8=Zhang|first8=Shuoqi|last9=Hu|first9=Ziwei|last10=Zhou|first10=Luoqi|last11=Qin|first11=Chuan|pmid=32161940|pmc=7108125}}</ref>\n\nMany of those who die of COVID-19 have [[pre-existing condition|pre-existing (underlying) conditions]], including [[hypertension]], [[diabetes mellitus]] and [[cardiovascular disease]].<ref name=\":8\">{{cite web |url=https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-the-advice-of-the-ihr-emergency-committee-on-novel-coronavirus |title=WHO Director-General's statement on the advice of the IHR Emergency Committee on Novel Coronavirus |website=[[World Health Organization]] (WHO) }}</ref> The [[Istituto Superiore di Sanit\u00e0]] reported that out of 8.8% of deaths where [[medical record|medical charts]] were available for review, 97.2% of sampled patients had at least one [[comorbidity]] with the average patient having 2.7 diseases.<ref name=\"ISSCharacteristics\">{{Cite report|vauthors=Palmieri L, Andrianou X, Barbariol P, Bella A, Bellino S, Benelli E, Bertinato L, Boros S, Brambilla G, Calcagnini G, Canevelli M, Castrucci MR, Censi F, Ciervo A, Colaizzo E, D'Ancona F, Del Manso M, Donfrancesco C, Fabiani M, Filia A, Floridia M, Giuliano M, Grisetti T, Langer M, Lega I, Lo Noce C, Maiozzi P, Malchiodi Albedi F, Manno V, Martini M, Mateo Urdiales A, Mattei E, Meduri C, Meli P, Minelli G, Nebuloni M, Nistic\u00f2 L, Nonis M, Onder G, Palmisano L, Petrosillo N, Pezzotti P, Pricci F, Punzo O, Puro V, Raparelli V, Rezza G, Riccardo F, Rota MC, Salerno P, Serra D, Siddu A, Stefanelli P, Tamburo De Bella M, Tiple D, Unim B, Vaianella L, Vanacore N, Vichi M, Villani ER, Brusaferro S|display-authors= 6|title=Characteristics of COVID-19 patients dying in Italy Report based on available data on April 2th, 2020|url=https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_2_april_2020.pdf|date=3 April 2020|publisher=[[Istituto Superiore di Sanit\u00e0]]|access-date=3 April 2020|url-status=live}}</ref> According to the same report, the median time between onset of symptoms and death was ten days, with five being spent hospitalised. However, patients transferred to an ICU had a median time of seven days between hospitalisation and death.<ref name=\"ISSCharacteristics\" /> In a study of early cases, the median time from exhibiting initial symptoms to death was 14 days, with a full range of six to 41 days.<ref>{{cite journal | vauthors = Wang W, Tang J, Wei F | title = Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China | journal = Journal of Medical Virology | volume = 92 | issue = 4 | pages = 441\u201347 | date = April 2020 | pmid = 31994742 |doi=10.1002/jmv.25689 |doi-access=free }}</ref> In a study by the [[National Health Commission]] (NHC) of China, men had a death rate of 2.8% while women had a death rate of 1.7%.<ref name=\"WM2020Feb26\">{{cite web |title=Coronavirus Age, Sex, Demographics (COVID-19) |url=https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/ |website=www.worldometers.info |access-date=26 February 2020 |archive-url=https://web.archive.org/web/20200227112932/https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/ |archive-date=27 February 2020 |url-status=live | name-list-format = vanc}}</ref> [[Histopathology|Histopathological]] examinations of post-mortem lung samples show [[diffuse alveolar damage]] with cellular fibromyxoid [[exudate]]s in both lungs. Viral [[cytopathic effect|cytopathic]] changes were observed in the [[pneumocytes]]. The lung picture resembled [[acute respiratory distress syndrome]] (ARDS).<ref name=\"WHOReport24Feb2020\" /> In 11.8% of the deaths reported by the National Health Commission of China, heart damage was noted by elevated levels of [[Troponin I|troponin]] or cardiac arrest.<ref name=\"Zheng Ma Zhang Xie p.\" />\n\nAvailability of medical resources and the [[socioeconomics]] of a region may also affect mortality.<ref name=\"Ji Ma Peppelenbosch Pan 2020 p.\">{{cite journal | vauthors=Ji Y, Ma Z, Peppelenbosch MP, Pan Q | title=Potential association between COVID-19 mortality and health-care resource availability | journal=Lancet Global Health | volume= 8| date=February 2020 | issue=4 | pages=e480 | pmid=32109372 | doi=10.1016/S2214-109X(20)30068-1 | doi-access=free }}</ref> Estimates of the mortality from the condition vary because of those regional differences,<ref name=\"pmid32159317\">{{cite journal | vauthors = Li XQ, Cai WF, Huang LF, Chen C, Liu YF, Zhang ZB, Yuan J, Li TG, Wang M | display-authors = 6 | title = [Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou] | language = Chinese | journal = Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi | volume = 41 | issue = 5 | pages = 634\u2013637 | date = March 2020 | pmid = 32159317 | doi = 10.3760/cma.j.cn112338-20200228-00209 }}</ref> but also because of [[Methodology|methodological]] difficulties. The under-counting of mild cases can cause the mortality rate to be overestimated.<ref>{{cite journal | vauthors = Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, Kobayashi T, Kinoshita R, Nishiura H | display-authors = 6 | title = Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases | journal = Journal of Clinical Medicine | volume = 9 | issue = 2 | page = 523 | date = February 2020 | pmid = 32075152 | doi = 10.3390/jcm9020523 | pmc = 7074479 }}</ref> However, the fact that deaths are the result of cases contracted in the past can mean the current mortality rate is underestimated.<ref>{{cite journal | vauthors = Chughtai A, Malik A | title = Is Coronavirus disease (COVID-19) case fatality ratio underestimated? | journal = Global Biosecurity | date = March 2020 | volume = 1 | issue = 3 | doi = 10.31646/gbio.56 | doi-broken-date = 19 March 2020 }}</ref><ref>{{cite journal | vauthors = Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G | title = Real estimates of mortality following COVID-19 infection. | journal = The Lancet Infectious Diseases | date = March 2020 | doi = 10.1016/S1473-3099(20)30195-X | pmid = 32171390 | pmc = 7118515 }}</ref>\n\nConcerns have been raised about long-term [[sequela]]e of the disease. The [[Hong Kong Hospital Authority]] found a drop of 20% to 30% in lung capacity in some people who recovered from the disease, and lung scans suggested organ damage.<ref>{{cite web |last1=Cheung |first1=Elizabeth |name-list-format=vanc |title=Some recovered Covid-19 patients may have lung damage, doctors say |url=https://www.scmp.com/news/hong-kong/health-environment/article/3074988/coronavirus-some-recovered-patients-may-have |website=[[South China Morning Post]] |language=en |date=13 March 2020 |access-date=15 March 2020 |archive-url=https://web.archive.org/web/20200315172445/https://www.scmp.com/news/hong-kong/health-environment/article/3074988/coronavirus-some-recovered-patients-may-have |archive-date=15 March 2020 |url-status=live }}</ref>\n\n{| class=\"wikitable\"\n|+Case fatality rates (%) by age and country\n|-\n!Age\n!0\u20139\n!10\u201319\n!20\u201329\n!30\u201339\n!40\u201349\n!50\u201359\n!60\u201369\n!70\u201379\n!80-89\n!90+\n|-\n|China as of 11 February<ref name=\"Epidemiology2020Feb17\" />\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|1.3\n|style=\"text-align:center;\"|3.6\n|style=\"text-align:center;\"|8.0\n|colspan=\"2\" style=\"text-align:center;\"|14.8\n|-\n|Denmark as of 6 April<ref name=\"SSIReport\">{{cite report|url=https://www.ssi.dk/-/media/ssi-files/covid19-overvaagningsrapport-06042020-hu4v.pdf|title=COVID-19 i Danmark: Epidemiologisk overv\u00e5gningsrapport den 6. april 2020|date=6 April 2020|publisher=[[Statens Serum Institut]]|language=Danish|access-date=6 April 2020|url-status=live}}</ref>\n|colspan=\"6\" style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|3.2\n|style=\"text-align:center;\"|11.0\n|style=\"text-align:center;\"|20.3\n|style=\"text-align:center;\"|32.6\n|-\n|Italy as of 6 April<ref name=\"ISSReport\">{{cite report|url=https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_6-aprile-2020.pdf|title=Epidemia COVID-19. Aggiornamento nazionale 6 aprile 2020|last=|first=|date=6 April 2020|publisher=[[Istituto Superiore di Sanit\u00e0]]|issue=|doi=|location=Rome|volume=|language=Italian|pmid=|access-date=7 April 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|0.8\n|style=\"text-align:center;\"|2.3\n|style=\"text-align:center;\"|8.4\n|style=\"text-align:center;\"|22.7\n|style=\"text-align:center;\"|30.6\n|style=\"text-align:center;\"|26.8\n|-\n|Netherlands as of 3 April<ref name=\"RIVMReport\">{{cite report|url=https://www.rivm.nl/sites/default/files/2020-04/COVID-19_WebSite_rapport_20200406_1005_1.pdf|title=Epidemiologische situatie COVID-19 in Nederland 06 april 2020|date=6 April 2020|publisher=[[Netherlands National Institute for Public Health and the Environment|Rijksinstituut voor Volksgezondheid en Milie]]|location=Bilthoven|language=Dutch|access-date=6 April 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|1.2\n|style=\"text-align:center;\"|6.2\n|style=\"text-align:center;\"|16.0\n|style=\"text-align:center;\"|25.1\n|style=\"text-align:center;\"|22.0\n|-\n|South Korea as of 5 April<ref name=\"KCDCReport\">{{cite report|url=https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030|title=The updates on COVID-19 in Korea as of 5 April|date=5 April 2020|publisher=[[Korea Centers for Disease Control and Prevention]]|access-date=6 April 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.7\n|style=\"text-align:center;\"|1.9\n|style=\"text-align:center;\"|7.5\n|colspan=\"2\" style=\"text-align:center;\"|19.7\n|-\n|Spain as of 5 April<ref name=\"MSCBSReport\">{{cite report|url=https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_67_COVID-19.pdf|title=Actualizaci\u00f3n n\u00ba 67. Enfermedad por el coronavirus (COVID-19).|date=6 April 2020|publisher=[[Ministry of Health (Spain)|Ministerio de Sanidad, Consumo y Bienestar Social]]|language=Spanish|access-date=6 April 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.1\n|style=\"text-align:center;\"|0.2\n|style=\"text-align:center;\"|0.4\n|style=\"text-align:center;\"|0.9\n|style=\"text-align:center;\"|2.8\n|style=\"text-align:center;\"|9.4\n|style=\"text-align:center;\"|18.9\n|style=\"text-align:center;\"|22.9\n|}\n{| class=\"wikitable\"\n|+Case fatality rates (%) by age in the United States\n|-\n!Age\n!0\u201319\n!20\u201344\n!45\u201354\n!55\u201364\n!65\u201374\n!75\u201384\n!85+\n|-\n|United States as of 16 March<ref name=\"CDCMMWR18Mar2020\">{{cite journal|author=CDC COVID-19 Response Team|title=Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)\u2014United States, February 12 \u2013 March 16, 2020|url=https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm|journal=[[Morbidity and Mortality Weekly Report]]|volume=69|issue=12|pages=343\u2013346|date=18 March 2020|publisher=[[Centers for Disease Control]]|doi=10.15585/mmwr.mm6912e2|pmid=32214079|access-date=22 March 2020|archive-url=https://web.archive.org/web/20200322021219/https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm|archive-date=22 March 2020|url-status=live}}</ref>\n|style=\"text-align:center;\"|0.0\n|style=\"text-align:center;\"|0.1\u20130.2\n|style=\"text-align:center;\"|0.5\u20130.8\n|style=\"text-align:center;\"|1.4\u20132.6\n|style=\"text-align:center;\"|2.7\u20134.9\n|style=\"text-align:center;\"|4.3\u201310.5\n|style=\"text-align:center;\"|10.4\u201327.3\n|-\n| colspan=\"8\" |Note: The lower bound includes all cases. The upper bound excludes cases that were missing data.\n|}\n\n{| class=\"wikitable\"\n|+Estimate of infection fatality rates and probability of severe disease course (%) by age based on cases from China<ref>{{Cite journal|last=Verity|first=Robert|last2=Okell|first2=Lucy C|last3=Dorigatti|first3=Ilaria|last4=Winskill|first4=Peter|last5=Whittaker|first5=Charles|last6=Imai|first6=Natsuko|last7=Cuomo-Dannenburg|first7=Gina|last8=Thompson|first8=Hayley|last9=Walker|first9=Patrick G T|last10=Fu|first10=Han|last11=Dighe|first11=Amy|date=30 March 2020|title=Estimates of the severity of coronavirus disease 2019: a model-based analysis|journal=The Lancet Infectious Diseases|doi=10.1016/s1473-3099(20)30243-7|pmid=32240634|doi-access=free|issn=1473-3099}}</ref>\n|-\n!\n!0\u20139\n!10\u201319\n!20\u201329\n!30\u201339\n!40\u201349\n!50\u201359\n!60\u201369\n!70\u201379\n!80+\n|-\n!Severe disease\n|style=\"text-align:center;\"|0.0<br /><small>(0.0\u20130.0)</small>\n|style=\"text-align:center;\"|0.04<br /><small>(0.02\u20130.08)</small>\n|style=\"text-align:center;\"|1.0<br /><small>(0.62\u20132.1)</small>\n|style=\"text-align:center;\"|3.4<br /><small>(2.0\u20137.0)</small>\n|style=\"text-align:center;\"|4.3<br /><small>(2.5\u20138.7)</small>\n|style=\"text-align:center;\"|8.2<br /><small>(4.9\u201317)</small>\n|style=\"text-align:center;\"|11<br /><small>(7.0\u201324)</small>\n|style=\"text-align:center;\"|17<br /><small>(9.9\u201334)</small>\n|style=\"text-align:center;\"|18<br /><small>(11\u201338)</small>\n|-\n!Death\n|style=\"text-align:center;\"|0.0016<br /><small>(0.00016\u20130.025)</small>\n|style=\"text-align:center;\"|0.0070<br /><small>(0.0015\u20130.050)</small>\n|style=\"text-align:center;\"|0.031<br /><small>(0.014\u20130.092)</small>\n|style=\"text-align:center;\"|0.084<br /><small>(0.041\u20130.19)</small>\n|style=\"text-align:center;\"|0.16<br /><small>(0.076\u20130.32)</small>\n|style=\"text-align:center;\"|0.60<br /><small>(0.34\u20131.3)</small>\n|style=\"text-align:center;\"|1.9<br /><small>(1.1\u20133.9)</small>\n|style=\"text-align:center;\"|4.3<br /><small>(2.5\u20138.4)</small>\n|style=\"text-align:center;\"|7.8<br /><small>(3.8\u201313)</small>\n|-\n|colspan=10| Total infection fatality rate is estimated to be 0.66% (0.39\u20131.3). Infection fatality rate is fatality per all infected individuals, regardless of whether they were diagnosed or had any symptoms. Numbers in parentheses are 95% [[credible interval]]s for the estimates. \n|}\n\n===Reinfection===\n\nAs of March 2020, it was unknown if past infection provides effective and long-term [[Immunity (medical)|immunity]] in people who recover from the disease.<ref>{{cite web|url=https://www.immunology.org/news/bsi-open-letter-government-sars-cov-2-outbreak-response|title=BSI open letter to Government on SARS-CoV-2 outbreak response | publisher= British Society for Immunology|website= immunology.org|access-date=15 March 2020|archive-url= https://web.archive.org/web/20200314221816/https://www.immunology.org/news/bsi-open-letter-government-sars-cov-2-outbreak-response|archive-date=14 March 2020 |url-status=live}}</ref> Immunity is seen as likely, based on the behaviour of other coronaviruses,<ref>{{cite news| url= https://www.independent.co.uk/life-style/health-and-families/coronavirus-immunity-reinfection-get-covid-19-twice-sick-spread-relapse-a9400691.html |title= Can you get coronavirus twice or does it cause immunity?|date=13 March 2020|website=The Independent|language=en|access-date=15 March 2020|archive-url= https://web.archive.org/web/20200314211439/https://www.independent.co.uk/life-style/health-and-families/coronavirus-immunity-reinfection-get-covid-19-twice-sick-spread-relapse-a9400691.html|archive-date=14 March 2020|url-status=live}}</ref> but cases in which recovery from COVID-19 have been followed by positive tests for coronavirus at a later date have been reported.<ref>{{cite web|url=https://www.latimes.com/world-nation/story/2020-03-13/china-japan-korea-coronavirus-reinfection-test-positive|title=They survived the coronavirus. Then they tested positive again. Why?|date=13 March 2020|website=Los Angeles Times|language=en-US|access-date=15 March 2020|archive-url=https://web.archive.org/web/20200314220822/https://www.latimes.com/world-nation/story/2020-03-13/china-japan-korea-coronavirus-reinfection-test-positive|archive-date=14 March 2020|url-status=live}}</ref><ref>{{cite web |url= https://www.caixinglobal.com/2020-02-26/14-of-recovered-covid-19-patients-in-guangdong-tested-positive-again-101520415.html|title=14% of Recovered Covid-19 Patients in Guangdong Tested Positive Again| publisher= Caixin Global|website= caixinglobal.com|language=en|access-date=15 March 2020|archive-url= https://web.archive.org/web/20200303181249/https://www.caixinglobal.com/2020-02-26/14-of-recovered-covid-19-patients-in-guangdong-tested-positive-again-101520415.html|archive-date=3 March 2020|url-status=live}}</ref><ref name=\"Omer2020\">{{cite journal |last1=Omer |first1=SB |last2=Malani |first2=P |last3=del Rio |first3=C |title=The COVID-19 Pandemic in the US A Clinical Update |journal=JAMA |date= 6 April 2020 |doi=10.1001/jama.2020.5788|pmid=32250388 }}</ref> These cases are believed to be worsening of a lingering infection rather than re-infection.<ref name=\"Omer2020\"/>\n\n==History==\n\nThe virus is thought to be natural and have an [[zoonosis|animal origin]],<ref name=\"NM-20200317\">{{cite journal |vauthors=Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF |title=The proximal origin of SARS-CoV-2 |url=https://www.nature.com/articles/s41591-020-0820-9 |date=17 March 2020 |journal=[[Nature Medicine]] |pages=1\u20133 |doi=10.1038/s41591-020-0820-9 |issn=1546-170X |access-date=18 March 2020 |archive-url=https://web.archive.org/web/20200318001738/https://www.nature.com/articles/s41591-020-0820-9 |archive-date=18 March 2020 |url-status=live }}</ref> through [[spillover infection]].<ref>{{cite web|url=http://nautil.us/issue/83/intelligence/the-man-who-saw-the-pandemic-coming|title=The Man Who Saw the Pandemic Coming|last=Berger|first=Kevin|name-list-format=vanc|date=12 March 2020|website=Nautilus|access-date=16 March 2020|archive-url=https://web.archive.org/web/20200315180124/http://nautil.us/issue/83/intelligence/the-man-who-saw-the-pandemic-coming|archive-date=15 March 2020|url-status=live}}</ref> The origin is unknown but by December 2019 the spread of infection was almost entirely driven by human-to-human transmission.<ref name=\"Epidemiology2020Feb17\">{{cite journal|vauthors=Yanping Z, et al.|collaboration=The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team|title=The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)\u2014China, 2020|url=http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51|journal=China CDC Weekly|volume=2|issue=8|pages=113\u2013122|date=17 February 2020|publisher=[[Chinese Center for Disease Control and Prevention]]|access-date=18 March 2020|archive-url=https://web.archive.org/web/20200219142101/http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51|archive-date=19 February 2020|url-status=live}}</ref><ref name=\"Heymann Shindo 2020 pp. 542\u201345\">{{cite journal | vauthors=Heymann DL, Shindo N | title=COVID-19: what is next for public health? | journal=Lancet | volume=395 | issue=10224 | date=February 2020 | pmid=32061313 | doi=10.1016/S0140-6736(20)30374-3 | doi-access=free | pages=542\u201345 }}</ref> The earliest reported infection has been unofficially reported to have occurred on 17 November 2019 in [[2019\u201320 coronavirus pandemic in Hubei|Wuhan, China]].<ref name=Davidson13March2020>{{cite news |author= Davidson, Helen |date= 13 March 2020 |title= First Covid-19 case happened in November, China government records show\u2014report |url= https://www.theguardian.com/world/2020/mar/13/first-covid-19-case-happened-in-november-china-government-records-show-report |work= The Guardian |access-date= 21 March 2020 |archive-url= https://web.archive.org/web/20200320235432/https://www.theguardian.com/world/2020/mar/13/first-covid-19-case-happened-in-november-china-government-records-show-report |archive-date= 20 March 2020 |url-status= live }}</ref> A study of the first 41 cases of confirmed COVID-19, published in January 2020 in ''The Lancet'', revealed the earliest date of onset of symptoms as 1{{nbsp}}December 2019.<ref name=WuMarch2020>{{Cite journal|last=Wu|first=Yi-Chi|last2=Chen|first2=Ching-Sung|last3=Chan|first3=Yu-Jiun|date=March 2020|title=The outbreak of COVID-19: An overview|journal=Journal of the Chinese Medical Association|language=en-US|volume=83|issue=3|pages=217\u2013220|doi=10.1097/JCMA.0000000000000270|issn=1726-4901}}</ref><ref name=\"Wang24Jan2020\">{{cite journal |last1=Wang |first1=C. |last2=Horby |first2=P. W. |last3=Hayden |first3=F. G. |last4=Gao |first4=G. F. |title=A novel coronavirus outbreak of global health concern |journal=[[Lancet (journal)|Lancet]] |volume=395 |issue=10223 |pages=470\u2013473 |date=February 2020 |pmid=31986257 |doi=10.1016/S0140-6736(20)30185-9 |url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30185-9/abstract}} {{free access}}</ref><ref name=\"AutoDW-67\">{{Cite journal |last=Cohen |first=Jon |date=January 2020 |title=Wuhan seafood market may not be source of novel virus spreading globally |url=https://www.sciencemag.org/news/2020/01/wuhan-seafood-market-may-not-be-source-novel-virus-spreading-globally |journal=[[Science (journal)|Science]] |doi=10.1126/science.abb0611}}</ref> Official publications from the WHO reported the earliest onset of symptoms as 8{{nbsp}}December 2019.<ref name=Davidson13March2020/>\n\n==Epidemiology==\n\n{{main|2019\u201320 coronavirus pandemic}}\nSeveral measures are commonly used to quantify mortality.<ref>{{cite web|url=https://www.cdc.gov/csels/dsepd/ss1978/lesson3/section3.html|title=Principles of Epidemiology {{!}} Lesson 3\u2014Section 3|date=18 February 2019|website=www.cdc.gov|language=en-us|access-date=28 March 2020|archive-url=https://web.archive.org/web/20200228150607/https://www.cdc.gov/csels/dsepd/ss1978/lesson3/section3.html|archive-date=28 February 2020|url-status=live}}</ref> These numbers vary by region and over time and are influenced by the volume of testing, healthcare system quality, treatment options, time since initial outbreak and population characteristics such as age, sex and overall health.<ref>{{cite web |url=https://ourworldindata.org/covid-mortality-risk |title=What do we know about the risk of dying from COVID-19? |last=Ritchie |first=Hannah |last2=Roser |first2=Max |date=25 March 2020 |editor-last=Chivers |editor-first=Tom |website=[[Our World in Data]] |url-status=live |access-date=28 March 2020 |archive-url=https://web.archive.org/web/20200328192730/https://ourworldindata.org/covid-mortality-risk |archive-date=28 March 2020 }}</ref> In late 2019, WHO assigned the emergency [[ICD-10]] disease codes [[ICD-10 Chapter XXII: Codes for special purposes|U07.1]] for deaths from lab-confirmed SARS-CoV-2 infection and U07.2 for deaths from clinically or epidemiologically diagnosed COVID-19 without lab-confirmed SARS-CoV-2 infection.<ref name=\"ICD10_2019_U07p2\">{{cite web | title = ICD-10 Version:2019 | website = [[World Health Organization]] | quote = U07.2\u2014COVID-19, virus not identified\u2014COVID-19 NOS\u2014Use this code when COVID-19 is diagnosed clinically or epidemiologically but laboratory testing is inconclusive or not available. Use additional code, if desired, to identify pneumonia or other manifestations | year = 2019 | url = https://icd.who.int/browse10/2019/en#/U07.1 | accessdate = 2020-03-31 | archiveurl = https://archive.today/20200331004754/https://icd.who.int/browse10/2019/en%23/U07.1#/U07.1 | archivedate = 31 March 2020 | url-status = live | url-access = <!--(subscription/registration/limited) default=free--> }}</ref>\n\nThe death-to-case ratio reflects the number of deaths divided by the number of diagnosed cases within a given time interval. Based on Johns Hopkins University statistics, the global death-to-case ratio is {{Cases in 2019\u201320 coronavirus pandemic|ratio|editlink=|ref=no}} ({{Cases in 2019\u201320 coronavirus pandemic|deaths|editlink=|ref=no}}/{{Cases in 2019\u201320 coronavirus pandemic|confirmed|editlink=|ref=no}}) as of {{Cases in 2019\u201320 coronavirus pandemic|date|editlink=|ref=no}}.{{Cases in 2019\u201320 coronavirus pandemic|ref=yes}} The number varies by region.<ref>{{Cite journal |last=Lazzerini |first=Marzia |last2=Putoto |first2=Giovanni |date=18 March 2020 |title=COVID-19 in Italy: momentous decisions and many uncertainties |url=https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30110-8/abstract |journal=The Lancet Global Health |language=English |volume=0 |doi=10.1016/S2214-109X(20)30110-8 |issn=2214-109X |pmid=32199072|pmc=7104294 }}</ref>\n\nOther measures include the [[case fatality rate]] (CFR), which reflects the percent of diagnosed individuals who die from a disease, and the infection fatality rate (IFR), which reflects the percent of infected individuals (diagnosed and undiagnosed) who die from a disease. These statistics are not time bound and follow a specific population from infection through case resolution. A number of academics have attempted to calculate these numbers for specific populations.<ref>{{cite web |url=https://ourworldindata.org/covid-mortality-risk |title=What do we know about the risk of dying from COVID-19? |website=Our World in Data |access-date=28 March 2020 |archive-url=https://web.archive.org/web/20200328192730/https://ourworldindata.org/covid-mortality-risk |archive-date=28 March 2020 |url-status=live }}</ref> In the epicentre of the outbreak in Italy, Castiglione d'Adda, a small village of 4500, 80 (1.8%) are already dead. Most people in the village appear to have developed [[antibodies]] and plausible immunity, most did so without being diagnosed, and many did not have symptoms.<ref>{{cite web|url=http://www.ilcittadino.it/cronaca/2020/04/02/contagiati-senza-saperlo-all-avis-sono-ben-40-su-60/KYwVaGiHShP3odU4dY4zx3/index.html|title=Castiglione: contagiati senza saperlo, all'Avis sono ben 40 donatori su 60|website=Il Cittadino di Lodi|language=it|access-date=2020-04-05}}</ref><ref>{{cite web|url=https://www.ilgiornale.it/news/cronache/asintomatici-anticorpi-loro-plasma-cura-virus-1848999.html|title=Asintomatici, ma con anticorpi: dal loro plasma arriva la cura?|last=Bernasconi|first=Francesca|date=2020-04-02|website=ilGiornale.it|language=it|access-date=2020-04-05}}</ref> An investigation is underway to test the entire population to learn more about the disease.<ref>{{cite web|url=https://www.adnkronos.com/fatti/cronaca/2020/04/02/coronavirus-galli-pronti-test-tappeto-castiglione-adda_p1pDUsh8cd1En9PvyqTRWM.html|title=Coronavirus, Galli: \"Pronti a test a tappeto a Castiglione d'Adda\"|website=Adnkronos|access-date=2020-04-05}}</ref>\n<gallery mode=\"packed\" heights=\"210\">\nFile:Total-cases-covid-19-who.png|Total confirmed cases over time\nFile:Total-deaths-covid-19-who (1).png|Total deaths over time\nFile:Total-confirmed-cases-of-covid-19-per-million-people.png|Total confirmed cases of COVID-19 per million people, 20 March 2020<ref>{{cite web |title=Total confirmed cases of COVID-19 per million people |url=https://ourworldindata.org/grapher/total-confirmed-cases-of-covid-19-per-million-people |website=Our World in Data |access-date=20 March 2020 |archive-url=https://web.archive.org/web/20200319163452/https://ourworldindata.org/grapher/total-confirmed-cases-of-covid-19-per-million-people |archive-date=19 March 2020 |url-status=live }}</ref>\nFile:Total-covid-deaths-per-million.png|Total confirmed deaths due to COVID-19 per million people, 24 March 2020<ref>{{cite web |title=Total confirmed deaths due to COVID-19 per million people |url=https://ourworldindata.org/grapher/total-covid-deaths-per-million |website=Our World in Data |access-date=24 March 2020 |archive-url=https://web.archive.org/web/20200319163452/https://ourworldindata.org/grapher/total-covid-deaths-per-million |archive-date=19 March 2020 |url-status=live }}</ref>\n</gallery>\n\n==Society and culture==\n===Nomenclature===\n\nThe [[World Health Organization]] announced in February 2020 that COVID-19 is the official name of the disease. World Health Organisation chief [[Tedros Adhanom|Tedros Adhanom Ghebreyesus]] explained that ''CO'' stands for {{Em|corona}}, ''VI'' for {{Em|virus}} and ''D'' for {{Em|disease}}, while ''19'' is for when the outbreak was first identified: 31 December 2019.<ref>{{cite news |title=Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK\u2014sixth update |url=https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.pdf |access-date=26 March 2020 |publisher=ecdc |archive-url=https://web.archive.org/web/20200314223709/https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.pdf |archive-date=14 March 2020 |url-status=live }}</ref> The name had been chosen to avoid references to a specific geographical location (e.g. China), animal species or group of people, in line with international recommendations for naming aimed at preventing [[Social stigma|stigmatisation]].<ref>{{cite news |title=Novel coronavirus named 'Covid-19': WHO |url=https://www.todayonline.com/world/wuhan-novel-coronavirus-named-covid-19-who |access-date=11 February 2020 |publisher=TODAYonline |name-list-format=vanc |archive-url=https://archive.today/20200321085608/https://www.todayonline.com/world/wuhan-novel-coronavirus-named-covid-19-who |archive-date=21 March 2020 |url-status=live }}</ref><ref name=\"veconomist\">{{cite news|author= |title= The coronavirus spreads racism against\u2014and among\u2014ethnic Chinese|url= https://www.economist.com/china/2020/02/17/the-coronavirus-spreads-racism-against-and-among-ethnic-chinese|work= [[The Economist]]|date= 17 February 2020|access-date= 17 February 2020|archive-url= https://web.archive.org/web/20200217223902/https://www.economist.com/china/2020/02/17/the-coronavirus-spreads-racism-against-and-among-ethnic-chinese|archive-date= 17 February 2020|url-status= live| name-list-format = vanc}}</ref>\n\nThe virus that causes COVID-19 is named [[severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2).<ref name=\"WHO-naming\">{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it|title=Naming the coronavirus disease (COVID-19) and the virus that causes it|website=[[World Health Organization]] (WHO)|access-date=13 March 2020|archive-url=https://web.archive.org/web/20200228035651/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it|archive-date=28 February 2020|url-status=live}}</ref> The WHO additionally uses \"the COVID-19 virus\" and \"the virus responsible for COVID-19\" in public communications.<ref name=\"WHO-naming\" /> Coronaviruses were named in 1968 for their appearance in [[electron microscope|electron micrographs]] which was reminiscent of the [[solar corona]], [[:wikt:corona#Latin|''cor\u014dna'']] meaning crown in [[Latin]].<ref>{{cite journal|title=Virology: Coronaviruses|journal=Nature|volume=220|issue=5168|date=1968|page=650|issn=0028-0836|doi=10.1038/220650b0|bibcode=1968Natur.220..650.}}</ref><ref>{{citation |title= Definition of Coronavirus by Merriam-Webster |publisher= Merriam-Webster |url= https://www.merriam-webster.com/dictionary/coronavirus |access-date= 24 March 2020 |archive-url= https://web.archive.org/web/20200323161218/https://www.merriam-webster.com/dictionary/coronavirus |archive-date= 23 March 2020 |url-status= live }}</ref><ref>{{citation |title= Definition of Corona by Merriam-Webster |publisher= Merriam-Webster |url= https://www.merriam-webster.com/dictionary/corona |access-date= 24 March 2020 |archive-url= https://web.archive.org/web/20200324161709/https://www.merriam-webster.com/dictionary/corona |archive-date= 24 March 2020 |url-status= live }}</ref> Both the disease and virus are commonly referred to as \"coronavirus\".\n\nDuring the initial outbreak in Wuhan, China, the virus and disease were commonly referred to as \"coronavirus\" and \"Wuhan coronavirus\".<ref>{{cite web|url=https://www.npr.org/sections/health-shots/2020/01/24/799208865/a-second-u-s-case-of-wuhan-coronavirus-is-confirmed|title=2nd U.S. Case Of Wuhan Coronavirus Confirmed|website=NPR.org|language=en|access-date=2020-04-04}}</ref><ref>{{Cite news|last=Jr|first=Donald G. McNeil|url=https://www.nytimes.com/2020/02/02/health/coronavirus-pandemic-china.html|title=Wuhan Coronavirus Looks Increasingly Like a Pandemic, Experts Say|date=2020-02-02|work=The New York Times|access-date=2020-04-04|language=en-US|issn=0362-4331}}</ref><ref>{{cite news|url=https://www.cnn.com/2020/02/05/asia/wuhan-coronavirus-update-death-toll-spike-intl-hnk/index.html|title=Wuhan coronavirus deaths spike again as outbreak shows no signs of slowing|last=Griffiths|first=James|website=CNN|access-date=2020-04-04}}</ref> In January 2020, WHO recommended 2019-nCov<ref>{{cite web|url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf|title=Novel Coronavirus (2019-nCoV) SITUATION REPORT\u20141|last=|first=|date=21 January 2020|website=WHO|url-status=live|archive-url=|archive-date=|access-date=}}</ref> and 2019-nCoV acute respiratory disease<ref>{{cite web|url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf|title=Novel Coronavirus(2019-nCoV) Situation Report\u201410|last=|first=|date=30 January 2020|website=WHO|url-status=live|archive-url=|archive-date=|access-date=}}</ref> as interim names for the virus and disease in accordance with 2015 guidance against using locations in disease and virus names.<ref>{{cite web|url=https://apps.who.int/iris/bitstream/handle/10665/163636/WHO_HSE_FOS_15.1_eng.pdf|title=World Health Organization Best Practices for the Naming of New Human Infectious Diseases|last=|first=|date=May 2015|website=WHO|url-status=live|archive-url=|archive-date=|access-date=}}</ref> The official names COVID-19 and SARS-CoV-2 were issued on 11 February 2020.<ref>{{cite web|url=https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it|title=Naming the coronavirus disease (COVID-19) and the virus that causes it|website=www.who.int|language=en|access-date=2020-04-04}}</ref><ref>{{cite web|url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2|title=Novel Coronavirus(2019-nCoV) Situation Report\u201410|date=30 January 2020|website=[[World Health Organization]] (WHO)|url-status=live|archive-url=https://web.archive.org/web/20200131005409/https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf|archive-date=31 January 2020|access-date=15 March 2020}}</ref>\n\n===Manufacturing===\n\nDue to capacity limitations in the standard [[supply chain]]s, some digital manufacturers are [[3D printing|printing]] healthcare material such as nasal swabs and ventilator parts.<ref>{{cite news |last1=Temple |first1=James |title=How 3D printing could save lives in the coronavirus outbreak |url=https://www.technologyreview.com/s/615420/3d-printing-coronavirus-covid-19-medical-supplies-devices/ |accessdate=5 April 2020 |work=MIT Technology Review}}</ref><ref>{{cite news |last1=Tibken |first1=Shara |title=3D printing may help supply more essential coronavirus medical gear |url=https://www.cnet.com/news/3d-printing-may-help-supply-more-essential-coronavirus-medical-gear/ |accessdate=5 April 2020 |work=CNET |language=en}}</ref> In one example, when an Italian hospital urgently required a ventilator valve, and the supplier was unable to deliver in the timescale required, a local startup reverse-engineered and printed the required 100 valves overnight.<ref>{{cite news |title=[Updating] Italian hospital saves Covid-19 patients lives by 3D printing valves for reanimation devices |url=https://www.3dprintingmedia.network/covid-19-3d-printed-valve-for-reanimation-device/ |accessdate=20 March 2020 |work=3D Printing Media Network |date=14 March 2020}}</ref><ref>{{cite news |last1=Peters |first1=Jay |title=Volunteers produce 3D-printed valves for life-saving coronavirus treatments |url=https://www.theverge.com/2020/3/17/21184308/coronavirus-italy-medical-3d-print-valves-treatments |accessdate=20 March 2020 |work=The Verge |date=17 March 2020 |language=en}}</ref>\n\n===Misinformation===\n\n{{main|Misinformation related to the 2019\u201320 coronavirus pandemic}}\nAfter the initial [[2019\u201320 coronavirus pandemic|outbreak]] of COVID-19, conspiracy theories, [[misinformation]] and [[disinformation]] emerged regarding the origin, scale, prevention, treatment and other aspects of the disease and rapidly spread online.<ref name=\"bbc_misinfo\">{{Cite news |url=https://www.bbc.com/news/blogs-trending-51271037 |title=China coronavirus: Misinformation spreads online about origin and scale |date=30 January 2020 |work=[[BBC News]] |access-date=10 February 2020 |archive-url= https://web.archive.org/web/20200204163412/https://www.bbc.com/news/blogs-trending-51271037 |archive-date=4 February 2020 |url-status=live}}</ref><ref name=GUAR>{{cite newspaper | url=https://www.theguardian.com/world/2020/jan/31/bat-soup-dodgy-cures-and-diseasology-the-spread-of-coronavirus-bunkum | title=Bat soup, dodgy cures and 'diseasology': the spread of coronavirus misinformation | date=January 31, 2020 | accessdate=February 3, 2020 | first=Josh | last=Taylor | newspaper=[[The Guardian]] | archive-url=https://web.archive.org/web/20200202141231/https://www.theguardian.com/world/2020/jan/31/bat-soup-dodgy-cures-and-diseasology-the-spread-of-coronavirus-bunkum | archive-date=February 2, 2020 | url-status=live }}</ref><ref name=Lowy>{{Cite news|first=Natasha|last=Kassam|url=https://www.lowyinstitute.org/the-interpreter/disinformation-and-coronavirus|work=The Interpreter|publisher=Lowy Institute|title=Disinformation and coronavirus|date=March 25, 2020}}</ref><ref name=RunningList>{{cite web |url=https://www.buzzfeednews.com/article/janelytvynenko/coronavirus-disinformation-spread |title=Here's A Running List Of Disinformation Spreading About The Coronavirus |website=Buzzfeed News |access-date=February 8, 2020 |archive-url=https://web.archive.org/web/20200206212717/https://www.buzzfeednews.com/article/janelytvynenko/coronavirus-disinformation-spread |archive-date=February 6, 2020 |url-status=live }}</ref>\n\n==Research==\n\n{{Main|COVID-19 drug development}}\nInternational [[clinical research]] programs on vaccines and therapeutic drug candidates having potential to reduce illnesses caused by COVID-19 are underway by government organisations, academic groups and industry researchers.<ref name=\"dhama\">{{cite journal | vauthors=Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W | display-authors=6 | title=COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics | journal=Human Vaccines and Immunotherapeutics| date=March 2020 | issn=2164-5515 | pmid=32186952 | doi=10.1080/21645515.2020.1735227 | pages=1\u20137 | pmc=7103671 |doi-access=free}}</ref><ref name=\"zhang2020\">{{cite journal | vauthors=Zhang L, Liu Y | title=Potential interventions for novel coronavirus in China: A systematic review | journal=Journal of Medical Virology | volume=92 | issue=5 | date=March 2020 | issn=0146-6615 | doi=10.1002/jmv.25707 | pages=479\u201390 | pmid=32052466 }}</ref> In March, the [[World Health Organization]] initiated the \"[[Solidarity Trial|SOLIDARITY Trial]]\" in 10 countries, enrolling thousands of people infected with COVID-19 to assess treatment effects of four existing antiviral compounds with the most promise of efficacy.<ref name=\"kai\">{{cite journal|last1=Kupferschmidt|first1=Kai|last2=Cohen|first2=Jon| title=WHO launches global megatrial of the four most promising coronavirus treatments |journal=Science Magazine | date=22 March 2020 | url=https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-four-most-promising-coronavirus-treatments | access-date=27 March 2020|doi=10.1126/science.abb8497}}</ref>\n\nPersonal hygiene and a healthy lifestyle and [[Healthy diet|diet]] have been recommended to improve immunity.<ref>{{cite journal |last1=Wang |first1=Li-sheng |last2=Wang |first2=Yi-ru |last3=Ye |first3=Da-wei |last4=Liu |first4=Qing-quan |title=A review of the 2019 novel coronavirus (COVID-19) based on current evidence |journal=International Journal of Antimicrobial Agents |date=19 March 2020 |page=105948 |doi=10.1016/j.ijantimicag.2020.105948 |pmid=32201353 |url=https://www.sciencedirect.com/science/article/pii/S0924857920300984 |accessdate=27 March 2020 |language=en |issn=0924-8579 |archive-url=https://web.archive.org/web/20200327232545/https://www.sciencedirect.com/science/article/pii/S0924857920300984 |archive-date=27 March 2020 |url-status=live }}</ref>\n\n===Vaccine===\n\n{{main|COVID-19 vaccine}}\nThere is no available vaccine, but various agencies are actively developing vaccine candidates. Previous work on [[SARS-CoV]] is being utilised because SARS-CoV-2 and SARS-CoV both use the ACE2 receptor to enter human cells.<ref>{{cite book | vauthors=Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R | chapter=Features, Evaluation and Treatment Coronavirus (COVID-19) | title=StatPearls [Internet] | chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK554776/ |date=March 2020 | publisher=StatPearls |pmid= 32150360 | id=Bookshelf ID: NBK554776 }}</ref> There are three vaccination strategies being investigated. First, researchers aim to build a whole virus vaccine. The use of such a virus, be it [[inactivated vaccine|inactive]] or dead, aims to elicit a prompt [[immune response]] of the human body to a new infection with COVID-19. A second strategy, subunit vaccines, aims to create a vaccine that sensitises the immune system to certain subunits of the virus. In the case of SARS-CoV-2, such research focuses on the S-spike protein that helps the virus intrude the [[ACE2 enzyme]] receptor. A third strategy is that of the nucleic acid vaccines ([[DNA vaccination|DNA]] or [[RNA vaccines]], a novel technique for creating a vaccination). Experimental vaccines from any of these strategies would have to be tested for safety and efficacy.<ref name=\"Chen Strych Hotez Bottazzi p.\">{{cite journal | vauthors = Chen WH, Strych U, Hotez PJ, Bottazzi ME | title=The SARS-CoV-2 Vaccine Pipeline: an Overview | journal=Current Tropical Medicine Reports | date=3 March 2020 | pages=1\u20134 |doi=10.1007/s40475-020-00201-6 |doi-access=free | pmid=32219057 | pmc=7094941 | name-list-format = vanc}}</ref>\n\nOn 16 March 2020, the first clinical trial of a vaccine started with four volunteers in [[Seattle]]. The vaccine contains a harmless genetic code copied from the virus that causes the disease.<ref>{{Cite news |last=Roberts |first=Michelle |name-list-format=vanc |url=https://www.bbc.com/news/health-51906604 |title=Coronavirus: US volunteers test first vaccine |date=17 March 2020 |work=BBC News |access-date=17 March 2020 |language=en-GB |archive-url=https://web.archive.org/web/20200317034657/https://www.bbc.com/news/health-51906604 |archive-date=17 March 2020 |url-status=live }}</ref>\n\nA key challenge for vaccine development for SARS-COV-2, SARS-COV, and MERS-COV is the phenomenon of [[antibody dependent enhancement]].\n\n===Post-infection treatments===\n\n{{Main|COVID-19 drug repurposing research}}\nAccording to two organisations tracking clinical trial progress on potential therapeutic drugs for COVID-19 infections, 29 Phase II-IV efficacy trials were concluded in March 2020 or scheduled to provide results in April from hospitals in China &ndash; which experienced the first outbreak of COVID-19 in late 2019.<ref name=\"milken\">{{cite web |title=COVID-19 treatment and vaccine tracker |url=https://milkeninstitute.org/sites/default/files/2020-04/Covid19%20Tracker%20NEW4-2-20-final.pdf |publisher=Milken Institute |accessdate=2 April 2020 |date=2 April 2020 |lay-url=https://milkeninstitute.org/covid-19-tracker }}</ref><ref name=\"koch\">{{cite web |author1=Selina Koch |author2=Winnie Pong |title=First up for COVID-19: nearly 30 clinical readouts before end of April |url=https://www.biocentury.com/article/304658 |publisher=BioCentury Inc. |accessdate=1 April 2020 |date=13 March 2020}}</ref> Seven trials were evaluating repurposed drugs already approved to treat [[malaria]], including four studies on hydroxychloroquine or chloroquine phosphate.<ref name=koch/> Repurposed [[antiviral drug]]s make up most of the Chinese research, with nine Phase III trials on remdesivir across several countries due to report by the end of April.<ref name=milken/><ref name=koch/> Other potential therapeutic candidates under pivotal clinical trials concluding in March\u2013April are [[vasodilator]]s, [[corticosteroid]]s, [[immunotherapy|immune therapies]], [[lipoic acid]], [[bevacizumab]] and [[recombinant DNA|recombinant]] [[angiotensin-converting enzyme 2]], among others.<ref name=koch/>\n\nThe COVID-19 Clinical Research Coalition has goals to 1) facilitate rapid reviews of clinical trial proposals by [[ethics committee]]s and national regulatory agencies, 2) fast-track approvals for the candidate therapeutic compounds, 3) ensure standardised and rapid analysis of emerging efficacy and safety data and 4) facilitate sharing of clinical trial outcomes before publication.<ref name=\"coalition\">{{cite journal | title=Global coalition to accelerate COVID-19 clinical research in resource-limited settings | journal=The Lancet |author=COVID-19 Clinical Research Coalition| year=2020 | issn=0140-6736 | doi=10.1016/s0140-6736(20)30798-4 | pmid=32247324 |url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30798-4/fulltext#articleInformation}}</ref><ref name=\"maguire\">{{cite journal | last=Maguire | first=Brittany J. | last2=Gu\u00e9rin | first2=Philippe J. | title=A living systematic review protocol for COVID-19 clinical trial registrations | journal=Wellcome Open Research | volume=5 | date=2 April 2020 | issn=2398-502X | doi=10.12688/wellcomeopenres.15821.1 | page=60|url=https://wellcomeopenresearch.org/articles/5-60/v1}}</ref> A dynamic review of clinical development for COVID-19 vaccine and drug candidates was in place, as of April 2020.<ref name=maguire/>\n\nSeveral existing [[Antiviral drug|antiviral medications]] are being evaluated for treatment of COVID-19,<ref name=\"LiDeClerq\" /> including [[remdesivir]], [[chloroquine]] and [[hydroxychloroquine]], [[lopinavir/ritonavir]] and lopinavir/ritonavir combined with [[Interferon-beta|interferon beta]].<ref name=kai/><ref>{{cite web|url=https://news.un.org/en/story/2020/03/1059722|title=UN health chief announces global 'solidarity trial' to jumpstart search for COVID-19 treatment|date=18 March 2020|website=UN News|language=en|access-date=23 March 2020|archive-url=https://web.archive.org/web/20200323101633/https://news.un.org/en/story/2020/03/1059722|archive-date=23 March 2020|url-status=live}}</ref> There is tentative evidence for efficacy by remdesivir, as of March 2020.<ref>{{cite journal|vauthors=Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR|date=March 2020|title=Arguments in favor of remdesivir for treating SARS-CoV-2 infections|journal=International Journal of Antimicrobial Agents|page=105933|doi=10.1016/j.ijantimicag.2020.105933|pmid=32147516|doi-access=free}}</ref> Remdesivir inhibits SARS-CoV-2 ''[[in vitro]]''.<ref name=\"pmid32020029\">{{cite journal|display-authors=6|vauthors=Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G|date=February 2020 |title= Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro|journal=Cell Research |volume= 30| issue= 3|pages=269\u201371|doi=10.1038/s41422-020-0282-0|pmc=7054408|pmid=32020029|doi-access=free|name-list-format=vanc}}</ref> [[Phase 3 clinical trial]]s are being conducted in the U.S., China and Italy.<ref name=\"LiDeClerq\" /><ref name=milken/><ref>{{cite journal |last1=Beeching |first1=Nicholas J. |last2=Fletcher |first2=Tom E. |last3=Fowler |first3=Robert |name-list-format=vanc |date=2020 |title=BMJ Best Practices: COVID-19 |url= https://bestpractice.bmj.com/topics/en-gb/3000168/pdf/3000168/COVID-19.pdf |url-status=live |journal=BMJ |access-date=11 March 2020 |archive-url=https://web.archive.org/web/20200222170544/https://bestpractice.bmj.com/topics/en-gb/3000168/pdf/3000168/COVID-19.pdf |archive-date=22 February 2020 }}</ref>\n\nChloroquine, previously used to treat [[malaria]], was studied in China in February 2020, with preliminary results.<ref name=\"JianjunZhXu_chloroquine\">{{cite journal | vauthors = Gao J, Tian Z, Yang X | title = Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies | journal = Bioscience Trends | volume = 14 | pages = 72\u201373 | date = February 2020 | issue = 1 | pmid = 32074550 |doi=10.5582/bst.2020.01047 |doi-access=free | name-list-format = vanc}}</ref> However, there are calls for peer review of the research.<ref>{{cite journal | vauthors = Touret F, de Lamballerie X | title = Of chloroquine and COVID-19 | journal = Antiviral Research | volume = 177 | page = 104762 | date = March 2020 | pmid = 32147496 | doi = 10.1016/j.antiviral.2020.104762 }}</ref> The Guangdong Provincial Department of Science and Technology and the Guangdong Provincial Health and Health Commission issued a report stating that chloroquine phosphate \"improves the success rate of treatment and shortens the length of person's hospital stay\" and recommended it for people diagnosed with mild, moderate and severe cases of novel coronavirus pneumonia.<ref>{{cite journal | title = [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia] | journal = Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases | volume = 43 | pages = E019 | date = February 2020 | pmid = 32075365 | doi = 10.3760/cma.j.issn.1001-0939.2020.0019 | author1 = multicenter collaboration group of Department of Science Technology of Guangdong Province Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia }}</ref>\n\nOn 17 March, the Italian Pharmaceutical Agency included chloroquine and hydroxychloroquine in the list of drugs with positive preliminary results for treatment of COVID-19.<ref name=\":15\">{{cite web|url=https://aifa.gov.it/-/azioni-intraprese-per-favorire-la-ricerca-e-l-accesso-ai-nuovi-farmaci-per-il-trattamento-del-covid-19|title=Azioni intraprese per favorire la ricerca e l'accesso ai nuovi farmaci per il trattamento del COVID-19 |website= aifa.gov.it|language=it-IT|access-date=18 March 2020}}</ref> Korean and Chinese Health Authorities recommend the use of [[chloroquine]].<ref>{{cite web|url=http://m.koreabiomed.com/news/articleView.html?idxno=7428|title=Physicians work out treatment guidelines for coronavirus|date=13 February 2020|website=m.koreabiomed.com|language=Korean|name-list-format=vanc|access-date=10 March 2020|archive-url= https://web.archive.org/web/20200317061347/http://m.koreabiomed.com/news/articleView.html?idxno=7428|archive-date=17 March 2020|url-status=live}}</ref><ref name=\":9\">{{cite web|url=https://www.chinalawtranslate.com/en/coronavirus-treatment-plan-7/|title=Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Provisional 7th Edition)|date=4 March 2020|website=China Law Translate|name-list-format=vanc|access-date=10 March 2020|archive-url= https://web.archive.org/web/20200310082919/https://www.chinalawtranslate.com/en/coronavirus-treatment-plan-7/|archive-date=10 March 2020|url-status=live}}</ref> However, the Wuhan Institute of Virology, while recommending a daily dose of one gram, notes that twice that dose is highly dangerous and could be lethal. On 28 March 2020, the [[Food and Drug Administration|FDA]] issued an [[emergency use authorisation]] for hydroxychloroquine and chloroquine at the discretion of physicians treating people with COVID-19.<ref name=\"hinton\">{{cite web |author1=Denise M Hinton |title=Request for Emergency Use Authorization For Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease |url=https://www.fda.gov/media/136534/download |publisher=US Food and Drug Administration |accessdate=30 March 2020 |date=28 March 2020 |archive-url=https://web.archive.org/web/20200330074008/https://www.fda.gov/media/136534/download |archive-date=30 March 2020 |url-status=live }}</ref><ref>{{cite web |last1=Commissioner |first1=Office of the |title=Emergency Use Authorization |url=https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization |website=FDA |accessdate=30 March 2020 |language=en |date=29 March 2020 |archive-url=https://web.archive.org/web/20200305013118/https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization |archive-date=5 March 2020 |url-status=live }}</ref>\n\nThe Chinese 7th edition guidelines also include [[interferon]], [[ribavirin]] or [[umifenovir]] for use against COVID-19.<ref name=\":9\" />\n\nIn 2020, a trial found that lopinavir/ritonavir was ineffective in the treatment of severe illness.<ref>{{cite journal | vauthors = Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C | display-authors = 6 | title = A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 | journal = The New England Journal of Medicine | date = March 2020 | pmid = 32187464 | doi = 10.1056/NEJMoa2001282 | pmc = 7121492 }}</ref> [[Nitazoxanide]] has been recommended for further ''[[in vivo]]'' study after demonstrating low concentration inhibition of SARS-CoV-2.<ref name=\"pmid32020029\" />\n\nStudies have demonstrated that initial spike protein priming by transmembrane protease serine{{nbsp}}2 ([[TMPRSS2]]) is essential for entry of SARS-CoV-2 via interaction with the [[ACE2]] receptor.<ref>{{cite journal | vauthors = Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N | title = TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection | journal = Journal of Virology | volume = 93 | issue = 6 | date = March 2019 | pmid = 30626688 | pmc = 6401451 | doi = 10.1128/JVI.01815-18 | doi-access = free }}</ref> These findings suggest that the TMPRSS2 inhibitor [[camostat]] approved for use in Japan for inhibiting fibrosis in liver and kidney disease might constitute an effective off-label treatment.\n\nIn February 2020, [[favipiravir]] was being studied in China for experimental treatment of the emergent COVID-19 disease.<ref>Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). ''Nature Reviews Drug Discovery'' 2020 Feb {{doi|10.1038/d41573-020-00016-0}}</ref><ref>[https://www.reuters.com/article/brief-corrected-zhejiang-hisun-pharma-ge/brief-corrected-zhejiang-hisun-pharma-gets-approval-for-clinical-trial-to-test-flu-drug-favipiravir-for-pneumonia-caused-by-new-coronavirus-idUSL4N2AH0C8 BRIEF-Corrected-Zhejiang Hisun Pharma gets approval for clinical trial to test flu drug Favipiravir for pneumonia caused by new coronavirus] {{Webarchive|url=https://web.archive.org/web/20200318220901/https://www.reuters.com/article/brief-corrected-zhejiang-hisun-pharma-ge/brief-corrected-zhejiang-hisun-pharma-gets-approval-for-clinical-trial-to-test-flu-drug-favipiravir-for-pneumonia-caused-by-new-coronavirus-idUSL4N2AH0C8 |date=18 March 2020 }}. Reuters Healthcare, 16 February 2020.</ref>\n\nIn April 2020 [[ivermectin]] is being studied in Australia for a possible treatment for COVID-19 and has been shown to stop viral growth within 48 hours in vitro.<ref>{{Cite journal|url=http://www.sciencedirect.com/science/article/pii/S0166354220302011|title=The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro|first1=Leon|last1=Caly|first2=Julian D.|last2=Druce|first3=Mike G.|last3=Catton|first4=David A.|last4=Jans|first5=Kylie M.|last5=Wagstaff|date=3 April 2020|journal=Antiviral Research|page=104787|via=ScienceDirect|doi=10.1016/j.antiviral.2020.104787|pmid=32251768}}</ref><ref>{{cite web|website=Monash Biomedicine Discovery Institute|title= Possible coronavirus drug identified by Monash University scientists |url=https://www.monash.edu/discovery-institute/news-and-events/news/2020-articles/possible-coronavirus-drug-identified-by-monash-university-scientists |date=3 April 2020|access-date= 7 April 2020}}</ref>\n\nThere are mixed results as of April 3 as to the effectiveness of [[hydroxychloroquine]] as a treatment for COVID-19. With studies showing little to no improvement over the control groups.<ref>{{cite news |last1=Seley-Radtke |first1=Katherine |title=Professor of Chemistry and Biochemistry and President-Elect of the International Society for Antiviral Research, University of Maryland, Baltimore County |url=https://theconversation.com/a-small-trial-finds-that-hydroxychloroquine-is-not-effective-for-treating-coronavirus-135484 |accessdate=5 April 2020 |publisher=The Conversation |date=3 April 2020}}</ref>\n\n===Anti-cytokine storm===\n\n[[Cytokine release syndrome|Cytokine storm]] can be a complication in the later stages of severe COVID-19. There is evidence that [[hydroxychloroquine]] may have anti-cytokine storm properties.<ref name=\"pmid32150618\">{{cite journal |vauthors=Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D |title=In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |journal=Clin. Infect. Dis. |volume= |issue= |pages= |date=March 2020 |pmid=32150618 |doi=10.1093/cid/ciaa237 |pmc=7108130 }}</ref>\n\n[[Tocilizumab]] has been included in treatment guidelines by China's [[National Health Commission]] after a small study was completed.<ref name=\"tocil-1\">{{cite news|last1=Liu|first1=Roxanne|last2=Miller|first2=Josh|name-list-format=vanc|url=https://www.reuters.com/article/us-health-coronavirus-china-roche-hldg/china-approves-use-of-roche-arthritis-drug-for-coronavirus-patients-idUSKBN20R0LF|title=China approves use of Roche drug in battle against coronavirus complications|date=3 March 2020|work=[[Reuters]]|access-date=14 March 2020|archive-url=https://web.archive.org/web/20200312204625/https://www.reuters.com/article/us-health-coronavirus-china-roche-hldg/china-approves-use-of-roche-arthritis-drug-for-coronavirus-patients-idUSKBN20R0LF|archive-date=12 March 2020|url-status=live}}</ref><ref name=\"tocil-2\">{{cite document |date=5 March 2020 |title=Effective Treatment of Severe COVID-19 Patients with Tocilizumab |url=http://chinaxiv.org/abs/202003.00026 |publisher=ChinaXiv.org |doi=10.12074/202003.00026|doi-broken-date=2020-03-16 |accessdate=14 March 2020|journal=|archive-url=https://web.archive.org/web/20200319022047/http://chinaxiv.org/abs/202003.00026|archive-date=19 March 2020|url-status=live}}</ref> It is undergoing a [[Phase IIb|phase{{nbsp}}2]] non randomised test at the national level in Italy after showing positive results in people with severe disease.<ref name=\":15\" /><ref name=\"tocil-3\">{{cite web|url=http://www.ansa.it/english/news/general_news/2020/03/13/3-patients-get-better-on-arthritis-drug_90d4764d-d93f-463e-ab07-168b34b084d0.html|title=3 patients get better on arthritis drug|date=5 March 2020|accessdate=14 March 2020|archive-url=https://web.archive.org/web/20200319022045/http://www.ansa.it/english/news/general_news/2020/03/13/3-patients-get-better-on-arthritis-drug_90d4764d-d93f-463e-ab07-168b34b084d0.html|archive-date=19 March 2020|url-status=live}}</ref><ref name=\"tocil-4\">{{cite news|url=https://www.ilmessaggero.it/italia/coronavirus_farmaco_artrite_ultime_notizie_news_napoli-5109045.html|title=Coronavirus, via libera dell'Aifa al farmaco anti-artrite efficace su 3 pazienti e a un antivirale: test in 5 centri|trans-title=Coronavirus, Aifa gives go-ahead to effective anti-arthritis drug on 3 patients and an antiviral: test in 5 centers|newspaper=[[Il Messaggero]]|language=it|accessdate=14 March 2020|archive-url=https://web.archive.org/web/20200319022047/https://www.ilmessaggero.it/italia/coronavirus_farmaco_artrite_ultime_notizie_news_napoli-5109045.html|archive-date=19 March 2020|url-status=live}}</ref>{{MEDRS|date=March 2020}} Combined with a [[Ferritin|serum ferritin blood test]] to identify [[Cytokine release syndrome|cytokine storms]], it is meant to counter such developments, which are thought to be the cause of death in some affected people.<ref name=\"tocil-5\">{{cite web|url=https://www.vox.com/2020/3/12/21176783/coronavirus-covid-19-deaths-china-treatment-cytokine-storm-syndrome|title=How doctors can potentially significantly reduce the number of deaths from Covid-19|publisher=[[Vox (website)|Vox]]|accessdate=14 March 2020|date=12 March 2020|archive-url=https://web.archive.org/web/20200319155218/https://www.vox.com/2020/3/12/21176783/coronavirus-covid-19-deaths-china-treatment-cytokine-storm-syndrome|archive-date=19 March 2020|url-status=live}}</ref><ref name=\"tocil-6\">{{cite journal | vauthors = Ruan Q, Yang K, Wang W, Jiang L, Song J | title = Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China | journal = Intensive Care Medicine | date = March 2020 | pmid = 32125452 | doi = 10.1007/s00134-020-05991-x | pmc = 7080116 }}</ref><ref name=\"tocil-8\">{{cite journal |display-authors=3 |vauthors=Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ |title=COVID-19: consider cytokine storm syndromes and immunosuppression |journal=[[The Lancet]] |date=16 March 2020 |volume=395 |issue=10229 |pages=1033\u20131034 |doi=10.1016/S0140-6736(20)30628-0 |pmid=32192578 |url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext |access-date=19 March 2020 |archive-url=https://web.archive.org/web/20200322045751/https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext |archive-date=22 March 2020 |url-status=live }}</ref> The [[Interleukin 6|interleukin-6]] [[receptor antagonist]] was approved by the [[Food and Drug Administration|FDA]] based on retrospective case studies for treatment of steroid refractory cytokine release syndrome induced by a different cause, [[Chimeric antigen receptor T cell|CAR T cell]] [[Gene therapy|therapy]], in 2017.<ref name=\"tocil-7\">{{cite web|url=https://www.fiercepharma.com/pharma-asia/china-turns-roche-arthritis-drug-actemra-against-covid-19-new-treatment-guidelines|title=China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines|publisher=FiercePharma|accessdate=14 March 2020|archive-url=https://web.archive.org/web/20200319022042/https://www.fiercepharma.com/pharma-asia/china-turns-roche-arthritis-drug-actemra-against-covid-19-new-treatment-guidelines|archive-date=19 March 2020|url-status=live}}</ref>{{MEDRS|date=March 2020}} To date, there is no randomised, controlled evidence that [[tocilizumab]] is an efficacious treatment for CRS. Prophylactic [[tocilizumab]] has been shown increase serum IL-6 levels by saturating the IL-6R, driving IL-6 across the blood brain barrier and exacerbating neurotoxicity while having no impact on incidence of CRS.<ref>{{cite journal | vauthors = Locke F et al | display-authors = 1 | title = Preliminary Results of Prophylactic Tocilizumab after Axicabtageneciloleucel (axi-cel; KTE-C19) Treatment for Patients with Refractory,Aggressive Non-Hodgkin Lymphoma (NHL) | journal = Blood | date = 2017 | url = https://ashpublications.org/blood/article/130/Supplement%201/1547/79746}}</ref>\n\n[[Lenzilumab]], an anti-GM-CSF monoclonal antibody, has been shown to be protective in murine models for [[Chimeric antigen receptor T cell|CAR T cell]] induced CRS and neurotoxicity and is a viable therapeutic option due to the observed increase of pathogenic GM-CSF secreting T-cells in hospitalised patients with COVID-19.<ref>{{cite journal | vauthors = Sterner RM et al. | display-authors = 1 | title = GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts. | journal = Blood. | date = 2019 | pmid = 30463995 | doi = 10.1182/blood-2018-10-881722 | volume = 133 | issue = 7 | pmc = 6376281 | pages = 697\u2013709}}</ref>\n\nThe [[Feinstein Institute for Medical Research|Feinstein Institute]] of [[Northwell Health]] announced in March a study on \"a human antibody that may prevent the activity\" of IL-6.<ref>{{cite news|url=https://www.longislandpress.com/2020/03/21/northwell-health-initiates-clinical-trials-of-2-covid-19-drugs/|title=Northwell Health Initiates Clinical Trials of 2 COVID-19 Drugs|date=21 March 2020|accessdate=23 March 2020|archive-url=https://web.archive.org/web/20200323081238/https://www.longislandpress.com/2020/03/21/northwell-health-initiates-clinical-trials-of-2-covid-19-drugs/|archive-date=23 March 2020|url-status=live}}</ref>\n\n===Passive antibody therapy===\n\nTransferring purified and concentrated [[Immunoglobulin therapy|antibodies]] produced by the [[immune system]]s of those who have recovered from COVID-19 to people who need them is being investigated as a non-vaccine method of [[Passive immunity|passive immunisation]].<ref name=\"pmid-32167489\">{{cite journal | vauthors = Casadevall A, Pirofski LA | title = The convalescent sera option for containing COVID-19 | journal = The Journal of Clinical Investigation | date = March 2020 | volume = 130 | issue = 4 | pages = 1545\u20131548 | pmid = 32167489 | doi = 10.1172/JCI138003 | pmc = 7108922 }}</ref> This strategy was tried for SARS with inconclusive results.<ref name=\"pmid-32167489\" /> [[Neutralisation (immunology)|Viral neutralisation]] is the anticipated [[mechanism of action]] by which passive antibody therapy can mediate defence against SARS-CoV-2. Other mechanisms however, such as [[antibody-dependent cellular cytotoxicity]] and/or [[phagocytosis]], may be possible.<ref name=\"pmid-32167489\" /> Other forms of passive antibody therapy, for example, using manufactured [[Monoclonal antibody|monoclonal antibodies]], are in development.<ref name=\"pmid-32167489\" /> Production of [[convalescent serum]], which consists of the liquid portion of the blood from recovered patients and contains antibodies specific to this virus, could be increased for quicker deployment.<ref name=\"Pearce-2020-03-13\">{{cite web |last=Pearce |first=Katie |name-list-format=vanc |date=13 March 2020 |title=Antibodies from COVID-19 survivors could be used to treat patients, protect those at risk: Infusions of antibody-laden blood have been used with reported success in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic |work=The Hub at Johns Hopkins University |url=https://hub.jhu.edu/2020/03/13/covid-19-antibody-sera-arturo-casadevall/ |accessdate=14 March 2020 |archive-url=https://web.archive.org/web/20200314185825/https://hub.jhu.edu/2020/03/13/covid-19-antibody-sera-arturo-casadevall/ |archive-date=14 March 2020 |url-status=live }}</ref>\n\n==See also==\n\n* {{annotated link|Coronavirus Act 2020}}\n* [[Coronavirus Aid, Relief, and Economic Security Act]], a US law\n* [[Coronavirus disease]]s, a group of closely related syndromes\n* [[Coronavirus recession]]\n* [[Disease X]], a WHO term\n* [[Li Wenliang]], a doctor at [[Central Hospital of Wuhan]], who later contracted and died of COVID-19 after raising awareness of the spread of the virus.\n* [[:Template:2019\u201320 coronavirus pandemic]] for conditions in various countries\n\n==Notes==\n\n{{notelist}}\n\n==References==\n\n{{reflist|refs=\n<ref name=\"Reut_NIH_Moderna_3months\">{{cite news | last1= Steenhuysen | first1= Julie | last2= Kelland | first2= Kate | name-list-format = vanc | title= With Wuhan virus genetic code in hand, scientists begin work on a vaccine | date= 24 January 2020 | agency= [[Reuters]] | url= https://www.reuters.com/article/us-china-health-vaccines-idUSKBN1ZN2J8 |accessdate=25 January 2020 |archive-url= https://web.archive.org/web/20200125203723/https://www.reuters.com/article/us-china-health-vaccines-idUSKBN1ZN2J8 |archive-date= 25 January 2020 |url-status=live }}</ref>\n}}\n\n==External links==\n\n{{Portalbar|border=n|Coronavirus disease 2019 | Medicine | Viruses}}\n{{Sister project links|wikt=COVID-19|c=category:COVID-19|n=category:COVID-19|q=COVID-19|s=category:COVID-19|voy=2019\u20132020 coronavirus pandemic|v=COVID-19|b=no}}\n{{Scholia|topic}}\n* [https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Coronavirus disease (COVID-19)] by the [[World Health Organization]]\n* [https://www.cdc.gov/coronavirus/2019-ncov/index.html Coronavirus 2019 (COVID-19)] by the [[Centers for Disease Control and Prevention|U.S. Centers for Disease Control and Prevention]]\n* {{Curlie|Health/Conditions_and_Diseases/Respiratory_Disorders/COVID-19|COVID-19}}\n* [https://openmd.com/directory/covid-19 COVID-19 Resource Directory on OpenMD]\n* [https://jamanetwork.com/journals/jama/pages/coronavirus-alert Coronavirus Disease 2019 (COVID-19)] by ''[[JAMA (journal)|JAMA]]''\n* [https://www.bmj.com/coronavirus Coronavirus: News and Resources] by the [[BMJ (company)|BMJ Publishing Group]]\n* [https://www.elsevier.com/connect/coronavirus-information-center Novel Coronavirus Information Center] by [[Elsevier]]\n* [https://www.thelancet.com/coronavirus COVID-19 Resource Centre] by ''[[The Lancet]]''\n* [https://www.springernature.com/gp/researchers/campaigns/coronavirus SARS-CoV-2 and COVID-19] by ''[[Nature (journal)|Nature]]''\n* [https://www.nejm.org/coronavirus Coronavirus (Covid-19)] by the ''[[New England Journal of Medicine]]''\n* [https://novel-coronavirus.onlinelibrary.wiley.com/ Covid-19: Novel Coronavirus] by [[Wiley (publisher)|Wiley Publishing]]\n* [http://gabgoh.github.io/COVID/index.html Epidemiology simulator]<!--referenced by https://medium.com/@tomaspueyo/coronavirus-the-hammer-and-the-dance-be9337092b56 , in turn endorsed by hundreds of experts https://medium.com/tomas-pueyo/coronavirus-articles-endorsements-fdc68614f8e3-->\n\n{{medical resources| ICD10 = {{ICD10|U07.1}}, {{ICD10|U07.2}}}}\n{{Respiratory pathology}}\n{{Viral diseases}}\n{{2019\u201320 coronavirus pandemic}}\n{{Authority control}}\n\n[[Category:COVID-19| ]]\n[[Category:Occupational safety and health]]\n[[Category:Viral respiratory tract infections]]\n[[Category:Zoonoses]]\n", "name_user": "Jo3sampl", "label": "safe", "comment": "\u2192\u200eImmunopathology:Copyedit (minor)", "url_page": "//en.wikipedia.org/wiki/Coronavirus_disease_2019"}
{"title_page": "Orlaith Carmody", "text_new": "{{Infobox person\n| name               = Orlaith Carmody\n| image              = \n| birth_name         = \n| birth_date         = \n| birth_place        = [[Kilmacud]], [[Dublin]], Ireland\n| death_date         = \n| death_place        = \n| nationality        = [[Irish people|Irish]]\n| spouse             = Kieran Gleeson<br>{{small|(m. 1983; died. 1989)}}<br>[[Gavin Duffy]] {{small|(m. 1993)}}\n| children           = 4\n| occupation         = {{Hlist|[[Author]]|[[Journalist]]}}\n| boards             = {{Hlist|HRM|[[RT\u00c9]]|Ablevision Ireland|HCCI}}\n| alma_mater         = {{Ubl|[[Dublin Institute of Technology]]|[[Dublin City University]]}}\n| website            = {{url|gavinduffyandassociates.com|Official website}}|\n}}\n'''Orlaith Carmody''' is an Irish businesswoman, [[author]], [[News reporter]]<ref>{{cite web|title=Women told networking is vital in order to grow your own business|url=http://www.belfasttelegraph.co.uk/business/news/women-told-networking-is-vital-in-order-to-grow-your-own-business-28792517.html|website=[[Belfast Telegraph]]|accessdate=21 December 2015}}</ref> and co-founder of Gavin Duffy and Associates (formerly Media Training),<ref name=ad>{{cite web|title=Learn how to perform as a leader|url=http://www.advertiser.ie/galway/article/81545/learn-how-to-perform-as-a-leader|website=[[Galway Advertiser]]|accessdate=21 December 2015}}</ref> along with her husband and business partner, ''[[Dragons' Den]]'' investor [[Gavin Duffy]].<ref>{{cite web|title=TV's Gavin Duffy takes off pounds to help would-be entrepreneurs put on \u20acuro|url=http://www.irishmirror.ie/whats-on/film-and-tv/tvs-gavin-duffy-takes-pounds-3273040|website=[[Irish Mirror]]|accessdate=21 December 2015}}</ref>\n\n== Career ==\nCarmody was previously a newscaster and reporter at [[LMFM]] and [[Century Radio]].<ref>{{cite web|title=If it wasn't for the hen parties, I'd have quit the Den \u2013 Duffy - Herald.ie|url=http://www.herald.ie/news/if-it-wasnt-for-the-hen-parties-id-have-quit-the-den-duffy-30318118.html|website=[[The Herald (Ireland)|The Herald]]|accessdate=21 December 2015}}</ref><ref name=ie>{{cite web|title=From broken wings to soaring high - former journalist Orlaith Carmody - Independent.ie|url=http://www.independent.ie/entertainment/books/from-broken-wings-to-soaring-high-former-journalist-orlaith-carmody-31538626.html|website=[[Irish Independent]]|accessdate=21 December 2015}}</ref> As a Director of Aerga Productions,<ref>{{cite web|title='Am I giving my children an advantage? I'm trying my hardest'|url=http://www.irishtimes.com/news/education/am-i-giving-my-children-an-advantage-i-m-trying-my-hardest-1.747230|website=[[The Irish Times]]|accessdate=21 December 2015|language=en-US}}</ref> she won a Screen Training Ireland bursary to attend the Entertainment Master Class international media leadership programme.<ref>{{cite web|url=http://www.independent.ie/regionals/droghedaindependent/news/local-production-company-secures-major-bursary-27146903.html |publisher=[[Irish Independent]]|title=Local Producer wins place on the prestigious Entertainment Master Class.}}</ref><ref>{{cite web |url=http://www.businessandleadership.com/leadership/item/41255-women-in-the-boardroom-orl |title=RTE Board Members - Orlaith Carmody |url-status=dead |archiveurl=https://web.archive.org/web/20131221132704/http://businessandleadership.com/leadership/item/41255-women-in-the-boardroom-orl |archivedate=2013-12-21 }}</ref> She spoke at TEDxTallaght in 2013,<ref>{{cite web|title=Find a Customer not a Job: Orlaith Carmody at TEDxTallaght|url=http://tedxtalks.ted.com/video/Find-a-Customer-not-a-Job-Orlai|website=[[Ted.com]]|accessdate=21 December 2015}}</ref> TEDxDCU in 2015<ref>{{cite web|title=Give Your Family The World |url=http://tedxtalks.ted.com/video/Give-Your-Family-The-World-Orla|website=Ted.com|accessdate=21 December 2015}}</ref><ref>{{cite web|title=TEDxDCU Changing Lives, Challenging Perceptions|url=https://www.dcu.ie/news/2015/jan/s0115c.shtml|website=[[Dublin City University]]|accessdate=21 December 2015}}</ref> and at the SME Assembly 2014 in [[Naples]], [[Italy]].<ref>{{cite web|url=http://blogs.ec.europa.eu/promotingenterprise/the-2014-sme-assembly-programme/ |title=2014 SME Assembly - The Big Debate}}</ref>\n\nCarmody was a board member of [[RT\u00c9]] from 2010 until 2015,<ref>{{cite web |url=http://www.personallyspeakingbureau.com/speaker/orlaith-carmody/ |title=Orlaith Carmody - Personally Speaking Bureau |accessdate=27 April 2016}}</ref>/<ref>{{cite web|title=Why broads on the board can be good for profits - Independent.ie|url=http://www.independent.ie/business/why-broads-on-the-board-can-be-good-for-profits-29229986.html|website=[[Irish Independent]]|accessdate=21 December 2015}}</ref><ref>{{cite web|title=Rabbitte to discuss report with RT\u00c9 board|url=http://www.irishtimes.com/news/rabbitte-to-discuss-report-with-rt%C3%A9-board-1.516451|website=[[The Irish Times]]|accessdate=21 December 2015|language=en-US}}</ref> HRM Recruit,<ref>{{cite web|title=I don't horse around with my money|url=http://www.thesundaytimes.co.uk/sto/news/ireland/Business/article1623522.ece|website=[[The Sunday Times]]|accessdate=21 December 2015}}</ref> and Ablevision Ireland,<ref>{{cite web|title=Ablevision launch - Independent.ie|url=http://www.independent.ie/regionals/droghedaindependent/news/ablevision-launch-27166906.html|website=[[Irish Independent]]|accessdate=21 December 2015}}</ref> and is a founder member and president 2014\u201315 of the Irish chapter of the International [[Entrepreneurs' Organization]] (EO).<ref name=ad /> She is Chairperson of Home and Community Care Ireland (HCCI), a fellow of the Irish Institute of Training and Development and a member of the Institute of Directors.<ref>{{cite web |title=Orlaith Carmody Chairperson of HCCI |url=https://www.womenmeanbusiness.com/2018/03/orlaith-carmody-chairperson-of-hcci/ |publisher=Women Mean Business}}</ref>\n\n== Books ==\n*''Perform As A Leader''. Ballpoint Press Limited. September{{nbsp}}24, 2015. {{ISBN|9780993289200}}.<ref>{{cite web|title=Perform as a Leader|url=http://www.galwayindependent.com/business/topics/articles/2015/12/16/4111313-perform-as-a-leader/|website=Galway Independent|accessdate=21 December 2015}}</ref><ref>{{cite web|title=\u2018Perform as a Leader' book signing next week|url=http://www.galwayindependent.com/business/topics/articles/2015/12/09/4110924-perform-as-a-leader-book-signing-next-week/|website=Galway Independent|accessdate=21 December 2015}}</ref><ref>{{cite web|title=Carmody launches book on strong leadership|url=http://marketing.ie/carmody-launches-book-on-strong-leadership/|website=Marketing.ie|accessdate=21 December 2015}}</ref>\n*''Without You, Living With Loss''. Ballpoint Press Limited. April 26, 2018.<ref>{{cite web |last1=O'Connor |first1=Siobhan |title=Orlaith Carmody unites famous faces in moving new book about lost love ones |url=https://www.irishmirror.ie/showbiz/irish-showbiz/i-parked-lot-grief-life-12447165 |website=Irish Mirror |date=29 April 2018}}</ref>\n\n==References==\n{{reflist}}\n\n{{authority control}}\n\n{{DEFAULTSORT:Carmody, Orlaith}}\n\n[[Category:Living people]]\n[[Category:1960 births]]\n[[Category:Irish women writers]]\n[[Category:Irish women in business]]\n[[Category:20th-century Irish businesspeople]]\n[[Category:21st-century Irish businesspeople]]\n[[Category:20th-century businesswomen]]\n", "text_old": "{{Infobox person\n| name               = Orlaith Carmody\n| image              = \n| birth_name         = \n| birth_date         = \n| birth_place        = [[Kilmacud]], [[Dublin]], Ireland\n| death_date         = \n| death_place        = \n| nationality        = [[Irish people|Irish]]\n| spouse             = Kieran Gleeson<br>{{small|(m. 1983; died. 1989)}}<br>[[Gavin Duffy]] {{small|(m. 1993)}}\n| children           = 4\n| occupation         = {{Hlist|[[Author]]|[[Journalist]]}}\n| boards             = {{Hlist|HRM|[[RT\u00c9]]|Ablevision Ireland|HCCI}}\n| alma_mater         = {{Ubl|[[Dublin Institute of Technology]]|[[Dublin City University]]}}\n| website            = {{url|gavinduffyandassociates.com|Official website}}|\n}}\n'''Orlaith Carmody''' (born 10 February 1960) is an Irish businesswoman, [[author]], [[News reporter]]<ref>{{cite web|title=Women told networking is vital in order to grow your own business|url=http://www.belfasttelegraph.co.uk/business/news/women-told-networking-is-vital-in-order-to-grow-your-own-business-28792517.html|website=[[Belfast Telegraph]]|accessdate=21 December 2015}}</ref> and co-founder of Gavin Duffy and Associates (formerly Media Training),<ref name=ad>{{cite web|title=Learn how to perform as a leader|url=http://www.advertiser.ie/galway/article/81545/learn-how-to-perform-as-a-leader|website=[[Galway Advertiser]]|accessdate=21 December 2015}}</ref> along with her husband and business partner, ''[[Dragons' Den]]'' investor [[Gavin Duffy]].<ref>{{cite web|title=TV's Gavin Duffy takes off pounds to help would-be entrepreneurs put on \u20acuro|url=http://www.irishmirror.ie/whats-on/film-and-tv/tvs-gavin-duffy-takes-pounds-3273040|website=[[Irish Mirror]]|accessdate=21 December 2015}}</ref>\n\n== Career ==\nCarmody was previously a newscaster and reporter at [[LMFM]] and [[Century Radio]].<ref>{{cite web|title=If it wasn't for the hen parties, I'd have quit the Den \u2013 Duffy - Herald.ie|url=http://www.herald.ie/news/if-it-wasnt-for-the-hen-parties-id-have-quit-the-den-duffy-30318118.html|website=[[The Herald (Ireland)|The Herald]]|accessdate=21 December 2015}}</ref><ref name=ie>{{cite web|title=From broken wings to soaring high - former journalist Orlaith Carmody - Independent.ie|url=http://www.independent.ie/entertainment/books/from-broken-wings-to-soaring-high-former-journalist-orlaith-carmody-31538626.html|website=[[Irish Independent]]|accessdate=21 December 2015}}</ref> As a Director of Aerga Productions,<ref>{{cite web|title='Am I giving my children an advantage? I'm trying my hardest'|url=http://www.irishtimes.com/news/education/am-i-giving-my-children-an-advantage-i-m-trying-my-hardest-1.747230|website=[[The Irish Times]]|accessdate=21 December 2015|language=en-US}}</ref> she won a Screen Training Ireland bursary to attend the Entertainment Master Class international media leadership programme.<ref>{{cite web|url=http://www.independent.ie/regionals/droghedaindependent/news/local-production-company-secures-major-bursary-27146903.html |publisher=[[Irish Independent]]|title=Local Producer wins place on the prestigious Entertainment Master Class.}}</ref><ref>{{cite web |url=http://www.businessandleadership.com/leadership/item/41255-women-in-the-boardroom-orl |title=RTE Board Members - Orlaith Carmody |url-status=dead |archiveurl=https://web.archive.org/web/20131221132704/http://businessandleadership.com/leadership/item/41255-women-in-the-boardroom-orl |archivedate=2013-12-21 }}</ref> She spoke at TEDxTallaght in 2013,<ref>{{cite web|title=Find a Customer not a Job: Orlaith Carmody at TEDxTallaght|url=http://tedxtalks.ted.com/video/Find-a-Customer-not-a-Job-Orlai|website=[[Ted.com]]|accessdate=21 December 2015}}</ref> TEDxDCU in 2015<ref>{{cite web|title=Give Your Family The World |url=http://tedxtalks.ted.com/video/Give-Your-Family-The-World-Orla|website=Ted.com|accessdate=21 December 2015}}</ref><ref>{{cite web|title=TEDxDCU Changing Lives, Challenging Perceptions|url=https://www.dcu.ie/news/2015/jan/s0115c.shtml|website=[[Dublin City University]]|accessdate=21 December 2015}}</ref> and at the SME Assembly 2014 in [[Naples]], [[Italy]].<ref>{{cite web|url=http://blogs.ec.europa.eu/promotingenterprise/the-2014-sme-assembly-programme/ |title=2014 SME Assembly - The Big Debate}}</ref>\n\nCarmody was a board member of [[RT\u00c9]] from 2010 until 2015,<ref>{{cite web |url=http://www.personallyspeakingbureau.com/speaker/orlaith-carmody/ |title=Orlaith Carmody - Personally Speaking Bureau |accessdate=27 April 2016}}</ref>/<ref>{{cite web|title=Why broads on the board can be good for profits - Independent.ie|url=http://www.independent.ie/business/why-broads-on-the-board-can-be-good-for-profits-29229986.html|website=[[Irish Independent]]|accessdate=21 December 2015}}</ref><ref>{{cite web|title=Rabbitte to discuss report with RT\u00c9 board|url=http://www.irishtimes.com/news/rabbitte-to-discuss-report-with-rt%C3%A9-board-1.516451|website=[[The Irish Times]]|accessdate=21 December 2015|language=en-US}}</ref> HRM Recruit,<ref>{{cite web|title=I don't horse around with my money|url=http://www.thesundaytimes.co.uk/sto/news/ireland/Business/article1623522.ece|website=[[The Sunday Times]]|accessdate=21 December 2015}}</ref> and Ablevision Ireland,<ref>{{cite web|title=Ablevision launch - Independent.ie|url=http://www.independent.ie/regionals/droghedaindependent/news/ablevision-launch-27166906.html|website=[[Irish Independent]]|accessdate=21 December 2015}}</ref> and is a founder member and president 2014\u201315 of the Irish chapter of the International [[Entrepreneurs' Organization]] (EO).<ref name=ad /> She is Chairperson of Home and Community Care Ireland (HCCI), a fellow of the Irish Institute of Training and Development and a member of the Institute of Directors.<ref>{{cite web |title=Orlaith Carmody Chairperson of HCCI |url=https://www.womenmeanbusiness.com/2018/03/orlaith-carmody-chairperson-of-hcci/ |publisher=Women Mean Business}}</ref>\n\n== Books ==\n*''Perform As A Leader''. Ballpoint Press Limited. September{{nbsp}}24, 2015. {{ISBN|9780993289200}}.<ref>{{cite web|title=Perform as a Leader|url=http://www.galwayindependent.com/business/topics/articles/2015/12/16/4111313-perform-as-a-leader/|website=Galway Independent|accessdate=21 December 2015}}</ref><ref>{{cite web|title=\u2018Perform as a Leader' book signing next week|url=http://www.galwayindependent.com/business/topics/articles/2015/12/09/4110924-perform-as-a-leader-book-signing-next-week/|website=Galway Independent|accessdate=21 December 2015}}</ref><ref>{{cite web|title=Carmody launches book on strong leadership|url=http://marketing.ie/carmody-launches-book-on-strong-leadership/|website=Marketing.ie|accessdate=21 December 2015}}</ref>\n*''Without You, Living With Loss''. Ballpoint Press Limited. April 26, 2018.<ref>{{cite web |last1=O'Connor |first1=Siobhan |title=Orlaith Carmody unites famous faces in moving new book about lost love ones |url=https://www.irishmirror.ie/showbiz/irish-showbiz/i-parked-lot-grief-life-12447165 |website=Irish Mirror |date=29 April 2018}}</ref>\n\n==References==\n{{reflist}}\n\n{{authority control}}\n\n{{DEFAULTSORT:Carmody, Orlaith}}\n\n[[Category:Living people]]\n[[Category:1960 births]]\n[[Category:Irish women writers]]\n[[Category:Irish women in business]]\n[[Category:20th-century Irish businesspeople]]\n[[Category:21st-century Irish businesspeople]]\n[[Category:20th-century businesswomen]]\n", "name_user": "Gabhmoleithscealanbhfuilceadagamdulamach", "label": "safe", "comment": "", "url_page": "//en.wikipedia.org/wiki/Orlaith_Carmody"}
{"title_page": "Confederation of African Football", "text_new": "{{Use dmy dates|date=February 2020}}\n{{Infobox organization\n| name                = Confederation of African Football\n| image               = Confederation of African Football logo.svg\n| size                = 200px\n| abbreviation        = CAF\n| formation           = {{Start date and years ago|df=y|1957|02|10}}\n| map                 = CAF.svg\n| type                = Sports organisation\n| headquarters        = [[6th of October (city)|6th of October City]], [[Giza]], [[Egypt]]\n| region_served       = [[Africa]]\n| membership          = [[List of men's national association football teams#CAF (Africa)|56 member associations]]\n| language            = [[English language|English]], [[French language|French]], [[Arabic language|Arabic]]\n| leader_title        = [[List of presidents of CAF|President]]\n| leader_name         = [[Ahmad Ahmad]]\n| general             = Hajji Mouad\n| parent_organization = [[FIFA]]\n| website             = {{URL|www.cafonline.com/}}\n}}\n\n{{FIFA confederations}}\nThe '''Confederation of African Football''' or '''CAF''' ({{lang-fr|link=no|Conf\u00e9d\u00e9ration Africaine de Football}}) is the administrative and controlling body for African association football.\n\nCAF represents the national football associations of [[Africa]], runs continental, national, and club competitions, and controls the prize money, regulations and media rights to those competitions.\n\nCAF was a trailblazing pan-Africanist institution in the era of independence.<ref>{{cite book |last1=Alegi |first1=Peter |title=African Soccerscapes |date=2010 |publisher=Ohio University Press |isbn=978-0-89680}}</ref> CAF is the biggest of the six continental confederations of [[FIFA]], essentially the ruling body of the game in Africa.<ref>{{cite book |last1=Alegi |first1=Peter |title=African Soccerscapes |date=2010 |publisher=Ohio University Press |isbn=978-0-89680-278-0}}</ref> Since the expansion of the number of teams at the [[FIFA World Cup|World Cup]] finals to 32 in [[1998 FIFA World Cup|1998]], CAF has been allocated five places, though this was expanded to six for the [[2010 FIFA World Cup|2010]] tournament in South Africa, to include the [[South Africa national football team|hosts]].\n\nCAF was established on 8 February 1957 at the Grand Hotel<ref>{{cite book |last1=Alegi |first1=Peter |title=African Soccerscapes |date=2010 |publisher=Ohio University Press |isbn=978-0-89680-278-0 |pages=65}}</ref> in [[Khartoum]],and was attended by representatives from Suden, Egypt, Ethiopia, and South Africa.<ref>{{cite book |last1=Alegi |first1=Peter |title=African Soccerscapes |isbn=9780896802780 |page=65}} FAs, following former discussions between the Egyptian, [[Somali Football Federation|Somali]], South African and Sudanese FAs earlier on 7 June 1956 at the Avenida Hotel in [[Lisbon]], Portugal. Its first headquarters was situated in Khartoum for some months until a fire outbreak in the offices of the Sudanese Football Association when the organization moved near [[Cairo]], Egypt. [[Youssef Mohamad]] was the first general secretary and [[Abdel Aziz Abdallah Salem]] the first<ref>{{cite book |last1=Alegi |first1=Peter |title=African Soccerscapes |isbn=9780896802780 |page=65}}</ref> [[List of Presidents of UEFA|president]]. Since 2002, the administrative center has been located in [[6th of October City]], Cairo, Egypt. CAF currently has 56 member associations: 54 are full members, while [[Zanzibar Football Association|Zanzibar]] and [[R\u00e9unionese Football League|R\u00e9union]] are associate members (see the CAF Members and Zones section below).\n\nThe current [[List of presidents of CAF|CAF President]] is [[Ahmad Ahmad]] from Madagascar, who was elected on 16 March 2017.<ref>{{cite web |url=https://www.bbc.co.uk/sport/football/39270007 |title=Madagascar FA chief Ahmad elected as new Caf president |date=16 March 2017 |website=BBC News |last1= |first1= |accessdate=16 March 2017}}</ref> The 1st Vice-President is Amaju Melvin Pinnick from Nigeria, the 2nd Vice-President is called Constant Omari Selemani from RD Congo and the 3rd Vice-President is Fouzi Lekjaa from Morocco.<ref>{{cite web |last1=Football |first1=CAF \u2013 Confederation of African |title=CAF \u2013 CAF \u2013 Organization \u2013 Bodies \u2013 Executive Committee |url=http://www.cafonline.com/en-us/caf/organization/bodies/executivecommittee.aspx |website=www.cafonline.com}}</ref> Current CAF General Secretary is Moroccan Hajji Mouad since 11 April 2019.<ref>{{Cite news |url=https://www.bbc.com/sport/football/47898603 |title=Caf appoints Moroccan Hajji Mouad as new General Secretary |date=13 April 2019|access-date=7 August 2019 |language=en-GB}}</ref>\n\n==History==\n{{Main|History of CAF}}\n\n==CAF's anthem==\nOn 18 September 2007 the CAF launched a competition for all African composers to create its [[Anthem]].<ref>{{cite web |url=http://www.cafonline.com/index.php?lng=1&module=media&idrub=94637&idnews=82041 |title=Competition for the CAF's anthem |publisher=CAF |date=18 September 2007 |accessdate=13 November 2008}}</ref> The CAF anthem is a musical composition, without lyrics, which and reflect the cultural patrimony and [[Music of Africa|African music]]. The duration of the anthem is 74 seconds. The chosen anthem was first published to the site on 16 January 2008. The usage of the anthem and its composer are still unknown.\n\n[http://www.cafonline.com/index.php?lng=1&module=media&idrub=94637&idnews=82041 Announced 18 September 2007]\n\n==Current leaders==\n\n{|class=\"wikitable hlist\" style=\"text-align:left\"\n|-\n!Name\n!Position\n|-\n|{{flagicon|Madagascar}} [[Ahmad Ahmad]]\n|President\n|-\n|{{flagicon|DR Congo}} [[Constant Omari]]\n|Vice President\n|-\n|{{flagicon|Morocco}} [[Fouzi Lekjaa]]\n|Vice President\n|-\n|{{flagicon|Morocco}} [[Mouad Hajji]]\n|General Secretary \n|-\n|{{flagicon|Egypt}} [[Essameldin Agha]]\n|Acting General Secretary \n|-\n|{{flagicon|Egypt}} [[Mohamed El Sherei]]\n|Treasurer\n|-\n|{{flagicon|Cameroon}} [[Junior Binyam]]\n|Media and Communication Manager\n|}\n\nSource: <ref>[https://www.fifa.com/associations/caf/ FIFA (CAF)]</ref><ref>[http://www.cafonline.com/en-us/caf/organization/bodies/executivecommittee.aspx CAF]</ref>\n\n==CAF members and zones==\n{{Context|section|date=June 2016}}\n\n===Members===\n[[File:Carte Afrique CAF.png|thumb|right|\n{{Color box|#8fbc8f|[[Sahara (African Region)|Sahara]]|border=darkgray}}\n{{Color box|#ffd700|[[Regions of the African Union|Niger and Volta-Niger (Zones A and B)]]|border=darkgray}}\n{{Color box|#db7093|[[Congo (African Region)|Congo]]|border=darkgray}}\n{{Color box|#4682b4|[[Nile (African Region)|Nile]]|border=darkgray}}\n{{Color box|#deb887|[[Kalahari (African Region)|Kalahari]]|border=darkgray}}]]\n\n;African regional federations\n{{legend|#8fbc8f|[[Union of North African Football Federations|UNAF]] (North Africa)}}\n{{legend|#ffd700|[[West African Football Union|WAFU-UFOA]] (West Africa)}}\n{{legend|#db7093|[[Central African Football Federations' Union|UNIFFAC]] (Central Africa)}}\n{{legend|#4682b4|[[CECAFA]] (East Africa)}}\n{{legend|#deb887|[[Council of Southern Africa Football Associations|COSAFA]] (Southern Africa)}}\n\n;Other federation\n{{legend|#007F00|[[Union of Arab Football Associations|UAFA]] ([[Arab World]])}}\n\n{|class=\"wikitable sortable hlist\" style=\"text-align:center; font-size:95%;\"\n! [[List of FIFA country codes|{{tooltip|Code|List of FIFA country codes}}]] !! Association !! National teams !! Founded !! FIFA affiliation !! CAF affiliation !! Regional affiliation !! [[List of members of the International Olympic Committee|{{tooltip|IOC member|List of members of the International Olympic Committee}}]]\n|-\n!colspan=8|[[Union of North African Football Federations|Union of North African Football Federations (UNAF)]]\n|-\n| ALG ||style=\"text-align:left;\"| {{fba|Algeria}} || {{Nft Alt Links|Algeria|sublist_style=font-size:90%}} || 1962 || 1963 || 1964 || 2005 || {{yes}}\n|-\n| EGY ||style=\"text-align:left;\"| {{fba|Egypt}} {{ref|n2|2}} || {{Nft Alt Links|Egypt|sublist_style=font-size:90%}} || 1921 || 1923 || 1957 || 2005 || {{yes}}\n|-\n| LBY ||style=\"text-align:left;\"| {{fba|Libya}} || {{Nft Alt Links|Libya|sublist_style=font-size:90%}} || 1962 || 1964 || 1965 || 2005 || {{yes}}\n|-\n| MAR ||style=\"text-align:left;\"| {{fba|Morocco}} || {{Nft Alt Links|Morocco|sublist_style=font-size:90%}} || 1955 || 1960 || 1959 || 2005 || {{yes}}\n|-\n| TUN ||style=\"text-align:left;\"| {{fba|Tunisia}} || {{Nft Alt Links|Tunisia|sublist_style=font-size:90%}} || 1957 || 1960 || 1960 || 2005 || {{yes}}\n|-\n!colspan=8|[[West African Football Union|West African Football Union (WAFU-UFOA)]]\n|-\n| BEN ||style=\"text-align:left;\"| {{fba|Benin}} || {{Nft Alt Links|Benin|sublist_style=font-size:90%}} || 1962 || 1962 || 1962 || 1975 || {{yes}}\n|-\n| BFA ||style=\"text-align:left;\"| {{fba|Burkina Faso}} || {{Nft Alt Links|Burkina Faso|sublist_style=font-size:90%}} || 1960 || 1964 || 1964 || 1975 || {{yes}}\n|-\n| CPV ||style=\"text-align:left;\"| {{fba|Cape Verde}} || {{Nft Alt Links|Cape Verde|sublist_style=font-size:90%}} || 1982 || 1986 || 2000 || 1975 || {{yes}}\n|-\n| GAM ||style=\"text-align:left;\"| {{fba|Gambia}} || {{Nft Alt Links|Gambia|sublist_style=font-size:90%}} || 1952 || 1968 || 1966 || 1975 || {{yes}}\n|-\n| GHA ||style=\"text-align:left;\"| {{fba|Ghana}} || {{Nft Alt Links|Ghana|sublist_style=font-size:90%}} || 1957 || 1958 || 1958 || 1975 || {{yes}}\n|-\n| GUI ||style=\"text-align:left;\"| {{fba|Guinea}} || {{Nft Alt Links|Guinea|sublist_style=font-size:90%}} || 1960 || 1962 || 1963 || 1975 || {{yes}}\n|-\n| GNB ||style=\"text-align:left;\"| {{fba|Guinea-Bissau}} || {{Nft Alt Links|Guinea-Bissau|sublist_style=font-size:90%}} || 1974 || 1986 || 1986 || 1975 || {{yes}}\n|-\n| CIV ||style=\"text-align:left;\"| {{fba|Ivory Coast}} || {{Nft Alt Links|Ivory Coast|sublist_style=font-size:90%}} || 1960 || 1964 || 1960 || 1975 || {{yes}}\n|-\n| LBR ||style=\"text-align:left;\"| {{fba|Liberia}} || {{Nft Alt Links|Liberia|sublist_style=font-size:90%}} || 1936 || 1964 || 1962 || 1975 || {{yes}}\n|-\n| MLI ||style=\"text-align:left;\"| {{fba|Mali}} || {{Nft Alt Links|Mali|sublist_style=font-size:90%}} || 1960 || 1963 || 1963 || 1975 || {{yes}}\n|-\n| MTN ||style=\"text-align:left;\"| {{fba|Mauritania}} || {{Nft Alt Links|Mauritania|sublist_style=font-size:90%}} || 1961 || 1970 || 1968 || 1975 || {{yes}}\n|-\n| NIG ||style=\"text-align:left;\"| {{fba|Niger}} || {{Nft Alt Links|Niger|sublist_style=font-size:90%}} || 1962 || 1967 || 1967 || 1975 || {{yes}}\n|-\n| NGA ||style=\"text-align:left;\"| {{fba|Nigeria}} || {{Nft Alt Links|Nigeria|sublist_style=font-size:90%}} || 1945 || 1960 || 1960 || 1975 || {{yes}}\n|-\n| SEN ||style=\"text-align:left;\"| {{fba|Senegal}} || {{Nft Alt Links|Senegal|sublist_style=font-size:90%}} || 1960 || 1964 || 1964 || 1975 || {{yes}}\n|-\n| SLE ||style=\"text-align:left;\"| {{fba|Sierra Leone}} || {{Nft Alt Links|Sierra Leone|sublist_style=font-size:90%}} || 1960 || 1960 || 1960 || 1975 || {{yes}}\n|-\n| TOG ||style=\"text-align:left;\"| {{fba|Togo}} || {{Nft Alt Links|Togo|sublist_style=font-size:90%}} || 1960 || 1962 || 1964 || 1975 || {{yes}}\n|-\n!colspan=8|[[Central African Football Federations' Union|Central African Football Federations' Union (UNIFFAC)]]\n|-\n| CMR ||style=\"text-align:left;\"| {{fba|Cameroon}} || {{Nft Alt Links|Cameroon|sublist_style=font-size:90%}} || 1959 || 1962 || 1963 || 1978 || {{yes}}\n|-\n| CTA ||style=\"text-align:left;\"| {{fba|Central African Republic}} || {{Nft Alt Links|Central African Republic|sublist_style=font-size:90%}} || 1961 || 1964 || 1965 || 1978 || {{yes}}\n|-\n| CHA ||style=\"text-align:left;\"| {{fba|Chad}} || {{Nft Alt Links|Chad|sublist_style=font-size:90%}} || 1962 || 1964 || 1964 || 1978 || {{yes}}\n|-\n| CGO ||style=\"text-align:left;\"| {{fba|Congo}} || {{Nft Alt Links|Congo|sublist_style=font-size:90%}} || 1962 || 1964 || 1966 || 1978 || {{yes}}\n|-\n| COD ||style=\"text-align:left;\"| {{fba|DR Congo}} || {{Nft Alt Links|DR Congo|sublist_style=font-size:90%}} || 1919 || 1964 || 1964 || 1978 || {{yes}}\n|-\n| EQG ||style=\"text-align:left;\"| {{fba|Equatorial Guinea}} || {{Nft Alt Links|Equatorial Guinea|sublist_style=font-size:90%}} || 1957 || 1986 || 1986 || 1978 || {{yes}}\n|-\n| GAB ||style=\"text-align:left;\"| {{fba|Gabon}} || {{Nft Alt Links|Gabon|sublist_style=font-size:90%}} || 1962 || 1966 || 1967 || 1978 || {{yes}}\n|-\n| STP ||style=\"text-align:left;\"| {{fba|S\u00e3o Tom\u00e9 and Pr\u00edncipe}} || {{Nft Alt Links|S\u00e3o Tom\u00e9 and Pr\u00edncipe|sublist_style=font-size:90%}} || 1975 || 1986 || 1986 || 1978 || {{yes}}\n|-\n!colspan=8|[[CECAFA|Council for East and Central Africa Football Associations (CECAFA)]]\n|-\n| BDI ||style=\"text-align:left;\"| {{fba|Burundi}} || {{Nft Alt Links|Burundi|sublist_style=font-size:90%}} || 1948 || 1972 || 1972 || 1994 || {{yes}}\n|-\n| DJI ||style=\"text-align:left;\"| {{fba|Djibouti}} || {{Nft Alt Links|Djibouti|sublist_style=font-size:90%}} || 1979 || 1994 || 1994 || 1995 || {{yes}}\n|-\n| ERI ||style=\"text-align:left;\"| {{fba|Eritrea}} || {{Nft Alt Links|Eritrea|sublist_style=font-size:90%}} || 1996 || 1998 || 1998 || 1973 || {{yes}}\n|-\n| ETH ||style=\"text-align:left;\"| {{fba|Ethiopia}} || {{Nft Alt Links|Ethiopia|sublist_style=font-size:90%}} || 1943 || 1952 || 1957 || 1994 || {{yes}}\n|-\n| KEN ||style=\"text-align:left;\"| {{fba|Kenya}} || {{Nft Alt Links|Kenya|sublist_style=font-size:90%}} || 1960 || 1960 || 1968 || 1973 || {{yes}}\n|-\n| RWA ||style=\"text-align:left;\"| {{fba|Rwanda}} || {{Nft Alt Links|Rwanda|sublist_style=font-size:90%}} || 1972 || 1978 || 1978 || 1994 || {{yes}}\n|-\n| SOM ||style=\"text-align:left;\"| {{fba|Somalia}} || {{Nft Alt Links|Somalia|sublist_style=font-size:90%}} || 1951 || 1962 || 1968 || 1973 || {{yes}}\n|-\n| SSD ||style=\"text-align:left;\"| {{fba|South Sudan}} || {{Nft Alt Links|South Sudan|sublist_style=font-size:90%}} || 2011 || 2012 || 2012 || 2012 || {{yes}}\n|-\n| SDN ||style=\"text-align:left;\"| {{fba|Sudan}} || {{Nft Alt Links|Sudan|sublist_style=font-size:90%}} || 1936 || 1948 || 1957 || 1975 || {{yes}}\n|-\n| TAN ||style=\"text-align:left;\"| {{fba|Tanzania}} || {{Nft Alt Links|Tanzania|sublist_style=font-size:90%}} || 1930 || 1964 || 1964 || 1973 || {{yes}}\n|-\n| UGA ||style=\"text-align:left;\"| {{fba|Uganda}} || {{Nft Alt Links|Uganda|sublist_style=font-size:90%}} || 1924 || 1960 || 1960 || 1973 || {{yes}}\n|-\n| ZAN ||style=\"text-align:left;\"| {{fba|Zanzibar}} {{ref|n3|3}} || {{Nft Alt Links|Zanzibar|sublist_style=font-size:90%}} || 1965 ||  || 1980 || 1973 & 2003 || {{no}}\n|-\n!colspan=8|[[Council of Southern Africa Football Associations|Council of Southern Africa Football Associations (COSAFA)]]\n|-\n| ANG ||style=\"text-align:left;\"| {{fba|Angola}} || {{Nft Alt Links|Angola|sublist_style=font-size:90%}} || 1979 || 1980 || 1980 || 1997 || {{yes}}\n|-\n| BOT ||style=\"text-align:left;\"| {{fba|Botswana}} || {{Nft Alt Links|Botswana|sublist_style=font-size:90%}} || 1970 || 1978 || 1976 || 1997 || {{yes}}\n|-\n| COM ||style=\"text-align:left;\"| {{fba|Comoros}} || {{Nft Alt Links|Comoros|sublist_style=font-size:90%}} || 1979 || 2005 || 2005 || 2007 || {{yes}}\n|-\n| SWZ ||style=\"text-align:left;\"| {{fba|Eswatini}} || {{Nft Alt Links|Eswatini|sublist_style=font-size:90%}} || 1968 || 1978 || 1978 || 1997 || {{yes}}\n|-\n| LES ||style=\"text-align:left;\"| {{fba|Lesotho}} || {{Nft Alt Links|Lesotho|sublist_style=font-size:90%}} || 1932 || 1964 || 1964 || 1997 || {{yes}}\n|-\n| MAD ||style=\"text-align:left;\"| {{fba|Madagascar}} || {{Nft Alt Links|Madagascar|sublist_style=font-size:90%}} || 1961 || 1964 || 1963 || 2000 || {{yes}}\n|-\n| MWI ||style=\"text-align:left;\"| {{fba|Malawi}} || {{Nft Alt Links|Malawi|sublist_style=font-size:90%}} || 1966 || 1968 || 1968 || 1997 || {{yes}}\n|-\n| MRI ||style=\"text-align:left;\"| {{fba|Mauritius}} || {{Nft Alt Links|Mauritius|sublist_style=font-size:90%}} || 1952 || 1964 || 1963 || 2000 || {{yes}}\n|-\n| MOZ ||style=\"text-align:left;\"| {{fba|Mozambique}} || {{Nft Alt Links|Mozambique|sublist_style=font-size:90%}} || 1976 || 1980 || 1980 || 1997 || {{yes}}\n|-\n| NAM ||style=\"text-align:left;\"| {{fba|Namibia}} || {{Nft Alt Links|Namibia|sublist_style=font-size:90%}} || 1990 || 1992 || 1992 || 1997 || {{yes}}\n|-\n| SEY ||style=\"text-align:left;\"| {{fba|Seychelles}} || {{Nft Alt Links|Seychelles|sublist_style=font-size:90%}} || 1979 || 1986 || 1986 || 2000 || {{yes}}\n|-\n| RSA ||style=\"text-align:left;\"| {{fba|South Africa}} {{ref|n1|1}} || {{Nft Alt Links|South Africa|sublist_style=font-size:90%}} || 1991 || 1992 || 1992 || 1997 || {{yes}}\n|-\n| ZAM ||style=\"text-align:left;\"| {{fba|Zambia}} || {{Nft Alt Links|Zambia|sublist_style=font-size:90%}} || 1929 || 1964 || 1964 || 1997 || {{yes}}\n|-\n| ZIM ||style=\"text-align:left;\"| {{fba|Zimbabwe}} || {{Nft Alt Links|Zimbabwe|sublist_style=font-size:90%}} || 1965 || 1965 || 1980 || 1997 || {{yes}}\n|-\n!colspan=8|Non-regional members\n|-\n| REU ||style=\"text-align:left;\"| {{fba|R\u00e9union}} {{ref|n3|3|noid=noid}} || {{Nft Alt Links|R\u00e9union|sublist_style=font-size:90%}} || 1926 ||  || 2004 || || {{no}}\n|}\n\n#{{note|n1}} \u2013 Excluded from CAF and from 1st [[African Cup of Nations]] in 1957 due to Apartheid\n#{{note|n2}} \u2013 Member of [[UNAF]] from 2005 to 2009 and from 2011 \u2013 Withdrew from UNAF on 19 November 2009 but return on 2011\n#{{note|n3}} \u2013 Associate members, not part of [[FIFA]]. Zanzibar held full membership for four months in 2017, when its status was changed after CAF admitted its membership was an error.<ref>{{cite web |last1=Gleason |first1=Mark |title=Zanzibar loses Caf membership in embarrassing U-turn |url=https://www.bbc.co.uk/sport/football/40682462 |publisher=BBC Sport |accessdate=31 May 2018}}</ref>\n\n===Regional zones===\nCAF National League \n====CAF Zone 1 \u2013 North Zone====\n{{colbegin|colwidth=15em}}\n*{{fba|Algeria}}\n*{{fba|Egypt}}\n*{{fba|Libya}}\n*{{fba|Morocco}}\n*{{fba|Tunisia}}\n{{colend}}\n\n====CAF Zone 2 \u2013 Zone West A====\n{{colbegin|colwidth=15em}}\n*{{fba|Cape Verde}}\n*{{fba|Gambia}}\n*{{fba|Guinea}}\n*{{fba|Guinea-Bissau}}\n*{{fba|Liberia}}\n*{{fba|Mali}}\n*{{fba|Mauritania}}\n*{{fba|Senegal}}\n*{{fba|Sierra Leone}}\n{{colend}}\n\n====CAF Zone 3 \u2013 Zone West B====\n{{colbegin|colwidth=15em}}\n*{{fba|Benin}}\n*{{fba|Burkina Faso}}\n*{{fba|Ghana}}\n*{{fba|Ivory Coast}}\n*{{fba|Niger}}\n*{{fba|Nigeria}}\n*{{fba|Togo}}\n{{colend}}\n\n====CAF Zone 4 \u2013 Central Zone====\n{{colbegin|colwidth=15em}}\n*{{fba|Cameroon}}\n*{{fba|Central African Republic}}\n*{{fba|Chad}}\n*{{fba|Congo}}\n*{{fba|DR Congo}}\n*{{fba|Equatorial Guinea}}\n*{{fba|Gabon}}\n*{{fba|Sao Tome and Principe}}\n{{colend}}\n\n====CAF Zone 5 \u2013 Central-East Zone====\n{{colbegin|colwidth=15em}}\n*{{fba|Burundi}}\n*{{fba|Djibouti}}\n*{{fba|Eritrea}}\n*{{fba|Ethiopia}}\n*{{fba|Kenya}}\n*{{fba|Rwanda}}\n*{{fba|Somalia}}\n*{{fba|South Sudan}}\n*{{fba|Sudan}}\n*{{fba|Tanzania}}\n*{{fba|Uganda}}\n{{colend}}\n\n====CAF Zone 6 \u2013 Southern Zone====\n{{colbegin|colwidth=15em}}\n*{{fba|Angola}}\n*{{fba|Botswana}}\n*{{fba|Comoros}}\n*{{fba|Eswatini}}\n*{{fba|Lesotho}}\n*{{fba|Madagascar}}\n*{{fba|Malawi}}\n*{{fba|Mauritius}}\n*{{fba|Mozambique}}\n*{{fba|Namibia}}\n*{{fba|Seychelles}}\n*{{fba|South Africa}}\n*{{fba|Zambia}}\n*{{fba|Zimbabwe}}\n{{colend}}\n\n==Competitions==\n\n===CAF competitions===\n{{col-start}}\n{{col-break}}\n'''National teams:'''\n*[[Africa Cup of Nations]]\n*[[African Nations Championship]]\n*[[Africa U-23 Cup of Nations]]\n*[[Africa U-20 Cup of Nations]]\n*[[Africa U-17 Cup of Nations]]\n*[[Africa Women Cup of Nations]]\n*[[African U-20 Women's World Cup qualification]]\n*[[African U-17 Cup of Nations for Women]]\n*[[Africa Futsal Cup of Nations]]\n*[[Africa Beach Soccer Cup of Nations]]\n{{col-break}}\n'''Clubs:'''\n*[[CAF Champions League]]\n*[[CAF Confederation Cup]]\n*[[CAF Super Cup]]\n;Defunct\n*[[African Cup Winners' Cup]]\n{{col-break}}\n'''Inter Continental:'''\n*[[Arab Nations Cup]]\n*[[Arab Club Championship]]\n;Defunct\n*[[Afro-Asian Cup of Nations]]\n*[[Afro-Asian Club Championship]]\n*[[UEFA\u2013CAF Meridian Cup]]\n{{col-break}}\n'''Regional:'''\n*[[CECAFA Cup]]\n*[[WAFU Nations Cup]]\n*[[Amilcar Cabral Cup]]\n*[[COSAFA Cup]]\n*[[CEMAC Cup]]\n*[[UNIFFAC Cup]] (U-17)\n*[[UNAF U-23 Tournament]]\n{{col-end}}\n\n===International===\nThe main competition for men's national teams [[Africa Cup of Nations]], started in 1957. In 2009, the CAF started organising another competition for men's national teams, the [[African Nations Championship]] composed exclusively of national players playing in the national championship. CAF also runs national competitions at [[Africa U-20 Cup of Nations|Under-20]] and [[African Under-17 Championship|Under-17]] levels. For women's national teams, CAF operates the [[Africa Women Cup of Nations]] for senior national sides and the [[African U-20 Women's World Cup qualification]] at under-20 level, since 2008 there is an [[African U-17 Cup of Nations for Women]] for under-17 sides.\n\n===Club===\nCAF also runs the two main club competitions in Africa: the [[CAF Champions League]] was first held in 1964, and was known as the African Cup of Champions Clubs (or just African Cup) until 1997; and the [[CAF Confederation Cup]], for national cup winners and high-placed league teams, was launched by CAF in 2004 as a successor to the [[African Cup Winners' Cup]] (begun in 1975). A third competition, the [[CAF Cup]], started in 1992 and was absorbed into the CAF Confederation Cup in 2004.<ref>{{cite web |url=http://www.cafonline.com/index.php?lng=1&opt=44&cmpt=19&titre=Past%20Competitions |title=Confederation Cup |publisher=CAF |accessdate=17 December 2008}}</ref>\n\nThe [[CAF Super Cup]], which pits the winners of the Champions League against the winners of the CAF Confederation Cup (previously the winners of the Cup Winners' Cup), came into being in 1992.\n\nThe [[Afro-Asian Club Championship]] was jointly organised with [[Asian Football Confederation|AFC]] between the winners of the [[CAF Champions League]] and the winners of the [[AFC Champions League]].\nThe last [[Afro-Asian Club Championship]] took place in 1998.\n\n===Current title holders===\n{| class=\"wikitable sortable\"\n|-\n!Competition\n!Champion\n!Title\n!Runner-up\n!Next edition\n|-\n!colspan=5|Nations men\n|-\n| [[Africa Cup of Nations]]\n| {{fb|Algeria}} \n| 2nd\n|{{fb|Senegal}}\n| [[2021 Africa Cup of Nations|2021]]\n|-\n| [[African Nations Championship]]\n| {{fb|Morocco}}\n| 1st\n|{{fb|Nigeria}}\n| [[2020 African Nations Championship|2020]]\n|-\n| [[Africa U-23 Cup of Nations]]\n| {{fbu|23|Egypt}}\n| 1st\n| {{fbu|23|Ivory Coast}}\n| [[2023 Africa U-23 Cup of Nations|2023]]\n|-\n| [[Football at the African Games|African Games Men's Football Tournament]]\n| {{fbu|23|BFA}}\n| 1st\n| {{fbu|23|NGR}}\n| [[Football at the 2023 African Games \u2013 Men's tournament|2023]]\n|-\n| [[Africa U-20 Cup of Nations]]{{refn|group=cc|This competition has been known by four different names, most recently the African U-21 Championship from 2003 through the 2015 competition. The first tournament under the current name of \"Africa U-20 Cup of Nations\" will tale place in 2017.}}\n| {{fbu|20|MLI}}\n| 1st\n| {{fbu|20|SEN}}\n| [[2021 Africa U-20 Cup of Nations|2021]]\n|-\n| [[Africa U-17 Cup of Nations]]{{refn|group=cc|From 1995 through the 2015 tournament, the competition was known as the African U-17 Championship. The first tournament under the current name of \"Africa U-17 Cup of Nations\" will tale place in 2017.}}\n| {{fbu|17|CMR}}\n| 2nd\n| {{fbu|17|GHA}}\n| [[2021 Africa U-17 Cup of Nations|2021]]\n|-\n| [[Africa Futsal Cup of Nations]]\n| {{futsal|MAR}}\n| 1st\n| {{futsal|EGY}}\n| [[2020 Africa Futsal Cup of Nations|2020]]\n|-\n| [[Africa Beach Soccer Cup of Nations]]\n| {{beachsoccer|SEN}}\n| 5th\n| {{beachsoccer|NGR}}\n| [[2020 Africa Beach Soccer Cup of Nations|2020]]\n|-\n!colspan=5|Nations women\n|-\n| [[Africa Women Cup of Nations]]\n| {{fbw|NGA}}\n| 11th\n| {{fbw|RSA}}\n| [[2020 Africa Women Cup of Nations|2020]]\n|-\n| [[Football at the African Games|African Games Women's Football Tournament]]\n| {{fbw|NGR}}\n| 3rd\n| {{fbw|CMR}}\n| [[Football at the 2023 African Games \u2013 Women's tournament|2023]]\n|-\n| [[African U-20 Women's World Cup qualification]]\n| {{fbwu|20|GHA}}<br>{{fbwu|20|NGR}}\n| 5th<br>9th\n| {{fbwu|20|CMR}}<br>{{fbwu|20|RSA}}\n| [[2020 African U-20 Women's World Cup Qualifying Tournament|2020]]\n|-\n| [[African U-17 Cup of Nations for Women]]\n| {{fbwu|17|GHA}}<br>{{fbwu|17|RSA}}<br>{{fbwu|17|CMR}}\n| 5th<br>2nd<br>1st\n| {{fbwu|17|DJI}}<br>{{fbwu|17|MAR}}<br>{{fbwu|17|NGA}}\n| [[2020 African U-17 Women's World Cup Qualifying Tournament|2020]]\n|-\n!colspan=5|Clubs\n|-\n| [[CAF Champions League]]\n| {{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance de Tunis]]\n| 4th\n| {{flagicon|MAR}} [[Wydad AC]]\n| [[2019\u201320 CAF Champions League|2019\u201320]]\n|-\n| [[CAF Confederation Cup]]\n| {{flagicon|EGY}} [[Zamalek SC|Zamalek]]\n| 1st\n| {{flagicon|MAR}} [[RS Berkane]]\n| [[2019\u201320 CAF Confederation Cup|2019\u201320]]\n|-\n| [[CAF Super Cup]]\n| {{flagicon|EGY}} [[Zamalek SC|Zamalek]]\n| 4th\n| {{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance de Tunis]]\n| [[2020 CAF Super Cup (August)|2020]]\n|}\n\n{{reflist|group=cc}}\n\n===Competition Winners===\n{| class=\"wikitable sortable\"style=\"font-size:95%\n|-\n!rowspan=2|Nation\n!colspan=8|Men\n!colspan=2|Women\n!rowspan=2|Total\n|-\n![[Africa Cup of Nations]]\n![[African Nations Championship|CHAN]]\n![[Africa U-23 Cup of Nations|U-23's]]\n![[Africa U-20 Cup of Nations|U-20's]]\n![[Africa U-17 Cup of Nations|U-17's]]\n![[Africa Futsal  Cup of Nations|Futsal]]\n![[Africa Beach Soccer Cup of Nations|Beach Soccer]]\n![[All-Africa Games]]\n![[ Africa Women Cup of Nations]]\n![[All-Africa Games]]\n|-align=center\n|-style=\"background:lightgreen\"\n|align=left|{{flagicon|NGR}} [[Nigeria ]]||3(4)||0(1)||1||7(2)||2(2)|| \u2013 ||2(4)||1(4)||11||3||'''3O(17)'''\n|-align=center\n|-style=\"background:lightblue\"\n|align=left|{{flagicon|EGY}}Egypt||7(2)|| \u2013 ||1||4(1)||1||3(2)||-||2||-||-||'''18(5)'''\n|-align=center\n|-style=\"background:Pink\"\n|align=left|{{flagicon|CMR}}Cameroon||5(2)||-||-||1(4)||2||-||1(1)||4||0(4)||1(2)||'''14(13)'''\n|-align=center\n|-style=\"background:lightgreen\"\n|align=left|{{flagicon|GHA}}Ghana||4(5)||0(2)||-||3(2)||2(2)||0(1)||-||1||1(1)||0(3)'''||'''11(16)'''\n|-align=center\n|-style=\"background:lightgreen\"\n|align=left|{{flagicon|SEN}}Senegal||0(2)|| \u2013 ||-||0(3)||-||-||5(2)||1||-||-||'''6(7)'''\n|-align=center\n|-style=\"background:lightblue\"\n|align=left|{{flagicon|ALG}}Algeria||2(1)||-||0(1)||1||0(1)||-||-||1||-||-||'''4(3)'''\n|-align=center\n|-style=\"background:lightgreen\"\n|align=left|{{flagicon|MAR}}Morocco||1(1)||1||0(1)||1||-||1(1)||-||-||-||-||'''4(3)'''\n|-align=center\n|-style=\"background:Pink\"\n|align=left|{{flagicon |DRC}}DR Congo||2||2||-||-||-||-||-||-||-||-||'''4'''\n|}\n\n==Sponsors==\nIn October 2004, [[MTN Group|MTN]] has contracted a four-year deal to sponsor African football's major competitions. This agreement, which worthed US$12.5&nbsp;million, was the biggest sponsorship deal in African sporting history at that time.<ref name=\"news.bbc.co.uk\">{{cite news |url=http://news.bbc.co.uk/sport2/hi/football/africa/3763112.stm |title=CAF signs sponsorship deal |date=21 October 2004 |work=BBC |publisher=BBC |accessdate=14 February 2018}}</ref>\n\nIn July 2009, [[Orange S.A.|Orange]] has signed an eight-year deal to sponsor African football's major competitions. Terms of the deal were not disclosed but CAF previous year put a value of  \u20ac100&nbsp;million for a comprehensive and long-term package of its competitions when it opened tenders for a new sponsor. The deal included the [[African Nations Cup]], the '''CAF Champions League''', the [[CAF Confederation Cup]], the [[CAF Super Cup]], the [[African Nations Championship]] and the [[African Youth Championship]].<ref name=\"reuters.com\">{{cite news |url=https://www.reuters.com/article/ozabs-soccer-africa-sponsor-20090728-idAFJOE56R0N320090728 |title=Orange signs deal to sponsor African soccer competitions |date=28 July 2009 |work=Reuters |publisher=Reuters |accessdate=12 February 2018}}</ref>\n\nIn July 2016, [[Total S.A.|Total]] replaced [[Orange S.A.|Orange]] as the main sponsor and has secured an eight-year sponsorship package from the Confederation of African Football (CAF) for a value of \u20ac950&nbsp;million<ref name=\"africanews.com\">{{cite news |url=http://www.africanews.com/2016/11/09/caf-reviews-prize-money-afcon-2017-winner-to-pocket-4-million/ |title=CAF reviews prize money, AFCON 2017 winner to pocket $4&nbsp;million |date=9 November 2016 |work=Africa News |publisher=Africa News |accessdate=14 February 2018}}</ref> to support ETof its principal competitions, including the CAF Champions League, renamed Total CAF Champions League.<ref name=\"africanews.com 2\">{{cite news |url=http://www.africanews.com/2016/07/21/total-to-sponsor-caf-competitions-for-the-next-eight-years/ |title=Total to sponsor CAF competitions for the next eight years |date=21 July 2016 |work=Africa News |publisher=Africa News |accessdate=21 July 2016}}</ref>\n\nThe CAF current main sponsors are:\n* 1XBET\n* [[Total S.A.|Total]]\n* [[Visa Inc.|Visa]]\n* [[Gilead Sciences|Gilead]]\n* Temmy's Cereal\n* [[Orange S.A.|Orange]]\n* [[Continental AG|Continental]]\n* [[Yamaha Motor Company|Yamaha]]\n\n==Rankings==\n\n====Top ranked men's national teams by FIFA====\n<timeline>\nImageSize = width:160 height:1800\nPlotArea = left:40 right:0 bottom:10 top:10\n\n# Just short of the date the next version of the FIFA World Ranking will be released (dd/mm/yyyy)\nDefine $enddate = 24/10/2019\n\nDateFormat = dd/mm/yyyy\nPeriod = from:08/08/1993 till:$enddate\nTimeAxis = orientation:vertical format:yyyy\nScaleMajor = unit:year increment:1 start:1994\n\n# Colors for teams (typically derived from jersey's first colors)\nColors =\n  id:Algeria     value:rgb(0.32, 0.66, 0.22) \n  id:Cameroon    value:rgb(0,    0.39, 0.20) \n  id:CapeVerde   value:rgb(0,    0.22, 0.58) \n  id:Egypt       value:rgb(0.87, 0,    0) \n  id:IvoryCoast  value:rgb(0.97, 0.47, 0)\n  id:Ghana       value:rgb(1,    1,    1) \n  id:Morocco     value:rgb(0.73, 0.07, 0.10)   \n  id:Nigeria     value:rgb(0,    0.53, 0.32)\n  id:Senegal     value:rgb(0,    0.52, 0.22) \n  id:SouthAfrica value:rgb(0.99, 0.71, 0.08) \n  id:Tunisia     value:rgb(1,    1,    1) \n  id:Zambia      value:rgb(0,    0.5,    0) \n\n# A line at the right side of the graph\nLineData =\n  from:08/08/1993 till:end atpos:65 color:black width:0.5\n\n# Setup text and color to use in the labeled bars\nDefine $labelAlgeria     = text:\"Algeria\" color:Algeria\nDefine $labelCameroon    = text:\"Cameroon\" color:Cameroon\nDefine $labelCapeVerde   = text:\"Cape Verde\" color:CapeVerde\nDefine $labelEgypt       = text:\"Egypt\" color:Egypt\nDefine $labelIvoryCoast  = text:\"Ivory Coast\" color:IvoryCoast\nDefine $labelGhana       = text:\"Ghana\" color:Ghana\nDefine $labelMorocco     = text:\"Morocco\" color:Morocco\nDefine $labelNigeria     = text:\"Nigeria\" color:Nigeria\nDefine $labelSenegal     = text:\"Senegal\" color:Senegal\nDefine $labelSouthAfrica = text:\"South Africa\" color:SouthAfrica\nDefine $labelTunisia     = text:\"Tunisia\" color:Tunisia\nDefine $labelZambia      = text:\"Zambia\" color:Zambia\n\nPlotData =\n  bar:Leaders width:25 mark:(line,black)\n\n  from:08/08/1993 till:25/07/1995 shift:(20,-5) $labelNigeria\n  from:25/07/1995 till:22/08/1995 shift:(20,-10) $labelTunisia\n  from:22/08/1995 till:19/09/1995 shift:(20,-5) $labelEgypt\n  from:19/09/1995 till:17/10/1995 shift:(20,-5) $labelNigeria\n  from:17/10/1995 till:21/11/1995 shift:(20,-5) $labelEgypt  \n  from:21/11/1995 till:19/12/1995 shift:(20,-5) $labelTunisia\n  from:19/12/1995 till:24/01/1996 shift:(20,-5) $labelIvoryCoast\n  from:24/01/1996 till:21/02/1996 shift:(20,-5) $labelGhana\n  from:21/02/1996 till:22/05/1996 shift:(20,-5) $labelZambia\n  from:24/04/1996 till:22/05/1996 shift:(20,-5) color:Ghana width:11 text:\"Ghana / Zambia\"\n  from:22/05/1996 till:18/12/1996 shift:(20,-5) $labelZambia\n  from:18/12/1996 till:27/02/1997 shift:(20,-5) $labelSouthAfrica\n  from:27/02/1997 till:14/05/1997 shift:(20,-5) $labelZambia\n  from:14/05/1997 till:16/02/2000 shift:(20,-5) $labelMorocco\n  from:16/02/2000 till:18/07/2001 shift:(20,-5) $labelSouthAfrica\n  from:18/07/2001 till:13/02/2002 shift:(20,-5) $labelTunisia\n  from:13/02/2002 till:06/10/2004 shift:(20,-5) $labelCameroon\n  from:06/10/2004 till:15/06/2005 shift:(20,-5) $labelNigeria\n  from:15/06/2005 till:20/07/2005 shift:(20,-5) $labelCameroon\n  from:20/07/2005 till:12/09/2005 shift:(20,-5) $labelEgypt  \n  from:12/09/2005 till:21/11/2005 shift:(20,-5) $labelCameroon\n  from:17/10/2005 till:21/11/2005 shift:(20,-5) color:Nigeria width:11 text:\"Cameroon / Nigeria\"\n  from:21/11/2005 till:15/02/2006 shift:(20,-5) $labelCameroon\n  from:15/02/2006 till:14/02/2007 shift:(20,-5) $labelNigeria\n  from:14/02/2007 till:19/09/2007 shift:(20,-5) $labelCameroon\n  from:19/09/2007 till:13/02/2008 shift:(20,-5) $labelNigeria\n  from:13/02/2008 till:04/06/2008 shift:(20,-5) $labelGhana\n  from:04/06/2008 till:01/07/2009 shift:(20,-5) $labelCameroon\n  from:01/07/2009 till:16/10/2009 shift:(20,-5) $labelIvoryCoast\n  from:16/10/2009 till:03/02/2010 shift:(20,-5) $labelCameroon\n  from:03/02/2010 till:02/02/2011 shift:(20,-5) $labelEgypt  \n  from:02/02/2011 till:29/06/2011 shift:(20,-5) $labelGhana\n  from:29/06/2011 till:05/06/2014 shift:(20,-5) $labelIvoryCoast\n  from:05/06/2014 till:05/11/2015 shift:(20,-5) $labelAlgeria\n  from:05/11/2015 till:03/03/2016 shift:(20,-5) $labelIvoryCoast\n  from:03/03/2016 till:07/04/2016 shift:(20,-5) $labelCapeVerde\n  from:07/04/2016 till:15/09/2016 shift:(20,-5) $labelAlgeria\n  from:15/09/2016 till:24/11/2016 shift:(20,-5) $labelIvoryCoast\n  from:24/11/2016 till:09/02/2017 shift:(20,-5) $labelSenegal\n  from:09/02/2017 till:16/10/2017 shift:(20,-5) $labelEgypt  \n  from:16/10/2017 till:23/11/2017 shift:(20,-5) $labelTunisia\n  from:23/11/2017 till:18/01/2018 shift:(20,-5) $labelSenegal\n  from:18/01/2018 till:20/09/2018 shift:(20,-5) $labelTunisia\n  from:16/08/2018 till:20/09/2018 shift:(20,-5) color:Senegal width:11 text:\"Senegal / Tunisia\"\n  from:20/09/2018 till:29/11/2018 shift:(20,-5) $labelTunisia\n  from:29/11/2018 till:end shift:(20,-5) $labelSenegal\n</timeline><noinclude>\n\nThis graph shows the time periods each (male) national football team has been at the highest ranked CAF member on the [[FIFA World Rankings]]. \n</noinclude>\n\n{{col-begin}}\n{{col-2}}\n\n====Top ranked  women's national teams by FIFA====\n<timeline>\nImageSize = width:160 height:300\nPlotArea = left:40 right:0 bottom:10 top:10\nDateFormat = dd/mm/yyyy\nPeriod = from:01/01/2003 till:29/09/2019\nScaleMajor = unit:year increment:1 start:2003\nTimeAxis = orientation:vertical format:yyyy\n\nColors =\n  id:NGA         value:green\n\nPlotData= \n  bar:Leaders width:25 mark:(line,black) align:left fontsize:S\n\n  from:01/01/2003 till:27/09/2019 shift:(20,-3) text:\"Nigeria\" color:NGA\n</timeline>\n{{col-end}}\n\n{{col-begin}}\n{{col-2}}\n\n===Men's national teams===\nRankings are calculated by [[FIFA]].<ref>{{cite web |title=The FIFA/Coca-Cola World Ranking - Ranking Table - African Zone  - FIFA.com |url=https://www.fifa.com/fifa-world-ranking/ranking-table/men/#CAF |website=FIFA.com}}</ref>\n\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|-\n!CAF\n![[FIFA]]\n!Country\n!Point\n!+/\u2212\n!Region\n|- \n|'''1'''\n|'''20'''\n|align=left|{{fb|SEN}}\n|1546\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''2'''\n|'''29'''\n|align=left|{{fb|TUN}}\n|1495\n|{{steady}}\n|  style=\"text-align:center; background:#8fbc8f;\"|[[Union of North African Football Federations|{{white|UNAF}}]]\n|-\n|'''3'''\n|'''35'''\n|align=left|{{fb|NGA}}\n|1481\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''4'''\n|'''38'''\n|align=left|{{fb|ALG}}\n|1469\n|{{steady}}\n|  style=\"text-align:center; background:#8fbc8f;\"|[[Union of North African Football Federations|{{white|UNAF}}]]\n|-\n|'''5'''\n|'''42'''\n|align=left|{{fb|MAR}}\n|1457\n|{{decrease}} \u22123\n|  style=\"text-align:center; background:#8fbc8f;\"|[[Union of North African Football Federations|{{white|UNAF}}]]\n|-\n|'''6'''\n|'''49'''\n|align=left|{{fb|EGY}}\n|1433\n|{{steady}}\n|  style=\"text-align:center; background:#8fbc8f;\"|[[Union of North African Football Federations|{{white|UNAF}}]]\n|-\n|'''7'''\n|'''51'''\n|align=left|{{fb|GHA}}\n|1426\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''8'''\n|'''52'''\n|align=left|{{fb|CMR}}\n|1409\n|{{steady}}\n|  style=\"text-align:center; background:#db7093;\"|[[Central African Football Federations' Union|{{white|UNIFFAC}}]]\n|-\n|'''9'''\n|'''54'''\n|align=left|{{fb|COD}}\n|1399\n|{{increase}} +1\n|  style=\"text-align:center; background:#db7093;\"|[[Central African Football Federations' Union|{{white|UNIFFAC}}]]\n|-\n|'''10'''\n|'''56'''\n|align=left|{{fb|CIV}}\n|1392\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''11'''\n|'''59'''\n|align=left|{{fb|MLI}}\n|1386\n|{{decrease}} \u22122\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''12'''\n|'''60'''\n|align=left|{{fb|BFA}}\n|1378\n|{{increase}} +1\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''13'''\n|'''72'''\n|align=left|{{fb|RSA}}\n|1337\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#deb887;\"|[[Counsel of Southern African Football Association|{{white|COSAFA}}]]\n|-\n|'''14'''\n|'''77'''\n|align=left|{{fb|CPV}}\n|1319\n|{{increase}} +1\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''15'''\n|'''78'''\n|align=left|{{fb|GUI}}\n|1317\n|{{decrease}} \u22124\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''16'''\n|'''79'''\n|align=left|{{fb|UGA}}\n|1311\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''17'''\n|'''81'''\n|align=left|{{fb|ZAM}}\n|1299\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''18'''\n|'''82'''\n|align=left|{{fb|BEN}}\n|1293\n|{{increase}} +1\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''19'''\n|'''87'''\n|align=left|{{fb|GAB}}\n|1285\n|{{increase}} +1\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''20'''\n|'''92'''\n|align=left|{{fb|CGO}}\n|1265\n|{{decrease}} \u22122\n|  style=\"text-align:center;background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''21'''\n|'''95'''\n|align=left|{{fb|MAD}}\n|1249\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''22'''\n|'''103'''\n|align=left|{{fb|LBY}}\n|1211\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#8fbc8f;\"|[[UNAF|{{white|UNAF}}]]\n|-\n|'''23'''\n|'''105'''\n|align=left|{{fb|MTN}}\n|1205\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''24'''\n|'''107'''\n|align=left|{{fb|NIG}}\n|1198\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''24'''\n|'''108'''\n|align=left|{{fb|KEN}}\n|1195\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''26'''\n|'''112'''\n|align=left|{{fb|CTA}}\n|1186\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''23'''\n|'''105'''\n|align=left|{{fb|MOZ}}\n|1205\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''28'''\n|'''117'''\n|align=left|{{fb|SLE}}\n|1167\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''28'''\n|'''117'''\n|align=left|{{fb|ZIM}}\n|1167\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''30'''\n|'''119'''\n|align=left|{{fb|NAM}}\n|1163\n|{{increase}} +1\n|  style=\"text-align:center; background:#deb887;\"|[[Council of Southern Africa Football Associations|{{white|COSAFA}}]]\n|-\n|'''31'''\n|'''120'''\n|align=left|{{fb|ANG}}\n|1161\n|{{increase}} +1\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''32'''\n|'''123'''\n|align=left|{{fb|GNB}}\n|1155\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''33'''\n|'''124'''\n|align=left|{{fb|MWI}}\n|1140\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''33'''\n|'''124'''\n|align=left|{{fb|TOG}}\n|1140\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''35'''\n|'''128'''\n|align=left|{{fb|SDN}}\n|1111\n|{{steady}}\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''36'''\n|'''129'''\n|align=left|{{fb|RWA}}\n|1106\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''37'''\n|'''133'''\n|align=left|{{fb|TAN}}\n|1084\n|{{increase}} +2\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''38'''\n|'''135'''\n|align=left|{{fb|EQG}}\n|1083\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''39'''\n|'''138'''\n|align=left|{{fb|LES}}\n|1076\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''40'''\n|'''142'''\n|align=left|{{fb|COM}}\n|1067\n|{{increase}} +5\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''41'''\n|'''143'''\n|align=left|{{fb|BDI}}\n|1063\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''42'''\n|'''146'''\n|align=left|{{fb|BOT}}\n|1057\n|{{increase}} +2\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''43'''\n|'''147'''\n|align=left|{{fb|ESW}}\n|1055\n|{{increase}} +3\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''44'''\n|'''151'''\n|align=left|{{fb|ETH}}\n|1049\n|{{steady}}\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''45'''\n|'''152'''\n|align=left|{{fb|LBR}}\n|1047\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''46'''\n|'''162'''\n|align=left|{{fb|SSD}}\n|997\n|{{increase}} +11\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''47'''\n|'''166'''\n|align=left|{{fb|GAM}}\n|990\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''48'''\n|'''173'''\n|align=left|{{fb|MRI}}\n|970\n|{{decrease}} \u221212\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''49'''\n|'''176'''\n|align=left|{{fb|CHA}}\n|955\n|{{increase}} +1\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''50'''\n|'''180'''\n|align=left|{{fb|STP}}\n|934\n|{{increase}} +10\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''51'''\n|'''185'''\n|align=left|{{fb|DJI}}\n|916\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''52'''\n|'''198'''\n|align=left|{{fb|SOM}}\n|879\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''53'''\n|'''200'''\n|align=left|{{fb|SEY}}\n|868\n|{{decrease}} \u22122\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''54'''\n|'''206'''\n|align=left|{{fb|ERI}}\n|856\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|}\n[https://www.fifa.com/fifa-world-ranking/ranking-table/men/#CAF Last updated 24 October 2019]\n{{col-2}}\n\n===Women's national teams===\nRankings are calculated by [[FIFA]].<ref>{{cite web |url=https://www.fifa.com/fifa-world-ranking/ranking-table/women/#CAF |title=The FIFA/Coca-Cola World Ranking (Women) \u2013 CAF Region |publisher=FIFA |date=23 December 2011 |accessdate=}}</ref>\n{{updated|12 July 2019}}\n{| class=\"wikitable\" cellpadding=\"5\" style=\"text-align: center;\"\n|-\n!CAF\n![[FIFA]]\n!Country\n!Point\n!+/\u2212\n|-\n|'''1'''\n|'''36'''\n|align=left|{{fbw|NGA}}\n|1643\n|{{increase}} 2 \n|-\n|'''2'''\n|'''41'''\n|align=left|{{fbw|CMR}}\n|1552\n|{{increase}} 5 \n|-\n|'''3'''\n|'''49'''\n|align=left|{{fbw|RSA}}\n|1486\n|{{steady}} \n|-\n|'''4'''\n|'''53'''\n|align=left|{{fbw|GHA}}\n|1452\n|{{decrease}} 2 \n|-\n|'''5'''\n|'''69'''\n|align=left|{{fbw|CIV}}\n|1363\n|{{steady}}\n|-\n|'''6'''\n|'''71'''\n|align=left|{{fbw|EQG}}\n|1356\n|{{decrease}} 1\n|-\n|'''7'''\n|'''80'''\n|align=left|{{fbw|MLI}}\n|1288\n|{{increase}} 5\n|-\n|'''8'''\n|'''83'''\n|align=left|{{fbw|MAR}}\n|1280\n|{{decrease}} 4 \n|-\n|'''9'''\n|'''86'''\n|align=left|{{fbw|ALG}}\n|1271\n|{{decrease}} 2 \n|-\n|'''10'''\n|'''88'''\n|align=left|{{fbw|SEN}}\n|1232\n|{{steady}}\n|-\n|'''11'''\n|'''102'''\n|align=left|{{fbw|ZIM}}\n|1192\n|{{steady}} \n|-\n|'''12'''\n|'''105'''\n|align=left|{{fbw|CGO}}\n|1178\n|{{decrease}} 5\n|-\n|'''13'''\n|'''116'''\n|align=left|{{fbw|COD}}\n|1128\n|{{steady}}\n|-\n|'''14'''\n|'''118'''\n|align=left|{{fbw|ETH}}\n|1122\n|{{decrease}} 1\n|-\n|'''15'''\n|'''119'''\n|align=left|{{fbw|ZAM}}\n|1119\n|{{decrease}} 3\n|-\n|'''16'''\n|'''124'''\n|align=left|{{fbw|GAB}}\n|1070\n|{{steady}}\n|-\n|'''17'''\n|'''125'''\n|align=left|{{fbw|BFA}}\n|1062\n|{{decrease}} 3\n|-\n|'''18'''\n|'''135'''\n|align=left|{{fbw|TAN}}\n|978\n|{{decrease}} 2\n|-\n|'''19'''\n|'''138'''\n|align=left|{{fbw|NAM}}\n|966\n|{{decrease}} 10\n|-\n|'''20'''\n|'''141'''\n|align=left|{{fbw|KEN}}\n|921\n|{{decrease}} 3\n|-\n|'''21'''\n|'''143'''\n|align=left|{{fbw|RWA}}\n|899\n|{{decrease}} 3\n|-\n|'''22'''\n|'''146'''\n|align=left|{{fbw|MWI}}\n|881\n|{{increase}} 1\n|-\n|'''23'''\n|'''148'''\n|align=left|{{fbw|UGA}}\n|868\n|{{decrease}} 4\n|-\n|'''24'''\n|'''149'''\n|align=left|{{fbw|LES}}\n|850\n|{{decrease}} 3\n|-\n|'''25'''\n|'''150'''\n|align=left|{{fbw|MOZ}}\n|823\n|{{decrease}} 5\n|-\n|'''26'''\n|'''151'''\n|align=left|{{fbw|SWZ}}\n|804\n|{{decrease}} 3\n|-\n|'''27'''\n|'''152'''\n|align=left|{{fbw|BOT}}\n|796\n|{{decrease}} 1\n|-\n|'''28'''\n|'''158'''\n|align=left|{{fbw|MAD}}\n|693\n|{{decrease}} 3\n|-\n|'''29'''\n|'''**'''\n|align=left|{{fbw|TUN}}\n|1313\n|{{decrease}} 7\n|-\n|'''30'''\n|'''**'''\n|align=left|{{fbw|EGY}}\n|1256\n|{{decrease}} 7\n|-\n|'''31'''\n|'''*'''\n|align=left|{{fbw|GAM}}\n|1183\n|{{decrease}} 7\n|-\n|'''32'''\n|'''*'''\n|align=left|{{fbw|ANG}}\n|1134\n|{{decrease}} 7\n|-\n|'''33'''\n|'''**'''\n|align=left|{{fbw|SLE}}\n|1132\n|{{decrease}} 7\n|-\n|'''34'''\n|'''**'''\n|align=left|{{fbw|Guinea}}\n|1077\n|{{decrease}} 7\n|-\n|'''35'''\n|'''**'''\n|align=left|{{fbw|Eritrea}}\n|1060\n|{{decrease}} 7\n|-\n|'''36'''\n|'''*'''\n|align=left|{{fbw|CAR}}\n|1056\n|{{decrease}} 7\n|-\n|'''37'''\n|'''*'''\n|align=left|{{fbw|Togo}}\n|962\n|{{decrease}} 7\n|-\n|'''38'''\n|'''**'''\n|align=left|{{fbw|Guinea-Bissau}}\n|927\n|{{decrease}} 7\n|-\n|'''39'''\n|'''*'''\n|align=left|{{fbw|Niger}}\n|891\n|{{decrease}} 7\n|-\n|'''40'''\n|'''**'''\n|align=left|{{fbw|Liberia}}\n|877\n|{{decrease}} 7\n|-\n|'''41'''\n|'''*'''\n|align=left|{{fbw|Comoros}}\n|837\n|{{decrease}} 7\n|-\n|'''42'''\n|'''*'''\n|align=left|{{fbw|Libya}}\n|761\n|{{decrease}} 7\n|-\n|'''43'''\n|'''**'''\n|align=left|{{fbw|Burundi}}\n|519\n|{{decrease}} 7\n|-\n|'''44'''\n|'''*'''\n|align=left|{{fbw|Mauritius}}\n|358\n|{{decrease}} 7\n|}\n: * Provisionally listed due to not having played more than five matches against officially ranked teams.\n: ** Unranked teams are inactive for more than 18 months and therefore not ranked.\n{{col-end}}\n\n===CAF overall ranking of African clubs titles===\nThe following clubs are the top 10 clubs in CAF competitions.\n{| class=\"wikitable\" style=\"text-align: left;\"\n|-\n!width=2%| Pos\n!width=17%| Club\n!width=3%| Titles\n!width=65%| Trophies won\n|-\n| style=\"text-align:center;\"| 1||{{Flagicon|Egypt}} [[Al Ahly SC]]||align=center|20||8 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Confederation Cup]], 4 [[African Cup Winners' Cup]], 6 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n| style=\"text-align:center;\"| 2||{{Flagicon|Egypt}} [[Zamalek SC]]||align=center|13||5 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Confederation Cup]], 1 [[African Cup Winners' Cup]], 4 [[CAF Super Cup]], 2 [[Afro-Asian Club Championship]]\n|-\n| style=\"text-align:center;\"| 3||{{Flagicon|Democratic Republic of the Congo}} [[TP Mazembe]]||align=center|11||5 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 2 [[CAF Confederation Cup]], 1 [[African Cup Winners' Cup]], 3 [[CAF Super Cup]]\n|-\n| style=\"text-align:center;\"| 4||{{Flagicon|Tunisia}} [[\u00c9toile du Sahel]]||align=center|9||1 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 2 [[African Cup Winners' Cup]], 2 [[CAF Confederation Cup]], 2 [[CAF Cup]], 2 [[CAF Super Cup]]\n|-\n| style=\"text-align:center;\"| 5||{{Flagicon|Tunisia}} [[Esp\u00e9rance Sportive de Tunis]]||align=center |8||4 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[African Cup Winners' Cup]], 1 [[CAF Cup]], 1 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n| style=\"text-align:center;\"| 6\n|{{Flagicon|Morocco}} [[Raja Casablanca]]||align=center|8||3 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Confederation Cup]], 1 [[CAF Cup]], 2 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n\n| style=\"text-align:center;\"| 7\n|{{Flagicon|Algeria}} [[JS Kabylie]]||align=center|6||2 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[African Cup Winners' Cup]], 3 [[CAF Cup]]\n|-\n| style=\"text-align:center;\"| 8\n|{{Flagicon|Morocco}} [[Wydad Casablanca]]||align=center|5||2 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Cup Winners' Cup]], 1 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n| rowspan=\"4\" style=\"text-align:center;\"| 9\n|{{Flagicon|Algeria}} [[ES S\u00e9tif]]||align=center|4||2 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n|{{Flagicon|Cameroon}} [[Canon Yaound\u00e9]]||align=center|4||3 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[African Cup Winners' Cup]]\n|-\n|{{Flagicon|Nigeria}} [[Enyimba International F.C.|Enyimba F.C.]]||align=center|4||2 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 2 [[CAF Super Cup]]\n\n|-\n|{{Flagicon|Tunisia}} [[CS Sfaxien]] ||align=center|4|| 3 [[CAF Confederation Cup]], 1 [[CAF Cup]]\n|}\n{{refbegin}}''Update as of 21 February 2015 in chronological order.''{{refend}}\n\n===CAF overall ranking of African clubs===\nRankings are calculated by the CAF based on points gathered by African teams throughout their participation in international club tournaments organized by either the [[FIFA]], Harrison Campbell, or the CAF since the establishment of the first [[African Cup of Champions Clubs]] in 1964.<ref>{{cite web |url=http://www.cafonline.com/index.php?lng=1&cmpt=0&module=media&ANC=actualite&TNews=&idrub=97076&idnews=83214 |title=African Club Ranking: Old-Time records from 2000 to 2010 |publisher=CAF |date=1 May 2014 |accessdate=1 November 2014}}</ref>\n{{col-begin}}\n{{col-3}}\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|+ Overall\n|-\n!Rank\n!Club\n!Points\n|- \n|'''1'''\n|align=left|{{flagicon|EGY}} [[Al Ahly SC]]\n|'''90'''\n|-\n|2\n|align=left|{{flagicon|TUN}} [[\u00c9toile du Sahel]]\n\n|60\n|-\n|3\n|align=left|{{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance Tunis]]\n|59\n|-\n|4\n|align=left|{{flagicon|EGY}} [[Zamalek SC|Zamalek]]\n|56\n|-\n|5\n|align=left|{{flagicon|COD}} [[TP Mazembe]]\n|49\n|-\n|6\n|align=left|{{flagicon|COD}} [[A.S. Vita Club|Vita Club]]\n|44\n|-\n|7\n|align=left|{{flagicon|CIV}} [[ASEC Mimosas]]\n|43\n|-\n|8\n|align=left|{{flagicon|ALG}} [[JS Kabylie]]\n|39\n|-\n|9\n|align=left|{{flagicon|CMR}} [[Canon Yaound\u00e9]]\n|36\n|-\n|10\n|align=left|{{flagicon|GHA}} [[Accra Hearts of Oak SC|Hearts of Oak]]\n|31\n|}\n{{col-3}}\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|+ CAF Ranking of the 20th Century\n|-\n! Rank\n! Club\n! Points\n|-\n| 1\n| align=left|{{flagicon|EGY}} [[Al-Ahly Sporting Club|Al-Ahly]]\n| '''40'''\n|-\n| 2\n| align=left|{{flagicon|EGY}} [[Zamalek Sporting Club|El-Zamalek]]\n| 37\n|-\n| 3\n| align=left|{{flagicon|MAR}} [[Raja Casablanca]]\n| 35\n|-\n| 4\n| align=left|{{flagicon|GHA}} [[Asante Kotoko F.C.|Asante Kotoko]]\n| 34\n|-\n| 4\n| align=left|{{flagicon|CMR}} [[Canon Sportif de Yaound\u00e9|Canon Yaound\u00e9]]  \n| 34\n|-\n| 6\n| align=left|{{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance Tunis]]   \n| 27\n|-\n| 6\n| align=left|{{flagicon|CIV}} [[ASEC Mimosas]]    \n| 27\n|-\n| 8\n| align=left|{{flagicon|GHA}} [[Accra Hearts of Oak Sporting Club|Hearts of Oak]]  \n| 26\n|-\n| 9 \n| align=left|{{flagicon|CIV}} [[Africa Sports National|Africa Sports]]   \n| 25\n|-\n| 10\n| align=left|{{flagicon|ALG}} [[Jeunesse Sportive de Kabylie|JS Kabylie]]\n| 20\n|}\n{{col-3}}\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|+ IFFHS Ranking of the 20th Century\n|-\n!Rank\n!club\n!Points\n|-\n| '''1'''\n| align=left|{{flagicon|GHA}} [[Asante Kotoko]]\n| '''149,00'''\n|- \n| 2\n| align=left|{{flagicon|EGY}} [[Al Ahly SC]]\n| 131,50\n|-\n| 3\n| align=left|{{flagicon|EGY}} [[Zamalek SC|Zamalek]]\n| 126,75\n|-\n| 4\n| align=left|{{flagicon|CMR}} [[Canon Sportif de Yaound\u00e9|Canon Yaound\u00e9]]\n| 125,50\n|-\n| 5\n| align=left|{{flagicon|CIV}} [[ASEC Mimosas]]\n| 111,50\n|-\n| 6\n| align=left|{{flagicon|GHA}} [[Accra Hearts of Oak Sporting Club|Hearts of Oak]]\n| 104,00\n|-\n| 7\n| align=left|{{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance Tunis]]\n| 98,00\n|-\n| 8\n| align=left|{{flagicon|GUI}} [[Hafia Football Club|Hafia FC]]\n| 96,00\n|-\n| 9\n| align=left|{{flagicon|CIV}} [[Africa Sports National|Africa Sports]]\n| 88,25\n|-\n| 10\n| align=left|{{flagicon|COD}} [[TP Mazembe]]\n| 77,50\n|}\n{{col-end}}\n\n=== Men's Futsal===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align:center;\"\n|-\n!CAF\n![[FIFA]]\n!Country\n!Points\n!+/-\n|}\n\n=== Women's Futsal===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align:center;\"\n|-\n!CAF\n![[FIFA]]\n!Country\n!Points\n!+/-\n|}\n\n===Beach soccer national teams===\nRankings are calculated by [[Beach Soccer Worldwide]] (BSWW). Top ten, [http://beachsoccer.com/ranking/overall/africa last updated 12 March 2018]\n{|class=\"wikitable\" cellpadding=\"1\" style=\"text-align:center;\"\n|-\n!CAF\n![[BSWW]]\n!Country\n!Points\n|-\n|1\n|12\n|align=left|{{beachsoccer|SEN}}\n|1084\n|-\n|2\n|17\n|align=left|{{beachsoccer|EGY}}\n|782\n|-\n|3\n|20\n|align=left|{{beachsoccer|NGA}}\n|720\n|-\n|4\n|24\n|align=left|{{beachsoccer|Morocco}}\n|609\n|-\n|5\n|34\n|align=left|{{beachsoccer|MAD}}\n|339\n|-\n|6\n|41\n|align=left|{{beachsoccer|Ivory Coast}}\n|330\n|-\n|7\n|57\n|align=left|{{beachsoccer|GHA}}\n|177\n|-\n|8\n|66\n|align=left|{{beachsoccer|LBY}}\n|125\n|-\n|9\n|68\n|align=left|{{beachsoccer|MOZ}}\n|117\n|-\n|10\n|69\n|align=left|{{beachsoccer|Cape Verde}}\n|115\n|}\n\n==Major Tournaments==\n\n===FIFA World Cup===\n{{Main|African nations at the FIFA World Cup}}\n\n;''Legend''\n{{col-begin|width=auto}}\n{{col-2}}\n*{{bg|gold|1st}} \u2013 Champions\n*{{bg|silver|2nd}} \u2013 Runners-up\n*{{bg|#cc9966|3rd}} \u2013 Third place\n*{{bg|#9acdff|4th}} \u2013 Fourth place\n*QF \u2013 Quarterfinals (1934\u20131938, 1954\u20131970, and 1986\u2013present: knockout round of 8)\n*R2 \u2014 Round 2 (1974\u20131978, second group stage, top 8; 1982: second group stage, top 12; 1986\u2013present: knockout round of 16)\n*R1 \u2014 Round 1\n{{col-break}}\n*q \u2014 Qualified for upcoming tournament\n*{{border|width=1px|color=gray|&nbsp;\u2022\u2022&nbsp;}} \u2013 Qualified but withdrew\n*{{border|width=1px|color=gray|&nbsp;\u2022&nbsp;}} \u2013 Did not qualify\n*{{border|width=1px|color=gray|&nbsp;\u00d7&nbsp;}} \u2013 Did not enter / Withdrew / Banned\n*{{border|width=3px|color=red|&nbsp;&nbsp;}} \u2013 Hosts\n*{{border|width=1px|color=gray|&nbsp;&nbsp;&nbsp;}} \u2013 Not affiliated in FIFA\n{{col-end}}\n\nFor each tournament, the number of teams in each finals tournament (in brackets) are shown.\n\n{| class=\"wikitable\" style=\"text-align:center; font-size:85%;\"\n|-\n! Team\n![[1930 FIFA World Cup|1930]]<br>{{Flagicon|Uruguay}}<br>(13)\n![[1934 FIFA World Cup|1934]]<br>{{Flagicon|Italy|1861}}<br>(16)\n![[1938 FIFA World Cup|1938]]<br>{{Flagicon|France}}<br>(15)\n![[1950 FIFA World Cup|1950]]<br>{{Flagicon|Brazil}}<br>(13)\n![[1954 FIFA World Cup|1954]]<br>{{Flagicon|Switzerland}}<br>(16)\n![[1958 FIFA World Cup|1958]]<br>{{Flagicon|Sweden}}<br>(16)\n![[1962 FIFA World Cup|1962]]<br>{{Flagicon|Chile}}<br>(16)\n![[1966 FIFA World Cup|1966]]<br>{{Flagicon|England}}<br>(16)\n![[1970 FIFA World Cup|1970]]<br>{{Flagicon|Mexico}}<br>(16)\n![[1974 FIFA World Cup|1974]]<br>{{Flagicon|West Germany}}<br>(16)\n![[1978 FIFA World Cup|1978]]<br>{{Flagicon|Argentina}}<br>(16)\n![[1982 FIFA World Cup|1982]]<br>{{Flagicon|Spain}}<br>(24)\n![[1986 FIFA World Cup|1986]]<br>{{Flagicon|Mexico}}<br>(24)\n![[1990 FIFA World Cup|1990]]<br>{{Flagicon|Italy}}<br>(24)\n![[1994 FIFA World Cup|1994]]<br>{{Flagicon|USA}}<br>(24)\n![[1998 FIFA World Cup|1998]]<br>{{Flagicon|France}}<br>(32)\n![[2002 FIFA World Cup|2002]]<br>{{Flagicon|South Korea}}<br>{{Flagicon|Japan}}<br>(32)\n![[2006 FIFA World Cup|2006]]<br>{{Flagicon|Germany}}<br>(32)\n![[2010 FIFA World Cup|2010]]<br>{{Flagicon|South Africa}}<br>(32)\n![[2014 FIFA World Cup|2014]]<br>{{Flagicon|Brazil}}<br>(32)\n![[2018 FIFA World Cup|2018]]<br>{{Flagicon|Russia}}<br>(32)\n![[2022 FIFA World Cup|2022]]<br>{{Flagicon|Qatar}}<br>(32)\n![[2026 FIFA World Cup|2026]]<br>{{Flagicon|Canada}}<br>{{Flagicon|Mexico}}<br>{{Flagicon|United States}}<br>(48)\n!Total\n|-\n| id=\"ALG\" style=\"text-align:left;\"| {{fb|ALG}}\n|colspan=7| ''Part of France''<ref>''[[Algeria]]'' gained independence in 1962, but they joined with other African nations to boycott the [[1966 FIFA World Cup]]. Thus the [[1970 FIFA World Cup qualification]] was their first participation.</ref> ||\u00d7||\u2022||\u2022||\u2022|| R1<br>{{small|13th}} || R1<br>{{small|22nd}} ||\u2022||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|28th}} || R2<br>{{small|14th}} ||\u2022|| || || 4/13\n|-\n| id=\"ANG\" style=\"text-align:left;\"| {{fb|ANG}}\n|colspan=11| ''Part of Portugal''<ref>''[[Angola]]'' gained independence in 1975. Thus the [[1986 FIFA World Cup qualification]] was their first participation.</ref> ||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|23rd}} ||\u2022||\u2022||\u2022|| || || 1/9\n|-\n| id=\"CMR\" style=\"text-align:left;\"| {{fb|CMR}}\n|colspan=6| ''Part of France'' ||\u00d7||\u00d7||\u2022||\u2022||\u2022|| R1<br>{{small|17th}}||\u2022|| QF<br>{{small|7th}} || R1<br>{{small|22nd}} || R1<br>{{small|25th}} || R1<br>{{small|20th}} ||\u2022|| R1<br>{{small|31st}} || R1<br>{{small|32nd}} ||\u2022|| || || 7/13\n|-\n| id=\"COD\" style=\"text-align:left;\"| {{fb|COD}}<ref name=\"Zaire\">The [[Democratic Republic of the Congo]] competed as [[Zaire]] in 1974.</ref>\n|colspan=6| ''Part of Belgium''<ref>''[[Democratic Republic of the Congo]]'' gained independence in 1960, but they joined with other African nations to boycott the [[1966 FIFA World Cup]]. Thus the [[1974 FIFA World Cup qualification]] was their first participation.</ref> || ||\u00d7||\u00d7|| R1<br>{{small|16th}} ||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022|| || || 1/11\n|-\n| id=\"EGY\" style=\"text-align:left;\"| {{fb|EGY}}\n|\u00d7|| R1<br>{{small|13th}} ||\u00d7||\u00d7||\u2022||\u00d7||\u00d7||\u00d7||\u00d7||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|20th}} ||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|31st}} || || || 3/14\n|-\n| id=\"GHA\" style=\"text-align:left;\"| {{fb|GHA}}\n|colspan=5| ''Part of the United Kingdom'' ||\u00d7||\u2022||\u00d7||\u2022||\u2022||\u2022||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022|| R2<br>{{small|13th}} || QF<br>{{small|7th}} || R1<br>{{small|25th}} ||\u2022|| || || 3/13\n|-\n| id=\"CIV\" style=\"text-align:left;\"| {{fb|CIV}}\n|colspan=6| ''Part of France'' ||\u00d7||\u00d7||\u00d7||\u2022||\u2022||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|19th}} || R1<br>{{small|17th}} || R1<br>{{small|21st}} ||\u2022|| || || 3/11\n|-\n| id=\"MAR\" style=\"text-align:left;\"| {{fb|MAR}}\n|colspan=5| ''Part of France'' || ||\u2022||\u00d7|| R1<br>{{small|14th}} ||\u2022||\u2022||\u2022|| R2<br>{{small|11th}} ||\u2022|| R1<br>{{small|23rd}} || R1<br>{{small|18th}} ||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|27th}} || || || 5/14\n|-\n| id=\"NGA\" style=\"text-align:left;\"| {{fb|NGA}}\n|colspan=6| ''Part of the United Kingdom'' ||\u2022||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022|| R2<br>{{small|9th}} || R2<br>{{small|12th}} || R1<br>{{small|27th}} ||\u2022|| R1<br>{{small|27th}} || R2<br>{{small|16th}} || R1<br>{{small|21st}} || || || 6/14\n|-\n| id=\"SEN\" style=\"text-align:left;\"| {{fb|SEN}}\n|colspan=6| ''Part of France'' ||\u00d7||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022||\u00d7||\u2022||\u2022|| QF<br>{{small|7th}} ||\u2022||\u2022||\u2022|| R1<br>{{small|17th}} || || || 2/11\n|-\n| id=\"RSA\" style=\"text-align:left;\"| {{fb|RSA}}\n|colspan=4| ||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u2022|| R1<br>{{small|24th}} || R1<br>{{small|17th}} ||\u2022||style=\"border: 3px solid red\"| R1<br>{{small|20th}} ||\u2022||\u2022|| || || 3/7\n|-\n| id=\"TOG\" style=\"text-align:left;\"| {{fb|TOG}}\n|colspan=6| ''Part of France'' ||\u00d7||\u00d7||\u00d7||\u2022||\u2022||\u2022||\u00d7||\u00d7||\u2022||\u2022||\u2022|| R1<br>{{small|30th}} ||\u2022||\u2022||\u2022|| || || 1/10\n|-\n| id=\"TUN\" style=\"text-align:left;\"| {{fb|TUN}}\n|colspan=5| ''Part of France'' || ||\u2022||\u00d7||\u2022||\u2022|| R1<br>{{small|9th}} ||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|26th}} || R1<br>{{small|29th}} || R1<br>{{small|24th}} ||\u2022||\u2022|| R1<br>{{small|24th}} || || || 5/14\n|-\n!align=left| Total || 0 || 1 || 0 || 0 || 0 || 0 || 0 || 0 || 1 || 1 || 1 || 2 || 2 || 2 || 3 || 5 || 5 || 5 || 6 || 5 || 5 || 5 || || 44\n|}\n\n;''Firsts''\n*1934: {{fb|Egypt|1922}} first African team to qualify for the World Cup\n*1970: {{fb|Morocco}} first African team to draw a match in the World Cup\n*1978: {{fb|Tunisia}} first African team to win a match in the World Cup\n*1982: {{fb|Algeria}} first African team to win two matches in the World Cup\n*1986: {{fb|Algeria}} first African team to qualify two consecutive World Cups\n*1986: {{fb|Morocco}} first African team to reach the knockout stage (round of sixteen)\n*1990: {{fb|Cameroon}} first African team to reach the knockout stage (quarter-finals)\n*1994 and 1998: {{fb|Nigeria}} first African team to win and reach the knockout stage (round of sixteen) in two consecutive World Cups\n*2002: {{fb|Senegal}} first African team to reach the knockout stage (quarter-finals) further on the World Cup debut\n*2010: {{fb|South Africa}} first African team to host the World Cup\n*2014: {{fb|Algeria}} & {{fb|Nigeria}} first African teams to reach the knockout stage (round of sixteen) simultaneously in the World Cup\n\n===FIFA Women's World Cup===\nThe following CAF members have competed in the following [[FIFA Women's World Cup]]s.  Teams are sorted by number of appearances.\n\n{| class=\"wikitable\" style=\"text-align:center; font-size:85%;\"\n\n|-  style=\"background:#ccc;\"\n!Team\n![[1991 FIFA Women's World Cup|1991]]<br>{{Flagicon|CHN}}<br>(12)\n![[1995 FIFA Women's World Cup|1995]]<br>{{Flagicon|SWE}}<br>(12)\n![[1999 FIFA Women's World Cup|1999]]<br>{{Flagicon|USA}}<br>(16)\n![[2003 FIFA Women's World Cup|2003]]<br>{{Flagicon|USA}}<br>(16)\n![[2007 FIFA Women's World Cup|2007]]<br>{{Flagicon|CHN}}<br>(16)\n![[2011 FIFA Women's World Cup|2011]]<br>{{Flagicon|GER}}<br>(16)\n![[2015 FIFA Women's World Cup|2015]]<br>{{Flagicon|CAN}}<br>(24)\n![[2019 FIFA Women's World Cup|2019]]<br>{{Flagicon|FRA}}<br>(24)\n![[2023 FIFA Women's World Cup|2023]]<br>{{Flagicon| }}<br>(32)\n!Total\n|-\n| align=left| {{fbw|CMR}}\n|  \u2022 || \u00d7 || \u2022 || \u2022 || \u2022 || \u2022 || R2<br>{{small|11th}} || R2<br>{{small|15th}} || || 2/7\n|- \"background:#f4f4f4;\"\n| align=left| {{fbw|CIV}}\n| \u00d7 || \u00d7 || \u00d7 || \u2022 || \u2022 || \u2022 || R1<br>{{small|23rd}} || \u2022 || || 1/5\n|-\n| align=left| {{fbw|GEQ}}\n| \u00d7 || \u00d7 || \u00d7 || \u2022 || \u2022 || R1<br>{{small|15th}} || \u2022 || \u00d7 || || 1/4\n|- \"background:#f4f4f4;\"\n| align=left| {{fbw|GHA}}\n| \u2022 || \u2022 || R1<br>{{small|13\u201314}} || R1<br>{{small|12th}} || R1<br>{{small|15th}} || \u2022 || \u2022 || \u2022 || || 3/8\n|-\n| align=left| {{fbw|NGA}}\n| R1<br>{{small|10th}} || R1<br>{{small|11th}} || QF<br>{{small|7th}} || R1<br>{{small|15th}} || R1<br>{{small|13th}} || R1<br>{{small|9th}} || R1<br>{{small|21st}} || R2<br>{{small|16th}} || || 8/8\n|-\n| align=left| {{fbw|RSA}}\n|  \u00d7 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br>{{small|22nd}} || || 1/7\n|}\n\n=== Summer Olympics for men ===\n\n{| class=\"wikitable\" style=\"text-align:center; font-size:90%;\"\n|-\n! Nation || {{flagicon|France}}<br/>[[Football at the 1900 Summer Olympics|00]] || colspan=2|{{flagicon|United States|1896}}<br/>[[Football at the 1904 Summer Olympics|04]] || {{flagicon|United Kingdom}}<br/>[[Football at the 1908 Summer Olympics|08]] || {{flagicon|Sweden}}<br/>[[Football at the 1912 Summer Olympics|12]] || {{flagicon|Belgium}}<br/>[[Football at the 1920 Summer Olympics|20]] || {{flagicon|France}}<br/>[[Football at the 1924 Summer Olympics|24]] || {{flagicon|Netherlands}}<br/>[[Football at the 1928 Summer Olympics|28]] || {{flagicon|Germany|Nazi}}<br/>[[Football at the 1936 Summer Olympics|36]] || {{flagicon|United Kingdom}}<br/>[[Football at the 1948 Summer Olympics|48]] || {{flagicon|Finland}}<br/>[[Football at the 1952 Summer Olympics|52]] || {{flagicon|Australia}}<br/>[[Association football at the 1956 Summer Olympics|56]] || {{flagicon|Italy}}<br/>[[Football at the 1960 Summer Olympics|60]] || {{flagicon|Japan}}<br/>[[Football at the 1964 Summer Olympics|64]] || {{flagicon|Mexico}}<br/>[[Football at the 1968 Summer Olympics|68]] || {{flagicon|West Germany}}<br/>[[Football at the 1972 Summer Olympics|72]] ||{{flagicon|Canada}}<br/> [[Football at the 1976 Summer Olympics|76]] || {{flagicon|Soviet Union|1955}}<br/>[[Football at the 1980 Summer Olympics|80]] || {{flagicon|United States}}<br/>[[Football at the 1984 Summer Olympics|84]] || {{flagicon|South Korea}}<br/>[[Football at the 1988 Summer Olympics|88]] || {{flagicon|Spain}}<br/>[[Football at the 1992 Summer Olympics|92]] || {{flagicon|United States}}<br/>[[Football at the 1996 Summer Olympics|96]] || {{flagicon|Australia}}<br/>[[Football at the 2000 Summer Olympics|00]] || {{flagicon|Greece}}<br/>[[Football at the 2004 Summer Olympics|04]] || {{flagicon|China}}<br/>[[Football at the 2008 Summer Olympics|08]] || {{flagicon|United Kingdom}}<br/>[[Football at the 2012 Summer Olympics \u2013 Men's tournament|12]] || {{flagicon|Brazil}}<br/>[[Football at the 2016 Summer Olympics \u2013 Men's tournament|16]] || {{flagicon|Japan}}<br/>[[Football at the 2020 Summer Olympics \u2013 Men's tournament|20]] || Years\n|-\n|align=left| {{flagIOC|ALG}} || colspan=13| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || 8 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 14 ||\n! 2\n|-\n|align=left| {{flagIOC|CMR}} || colspan=\"5\" style=\"background:#efefef;\"| ||colspan=8| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 11 || \u2013 || \u2013 || \u2013 ||bgcolor=gold| 1 || \u2013 || 8 || \u2013 || \u2013 ||\n! 3\n|-\n|align=left| {{flagIOC|EGY}}<ref>Egypt team represented the [[United Arab Republic]] with Syria in 1960 finishing the 12th and alone in 1964 finishing the 4th.</ref> || colspan=\"4\" style=\"background:#efefef;\"|  || \u2013 || 8 || 8 || 4 || 9 || 11 || 9 || \u2013 || 12 || 4 || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || 8 || \u2013 || 12 || \u2013 || \u2013 || \u2013 || \u2013 || 8 || \u2013 || q\n! 12\n|-\n|align=left| {{flagIOC|CIV}} || colspan=13| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 6 || \u2013 ||  || q\n! 2\n|-\n|align=left| {{flagIOC|GAB}} || colspan=13| ''{{small|Part of France}}'' || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 12 || \u2013 ||\n! 1\n|-\n|align=left| {{flagIOC|GHA}} || colspan=10| ''{{small|Part of the United Kingdom}}'' || \u2013 || style=\"background:#efefef;\"|  || \u2013 || 7 || 12 || 16 || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || \u2013 || style=\"background:#c96;\"| 3 || 8 || \u2013 || 9 || \u2013 || \u2013 || \u2013 ||\n! 6\n|-\n|align=left| {{flagIOC|GUI}} || colspan=12| ''{{small|Part of France}}'' || colspan=\"2\" style=\"background:#efefef;\"|  || 11 || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 ||\n! 1\n|-\n|align=left| {{flagIOC|MLI}} || colspan=13| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 5 || \u2013 || \u2013 || \u2013 ||\n! 1\n|-\n|align=left| {{flagIOC|MAR}} || colspan=\"4\" style=\"background:#efefef;\"| ||colspan=7| ''{{small|Part of France}}'' || style=\"background:#efefef;\"|  || \u2013 || 13 || \u2013 || 8 || \u2013 || style=\"background:#efefef;\"|  || 12 || \u2013 || 15 || \u2013 || 16 || =10 || \u2013 || 11 || \u2013 ||\n! 7\n|-\n|align=left| {{flagIOC|NGR}} || colspan=\"5\" style=\"background:#efefef;\"| ||colspan=5| ''{{small|Part of the United Kingdom}}'' || \u2013 || \u2013 || \u2013 || \u2013 || 14 || \u2013 || style=\"background:#efefef;\"|  || 13 || \u2013 || 15 || \u2013 ||bgcolor=gold| 1 || 8 || \u2013 || style=\"background:silver;\"| 2 || \u2013 || style=\"background:#c96;\"| 3 ||\n! 7\n|-\n|align=left| {{flagIOC|SEN}} || colspan=13| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 6 ||-||\n! 1\n|-\n|align=left| {{flagIOC|RSA}} || style=\"background:#efefef;\"|  || colspan=\"2\"| \u2013 || \u2013 || \u2013 || \u2013 | \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || colspan=\"7\" style=\"background:#efefef;\"| ''{{small|Banned because of apartheid}}'' || \u2013 | \u2013 || \u2013 || \u2013 | 11 || \u2013 || \u2013 || \u2013 || 13 || q\n! 3\n|-\n|align=left| {{flagIOC|SUD}} || colspan=12| ''{{small|Part of the United Kingdom}}'' || \u2013 || style=\"background:#efefef;\"|  || \u2013 || 15 || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 ||\n! 1\n|-\n|align=left| {{flagIOC|TUN}} || colspan=11| ''{{small|Part of France}}'' || style=\"background:#efefef;\"|  || 15 || \u2013 || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || \u2013 || 13 || \u2013 || 14 || \u2013 || 12 || \u2013 || \u2013 || \u2013 ||\n! 4\n|-\n|align=left| {{flagIOC|ZAM}} || colspan=\"6\" style=\"background:#efefef;\"| || colspan=5| ''{{small|Part of the United Kingdom}}'' || style=\"background:#efefef;\"|  || ''{{small|{{Tooltip|RHO|Part of Rhodesia}}}}'' || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || 15 || \u2013 || 5 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 ||\n! 2\n|-\n!align=left| Total nations || 3 || colspan=2| 2 || 5 || 11 || 14 || 22 || 17 || 16 || 18 || 25 || 11 || 16 || 14 || 16 || 16 || 13 || 16 || 16 || 16 || 16 || 16 || 16 || 16 || 16 || 16 || 16 || 16 ||\n|}\n\n=== Summer Olympics for women ===\n\n{| class=\"wikitable\" style=\"text-align:center; font-size:90%;\"\n|-\n! Team || {{flagicon|United States}}<br/>[[Football at the 1996 Summer Olympics|1996]]<br>(8) || {{flagicon|Australia}}<br/>[[Football at the 2000 Summer Olympics|2000]]<br>(8) || {{flagicon|Greece}}<br/>[[Football at the 2004 Summer Olympics|2004]]<br>(10) || {{flagicon|China}}<br/>[[Football at the 2008 Summer Olympics|2008]]<br>(12) || {{flagicon|United Kingdom}}<br/>[[Football at the 2012 Summer Olympics \u2013 Men's tournament|2012]]<br>(12) || {{flagicon|Brazil}}<br/>[[Football at the 2016 Summer Olympics \u2013 Men's tournament|2016]]<br>(12) || {{flagicon|Japan}}<br/>[[Football at the 2020 Summer Olympics \u2013 Women's tournament|2020]]<br>(12) || Total\n|-\n|align=left| {{flagIOC|CMR}} || \u2013 || \u2013 || \u2013 || \u2013 || 12 || \u2013 || \n! 1\n|-\n|align=left| {{flagIOC|NGR}} || \u2013 || 8 || 6 || 11 || \u2013 || \u2013 || \n! 3\n|-\n|align=left| {{flagIOC|RSA}} || \u2013 || \u2013 || \u2013 || \u2013 || 10 || 10 || \n! 2\n|-\n|align=left| {{flagIOC|ZAM}} || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || q\n! 1\n|-\n|align=left| {{flagIOC|ZIM}} || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 12 || \n! 1\n|-\n! Total || 0 || 1 || 1 || 1 || 2 || 2 ||  || \n|}\n\n=== FIFA U-20 Women's World Cup ===\n\n{| class=\"wikitable\"\n|- style=\"background:#cccccc;\" align=center\n!Team\n![[2002 FIFA U-19 Women's World Championship|2002]]<br>{{flagicon|CAN}}<br>(12)\n![[2004 FIFA U-19 Women's World Championship|2004]]<br>{{flagicon|THA}}<br>(12)\n![[2006 FIFA U-20 Women's World Championship|2006]]<br>{{flagicon|RUS}}<br>(16)\n![[2008 FIFA U-20 Women's World Cup|2008]]<br>{{flagicon|CHI}}<br>(16)\n![[2010 FIFA U-20 Women's World Cup|2010]]<br>{{flagicon|GER}}<br>(16)\n![[2012 FIFA U-20 Women's World Cup|2012]]<br>{{flagicon|JPN}}<br>(16)\n![[2014 FIFA U-20 Women's World Cup|2014]]<br>{{flagicon|CAN}}<br>(16)\n![[2016 FIFA U-20 Women's World Cup|2016]]<br>{{flagicon|PNG}}<br>(16)\n![[2018 FIFA U-20 Women's World Cup|2018]]<br>{{flagicon|FRA}}<br>(16)\n![[2020 FIFA U-20 Women's World Cup|2020]]<br>{{flagicon|CRC}}<br>{{flagicon|PAN}}<br>(16)\n!Total\n|- align=center\n| align=left| {{fbwu|20|COD}}\n| \u2022||\u2022||GS||GS||\u2022||\u2022||\u2022||\u2022||\u2022||\n|'''2'''\n|- align=center\n| align=left| {{fbwu|20|GHA}}\n| \u2022||\u2022||\u2022||\u2022||GS||GS||GS||GS||GS|| ||'''5'''\n|- align=center\n| align=left| {{fbwu|20|NGA}}\n| GS||QF||QF||QF||bgcolor=silver|2nd||bgcolor=#9acdff|4th||bgcolor=silver|2nd||GS||QF|| <!--style=\"border: 3px solid red\"| q ||'''10'''-->||'''9'''\n|- align=center\n|align=left| '''Total''' || '''1''' || '''1''' || '''2''' || '''2''' || '''2''' || '''2''' || '''2''' || '''2''' || '''2''' || '''2'''\n|'''18'''\n|}\n\n=== FIFA U-17 Women's World Cup ===\n\n{| class=\"wikitable\"\n|- style=\"background:#cccccc;\" align=center\n!Team\n![[2008 FIFA U-17 Women's World Cup|2008]]<br>(16)\n![[2010 FIFA U-17 Women's World Cup|2010]]<br>(16)\n![[2012 FIFA U-17 Women's World Cup|2012]]<br>(16)\n![[2014 FIFA U-17 Women's World Cup|2014]]<br>(16)\n![[2016 FIFA U-17 Women's World Cup|2016]]<br>(16)\n![[2018 FIFA U-17 Women's World Cup|2018]]<br>(16)\n![[2020 FIFA U-17 Women's World Cup|2020]]<br>(16)\n!Total\n|- align=center\n| align=left| {{fbwu|17|CMR}}\n| \u2022||\u00d7||\u2022||\u00d7||GS||GS|| ||'''2'''\n|- align=center\n| align=left| {{fbwu|17|GAM}}\n| \u00d7||\u00d7||R1||\u00d7||\u00d7||\u2022|| ||'''1'''\n|- align=center\n| align=left| {{fbwu|17|GHA}}\n| R1||R1||bgcolor=#cc9966|3rd||QF||QF||QF|| ||'''6'''\n|- align=center\n| align=left| {{fbwu|17|NGA}}\n| R1||QF||QF||QF||GS||\u2022|| ||'''5'''\n|- align=center\n| align=left| {{fbwu|17|RSA}}\n| \u2022||R1||\u2022||\u2022||\u2022||GS|| ||'''2'''\n|- align=center\n| align=left| {{fbwu|17|ZAM}}\n| \u2022||\u00d7||\u2022||GS||\u00d7||\u2022|| ||'''1'''\n|- align=center\n|align=left| '''Total''' || '''2''' || '''3''' || '''3''' || '''3''' || '''3''' || '''3''' || '''3'''\n|'''20'''\n|}\n\n===FIFA Futsal World Cup===\n\n{| class=\"wikitable\" style=\"text-align:center\"\n|-\n! Nation\n! [[1989 FIFA Futsal World Championship|1989]]<br>{{Flagicon|Netherlands}} !! [[1992 FIFA Futsal World Championship|1992]]<br>{{Flagicon|Hong Kong|1959}} !! [[1996 FIFA Futsal World Championship|1996]]<br>{{Flagicon|Spain}} !! [[2000 FIFA Futsal World Championship|2000]]<br>{{Flagicon|Guatemala}} !! [[2004 FIFA Futsal World Championship|2004]]<br>{{Flagicon|Chinese Taipei}} !! [[2008 FIFA Futsal World Cup|2008]]<br>{{Flagicon|Brazil}} !! [[2012 FIFA Futsal World Cup|2012]]<br>{{Flagicon|Thailand}} !! [[2016 FIFA Futsal World Cup|2016]]<br>{{Flagicon|Colombia}} !! [[2020 FIFA Futsal World Cup|2020]]<br>{{Flagicon|Lithuania}} !! Years\n|-\n|align=left|{{futsal|ALG}} || R1 || || || || || || || || || 1\n|-\n|align=left|{{futsal|ANG}} || || || || || || || || || q || 1\n|-\n|align=left|{{futsal|EGY}} || || || R1 || R2 || R1 || R1 || R2 || QF || q || 7\n|-\n|align=left|{{futsal|LBY}} || || || || || || R1 || R1 || || || 2\n|-\n|align=left|{{futsal|MAR}} || || || || || || || R1 || R1 || q || 3\n|-\n|align=left|{{futsal|MOZ}} || || || || || || ||  || R1 || || 1\n|-\n|align=left|{{futsal|NGA}} || || R1 || || || || || || || || 1\n|-\n|align=left|{{futsal|ZIM}} || R1 || || || || || || || || || 1\n|-\n! ''Nations'' || 2 || 1 || 1 || 1 || 1 || 2 || 3 || 3 || 3 || 17\n|}\n\n===FIFA Beach Soccer World Cup===\n\n{| class=\"wikitable\" style=\"text-align: center\"\n|- valign=top\n!\n! ''[[Beach Soccer World Cup 1995|1995]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 1996|1996]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 1997|1997]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 1998|1998]]''<br> {{Flagicon|Brazil}}<br> (10)\n! ''[[Beach Soccer World Cup 1999|1999]]''<br> {{Flagicon|Brazil}}<br> (12)\n! ''[[Beach Soccer World Cup 2000|2000]]''<br> {{Flagicon|Brazil}}<br> (12)\n! ''[[Beach Soccer World Cup 2001|2001]]''<br> {{Flagicon|Brazil}}<br> (12)\n! ''[[Beach Soccer World Cup 2002|2002]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 2003|2003]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 2004|2004]]''<br> {{Flagicon|Brazil}}<br> (12)\n! [[2005 FIFA Beach Soccer World Cup|2005]]<br> {{Flagicon|Brazil}}<br> (12)\n! [[2006 FIFA Beach Soccer World Cup|2006]]<br> {{Flagicon|Brazil}}<br> (12)\n! [[2007 FIFA Beach Soccer World Cup|2007]]<br> {{Flagicon|Brazil}}<br> (16)\n! [[2008 FIFA Beach Soccer World Cup|2008]]<br> {{Flagicon|France}}<br> (16)\n! [[2009 FIFA Beach Soccer World Cup|2009]]<br> {{flagicon|UAE}}<br> (16)\n! [[2011 FIFA Beach Soccer World Cup|2011]]<br> {{flagicon|ITA}}<br> (16)\n! [[2013 FIFA Beach Soccer World Cup|2013]]<br> {{flagicon|TAH}}<br> (16)\n! [[2015 FIFA Beach Soccer World Cup|2015]]<br> {{flagicon|POR}}<br> (16)\n! [[2017 FIFA Beach Soccer World Cup|2017]]<br> {{flagicon|BAH}}<br> (16)\n! [[2019 FIFA Beach Soccer World Cup|2019]]<br> {{flagicon|PAR}}<br> (16)\n! Total Participations\n|-\n|style=\"text-align:left;\"|{{beachsoccer|CMR}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br><small>14th</small> || \u2022 || R1<br><small>16th</small> || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022\n|2/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|CIV}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br><small>11th </small>|| \u2022 || R1<br><small>16th </small>|| \u2022 || \u2022 || \u2022\n|2/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|MAD}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br><small>14th </small>|| \u2022 || \u2022\n|1/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|NGA}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br><small>9th </small>|| QF<br><small>6th </small>|| \u2022 || R1<br><small>12th </small>|| QF<br><small>6th </small>|| \u2022 || \u2022 || R1<br><small>12th </small> || R1<br><small>16th </small>\n|6/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|SEN}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || QF<br><small>5th </small>|| R1<br><small>9th </small>|| QF<br><small>7th </small>|| R1<br><small>13th </small>|| R1<br><small>13th </small>|| QF<br><small>6th </small> || QF<br><small>6th </small>\n|7/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|RSA}}\n| \u2022 || \u2022 || \u2022 || \u2022 ||R1<br><small>12th </small>|| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 ||R1<br><small>12th </small>|| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022\n|2/20\n|-\n!align=centre| Total || 0 || 0 || 1 || 0 || 2 || 1 || 1 || 1 || 0 || 0 || 2 || 3 || 3 || 3 || 3 || 3 || 3 || 3 || 3 || 2 || \n|}\n\n===FIFA Confederations Cup===\n\n{| class=\"wikitable\" style=\"text-align: center\"\n|-\n! Team\n! [[1992 King Fahd Cup|1992]]<br> {{flagicon|Saudi Arabia}}\n! [[1995 King Fahd Cup|1995]]<br> {{flagicon|Saudi Arabia}}\n! [[1997 FIFA Confederations Cup|1997]]<br> {{flagicon|Saudi Arabia}}\n! [[1999 FIFA Confederations Cup|1999]]<br> {{flagicon|Mexico}}\n! [[2001 FIFA Confederations Cup|2001]]<br> {{flagicon|South Korea}}<br>{{flagicon|Japan}}\n! [[2003 FIFA Confederations Cup|2003]]<br> {{flagicon|France}}\n! [[2005 FIFA Confederations Cup|2005]]<br> {{flagicon|Germany}}\n! [[2009 FIFA Confederations Cup|2009]]<br> {{flagicon|South Africa}}\n! [[2013 FIFA Confederations Cup|2013]]<br> {{flagicon|Brazil}}\n! [[2017 FIFA Confederations Cup|2017]]<br> {{flagicon|Russia}}\n! Total\n|-\n| align=left| {{fb|Cameroon}}\n| \u2022 || \u2022 || \u2022 || \u2022 || GS || style=\"background:Silver;\"|2nd || \u2022 || \u2022 || \u2022 || GS\n! 3\n|-\n| align=left| {{fb|Egypt}}\n| \u2022 || \u2022 || \u2022 || GS || \u2022 || \u2022 || \u2022 || GS || \u2022 || \u2022\n! 2\n|-\n| align=left| {{fb|C\u00f4te d'Ivoire}}\n| style=\"background:#9acdff;\"|4th || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022\n! 1\n|-\n| align=left| {{fb|Nigeria}}\n| \u2022 || style=\"background:#9acdff;\"|4th || \u00d7 || \u00d7 || \u2022 || \u2022 || \u2022 || \u2022 || GS || \u2022\n! 2\n|-\n| align=left| {{fb|South Africa}}\n| \u00d7 || \u2022 || GS || \u2022 || \u2022 || \u2022 || \u2022 || style=\"border:3px solid red; background:#9acdff;\"|4th || \u2022 || \u2022\n! 2\n|-\n| align=left| {{fb|Tunisia}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || GS || \u2022 || \u2022 || \u2022\n! 1\n|-\n! Total || 1 || 1 || 1 || 1 || 1 || 1 || 1 || 2 || 1 || 1\n! 11\n|}\n\n===Other Tournaments===\n\n;''Legend''\n{{col-begin|width=auto}}\n{{col-2}}\n*{{bg|gold|1st}} \u2013 Champions\n*{{bg|silver|2nd}} \u2013 Runners-up\n*{{bg|#cc9966|3rd}} \u2013 Third place\n*{{bg|#9acdff|4th}} \u2013 Fourth place\n*GS \u2013 Group stage\n*Q \u2013 Qualified for upcoming tournament\n{{col-2}}\n*{{border|width=1px|color=gray|&nbsp;\u2022\u2022&nbsp;}} \u2013 Qualified but withdrew\n*{{border|width=1px|color=gray|&nbsp;\u2022&nbsp;}} \u2013 Did not qualify\n*{{border|width=1px|color=gray|&nbsp;\u00d7&nbsp;}} \u2013 Did not enter / Withdrew from the Africa Cup of Nations or withdrew from the Confederations Cup / Banned\n*{{border|width=3px|color=red|&nbsp;&nbsp;}} \u2013 Hosts\n{{col-end}}\n\n==CAF Best Footballers of the Century==\nThe voting to select the best of the century refers to three categories: male player, goalkeeper and female player and is obtained from five different steps. The resulting best players and goalkeepers were honored during the \"World Football Gala 1999\".<ref>{{cite web |url=https://iffhs.de/iffhs-history-africa-player-of-the-century-1900-1999/ |title=IFFHS History : Africa \u2013 Player of the Century (1900\u20131999) |publisher=IFFHS |date=9 October 2017 |accessdate=}}</ref>\n\n{{col-begin}}\n{{col-3}}\n\n===CAF Best Player of the Century===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|-\n!Player Name\n!Points\n|-\n|align=left|{{Flagicon|Liberia}} [[George Weah]]\n|'''95'''\n|-\n|align=left|{{Flagicon|Cameroon}} [[Roger Milla]]\n|'''77'''\n|-\n|align=left|{{Flagicon|Ghana}} [[Ab\u00e9di Pel\u00e9]]\n|'''72'''\n|-\n|align=left|{{Flagicon|Algeria}} [[Lakhdar Belloumi]]\n|'''56'''\n|-\n|align=left|{{Flagicon|Algeria}} [[Rabah Madjer]]\n|'''51'''\n|-\n|align=left|{{Flagicon|Cameroon}} [[Th\u00e9ophile Abega]]\n|'''39'''\n|-\n|align=left|{{Flagicon|CIV}} [[Laurent Pokou]]\n|'''38'''\n|-\n|align=left|{{Flagicon|Zambia}} [[Kalusha Bwalya]]\n|'''37'''\n|-\n|align=left|{{Flagicon|Morocco}} [[Ahmed Faras]]\n|'''35'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Finidi George]]\n|'''32'''\n|}\n{{col-3}}\n\n===CAF Best Goalkeeper of the Century===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|-\n!Player Name\n!Points\n|-\n|align=left|{{Flagicon|Cameroon}} [[Joseph-Antoine Bell]]\n|'''39'''\n|-\n|align=left|{{Flagicon|Cameroon}} [[Thomas N'Kono]]\n|'''30'''\n|-\n|align=left|{{Flagicon|Tunisia}} [[Sadok Sassi|Sadok Sassi \"Attouga\"]]\n|'''26'''\n|-\n|align=left|{{Flagicon|Morocco}} [[Badou Zaki]]\n|'''24'''\n|-\n|align=left|{{Flagicon|Congo DR}} [[Mwamba Kazadi]]\n|'''19'''\n|-\n|align=left|{{Flagicon|Cameroon}} [[Jacques Songo'o]]\n|'''13'''\n|-\n|align=left|{{Flagicon|Zimbabwe}} [[Bruce Grobbelaar]]\n|'''11'''\n|-\n|align=left|{{Flagicon|Egypt}} [[Ahmed Shobair]]\n|'''10'''\n|-\n|align=left|{{Flagicon|CIV}} [[Alain Gouam\u00e9n\u00e9]]\n|'''9'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Peter Rufai]]\n|'''6'''\n|}\n{{col-3}}\n\n===CAF Best Women's Footballer of the Century===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|-\n!Player Name\n!Points\n|-\n|align=left|{{Flagicon|Nigeria}} [[Uche Eucharia|Uche Eucharia Ngozi]]\n|'''21'''\n|-\n|align=left|{{Flagicon|Ghana}} [[Nana Ama Gyamfuah]]\n|'''18'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Doris Nkiru Okosieme]]\n|'''17'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Florence Omagbemi]]\n|'''15'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Ann Chiejine]]\n|'''14'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Rita Nwadike]]\n|'''13'''\n|-\n|align=left|{{Flagicon|South Africa}} Fikhile Sitole\n|'''9'''\n|-\n|align=left|{{Flagicon|Ghana}} [[Vivian Mensah]]\n|'''8'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Mercy Akide]]\n|rowspan=2|'''7'''\n|-\n|align=left|{{Flagicon|Nigeria}} Ann Agumanu\n|}\n{{col-end}}\n\n==CAF Golden Jubilee Best Players poll==\nIn 2007 CAF published the list of top 30 African players who played in the period from 1957 to 2007, as part of the celebration of CAF's 50th anniversary, ordered according to an online poll.<ref>{{cite web |url=http://www.cafonline.com/caf/media-services/facts/77-caf-release-30-best-african-players-in-the-last-50-years.html |title=CAF release 30 best African players in the last 50 years |publisher=CAF |date=11 August 2007 |accessdate=15 January 2010}}</ref>\n\n{{Div col|colwidth=22em}}\n:{{0}}1. {{Flagicon|Cameroon}} [[Roger Milla]]\n:{{0}}2. {{Flagicon|Egypt}} [[Mahmoud El Khatib]]\n:{{0}}3. {{Flagicon|Egypt}} [[Hossam Hassan]]\n:{{0}}4. {{Flagicon|Cameroon}} [[Samuel Eto'o]]\n:{{0}}5. {{Flagicon|Ghana}} [[Abedi Pele]]\n:{{0}}6. {{Flagicon|Liberia}} [[George Weah]]\n:{{0}}7. {{Flagicon|Ivory Coast}} [[Didier Drogba]]\n:{{0}}8. {{Flagicon|Nigeria}} [[Nwankwo Kanu]]\n:{{0}}9. {{Flagicon|Algeria}} [[Rabah Madjer]]\n:10. {{Flagicon|Zambia}} [[Kalusha Bwalya]]\n:11. {{Flagicon|Ghana}} [[Michael Essien]]\n:12. {{Flagicon|Nigeria}} [[Augustine Okocha]]\n:13. {{Flagicon|Egypt}} [[Saleh Selim]]\n:14. {{Flagicon|Algeria}} [[Hac\u00e8ne Lalmas]]\n:15. {{Flagicon|South Africa}} [[Benni McCarthy]]\n:16. {{Flagicon|Senegal}} [[El Hadji Diouf]]\n:17. {{Flagicon|Morocco}} [[Noureddine Naybet]]\n:18. {{Flagicon|Nigeria}} [[Rashidi Yekini]]\n:19. {{Flagicon|Egypt}} [[Hany Ramzy]]\n:20. {{Flagicon|Egypt}} [[Hassan Shehata]]\n:21. {{Flagicon|South Africa}} [[Lucas Radebe]]\n:22. {{Flagicon|Tunisia}} [[Tarak Dhiab]]\n:23. {{Flagicon|Morocco}} [[Mohammed Timoumi]]\n:24. {{Flagicon|Ghana}} [[Anthony Yeboah]]\n:25. {{Flagicon|Mali}} [[Salif Keita (footballer)|Salif Keita]]\n:26. {{Flagicon|Ghana}} [[Karim Abdul Razak]]\n:27. {{Flagicon|Ghana}} [[Samuel Kuffour]]\n:28. {{Flagicon|Algeria}} [[Lakhdar Belloumi]]\n:29. {{Flagicon|Cameroon}} [[Rigobert Song]]\n:30. {{Flagicon|Sudan}} [[Nasr El-Deen Abbas|Nasr El-Deen \"Jaxa\" Abbas]]\n{{Div col end}}\n\n==CAF resolutions==\n{{col-begin|width=auto}}\n{{col-break}}\n'''Awards:'''\n*[[CAF Awards]]\n*[[African Footballer of the Year]]\n*[[CAF Clubs of the 20th Century]]\n{{col-break|gap=2em}}\n'''Qualifications:'''\n*[[CAF 5-Year Ranking]]\n{{col-end}}\n\n==International Top Goal Scorers==\n{{Updated|21 November 2019}}\nPlayers in '''bold''' are still active at international level\n{| class=\"wikitable sortable\"\nstyle=\"text-align:center\"\n|-\n!width=\"20\"|Rank\n!width=\"250\"|Player\n!width=\"80\"|Goals\n!width=\"80\"|Matches\n!width=\"80\"|Ratios\n!width=\"120\"|Span\n|-\n|-\n\n|-\n|1\n| align=\"left\"|\n{{flagicon|ZAM}} [[Godfrey Chitalu]]\n|79\n|111\n|0.71\n|1968\u20131980 \n|-style=\"background-color:pink\n|-\n|2\n| align=\"left|\n{{flagicon|MWI}} [[Kinnah Phiri]]\n|71\n|115\n|0.62\n|1973\u20131981\n|-\n|3\n|align=\"left\"|\n{{flagicon|EGY}} [[Hossam Hassan]]\n|69\n|169\n|0.41\n|1985\u20132006\n|-\n|4\n|align=\"left\"|\n{{flagicon|CIV}} [[Didier Drogba]]\n|65\n|105\n|0.62\n|2002\u20132014\n|-\n|5\n|{{flagicon|CMR}} [[Samuel Eto'o]]\n|56\n|118\n|0.47\n|1997\u20132014\n|-\n|6\n|align=\"left\"|\n{{flagicon|GHA}} '''[[Asamoah Gyan]]'''\n|51\n|109\n|0.47\n|2003\u2013''present''\n|-\n|7\n|align=\"left\"|\n{{flagicon|CIV}} [[Abdoulaye Traor\u00e9 (Ivorian footballer)|Abdoulaye Traore]]\n|50\n|88\n|0.57\n|1984\u20131996\n|-\n|8\n|align=\"left\"|\n{{flagicon|CMR}} [[Roger Milla]]\n|43\n|77\n|0.56\n|1973\u20131994\n|-\n|9\n|align=\"left\"|\n{{flagicon|ZAM}} [[Alex Chola]]\n|43\n|102\n|0.42\n|1975\u20131985\n|-\n|10\n|align=\"left\"|\n{{flagicon|EGY}} [[Hassan El-Shazly]]\n|42\n|62\n|0.68\n|1961\u20131975\n|-\n|11\n|align=\"left\"|\n{{flagicon|EGY}} '''[[Mohamed Salah]]'''\n|41\n|67\n|0.61\n|2011\u2013''present''\n|-\n|12\n|align=\"left\"|\n{{flagicon|LBY}} [[Fawzi Al-Issawi]]\n|40\n|90\n|0.44\n|1977\u20131985\n|-\n|13\n|align=\"left|\n{{flagicon|ANG}} [[Akw\u00e1|Akwa]]\n|39\n|78\n|0.5\n|1995\u20132006\n|-\n|14\n|align=\"left\"|\n{{flagicon|ZAM}} [[Kalusha Bwalya]]\n|39\n|87\n|0.45\n|1983\u20132006\n|-\n|15\n|align=\"left\"|\n{{flagicon|ZIM}} [[Peter Ndlovu]]\n|38\n|74\n|0.51\n|1991\u20132007\n|-\n|16\n|align=\"left\"|\n{{flagicon|EGY}} [[Mohamed Aboutrika]]\n|38\n|100\n|0.38\n|2001\u20132013\n|-\n|17\n|align=\"left\"|\n{{flagicon|NGR}} [[Rashidi Yekini]]\n|37\n|58\n|0.64\n|1984\u20131998\n|-\n|18\n|align=\"left \"|\n{{flagicon|TUN}} [[Issam Jem\u00e2a]]\n|36\n|84\n|0.43\n|2005\u20132014\n|-\n|19\n|align=\" left\"|\n{{flagicon|ALG}} [[Abdelhafid Tasfaout]]\n|34\n|79\n|0.43\n|1990\u20132002\n|-\n|20\n|align=\"left\"|\n{{flagicon|BFA}} [[Moumouni Dagano]]\n|34\n|83\n|0.41\n|1998\u20132014\n|-\n|21\n|align=\"left\"|\n{{flagicon|KEN}} [[Dennis Oliech]]\n|34\n|72\n|0.47\n|2002\u20132016\n|-\n|22\n|align=\"left\"|\n{{flagicon|CMR}} [[Patrick M'Boma]]\n|33\n|55\n|0.6\n|1995\u20132004\n|-\n|23\n|align=\"left\"|\n{{flagicon|GHA}} [[Abedi Pele]]\n|33\n|67\n|0.49\n|1982\u201398\n|-\n|24\n|align=\"left\"|\n{{flagicon|EGY}} [[Ahmed Hassan (footballer)|Ahmed Hassan]]\n|33\n|184\n|0.18\n|1995\u20132004\n|-\n|25\n|align=\"left\"|\n{{flagicon|RSA}} [[Benni McCarthy]]\n|32\n|80\n|0.4\n|1997\u20132011\n|-\n|26\n|align=\"left\"|\n{{flagicon|TOG}} '''[[Emmanuel Adebayor]]'''\n|32\n|87\n|0.37\n|2000\u2013''present''\n|-\n|27\n|align=\"left\"|\n{{flagicon|EGY}} [[Amr Zaki]]\n|30\n|63\n|0.48\n|2004\u20132013\n|-\n*This table is for players with more than 30 goals\n|}\n\n==See also==\n{{Portal|Football in Africa}}\n* [[History of CAF]]\n* [[List of association football sub-confederations]]\n* [[List of presidents of CAF]]\n* [[List of first international of African national teams]]\n* [[List of CAF club competition winners]]\n* [[List of CAF club competition winning coaches]]\n\n==References==\n{{Reflist}}\n\n==External links==\n* [http://www.cafonline.com Official website] ({{in lang|en|fr|ar}})\n* [http://soccerlens.com/caf-confederation-of-african-football/31184/ Confederation of African Football], Soccerlens.com. Retrieved 9 October 2010.\n* [https://web.archive.org/web/20071006202008/http://www.soccerpanna.com/ CAF video highlights]\n* [https://web.archive.org/web/20110501143801/http://www.zshare.net/info.html?51826090-91f38fa2c3945be45d3da455db6ecc80 Listen to CAF Anthem] CAF Anthem\n* [http://www.sportspromedia.com/news/caf-confirms-qnet-tie-up], Sportspromedia.com. Retrieved 26 February 2018.\n* [http://www.euprimetimefootball.com/africa/caf-unveil-new-sponsorship-for-club-competitions], euprimetimefootball.com Retrieved 26 February 2018.\n\n{{Navboxes colour\n| title = CAF\n| bg    = #FFE700\n| fg    = \n| list  = \n{{CAF presidents}}\n{{African football}}\n{{CAF associations}}\n{{CAF teams}}\n{{CAF sub-regions}}\n{{CAF women's teams}}\n{{CAF Leagues}}\n{{CAF women's leagues}}\n}}\n{{FIFA navbox}}\n{{Navboxes\n| title = International football\n| list  = \n{{International football}}\n{{International women's football}}\n{{International club football}}\n{{International futsal}}\n{{International Beach Soccer}}\n}}\n{{Sports governing bodies in Africa}}\n{{Africa topics}}\n\n{{Authority control}}\n\n{{DEFAULTSORT:Confederation Of African Football}}\n[[Category:Confederation of African Football| ]]\n[[Category:Association football governing bodies in Africa| ]]\n[[Category:Sports organizations established in 1957]]\n[[Category:Sports governing bodies in Africa|Foot]]\n[[Category:FIFA confederations]]\n[[Category:1957 establishments in Africa]]\n", "text_old": "{{Use dmy dates|date=February 2020}}\n{{Infobox organization\n| name                = Confederation of African Football\n| image               = Confederation of African Football logo.svg\n| size                = 200px\n| abbreviation        = CAF\n| formation           = {{Start date and years ago|df=y|1957|02|10}}\n| map                 = CAF.svg\n| type                = Sports organisation\n| headquarters        = [[6th of October (city)|6th of October City]], [[Giza]], [[Egypt]]\n| region_served       = [[Africa]]\n| membership          = [[List of men's national association football teams#CAF (Africa)|56 member associations]]\n| language            = [[English language|English]], [[French language|French]], [[Arabic language|Arabic]]\n| leader_title        = [[List of presidents of CAF|President]]\n| leader_name         = [[Ahmad Ahmad]]\n| general             = Hajji Mouad\n| parent_organization = [[FIFA]]\n| website             = {{URL|www.cafonline.com/}}\n}}\n\n{{FIFA confederations}}\nThe '''Confederation of African Football''' or '''CAF''' ({{lang-fr|link=no|Conf\u00e9d\u00e9ration Africaine de Football}}) is the administrative and controlling body for African association football.\n\nCAF represents the national football associations of [[Africa]], runs continental, national, and club competitions, and controls the prize money, regulations and media rights to those competitions.\n\nCAF is the biggest of the six continental confederations of [[FIFA]]. Since the expansion of the number of teams at the [[FIFA World Cup|World Cup]] finals to 32 in [[1998 FIFA World Cup|1998]], CAF has been allocated five places, though this was expanded to six for the [[2010 FIFA World Cup|2010]] tournament in South Africa, to include the [[South Africa national football team|hosts]].\n\nCAF was established on 8 February 1957 in [[Khartoum]], [[Sudan]],<ref>{{Cite book |title=Historical Dictionary of Soccer |last= |first= |publisher= |year=2011 |isbn=9780810873957 |location= |page=21}}</ref> by [[Egyptian Football Association|Egyptian]], [[Ethiopian Football Federation|Ethiopian]], [[South African Football Association|South African]] and [[Sudan Football Association|Sudanese]]<ref>{{Cite book |url=https://books.google.com/books?id=udBgtzFSlBIC&pg=PA169&dq=Confederation+of+African+Football&hl=en&sa=X&ved=0ahUKEwjQ24jg1t7XAhWIPBQKHR9lDi8Q6AEISTAI#v=onepage&q=Confederation%20of%20African%20Football&f=false |title=International Sport Management |last= |first= |publisher=Human Kinetics |year= |isbn=9781450422413 |location= |pages= |language=en}}</ref> FAs, following former discussions between the Egyptian, [[Somali Football Federation|Somali]], South African and Sudanese FAs earlier on 7 June 1956 at the Avenida Hotel in [[Lisbon]], Portugal. Its first headquarters was situated in Khartoum for some months until a fire outbreak in the offices of the Sudanese Football Association when the organization moved near [[Cairo]], Egypt. [[Youssef Mohamad]] was the first general secretary and [[Abdel Aziz Abdallah Salem]] the [[List of Presidents of UEFA|president]]. Since 2002, the administrative center has been located in [[6th of October City]], Cairo, Egypt. CAF currently has 56 member associations: 54 are full members, while [[Zanzibar Football Association|Zanzibar]] and [[R\u00e9unionese Football League|R\u00e9union]] are associate members (see the CAF Members and Zones section below).\n\nThe current [[List of presidents of CAF|CAF President]] is [[Ahmad Ahmad]] from Madagascar, who was elected on 16 March 2017.<ref>{{cite web |url=https://www.bbc.co.uk/sport/football/39270007 |title=Madagascar FA chief Ahmad elected as new Caf president |date=16 March 2017 |website=BBC News |last1= |first1= |accessdate=16 March 2017}}</ref> The 1st Vice-President is Amaju Melvin Pinnick from Nigeria, the 2nd Vice-President is called Constant Omari Selemani from RD Congo and the 3rd Vice-President is Fouzi Lekjaa from Morocco.<ref>{{cite web |last1=Football |first1=CAF \u2013 Confederation of African |title=CAF \u2013 CAF \u2013 Organization \u2013 Bodies \u2013 Executive Committee |url=http://www.cafonline.com/en-us/caf/organization/bodies/executivecommittee.aspx |website=www.cafonline.com}}</ref> Current CAF General Secretary is Moroccan Hajji Mouad since 11 April 2019.<ref>{{Cite news |url=https://www.bbc.com/sport/football/47898603 |title=Caf appoints Moroccan Hajji Mouad as new General Secretary |date=13 April 2019|access-date=7 August 2019 |language=en-GB}}</ref>\n\n==History==\n{{Main|History of CAF}}\n\n==CAF's anthem==\nOn 18 September 2007 the CAF launched a competition for all African composers to create its [[Anthem]].<ref>{{cite web |url=http://www.cafonline.com/index.php?lng=1&module=media&idrub=94637&idnews=82041 |title=Competition for the CAF's anthem |publisher=CAF |date=18 September 2007 |accessdate=13 November 2008}}</ref> The CAF anthem is a musical composition, without lyrics, which and reflect the cultural patrimony and [[Music of Africa|African music]]. The duration of the anthem is 74 seconds. The chosen anthem was first published to the site on 16 January 2008. The usage of the anthem and its composer are still unknown.\n\n[http://www.cafonline.com/index.php?lng=1&module=media&idrub=94637&idnews=82041 Announced 18 September 2007]\n\n==Current leaders==\n\n{|class=\"wikitable hlist\" style=\"text-align:left\"\n|-\n!Name\n!Position\n|-\n|{{flagicon|Madagascar}} [[Ahmad Ahmad]]\n|President\n|-\n|{{flagicon|DR Congo}} [[Constant Omari]]\n|Vice President\n|-\n|{{flagicon|Morocco}} [[Fouzi Lekjaa]]\n|Vice President\n|-\n|{{flagicon|Morocco}} [[Mouad Hajji]]\n|General Secretary \n|-\n|{{flagicon|Egypt}} [[Essameldin Agha]]\n|Acting General Secretary \n|-\n|{{flagicon|Egypt}} [[Mohamed El Sherei]]\n|Treasurer\n|-\n|{{flagicon|Cameroon}} [[Junior Binyam]]\n|Media and Communication Manager\n|}\n\nSource: <ref>[https://www.fifa.com/associations/caf/ FIFA (CAF)]</ref><ref>[http://www.cafonline.com/en-us/caf/organization/bodies/executivecommittee.aspx CAF]</ref>\n\n==CAF members and zones==\n{{Context|section|date=June 2016}}\n\n===Members===\n[[File:Carte Afrique CAF.png|thumb|right|\n{{Color box|#8fbc8f|[[Sahara (African Region)|Sahara]]|border=darkgray}}\n{{Color box|#ffd700|[[Regions of the African Union|Niger and Volta-Niger (Zones A and B)]]|border=darkgray}}\n{{Color box|#db7093|[[Congo (African Region)|Congo]]|border=darkgray}}\n{{Color box|#4682b4|[[Nile (African Region)|Nile]]|border=darkgray}}\n{{Color box|#deb887|[[Kalahari (African Region)|Kalahari]]|border=darkgray}}]]\n\n;African regional federations\n{{legend|#8fbc8f|[[Union of North African Football Federations|UNAF]] (North Africa)}}\n{{legend|#ffd700|[[West African Football Union|WAFU-UFOA]] (West Africa)}}\n{{legend|#db7093|[[Central African Football Federations' Union|UNIFFAC]] (Central Africa)}}\n{{legend|#4682b4|[[CECAFA]] (East Africa)}}\n{{legend|#deb887|[[Council of Southern Africa Football Associations|COSAFA]] (Southern Africa)}}\n\n;Other federation\n{{legend|#007F00|[[Union of Arab Football Associations|UAFA]] ([[Arab World]])}}\n\n{|class=\"wikitable sortable hlist\" style=\"text-align:center; font-size:95%;\"\n! [[List of FIFA country codes|{{tooltip|Code|List of FIFA country codes}}]] !! Association !! National teams !! Founded !! FIFA affiliation !! CAF affiliation !! Regional affiliation !! [[List of members of the International Olympic Committee|{{tooltip|IOC member|List of members of the International Olympic Committee}}]]\n|-\n!colspan=8|[[Union of North African Football Federations|Union of North African Football Federations (UNAF)]]\n|-\n| ALG ||style=\"text-align:left;\"| {{fba|Algeria}} || {{Nft Alt Links|Algeria|sublist_style=font-size:90%}} || 1962 || 1963 || 1964 || 2005 || {{yes}}\n|-\n| EGY ||style=\"text-align:left;\"| {{fba|Egypt}} {{ref|n2|2}} || {{Nft Alt Links|Egypt|sublist_style=font-size:90%}} || 1921 || 1923 || 1957 || 2005 || {{yes}}\n|-\n| LBY ||style=\"text-align:left;\"| {{fba|Libya}} || {{Nft Alt Links|Libya|sublist_style=font-size:90%}} || 1962 || 1964 || 1965 || 2005 || {{yes}}\n|-\n| MAR ||style=\"text-align:left;\"| {{fba|Morocco}} || {{Nft Alt Links|Morocco|sublist_style=font-size:90%}} || 1955 || 1960 || 1959 || 2005 || {{yes}}\n|-\n| TUN ||style=\"text-align:left;\"| {{fba|Tunisia}} || {{Nft Alt Links|Tunisia|sublist_style=font-size:90%}} || 1957 || 1960 || 1960 || 2005 || {{yes}}\n|-\n!colspan=8|[[West African Football Union|West African Football Union (WAFU-UFOA)]]\n|-\n| BEN ||style=\"text-align:left;\"| {{fba|Benin}} || {{Nft Alt Links|Benin|sublist_style=font-size:90%}} || 1962 || 1962 || 1962 || 1975 || {{yes}}\n|-\n| BFA ||style=\"text-align:left;\"| {{fba|Burkina Faso}} || {{Nft Alt Links|Burkina Faso|sublist_style=font-size:90%}} || 1960 || 1964 || 1964 || 1975 || {{yes}}\n|-\n| CPV ||style=\"text-align:left;\"| {{fba|Cape Verde}} || {{Nft Alt Links|Cape Verde|sublist_style=font-size:90%}} || 1982 || 1986 || 2000 || 1975 || {{yes}}\n|-\n| GAM ||style=\"text-align:left;\"| {{fba|Gambia}} || {{Nft Alt Links|Gambia|sublist_style=font-size:90%}} || 1952 || 1968 || 1966 || 1975 || {{yes}}\n|-\n| GHA ||style=\"text-align:left;\"| {{fba|Ghana}} || {{Nft Alt Links|Ghana|sublist_style=font-size:90%}} || 1957 || 1958 || 1958 || 1975 || {{yes}}\n|-\n| GUI ||style=\"text-align:left;\"| {{fba|Guinea}} || {{Nft Alt Links|Guinea|sublist_style=font-size:90%}} || 1960 || 1962 || 1963 || 1975 || {{yes}}\n|-\n| GNB ||style=\"text-align:left;\"| {{fba|Guinea-Bissau}} || {{Nft Alt Links|Guinea-Bissau|sublist_style=font-size:90%}} || 1974 || 1986 || 1986 || 1975 || {{yes}}\n|-\n| CIV ||style=\"text-align:left;\"| {{fba|Ivory Coast}} || {{Nft Alt Links|Ivory Coast|sublist_style=font-size:90%}} || 1960 || 1964 || 1960 || 1975 || {{yes}}\n|-\n| LBR ||style=\"text-align:left;\"| {{fba|Liberia}} || {{Nft Alt Links|Liberia|sublist_style=font-size:90%}} || 1936 || 1964 || 1962 || 1975 || {{yes}}\n|-\n| MLI ||style=\"text-align:left;\"| {{fba|Mali}} || {{Nft Alt Links|Mali|sublist_style=font-size:90%}} || 1960 || 1963 || 1963 || 1975 || {{yes}}\n|-\n| MTN ||style=\"text-align:left;\"| {{fba|Mauritania}} || {{Nft Alt Links|Mauritania|sublist_style=font-size:90%}} || 1961 || 1970 || 1968 || 1975 || {{yes}}\n|-\n| NIG ||style=\"text-align:left;\"| {{fba|Niger}} || {{Nft Alt Links|Niger|sublist_style=font-size:90%}} || 1962 || 1967 || 1967 || 1975 || {{yes}}\n|-\n| NGA ||style=\"text-align:left;\"| {{fba|Nigeria}} || {{Nft Alt Links|Nigeria|sublist_style=font-size:90%}} || 1945 || 1960 || 1960 || 1975 || {{yes}}\n|-\n| SEN ||style=\"text-align:left;\"| {{fba|Senegal}} || {{Nft Alt Links|Senegal|sublist_style=font-size:90%}} || 1960 || 1964 || 1964 || 1975 || {{yes}}\n|-\n| SLE ||style=\"text-align:left;\"| {{fba|Sierra Leone}} || {{Nft Alt Links|Sierra Leone|sublist_style=font-size:90%}} || 1960 || 1960 || 1960 || 1975 || {{yes}}\n|-\n| TOG ||style=\"text-align:left;\"| {{fba|Togo}} || {{Nft Alt Links|Togo|sublist_style=font-size:90%}} || 1960 || 1962 || 1964 || 1975 || {{yes}}\n|-\n!colspan=8|[[Central African Football Federations' Union|Central African Football Federations' Union (UNIFFAC)]]\n|-\n| CMR ||style=\"text-align:left;\"| {{fba|Cameroon}} || {{Nft Alt Links|Cameroon|sublist_style=font-size:90%}} || 1959 || 1962 || 1963 || 1978 || {{yes}}\n|-\n| CTA ||style=\"text-align:left;\"| {{fba|Central African Republic}} || {{Nft Alt Links|Central African Republic|sublist_style=font-size:90%}} || 1961 || 1964 || 1965 || 1978 || {{yes}}\n|-\n| CHA ||style=\"text-align:left;\"| {{fba|Chad}} || {{Nft Alt Links|Chad|sublist_style=font-size:90%}} || 1962 || 1964 || 1964 || 1978 || {{yes}}\n|-\n| CGO ||style=\"text-align:left;\"| {{fba|Congo}} || {{Nft Alt Links|Congo|sublist_style=font-size:90%}} || 1962 || 1964 || 1966 || 1978 || {{yes}}\n|-\n| COD ||style=\"text-align:left;\"| {{fba|DR Congo}} || {{Nft Alt Links|DR Congo|sublist_style=font-size:90%}} || 1919 || 1964 || 1964 || 1978 || {{yes}}\n|-\n| EQG ||style=\"text-align:left;\"| {{fba|Equatorial Guinea}} || {{Nft Alt Links|Equatorial Guinea|sublist_style=font-size:90%}} || 1957 || 1986 || 1986 || 1978 || {{yes}}\n|-\n| GAB ||style=\"text-align:left;\"| {{fba|Gabon}} || {{Nft Alt Links|Gabon|sublist_style=font-size:90%}} || 1962 || 1966 || 1967 || 1978 || {{yes}}\n|-\n| STP ||style=\"text-align:left;\"| {{fba|S\u00e3o Tom\u00e9 and Pr\u00edncipe}} || {{Nft Alt Links|S\u00e3o Tom\u00e9 and Pr\u00edncipe|sublist_style=font-size:90%}} || 1975 || 1986 || 1986 || 1978 || {{yes}}\n|-\n!colspan=8|[[CECAFA|Council for East and Central Africa Football Associations (CECAFA)]]\n|-\n| BDI ||style=\"text-align:left;\"| {{fba|Burundi}} || {{Nft Alt Links|Burundi|sublist_style=font-size:90%}} || 1948 || 1972 || 1972 || 1994 || {{yes}}\n|-\n| DJI ||style=\"text-align:left;\"| {{fba|Djibouti}} || {{Nft Alt Links|Djibouti|sublist_style=font-size:90%}} || 1979 || 1994 || 1994 || 1995 || {{yes}}\n|-\n| ERI ||style=\"text-align:left;\"| {{fba|Eritrea}} || {{Nft Alt Links|Eritrea|sublist_style=font-size:90%}} || 1996 || 1998 || 1998 || 1973 || {{yes}}\n|-\n| ETH ||style=\"text-align:left;\"| {{fba|Ethiopia}} || {{Nft Alt Links|Ethiopia|sublist_style=font-size:90%}} || 1943 || 1952 || 1957 || 1994 || {{yes}}\n|-\n| KEN ||style=\"text-align:left;\"| {{fba|Kenya}} || {{Nft Alt Links|Kenya|sublist_style=font-size:90%}} || 1960 || 1960 || 1968 || 1973 || {{yes}}\n|-\n| RWA ||style=\"text-align:left;\"| {{fba|Rwanda}} || {{Nft Alt Links|Rwanda|sublist_style=font-size:90%}} || 1972 || 1978 || 1978 || 1994 || {{yes}}\n|-\n| SOM ||style=\"text-align:left;\"| {{fba|Somalia}} || {{Nft Alt Links|Somalia|sublist_style=font-size:90%}} || 1951 || 1962 || 1968 || 1973 || {{yes}}\n|-\n| SSD ||style=\"text-align:left;\"| {{fba|South Sudan}} || {{Nft Alt Links|South Sudan|sublist_style=font-size:90%}} || 2011 || 2012 || 2012 || 2012 || {{yes}}\n|-\n| SDN ||style=\"text-align:left;\"| {{fba|Sudan}} || {{Nft Alt Links|Sudan|sublist_style=font-size:90%}} || 1936 || 1948 || 1957 || 1975 || {{yes}}\n|-\n| TAN ||style=\"text-align:left;\"| {{fba|Tanzania}} || {{Nft Alt Links|Tanzania|sublist_style=font-size:90%}} || 1930 || 1964 || 1964 || 1973 || {{yes}}\n|-\n| UGA ||style=\"text-align:left;\"| {{fba|Uganda}} || {{Nft Alt Links|Uganda|sublist_style=font-size:90%}} || 1924 || 1960 || 1960 || 1973 || {{yes}}\n|-\n| ZAN ||style=\"text-align:left;\"| {{fba|Zanzibar}} {{ref|n3|3}} || {{Nft Alt Links|Zanzibar|sublist_style=font-size:90%}} || 1965 ||  || 1980 || 1973 & 2003 || {{no}}\n|-\n!colspan=8|[[Council of Southern Africa Football Associations|Council of Southern Africa Football Associations (COSAFA)]]\n|-\n| ANG ||style=\"text-align:left;\"| {{fba|Angola}} || {{Nft Alt Links|Angola|sublist_style=font-size:90%}} || 1979 || 1980 || 1980 || 1997 || {{yes}}\n|-\n| BOT ||style=\"text-align:left;\"| {{fba|Botswana}} || {{Nft Alt Links|Botswana|sublist_style=font-size:90%}} || 1970 || 1978 || 1976 || 1997 || {{yes}}\n|-\n| COM ||style=\"text-align:left;\"| {{fba|Comoros}} || {{Nft Alt Links|Comoros|sublist_style=font-size:90%}} || 1979 || 2005 || 2005 || 2007 || {{yes}}\n|-\n| SWZ ||style=\"text-align:left;\"| {{fba|Eswatini}} || {{Nft Alt Links|Eswatini|sublist_style=font-size:90%}} || 1968 || 1978 || 1978 || 1997 || {{yes}}\n|-\n| LES ||style=\"text-align:left;\"| {{fba|Lesotho}} || {{Nft Alt Links|Lesotho|sublist_style=font-size:90%}} || 1932 || 1964 || 1964 || 1997 || {{yes}}\n|-\n| MAD ||style=\"text-align:left;\"| {{fba|Madagascar}} || {{Nft Alt Links|Madagascar|sublist_style=font-size:90%}} || 1961 || 1964 || 1963 || 2000 || {{yes}}\n|-\n| MWI ||style=\"text-align:left;\"| {{fba|Malawi}} || {{Nft Alt Links|Malawi|sublist_style=font-size:90%}} || 1966 || 1968 || 1968 || 1997 || {{yes}}\n|-\n| MRI ||style=\"text-align:left;\"| {{fba|Mauritius}} || {{Nft Alt Links|Mauritius|sublist_style=font-size:90%}} || 1952 || 1964 || 1963 || 2000 || {{yes}}\n|-\n| MOZ ||style=\"text-align:left;\"| {{fba|Mozambique}} || {{Nft Alt Links|Mozambique|sublist_style=font-size:90%}} || 1976 || 1980 || 1980 || 1997 || {{yes}}\n|-\n| NAM ||style=\"text-align:left;\"| {{fba|Namibia}} || {{Nft Alt Links|Namibia|sublist_style=font-size:90%}} || 1990 || 1992 || 1992 || 1997 || {{yes}}\n|-\n| SEY ||style=\"text-align:left;\"| {{fba|Seychelles}} || {{Nft Alt Links|Seychelles|sublist_style=font-size:90%}} || 1979 || 1986 || 1986 || 2000 || {{yes}}\n|-\n| RSA ||style=\"text-align:left;\"| {{fba|South Africa}} {{ref|n1|1}} || {{Nft Alt Links|South Africa|sublist_style=font-size:90%}} || 1991 || 1992 || 1992 || 1997 || {{yes}}\n|-\n| ZAM ||style=\"text-align:left;\"| {{fba|Zambia}} || {{Nft Alt Links|Zambia|sublist_style=font-size:90%}} || 1929 || 1964 || 1964 || 1997 || {{yes}}\n|-\n| ZIM ||style=\"text-align:left;\"| {{fba|Zimbabwe}} || {{Nft Alt Links|Zimbabwe|sublist_style=font-size:90%}} || 1965 || 1965 || 1980 || 1997 || {{yes}}\n|-\n!colspan=8|Non-regional members\n|-\n| REU ||style=\"text-align:left;\"| {{fba|R\u00e9union}} {{ref|n3|3|noid=noid}} || {{Nft Alt Links|R\u00e9union|sublist_style=font-size:90%}} || 1926 ||  || 2004 || || {{no}}\n|}\n\n#{{note|n1}} \u2013 Excluded from CAF and from 1st [[African Cup of Nations]] in 1957 due to Apartheid\n#{{note|n2}} \u2013 Member of [[UNAF]] from 2005 to 2009 and from 2011 \u2013 Withdrew from UNAF on 19 November 2009 but return on 2011\n#{{note|n3}} \u2013 Associate members, not part of [[FIFA]]. Zanzibar held full membership for four months in 2017, when its status was changed after CAF admitted its membership was an error.<ref>{{cite web |last1=Gleason |first1=Mark |title=Zanzibar loses Caf membership in embarrassing U-turn |url=https://www.bbc.co.uk/sport/football/40682462 |publisher=BBC Sport |accessdate=31 May 2018}}</ref>\n\n===Regional zones===\nCAF National League \n====CAF Zone 1 \u2013 North Zone====\n{{colbegin|colwidth=15em}}\n*{{fba|Algeria}}\n*{{fba|Egypt}}\n*{{fba|Libya}}\n*{{fba|Morocco}}\n*{{fba|Tunisia}}\n{{colend}}\n\n====CAF Zone 2 \u2013 Zone West A====\n{{colbegin|colwidth=15em}}\n*{{fba|Cape Verde}}\n*{{fba|Gambia}}\n*{{fba|Guinea}}\n*{{fba|Guinea-Bissau}}\n*{{fba|Liberia}}\n*{{fba|Mali}}\n*{{fba|Mauritania}}\n*{{fba|Senegal}}\n*{{fba|Sierra Leone}}\n{{colend}}\n\n====CAF Zone 3 \u2013 Zone West B====\n{{colbegin|colwidth=15em}}\n*{{fba|Benin}}\n*{{fba|Burkina Faso}}\n*{{fba|Ghana}}\n*{{fba|Ivory Coast}}\n*{{fba|Niger}}\n*{{fba|Nigeria}}\n*{{fba|Togo}}\n{{colend}}\n\n====CAF Zone 4 \u2013 Central Zone====\n{{colbegin|colwidth=15em}}\n*{{fba|Cameroon}}\n*{{fba|Central African Republic}}\n*{{fba|Chad}}\n*{{fba|Congo}}\n*{{fba|DR Congo}}\n*{{fba|Equatorial Guinea}}\n*{{fba|Gabon}}\n*{{fba|Sao Tome and Principe}}\n{{colend}}\n\n====CAF Zone 5 \u2013 Central-East Zone====\n{{colbegin|colwidth=15em}}\n*{{fba|Burundi}}\n*{{fba|Djibouti}}\n*{{fba|Eritrea}}\n*{{fba|Ethiopia}}\n*{{fba|Kenya}}\n*{{fba|Rwanda}}\n*{{fba|Somalia}}\n*{{fba|South Sudan}}\n*{{fba|Sudan}}\n*{{fba|Tanzania}}\n*{{fba|Uganda}}\n{{colend}}\n\n====CAF Zone 6 \u2013 Southern Zone====\n{{colbegin|colwidth=15em}}\n*{{fba|Angola}}\n*{{fba|Botswana}}\n*{{fba|Comoros}}\n*{{fba|Eswatini}}\n*{{fba|Lesotho}}\n*{{fba|Madagascar}}\n*{{fba|Malawi}}\n*{{fba|Mauritius}}\n*{{fba|Mozambique}}\n*{{fba|Namibia}}\n*{{fba|Seychelles}}\n*{{fba|South Africa}}\n*{{fba|Zambia}}\n*{{fba|Zimbabwe}}\n{{colend}}\n\n==Competitions==\n\n===CAF competitions===\n{{col-start}}\n{{col-break}}\n'''National teams:'''\n*[[Africa Cup of Nations]]\n*[[African Nations Championship]]\n*[[Africa U-23 Cup of Nations]]\n*[[Africa U-20 Cup of Nations]]\n*[[Africa U-17 Cup of Nations]]\n*[[Africa Women Cup of Nations]]\n*[[African U-20 Women's World Cup qualification]]\n*[[African U-17 Cup of Nations for Women]]\n*[[Africa Futsal Cup of Nations]]\n*[[Africa Beach Soccer Cup of Nations]]\n{{col-break}}\n'''Clubs:'''\n*[[CAF Champions League]]\n*[[CAF Confederation Cup]]\n*[[CAF Super Cup]]\n;Defunct\n*[[African Cup Winners' Cup]]\n{{col-break}}\n'''Inter Continental:'''\n*[[Arab Nations Cup]]\n*[[Arab Club Championship]]\n;Defunct\n*[[Afro-Asian Cup of Nations]]\n*[[Afro-Asian Club Championship]]\n*[[UEFA\u2013CAF Meridian Cup]]\n{{col-break}}\n'''Regional:'''\n*[[CECAFA Cup]]\n*[[WAFU Nations Cup]]\n*[[Amilcar Cabral Cup]]\n*[[COSAFA Cup]]\n*[[CEMAC Cup]]\n*[[UNIFFAC Cup]] (U-17)\n*[[UNAF U-23 Tournament]]\n{{col-end}}\n\n===International===\nThe main competition for men's national teams [[Africa Cup of Nations]], started in 1957. In 2009, the CAF started organising another competition for men's national teams, the [[African Nations Championship]] composed exclusively of national players playing in the national championship. CAF also runs national competitions at [[Africa U-20 Cup of Nations|Under-20]] and [[African Under-17 Championship|Under-17]] levels. For women's national teams, CAF operates the [[Africa Women Cup of Nations]] for senior national sides and the [[African U-20 Women's World Cup qualification]] at under-20 level, since 2008 there is an [[African U-17 Cup of Nations for Women]] for under-17 sides.\n\n===Club===\nCAF also runs the two main club competitions in Africa: the [[CAF Champions League]] was first held in 1964, and was known as the African Cup of Champions Clubs (or just African Cup) until 1997; and the [[CAF Confederation Cup]], for national cup winners and high-placed league teams, was launched by CAF in 2004 as a successor to the [[African Cup Winners' Cup]] (begun in 1975). A third competition, the [[CAF Cup]], started in 1992 and was absorbed into the CAF Confederation Cup in 2004.<ref>{{cite web |url=http://www.cafonline.com/index.php?lng=1&opt=44&cmpt=19&titre=Past%20Competitions |title=Confederation Cup |publisher=CAF |accessdate=17 December 2008}}</ref>\n\nThe [[CAF Super Cup]], which pits the winners of the Champions League against the winners of the CAF Confederation Cup (previously the winners of the Cup Winners' Cup), came into being in 1992.\n\nThe [[Afro-Asian Club Championship]] was jointly organised with [[Asian Football Confederation|AFC]] between the winners of the [[CAF Champions League]] and the winners of the [[AFC Champions League]].\nThe last [[Afro-Asian Club Championship]] took place in 1998.\n\n===Current title holders===\n{| class=\"wikitable sortable\"\n|-\n!Competition\n!Champion\n!Title\n!Runner-up\n!Next edition\n|-\n!colspan=5|Nations men\n|-\n| [[Africa Cup of Nations]]\n| {{fb|Algeria}} \n| 2nd\n|{{fb|Senegal}}\n| [[2021 Africa Cup of Nations|2021]]\n|-\n| [[African Nations Championship]]\n| {{fb|Morocco}}\n| 1st\n|{{fb|Nigeria}}\n| [[2020 African Nations Championship|2020]]\n|-\n| [[Africa U-23 Cup of Nations]]\n| {{fbu|23|Egypt}}\n| 1st\n| {{fbu|23|Ivory Coast}}\n| [[2023 Africa U-23 Cup of Nations|2023]]\n|-\n| [[Football at the African Games|African Games Men's Football Tournament]]\n| {{fbu|23|BFA}}\n| 1st\n| {{fbu|23|NGR}}\n| [[Football at the 2023 African Games \u2013 Men's tournament|2023]]\n|-\n| [[Africa U-20 Cup of Nations]]{{refn|group=cc|This competition has been known by four different names, most recently the African U-21 Championship from 2003 through the 2015 competition. The first tournament under the current name of \"Africa U-20 Cup of Nations\" will tale place in 2017.}}\n| {{fbu|20|MLI}}\n| 1st\n| {{fbu|20|SEN}}\n| [[2021 Africa U-20 Cup of Nations|2021]]\n|-\n| [[Africa U-17 Cup of Nations]]{{refn|group=cc|From 1995 through the 2015 tournament, the competition was known as the African U-17 Championship. The first tournament under the current name of \"Africa U-17 Cup of Nations\" will tale place in 2017.}}\n| {{fbu|17|CMR}}\n| 2nd\n| {{fbu|17|GHA}}\n| [[2021 Africa U-17 Cup of Nations|2021]]\n|-\n| [[Africa Futsal Cup of Nations]]\n| {{futsal|MAR}}\n| 1st\n| {{futsal|EGY}}\n| [[2020 Africa Futsal Cup of Nations|2020]]\n|-\n| [[Africa Beach Soccer Cup of Nations]]\n| {{beachsoccer|SEN}}\n| 5th\n| {{beachsoccer|NGR}}\n| [[2020 Africa Beach Soccer Cup of Nations|2020]]\n|-\n!colspan=5|Nations women\n|-\n| [[Africa Women Cup of Nations]]\n| {{fbw|NGA}}\n| 11th\n| {{fbw|RSA}}\n| [[2020 Africa Women Cup of Nations|2020]]\n|-\n| [[Football at the African Games|African Games Women's Football Tournament]]\n| {{fbw|NGR}}\n| 3rd\n| {{fbw|CMR}}\n| [[Football at the 2023 African Games \u2013 Women's tournament|2023]]\n|-\n| [[African U-20 Women's World Cup qualification]]\n| {{fbwu|20|GHA}}<br>{{fbwu|20|NGR}}\n| 5th<br>9th\n| {{fbwu|20|CMR}}<br>{{fbwu|20|RSA}}\n| [[2020 African U-20 Women's World Cup Qualifying Tournament|2020]]\n|-\n| [[African U-17 Cup of Nations for Women]]\n| {{fbwu|17|GHA}}<br>{{fbwu|17|RSA}}<br>{{fbwu|17|CMR}}\n| 5th<br>2nd<br>1st\n| {{fbwu|17|DJI}}<br>{{fbwu|17|MAR}}<br>{{fbwu|17|NGA}}\n| [[2020 African U-17 Women's World Cup Qualifying Tournament|2020]]\n|-\n!colspan=5|Clubs\n|-\n| [[CAF Champions League]]\n| {{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance de Tunis]]\n| 4th\n| {{flagicon|MAR}} [[Wydad AC]]\n| [[2019\u201320 CAF Champions League|2019\u201320]]\n|-\n| [[CAF Confederation Cup]]\n| {{flagicon|EGY}} [[Zamalek SC|Zamalek]]\n| 1st\n| {{flagicon|MAR}} [[RS Berkane]]\n| [[2019\u201320 CAF Confederation Cup|2019\u201320]]\n|-\n| [[CAF Super Cup]]\n| {{flagicon|EGY}} [[Zamalek SC|Zamalek]]\n| 4th\n| {{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance de Tunis]]\n| [[2020 CAF Super Cup (August)|2020]]\n|}\n\n{{reflist|group=cc}}\n\n===Competition Winners===\n{| class=\"wikitable sortable\"style=\"font-size:95%\n|-\n!rowspan=2|Nation\n!colspan=8|Men\n!colspan=2|Women\n!rowspan=2|Total\n|-\n![[Africa Cup of Nations]]\n![[African Nations Championship|CHAN]]\n![[Africa U-23 Cup of Nations|U-23's]]\n![[Africa U-20 Cup of Nations|U-20's]]\n![[Africa U-17 Cup of Nations|U-17's]]\n![[Africa Futsal  Cup of Nations|Futsal]]\n![[Africa Beach Soccer Cup of Nations|Beach Soccer]]\n![[All-Africa Games]]\n![[ Africa Women Cup of Nations]]\n![[All-Africa Games]]\n|-align=center\n|-style=\"background:lightgreen\"\n|align=left|{{flagicon|NGR}} [[Nigeria ]]||3(4)||0(1)||1||7(2)||2(2)|| \u2013 ||2(4)||1(4)||11||3||'''3O(17)'''\n|-align=center\n|-style=\"background:lightblue\"\n|align=left|{{flagicon|EGY}}Egypt||7(2)|| \u2013 ||1||4(1)||1||3(2)||-||2||-||-||'''18(5)'''\n|-align=center\n|-style=\"background:Pink\"\n|align=left|{{flagicon|CMR}}Cameroon||5(2)||-||-||1(4)||2||-||1(1)||4||0(4)||1(2)||'''14(13)'''\n|-align=center\n|-style=\"background:lightgreen\"\n|align=left|{{flagicon|GHA}}Ghana||4(5)||0(2)||-||3(2)||2(2)||0(1)||-||1||1(1)||0(3)'''||'''11(16)'''\n|-align=center\n|-style=\"background:lightgreen\"\n|align=left|{{flagicon|SEN}}Senegal||0(2)|| \u2013 ||-||0(3)||-||-||5(2)||1||-||-||'''6(7)'''\n|-align=center\n|-style=\"background:lightblue\"\n|align=left|{{flagicon|ALG}}Algeria||2(1)||-||0(1)||1||0(1)||-||-||1||-||-||'''4(3)'''\n|-align=center\n|-style=\"background:lightgreen\"\n|align=left|{{flagicon|MAR}}Morocco||1(1)||1||0(1)||1||-||1(1)||-||-||-||-||'''4(3)'''\n|-align=center\n|-style=\"background:Pink\"\n|align=left|{{flagicon |DRC}}DR Congo||2||2||-||-||-||-||-||-||-||-||'''4'''\n|}\n\n==Sponsors==\nIn October 2004, [[MTN Group|MTN]] has contracted a four-year deal to sponsor African football's major competitions. This agreement, which worthed US$12.5&nbsp;million, was the biggest sponsorship deal in African sporting history at that time.<ref name=\"news.bbc.co.uk\">{{cite news |url=http://news.bbc.co.uk/sport2/hi/football/africa/3763112.stm |title=CAF signs sponsorship deal |date=21 October 2004 |work=BBC |publisher=BBC |accessdate=14 February 2018}}</ref>\n\nIn July 2009, [[Orange S.A.|Orange]] has signed an eight-year deal to sponsor African football's major competitions. Terms of the deal were not disclosed but CAF previous year put a value of  \u20ac100&nbsp;million for a comprehensive and long-term package of its competitions when it opened tenders for a new sponsor. The deal included the [[African Nations Cup]], the '''CAF Champions League''', the [[CAF Confederation Cup]], the [[CAF Super Cup]], the [[African Nations Championship]] and the [[African Youth Championship]].<ref name=\"reuters.com\">{{cite news |url=https://www.reuters.com/article/ozabs-soccer-africa-sponsor-20090728-idAFJOE56R0N320090728 |title=Orange signs deal to sponsor African soccer competitions |date=28 July 2009 |work=Reuters |publisher=Reuters |accessdate=12 February 2018}}</ref>\n\nIn July 2016, [[Total S.A.|Total]] replaced [[Orange S.A.|Orange]] as the main sponsor and has secured an eight-year sponsorship package from the Confederation of African Football (CAF) for a value of \u20ac950&nbsp;million<ref name=\"africanews.com\">{{cite news |url=http://www.africanews.com/2016/11/09/caf-reviews-prize-money-afcon-2017-winner-to-pocket-4-million/ |title=CAF reviews prize money, AFCON 2017 winner to pocket $4&nbsp;million |date=9 November 2016 |work=Africa News |publisher=Africa News |accessdate=14 February 2018}}</ref> to support ETof its principal competitions, including the CAF Champions League, renamed Total CAF Champions League.<ref name=\"africanews.com 2\">{{cite news |url=http://www.africanews.com/2016/07/21/total-to-sponsor-caf-competitions-for-the-next-eight-years/ |title=Total to sponsor CAF competitions for the next eight years |date=21 July 2016 |work=Africa News |publisher=Africa News |accessdate=21 July 2016}}</ref>\n\nThe CAF current main sponsors are:\n* 1XBET\n* [[Total S.A.|Total]]\n* [[Visa Inc.|Visa]]\n* [[Gilead Sciences|Gilead]]\n* Temmy's Cereal\n* [[Orange S.A.|Orange]]\n* [[Continental AG|Continental]]\n* [[Yamaha Motor Company|Yamaha]]\n\n==Rankings==\n\n====Top ranked men's national teams by FIFA====\n<timeline>\nImageSize = width:160 height:1800\nPlotArea = left:40 right:0 bottom:10 top:10\n\n# Just short of the date the next version of the FIFA World Ranking will be released (dd/mm/yyyy)\nDefine $enddate = 24/10/2019\n\nDateFormat = dd/mm/yyyy\nPeriod = from:08/08/1993 till:$enddate\nTimeAxis = orientation:vertical format:yyyy\nScaleMajor = unit:year increment:1 start:1994\n\n# Colors for teams (typically derived from jersey's first colors)\nColors =\n  id:Algeria     value:rgb(0.32, 0.66, 0.22) \n  id:Cameroon    value:rgb(0,    0.39, 0.20) \n  id:CapeVerde   value:rgb(0,    0.22, 0.58) \n  id:Egypt       value:rgb(0.87, 0,    0) \n  id:IvoryCoast  value:rgb(0.97, 0.47, 0)\n  id:Ghana       value:rgb(1,    1,    1) \n  id:Morocco     value:rgb(0.73, 0.07, 0.10)   \n  id:Nigeria     value:rgb(0,    0.53, 0.32)\n  id:Senegal     value:rgb(0,    0.52, 0.22) \n  id:SouthAfrica value:rgb(0.99, 0.71, 0.08) \n  id:Tunisia     value:rgb(1,    1,    1) \n  id:Zambia      value:rgb(0,    0.5,    0) \n\n# A line at the right side of the graph\nLineData =\n  from:08/08/1993 till:end atpos:65 color:black width:0.5\n\n# Setup text and color to use in the labeled bars\nDefine $labelAlgeria     = text:\"Algeria\" color:Algeria\nDefine $labelCameroon    = text:\"Cameroon\" color:Cameroon\nDefine $labelCapeVerde   = text:\"Cape Verde\" color:CapeVerde\nDefine $labelEgypt       = text:\"Egypt\" color:Egypt\nDefine $labelIvoryCoast  = text:\"Ivory Coast\" color:IvoryCoast\nDefine $labelGhana       = text:\"Ghana\" color:Ghana\nDefine $labelMorocco     = text:\"Morocco\" color:Morocco\nDefine $labelNigeria     = text:\"Nigeria\" color:Nigeria\nDefine $labelSenegal     = text:\"Senegal\" color:Senegal\nDefine $labelSouthAfrica = text:\"South Africa\" color:SouthAfrica\nDefine $labelTunisia     = text:\"Tunisia\" color:Tunisia\nDefine $labelZambia      = text:\"Zambia\" color:Zambia\n\nPlotData =\n  bar:Leaders width:25 mark:(line,black)\n\n  from:08/08/1993 till:25/07/1995 shift:(20,-5) $labelNigeria\n  from:25/07/1995 till:22/08/1995 shift:(20,-10) $labelTunisia\n  from:22/08/1995 till:19/09/1995 shift:(20,-5) $labelEgypt\n  from:19/09/1995 till:17/10/1995 shift:(20,-5) $labelNigeria\n  from:17/10/1995 till:21/11/1995 shift:(20,-5) $labelEgypt  \n  from:21/11/1995 till:19/12/1995 shift:(20,-5) $labelTunisia\n  from:19/12/1995 till:24/01/1996 shift:(20,-5) $labelIvoryCoast\n  from:24/01/1996 till:21/02/1996 shift:(20,-5) $labelGhana\n  from:21/02/1996 till:22/05/1996 shift:(20,-5) $labelZambia\n  from:24/04/1996 till:22/05/1996 shift:(20,-5) color:Ghana width:11 text:\"Ghana / Zambia\"\n  from:22/05/1996 till:18/12/1996 shift:(20,-5) $labelZambia\n  from:18/12/1996 till:27/02/1997 shift:(20,-5) $labelSouthAfrica\n  from:27/02/1997 till:14/05/1997 shift:(20,-5) $labelZambia\n  from:14/05/1997 till:16/02/2000 shift:(20,-5) $labelMorocco\n  from:16/02/2000 till:18/07/2001 shift:(20,-5) $labelSouthAfrica\n  from:18/07/2001 till:13/02/2002 shift:(20,-5) $labelTunisia\n  from:13/02/2002 till:06/10/2004 shift:(20,-5) $labelCameroon\n  from:06/10/2004 till:15/06/2005 shift:(20,-5) $labelNigeria\n  from:15/06/2005 till:20/07/2005 shift:(20,-5) $labelCameroon\n  from:20/07/2005 till:12/09/2005 shift:(20,-5) $labelEgypt  \n  from:12/09/2005 till:21/11/2005 shift:(20,-5) $labelCameroon\n  from:17/10/2005 till:21/11/2005 shift:(20,-5) color:Nigeria width:11 text:\"Cameroon / Nigeria\"\n  from:21/11/2005 till:15/02/2006 shift:(20,-5) $labelCameroon\n  from:15/02/2006 till:14/02/2007 shift:(20,-5) $labelNigeria\n  from:14/02/2007 till:19/09/2007 shift:(20,-5) $labelCameroon\n  from:19/09/2007 till:13/02/2008 shift:(20,-5) $labelNigeria\n  from:13/02/2008 till:04/06/2008 shift:(20,-5) $labelGhana\n  from:04/06/2008 till:01/07/2009 shift:(20,-5) $labelCameroon\n  from:01/07/2009 till:16/10/2009 shift:(20,-5) $labelIvoryCoast\n  from:16/10/2009 till:03/02/2010 shift:(20,-5) $labelCameroon\n  from:03/02/2010 till:02/02/2011 shift:(20,-5) $labelEgypt  \n  from:02/02/2011 till:29/06/2011 shift:(20,-5) $labelGhana\n  from:29/06/2011 till:05/06/2014 shift:(20,-5) $labelIvoryCoast\n  from:05/06/2014 till:05/11/2015 shift:(20,-5) $labelAlgeria\n  from:05/11/2015 till:03/03/2016 shift:(20,-5) $labelIvoryCoast\n  from:03/03/2016 till:07/04/2016 shift:(20,-5) $labelCapeVerde\n  from:07/04/2016 till:15/09/2016 shift:(20,-5) $labelAlgeria\n  from:15/09/2016 till:24/11/2016 shift:(20,-5) $labelIvoryCoast\n  from:24/11/2016 till:09/02/2017 shift:(20,-5) $labelSenegal\n  from:09/02/2017 till:16/10/2017 shift:(20,-5) $labelEgypt  \n  from:16/10/2017 till:23/11/2017 shift:(20,-5) $labelTunisia\n  from:23/11/2017 till:18/01/2018 shift:(20,-5) $labelSenegal\n  from:18/01/2018 till:20/09/2018 shift:(20,-5) $labelTunisia\n  from:16/08/2018 till:20/09/2018 shift:(20,-5) color:Senegal width:11 text:\"Senegal / Tunisia\"\n  from:20/09/2018 till:29/11/2018 shift:(20,-5) $labelTunisia\n  from:29/11/2018 till:end shift:(20,-5) $labelSenegal\n</timeline><noinclude>\n\nThis graph shows the time periods each (male) national football team has been at the highest ranked CAF member on the [[FIFA World Rankings]]. \n</noinclude>\n\n{{col-begin}}\n{{col-2}}\n\n====Top ranked  women's national teams by FIFA====\n<timeline>\nImageSize = width:160 height:300\nPlotArea = left:40 right:0 bottom:10 top:10\nDateFormat = dd/mm/yyyy\nPeriod = from:01/01/2003 till:29/09/2019\nScaleMajor = unit:year increment:1 start:2003\nTimeAxis = orientation:vertical format:yyyy\n\nColors =\n  id:NGA         value:green\n\nPlotData= \n  bar:Leaders width:25 mark:(line,black) align:left fontsize:S\n\n  from:01/01/2003 till:27/09/2019 shift:(20,-3) text:\"Nigeria\" color:NGA\n</timeline>\n{{col-end}}\n\n{{col-begin}}\n{{col-2}}\n\n===Men's national teams===\nRankings are calculated by [[FIFA]].<ref>{{cite web |title=The FIFA/Coca-Cola World Ranking - Ranking Table - African Zone  - FIFA.com |url=https://www.fifa.com/fifa-world-ranking/ranking-table/men/#CAF |website=FIFA.com}}</ref>\n\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|-\n!CAF\n![[FIFA]]\n!Country\n!Point\n!+/\u2212\n!Region\n|- \n|'''1'''\n|'''20'''\n|align=left|{{fb|SEN}}\n|1546\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''2'''\n|'''29'''\n|align=left|{{fb|TUN}}\n|1495\n|{{steady}}\n|  style=\"text-align:center; background:#8fbc8f;\"|[[Union of North African Football Federations|{{white|UNAF}}]]\n|-\n|'''3'''\n|'''35'''\n|align=left|{{fb|NGA}}\n|1481\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''4'''\n|'''38'''\n|align=left|{{fb|ALG}}\n|1469\n|{{steady}}\n|  style=\"text-align:center; background:#8fbc8f;\"|[[Union of North African Football Federations|{{white|UNAF}}]]\n|-\n|'''5'''\n|'''42'''\n|align=left|{{fb|MAR}}\n|1457\n|{{decrease}} \u22123\n|  style=\"text-align:center; background:#8fbc8f;\"|[[Union of North African Football Federations|{{white|UNAF}}]]\n|-\n|'''6'''\n|'''49'''\n|align=left|{{fb|EGY}}\n|1433\n|{{steady}}\n|  style=\"text-align:center; background:#8fbc8f;\"|[[Union of North African Football Federations|{{white|UNAF}}]]\n|-\n|'''7'''\n|'''51'''\n|align=left|{{fb|GHA}}\n|1426\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''8'''\n|'''52'''\n|align=left|{{fb|CMR}}\n|1409\n|{{steady}}\n|  style=\"text-align:center; background:#db7093;\"|[[Central African Football Federations' Union|{{white|UNIFFAC}}]]\n|-\n|'''9'''\n|'''54'''\n|align=left|{{fb|COD}}\n|1399\n|{{increase}} +1\n|  style=\"text-align:center; background:#db7093;\"|[[Central African Football Federations' Union|{{white|UNIFFAC}}]]\n|-\n|'''10'''\n|'''56'''\n|align=left|{{fb|CIV}}\n|1392\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''11'''\n|'''59'''\n|align=left|{{fb|MLI}}\n|1386\n|{{decrease}} \u22122\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''12'''\n|'''60'''\n|align=left|{{fb|BFA}}\n|1378\n|{{increase}} +1\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''13'''\n|'''72'''\n|align=left|{{fb|RSA}}\n|1337\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#deb887;\"|[[Counsel of Southern African Football Association|{{white|COSAFA}}]]\n|-\n|'''14'''\n|'''77'''\n|align=left|{{fb|CPV}}\n|1319\n|{{increase}} +1\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''15'''\n|'''78'''\n|align=left|{{fb|GUI}}\n|1317\n|{{decrease}} \u22124\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''16'''\n|'''79'''\n|align=left|{{fb|UGA}}\n|1311\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''17'''\n|'''81'''\n|align=left|{{fb|ZAM}}\n|1299\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''18'''\n|'''82'''\n|align=left|{{fb|BEN}}\n|1293\n|{{increase}} +1\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''19'''\n|'''87'''\n|align=left|{{fb|GAB}}\n|1285\n|{{increase}} +1\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''20'''\n|'''92'''\n|align=left|{{fb|CGO}}\n|1265\n|{{decrease}} \u22122\n|  style=\"text-align:center;background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''21'''\n|'''95'''\n|align=left|{{fb|MAD}}\n|1249\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''22'''\n|'''103'''\n|align=left|{{fb|LBY}}\n|1211\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#8fbc8f;\"|[[UNAF|{{white|UNAF}}]]\n|-\n|'''23'''\n|'''105'''\n|align=left|{{fb|MTN}}\n|1205\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''24'''\n|'''107'''\n|align=left|{{fb|NIG}}\n|1198\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''24'''\n|'''108'''\n|align=left|{{fb|KEN}}\n|1195\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''26'''\n|'''112'''\n|align=left|{{fb|CTA}}\n|1186\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''23'''\n|'''105'''\n|align=left|{{fb|MOZ}}\n|1205\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''28'''\n|'''117'''\n|align=left|{{fb|SLE}}\n|1167\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''28'''\n|'''117'''\n|align=left|{{fb|ZIM}}\n|1167\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''30'''\n|'''119'''\n|align=left|{{fb|NAM}}\n|1163\n|{{increase}} +1\n|  style=\"text-align:center; background:#deb887;\"|[[Council of Southern Africa Football Associations|{{white|COSAFA}}]]\n|-\n|'''31'''\n|'''120'''\n|align=left|{{fb|ANG}}\n|1161\n|{{increase}} +1\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''32'''\n|'''123'''\n|align=left|{{fb|GNB}}\n|1155\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''33'''\n|'''124'''\n|align=left|{{fb|MWI}}\n|1140\n|{{steady}}\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''33'''\n|'''124'''\n|align=left|{{fb|TOG}}\n|1140\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''35'''\n|'''128'''\n|align=left|{{fb|SDN}}\n|1111\n|{{steady}}\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''36'''\n|'''129'''\n|align=left|{{fb|RWA}}\n|1106\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''37'''\n|'''133'''\n|align=left|{{fb|TAN}}\n|1084\n|{{increase}} +2\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''38'''\n|'''135'''\n|align=left|{{fb|EQG}}\n|1083\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''39'''\n|'''138'''\n|align=left|{{fb|LES}}\n|1076\n|{{decrease}} \u22121\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''40'''\n|'''142'''\n|align=left|{{fb|COM}}\n|1067\n|{{increase}} +5\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''41'''\n|'''143'''\n|align=left|{{fb|BDI}}\n|1063\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''42'''\n|'''146'''\n|align=left|{{fb|BOT}}\n|1057\n|{{increase}} +2\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''43'''\n|'''147'''\n|align=left|{{fb|ESW}}\n|1055\n|{{increase}} +3\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''44'''\n|'''151'''\n|align=left|{{fb|ETH}}\n|1049\n|{{steady}}\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''45'''\n|'''152'''\n|align=left|{{fb|LBR}}\n|1047\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''46'''\n|'''162'''\n|align=left|{{fb|SSD}}\n|997\n|{{increase}} +11\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''47'''\n|'''166'''\n|align=left|{{fb|GAM}}\n|990\n|{{steady}}\n|  style=\"text-align:center; background:gold;\"|[[West African Football Union|{{white|WAFU}}]]\n|-\n|'''48'''\n|'''173'''\n|align=left|{{fb|MRI}}\n|970\n|{{decrease}} \u221212\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''49'''\n|'''176'''\n|align=left|{{fb|CHA}}\n|955\n|{{increase}} +1\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''50'''\n|'''180'''\n|align=left|{{fb|STP}}\n|934\n|{{increase}} +10\n|  style=\"text-align:center; background:#db7093;\"|[[UNIFFAC|{{white|UNIFFAC}}]]\n|-\n|'''51'''\n|'''185'''\n|align=left|{{fb|DJI}}\n|916\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''52'''\n|'''198'''\n|align=left|{{fb|SOM}}\n|879\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|-\n|'''53'''\n|'''200'''\n|align=left|{{fb|SEY}}\n|868\n|{{decrease}} \u22122\n|  style=\"text-align:center; background:#deb887;\"|[[COSAFA|{{white|COSAFA}}]]\n|-\n|'''54'''\n|'''206'''\n|align=left|{{fb|ERI}}\n|856\n|{{increase}} +1\n|  style=\"text-align:center; background:#4682b4;\"|[[CECAFA|{{white|CECAFA}}]]\n|}\n[https://www.fifa.com/fifa-world-ranking/ranking-table/men/#CAF Last updated 24 October 2019]\n{{col-2}}\n\n===Women's national teams===\nRankings are calculated by [[FIFA]].<ref>{{cite web |url=https://www.fifa.com/fifa-world-ranking/ranking-table/women/#CAF |title=The FIFA/Coca-Cola World Ranking (Women) \u2013 CAF Region |publisher=FIFA |date=23 December 2011 |accessdate=}}</ref>\n{{updated|12 July 2019}}\n{| class=\"wikitable\" cellpadding=\"5\" style=\"text-align: center;\"\n|-\n!CAF\n![[FIFA]]\n!Country\n!Point\n!+/\u2212\n|-\n|'''1'''\n|'''36'''\n|align=left|{{fbw|NGA}}\n|1643\n|{{increase}} 2 \n|-\n|'''2'''\n|'''41'''\n|align=left|{{fbw|CMR}}\n|1552\n|{{increase}} 5 \n|-\n|'''3'''\n|'''49'''\n|align=left|{{fbw|RSA}}\n|1486\n|{{steady}} \n|-\n|'''4'''\n|'''53'''\n|align=left|{{fbw|GHA}}\n|1452\n|{{decrease}} 2 \n|-\n|'''5'''\n|'''69'''\n|align=left|{{fbw|CIV}}\n|1363\n|{{steady}}\n|-\n|'''6'''\n|'''71'''\n|align=left|{{fbw|EQG}}\n|1356\n|{{decrease}} 1\n|-\n|'''7'''\n|'''80'''\n|align=left|{{fbw|MLI}}\n|1288\n|{{increase}} 5\n|-\n|'''8'''\n|'''83'''\n|align=left|{{fbw|MAR}}\n|1280\n|{{decrease}} 4 \n|-\n|'''9'''\n|'''86'''\n|align=left|{{fbw|ALG}}\n|1271\n|{{decrease}} 2 \n|-\n|'''10'''\n|'''88'''\n|align=left|{{fbw|SEN}}\n|1232\n|{{steady}}\n|-\n|'''11'''\n|'''102'''\n|align=left|{{fbw|ZIM}}\n|1192\n|{{steady}} \n|-\n|'''12'''\n|'''105'''\n|align=left|{{fbw|CGO}}\n|1178\n|{{decrease}} 5\n|-\n|'''13'''\n|'''116'''\n|align=left|{{fbw|COD}}\n|1128\n|{{steady}}\n|-\n|'''14'''\n|'''118'''\n|align=left|{{fbw|ETH}}\n|1122\n|{{decrease}} 1\n|-\n|'''15'''\n|'''119'''\n|align=left|{{fbw|ZAM}}\n|1119\n|{{decrease}} 3\n|-\n|'''16'''\n|'''124'''\n|align=left|{{fbw|GAB}}\n|1070\n|{{steady}}\n|-\n|'''17'''\n|'''125'''\n|align=left|{{fbw|BFA}}\n|1062\n|{{decrease}} 3\n|-\n|'''18'''\n|'''135'''\n|align=left|{{fbw|TAN}}\n|978\n|{{decrease}} 2\n|-\n|'''19'''\n|'''138'''\n|align=left|{{fbw|NAM}}\n|966\n|{{decrease}} 10\n|-\n|'''20'''\n|'''141'''\n|align=left|{{fbw|KEN}}\n|921\n|{{decrease}} 3\n|-\n|'''21'''\n|'''143'''\n|align=left|{{fbw|RWA}}\n|899\n|{{decrease}} 3\n|-\n|'''22'''\n|'''146'''\n|align=left|{{fbw|MWI}}\n|881\n|{{increase}} 1\n|-\n|'''23'''\n|'''148'''\n|align=left|{{fbw|UGA}}\n|868\n|{{decrease}} 4\n|-\n|'''24'''\n|'''149'''\n|align=left|{{fbw|LES}}\n|850\n|{{decrease}} 3\n|-\n|'''25'''\n|'''150'''\n|align=left|{{fbw|MOZ}}\n|823\n|{{decrease}} 5\n|-\n|'''26'''\n|'''151'''\n|align=left|{{fbw|SWZ}}\n|804\n|{{decrease}} 3\n|-\n|'''27'''\n|'''152'''\n|align=left|{{fbw|BOT}}\n|796\n|{{decrease}} 1\n|-\n|'''28'''\n|'''158'''\n|align=left|{{fbw|MAD}}\n|693\n|{{decrease}} 3\n|-\n|'''29'''\n|'''**'''\n|align=left|{{fbw|TUN}}\n|1313\n|{{decrease}} 7\n|-\n|'''30'''\n|'''**'''\n|align=left|{{fbw|EGY}}\n|1256\n|{{decrease}} 7\n|-\n|'''31'''\n|'''*'''\n|align=left|{{fbw|GAM}}\n|1183\n|{{decrease}} 7\n|-\n|'''32'''\n|'''*'''\n|align=left|{{fbw|ANG}}\n|1134\n|{{decrease}} 7\n|-\n|'''33'''\n|'''**'''\n|align=left|{{fbw|SLE}}\n|1132\n|{{decrease}} 7\n|-\n|'''34'''\n|'''**'''\n|align=left|{{fbw|Guinea}}\n|1077\n|{{decrease}} 7\n|-\n|'''35'''\n|'''**'''\n|align=left|{{fbw|Eritrea}}\n|1060\n|{{decrease}} 7\n|-\n|'''36'''\n|'''*'''\n|align=left|{{fbw|CAR}}\n|1056\n|{{decrease}} 7\n|-\n|'''37'''\n|'''*'''\n|align=left|{{fbw|Togo}}\n|962\n|{{decrease}} 7\n|-\n|'''38'''\n|'''**'''\n|align=left|{{fbw|Guinea-Bissau}}\n|927\n|{{decrease}} 7\n|-\n|'''39'''\n|'''*'''\n|align=left|{{fbw|Niger}}\n|891\n|{{decrease}} 7\n|-\n|'''40'''\n|'''**'''\n|align=left|{{fbw|Liberia}}\n|877\n|{{decrease}} 7\n|-\n|'''41'''\n|'''*'''\n|align=left|{{fbw|Comoros}}\n|837\n|{{decrease}} 7\n|-\n|'''42'''\n|'''*'''\n|align=left|{{fbw|Libya}}\n|761\n|{{decrease}} 7\n|-\n|'''43'''\n|'''**'''\n|align=left|{{fbw|Burundi}}\n|519\n|{{decrease}} 7\n|-\n|'''44'''\n|'''*'''\n|align=left|{{fbw|Mauritius}}\n|358\n|{{decrease}} 7\n|}\n: * Provisionally listed due to not having played more than five matches against officially ranked teams.\n: ** Unranked teams are inactive for more than 18 months and therefore not ranked.\n{{col-end}}\n\n===CAF overall ranking of African clubs titles===\nThe following clubs are the top 10 clubs in CAF competitions.\n{| class=\"wikitable\" style=\"text-align: left;\"\n|-\n!width=2%| Pos\n!width=17%| Club\n!width=3%| Titles\n!width=65%| Trophies won\n|-\n| style=\"text-align:center;\"| 1||{{Flagicon|Egypt}} [[Al Ahly SC]]||align=center|20||8 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Confederation Cup]], 4 [[African Cup Winners' Cup]], 6 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n| style=\"text-align:center;\"| 2||{{Flagicon|Egypt}} [[Zamalek SC]]||align=center|13||5 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Confederation Cup]], 1 [[African Cup Winners' Cup]], 4 [[CAF Super Cup]], 2 [[Afro-Asian Club Championship]]\n|-\n| style=\"text-align:center;\"| 3||{{Flagicon|Democratic Republic of the Congo}} [[TP Mazembe]]||align=center|11||5 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 2 [[CAF Confederation Cup]], 1 [[African Cup Winners' Cup]], 3 [[CAF Super Cup]]\n|-\n| style=\"text-align:center;\"| 4||{{Flagicon|Tunisia}} [[\u00c9toile du Sahel]]||align=center|9||1 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 2 [[African Cup Winners' Cup]], 2 [[CAF Confederation Cup]], 2 [[CAF Cup]], 2 [[CAF Super Cup]]\n|-\n| style=\"text-align:center;\"| 5||{{Flagicon|Tunisia}} [[Esp\u00e9rance Sportive de Tunis]]||align=center |8||4 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[African Cup Winners' Cup]], 1 [[CAF Cup]], 1 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n| style=\"text-align:center;\"| 6\n|{{Flagicon|Morocco}} [[Raja Casablanca]]||align=center|8||3 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Confederation Cup]], 1 [[CAF Cup]], 2 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n\n| style=\"text-align:center;\"| 7\n|{{Flagicon|Algeria}} [[JS Kabylie]]||align=center|6||2 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[African Cup Winners' Cup]], 3 [[CAF Cup]]\n|-\n| style=\"text-align:center;\"| 8\n|{{Flagicon|Morocco}} [[Wydad Casablanca]]||align=center|5||2 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Cup Winners' Cup]], 1 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n| rowspan=\"4\" style=\"text-align:center;\"| 9\n|{{Flagicon|Algeria}} [[ES S\u00e9tif]]||align=center|4||2 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[CAF Super Cup]], 1 [[Afro-Asian Club Championship]]\n|-\n|{{Flagicon|Cameroon}} [[Canon Yaound\u00e9]]||align=center|4||3 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 1 [[African Cup Winners' Cup]]\n|-\n|{{Flagicon|Nigeria}} [[Enyimba International F.C.|Enyimba F.C.]]||align=center|4||2 [[CAF Champions League|African Cup of Champions Clubs/CAF Champions League]], 2 [[CAF Super Cup]]\n\n|-\n|{{Flagicon|Tunisia}} [[CS Sfaxien]] ||align=center|4|| 3 [[CAF Confederation Cup]], 1 [[CAF Cup]]\n|}\n{{refbegin}}''Update as of 21 February 2015 in chronological order.''{{refend}}\n\n===CAF overall ranking of African clubs===\nRankings are calculated by the CAF based on points gathered by African teams throughout their participation in international club tournaments organized by either the [[FIFA]], Harrison Campbell, or the CAF since the establishment of the first [[African Cup of Champions Clubs]] in 1964.<ref>{{cite web |url=http://www.cafonline.com/index.php?lng=1&cmpt=0&module=media&ANC=actualite&TNews=&idrub=97076&idnews=83214 |title=African Club Ranking: Old-Time records from 2000 to 2010 |publisher=CAF |date=1 May 2014 |accessdate=1 November 2014}}</ref>\n{{col-begin}}\n{{col-3}}\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|+ Overall\n|-\n!Rank\n!Club\n!Points\n|- \n|'''1'''\n|align=left|{{flagicon|EGY}} [[Al Ahly SC]]\n|'''90'''\n|-\n|2\n|align=left|{{flagicon|TUN}} [[\u00c9toile du Sahel]]\n\n|60\n|-\n|3\n|align=left|{{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance Tunis]]\n|59\n|-\n|4\n|align=left|{{flagicon|EGY}} [[Zamalek SC|Zamalek]]\n|56\n|-\n|5\n|align=left|{{flagicon|COD}} [[TP Mazembe]]\n|49\n|-\n|6\n|align=left|{{flagicon|COD}} [[A.S. Vita Club|Vita Club]]\n|44\n|-\n|7\n|align=left|{{flagicon|CIV}} [[ASEC Mimosas]]\n|43\n|-\n|8\n|align=left|{{flagicon|ALG}} [[JS Kabylie]]\n|39\n|-\n|9\n|align=left|{{flagicon|CMR}} [[Canon Yaound\u00e9]]\n|36\n|-\n|10\n|align=left|{{flagicon|GHA}} [[Accra Hearts of Oak SC|Hearts of Oak]]\n|31\n|}\n{{col-3}}\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|+ CAF Ranking of the 20th Century\n|-\n! Rank\n! Club\n! Points\n|-\n| 1\n| align=left|{{flagicon|EGY}} [[Al-Ahly Sporting Club|Al-Ahly]]\n| '''40'''\n|-\n| 2\n| align=left|{{flagicon|EGY}} [[Zamalek Sporting Club|El-Zamalek]]\n| 37\n|-\n| 3\n| align=left|{{flagicon|MAR}} [[Raja Casablanca]]\n| 35\n|-\n| 4\n| align=left|{{flagicon|GHA}} [[Asante Kotoko F.C.|Asante Kotoko]]\n| 34\n|-\n| 4\n| align=left|{{flagicon|CMR}} [[Canon Sportif de Yaound\u00e9|Canon Yaound\u00e9]]  \n| 34\n|-\n| 6\n| align=left|{{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance Tunis]]   \n| 27\n|-\n| 6\n| align=left|{{flagicon|CIV}} [[ASEC Mimosas]]    \n| 27\n|-\n| 8\n| align=left|{{flagicon|GHA}} [[Accra Hearts of Oak Sporting Club|Hearts of Oak]]  \n| 26\n|-\n| 9 \n| align=left|{{flagicon|CIV}} [[Africa Sports National|Africa Sports]]   \n| 25\n|-\n| 10\n| align=left|{{flagicon|ALG}} [[Jeunesse Sportive de Kabylie|JS Kabylie]]\n| 20\n|}\n{{col-3}}\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|+ IFFHS Ranking of the 20th Century\n|-\n!Rank\n!club\n!Points\n|-\n| '''1'''\n| align=left|{{flagicon|GHA}} [[Asante Kotoko]]\n| '''149,00'''\n|- \n| 2\n| align=left|{{flagicon|EGY}} [[Al Ahly SC]]\n| 131,50\n|-\n| 3\n| align=left|{{flagicon|EGY}} [[Zamalek SC|Zamalek]]\n| 126,75\n|-\n| 4\n| align=left|{{flagicon|CMR}} [[Canon Sportif de Yaound\u00e9|Canon Yaound\u00e9]]\n| 125,50\n|-\n| 5\n| align=left|{{flagicon|CIV}} [[ASEC Mimosas]]\n| 111,50\n|-\n| 6\n| align=left|{{flagicon|GHA}} [[Accra Hearts of Oak Sporting Club|Hearts of Oak]]\n| 104,00\n|-\n| 7\n| align=left|{{flagicon|TUN}} [[Esp\u00e9rance Sportive de Tunis|Esp\u00e9rance Tunis]]\n| 98,00\n|-\n| 8\n| align=left|{{flagicon|GUI}} [[Hafia Football Club|Hafia FC]]\n| 96,00\n|-\n| 9\n| align=left|{{flagicon|CIV}} [[Africa Sports National|Africa Sports]]\n| 88,25\n|-\n| 10\n| align=left|{{flagicon|COD}} [[TP Mazembe]]\n| 77,50\n|}\n{{col-end}}\n\n=== Men's Futsal===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align:center;\"\n|-\n!CAF\n![[FIFA]]\n!Country\n!Points\n!+/-\n|}\n\n=== Women's Futsal===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align:center;\"\n|-\n!CAF\n![[FIFA]]\n!Country\n!Points\n!+/-\n|}\n\n===Beach soccer national teams===\nRankings are calculated by [[Beach Soccer Worldwide]] (BSWW). Top ten, [http://beachsoccer.com/ranking/overall/africa last updated 12 March 2018]\n{|class=\"wikitable\" cellpadding=\"1\" style=\"text-align:center;\"\n|-\n!CAF\n![[BSWW]]\n!Country\n!Points\n|-\n|1\n|12\n|align=left|{{beachsoccer|SEN}}\n|1084\n|-\n|2\n|17\n|align=left|{{beachsoccer|EGY}}\n|782\n|-\n|3\n|20\n|align=left|{{beachsoccer|NGA}}\n|720\n|-\n|4\n|24\n|align=left|{{beachsoccer|Morocco}}\n|609\n|-\n|5\n|34\n|align=left|{{beachsoccer|MAD}}\n|339\n|-\n|6\n|41\n|align=left|{{beachsoccer|Ivory Coast}}\n|330\n|-\n|7\n|57\n|align=left|{{beachsoccer|GHA}}\n|177\n|-\n|8\n|66\n|align=left|{{beachsoccer|LBY}}\n|125\n|-\n|9\n|68\n|align=left|{{beachsoccer|MOZ}}\n|117\n|-\n|10\n|69\n|align=left|{{beachsoccer|Cape Verde}}\n|115\n|}\n\n==Major Tournaments==\n\n===FIFA World Cup===\n{{Main|African nations at the FIFA World Cup}}\n\n;''Legend''\n{{col-begin|width=auto}}\n{{col-2}}\n*{{bg|gold|1st}} \u2013 Champions\n*{{bg|silver|2nd}} \u2013 Runners-up\n*{{bg|#cc9966|3rd}} \u2013 Third place\n*{{bg|#9acdff|4th}} \u2013 Fourth place\n*QF \u2013 Quarterfinals (1934\u20131938, 1954\u20131970, and 1986\u2013present: knockout round of 8)\n*R2 \u2014 Round 2 (1974\u20131978, second group stage, top 8; 1982: second group stage, top 12; 1986\u2013present: knockout round of 16)\n*R1 \u2014 Round 1\n{{col-break}}\n*q \u2014 Qualified for upcoming tournament\n*{{border|width=1px|color=gray|&nbsp;\u2022\u2022&nbsp;}} \u2013 Qualified but withdrew\n*{{border|width=1px|color=gray|&nbsp;\u2022&nbsp;}} \u2013 Did not qualify\n*{{border|width=1px|color=gray|&nbsp;\u00d7&nbsp;}} \u2013 Did not enter / Withdrew / Banned\n*{{border|width=3px|color=red|&nbsp;&nbsp;}} \u2013 Hosts\n*{{border|width=1px|color=gray|&nbsp;&nbsp;&nbsp;}} \u2013 Not affiliated in FIFA\n{{col-end}}\n\nFor each tournament, the number of teams in each finals tournament (in brackets) are shown.\n\n{| class=\"wikitable\" style=\"text-align:center; font-size:85%;\"\n|-\n! Team\n![[1930 FIFA World Cup|1930]]<br>{{Flagicon|Uruguay}}<br>(13)\n![[1934 FIFA World Cup|1934]]<br>{{Flagicon|Italy|1861}}<br>(16)\n![[1938 FIFA World Cup|1938]]<br>{{Flagicon|France}}<br>(15)\n![[1950 FIFA World Cup|1950]]<br>{{Flagicon|Brazil}}<br>(13)\n![[1954 FIFA World Cup|1954]]<br>{{Flagicon|Switzerland}}<br>(16)\n![[1958 FIFA World Cup|1958]]<br>{{Flagicon|Sweden}}<br>(16)\n![[1962 FIFA World Cup|1962]]<br>{{Flagicon|Chile}}<br>(16)\n![[1966 FIFA World Cup|1966]]<br>{{Flagicon|England}}<br>(16)\n![[1970 FIFA World Cup|1970]]<br>{{Flagicon|Mexico}}<br>(16)\n![[1974 FIFA World Cup|1974]]<br>{{Flagicon|West Germany}}<br>(16)\n![[1978 FIFA World Cup|1978]]<br>{{Flagicon|Argentina}}<br>(16)\n![[1982 FIFA World Cup|1982]]<br>{{Flagicon|Spain}}<br>(24)\n![[1986 FIFA World Cup|1986]]<br>{{Flagicon|Mexico}}<br>(24)\n![[1990 FIFA World Cup|1990]]<br>{{Flagicon|Italy}}<br>(24)\n![[1994 FIFA World Cup|1994]]<br>{{Flagicon|USA}}<br>(24)\n![[1998 FIFA World Cup|1998]]<br>{{Flagicon|France}}<br>(32)\n![[2002 FIFA World Cup|2002]]<br>{{Flagicon|South Korea}}<br>{{Flagicon|Japan}}<br>(32)\n![[2006 FIFA World Cup|2006]]<br>{{Flagicon|Germany}}<br>(32)\n![[2010 FIFA World Cup|2010]]<br>{{Flagicon|South Africa}}<br>(32)\n![[2014 FIFA World Cup|2014]]<br>{{Flagicon|Brazil}}<br>(32)\n![[2018 FIFA World Cup|2018]]<br>{{Flagicon|Russia}}<br>(32)\n![[2022 FIFA World Cup|2022]]<br>{{Flagicon|Qatar}}<br>(32)\n![[2026 FIFA World Cup|2026]]<br>{{Flagicon|Canada}}<br>{{Flagicon|Mexico}}<br>{{Flagicon|United States}}<br>(48)\n!Total\n|-\n| id=\"ALG\" style=\"text-align:left;\"| {{fb|ALG}}\n|colspan=7| ''Part of France''<ref>''[[Algeria]]'' gained independence in 1962, but they joined with other African nations to boycott the [[1966 FIFA World Cup]]. Thus the [[1970 FIFA World Cup qualification]] was their first participation.</ref> ||\u00d7||\u2022||\u2022||\u2022|| R1<br>{{small|13th}} || R1<br>{{small|22nd}} ||\u2022||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|28th}} || R2<br>{{small|14th}} ||\u2022|| || || 4/13\n|-\n| id=\"ANG\" style=\"text-align:left;\"| {{fb|ANG}}\n|colspan=11| ''Part of Portugal''<ref>''[[Angola]]'' gained independence in 1975. Thus the [[1986 FIFA World Cup qualification]] was their first participation.</ref> ||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|23rd}} ||\u2022||\u2022||\u2022|| || || 1/9\n|-\n| id=\"CMR\" style=\"text-align:left;\"| {{fb|CMR}}\n|colspan=6| ''Part of France'' ||\u00d7||\u00d7||\u2022||\u2022||\u2022|| R1<br>{{small|17th}}||\u2022|| QF<br>{{small|7th}} || R1<br>{{small|22nd}} || R1<br>{{small|25th}} || R1<br>{{small|20th}} ||\u2022|| R1<br>{{small|31st}} || R1<br>{{small|32nd}} ||\u2022|| || || 7/13\n|-\n| id=\"COD\" style=\"text-align:left;\"| {{fb|COD}}<ref name=\"Zaire\">The [[Democratic Republic of the Congo]] competed as [[Zaire]] in 1974.</ref>\n|colspan=6| ''Part of Belgium''<ref>''[[Democratic Republic of the Congo]]'' gained independence in 1960, but they joined with other African nations to boycott the [[1966 FIFA World Cup]]. Thus the [[1974 FIFA World Cup qualification]] was their first participation.</ref> || ||\u00d7||\u00d7|| R1<br>{{small|16th}} ||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022|| || || 1/11\n|-\n| id=\"EGY\" style=\"text-align:left;\"| {{fb|EGY}}\n|\u00d7|| R1<br>{{small|13th}} ||\u00d7||\u00d7||\u2022||\u00d7||\u00d7||\u00d7||\u00d7||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|20th}} ||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|31st}} || || || 3/14\n|-\n| id=\"GHA\" style=\"text-align:left;\"| {{fb|GHA}}\n|colspan=5| ''Part of the United Kingdom'' ||\u00d7||\u2022||\u00d7||\u2022||\u2022||\u2022||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022|| R2<br>{{small|13th}} || QF<br>{{small|7th}} || R1<br>{{small|25th}} ||\u2022|| || || 3/13\n|-\n| id=\"CIV\" style=\"text-align:left;\"| {{fb|CIV}}\n|colspan=6| ''Part of France'' ||\u00d7||\u00d7||\u00d7||\u2022||\u2022||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|19th}} || R1<br>{{small|17th}} || R1<br>{{small|21st}} ||\u2022|| || || 3/11\n|-\n| id=\"MAR\" style=\"text-align:left;\"| {{fb|MAR}}\n|colspan=5| ''Part of France'' || ||\u2022||\u00d7|| R1<br>{{small|14th}} ||\u2022||\u2022||\u2022|| R2<br>{{small|11th}} ||\u2022|| R1<br>{{small|23rd}} || R1<br>{{small|18th}} ||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|27th}} || || || 5/14\n|-\n| id=\"NGA\" style=\"text-align:left;\"| {{fb|NGA}}\n|colspan=6| ''Part of the United Kingdom'' ||\u2022||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022||\u2022|| R2<br>{{small|9th}} || R2<br>{{small|12th}} || R1<br>{{small|27th}} ||\u2022|| R1<br>{{small|27th}} || R2<br>{{small|16th}} || R1<br>{{small|21st}} || || || 6/14\n|-\n| id=\"SEN\" style=\"text-align:left;\"| {{fb|SEN}}\n|colspan=6| ''Part of France'' ||\u00d7||\u00d7||\u2022||\u2022||\u2022||\u2022||\u2022||\u00d7||\u2022||\u2022|| QF<br>{{small|7th}} ||\u2022||\u2022||\u2022|| R1<br>{{small|17th}} || || || 2/11\n|-\n| id=\"RSA\" style=\"text-align:left;\"| {{fb|RSA}}\n|colspan=4| ||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u00d7||\u2022|| R1<br>{{small|24th}} || R1<br>{{small|17th}} ||\u2022||style=\"border: 3px solid red\"| R1<br>{{small|20th}} ||\u2022||\u2022|| || || 3/7\n|-\n| id=\"TOG\" style=\"text-align:left;\"| {{fb|TOG}}\n|colspan=6| ''Part of France'' ||\u00d7||\u00d7||\u00d7||\u2022||\u2022||\u2022||\u00d7||\u00d7||\u2022||\u2022||\u2022|| R1<br>{{small|30th}} ||\u2022||\u2022||\u2022|| || || 1/10\n|-\n| id=\"TUN\" style=\"text-align:left;\"| {{fb|TUN}}\n|colspan=5| ''Part of France'' || ||\u2022||\u00d7||\u2022||\u2022|| R1<br>{{small|9th}} ||\u2022||\u2022||\u2022||\u2022|| R1<br>{{small|26th}} || R1<br>{{small|29th}} || R1<br>{{small|24th}} ||\u2022||\u2022|| R1<br>{{small|24th}} || || || 5/14\n|-\n!align=left| Total || 0 || 1 || 0 || 0 || 0 || 0 || 0 || 0 || 1 || 1 || 1 || 2 || 2 || 2 || 3 || 5 || 5 || 5 || 6 || 5 || 5 || 5 || || 44\n|}\n\n;''Firsts''\n*1934: {{fb|Egypt|1922}} first African team to qualify for the World Cup\n*1970: {{fb|Morocco}} first African team to draw a match in the World Cup\n*1978: {{fb|Tunisia}} first African team to win a match in the World Cup\n*1982: {{fb|Algeria}} first African team to win two matches in the World Cup\n*1986: {{fb|Algeria}} first African team to qualify two consecutive World Cups\n*1986: {{fb|Morocco}} first African team to reach the knockout stage (round of sixteen)\n*1990: {{fb|Cameroon}} first African team to reach the knockout stage (quarter-finals)\n*1994 and 1998: {{fb|Nigeria}} first African team to win and reach the knockout stage (round of sixteen) in two consecutive World Cups\n*2002: {{fb|Senegal}} first African team to reach the knockout stage (quarter-finals) further on the World Cup debut\n*2010: {{fb|South Africa}} first African team to host the World Cup\n*2014: {{fb|Algeria}} & {{fb|Nigeria}} first African teams to reach the knockout stage (round of sixteen) simultaneously in the World Cup\n\n===FIFA Women's World Cup===\nThe following CAF members have competed in the following [[FIFA Women's World Cup]]s.  Teams are sorted by number of appearances.\n\n{| class=\"wikitable\" style=\"text-align:center; font-size:85%;\"\n\n|-  style=\"background:#ccc;\"\n!Team\n![[1991 FIFA Women's World Cup|1991]]<br>{{Flagicon|CHN}}<br>(12)\n![[1995 FIFA Women's World Cup|1995]]<br>{{Flagicon|SWE}}<br>(12)\n![[1999 FIFA Women's World Cup|1999]]<br>{{Flagicon|USA}}<br>(16)\n![[2003 FIFA Women's World Cup|2003]]<br>{{Flagicon|USA}}<br>(16)\n![[2007 FIFA Women's World Cup|2007]]<br>{{Flagicon|CHN}}<br>(16)\n![[2011 FIFA Women's World Cup|2011]]<br>{{Flagicon|GER}}<br>(16)\n![[2015 FIFA Women's World Cup|2015]]<br>{{Flagicon|CAN}}<br>(24)\n![[2019 FIFA Women's World Cup|2019]]<br>{{Flagicon|FRA}}<br>(24)\n![[2023 FIFA Women's World Cup|2023]]<br>{{Flagicon| }}<br>(32)\n!Total\n|-\n| align=left| {{fbw|CMR}}\n|  \u2022 || \u00d7 || \u2022 || \u2022 || \u2022 || \u2022 || R2<br>{{small|11th}} || R2<br>{{small|15th}} || || 2/7\n|- \"background:#f4f4f4;\"\n| align=left| {{fbw|CIV}}\n| \u00d7 || \u00d7 || \u00d7 || \u2022 || \u2022 || \u2022 || R1<br>{{small|23rd}} || \u2022 || || 1/5\n|-\n| align=left| {{fbw|GEQ}}\n| \u00d7 || \u00d7 || \u00d7 || \u2022 || \u2022 || R1<br>{{small|15th}} || \u2022 || \u00d7 || || 1/4\n|- \"background:#f4f4f4;\"\n| align=left| {{fbw|GHA}}\n| \u2022 || \u2022 || R1<br>{{small|13\u201314}} || R1<br>{{small|12th}} || R1<br>{{small|15th}} || \u2022 || \u2022 || \u2022 || || 3/8\n|-\n| align=left| {{fbw|NGA}}\n| R1<br>{{small|10th}} || R1<br>{{small|11th}} || QF<br>{{small|7th}} || R1<br>{{small|15th}} || R1<br>{{small|13th}} || R1<br>{{small|9th}} || R1<br>{{small|21st}} || R2<br>{{small|16th}} || || 8/8\n|-\n| align=left| {{fbw|RSA}}\n|  \u00d7 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br>{{small|22nd}} || || 1/7\n|}\n\n=== Summer Olympics for men ===\n\n{| class=\"wikitable\" style=\"text-align:center; font-size:90%;\"\n|-\n! Nation || {{flagicon|France}}<br/>[[Football at the 1900 Summer Olympics|00]] || colspan=2|{{flagicon|United States|1896}}<br/>[[Football at the 1904 Summer Olympics|04]] || {{flagicon|United Kingdom}}<br/>[[Football at the 1908 Summer Olympics|08]] || {{flagicon|Sweden}}<br/>[[Football at the 1912 Summer Olympics|12]] || {{flagicon|Belgium}}<br/>[[Football at the 1920 Summer Olympics|20]] || {{flagicon|France}}<br/>[[Football at the 1924 Summer Olympics|24]] || {{flagicon|Netherlands}}<br/>[[Football at the 1928 Summer Olympics|28]] || {{flagicon|Germany|Nazi}}<br/>[[Football at the 1936 Summer Olympics|36]] || {{flagicon|United Kingdom}}<br/>[[Football at the 1948 Summer Olympics|48]] || {{flagicon|Finland}}<br/>[[Football at the 1952 Summer Olympics|52]] || {{flagicon|Australia}}<br/>[[Association football at the 1956 Summer Olympics|56]] || {{flagicon|Italy}}<br/>[[Football at the 1960 Summer Olympics|60]] || {{flagicon|Japan}}<br/>[[Football at the 1964 Summer Olympics|64]] || {{flagicon|Mexico}}<br/>[[Football at the 1968 Summer Olympics|68]] || {{flagicon|West Germany}}<br/>[[Football at the 1972 Summer Olympics|72]] ||{{flagicon|Canada}}<br/> [[Football at the 1976 Summer Olympics|76]] || {{flagicon|Soviet Union|1955}}<br/>[[Football at the 1980 Summer Olympics|80]] || {{flagicon|United States}}<br/>[[Football at the 1984 Summer Olympics|84]] || {{flagicon|South Korea}}<br/>[[Football at the 1988 Summer Olympics|88]] || {{flagicon|Spain}}<br/>[[Football at the 1992 Summer Olympics|92]] || {{flagicon|United States}}<br/>[[Football at the 1996 Summer Olympics|96]] || {{flagicon|Australia}}<br/>[[Football at the 2000 Summer Olympics|00]] || {{flagicon|Greece}}<br/>[[Football at the 2004 Summer Olympics|04]] || {{flagicon|China}}<br/>[[Football at the 2008 Summer Olympics|08]] || {{flagicon|United Kingdom}}<br/>[[Football at the 2012 Summer Olympics \u2013 Men's tournament|12]] || {{flagicon|Brazil}}<br/>[[Football at the 2016 Summer Olympics \u2013 Men's tournament|16]] || {{flagicon|Japan}}<br/>[[Football at the 2020 Summer Olympics \u2013 Men's tournament|20]] || Years\n|-\n|align=left| {{flagIOC|ALG}} || colspan=13| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || 8 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 14 ||\n! 2\n|-\n|align=left| {{flagIOC|CMR}} || colspan=\"5\" style=\"background:#efefef;\"| ||colspan=8| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 11 || \u2013 || \u2013 || \u2013 ||bgcolor=gold| 1 || \u2013 || 8 || \u2013 || \u2013 ||\n! 3\n|-\n|align=left| {{flagIOC|EGY}}<ref>Egypt team represented the [[United Arab Republic]] with Syria in 1960 finishing the 12th and alone in 1964 finishing the 4th.</ref> || colspan=\"4\" style=\"background:#efefef;\"|  || \u2013 || 8 || 8 || 4 || 9 || 11 || 9 || \u2013 || 12 || 4 || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || 8 || \u2013 || 12 || \u2013 || \u2013 || \u2013 || \u2013 || 8 || \u2013 || q\n! 12\n|-\n|align=left| {{flagIOC|CIV}} || colspan=13| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 6 || \u2013 ||  || q\n! 2\n|-\n|align=left| {{flagIOC|GAB}} || colspan=13| ''{{small|Part of France}}'' || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 12 || \u2013 ||\n! 1\n|-\n|align=left| {{flagIOC|GHA}} || colspan=10| ''{{small|Part of the United Kingdom}}'' || \u2013 || style=\"background:#efefef;\"|  || \u2013 || 7 || 12 || 16 || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || \u2013 || style=\"background:#c96;\"| 3 || 8 || \u2013 || 9 || \u2013 || \u2013 || \u2013 ||\n! 6\n|-\n|align=left| {{flagIOC|GUI}} || colspan=12| ''{{small|Part of France}}'' || colspan=\"2\" style=\"background:#efefef;\"|  || 11 || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 ||\n! 1\n|-\n|align=left| {{flagIOC|MLI}} || colspan=13| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 5 || \u2013 || \u2013 || \u2013 ||\n! 1\n|-\n|align=left| {{flagIOC|MAR}} || colspan=\"4\" style=\"background:#efefef;\"| ||colspan=7| ''{{small|Part of France}}'' || style=\"background:#efefef;\"|  || \u2013 || 13 || \u2013 || 8 || \u2013 || style=\"background:#efefef;\"|  || 12 || \u2013 || 15 || \u2013 || 16 || =10 || \u2013 || 11 || \u2013 ||\n! 7\n|-\n|align=left| {{flagIOC|NGR}} || colspan=\"5\" style=\"background:#efefef;\"| ||colspan=5| ''{{small|Part of the United Kingdom}}'' || \u2013 || \u2013 || \u2013 || \u2013 || 14 || \u2013 || style=\"background:#efefef;\"|  || 13 || \u2013 || 15 || \u2013 ||bgcolor=gold| 1 || 8 || \u2013 || style=\"background:silver;\"| 2 || \u2013 || style=\"background:#c96;\"| 3 ||\n! 7\n|-\n|align=left| {{flagIOC|SEN}} || colspan=13| ''{{small|Part of France}}'' || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 6 ||-||\n! 1\n|-\n|align=left| {{flagIOC|RSA}} || style=\"background:#efefef;\"|  || colspan=\"2\"| \u2013 || \u2013 || \u2013 || \u2013 | \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || colspan=\"7\" style=\"background:#efefef;\"| ''{{small|Banned because of apartheid}}'' || \u2013 | \u2013 || \u2013 || \u2013 | 11 || \u2013 || \u2013 || \u2013 || 13 || q\n! 3\n|-\n|align=left| {{flagIOC|SUD}} || colspan=12| ''{{small|Part of the United Kingdom}}'' || \u2013 || style=\"background:#efefef;\"|  || \u2013 || 15 || colspan=\"2\" style=\"background:#efefef;\"|  || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 ||\n! 1\n|-\n|align=left| {{flagIOC|TUN}} || colspan=11| ''{{small|Part of France}}'' || style=\"background:#efefef;\"|  || 15 || \u2013 || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || \u2013 || 13 || \u2013 || 14 || \u2013 || 12 || \u2013 || \u2013 || \u2013 ||\n! 4\n|-\n|align=left| {{flagIOC|ZAM}} || colspan=\"6\" style=\"background:#efefef;\"| || colspan=5| ''{{small|Part of the United Kingdom}}'' || style=\"background:#efefef;\"|  || ''{{small|{{Tooltip|RHO|Part of Rhodesia}}}}'' || \u2013 || \u2013 || \u2013 || style=\"background:#efefef;\"|  || 15 || \u2013 || 5 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 ||\n! 2\n|-\n!align=left| Total nations || 3 || colspan=2| 2 || 5 || 11 || 14 || 22 || 17 || 16 || 18 || 25 || 11 || 16 || 14 || 16 || 16 || 13 || 16 || 16 || 16 || 16 || 16 || 16 || 16 || 16 || 16 || 16 || 16 ||\n|}\n\n=== Summer Olympics for women ===\n\n{| class=\"wikitable\" style=\"text-align:center; font-size:90%;\"\n|-\n! Team || {{flagicon|United States}}<br/>[[Football at the 1996 Summer Olympics|1996]]<br>(8) || {{flagicon|Australia}}<br/>[[Football at the 2000 Summer Olympics|2000]]<br>(8) || {{flagicon|Greece}}<br/>[[Football at the 2004 Summer Olympics|2004]]<br>(10) || {{flagicon|China}}<br/>[[Football at the 2008 Summer Olympics|2008]]<br>(12) || {{flagicon|United Kingdom}}<br/>[[Football at the 2012 Summer Olympics \u2013 Men's tournament|2012]]<br>(12) || {{flagicon|Brazil}}<br/>[[Football at the 2016 Summer Olympics \u2013 Men's tournament|2016]]<br>(12) || {{flagicon|Japan}}<br/>[[Football at the 2020 Summer Olympics \u2013 Women's tournament|2020]]<br>(12) || Total\n|-\n|align=left| {{flagIOC|CMR}} || \u2013 || \u2013 || \u2013 || \u2013 || 12 || \u2013 || \n! 1\n|-\n|align=left| {{flagIOC|NGR}} || \u2013 || 8 || 6 || 11 || \u2013 || \u2013 || \n! 3\n|-\n|align=left| {{flagIOC|RSA}} || \u2013 || \u2013 || \u2013 || \u2013 || 10 || 10 || \n! 2\n|-\n|align=left| {{flagIOC|ZAM}} || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || q\n! 1\n|-\n|align=left| {{flagIOC|ZIM}} || \u2013 || \u2013 || \u2013 || \u2013 || \u2013 || 12 || \n! 1\n|-\n! Total || 0 || 1 || 1 || 1 || 2 || 2 ||  || \n|}\n\n=== FIFA U-20 Women's World Cup ===\n\n{| class=\"wikitable\"\n|- style=\"background:#cccccc;\" align=center\n!Team\n![[2002 FIFA U-19 Women's World Championship|2002]]<br>{{flagicon|CAN}}<br>(12)\n![[2004 FIFA U-19 Women's World Championship|2004]]<br>{{flagicon|THA}}<br>(12)\n![[2006 FIFA U-20 Women's World Championship|2006]]<br>{{flagicon|RUS}}<br>(16)\n![[2008 FIFA U-20 Women's World Cup|2008]]<br>{{flagicon|CHI}}<br>(16)\n![[2010 FIFA U-20 Women's World Cup|2010]]<br>{{flagicon|GER}}<br>(16)\n![[2012 FIFA U-20 Women's World Cup|2012]]<br>{{flagicon|JPN}}<br>(16)\n![[2014 FIFA U-20 Women's World Cup|2014]]<br>{{flagicon|CAN}}<br>(16)\n![[2016 FIFA U-20 Women's World Cup|2016]]<br>{{flagicon|PNG}}<br>(16)\n![[2018 FIFA U-20 Women's World Cup|2018]]<br>{{flagicon|FRA}}<br>(16)\n![[2020 FIFA U-20 Women's World Cup|2020]]<br>{{flagicon|CRC}}<br>{{flagicon|PAN}}<br>(16)\n!Total\n|- align=center\n| align=left| {{fbwu|20|COD}}\n| \u2022||\u2022||GS||GS||\u2022||\u2022||\u2022||\u2022||\u2022||\n|'''2'''\n|- align=center\n| align=left| {{fbwu|20|GHA}}\n| \u2022||\u2022||\u2022||\u2022||GS||GS||GS||GS||GS|| ||'''5'''\n|- align=center\n| align=left| {{fbwu|20|NGA}}\n| GS||QF||QF||QF||bgcolor=silver|2nd||bgcolor=#9acdff|4th||bgcolor=silver|2nd||GS||QF|| <!--style=\"border: 3px solid red\"| q ||'''10'''-->||'''9'''\n|- align=center\n|align=left| '''Total''' || '''1''' || '''1''' || '''2''' || '''2''' || '''2''' || '''2''' || '''2''' || '''2''' || '''2''' || '''2'''\n|'''18'''\n|}\n\n=== FIFA U-17 Women's World Cup ===\n\n{| class=\"wikitable\"\n|- style=\"background:#cccccc;\" align=center\n!Team\n![[2008 FIFA U-17 Women's World Cup|2008]]<br>(16)\n![[2010 FIFA U-17 Women's World Cup|2010]]<br>(16)\n![[2012 FIFA U-17 Women's World Cup|2012]]<br>(16)\n![[2014 FIFA U-17 Women's World Cup|2014]]<br>(16)\n![[2016 FIFA U-17 Women's World Cup|2016]]<br>(16)\n![[2018 FIFA U-17 Women's World Cup|2018]]<br>(16)\n![[2020 FIFA U-17 Women's World Cup|2020]]<br>(16)\n!Total\n|- align=center\n| align=left| {{fbwu|17|CMR}}\n| \u2022||\u00d7||\u2022||\u00d7||GS||GS|| ||'''2'''\n|- align=center\n| align=left| {{fbwu|17|GAM}}\n| \u00d7||\u00d7||R1||\u00d7||\u00d7||\u2022|| ||'''1'''\n|- align=center\n| align=left| {{fbwu|17|GHA}}\n| R1||R1||bgcolor=#cc9966|3rd||QF||QF||QF|| ||'''6'''\n|- align=center\n| align=left| {{fbwu|17|NGA}}\n| R1||QF||QF||QF||GS||\u2022|| ||'''5'''\n|- align=center\n| align=left| {{fbwu|17|RSA}}\n| \u2022||R1||\u2022||\u2022||\u2022||GS|| ||'''2'''\n|- align=center\n| align=left| {{fbwu|17|ZAM}}\n| \u2022||\u00d7||\u2022||GS||\u00d7||\u2022|| ||'''1'''\n|- align=center\n|align=left| '''Total''' || '''2''' || '''3''' || '''3''' || '''3''' || '''3''' || '''3''' || '''3'''\n|'''20'''\n|}\n\n===FIFA Futsal World Cup===\n\n{| class=\"wikitable\" style=\"text-align:center\"\n|-\n! Nation\n! [[1989 FIFA Futsal World Championship|1989]]<br>{{Flagicon|Netherlands}} !! [[1992 FIFA Futsal World Championship|1992]]<br>{{Flagicon|Hong Kong|1959}} !! [[1996 FIFA Futsal World Championship|1996]]<br>{{Flagicon|Spain}} !! [[2000 FIFA Futsal World Championship|2000]]<br>{{Flagicon|Guatemala}} !! [[2004 FIFA Futsal World Championship|2004]]<br>{{Flagicon|Chinese Taipei}} !! [[2008 FIFA Futsal World Cup|2008]]<br>{{Flagicon|Brazil}} !! [[2012 FIFA Futsal World Cup|2012]]<br>{{Flagicon|Thailand}} !! [[2016 FIFA Futsal World Cup|2016]]<br>{{Flagicon|Colombia}} !! [[2020 FIFA Futsal World Cup|2020]]<br>{{Flagicon|Lithuania}} !! Years\n|-\n|align=left|{{futsal|ALG}} || R1 || || || || || || || || || 1\n|-\n|align=left|{{futsal|ANG}} || || || || || || || || || q || 1\n|-\n|align=left|{{futsal|EGY}} || || || R1 || R2 || R1 || R1 || R2 || QF || q || 7\n|-\n|align=left|{{futsal|LBY}} || || || || || || R1 || R1 || || || 2\n|-\n|align=left|{{futsal|MAR}} || || || || || || || R1 || R1 || q || 3\n|-\n|align=left|{{futsal|MOZ}} || || || || || || ||  || R1 || || 1\n|-\n|align=left|{{futsal|NGA}} || || R1 || || || || || || || || 1\n|-\n|align=left|{{futsal|ZIM}} || R1 || || || || || || || || || 1\n|-\n! ''Nations'' || 2 || 1 || 1 || 1 || 1 || 2 || 3 || 3 || 3 || 17\n|}\n\n===FIFA Beach Soccer World Cup===\n\n{| class=\"wikitable\" style=\"text-align: center\"\n|- valign=top\n!\n! ''[[Beach Soccer World Cup 1995|1995]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 1996|1996]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 1997|1997]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 1998|1998]]''<br> {{Flagicon|Brazil}}<br> (10)\n! ''[[Beach Soccer World Cup 1999|1999]]''<br> {{Flagicon|Brazil}}<br> (12)\n! ''[[Beach Soccer World Cup 2000|2000]]''<br> {{Flagicon|Brazil}}<br> (12)\n! ''[[Beach Soccer World Cup 2001|2001]]''<br> {{Flagicon|Brazil}}<br> (12)\n! ''[[Beach Soccer World Cup 2002|2002]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 2003|2003]]''<br> {{Flagicon|Brazil}}<br> (8)\n! ''[[Beach Soccer World Cup 2004|2004]]''<br> {{Flagicon|Brazil}}<br> (12)\n! [[2005 FIFA Beach Soccer World Cup|2005]]<br> {{Flagicon|Brazil}}<br> (12)\n! [[2006 FIFA Beach Soccer World Cup|2006]]<br> {{Flagicon|Brazil}}<br> (12)\n! [[2007 FIFA Beach Soccer World Cup|2007]]<br> {{Flagicon|Brazil}}<br> (16)\n! [[2008 FIFA Beach Soccer World Cup|2008]]<br> {{Flagicon|France}}<br> (16)\n! [[2009 FIFA Beach Soccer World Cup|2009]]<br> {{flagicon|UAE}}<br> (16)\n! [[2011 FIFA Beach Soccer World Cup|2011]]<br> {{flagicon|ITA}}<br> (16)\n! [[2013 FIFA Beach Soccer World Cup|2013]]<br> {{flagicon|TAH}}<br> (16)\n! [[2015 FIFA Beach Soccer World Cup|2015]]<br> {{flagicon|POR}}<br> (16)\n! [[2017 FIFA Beach Soccer World Cup|2017]]<br> {{flagicon|BAH}}<br> (16)\n! [[2019 FIFA Beach Soccer World Cup|2019]]<br> {{flagicon|PAR}}<br> (16)\n! Total Participations\n|-\n|style=\"text-align:left;\"|{{beachsoccer|CMR}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br><small>14th</small> || \u2022 || R1<br><small>16th</small> || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022\n|2/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|CIV}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br><small>11th </small>|| \u2022 || R1<br><small>16th </small>|| \u2022 || \u2022 || \u2022\n|2/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|MAD}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br><small>14th </small>|| \u2022 || \u2022\n|1/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|NGA}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || R1<br><small>9th </small>|| QF<br><small>6th </small>|| \u2022 || R1<br><small>12th </small>|| QF<br><small>6th </small>|| \u2022 || \u2022 || R1<br><small>12th </small> || R1<br><small>16th </small>\n|6/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|SEN}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || QF<br><small>5th </small>|| R1<br><small>9th </small>|| QF<br><small>7th </small>|| R1<br><small>13th </small>|| R1<br><small>13th </small>|| QF<br><small>6th </small> || QF<br><small>6th </small>\n|7/20\n|-\n|style=\"text-align:left;\"|{{beachsoccer|RSA}}\n| \u2022 || \u2022 || \u2022 || \u2022 ||R1<br><small>12th </small>|| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 ||R1<br><small>12th </small>|| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022\n|2/20\n|-\n!align=centre| Total || 0 || 0 || 1 || 0 || 2 || 1 || 1 || 1 || 0 || 0 || 2 || 3 || 3 || 3 || 3 || 3 || 3 || 3 || 3 || 2 || \n|}\n\n===FIFA Confederations Cup===\n\n{| class=\"wikitable\" style=\"text-align: center\"\n|-\n! Team\n! [[1992 King Fahd Cup|1992]]<br> {{flagicon|Saudi Arabia}}\n! [[1995 King Fahd Cup|1995]]<br> {{flagicon|Saudi Arabia}}\n! [[1997 FIFA Confederations Cup|1997]]<br> {{flagicon|Saudi Arabia}}\n! [[1999 FIFA Confederations Cup|1999]]<br> {{flagicon|Mexico}}\n! [[2001 FIFA Confederations Cup|2001]]<br> {{flagicon|South Korea}}<br>{{flagicon|Japan}}\n! [[2003 FIFA Confederations Cup|2003]]<br> {{flagicon|France}}\n! [[2005 FIFA Confederations Cup|2005]]<br> {{flagicon|Germany}}\n! [[2009 FIFA Confederations Cup|2009]]<br> {{flagicon|South Africa}}\n! [[2013 FIFA Confederations Cup|2013]]<br> {{flagicon|Brazil}}\n! [[2017 FIFA Confederations Cup|2017]]<br> {{flagicon|Russia}}\n! Total\n|-\n| align=left| {{fb|Cameroon}}\n| \u2022 || \u2022 || \u2022 || \u2022 || GS || style=\"background:Silver;\"|2nd || \u2022 || \u2022 || \u2022 || GS\n! 3\n|-\n| align=left| {{fb|Egypt}}\n| \u2022 || \u2022 || \u2022 || GS || \u2022 || \u2022 || \u2022 || GS || \u2022 || \u2022\n! 2\n|-\n| align=left| {{fb|C\u00f4te d'Ivoire}}\n| style=\"background:#9acdff;\"|4th || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022\n! 1\n|-\n| align=left| {{fb|Nigeria}}\n| \u2022 || style=\"background:#9acdff;\"|4th || \u00d7 || \u00d7 || \u2022 || \u2022 || \u2022 || \u2022 || GS || \u2022\n! 2\n|-\n| align=left| {{fb|South Africa}}\n| \u00d7 || \u2022 || GS || \u2022 || \u2022 || \u2022 || \u2022 || style=\"border:3px solid red; background:#9acdff;\"|4th || \u2022 || \u2022\n! 2\n|-\n| align=left| {{fb|Tunisia}}\n| \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || \u2022 || GS || \u2022 || \u2022 || \u2022\n! 1\n|-\n! Total || 1 || 1 || 1 || 1 || 1 || 1 || 1 || 2 || 1 || 1\n! 11\n|}\n\n===Other Tournaments===\n\n;''Legend''\n{{col-begin|width=auto}}\n{{col-2}}\n*{{bg|gold|1st}} \u2013 Champions\n*{{bg|silver|2nd}} \u2013 Runners-up\n*{{bg|#cc9966|3rd}} \u2013 Third place\n*{{bg|#9acdff|4th}} \u2013 Fourth place\n*GS \u2013 Group stage\n*Q \u2013 Qualified for upcoming tournament\n{{col-2}}\n*{{border|width=1px|color=gray|&nbsp;\u2022\u2022&nbsp;}} \u2013 Qualified but withdrew\n*{{border|width=1px|color=gray|&nbsp;\u2022&nbsp;}} \u2013 Did not qualify\n*{{border|width=1px|color=gray|&nbsp;\u00d7&nbsp;}} \u2013 Did not enter / Withdrew from the Africa Cup of Nations or withdrew from the Confederations Cup / Banned\n*{{border|width=3px|color=red|&nbsp;&nbsp;}} \u2013 Hosts\n{{col-end}}\n\n==CAF Best Footballers of the Century==\nThe voting to select the best of the century refers to three categories: male player, goalkeeper and female player and is obtained from five different steps. The resulting best players and goalkeepers were honored during the \"World Football Gala 1999\".<ref>{{cite web |url=https://iffhs.de/iffhs-history-africa-player-of-the-century-1900-1999/ |title=IFFHS History : Africa \u2013 Player of the Century (1900\u20131999) |publisher=IFFHS |date=9 October 2017 |accessdate=}}</ref>\n\n{{col-begin}}\n{{col-3}}\n\n===CAF Best Player of the Century===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|-\n!Player Name\n!Points\n|-\n|align=left|{{Flagicon|Liberia}} [[George Weah]]\n|'''95'''\n|-\n|align=left|{{Flagicon|Cameroon}} [[Roger Milla]]\n|'''77'''\n|-\n|align=left|{{Flagicon|Ghana}} [[Ab\u00e9di Pel\u00e9]]\n|'''72'''\n|-\n|align=left|{{Flagicon|Algeria}} [[Lakhdar Belloumi]]\n|'''56'''\n|-\n|align=left|{{Flagicon|Algeria}} [[Rabah Madjer]]\n|'''51'''\n|-\n|align=left|{{Flagicon|Cameroon}} [[Th\u00e9ophile Abega]]\n|'''39'''\n|-\n|align=left|{{Flagicon|CIV}} [[Laurent Pokou]]\n|'''38'''\n|-\n|align=left|{{Flagicon|Zambia}} [[Kalusha Bwalya]]\n|'''37'''\n|-\n|align=left|{{Flagicon|Morocco}} [[Ahmed Faras]]\n|'''35'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Finidi George]]\n|'''32'''\n|}\n{{col-3}}\n\n===CAF Best Goalkeeper of the Century===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|-\n!Player Name\n!Points\n|-\n|align=left|{{Flagicon|Cameroon}} [[Joseph-Antoine Bell]]\n|'''39'''\n|-\n|align=left|{{Flagicon|Cameroon}} [[Thomas N'Kono]]\n|'''30'''\n|-\n|align=left|{{Flagicon|Tunisia}} [[Sadok Sassi|Sadok Sassi \"Attouga\"]]\n|'''26'''\n|-\n|align=left|{{Flagicon|Morocco}} [[Badou Zaki]]\n|'''24'''\n|-\n|align=left|{{Flagicon|Congo DR}} [[Mwamba Kazadi]]\n|'''19'''\n|-\n|align=left|{{Flagicon|Cameroon}} [[Jacques Songo'o]]\n|'''13'''\n|-\n|align=left|{{Flagicon|Zimbabwe}} [[Bruce Grobbelaar]]\n|'''11'''\n|-\n|align=left|{{Flagicon|Egypt}} [[Ahmed Shobair]]\n|'''10'''\n|-\n|align=left|{{Flagicon|CIV}} [[Alain Gouam\u00e9n\u00e9]]\n|'''9'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Peter Rufai]]\n|'''6'''\n|}\n{{col-3}}\n\n===CAF Best Women's Footballer of the Century===\n{| class=\"wikitable\" cellpadding=\"1\" style=\"text-align: center;\"\n|-\n!Player Name\n!Points\n|-\n|align=left|{{Flagicon|Nigeria}} [[Uche Eucharia|Uche Eucharia Ngozi]]\n|'''21'''\n|-\n|align=left|{{Flagicon|Ghana}} [[Nana Ama Gyamfuah]]\n|'''18'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Doris Nkiru Okosieme]]\n|'''17'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Florence Omagbemi]]\n|'''15'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Ann Chiejine]]\n|'''14'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Rita Nwadike]]\n|'''13'''\n|-\n|align=left|{{Flagicon|South Africa}} Fikhile Sitole\n|'''9'''\n|-\n|align=left|{{Flagicon|Ghana}} [[Vivian Mensah]]\n|'''8'''\n|-\n|align=left|{{Flagicon|Nigeria}} [[Mercy Akide]]\n|rowspan=2|'''7'''\n|-\n|align=left|{{Flagicon|Nigeria}} Ann Agumanu\n|}\n{{col-end}}\n\n==CAF Golden Jubilee Best Players poll==\nIn 2007 CAF published the list of top 30 African players who played in the period from 1957 to 2007, as part of the celebration of CAF's 50th anniversary, ordered according to an online poll.<ref>{{cite web |url=http://www.cafonline.com/caf/media-services/facts/77-caf-release-30-best-african-players-in-the-last-50-years.html |title=CAF release 30 best African players in the last 50 years |publisher=CAF |date=11 August 2007 |accessdate=15 January 2010}}</ref>\n\n{{Div col|colwidth=22em}}\n:{{0}}1. {{Flagicon|Cameroon}} [[Roger Milla]]\n:{{0}}2. {{Flagicon|Egypt}} [[Mahmoud El Khatib]]\n:{{0}}3. {{Flagicon|Egypt}} [[Hossam Hassan]]\n:{{0}}4. {{Flagicon|Cameroon}} [[Samuel Eto'o]]\n:{{0}}5. {{Flagicon|Ghana}} [[Abedi Pele]]\n:{{0}}6. {{Flagicon|Liberia}} [[George Weah]]\n:{{0}}7. {{Flagicon|Ivory Coast}} [[Didier Drogba]]\n:{{0}}8. {{Flagicon|Nigeria}} [[Nwankwo Kanu]]\n:{{0}}9. {{Flagicon|Algeria}} [[Rabah Madjer]]\n:10. {{Flagicon|Zambia}} [[Kalusha Bwalya]]\n:11. {{Flagicon|Ghana}} [[Michael Essien]]\n:12. {{Flagicon|Nigeria}} [[Augustine Okocha]]\n:13. {{Flagicon|Egypt}} [[Saleh Selim]]\n:14. {{Flagicon|Algeria}} [[Hac\u00e8ne Lalmas]]\n:15. {{Flagicon|South Africa}} [[Benni McCarthy]]\n:16. {{Flagicon|Senegal}} [[El Hadji Diouf]]\n:17. {{Flagicon|Morocco}} [[Noureddine Naybet]]\n:18. {{Flagicon|Nigeria}} [[Rashidi Yekini]]\n:19. {{Flagicon|Egypt}} [[Hany Ramzy]]\n:20. {{Flagicon|Egypt}} [[Hassan Shehata]]\n:21. {{Flagicon|South Africa}} [[Lucas Radebe]]\n:22. {{Flagicon|Tunisia}} [[Tarak Dhiab]]\n:23. {{Flagicon|Morocco}} [[Mohammed Timoumi]]\n:24. {{Flagicon|Ghana}} [[Anthony Yeboah]]\n:25. {{Flagicon|Mali}} [[Salif Keita (footballer)|Salif Keita]]\n:26. {{Flagicon|Ghana}} [[Karim Abdul Razak]]\n:27. {{Flagicon|Ghana}} [[Samuel Kuffour]]\n:28. {{Flagicon|Algeria}} [[Lakhdar Belloumi]]\n:29. {{Flagicon|Cameroon}} [[Rigobert Song]]\n:30. {{Flagicon|Sudan}} [[Nasr El-Deen Abbas|Nasr El-Deen \"Jaxa\" Abbas]]\n{{Div col end}}\n\n==CAF resolutions==\n{{col-begin|width=auto}}\n{{col-break}}\n'''Awards:'''\n*[[CAF Awards]]\n*[[African Footballer of the Year]]\n*[[CAF Clubs of the 20th Century]]\n{{col-break|gap=2em}}\n'''Qualifications:'''\n*[[CAF 5-Year Ranking]]\n{{col-end}}\n\n==International Top Goal Scorers==\n{{Updated|21 November 2019}}\nPlayers in '''bold''' are still active at international level\n{| class=\"wikitable sortable\"\nstyle=\"text-align:center\"\n|-\n!width=\"20\"|Rank\n!width=\"250\"|Player\n!width=\"80\"|Goals\n!width=\"80\"|Matches\n!width=\"80\"|Ratios\n!width=\"120\"|Span\n|-\n|-\n\n|-\n|1\n| align=\"left\"|\n{{flagicon|ZAM}} [[Godfrey Chitalu]]\n|79\n|111\n|0.71\n|1968\u20131980 \n|-style=\"background-color:pink\n|-\n|2\n| align=\"left|\n{{flagicon|MWI}} [[Kinnah Phiri]]\n|71\n|115\n|0.62\n|1973\u20131981\n|-\n|3\n|align=\"left\"|\n{{flagicon|EGY}} [[Hossam Hassan]]\n|69\n|169\n|0.41\n|1985\u20132006\n|-\n|4\n|align=\"left\"|\n{{flagicon|CIV}} [[Didier Drogba]]\n|65\n|105\n|0.62\n|2002\u20132014\n|-\n|5\n|{{flagicon|CMR}} [[Samuel Eto'o]]\n|56\n|118\n|0.47\n|1997\u20132014\n|-\n|6\n|align=\"left\"|\n{{flagicon|GHA}} '''[[Asamoah Gyan]]'''\n|51\n|109\n|0.47\n|2003\u2013''present''\n|-\n|7\n|align=\"left\"|\n{{flagicon|CIV}} [[Abdoulaye Traor\u00e9 (Ivorian footballer)|Abdoulaye Traore]]\n|50\n|88\n|0.57\n|1984\u20131996\n|-\n|8\n|align=\"left\"|\n{{flagicon|CMR}} [[Roger Milla]]\n|43\n|77\n|0.56\n|1973\u20131994\n|-\n|9\n|align=\"left\"|\n{{flagicon|ZAM}} [[Alex Chola]]\n|43\n|102\n|0.42\n|1975\u20131985\n|-\n|10\n|align=\"left\"|\n{{flagicon|EGY}} [[Hassan El-Shazly]]\n|42\n|62\n|0.68\n|1961\u20131975\n|-\n|11\n|align=\"left\"|\n{{flagicon|EGY}} '''[[Mohamed Salah]]'''\n|41\n|67\n|0.61\n|2011\u2013''present''\n|-\n|12\n|align=\"left\"|\n{{flagicon|LBY}} [[Fawzi Al-Issawi]]\n|40\n|90\n|0.44\n|1977\u20131985\n|-\n|13\n|align=\"left|\n{{flagicon|ANG}} [[Akw\u00e1|Akwa]]\n|39\n|78\n|0.5\n|1995\u20132006\n|-\n|14\n|align=\"left\"|\n{{flagicon|ZAM}} [[Kalusha Bwalya]]\n|39\n|87\n|0.45\n|1983\u20132006\n|-\n|15\n|align=\"left\"|\n{{flagicon|ZIM}} [[Peter Ndlovu]]\n|38\n|74\n|0.51\n|1991\u20132007\n|-\n|16\n|align=\"left\"|\n{{flagicon|EGY}} [[Mohamed Aboutrika]]\n|38\n|100\n|0.38\n|2001\u20132013\n|-\n|17\n|align=\"left\"|\n{{flagicon|NGR}} [[Rashidi Yekini]]\n|37\n|58\n|0.64\n|1984\u20131998\n|-\n|18\n|align=\"left \"|\n{{flagicon|TUN}} [[Issam Jem\u00e2a]]\n|36\n|84\n|0.43\n|2005\u20132014\n|-\n|19\n|align=\" left\"|\n{{flagicon|ALG}} [[Abdelhafid Tasfaout]]\n|34\n|79\n|0.43\n|1990\u20132002\n|-\n|20\n|align=\"left\"|\n{{flagicon|BFA}} [[Moumouni Dagano]]\n|34\n|83\n|0.41\n|1998\u20132014\n|-\n|21\n|align=\"left\"|\n{{flagicon|KEN}} [[Dennis Oliech]]\n|34\n|72\n|0.47\n|2002\u20132016\n|-\n|22\n|align=\"left\"|\n{{flagicon|CMR}} [[Patrick M'Boma]]\n|33\n|55\n|0.6\n|1995\u20132004\n|-\n|23\n|align=\"left\"|\n{{flagicon|GHA}} [[Abedi Pele]]\n|33\n|67\n|0.49\n|1982\u201398\n|-\n|24\n|align=\"left\"|\n{{flagicon|EGY}} [[Ahmed Hassan (footballer)|Ahmed Hassan]]\n|33\n|184\n|0.18\n|1995\u20132004\n|-\n|25\n|align=\"left\"|\n{{flagicon|RSA}} [[Benni McCarthy]]\n|32\n|80\n|0.4\n|1997\u20132011\n|-\n|26\n|align=\"left\"|\n{{flagicon|TOG}} '''[[Emmanuel Adebayor]]'''\n|32\n|87\n|0.37\n|2000\u2013''present''\n|-\n|27\n|align=\"left\"|\n{{flagicon|EGY}} [[Amr Zaki]]\n|30\n|63\n|0.48\n|2004\u20132013\n|-\n*This table is for players with more than 30 goals\n|}\n\n==See also==\n{{Portal|Football in Africa}}\n* [[History of CAF]]\n* [[List of association football sub-confederations]]\n* [[List of presidents of CAF]]\n* [[List of first international of African national teams]]\n* [[List of CAF club competition winners]]\n* [[List of CAF club competition winning coaches]]\n\n==References==\n{{Reflist}}\n\n==External links==\n* [http://www.cafonline.com Official website] ({{in lang|en|fr|ar}})\n* [http://soccerlens.com/caf-confederation-of-african-football/31184/ Confederation of African Football], Soccerlens.com. Retrieved 9 October 2010.\n* [https://web.archive.org/web/20071006202008/http://www.soccerpanna.com/ CAF video highlights]\n* [https://web.archive.org/web/20110501143801/http://www.zshare.net/info.html?51826090-91f38fa2c3945be45d3da455db6ecc80 Listen to CAF Anthem] CAF Anthem\n* [http://www.sportspromedia.com/news/caf-confirms-qnet-tie-up], Sportspromedia.com. Retrieved 26 February 2018.\n* [http://www.euprimetimefootball.com/africa/caf-unveil-new-sponsorship-for-club-competitions], euprimetimefootball.com Retrieved 26 February 2018.\n\n{{Navboxes colour\n| title = CAF\n| bg    = #FFE700\n| fg    = \n| list  = \n{{CAF presidents}}\n{{African football}}\n{{CAF associations}}\n{{CAF teams}}\n{{CAF sub-regions}}\n{{CAF women's teams}}\n{{CAF Leagues}}\n{{CAF women's leagues}}\n}}\n{{FIFA navbox}}\n{{Navboxes\n| title = International football\n| list  = \n{{International football}}\n{{International women's football}}\n{{International club football}}\n{{International futsal}}\n{{International Beach Soccer}}\n}}\n{{Sports governing bodies in Africa}}\n{{Africa topics}}\n\n{{Authority control}}\n\n{{DEFAULTSORT:Confederation Of African Football}}\n[[Category:Confederation of African Football| ]]\n[[Category:Association football governing bodies in Africa| ]]\n[[Category:Sports organizations established in 1957]]\n[[Category:Sports governing bodies in Africa|Foot]]\n[[Category:FIFA confederations]]\n[[Category:1957 establishments in Africa]]\n", "name_user": "69.119.199.97", "label": "unsafe", "comment": "", "url_page": "//en.wikipedia.org/wiki/Confederation_of_African_Football"}
{"title_page": "Farid Mansurov", "text_new": "{{short description|Azerbaijani Greco-Roman wrestler}}\n{{MedalTableTop|Farid Mansurov 2013.jpg|150px}}{{MedalSport | Men's [[Greco-Roman Wrestling]]}}\n{{MedalCountry | {{AZE}} }}\n{{MedalCompetition |[[Olympic Games]]}}\n{{MedalGold | [[2004 Summer Olympics|2004 Athens]] | [[Wrestling at the 2004 Summer Olympics \u2013 Men's Greco-Roman 66 kg|66&nbsp;kg]]}}\n{{MedalCompetition|[[World Wrestling Championships|World Championships]]}}\n{{MedalSilver|[[2002 World Wrestling Championships|2002 Moscow]]|66 kg}}\n{{MedalGold|[[2007 World Wrestling Championships|2007 Baku]]|[[2007 World Wrestling Championships \u2013 Men's Greco-Roman 66 kg|66&nbsp;kg]]}}\n{{MedalGold|[[2009 World Wrestling Championships|2009 Herning]] | [[2009 World Wrestling Championships \u2013 Men's Greco-Roman 66 kg|66&nbsp;kg]]}}\n{{MedalBottom}}\n\n'''Farid Mansurov''' ({{lang-az|F\u0259rid Mansurov}}) (born May 10, 1982 in [[Dmanisi]], [[Georgia (country)|Georgia]]) is an [[Azerbaijan]]i [[Wrestling|wrestler]], gold medalist of the [[2004 Summer Olympic Games]] in [[Greco-Roman wrestling]] at 66&nbsp;kg. He retired in 2010, after conceding jaw injury during 2010 European Wrestling Championship.<ref>[http://azerisport.com/wrestling/20100629055003626.html \u0424\u0430\u0440\u0438\u0434 \u041c\u0430\u043d\u0441\u0443\u0440\u043e\u0432 \u0437\u0430\u0432\u0435\u0440\u0448\u0438\u043b \u043a\u0430\u0440\u044c\u0435\u0440\u0443] {{in lang|ru}}</ref> In 2010\u20142011, he coached the Azerbaijani national wrestling team. He is the head of the sport department in The Ministry of Youth and Sport of the Republic of Azerbaijan since 2016. He is also Vice President of Youth Wrestling Federation of Azerbaijan.\n\n== Career ==\nIn 1992, he started to train under the leadership of Alikulu Hasanoglu ({{Lang-az|\u018fliqulu H\u0259s\u0259no\u011flu}}) in Neftchi Sport Society. He achieved his first success in 1997. He took 2nd place in the World Championship among juniors. However, in 1998, he was unlucky in the junior Olympics so, he heavily injured his wrist during the semi-final match with a Cuban athlete.\n\nFarid Mansurov won the first place in the men's championship of [[Azerbaijan]] in 2000. A year later, He won gold medal in the World Championship held in [[Uzbekistan]]. In 2003, he won several Grand Prix tournaments and won the license to participate in the [[Athens Olympics 2004]]. At the [[2004 Summer Olympics]], he won the Olympic Champion title in the 66&nbsp;kg on [[Greco-Roman wrestling]]. He has been unable to train because of his back injury for three years after 2004.   In 2007, he returned to the sport and won a gold medal at the World Championship which took place in [[Baku]] and get the license for [[2008 Summer Olympics]]. He was defeated due to his illness in the [[Beijing Olympic 2008]]. After this failure, in 2009, he became the World Champion for the second time.\n\nOn June 30, 2010, Farid Mansurov announced his retirement from the sport due to his injury in the last World Championship. On the same day, he was appointed as the head coach of the [[Greco-Roman wrestling]] team of [[Azerbaijan]].<ref>{{Cite news|url=https://news.day.az/sport/216802.html|script-title=ru:\u0424\u0430\u0440\u0438\u0434 \u041c\u0430\u043d\u0441\u0443\u0440\u043e\u0432 \u043e\u0444\u0438\u0446\u0438\u0430\u043b\u044c\u043d\u043e \u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u043b\u0435\u043d \u0433\u043b\u0430\u0432\u043d\u044b\u043c \u0442\u0440\u0435\u043d\u0435\u0440\u043e\u043c \u0441\u0431\u043e\u0440\u043d\u043e\u0439 \u0410\u0437\u0435\u0440\u0431\u0430\u0439\u0434\u0436\u0430\u043d\u0430 \u043f\u043e \u0433\u0440\u0435\u043a\u043e-\u0440\u0438\u043c\u0441\u043a\u043e\u0439 \u0431\u043e\u0440\u044c\u0431\u0435|date=2010-06-30|work=Day.Az|access-date=2018-11-30|language=ru-RU}}</ref>\n\n==References==\n{{reflist}}\n\n==External links==\n* [https://sports.yahoo.com/olympics/athens2004/aze/Farid+Mansurov/369996 profile]\n\n{{S-start}}\n{{s-sports|oly}}\n{{succession box\n| before = [[Nizami Pashayev]]\n| title = [[List of flag bearers for Azerbaijan at the Olympics|Flagbearer]] for {{AZE}}\n| years = [[2008 Summer Olympics|Beijing 2008]]\n| after = [[Elnur Mammadli]]\n}}\n{{S-end}}\n\n{{Olympic medalists for Azerbaijan}}\n{{Footer Olympic Champions Greco-Roman wrestling lightweight}}\n\n{{DEFAULTSORT:Mansurov, Farid}}\n[[Category:1982 births]]\n[[Category:Living people]]\n[[Category:Azerbaijani male sport wrestlers]]\n[[Category:Olympic wrestlers of Azerbaijan]]\n[[Category:Wrestlers at the 2004 Summer Olympics]]\n[[Category:Wrestlers at the 2008 Summer Olympics]]\n[[Category:Olympic gold medalists for Azerbaijan]]\n[[Category:Olympic medalists in wrestling]]\n[[Category:Georgian Azerbaijanis]]\n[[Category:People from Dmanisi]]\n[[Category:Medalists at the 2004 Summer Olympics]]\n[[Category:World Wrestling Championships medalists]]\n\n\n{{Azerbaijan-Olympic-medalist-stub}}\n{{Azerbaijan-wrestling-bio-stub}}\n", "text_old": "{{short description|Azerbaijani Greco-Roman wrestler}}\n{{MedalTableTop|Farid Mansurov 2013.jpg|150px}}{{MedalSport | Men's [[Greco-Roman Wrestling]]}}\n{{MedalCountry | {{AZE}} }}\n{{MedalCompetition |[[Olympic Games]]}}\n{{MedalGold | [[2004 Summer Olympics|2004 Athens]] | [[Wrestling at the 2004 Summer Olympics \u2013 Men's Greco-Roman 66 kg|66&nbsp;kg]]}}\n{{MedalCompetition|[[FILA Wrestling World Championships|World Championships]]}}\n{{MedalSilver|[[2002 FILA Wrestling World Championships|2002 Tehran]]|66 kg}}\n{{MedalGold|[[2007 FILA Wrestling World Championships|2007 Baku]]|66 kg}}\n{{MedalGold|[[2009 World Wrestling Championships|2009 Herning]] | [[2009 World Wrestling Championships \u2013 Men's Greco-Roman 66 kg|66&nbsp;kg]]}}\n{{MedalBottom}}\n\n'''Farid Mansurov''' ({{lang-az|F\u0259rid Mansurov}}) (born May 10, 1982 in [[Dmanisi]], [[Georgia (country)|Georgia]]) is an [[Azerbaijan]]i [[Wrestling|wrestler]], gold medalist of the [[2004 Summer Olympic Games]] in [[Greco-Roman wrestling]] at 66&nbsp;kg. He retired in 2010, after conceding jaw injury during 2010 European Wrestling Championship.<ref>[http://azerisport.com/wrestling/20100629055003626.html \u0424\u0430\u0440\u0438\u0434 \u041c\u0430\u043d\u0441\u0443\u0440\u043e\u0432 \u0437\u0430\u0432\u0435\u0440\u0448\u0438\u043b \u043a\u0430\u0440\u044c\u0435\u0440\u0443] {{in lang|ru}}</ref> In 2010\u20142011, he coached the Azerbaijani national wrestling team. He is the head of the sport department in The Ministry of Youth and Sport of the Republic of Azerbaijan since 2016. He is also Vice President of Youth Wrestling Federation of Azerbaijan.\n\n== Career ==\nIn 1992, he started to train under the leadership of Alikulu Hasanoglu ({{Lang-az|\u018fliqulu H\u0259s\u0259no\u011flu}}) in Neftchi Sport Society. He achieved his first success in 1997. He took 2nd place in the World Championship among juniors. However, in 1998, he was unlucky in the junior Olympics so, he heavily injured his wrist during the semi-final match with a Cuban athlete.\n\nFarid Mansurov won the first place in the men's championship of [[Azerbaijan]] in 2000. A year later, He won gold medal in the World Championship held in [[Uzbekistan]]. In 2003, he won several Grand Prix tournaments and won the license to participate in the [[Athens Olympics 2004]]. At the [[2004 Summer Olympics]], he won the Olympic Champion title in the 66&nbsp;kg on [[Greco-Roman wrestling]]. He has been unable to train because of his back injury for three years after 2004.   In 2007, he returned to the sport and won a gold medal at the World Championship which took place in [[Baku]] and get the license for [[2008 Summer Olympics]]. He was defeated due to his illness in the [[Beijing Olympic 2008]]. After this failure, in 2009, he became the World Champion for the second time.\n\nOn June 30, 2010, Farid Mansurov announced his retirement from the sport due to his injury in the last World Championship. On the same day, he was appointed as the head coach of the [[Greco-Roman wrestling]] team of [[Azerbaijan]].<ref>{{Cite news|url=https://news.day.az/sport/216802.html|script-title=ru:\u0424\u0430\u0440\u0438\u0434 \u041c\u0430\u043d\u0441\u0443\u0440\u043e\u0432 \u043e\u0444\u0438\u0446\u0438\u0430\u043b\u044c\u043d\u043e \u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u043b\u0435\u043d \u0433\u043b\u0430\u0432\u043d\u044b\u043c \u0442\u0440\u0435\u043d\u0435\u0440\u043e\u043c \u0441\u0431\u043e\u0440\u043d\u043e\u0439 \u0410\u0437\u0435\u0440\u0431\u0430\u0439\u0434\u0436\u0430\u043d\u0430 \u043f\u043e \u0433\u0440\u0435\u043a\u043e-\u0440\u0438\u043c\u0441\u043a\u043e\u0439 \u0431\u043e\u0440\u044c\u0431\u0435|date=2010-06-30|work=Day.Az|access-date=2018-11-30|language=ru-RU}}</ref>\n\n==References==\n{{reflist}}\n\n==External links==\n* [https://sports.yahoo.com/olympics/athens2004/aze/Farid+Mansurov/369996 profile]\n\n{{S-start}}\n{{s-sports|oly}}\n{{succession box\n| before = [[Nizami Pashayev]]\n| title = [[List of flag bearers for Azerbaijan at the Olympics|Flagbearer]] for {{AZE}}\n| years = [[2008 Summer Olympics|Beijing 2008]]\n| after = [[Elnur Mammadli]]\n}}\n{{S-end}}\n\n{{Olympic medalists for Azerbaijan}}\n{{Footer Olympic Champions Greco-Roman wrestling lightweight}}\n\n{{DEFAULTSORT:Mansurov, Farid}}\n[[Category:1982 births]]\n[[Category:Living people]]\n[[Category:Azerbaijani male sport wrestlers]]\n[[Category:Olympic wrestlers of Azerbaijan]]\n[[Category:Wrestlers at the 2004 Summer Olympics]]\n[[Category:Wrestlers at the 2008 Summer Olympics]]\n[[Category:Olympic gold medalists for Azerbaijan]]\n[[Category:Olympic medalists in wrestling]]\n[[Category:Georgian Azerbaijanis]]\n[[Category:People from Dmanisi]]\n[[Category:Medalists at the 2004 Summer Olympics]]\n[[Category:World Wrestling Championships medalists]]\n\n\n{{Azerbaijan-Olympic-medalist-stub}}\n{{Azerbaijan-wrestling-bio-stub}}\n", "name_user": "Mohsen1248", "label": "safe", "comment": "", "url_page": "//en.wikipedia.org/wiki/Farid_Mansurov"}
